Clustering O 0 0.16377156972885132
of O 0 0.046854980289936066
missense O 0 0.15488238632678986
mutations O 0 0.03573080897331238
in O 0 0.015204548835754395
the O 0 0.04348133131861687
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.03305605798959732
in O 0 0.011059061624109745
a O 0 0.02384308911859989
sporadic B-Disease 1 0.8865876793861389
T I-Disease 1 1.0
- I-Disease 1 1.0
cell I-Disease 1 0.9993170499801636
leukaemia I-Disease 1 1.0
. O 0 0.06502258777618408

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.048306893557310104
A B-Disease 1 0.9999617338180542
- I-Disease 1 1.0
T I-Disease 1 0.9999983310699463
) O 0 0.014775477349758148
is O 0 0.008647545240819454
a O 0 0.019547507166862488
recessive B-Disease 1 0.9992204904556274
multi I-Disease 1 1.0
- I-Disease 1 1.0
system I-Disease 1 0.9993240833282471
disorder I-Disease 1 1.0
caused O 1 0.9951234459877014
by O 0 0.03363257646560669
mutations O 0 0.03068382665514946
in O 0 0.012367651797831059
the O 0 0.02420121617615223
ATM O 0 0.121141217648983
gene O 0 0.030131002888083458
at O 0 0.02863556705415249
11q22 O 1 0.9997653365135193
- O 1 0.9999985694885254
q23 O 1 0.999971866607666
( O 0 0.05792241171002388
ref O 1 0.9999536275863647
. O 0 0.026191750541329384
3 O 0 0.047576528042554855
) O 0 0.03104490041732788
. O 0 0.03211153671145439

The O 0 0.04852357506752014
risk O 0 0.07211220264434814
of O 0 0.1756698489189148
cancer B-Disease 1 1.0
, O 0 0.046616584062576294
especially O 0 0.06935730576515198
lymphoid B-Disease 1 1.0
neoplasias I-Disease 1 0.9999998807907104
, O 0 0.026112189516425133
is O 0 0.016122907400131226
substantially O 0 0.03238127380609512
elevated O 1 0.7754300236701965
in O 0 0.02056506648659706
A B-Disease 1 0.9999457597732544
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999923706054688
and O 0 0.02140704169869423
has O 0 0.019274789839982986
long O 0 0.025296911597251892
been O 0 0.016238801181316376
associated O 0 0.02707759104669094
with O 0 0.044942427426576614
chromosomal O 1 1.0
instability O 1 0.9999997615814209
. O 0 0.08205936849117279

By O 0 0.05453863739967346
analysing O 0 0.3605819642543793
tumour B-Disease 1 1.0
DNA O 0 0.06627830862998962
from O 0 0.027101866900920868
patients O 0 0.05271827429533005
with O 0 0.019285719841718674
sporadic B-Disease 1 0.8213945031166077
T I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999994039535522
cell I-Disease 0 0.1428695172071457
prolymphocytic I-Disease 1 0.9999986886978149
leukaemia I-Disease 1 1.0
( O 1 0.7002959847450256
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999998807907104
) O 0 0.02555840089917183
, O 0 0.015795031562447548
a O 0 0.027001021429896355
rare O 0 0.06647446751594543
clonal B-Disease 1 0.9999983310699463
malignancy I-Disease 1 0.9999998807907104
with O 0 0.021961994469165802
similarities O 0 0.01860293373465538
to O 0 0.01259655598551035
a O 0 0.023422908037900925
mature B-Disease 0 0.1006261482834816
T I-Disease 1 1.0
- I-Disease 1 1.0
cell I-Disease 1 0.992675244808197
leukaemia I-Disease 1 1.0
seen O 0 0.026853293180465698
in O 0 0.01990942843258381
A B-Disease 1 0.9999569654464722
- I-Disease 1 1.0
T I-Disease 1 0.9999994039535522
, O 0 0.017428888007998466
we O 0 0.00861472450196743
demonstrate O 0 0.02003917656838894
a O 0 0.01778402179479599
high O 0 0.029406005516648293
frequency O 0 0.021047944203019142
of O 0 0.024551426991820335
ATM O 1 0.9882577061653137
mutations O 0 0.039293404668569565
in O 0 0.0341891385614872
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999921321868896
. O 0 0.05729782581329346

In O 0 0.03488750010728836
marked O 0 0.050192706286907196
contrast O 0 0.03382487967610359
to O 0 0.018807971850037575
the O 0 0.0323014073073864
ATM O 1 0.8900415897369385
mutation O 0 0.05224991962313652
pattern O 0 0.030126448720693588
in O 0 0.01979007013142109
A B-Disease 1 0.9998266100883484
- I-Disease 1 1.0
T I-Disease 1 0.9999994039535522
, O 0 0.01848314143717289
the O 0 0.0178095530718565
most O 0 0.02066490240395069
frequent O 0 0.05852365121245384
nucleotide O 0 0.06208731606602669
changes O 0 0.015169084072113037
in O 0 0.016697969287633896
this O 0 0.02834882028400898
leukaemia B-Disease 1 1.0
were O 0 0.043177809566259384
missense O 1 0.9437774419784546
mutations O 0 0.08796507865190506
. O 0 0.050184573978185654

These O 0 0.03085729293525219
clustered O 0 0.08407586067914963
in O 0 0.01781066320836544
the O 0 0.02175118960440159
region O 0 0.02848197892308235
corresponding O 0 0.02344580553472042
to O 0 0.01994691602885723
the O 0 0.04108959436416626
kinase O 1 0.999988317489624
domain O 0 0.051345061510801315
, O 0 0.015047766268253326
which O 0 0.008840023539960384
is O 0 0.010950029827654362
highly O 0 0.021883828565478325
conserved O 0 0.02642427384853363
in O 0 0.01895647682249546
ATM O 1 0.9997170567512512
- O 1 0.9999958276748657
related O 0 0.03473646193742752
proteins O 0 0.034109678119421005
in O 0 0.022537967190146446
mouse O 0 0.07843580842018127
, O 0 0.04030650109052658
yeast O 0 0.13371820747852325
and O 0 0.04590997099876404
Drosophila O 0 0.14216838777065277
. O 0 0.05273502320051193

The O 0 0.05742279067635536
resulting O 0 0.07883680611848831
amino O 0 0.12046820670366287
- O 1 0.999998927116394
acid O 0 0.14224913716316223
substitutions O 0 0.05678064003586769
are O 0 0.009822971187531948
predicted O 0 0.02850963920354843
to O 0 0.023598726838827133
interfere O 0 0.06559638679027557
with O 0 0.03666084259748459
ATP O 1 0.9999991655349731
binding O 0 0.06899420917034149
or O 0 0.039858076721429825
substrate O 0 0.11383972316980362
recognition O 0 0.06294982135295868
. O 0 0.042012784630060196

Two O 0 0.015461855567991734
of O 0 0.025289110839366913
seventeen O 0 0.09907951951026917
mutated O 1 0.9946991205215454
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
PLL I-Disease 1 0.9999860525131226
samples O 0 0.02922739088535309
had O 0 0.01144053041934967
a O 0 0.0138462008908391
previously O 0 0.015468236990272999
reported O 0 0.026727324351668358
A B-Disease 1 0.9975804090499878
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
allele O 0 0.13475631177425385
. O 0 0.0443299300968647

In O 0 0.04369504749774933
contrast O 0 0.05616358667612076
, O 0 0.030157526955008507
no O 0 0.024176381528377533
mutations O 0 0.030790871009230614
were O 0 0.011740130372345448
detected O 0 0.027718234807252884
in O 0 0.01393422856926918
the O 0 0.036855489015579224
p53 O 1 0.9970449805259705
gene O 0 0.03829723596572876
, O 0 0.015067927539348602
suggesting O 0 0.019573885947465897
that O 0 0.011139379814267159
this O 0 0.03248029947280884
tumour B-Disease 1 1.0
suppressor O 1 1.0
is O 0 0.029804527759552002
not O 0 0.011906133033335209
frequently O 0 0.01871507428586483
altered O 0 0.029385216534137726
in O 0 0.01921854354441166
this O 0 0.034102436155080795
leukaemia B-Disease 1 1.0
. O 0 0.07183454185724258

Occasional O 0 0.17744407057762146
missense O 1 0.7487211227416992
mutations O 0 0.07028160989284515
in O 0 0.03279387578368187
ATM O 1 0.6406857967376709
were O 0 0.011220765300095081
also O 0 0.012007147073745728
found O 0 0.01338566280901432
in O 0 0.02756337821483612
tumour B-Disease 1 1.0
DNA O 0 0.04643122851848602
from O 0 0.021572057157754898
patients O 0 0.05258924886584282
with O 0 0.02372617833316326
B B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999982118606567
cell I-Disease 0 0.05549441650509834
non I-Disease 1 0.8751028180122375
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.0776631161570549
B B-Disease 1 0.9999998807907104
- I-Disease 1 0.999997615814209
NHL I-Disease 0 0.07566791027784348
) O 0 0.01429097168147564
and O 0 0.010285717435181141
a O 0 0.033506423234939575
B B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999994039535522
NHL I-Disease 1 0.9013952016830444
cell O 0 0.07602133601903915
line O 0 0.057926345616579056
. O 0 0.035002127289772034

The O 0 0.03422846645116806
evidence O 0 0.016720641404390335
of O 0 0.015752730891108513
a O 0 0.01846299134194851
significant O 0 0.01218720804899931
proportion O 0 0.021063711494207382
of O 0 0.017562702298164368
loss O 0 0.17233261466026306
- O 1 0.9999996423721313
of O 0 0.04824719950556755
- O 1 1.0
function O 0 0.04707302525639534
mutations O 0 0.03374047949910164
and O 0 0.014203778468072414
a O 0 0.02310115098953247
complete O 0 0.0331081785261631
absence O 0 0.04332921653985977
of O 0 0.02251213788986206
the O 0 0.02717163972556591
normal O 0 0.03275549039244652
copy O 0 0.04271085932850838
of O 0 0.02732149511575699
ATM O 0 0.07969646155834198
in O 0 0.01139035727828741
the O 0 0.013411972671747208
majority O 0 0.02069973759353161
of O 0 0.034902557730674744
mutated O 1 0.9965783953666687
tumours B-Disease 1 1.0
establishes O 1 0.9999926090240479
somatic O 1 0.9999574422836304
inactivation O 1 0.9999934434890747
of O 0 0.029867535457015038
this O 0 0.015238872729241848
gene O 0 0.019176693633198738
in O 0 0.009171082638204098
the O 0 0.02252478525042534
pathogenesis O 1 0.9999886751174927
of O 0 0.03556504845619202
sporadic B-Disease 1 0.9999927282333374
T I-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999996423721313
and O 0 0.025734879076480865
suggests O 0 0.025260237976908684
that O 0 0.012386991642415524
ATM O 0 0.0811954066157341
acts O 0 0.02932734787464142
as O 0 0.026003040373325348
a O 0 0.12921488285064697
tumour B-Disease 1 1.0
suppressor O 1 1.0
. O 0 0.06687240302562714

As O 0 0.05079398676753044
constitutional O 0 0.07240237295627594
DNA O 0 0.05099834129214287
was O 0 0.02934165671467781
not O 0 0.010585795156657696
available O 0 0.009946038946509361
, O 0 0.012847263365983963
a O 0 0.028601672500371933
putative O 1 0.9437236189842224
hereditary O 1 0.9999998807907104
predisposition O 1 0.9999998807907104
to O 1 0.8548014163970947
T B-Disease 1 1.0
- I-Disease 1 1.0
PLL I-Disease 1 0.9999957084655762
will O 0 0.023590099066495895
require O 0 0.01787538081407547
further O 0 0.021774033084511757
investigation O 0 0.0439455471932888
. O 0 0.024860333651304245
. O 0 0.03681308776140213

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9999977350234985
kinase O 1 0.9999599456787109
is O 0 0.02109680138528347
involved O 0 0.012659572064876556
in O 0 0.009813977405428886
the O 0 0.01764402538537979
modulation O 0 0.04448883980512619
of O 0 0.019657419994473457
the O 0 0.039891958236694336
Ca2 O 1 0.9999994039535522
+ O 1 0.999836802482605
homeostasis O 1 0.9999339580535889
in O 0 0.058050986379384995
skeletal O 1 1.0
muscle O 1 1.0
cells O 1 0.8027482032775879
. O 0 0.05372602120041847

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.028209630399942398
, O 0 0.011454776860773563
the O 0 0.01358849462121725
most O 0 0.021098928526043892
prevalent O 1 0.9999954700469971
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.854402482509613
adults O 0 0.4584742486476898
, O 0 0.023986170068383217
is O 0 0.018594849854707718
caused O 0 0.03273104131221771
by O 0 0.02293451875448227
( O 0 0.041045788675546646
CTG O 1 0.9999997615814209
) O 0 0.035460636019706726
n O 0 0.10549189150333405
- O 1 0.9966962337493896
repeat O 0 0.06211124733090401
expansion O 0 0.032323114573955536
in O 0 0.011434653773903847
a O 0 0.020307954400777817
gene O 0 0.023862412199378014
encoding O 0 0.023444082587957382
a O 0 0.031752604991197586
protein O 0 0.06456688791513443
kinase O 1 0.9882087707519531
( O 0 0.08115799725055695
DM B-Disease 1 1.0
protein O 0 0.2181457132101059
kinase O 1 0.9993243217468262
; O 0 0.04844139888882637
DMPK O 1 0.9999892711639404
) O 0 0.027429917827248573
and O 0 0.018564218655228615
involves O 0 0.028172574937343597
changes O 0 0.015613292343914509
in O 0 0.024052221328020096
cytoarchitecture O 1 0.9999622106552124
and O 0 0.05752028524875641
ion O 1 0.9999849796295166
homeostasis O 1 0.9998917579650879
. O 0 0.05603662505745888

To O 0 0.05498354136943817
obtain O 0 0.045481275767087936
clues O 0 0.037888746708631516
to O 0 0.01714135706424713
the O 0 0.02063506655395031
normal O 0 0.030024435371160507
biological O 0 0.029589688405394554
role O 0 0.03487417474389076
of O 0 0.03350966051220894
DMPK O 1 0.9999964237213135
in O 0 0.042880039662122726
cellular O 1 0.9985067248344421
ion O 1 0.99998939037323
homeostasis O 1 0.9998465776443481
, O 0 0.024436557665467262
we O 0 0.008951997384428978
have O 0 0.0053918687626719475
compared O 0 0.013520695269107819
the O 0 0.029569171369075775
resting O 1 0.9999791383743286
[ O 1 0.9983344674110413
Ca2 O 1 1.0
+ O 1 0.9999436140060425
] O 0 0.08173247426748276
i O 0 0.02614913135766983
, O 0 0.014621865935623646
the O 0 0.01937178149819374
amplitude O 0 0.04737880453467369
and O 0 0.013937486335635185
shape O 0 0.028423670679330826
of O 0 0.032482706010341644
depolarization O 1 0.9999998807907104
- O 1 1.0
induced O 1 1.0
Ca2 O 1 1.0
+ O 1 0.9999765157699585
transients O 1 0.9980142116546631
, O 0 0.019757185131311417
and O 0 0.010655862279236317
the O 0 0.01306018978357315
content O 0 0.013144916854798794
of O 0 0.02180013805627823
ATP O 1 0.9999997615814209
- O 1 0.9999955892562866
driven O 0 0.07449157536029816
ion O 0 0.14123763144016266
pumps O 0 0.08303062617778778
in O 0 0.027467619627714157
cultured O 1 0.9998251795768738
skeletal O 1 1.0
muscle O 1 0.999977707862854
cells O 0 0.047761477530002594
of O 0 0.02591211162507534
wild O 0 0.05261293798685074
- O 1 0.9999912977218628
type O 0 0.03446615859866142
and O 0 0.019910510629415512
DMPK O 1 0.9999992847442627
[ O 1 0.9269396066665649
- O 1 1.0
/ O 1 0.9999996423721313
- O 1 0.9999997615814209
] O 0 0.13021613657474518
knockout O 1 0.9952557682991028
mice O 0 0.08950738608837128
. O 0 0.04642290249466896

In O 0 0.034567754715681076
vitro O 0 0.21980243921279907
- O 1 0.9995183944702148
differentiated O 0 0.12186581641435623
DMPK O 1 0.9999951124191284
[ O 1 0.8364937901496887
- O 1 1.0
/ O 1 0.9999986886978149
- O 1 0.9999983310699463
] O 0 0.0823589637875557
myotubes O 0 0.20153744518756866
exhibit O 0 0.0461968295276165
a O 0 0.02434631437063217
higher O 0 0.03465213626623154
resting O 1 0.9999743700027466
[ O 1 0.9963975548744202
Ca2 O 1 0.9999998807907104
+ O 1 0.999815046787262
] O 0 0.07407636195421219
i O 0 0.022363826632499695
than O 0 0.009369896724820137
do O 0 0.01235745195299387
wild O 0 0.04769207537174225
- O 1 0.9999990463256836
type O 0 0.087222620844841
myotubes O 1 0.9995244741439819
because O 0 0.01710151694715023
of O 0 0.017826398834586143
an O 0 0.02066257782280445
altered O 0 0.028840212151408195
open O 0 0.02393505722284317
probability O 0 0.01747211068868637
of O 0 0.019421501085162163
voltage O 0 0.09256289899349213
- O 1 0.9998815059661865
dependent O 0 0.06428341567516327
l O 1 0.9913286566734314
- O 1 0.9999986886978149
type O 1 0.5243968963623047
Ca2 O 1 0.9999963045120239
+ O 1 0.9180358648300171
and O 0 0.0540204755961895
Na O 1 0.9999998807907104
+ O 0 0.3215157389640808
channels O 0 0.046473678201436996
. O 0 0.034167610108852386

The O 0 0.07194101810455322
mutant O 1 0.7252305150032043
myotubes O 1 0.998752236366272
exhibit O 0 0.07633263617753983
smaller O 0 0.030571237206459045
and O 0 0.02815178781747818
slower O 0 0.09506082534790039
Ca2 O 1 0.9999972581863403
+ O 0 0.3517187237739563
responses O 0 0.03474393114447594
upon O 0 0.030028700828552246
triggering O 0 0.08237021416425705
by O 0 0.036865346133708954
acetylcholine O 1 0.999299168586731
or O 0 0.038156215101480484
high O 0 0.1759604960680008
external O 0 0.4239109754562378
K O 1 0.9999728202819824
+ O 0 0.3404618799686432
. O 0 0.045191679149866104

In O 0 0.04120837524533272
addition O 0 0.03325193375349045
, O 0 0.01887010969221592
we O 0 0.010620160028338432
observed O 0 0.014922874979674816
that O 0 0.010039436630904675
these O 0 0.018662909045815468
Ca2 O 1 0.9999991655349731
+ O 1 0.9998952150344849
transients O 1 0.9994761347770691
partially O 0 0.08228130638599396
result O 0 0.018773840740323067
from O 0 0.013606863096356392
an O 0 0.016746900975704193
influx O 0 0.06481640040874481
of O 0 0.04567887261509895
extracellular O 1 0.9999769926071167
Ca2 O 1 0.9999908208847046
+ O 0 0.08605673164129257
through O 0 0.015515639446675777
the O 0 0.028336461633443832
l O 1 0.9994309544563293
- O 1 0.9999997615814209
type O 1 0.9917922019958496
Ca2 O 1 0.9999984502792358
+ O 1 0.7007058262825012
channel O 0 0.07421267777681351
. O 0 0.0370955727994442

Neither O 0 0.06805617362260818
the O 0 0.03381640836596489
content O 0 0.023261668160557747
nor O 0 0.02092585153877735
the O 0 0.012748380191624165
activity O 0 0.020359953865408897
of O 0 0.03321761265397072
Na O 1 1.0
+ O 1 0.9999352693557739
/ O 1 0.9999837875366211
K O 1 0.9999021291732788
+ O 1 0.9957492351531982
ATPase O 1 0.9985654950141907
and O 0 0.04274073615670204
sarcoplasmic O 1 0.9999988079071045
reticulum O 1 0.9999997615814209
Ca2 O 1 1.0
+ O 1 0.9999990463256836
- O 1 1.0
ATPase O 1 0.9998078942298889
are O 0 0.01111853588372469
affected O 0 0.02936255931854248
by O 0 0.03293278440833092
DMPK O 1 0.9999964237213135
absence O 0 0.3315773904323578
. O 0 0.054920900613069534

In O 0 0.0398341566324234
conclusion O 0 0.04821152612566948
, O 0 0.025930460542440414
our O 0 0.023514246568083763
data O 0 0.014244898222386837
suggest O 0 0.01907683163881302
that O 0 0.015429171733558178
DMPK O 1 0.9999029636383057
is O 0 0.02259148098528385
involved O 0 0.019612785428762436
in O 0 0.021681003272533417
modulating O 1 0.8968528509140015
the O 0 0.023363683372735977
initial O 0 0.02373877540230751
events O 0 0.012086735107004642
of O 0 0.024514196440577507
excitation O 1 0.9996395111083984
- O 1 1.0
contraction O 1 0.9983367919921875
coupling O 1 0.6122288107872009
in O 0 0.055059995502233505
skeletal O 1 1.0
muscle O 1 0.9999995231628418
. O 0 0.03995797410607338
. O 0 0.04267843812704086

Constitutional O 0 0.15992558002471924
RB1 O 1 1.0
- O 1 1.0
gene O 0 0.07596909254789352
mutations O 0 0.041398752480745316
in O 0 0.02462080307304859
patients O 1 0.9424265027046204
with O 0 0.033023469150066376
isolated O 1 0.9968360662460327
unilateral B-Disease 1 0.9999641180038452
retinoblastoma I-Disease 1 1.0
. O 0 0.07512830942869186

In O 0 0.031157933175563812
most O 0 0.03014306165277958
patients O 0 0.0724276751279831
with O 0 0.023884447291493416
isolated O 1 0.9036835432052612
unilateral B-Disease 1 0.9999758005142212
retinoblastoma I-Disease 1 1.0
, O 1 0.9987751841545105
tumor B-Disease 1 1.0
development O 0 0.045047271996736526
is O 0 0.022387055680155754
initiated O 0 0.06344591081142426
by O 0 0.030942104756832123
somatic O 1 0.9842599034309387
inactivation O 1 0.9997966885566711
of O 0 0.027200328186154366
both O 0 0.021447716280817986
alleles O 0 0.05478616803884506
of O 0 0.029829716309905052
the O 0 0.0684792548418045
RB1 O 1 1.0
gene O 0 0.08564537018537521
. O 0 0.04186452180147171

However O 0 0.02938641421496868
, O 0 0.016231605783104897
some O 0 0.00956621952354908
of O 0 0.02136440947651863
these O 0 0.02126198634505272
patients O 1 0.9975357055664062
can O 0 0.04131859540939331
transmit O 1 0.9836993217468262
retinoblastoma B-Disease 1 1.0
predisposition O 1 0.9999986886978149
to O 0 0.043222248554229736
their O 0 0.03378038853406906
offspring O 0 0.09781070798635483
. O 0 0.04227815195918083

To O 0 0.04357157647609711
determine O 0 0.02763066068291664
the O 0 0.02653118595480919
frequency O 0 0.027012033388018608
and O 0 0.013085125014185905
nature O 0 0.01762061007320881
of O 0 0.018541567027568817
constitutional O 0 0.08028598874807358
RB1 O 1 1.0
- O 1 1.0
gene O 0 0.05653417482972145
mutations O 0 0.03347163274884224
in O 0 0.020616911351680756
patients O 1 0.5794477462768555
with O 0 0.02681628055870533
isolated O 1 0.998526930809021
unilateral B-Disease 1 0.9999972581863403
retinoblastoma I-Disease 1 1.0
, O 0 0.028912372887134552
we O 0 0.01119703147560358
analyzed O 0 0.02307017892599106
DNA O 0 0.028250543400645256
from O 0 0.02931957133114338
peripheral O 1 0.9999961853027344
blood O 1 0.9978781938552856
and O 0 0.03902525454759598
from O 1 0.8324712514877319
tumor B-Disease 1 1.0
tissue O 1 0.999994158744812
. O 0 0.06125672906637192

The O 0 0.04541740566492081
analysis O 0 0.028636787086725235
of O 0 0.05073743686079979
tumors B-Disease 1 0.9999997615814209
from O 0 0.04437597095966339
54 O 0 0.08873189240694046
( O 0 0.04039038345217705
71 O 0 0.07403790205717087
% O 0 0.027124350890517235
) O 0 0.017657823860645294
of O 0 0.023317396640777588
76 O 0 0.10837975889444351
informative O 0 0.1131892129778862
patients O 1 0.5123917460441589
showed O 0 0.02774529904127121
loss O 0 0.03162079676985741
of O 0 0.026173526421189308
constitutional O 0 0.07725003361701965
heterozygosity O 1 0.9999994039535522
( O 0 0.26081547141075134
LOH O 1 1.0
) O 0 0.04768478870391846
at O 0 0.05467237904667854
intragenic O 1 0.9999293088912964
loci O 0 0.14702928066253662
. O 0 0.046544089913368225

Three O 0 0.02677500993013382
of O 0 0.03746846318244934
13 O 0 0.08818977326154709
uninformative O 1 0.9999938011169434
patients O 1 0.9989331364631653
had O 0 0.05135330557823181
constitutional O 0 0.0952211245894432
deletions O 0 0.1427476406097412
. O 0 0.05009351298213005

For O 0 0.029742544516921043
39 O 0 0.04919078201055527
randomly O 0 0.034852076321840286
selected O 0 0.05650819092988968
tumors B-Disease 1 0.9999991655349731
, O 0 0.040172141045331955
SSCP O 1 0.9999991655349731
, O 0 0.04816571623086929
hetero O 1 1.0
- O 1 1.0
duplex O 1 0.999976634979248
analysis O 0 0.029109589755535126
, O 0 0.024570517241954803
sequencing O 0 0.04269585758447647
, O 0 0.021019460633397102
and O 0 0.019449792802333832
Southern O 0 0.07429778575897217
blot O 1 0.9977777600288391
analysis O 0 0.023029828444123268
were O 0 0.010548478923738003
used O 0 0.014896542765200138
to O 0 0.026466278359293938
identify O 0 0.053903575986623764
mutations O 0 0.06089918315410614
. O 0 0.04576859623193741

Mutations O 0 0.0801398903131485
were O 0 0.019638076424598694
detected O 0 0.04460466653108597
in O 0 0.019899830222129822
21 O 0 0.04447875916957855
( O 0 0.03030700795352459
91 O 0 0.0734473392367363
% O 0 0.023989951238036156
) O 0 0.017677204683423042
of O 0 0.02537502348423004
23 O 0 0.09703192859888077
tumors B-Disease 1 1.0
with O 0 0.2140464037656784
LOH O 1 1.0
. O 0 0.07731959223747253

In O 0 0.042279426008462906
6 O 0 0.062340956181287766
( O 0 0.030730925500392914
38 O 0 0.04122132062911987
% O 0 0.021982818841934204
) O 0 0.0161806158721447
of O 0 0.023261135444045067
16 O 0 0.07058433443307877
tumors B-Disease 1 1.0
without O 0 0.051867518573999405
LOH O 1 1.0
, O 0 0.03361582010984421
one O 0 0.027058769017457962
mutation O 0 0.05745628848671913
was O 0 0.0377889908850193
detected O 0 0.042110491544008255
, O 0 0.0174341332167387
and O 0 0.013413631357252598
in O 0 0.016964858397841454
9 O 0 0.040710482746362686
( O 0 0.02535330131649971
56 O 0 0.04603535681962967
% O 0 0.0198515634983778
) O 0 0.014008394442498684
of O 0 0.02068996988236904
the O 0 0.0487813875079155
tumors B-Disease 1 1.0
without O 0 0.11951518803834915
LOH O 1 1.0
, O 0 0.04182892665266991
both O 0 0.0285330880433321
mutations O 0 0.042907580733299255
were O 0 0.01610400155186653
found O 0 0.024360526353120804
. O 0 0.03728387877345085

Thus O 0 0.043051887303590775
, O 0 0.01943895034492016
a O 0 0.01687328703701496
total O 0 0.015029394999146461
of O 0 0.023106660693883896
45 O 0 0.04098602384328842
mutations O 0 0.033361442387104034
were O 0 0.009831154718995094
identified O 0 0.024967797100543976
in O 0 0.029224328696727753
tumors B-Disease 1 0.9999998807907104
of O 0 0.05373892933130264
36 O 1 0.7572503685951233
patients O 1 0.999958872795105
. O 0 0.057668741792440414

Thirty O 0 0.11113293468952179
- O 0 0.1736362874507904
nine O 0 0.01864715851843357
of O 0 0.018680252134799957
the O 0 0.029159484431147575
mutations O 0 0.05752825736999512
- O 1 0.99826979637146
including O 0 0.01647043041884899
34 O 0 0.038387980312108994
small O 0 0.02868063747882843
mutations O 0 0.0373917780816555
, O 0 0.020085297524929047
2 O 0 0.03924994170665741
large O 0 0.031495433300733566
structural O 1 0.503868043422699
alterations O 0 0.08113705366849899
, O 0 0.023788021877408028
and O 0 0.02646089345216751
hypermethylation O 1 0.9999911785125732
in O 0 0.038439951837062836
3 O 1 0.9908326268196106
tumors O 1 1.0
- O 1 0.9999939203262329
were O 0 0.015358129516243935
not O 0 0.011300479993224144
detected O 0 0.025348244234919548
in O 0 0.01235328707844019
the O 0 0.02660742960870266
corresponding O 0 0.08189745247364044
peripheral O 1 0.9999998807907104
blood O 1 0.9997071623802185
DNA O 0 0.0894542932510376
. O 0 0.048909418284893036

In O 0 0.04658769071102142
6 O 0 0.06843018531799316
( O 0 0.03661832585930824
17 O 0 0.03866998478770256
% O 0 0.02364286780357361
) O 0 0.0150963319465518
of O 0 0.014450541697442532
the O 0 0.025311041623353958
36 O 0 0.0587962307035923
patients O 1 0.9281947016716003
, O 0 0.02739643305540085
a O 0 0.039617735892534256
mutation O 0 0.060550324618816376
was O 0 0.03553464636206627
detected O 0 0.03622548654675484
in O 0 0.014192231930792332
constitutional O 0 0.0477137453854084
DNA O 0 0.039758455008268356
, O 0 0.01616775244474411
and O 0 0.013315396383404732
1 O 0 0.029771838337183
of O 0 0.020894654095172882
these O 0 0.01513744331896305
mutations O 0 0.04391391947865486
is O 0 0.020774638280272484
known O 0 0.028591936454176903
to O 0 0.018662050366401672
be O 0 0.013740957714617252
associated O 0 0.021609948948025703
with O 0 0.023088853806257248
reduced O 0 0.0829840898513794
expressivity O 1 0.9999830722808838
. O 0 0.06627040356397629

The O 0 0.042756710201501846
presence O 0 0.03546900302171707
of O 0 0.023149743676185608
a O 0 0.03564102575182915
constitutional O 0 0.06963088363409042
mutation O 0 0.06905493885278702
was O 0 0.031091783195734024
not O 0 0.011911610141396523
associated O 0 0.015718795359134674
with O 0 0.011393401771783829
an O 0 0.015756014734506607
early O 0 0.03236548230051994
age O 0 0.04442606866359711
at O 0 0.06450603157281876
treatment O 1 0.9999973773956299
. O 0 0.05664360523223877

In O 0 0.039230793714523315
1 O 0 0.0798632875084877
patient O 1 0.9995617270469666
, O 0 0.05103239417076111
somatic O 1 0.9998478889465332
mosaicism O 1 0.9999871253967285
was O 0 0.053008973598480225
demonstrated O 0 0.039686862379312515
by O 0 0.02169547602534294
molecular O 0 0.035998061299324036
analysis O 0 0.012155326083302498
of O 0 0.019584162160754204
DNA O 0 0.03678469732403755
and O 0 0.027328230440616608
RNA O 0 0.10211270302534103
from O 0 0.05611466243863106
peripheral O 1 0.9999954700469971
blood O 1 0.9950510859489441
. O 0 0.06231730058789253

In O 0 0.0443979874253273
2 O 0 0.0689600333571434
patients O 0 0.07391513884067535
without O 0 0.017435269430279732
a O 0 0.03691421449184418
detectable O 1 0.8304198980331421
mutation O 0 0.073654405772686
in O 0 0.04084281623363495
peripheral O 1 1.0
blood O 1 0.9999932050704956
, O 0 0.0544058196246624
mosaicism O 1 0.9999988079071045
was O 0 0.03890710324048996
suggested O 0 0.022450586780905724
because O 0 0.011081081815063953
1 O 0 0.01991855911910534
of O 0 0.014402051456272602
the O 0 0.02997606247663498
patients O 1 0.9999254941940308
showed O 1 0.999090313911438
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.033794764429330826
the O 0 0.02744888886809349
other O 0 0.01602860540151596
later O 0 0.03262358531355858
developed O 0 0.048751987516880035
bilateral B-Disease 0 0.37101778388023376
retinoblastoma I-Disease 1 0.9999998807907104
. O 0 0.06929381191730499

In O 0 0.04117115959525108
conclusion O 0 0.046585336327552795
, O 0 0.024822283536195755
our O 0 0.023017901927232742
results O 0 0.017142869532108307
emphasize O 0 0.03981902822852135
that O 0 0.009487837553024292
the O 0 0.028398601338267326
manifestation O 1 0.9998576641082764
and O 0 0.043494902551174164
transmissibility O 1 0.9999977350234985
of O 0 0.08582214266061783
retinoblastoma B-Disease 1 1.0
depend O 0 0.03471698239445686
on O 0 0.01754019781947136
the O 0 0.018186841160058975
nature O 0 0.018008247017860413
of O 0 0.014387689530849457
the O 0 0.020359786227345467
first O 0 0.03307860344648361
mutation O 0 0.04300513118505478
, O 0 0.01427687332034111
its O 0 0.014185323379933834
time O 0 0.014623569324612617
in O 0 0.014597010798752308
development O 0 0.025211995467543602
, O 0 0.017089875414967537
and O 0 0.01241466123610735
the O 0 0.01568777486681938
number O 0 0.014083648100495338
and O 0 0.016811946406960487
types O 0 0.02460671402513981
of O 0 0.036699190735816956
cells O 0 0.055351048707962036
that O 0 0.015543589368462563
are O 0 0.012733468785881996
affected O 0 0.036447182297706604
. O 0 0.027109531685709953
. O 0 0.03922542929649353

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.0679960623383522
the I-Disease 0 0.046702563762664795
fifth I-Disease 1 0.9990435242652893
component I-Disease 0 0.12135092914104462
of I-Disease 0 0.028109868988394737
complement I-Disease 0 0.06372480094432831
in O 0 0.02630271203815937
man O 0 0.0731169581413269
. O 0 0.04054120182991028

I O 0 0.13088826835155487
. O 0 0.05959905683994293

Clinical O 1 0.9991076588630676
, O 0 0.05630367249250412
immunochemical O 1 0.9999890327453613
, O 0 0.03612732142210007
and O 0 0.028714338317513466
family O 0 0.05485371872782707
studies O 0 0.036024414002895355
. O 0 0.035702675580978394

The O 0 0.033228710293769836
first O 0 0.027069291099905968
recognized O 0 0.037462759763002396
human O 0 0.03844670578837395
kindred O 1 0.9999972581863403
with O 0 0.05498714745044708
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.07218562066555023
the I-Disease 0 0.03513104096055031
fifth I-Disease 1 0.9949092268943787
component I-Disease 0 0.05139436572790146
of I-Disease 0 0.028800206258893013
complement I-Disease 1 0.9939583539962769
( O 0 0.4547084867954254
C5 O 1 1.0
) O 0 0.03232328221201897
is O 0 0.023551369085907936
described O 0 0.04638015851378441
. O 0 0.03676291182637215

The O 0 0.05989808961749077
proband O 1 0.992474377155304
, O 0 0.020258590579032898
a O 0 0.020773690193891525
20 O 0 0.027996469289064407
- O 1 0.9978777170181274
year O 0 0.022051392123103142
- O 1 0.9706004858016968
old O 0 0.04752666875720024
black O 0 0.05234890803694725
female O 0 0.05930838733911514
with O 0 0.14255204796791077
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999841451644897
age O 0 0.4395422637462616
11 O 0 0.03549708053469658
, O 0 0.02589314989745617
lacked O 0 0.15642103552818298
serum O 1 1.0
hemolytic O 1 1.0
complement O 1 0.9994483590126038
activity O 0 0.05239534378051758
, O 0 0.023039862513542175
even O 0 0.021928055211901665
during O 0 0.05122317373752594
remission O 1 0.9999994039535522
. O 0 0.0619463287293911

C5 O 1 0.9999991655349731
was O 0 0.08874905854463577
undetectable O 1 0.9996509552001953
in O 0 0.029763810336589813
her O 0 0.06344563513994217
serum O 1 0.9997689127922058
by O 0 0.024746734648942947
both O 0 0.028198396787047386
immunodiffusion O 1 0.9999628067016602
and O 0 0.08354344964027405
hemolytic O 1 1.0
assays O 1 0.6799494028091431
. O 0 0.0635947734117508

Other O 0 0.042863860726356506
complement O 0 0.08377877622842789
components O 0 0.033615242689847946
were O 0 0.010722706094384193
normal O 0 0.024358147755265236
during O 0 0.03542685881257057
remission O 1 0.9999997615814209
of O 1 0.9983831644058228
lupus O 1 1.0
, O 0 0.0455075278878212
but O 0 0.03217804431915283
C1 O 1 1.0
, O 0 0.04365114867687225
C4 O 1 0.9999998807907104
, O 0 0.0411674790084362
C2 O 1 1.0
, O 0 0.03006647154688835
and O 0 0.03833828493952751
C3 O 1 1.0
levels O 0 0.06171111762523651
fell O 1 0.6485344767570496
during O 0 0.08822987228631973
exacerbations O 1 0.9999998807907104
. O 0 0.06630188226699829

A O 0 0.06251178681850433
younger O 0 0.062306325882673264
half O 0 0.046251289546489716
- O 1 0.9999998807907104
sister O 0 0.14431840181350708
, O 0 0.0176098495721817
who O 0 0.02100219763815403
had O 0 0.019979124888777733
no O 0 0.03230709955096245
underlying O 1 0.9999978542327881
disease O 1 1.0
, O 0 0.04249478876590729
was O 0 0.03681424632668495
also O 0 0.013970686122775078
found O 0 0.010924670845270157
to O 0 0.017800627276301384
lack O 0 0.05513789504766464
immunochemically O 1 0.9999994039535522
detectable O 1 0.999996542930603
C5 O 1 0.9999998807907104
. O 0 0.0630161464214325

By O 0 0.09676425158977509
hemolytic O 1 1.0
assay O 1 0.9996819496154785
, O 0 0.035725537687540054
she O 0 0.02759612910449505
exhibited O 0 0.04870914667844772
1 O 0 0.06777171790599823
- O 1 0.9998674392700195
2 O 0 0.02890167199075222
% O 0 0.01064553763717413
of O 0 0.01340163592249155
the O 0 0.027238667011260986
normal O 0 0.07097356021404266
serum O 1 0.9999998807907104
C5 O 1 1.0
level O 0 0.05240578204393387
and O 0 0.024463217705488205
normal O 0 0.039204034954309464
concentrations O 0 0.06158805638551712
of O 0 0.025948157534003258
other O 0 0.024483060464262962
complement O 0 0.09112326055765152
components O 0 0.060949113219976425
. O 0 0.038607001304626465

C5 O 1 0.9999992847442627
levels O 0 0.05232762172818184
of O 0 0.026359105482697487
other O 0 0.018134241923689842
family O 0 0.03486660122871399
members O 0 0.0200391486287117
were O 0 0.012328295037150383
either O 0 0.02089104615151882
normal O 0 0.0289718396961689
or O 0 0.016404202207922935
approximately O 0 0.018825042992830276
half O 0 0.03936786949634552
- O 1 0.9999823570251465
normal O 0 0.03997224569320679
, O 0 0.019895413890480995
consistent O 0 0.034933555871248245
with O 0 0.028051070868968964
autosomal O 1 0.9986280202865601
codominant O 1 0.9998856782913208
inheritance O 0 0.06479030102491379
of O 0 0.023474613204598427
the O 0 0.0340786911547184
gene O 0 0.06541753560304642
determining O 1 0.9656557440757751
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.10330960899591446

Normal O 1 0.5505071878433228
hemolytic O 1 1.0
titers O 1 0.9999585151672363
were O 0 0.024075189605355263
restored O 0 0.05701299384236336
to O 0 0.015184455551207066
both O 0 0.01751876436173916
homozygous O 0 0.3147004246711731
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 0.08140386641025543
C5D B-Disease 1 1.0
) O 0 0.04452613741159439
sera O 1 0.8952537178993225
by O 0 0.01597226969897747
addition O 0 0.015381994657218456
of O 0 0.023922352120280266
highly O 0 0.07637909054756165
purified O 1 0.9999266862869263
human O 0 0.09497357904911041
C5 O 1 0.9999997615814209
. O 0 0.063013955950737

In O 0 0.047013528645038605
specific O 0 0.056981008499860764
C5 O 1 1.0
titrations O 1 0.9999725818634033
, O 0 0.03563313186168671
however O 0 0.018413325771689415
, O 0 0.017461396753787994
it O 0 0.011106709949672222
was O 0 0.024344932287931442
noted O 0 0.019460754469037056
that O 0 0.00983637385070324
when O 0 0.017523853108286858
limited O 0 0.019847974181175232
amounts O 0 0.021936997771263123
of O 0 0.043576497584581375
C5 O 1 0.9999990463256836
were O 0 0.022666657343506813
assayed O 0 0.07370874285697937
in O 0 0.013456662185490131
the O 0 0.017163608223199844
presence O 0 0.028103752061724663
of O 0 0.02440335601568222
low O 0 0.06511658430099487
dilutions O 1 0.9986529350280762
of O 0 0.041256025433540344
either O 0 0.06132819876074791
C5D B-Disease 1 1.0
serum O 1 0.9999995231628418
, O 0 0.04214605316519737
curving O 0 0.13813599944114685
rather O 0 0.01658680848777294
than O 0 0.013714189641177654
linear O 0 0.06507427990436554
dose O 1 0.9999904632568359
- O 1 0.9999986886978149
response O 0 0.05126817524433136
plots O 0 0.04345571622252464
were O 0 0.011466202326118946
consistently O 0 0.03416700288653374
obtained O 0 0.022689862176775932
, O 0 0.02053496055305004
suggesting O 0 0.032587431371212006
some O 0 0.020704619586467743
inhibitory O 0 0.13886432349681854
effect O 0 0.05161593109369278
. O 0 0.03956081345677376

Further O 0 0.0499439500272274
studies O 0 0.024908408522605896
suggested O 0 0.020769063383340836
that O 0 0.010804209858179092
low O 0 0.04916214197874069
dilutions O 1 0.9910382032394409
of O 0 0.0618562251329422
C5D B-Disease 1 1.0
serum O 1 0.9999985694885254
contain O 0 0.04752713814377785
a O 0 0.04541879892349243
factor O 1 0.5679203867912292
( O 0 0.0361776165664196
or O 0 0.029641365632414818
factors O 0 0.0312945581972599
) O 0 0.029524529352784157
interfering O 0 0.054821304976940155
at O 0 0.020783953368663788
some O 0 0.008824903517961502
step O 0 0.023948198184370995
in O 0 0.013292648829519749
the O 0 0.03934347629547119
hemolytic O 1 1.0
assay O 1 0.9999843835830688
of O 1 0.5918354988098145
C5 O 1 1.0
, O 0 0.023960763588547707
rather O 0 0.010343956761062145
than O 0 0.0074290866032242775
a O 0 0.026871761307120323
true O 0 0.07625840604305267
C5 O 1 1.0
inhibitor O 1 0.9999992847442627
or O 0 0.07059747725725174
inactivator O 1 0.9986152648925781
. O 0 0.055795129388570786

Of O 0 0.07551411539316177
clinical O 1 0.9987871050834656
interest O 0 0.03105892241001129
are O 0 0.011992448009550571
( O 0 0.021088246256113052
a O 0 0.020239688456058502
) O 0 0.011640539392828941
the O 0 0.014239931479096413
documentation O 0 0.04111788794398308
of O 0 0.04476321488618851
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999842643737793
vasculitis B-Disease 1 1.0
, O 1 0.986941397190094
and O 1 0.9994507431983948
arthritis B-Disease 1 1.0
in O 0 0.03908706456422806
an O 0 0.02804378606379032
individual O 0 0.02753601036965847
lacking O 1 0.9994487166404724
C5 O 1 1.0
( O 0 0.02675890177488327
and O 0 0.013373319059610367
its O 0 0.02826344594359398
biologic O 1 0.9999983310699463
functions O 0 0.03422367945313454
) O 0 0.024600647389888763
, O 0 0.020734082907438278
and O 0 0.022361617535352707
( O 0 0.035990696400403976
b O 1 0.8771522641181946
) O 0 0.018160734325647354
a O 0 0.019857771694660187
remarkable O 0 0.04283507540822029
propensity O 1 0.9993427395820618
to O 0 0.21290920674800873
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.04051359370350838
the O 0 0.05877138674259186
proband O 1 0.9999955892562866
, O 0 0.02190222032368183
even O 0 0.012831876054406166
during O 0 0.017452947795391083
periods O 0 0.023074736818671227
of O 0 0.02536129020154476
low O 1 0.9182190895080566
- O 1 0.9999997615814209
dose O 1 0.6668829321861267
or O 0 0.02107044868171215
alternate O 0 0.05408242344856262
- O 1 0.9999974966049194
day O 0 0.12626123428344727
corticosteroid O 1 1.0
therapy O 1 0.9999961853027344
. O 0 0.06131233274936676

Other O 0 0.033072084188461304
observations O 0 0.03228495642542839
indicate O 0 0.017209284007549286
that O 0 0.008500670082867146
the O 0 0.02655695006251335
C5D B-Disease 1 0.9999986886978149
state O 0 0.023479444906115532
is O 0 0.022289400920271873
compatible O 0 0.05434020981192589
with O 0 0.02981887198984623
normal O 0 0.085255466401577
coagulation O 1 1.0
function O 0 0.05026990547776222
and O 0 0.019199682399630547
the O 0 0.021566135808825493
capacity O 0 0.026002978906035423
to O 0 0.021050991490483284
mount O 0 0.27473220229148865
a O 0 0.0702500268816948
neutrophilic O 1 0.9999998807907104
leukocytosis O 1 0.9999997615814209
during O 1 0.9995707869529724
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.056036315858364105
. O 0 0.04871536046266556

Susceptibility O 1 0.9999548196792603
to O 1 0.8602594137191772
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.7432652711868286
twins O 1 0.9963775277137756
: O 0 0.021957559511065483
the O 0 0.015692340210080147
role O 0 0.02821476384997368
of O 0 0.025084642693400383
genes O 0 0.037136390805244446
, O 0 0.049357857555150986
HLA O 1 1.0
, O 0 0.0309610553085804
and O 0 0.021829869598150253
the O 0 0.03370274230837822
environment O 0 0.048997633159160614
. O 0 0.03403392806649208

OBJECTIVE O 0 0.10228140652179718
To O 0 0.025457965210080147
determine O 0 0.016480159014463425
the O 0 0.020775463432073593
relative O 0 0.05049251392483711
effects O 0 0.03982338309288025
of O 0 0.029243892058730125
genetic O 0 0.039528895169496536
and O 0 0.02035004459321499
environmental O 0 0.039228059351444244
factors O 0 0.02242998778820038
in O 0 0.02338440530002117
susceptibility O 1 0.9999971389770508
to O 1 0.9995297193527222
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.99996018409729
AS B-Disease 1 0.9999974966049194
) O 0 0.03849337249994278
. O 0 0.03321071341633797

METHODS O 0 0.08984100818634033
Twins O 0 0.11838288605213165
with O 0 0.026057984679937363
AS B-Disease 0 0.04723181203007698
were O 0 0.01064955536276102
identified O 0 0.01452556997537613
from O 0 0.00860660895705223
the O 0 0.014155041426420212
Royal O 0 0.04768933728337288
National O 0 0.04992010444402695
Hospital O 1 1.0
for O 1 0.9998745918273926
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9977855682373047
. O 0 0.052919767796993256

Clinical O 1 0.9953655004501343
and O 0 0.06389304250478745
radiographic O 1 0.9998490810394287
examinations O 0 0.14839744567871094
were O 0 0.018344376236200333
performed O 0 0.030881332233548164
to O 0 0.021759364753961563
establish O 0 0.0628315657377243
diagnoses O 1 0.9999998807907104
, O 0 0.048388298600912094
and O 1 0.8227583765983582
disease O 1 1.0
severity O 1 1.0
was O 1 0.9978967905044556
assessed O 0 0.04709991440176964
using O 0 0.013089410960674286
a O 0 0.022550448775291443
combination O 0 0.03771664947271347
of O 0 0.026697680354118347
validated O 0 0.08787853270769119
scoring O 0 0.05189511924982071
systems O 0 0.0628172755241394
. O 0 0.04004868492484093

HLA O 1 0.9999998807907104
typing O 0 0.13064387440681458
for O 0 0.04358511045575142
HLA O 1 1.0
- O 1 0.9999985694885254
B27 O 1 0.9995719790458679
, O 0 0.04914384335279465
HLA O 1 1.0
- O 1 0.9999992847442627
B60 O 1 0.9992165565490723
, O 0 0.022837990894913673
and O 0 0.03170150890946388
HLA O 1 1.0
- O 1 1.0
DR1 O 1 0.999985933303833
was O 0 0.0386146642267704
performed O 0 0.033345844596624374
by O 0 0.02723427675664425
polymerase O 1 0.9841324090957642
chain O 0 0.07569805532693863
reaction O 0 0.04185798019170761
with O 0 0.01885325461626053
sequence O 0 0.0352223739027977
- O 1 0.9980872273445129
specific O 0 0.02449311502277851
primers O 0 0.14919474720954895
, O 0 0.029467321932315826
and O 0 0.03206552565097809
zygosity O 1 0.99644535779953
was O 0 0.05078897625207901
assessed O 0 0.06202540174126625
using O 0 0.03999611735343933
microsatellite O 1 0.8583953976631165
markers O 0 0.1193438246846199
. O 0 0.0483277328312397

Genetic O 0 0.09600266069173813
and O 0 0.03644787147641182
environmental O 0 0.06674426794052124
variance O 0 0.06728590279817581
components O 0 0.033625002950429916
were O 0 0.010317684151232243
assessed O 0 0.02755594253540039
with O 0 0.014790339395403862
the O 0 0.0314030759036541
program O 0 0.06775520741939545
Mx O 1 0.9999974966049194
, O 0 0.028719699010252953
using O 0 0.013438885100185871
data O 0 0.011555762961506844
from O 0 0.011966893449425697
this O 0 0.008623713627457619
and O 0 0.012869173660874367
previous O 0 0.021531591191887856
studies O 0 0.018236007541418076
of O 0 0.027297018095850945
twins O 0 0.34309086203575134
with O 0 0.03803529217839241
AS B-Disease 1 0.959551215171814
. O 0 0.0531502403318882

RESULTS O 0 0.030505776405334473
Six O 0 0.017017561942338943
of O 0 0.0240374393761158
8 O 0 0.0620221272110939
monozygotic O 1 0.9995638728141785
( O 0 0.08744394779205322
MZ O 1 1.0
) O 0 0.05245746299624443
twin O 0 0.12038197368383408
pairs O 0 0.037633512169122696
were O 0 0.029290618374943733
disease O 1 0.999998927116394
concordant O 1 0.9999943971633911
, O 0 0.033273108303546906
compared O 0 0.02089846506714821
with O 0 0.012765795923769474
4 O 0 0.024238605052232742
of O 0 0.01834913343191147
15 O 0 0.03573557361960411
B27 O 1 0.9998713731765747
- O 1 0.9999780654907227
positive O 0 0.05476484075188637
dizygotic O 1 0.9993684887886047
( O 0 0.07371559739112854
DZ O 1 1.0
) O 0 0.05200031399726868
twin O 1 0.7277061343193054
pairs O 0 0.0373351126909256
( O 0 0.029763123020529747
27 O 0 0.04913134500384331
% O 0 0.026977799832820892
) O 0 0.018514882773160934
and O 0 0.012918301858007908
4 O 0 0.027387890964746475
of O 0 0.026235999539494514
32 O 0 0.08861015737056732
DZ O 1 1.0
twin O 1 0.9057466387748718
pairs O 0 0.0432622954249382
overall O 0 0.052307579666376114
( O 0 0.030943727120757103
12 O 0 0.03088528662919998
. O 0 0.019671013578772545
5 O 0 0.041423626244068146
% O 0 0.03452594578266144
) O 0 0.03265061229467392
. O 0 0.03532707691192627

Nonsignificant O 1 0.998708963394165
increases O 0 0.06017925217747688
in O 0 0.025024600327014923
similarity O 0 0.03519086167216301
with O 0 0.014598791487514973
regard O 0 0.029161157086491585
to O 0 0.02108270674943924
age O 0 0.041070327162742615
at O 1 0.9998576641082764
disease O 1 1.0
onset O 1 1.0
and O 0 0.026600927114486694
all O 0 0.015591447241604328
of O 0 0.02641388773918152
the O 0 0.09977846592664719
disease O 1 1.0
severity O 1 0.9999963045120239
scores O 0 0.05526300519704819
assessed O 0 0.03395722806453705
were O 0 0.009219369851052761
noted O 0 0.017558228224515915
in O 0 0.026926005259156227
disease O 1 0.9999998807907104
- O 1 1.0
concordant O 1 0.9999991655349731
MZ O 1 1.0
twins O 0 0.1326569765806198
compared O 0 0.03595205396413803
with O 0 0.03609062731266022
concordant O 1 0.9999325275421143
DZ O 1 1.0
twins O 1 0.6569978594779968
. O 0 0.06349991261959076

HLA O 1 1.0
- O 1 0.9999994039535522
B27 O 1 0.9996778964996338
and O 0 0.045247357338666916
B60 O 1 0.9352303147315979
were O 0 0.014328871853649616
associated O 0 0.01837906427681446
with O 0 0.015751801431179047
the O 0 0.04592495039105415
disease O 1 1.0
in O 0 0.04371326416730881
probands O 1 0.9999997615814209
, O 0 0.020175980404019356
and O 0 0.012035077437758446
the O 0 0.015578145161271095
rate O 0 0.026006652042269707
of O 0 0.040521081537008286
disease O 1 0.9999998807907104
concordance O 1 0.9999711513519287
was O 0 0.043136950582265854
significantly O 0 0.027540817856788635
increased O 0 0.027694817632436752
among O 0 0.05523655191063881
DZ O 1 1.0
twin O 1 0.9966802597045898
pairs O 0 0.022822534665465355
in O 0 0.009560329839587212
which O 0 0.008248399011790752
the O 0 0.022971289232373238
co O 1 0.9996795654296875
- O 1 0.9999997615814209
twin O 1 0.8237279057502747
was O 0 0.035413824021816254
positive O 0 0.026984624564647675
for O 0 0.017585836350917816
both O 0 0.029493845999240875
B27 O 1 0.9999618530273438
and O 0 0.05685853213071823
DR1 O 1 0.9999499320983887
. O 0 0.06100290268659592

Additive O 1 0.9976776242256165
genetic O 0 0.08900957554578781
effects O 0 0.0513312965631485
were O 0 0.016016189008951187
estimated O 0 0.02775404416024685
to O 0 0.02771291509270668
contribute O 0 0.043106671422719955
97 O 0 0.07469901442527771
% O 0 0.020674971863627434
of O 0 0.018628686666488647
the O 0 0.02643241360783577
population O 0 0.031113602221012115
variance O 0 0.06603801250457764
. O 0 0.042230237275362015

CONCLUSION O 0 0.13338610529899597
Susceptibility O 1 0.9985818862915039
to O 0 0.03909184783697128
AS B-Disease 1 0.6826134324073792
is O 0 0.022465547546744347
largely O 0 0.034324344247579575
genetically O 0 0.03611782565712929
determined O 0 0.03035605512559414
, O 0 0.015592075884342194
and O 0 0.012602915987372398
the O 0 0.023223135620355606
environmental O 0 0.04164678603410721
trigger O 0 0.06134415045380592
for O 0 0.025085531175136566
the O 0 0.43985962867736816
disease O 1 1.0
is O 0 0.044318802654743195
probably O 0 0.054989881813526154
ubiquitous O 1 0.783374011516571
. O 0 0.04563509672880173

HLA O 1 1.0
- O 1 0.9999990463256836
B27 O 1 0.9627899527549744
accounts O 0 0.021749496459960938
for O 0 0.011882572434842587
a O 0 0.020292110741138458
minority O 0 0.03433313965797424
of O 0 0.018652571365237236
the O 0 0.02912912517786026
overall O 0 0.07703842967748642
genetic O 0 0.08142351359128952
susceptibility O 1 0.9997947812080383
to O 0 0.04740505293011665
AS B-Disease 1 0.8710932731628418
. O 0 0.044041529297828674

Cell O 0 0.2365153729915619
cycle O 0 0.1018887311220169
- O 1 0.9974090456962585
dependent O 0 0.0598997063934803
colocalization O 0 0.423287034034729
of O 0 0.04405837878584862
BARD1 O 1 0.9999992847442627
and O 0 0.047564469277858734
BRCA1 O 1 0.9999898672103882
proteins O 0 0.0460149310529232
in O 0 0.02341397851705551
discrete O 0 0.06932893395423889
nuclear O 0 0.08536568284034729
domains O 0 0.08524271845817566
. O 0 0.04248681664466858

Germ O 1 0.9999998807907104
- O 1 0.9999889135360718
line O 0 0.05765371024608612
mutations O 0 0.02671281062066555
of O 0 0.018295247107744217
the O 0 0.042974941432476044
BRCA1 O 1 0.9999972581863403
gene O 0 0.06947451084852219
predispose O 0 0.15514640510082245
women O 0 0.023282695561647415
to O 0 0.01620924286544323
early O 0 0.039563629776239395
- O 1 1.0
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.06875606626272202
compromising O 1 0.9858815670013428
the O 0 0.031234845519065857
genes O 0 0.032623253762722015
presumptive O 1 0.9997314810752869
function O 0 0.034110523760318756
as O 0 0.026774857193231583
a O 0 0.0743768960237503
tumor B-Disease 1 1.0
suppressor O 1 0.999998927116394
. O 0 0.07004852592945099

Although O 0 0.03518342971801758
the O 0 0.03898407146334648
biochemical O 0 0.09130632132291794
properties O 0 0.049090418964624405
of O 0 0.05892874300479889
BRCA1 O 1 0.9999995231628418
polypeptides O 0 0.1301477700471878
are O 0 0.011244517751038074
not O 0 0.013220582157373428
understood O 0 0.030119899660348892
, O 0 0.016445845365524292
their O 0 0.016668720170855522
expression O 0 0.043328654021024704
pattern O 0 0.046320416033267975
and O 0 0.030799269676208496
subcellular O 0 0.1624644696712494
localization O 0 0.0916251391172409
suggest O 0 0.020385945215821266
a O 0 0.019432738423347473
role O 0 0.03517046570777893
in O 0 0.02785336971282959
cell O 1 0.9833774566650391
- O 1 0.999998927116394
cycle O 0 0.09025417268276215
regulation O 0 0.06074134260416031
. O 0 0.040877144783735275

When O 0 0.0927070677280426
resting O 1 0.999997615814209
cells O 0 0.08282768726348877
are O 0 0.022660279646515846
induced O 1 0.9694198369979858
to O 0 0.041733965277671814
proliferate O 0 0.17625576257705688
, O 0 0.017730427905917168
the O 0 0.020676199346780777
steady O 0 0.07469193637371063
- O 1 0.9969323873519897
state O 0 0.01517203263938427
levels O 0 0.02444152534008026
of O 0 0.030635148286819458
BRCA1 O 1 0.999452531337738
increase O 0 0.025590283796191216
in O 0 0.02236969769001007
late O 0 0.06896135210990906
G1 O 1 0.9999911785125732
and O 0 0.01937684416770935
reach O 0 0.028017500415444374
a O 0 0.02260671742260456
maximum O 0 0.034919288009405136
during O 0 0.052051298320293427
S O 1 0.9999929666519165
phase O 0 0.12416896969079971
. O 0 0.04889359697699547

Moreover O 0 0.05547160282731056
, O 0 0.019679440185427666
in O 0 0.02156241238117218
S O 1 0.9999969005584717
phase O 1 0.9983046054840088
cells O 0 0.07950320094823837
, O 0 0.050809070467948914
BRCA1 O 1 0.9998167157173157
polypeptides O 0 0.1343425065279007
are O 0 0.017390388995409012
hyperphosphorylated O 1 0.6703895330429077
and O 0 0.029547492042183876
accumulate O 0 0.08196526020765305
into O 0 0.02495642378926277
discrete O 0 0.06011129543185234
subnuclear O 1 0.9982120990753174
foci O 1 0.9998832941055298
termed O 1 0.9842169284820557
" O 0 0.0867064967751503
BRCA1 O 1 0.9999682903289795
nuclear O 0 0.11081395298242569
dots O 0 0.1229681521654129
. O 0 0.04361865669488907

" O 0 0.10493289679288864
BRCA1 O 1 0.9997263550758362
associates O 0 0.356785386800766
in O 0 0.030773358419537544
vivo O 0 0.09192958474159241
with O 0 0.017502320930361748
a O 0 0.040072619915008545
structurally O 0 0.15089616179466248
related O 0 0.0617237463593483
protein O 0 0.08282256871461868
termed O 1 0.606398344039917
BARD1 O 1 0.9999903440475464
. O 0 0.06271873414516449

Here O 0 0.04208630323410034
we O 0 0.014440481550991535
show O 0 0.015491941943764687
that O 0 0.006946403067559004
the O 0 0.017983656376600266
steady O 0 0.0822335034608841
- O 1 0.9992889165878296
state O 0 0.017171461135149002
levels O 0 0.026014888659119606
of O 0 0.036127734929323196
BARD1 O 1 0.9999984502792358
, O 0 0.02538617141544819
unlike O 0 0.024808183312416077
those O 0 0.012782309204339981
of O 0 0.03845968469977379
BRCA1 O 1 0.9999231100082397
, O 0 0.02686907909810543
remain O 0 0.03270154818892479
relatively O 0 0.02742338925600052
constant O 0 0.05793694779276848
during O 0 0.06040389835834503
cell O 1 0.9672351479530334
cycle O 0 0.2535321116447449
progression O 1 0.9983439445495605
. O 0 0.0627279281616211

However O 0 0.041616056114435196
, O 0 0.038087885826826096
immunostaining O 1 0.8663486838340759
revealed O 0 0.04644337296485901
that O 0 0.019941434264183044
BARD1 O 1 0.9998565912246704
resides O 0 0.10291830450296402
within O 0 0.04209506884217262
BRCA1 O 1 0.9989408850669861
nuclear O 0 0.06905466318130493
dots O 0 0.0706297978758812
during O 0 0.0395045131444931
S O 1 0.9985668063163757
phase O 0 0.060134969651699066
of O 0 0.027036558836698532
the O 0 0.04653840884566307
cell O 1 0.8071165084838867
cycle O 0 0.062219683080911636
, O 0 0.020043766126036644
but O 0 0.011271285824477673
not O 0 0.009884661063551903
during O 0 0.02825377695262432
the O 0 0.053809329867362976
G1 O 1 0.9999992847442627
phase O 0 0.15113720297813416
. O 0 0.053410619497299194

Nevertheless O 0 0.1181316152215004
, O 0 0.06473857164382935
BARD1 O 1 0.999997615814209
polypeptides O 0 0.14068378508090973
are O 0 0.01162424124777317
found O 0 0.015025596134364605
exclusively O 0 0.023030363023281097
in O 0 0.012380740605294704
the O 0 0.02194385789334774
nuclear O 0 0.03599198907613754
fractions O 0 0.03699538856744766
of O 0 0.015443145297467709
both O 0 0.022763187065720558
G1 O 1 0.9999998807907104
- O 1 0.9998370409011841
and O 0 0.031089605763554573
S O 1 0.9999996423721313
- O 1 1.0
phase O 1 0.991601288318634
cells O 0 0.0678858533501625
. O 0 0.03699842840433121

Therefore O 0 0.05480736121535301
, O 0 0.04418376460671425
progression O 1 0.9469432830810547
to O 0 0.05041103437542915
S O 1 0.9999958276748657
phase O 0 0.09570769965648651
is O 0 0.022624526172876358
accompanied O 0 0.04200136289000511
by O 0 0.01500796526670456
the O 0 0.024053962901234627
aggregation O 0 0.07338552176952362
of O 0 0.03095843829214573
nuclear O 0 0.07607617974281311
BARD1 O 1 0.9999321699142456
polypeptides O 0 0.14357489347457886
into O 0 0.06517798453569412
BRCA1 O 1 0.9994103908538818
nuclear O 0 0.10410662740468979
dots O 0 0.12459315359592438
. O 0 0.043029140681028366

This O 0 0.038850389420986176
cell O 0 0.08807094395160675
cycle O 0 0.0901988223195076
- O 1 0.9992077946662903
dependent O 0 0.061607107520103455
colocalization O 1 0.580619752407074
of O 0 0.05035019293427467
BARD1 O 1 0.9999997615814209
and O 0 0.04649178683757782
BRCA1 O 1 0.998908519744873
indicates O 0 0.03296621888875961
a O 0 0.01926545239984989
role O 0 0.025627661496400833
for O 0 0.016958244144916534
BARD1 O 1 0.9999901056289673
in O 0 0.03134744241833687
BRCA1 O 1 0.9999996423721313
- O 1 1.0
mediated O 1 0.9999997615814209
tumor B-Disease 1 1.0
suppression O 1 1.0
. O 0 0.06480637192726135

Ethnic O 0 0.06317005306482315
differences O 0 0.028549904003739357
in O 0 0.01965286210179329
the O 0 0.043566394597291946
HFE O 1 0.9999970197677612
codon O 0 0.17522750794887543
282 O 0 0.48935842514038086
( O 0 0.09737978875637054
Cys O 1 1.0
/ O 1 0.9999990463256836
Tyr O 1 0.9999998807907104
) O 0 0.07414161413908005
polymorphism O 0 0.12631119787693024
. O 0 0.04672969505190849

Recent O 0 0.04165179654955864
studies O 0 0.017940888181328773
have O 0 0.006733957678079605
shown O 0 0.013469909317791462
that O 0 0.024418864399194717
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.048574745655059814
is O 0 0.02104351669549942
likely O 0 0.019908053800463676
to O 0 0.015454480424523354
be O 0 0.012421292252838612
caused O 0 0.031580813229084015
by O 0 0.02399159036576748
homozygosity O 1 0.9746749401092529
for O 0 0.020637622103095055
a O 0 0.044105254113674164
Cys282Tyr O 1 0.9999101161956787
mutation O 0 0.04885631799697876
in O 0 0.017372269183397293
the O 0 0.042258672416210175
HFE O 1 0.9999998807907104
gene O 0 0.06970866024494171
located O 0 0.059700001031160355
4 O 0 0.06005711480975151
. O 0 0.04061200097203255

5 O 0 0.09418679028749466
Mb O 1 0.9988740086555481
telomeric O 1 0.944754958152771
to O 0 0.07671085745096207
HLA O 1 1.0
- O 1 0.9999994039535522
A O 0 0.08544187247753143
. O 0 0.04190392419695854

Population O 0 0.0441470742225647
studies O 0 0.0272622462362051
of O 0 0.027675988152623177
this O 0 0.02383451908826828
polymorphism O 0 0.08104251325130463
are O 0 0.012472051195800304
facilitated O 0 0.06036192551255226
by O 0 0.016818998381495476
the O 0 0.018498271703720093
fact O 0 0.014860277064144611
that O 0 0.00818762369453907
the O 0 0.029425526037812233
Cys282Tyr O 1 0.9999698400497437
mutation O 0 0.08880188316106796
creates O 0 0.0665929839015007
a O 0 0.05448729544878006
Rsal O 1 0.9999361038208008
restriction O 0 0.09506997466087341
site O 0 0.0629163607954979
. O 0 0.03092227131128311

We O 0 0.02459377609193325
have O 0 0.008522593416273594
studied O 0 0.020512090995907784
the O 0 0.024851234629750252
codon O 0 0.11641114950180054
282 O 0 0.4640248715877533
( O 0 0.09561695903539658
Cys O 1 1.0
/ O 1 0.9999997615814209
Tyr O 1 0.9999998807907104
) O 0 0.05824501812458038
polymorphism O 0 0.07830757647752762
in O 0 0.017081841826438904
different O 0 0.008722269907593727
ethnic O 0 0.037220388650894165
groups O 0 0.03129343315958977
. O 0 0.04098064452409744

In O 0 0.030941830947995186
agreement O 0 0.02736338973045349
with O 0 0.016750378534197807
previous O 0 0.027379726991057396
observations O 0 0.035948555916547775
the O 0 0.045774489641189575
Tyr O 1 0.9999997615814209
allele O 0 0.12367943674325943
appeared O 0 0.03692566603422165
to O 0 0.020085185766220093
be O 0 0.014002888463437557
rare O 0 0.033088814467191696
or O 0 0.025494158267974854
absent O 0 0.07115811854600906
in O 0 0.03389820456504822
Asiatic O 1 0.9999836683273315
( O 0 0.038051821291446686
Indian O 0 0.044817712157964706
, O 0 0.0289652980864048
Chinese O 0 0.04561471939086914
) O 0 0.030979035422205925
populations O 0 0.035196997225284576
. O 0 0.03629482537508011

The O 0 0.043762318789958954
highest O 0 0.10884065926074982
allele O 0 0.13845369219779968
frequency O 0 0.048612695187330246
( O 0 0.029775846749544144
7 O 0 0.03840063884854317
. O 0 0.01749345287680626
5 O 0 0.03526424989104271
% O 0 0.027083510532975197
) O 0 0.021032484248280525
was O 0 0.028004882857203484
found O 0 0.01798553392291069
in O 0 0.023610098287463188
Swedes O 0 0.1179819405078888
. O 0 0.045923151075839996

Saamis O 1 0.9999520778656006
( O 0 0.054706912487745285
2 O 0 0.05734717845916748
% O 0 0.029718458652496338
) O 0 0.023840077221393585
and O 0 0.02690807171165943
Mordvinians O 1 0.9999914169311523
( O 0 0.04044221714138985
1 O 0 0.0454501211643219
. O 0 0.018390392884612083
8 O 0 0.04241976514458656
% O 0 0.028852637857198715
) O 0 0.0210939459502697
had O 0 0.019292321056127548
significantly O 0 0.027526874095201492
lower O 0 0.03453489765524864
frequencies O 0 0.02061641775071621
of O 0 0.022531917318701744
the O 0 0.0568380281329155
Tyr O 1 0.9999994039535522
allele O 0 0.1843654215335846
. O 0 0.058062657713890076

Comparisons O 0 0.09565204381942749
with O 0 0.0389707051217556
allele O 0 0.09880340099334717
frequencies O 0 0.02680959738790989
based O 0 0.017146548256278038
on O 0 0.02112184278666973
prevalence O 1 0.7987515926361084
estimates O 0 0.0343254916369915
of O 0 0.04962421953678131
HH B-Disease 1 1.0
showed O 0 0.040431443601846695
some O 0 0.016430482268333435
disagreements O 0 0.060082707554101944
with O 0 0.02054472081363201
the O 0 0.04284314438700676
RFLP O 1 0.9999135732650757
data O 0 0.02383524365723133
, O 0 0.021395379677414894
particularly O 0 0.028028856962919235
in O 0 0.027933739125728607
Finns O 0 0.16241386532783508
. O 0 0.04916880279779434

The O 0 0.05040142685174942
newly O 0 0.10358176380395889
described O 0 0.09363240748643875
HFE O 1 0.9999994039535522
marker O 1 0.9677789211273193
provides O 0 0.038177743554115295
a O 0 0.02529987134039402
new O 0 0.026046739891171455
approach O 0 0.022414688020944595
to O 0 0.01194346696138382
the O 0 0.018432676792144775
screening O 0 0.06547199189662933
of O 0 0.05363123491406441
HH B-Disease 1 1.0
as O 0 0.03456829488277435
well O 0 0.01724625937640667
as O 0 0.01623847335577011
studies O 0 0.013565287925302982
of O 0 0.014689665287733078
the O 0 0.02294411137700081
relationship O 0 0.03205115720629692
between O 0 0.02204071171581745
the O 0 0.043758828192949295
HFE O 1 1.0
Tyr O 1 1.0
allele O 0 0.14090926945209503
and O 0 0.031373102217912674
different O 0 0.02645169198513031
disorders O 1 1.0
including O 1 0.9798926115036011
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999158382415771
dominant I-Disease 1 0.9999972581863403
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.05448806658387184
with O 0 0.02220192179083824
a O 0 0.03449803963303566
missense O 0 0.10867209732532501
mutation O 0 0.05121103674173355
encoding O 0 0.044597748667001724
Gly23 O 1 0.9999220371246338
- O 1 0.9999998807907104
- O 1 0.9999997615814209
> O 1 0.9944533705711365
Val O 1 0.9995429515838623
in O 0 0.04648955538868904
neurophysin O 1 0.9999794960021973
II O 1 0.9999990463256836
. O 0 0.062287911772727966

Autosomal B-Disease 1 0.9962866306304932
dominant I-Disease 1 0.9999479055404663
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9971134662628174
ADNDI B-Disease 1 1.0
) O 0 0.021612998098134995
is O 0 0.013752530328929424
an O 0 0.02742634154856205
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999951124191284
by O 1 0.9660910367965698
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.7772172093391418
the O 1 0.9486324787139893
magnocellular O 1 1.0
neurons O 0 0.04626902565360069
of O 0 0.025551652535796165
the O 0 0.043124157935380936
hypothalamus O 1 0.9997722506523132
leading O 0 0.0641324445605278
to O 0 0.028483660891652107
decreased O 0 0.047395553439855576
ability O 0 0.02108702063560486
to O 0 0.014602908864617348
produce O 0 0.015659311786293983
the O 0 0.03399789333343506
hormone O 1 0.9999120235443115
arginine O 1 0.9999862909317017
vasopressin O 1 0.9999926090240479
( O 0 0.10699263960123062
AVP O 1 1.0
) O 0 0.051958609372377396
. O 0 0.03898203745484352

Affected O 0 0.06999778747558594
individuals O 0 0.01791161298751831
are O 0 0.009041504934430122
not O 0 0.01994316279888153
symptomatic O 1 1.0
at O 0 0.10684149712324142
birth O 1 0.7328517436981201
, O 0 0.021222833544015884
but O 0 0.01492445357143879
usually O 0 0.02546512335538864
develop O 0 0.10314192622900009
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 0 0.1400301158428192
1 O 1 0.6181851029396057
- O 1 0.9999946355819702
6 O 0 0.0690755695104599
yr O 1 0.9998470544815063
of O 0 0.035569384694099426
age O 0 0.05195621773600578
. O 0 0.042738914489746094

The O 0 0.052305735647678375
genetic O 0 0.05249733477830887
locus O 0 0.09119074791669846
of O 0 0.03072309121489525
the O 0 0.0457540862262249
disease O 1 0.9999947547912598
is O 0 0.021756010130047798
the O 0 0.035804152488708496
AVP O 1 1.0
- O 1 1.0
neurophysin O 1 0.9999983310699463
II O 1 1.0
( O 0 0.06160815432667732
NPII O 1 0.9999996423721313
) O 0 0.04118098318576813
gene O 0 0.03720882162451744
, O 0 0.019130172207951546
and O 0 0.022603407502174377
mutations O 0 0.04446146637201309
that O 0 0.02426593378186226
cause O 1 0.9966662526130676
ADNDI B-Disease 1 1.0
have O 0 0.015731511637568474
been O 0 0.014405524358153343
found O 0 0.011034589260816574
in O 0 0.009790733456611633
both O 0 0.01043282076716423
the O 0 0.022459600120782852
signal O 0 0.051835764199495316
peptide O 0 0.051196351647377014
of O 0 0.01453327015042305
the O 0 0.025939879938960075
prepro O 1 0.9999858140945435
- O 1 1.0
AVP O 1 1.0
- O 1 0.9999998807907104
NPII O 1 0.9999994039535522
precursor O 0 0.16640135645866394
and O 0 0.025988200679421425
within O 0 0.03711699694395065
NPII O 1 0.9999890327453613
itself O 0 0.06851541996002197
. O 0 0.04133952781558037

An O 0 0.05544973909854889
affected O 0 0.06006455793976784
girl O 0 0.12305456399917603
who O 0 0.03632697835564613
presented O 0 0.036027196794748306
at O 0 0.029321646317839622
9 O 0 0.03418421745300293
months O 0 0.0213185865432024
of O 0 0.023915736004710197
age O 0 0.033894311636686325
and O 0 0.023374278098344803
her O 0 0.04659489914774895
similarly O 0 0.052790191024541855
affected O 0 0.051846377551555634
younger O 0 0.21909454464912415
brother O 1 0.9924269914627075
and O 0 0.0353921577334404
father O 0 0.06842844188213348
were O 0 0.015274591743946075
all O 0 0.012188644148409367
found O 0 0.011263761669397354
to O 0 0.011430983431637287
have O 0 0.006056973710656166
a O 0 0.017092134803533554
novel O 0 0.049735456705093384
missense O 0 0.12758688628673553
mutation O 0 0.06120218336582184
( O 0 0.03325701132416725
G1758 O 1 0.999994158744812
- O 1 1.0
- O 1 1.0
> O 1 0.9999818801879883
T O 1 0.9986521601676941
) O 0 0.020475860685110092
encoding O 0 0.021080492064356804
the O 0 0.01944604329764843
amino O 0 0.04270264878869057
acid O 0 0.06600445508956909
substitution O 0 0.0858168825507164
Gly23 O 1 0.9999935626983643
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.997399091720581
Val O 1 0.9996178150177002
within O 0 0.057536207139492035
NPII O 1 0.9999434947967529
. O 0 0.05755298584699631

The O 0 0.06958460062742233
mutation O 0 0.07739303261041641
was O 0 0.03632497414946556
confirmed O 0 0.03136502206325531
by O 0 0.028237363323569298
restriction O 0 0.08709955215454102
endonuclease O 1 0.9947474598884583
analysis O 0 0.03794170916080475
. O 0 0.032668326050043106

A O 0 0.15280334651470184
T1 O 1 0.9999998807907104
- O 1 0.9999487400054932
weighted O 0 0.09118619561195374
magnetic O 0 0.07225127518177032
resonance O 0 0.06761099398136139
imaging O 0 0.04743494093418121
of O 0 0.017091715708374977
the O 0 0.03768409416079521
fathers O 1 0.999809205532074
pituitary O 1 1.0
gland O 1 0.9999998807907104
demonstrates O 0 0.11864614486694336
an O 0 0.05666598305106163
attenuated O 1 1.0
posterior O 1 0.9999998807907104
pituitary O 1 1.0
bright O 1 0.9947964549064636
spot O 0 0.12280788272619247
. O 0 0.05044693872332573

This O 0 0.056715287268161774
mutation O 0 0.09503494948148727
may O 0 0.025256313383579254
be O 0 0.01145730260759592
valuable O 0 0.022978363558650017
for O 0 0.016697797924280167
developing O 0 0.03337067365646362
models O 0 0.022886065766215324
of O 0 0.039132170379161835
dominantly B-Disease 1 1.0
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.037486035376787186
as O 0 0.01962701417505741
the O 0 0.017543485388159752
early O 0 0.021254887804389
age O 0 0.02444678731262684
of O 0 0.03376885876059532
onset O 1 1.0
of O 1 0.9987686276435852
symptoms O 1 1.0
suggests O 0 0.05335176736116409
that O 0 0.01650582253932953
this O 0 0.022769801318645477
mutation O 0 0.06529536098241806
may O 0 0.021506961435079575
be O 0 0.012654703110456467
particularly O 0 0.02916537970304489
deleterious O 0 0.09609243273735046
to O 0 0.029433825984597206
the O 0 0.05924892798066139
magnocellular O 1 0.9999998807907104
neuron O 1 0.9996780157089233
. O 0 0.03897478058934212
. O 0 0.038366544991731644

Frequent O 0 0.11719884723424911
inactivation O 1 0.9999821186065674
of O 0 0.07164216041564941
PTEN O 1 1.0
/ O 1 0.9999985694885254
MMAC1 O 1 0.9999995231628418
in O 0 0.047626785933971405
primary O 1 0.9999997615814209
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.90797358751297

Sporadic B-Disease 1 0.9999997615814209
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.041764035820961
the O 0 0.024451270699501038
most O 0 0.019251681864261627
common O 0 0.04192206263542175
male B-Disease 1 0.9999326467514038
cancer I-Disease 1 1.0
in O 0 0.02062823250889778
the O 0 0.027783481404185295
Western O 0 0.04512535408139229
world O 0 0.03353220596909523
, O 0 0.015591525472700596
yet O 0 0.012995108962059021
many O 0 0.006982672028243542
of O 0 0.014575083740055561
the O 0 0.026838187128305435
major O 0 0.04704531282186508
genetic O 0 0.03700312599539757
events O 0 0.01847238466143608
involved O 0 0.015824176371097565
in O 0 0.013447726145386696
the O 0 0.028765235096216202
progression O 1 0.9952557682991028
of O 0 0.025537442415952682
this O 0 0.02100781537592411
often O 0 0.040050823241472244
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.08481121063232422
to O 0 0.03492238372564316
be O 0 0.028540555387735367
elucidated O 1 0.876498818397522
. O 0 0.04368915036320686

Numerous O 0 0.09016695618629456
cytogenetic O 1 0.9997335076332092
and O 0 0.058314383029937744
allelotype O 1 0.9999922513961792
studies O 0 0.02815345488488674
have O 0 0.009771180339157581
reported O 0 0.024112792685627937
frequent O 0 0.04314757511019707
loss O 0 0.04001692309975624
of O 0 0.03758087381720543
heterozygosity O 1 0.9999762773513794
on O 0 0.04226544871926308
chromosomal O 1 0.9988263249397278
arm O 1 0.8996044397354126
10q O 1 0.9997866749763489
in O 0 0.04394246265292168
sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.869749903678894

Deletion O 0 0.25598183274269104
mapping O 0 0.09256880730390549
studies O 0 0.027605125680565834
have O 0 0.013908086344599724
unambiguously O 0 0.09016293287277222
identified O 0 0.025720544159412384
a O 0 0.02526422031223774
region O 0 0.034845542162656784
of O 0 0.04275503382086754
chromosome O 0 0.11232385784387589
10q23 O 1 0.9950900077819824
to O 0 0.02436104416847229
be O 0 0.01214446872472763
the O 0 0.021560270339250565
minimal O 0 0.043566569685935974
area O 0 0.03170371055603027
of O 0 0.03140280768275261
loss O 0 0.39841967821121216
. O 0 0.05316159501671791

A O 0 0.0587332546710968
new O 0 0.06491555273532867
tumor B-Disease 1 1.0
suppressor O 1 1.0
gene O 0 0.06595809012651443
, O 0 0.046958379447460175
PTEN O 1 1.0
/ O 1 0.9999996423721313
MMAC1 O 1 0.9999995231628418
, O 0 0.028090113773941994
was O 0 0.033929772675037384
isolated O 0 0.059105999767780304
recently O 0 0.031009994447231293
at O 0 0.019125690683722496
this O 0 0.009559210389852524
region O 0 0.028171490877866745
of O 0 0.037387728691101074
chromosome O 0 0.11776436120271683
10q23 O 1 0.998461127281189
and O 0 0.024789640679955482
found O 0 0.013603036291897297
to O 0 0.013711153529584408
be O 0 0.012516245245933533
inactivated O 0 0.10173981636762619
by O 0 0.017502568662166595
mutation O 0 0.03588893637061119
in O 0 0.017950745299458504
three O 0 0.06133941188454628
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.0651816576719284
. O 0 0.042422160506248474

We O 0 0.027636796236038208
screened O 0 0.10180118680000305
80 O 1 0.9219982028007507
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.06980789452791214
microsatellite O 1 0.9963220357894897
analysis O 0 0.029521863907575607
and O 0 0.021342603489756584
found O 0 0.028210606426000595
chromosome O 0 0.088069848716259
10q23 O 1 0.9888014793395996
to O 0 0.029457831755280495
be O 0 0.017863590270280838
deleted O 0 0.049223385751247406
in O 0 0.02042524702847004
23 O 0 0.05071350932121277
cases O 0 0.04522041231393814
. O 0 0.048014067113399506

We O 0 0.03654734045267105
then O 0 0.02981039136648178
proceeded O 0 0.0524413138628006
with O 0 0.01694530062377453
sequence O 0 0.017078833654522896
analysis O 0 0.010043561458587646
of O 0 0.011529148556292057
the O 0 0.023434769362211227
entire O 0 0.08225786685943604
PTEN O 1 1.0
/ O 1 0.9999992847442627
MMAC1 O 1 0.9999998807907104
coding O 0 0.1250767707824707
region O 0 0.04648348689079285
and O 0 0.023282114416360855
tested O 0 0.04239598661661148
for O 0 0.025512773543596268
homozygous O 0 0.10078705102205276
deletion O 0 0.09668666124343872
with O 0 0.026072293519973755
new O 0 0.058304496109485626
intragenic O 1 0.999955415725708
markers O 0 0.08477236330509186
in O 0 0.016610881313681602
these O 0 0.010220306925475597
23 O 0 0.02891699969768524
cases O 0 0.0216617863625288
with O 0 0.02703704684972763
10q23 O 1 0.9999809265136719
loss O 0 0.15534783899784088
of O 0 0.06661594659090042
heterozygosity O 1 0.9999954700469971
. O 0 0.06198454275727272

The O 0 0.03984929993748665
identification O 0 0.03027111478149891
of O 0 0.020060911774635315
the O 0 0.028628353029489517
second O 0 0.0686759203672409
mutational O 1 0.9969293475151062
event O 0 0.03870244696736336
in O 0 0.016995424404740334
10 O 0 0.021201450377702713
( O 0 0.02140531875193119
43 O 0 0.04557986930012703
% O 0 0.032931290566921234
) O 0 0.04876743629574776
tumors B-Disease 1 0.9999997615814209
establishes O 1 0.9999973773956299
PTEN O 1 1.0
/ O 1 0.9999992847442627
MMAC1 O 1 0.9999825954437256
as O 0 0.024828020483255386
a O 0 0.026363659650087357
main O 0 0.05027060955762863
inactivation O 1 0.9854352474212646
target O 0 0.023370111361145973
of O 0 0.02226055972278118
10q O 1 0.9797381162643433
loss O 0 0.044735152274370193
in O 0 0.03627384454011917
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3850290775299072
. O 0 0.04747851565480232

Risk O 0 0.1447136551141739
reversals O 0 0.15611374378204346
in O 0 0.032802704721689224
predictive O 0 0.09254865348339081
testing O 0 0.05609806254506111
for O 0 0.09550511837005615
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.11539629101753235

The O 0 0.032604508101940155
first O 0 0.03007873333990574
predictive O 0 0.06301965564489365
testing O 0 0.039235081523656845
for O 0 0.0506783202290535
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9993323683738708
HD B-Disease 1 0.9999997615814209
) O 0 0.028924139216542244
was O 0 0.024200132116675377
based O 0 0.016107996925711632
on O 0 0.013871212489902973
analysis O 0 0.012272331863641739
of O 0 0.02704806998372078
linked O 0 0.09990716725587845
polymorphic O 1 0.9971760511398315
DNA O 0 0.07169757038354874
markers O 0 0.06165177375078201
to O 0 0.019515838474035263
estimate O 0 0.01824779249727726
the O 0 0.01910446584224701
likelihood O 0 0.0396222360432148
of O 0 0.028857139870524406
inheriting O 1 0.8301944732666016
the O 0 0.05330798029899597
mutation O 0 0.08315854519605637
for O 0 0.04152987524867058
HD B-Disease 1 0.9942717552185059
. O 0 0.054041262716054916

Limits O 0 0.05558653548359871
to O 0 0.0277099572122097
accuracy O 0 0.029948752373456955
included O 0 0.029487259685993195
recombination O 0 0.07039297372102737
between O 0 0.021583912894129753
the O 0 0.031118733808398247
DNA O 0 0.05139201506972313
markers O 0 0.056411683559417725
and O 0 0.01737823709845543
the O 0 0.033373430371284485
mutation O 0 0.06821903586387634
, O 0 0.0369931161403656
pedigree O 0 0.37835565209388733
structure O 0 0.0484483428299427
, O 0 0.022520650178194046
and O 0 0.017709676176309586
whether O 0 0.024816887453198433
DNA O 0 0.03596055507659912
samples O 0 0.02228137105703354
were O 0 0.009421855211257935
available O 0 0.014297522604465485
from O 0 0.020631715655326843
family O 0 0.04440026357769966
members O 0 0.03795015066862106
. O 0 0.039277639240026474

With O 0 0.03447197750210762
direct O 0 0.034823767840862274
tests O 0 0.020835479721426964
for O 0 0.0195449311286211
the O 0 0.05142632871866226
HD B-Disease 1 0.9999982118606567
mutation O 0 0.08974730223417282
, O 0 0.02560102939605713
we O 0 0.012301198206841946
have O 0 0.008575795218348503
assessed O 0 0.025981849059462547
the O 0 0.01883450523018837
accuracy O 0 0.020770322531461716
of O 0 0.01846831478178501
results O 0 0.017152832821011543
obtained O 0 0.020816391333937645
by O 0 0.029362646862864494
linkage O 0 0.2996671497821808
approaches O 0 0.06373749673366547
when O 0 0.028594970703125
requested O 0 0.044896338135004044
to O 0 0.02179436758160591
do O 0 0.015252244658768177
so O 0 0.012331645004451275
by O 0 0.014112132601439953
the O 0 0.029074935242533684
test O 0 0.05272014066576958
individuals O 0 0.02811530791223049
. O 0 0.04121332988142967

For O 0 0.03906724229454994
six O 0 0.028209257870912552
such O 0 0.021547425538301468
individuals O 0 0.021890340372920036
, O 0 0.020043998956680298
there O 0 0.012143805623054504
was O 0 0.030188385397195816
significant O 0 0.027344390749931335
disparity O 0 0.0977405458688736
between O 0 0.030815379694104195
the O 0 0.0387183353304863
tests O 0 0.04231714457273483
. O 0 0.0406462736427784

Three O 0 0.02899586595594883
went O 0 0.03449020907282829
from O 0 0.021001797169446945
a O 0 0.04094185307621956
decreased O 1 0.924699068069458
risk O 0 0.34515535831451416
to O 0 0.024776149541139603
an O 0 0.029101857915520668
increased O 0 0.04188366234302521
risk O 1 0.5652409195899963
, O 0 0.02028823085129261
while O 0 0.014412126503884792
in O 0 0.012140191160142422
another O 0 0.01857924647629261
three O 0 0.01272604987025261
the O 0 0.03132786229252815
risk O 1 0.5319911241531372
was O 0 0.06534769386053085
decreased O 1 0.5456146597862244
. O 0 0.049846351146698

Knowledge O 0 0.046415042132139206
of O 0 0.02833702601492405
the O 0 0.03473358601331711
potential O 0 0.04203122854232788
reasons O 0 0.027112912386655807
for O 0 0.017502741888165474
these O 0 0.010304175317287445
changes O 0 0.01425099465996027
in O 0 0.016785340383648872
results O 0 0.01850706897675991
and O 0 0.01926427148282528
impact O 0 0.030277013778686523
of O 0 0.024541504681110382
these O 0 0.017809562385082245
risk O 0 0.07623164355754852
reversals O 1 0.9712771773338318
on O 0 0.032443564385175705
both O 0 0.026676613837480545
patients O 1 0.999404788017273
and O 0 0.024526122957468033
the O 0 0.04462718591094017
counseling O 1 0.9999983310699463
team O 0 0.03324799984693527
can O 0 0.012895410880446434
assist O 0 0.03417398780584335
in O 0 0.012796197086572647
the O 0 0.016599558293819427
development O 0 0.021964365616440773
of O 0 0.021325483918190002
strategies O 0 0.03530555218458176
for O 0 0.01711190864443779
the O 0 0.036878280341625214
prevention O 1 1.0
and O 0 0.027622167021036148
, O 0 0.02203153446316719
where O 0 0.021163642406463623
necessary O 0 0.022242635488510132
, O 0 0.01825922168791294
management O 0 0.030865158885717392
of O 0 0.022750938311219215
a O 0 0.04404020309448242
risk O 0 0.36886587738990784
reversal O 0 0.08573338389396667
in O 0 0.020445553585886955
any O 0 0.022236045449972153
predictive O 0 0.08746428787708282
testing O 0 0.05293595790863037
program O 0 0.044366687536239624
. O 0 0.023939751088619232
. O 0 0.032892972230911255

A O 0 0.08191535621881485
novel O 0 0.07980936020612717
common O 0 0.04787743464112282
missense O 0 0.1799020618200302
mutation O 0 0.08311311155557632
G301C O 0 0.4083324074745178
in O 0 0.013526331633329391
the O 0 0.022120581939816475
N O 1 0.978424072265625
- O 1 0.9999812841415405
acetylgalactosamine O 1 0.9997456669807434
- O 1 0.999981164932251
6 O 0 0.07721506804227829
- O 1 0.9999997615814209
sulfate O 1 0.9999977350234985
sulfatase O 1 0.9999994039535522
gene O 0 0.06266969442367554
in O 0 0.03680794686079025
mucopolysaccharidosis B-Disease 1 0.9999768733978271
IVA I-Disease 1 0.9999998807907104
. O 0 0.07758387178182602

Mucopolysaccharidosis B-Disease 1 0.999997615814209
IVA I-Disease 1 1.0
( O 0 0.07615340501070023
MPS B-Disease 1 0.9999954700469971
IVA I-Disease 1 1.0
) O 0 0.02967577427625656
is O 0 0.014485979452729225
an O 0 0.023232921957969666
autosomal B-Disease 1 0.9999420642852783
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9986405968666077
by O 0 0.029093297198414803
a O 0 0.042069293558597565
genetic B-Disease 0 0.07890134304761887
defect I-Disease 1 0.9999666213989258
in O 0 0.023947162553668022
N O 1 0.9968235492706299
- O 1 0.9999743700027466
acetylgalactosamine O 1 0.9999028444290161
- O 1 0.9999154806137085
6 O 0 0.08197630941867828
- O 1 0.9999998807907104
sulfate O 1 0.9999998807907104
sulfatase O 1 1.0
( O 0 0.0924304947257042
GALNS O 1 0.9999986886978149
) O 0 0.05158500373363495
. O 0 0.038408100605010986

In O 0 0.03701035678386688
previous O 0 0.04170804098248482
studies O 0 0.03214029222726822
, O 0 0.01986829750239849
we O 0 0.009950712323188782
have O 0 0.006649221293628216
found O 0 0.01019969116896391
two O 0 0.012239718809723854
common O 0 0.039388030767440796
mutations O 0 0.052311331033706665
in O 0 0.03193503990769386
Caucasians O 1 0.9998714923858643
and O 0 0.037416569888591766
Japanese O 0 0.07609418034553528
, O 0 0.033917080610990524
respectively O 0 0.043678879737854004
. O 0 0.03934415057301521

To O 0 0.05837159976363182
characterize O 0 0.11809379607439041
the O 0 0.06331287324428558
mutational O 1 0.9999423027038574
spectrum O 0 0.07050204277038574
in O 0 0.01982167363166809
various O 0 0.013596908189356327
ethnic O 0 0.03333291783928871
groups O 0 0.023872755467891693
, O 0 0.02248855121433735
mutations O 0 0.027129095047712326
in O 0 0.014609161764383316
the O 0 0.03307656571269035
GALNS O 1 0.9999979734420776
gene O 0 0.03907664120197296
in O 0 0.019623715430498123
Colombian O 0 0.1410241723060608
MPS B-Disease 1 0.9999812841415405
IVA I-Disease 1 1.0
patients O 1 0.9999809265136719
were O 0 0.029219409450888634
investigated O 0 0.08114258944988251
, O 0 0.03394986316561699
and O 0 0.031777273863554
genetic O 0 0.04979609698057175
backgrounds O 0 0.038939740508794785
were O 0 0.01599377766251564
extensively O 0 0.03875640779733658
analyzed O 0 0.029576057568192482
to O 0 0.022528035566210747
identify O 0 0.0322793684899807
racial O 0 0.05437377467751503
origin O 0 0.018444696441292763
, O 0 0.015180127695202827
based O 0 0.019231678918004036
on O 0 0.028969699516892433
mitochondrial O 0 0.11700610816478729
DNA O 0 0.07100897282361984
( O 0 0.04928872361779213
mtDNA O 0 0.08830517530441284
) O 0 0.04077308997511864
lineages O 0 0.09017676115036011
. O 0 0.040859244763851166

Three O 0 0.050064604729413986
novel O 0 0.1242440789937973
missense O 0 0.3622223734855652
mutations O 0 0.07686232030391693
never O 0 0.039907339960336685
identified O 0 0.028376232832670212
previously O 0 0.02422957308590412
in O 0 0.016401279717683792
other O 0 0.014710093848407269
populations O 0 0.02771962247788906
and O 0 0.018156562000513077
found O 0 0.014928658492863178
in O 0 0.013820812106132507
16 O 0 0.02191736362874508
out O 0 0.016109175980091095
of O 0 0.018533749505877495
19 O 0 0.04474303126335144
Colombian O 0 0.12790632247924805
MPS B-Disease 1 0.9998874664306641
IVA I-Disease 1 1.0
unrelated O 0 0.12435970455408096
alleles O 0 0.08962607383728027
account O 0 0.030770273879170418
for O 0 0.029531648382544518
84 O 0 0.10890218615531921
. O 0 0.05268871411681175

2 O 0 0.06959741562604904
% O 0 0.02554229460656643
of O 0 0.025166846811771393
the O 0 0.03931977599859238
alleles O 0 0.08067760616540909
in O 0 0.024150298908352852
this O 0 0.019830210134387016
study O 0 0.03336246684193611
. O 0 0.038863420486450195

The O 0 0.08244889229536057
G301C O 1 0.9982360601425171
and O 0 0.06197066232562065
S162F O 1 0.9999125003814697
mutations O 0 0.05554922670125961
account O 0 0.024000847712159157
for O 0 0.027527831494808197
68 O 0 0.09010548144578934
. O 0 0.04827297478914261

4 O 0 0.08481568843126297
% O 0 0.03978633135557175
and O 0 0.02920110523700714
10 O 0 0.03865024447441101
. O 0 0.04072963818907738

5 O 0 0.05444358289241791
% O 0 0.030888767912983894
of O 0 0.03745613992214203
mutations O 0 0.05519070476293564
, O 0 0.026329131796956062
respectively O 0 0.03323197737336159
, O 0 0.021155711263418198
whereas O 0 0.027402352541685104
the O 0 0.025778695940971375
remaining O 0 0.05950046330690384
F69V O 1 0.999994158744812
is O 0 0.024107694625854492
limited O 0 0.018551502376794815
to O 0 0.01696735806763172
a O 0 0.03191978856921196
single O 0 0.06285180896520615
allele O 0 0.11458058655261993
. O 0 0.04236947372555733

The O 0 0.056078001856803894
skewed O 0 0.11782706528902054
prevalence O 1 0.987313449382782
of O 0 0.05055505409836769
G301C O 1 0.9998633861541748
in O 0 0.0216996893286705
only O 0 0.022197185084223747
Colombian O 1 0.6683909893035889
patients O 1 0.9921191930770874
and O 0 0.04166121035814285
haplotype O 1 0.7272221446037292
analysis O 0 0.021079570055007935
by O 0 0.020791903138160706
restriction O 0 0.0623776838183403
fragment O 0 0.07836194336414337
length O 0 0.028425348922610283
polymorphisms O 0 0.06592599302530289
in O 0 0.015834849327802658
the O 0 0.04211557283997536
GALNS O 1 0.9999988079071045
gene O 0 0.050156354904174805
suggest O 0 0.024155547842383385
that O 0 0.017210744321346283
G301C O 1 0.5287925601005554
originated O 0 0.04629562795162201
from O 0 0.0220511294901371
a O 0 0.037256963551044464
common O 0 0.04644402489066124
ancestor O 0 0.12568479776382446
. O 0 0.05279029533267021

Investigation O 0 0.06538613140583038
of O 0 0.03391413018107414
the O 0 0.04394739121198654
genetic O 0 0.0447072759270668
background O 0 0.03167881444096565
by O 0 0.018562255427241325
means O 0 0.028911428526043892
of O 0 0.03758345916867256
mtDNA O 0 0.08982306718826294
lineages O 0 0.0677853599190712
indicate O 0 0.02279764786362648
that O 0 0.01009028684347868
all O 0 0.016035171225667
our O 0 0.039945539087057114
patients O 1 0.9782562255859375
are O 0 0.012157541699707508
probably O 0 0.024187421426177025
of O 0 0.023297034204006195
native O 0 0.04237306863069534
American O 0 0.0791899785399437
descent O 0 0.14046327769756317

Low O 0 0.07930274307727814
frequency O 0 0.03794952481985092
of O 0 0.04450124874711037
BRCA1 O 1 0.9999916553497314
germline O 1 0.998298704624176
mutations O 0 0.03343891724944115
in O 0 0.012547544203698635
45 O 0 0.03706089034676552
German O 1 0.9996483325958252
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9766985774040222
. O 0 0.06265857815742493

In O 0 0.029850799590349197
this O 0 0.013970756903290749
study O 0 0.013770145364105701
we O 0 0.008211436681449413
investigated O 0 0.026561016216874123
45 O 0 0.034721020609140396
German O 1 0.9988903403282166
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.31794270873069763
for O 0 0.043340761214494705
germline O 1 0.999496340751648
mutations O 0 0.03824383020401001
in O 0 0.017707571387290955
the O 0 0.04797850921750069
BRCA1 O 1 0.9999966621398926
gene O 0 0.07569294422864914
. O 0 0.04039047658443451

We O 0 0.021097511053085327
identified O 0 0.022091923281550407
four O 0 0.02441977709531784
germline O 1 0.825046956539154
mutations O 0 0.040570273995399475
in O 0 0.017834166064858437
three O 0 0.0471503809094429
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.029130633920431137
and O 0 0.011798389256000519
in O 0 0.011312154121696949
one O 0 0.03255129233002663
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999580383300781
. O 0 0.021033138036727905
among O 0 0.017403433099389076
these O 0 0.005740715190768242
were O 0 0.009051148779690266
one O 0 0.027524417266249657
frameshift O 1 0.9996113181114197
mutation O 0 0.0648249015212059
, O 0 0.02041022665798664
one O 0 0.02625185064971447
nonsense O 0 0.4399101138114929
mutation O 0 0.05776778236031532
, O 0 0.01770946942269802
one O 0 0.019719615578651428
novel O 0 0.06808817386627197
splice O 0 0.252006858587265
site O 0 0.0679783970117569
mutation O 0 0.061433181166648865
, O 0 0.019970793277025223
and O 0 0.01973544992506504
one O 0 0.03365268558263779
missense O 0 0.31534847617149353
mutation O 0 0.10527928918600082
. O 0 0.049279991537332535

The O 0 0.07617636024951935
missense O 1 0.5236136317253113
mutation O 0 0.09836496412754059
was O 0 0.04214876890182495
also O 0 0.020546337589621544
found O 0 0.0164851825684309
in O 0 0.02120232954621315
2 O 0 0.05720878019928932
. O 0 0.03958752378821373

8 O 0 0.05957832187414169
% O 0 0.02184002287685871
of O 0 0.01837131381034851
the O 0 0.02423361875116825
general O 0 0.04173720255494118
population O 0 0.021546192467212677
, O 0 0.01849566213786602
suggesting O 0 0.02278096042573452
that O 0 0.007517337333410978
it O 0 0.009941138327121735
is O 0 0.018961189314723015
not O 0 0.028688935562968254
disease O 1 0.9999992847442627
associated O 0 0.060770437121391296
. O 0 0.052205320447683334

The O 0 0.03326917067170143
average O 0 0.028740528970956802
age O 0 0.04012390971183777
of O 0 0.3713356554508209
disease O 1 1.0
onset O 1 1.0
in O 0 0.035433199256658554
those O 0 0.022526975721120834
families O 0 0.05976119637489319
harbouring O 1 0.9999997615814209
causative O 1 0.9999997615814209
mutations O 0 0.07098717987537384
was O 0 0.04352772608399391
between O 0 0.032346226274967194
32 O 0 0.057920582592487335
. O 0 0.04125566780567169

3 O 0 0.080071359872818
and O 0 0.03572961688041687
37 O 0 0.07674434036016464
. O 0 0.04466674476861954

4 O 0 0.06282475590705872
years O 0 0.029102059081196785
, O 0 0.021543273702263832
whereas O 0 0.026973197236657143
the O 0 0.025074152275919914
family O 0 0.055893201380968094
harbouring O 1 0.9999704360961914
the O 0 0.056395888328552246
missense O 1 0.9612211585044861
mutation O 0 0.06395772099494934
had O 0 0.018818499520421028
an O 0 0.01694478467106819
average O 0 0.024217136204242706
age O 0 0.02968214638531208
of O 0 0.040018029510974884
onset O 1 0.9999996423721313
of O 0 0.06322618573904037
51 O 0 0.12359264492988586
. O 0 0.05353465676307678

2 O 0 0.09217900037765503
years O 0 0.04967084527015686
. O 0 0.05025767162442207

These O 0 0.01915876194834709
findings O 0 0.028995880857110023
show O 0 0.02678346075117588
that O 0 0.021129945293068886
BRCA1 O 1 0.9991081357002258
is O 0 0.02815486676990986
implicated O 0 0.06208112835884094
in O 0 0.011487993411719799
a O 0 0.015202691778540611
small O 0 0.012837289832532406
fraction O 0 0.03448006510734558
of O 0 0.05711338296532631
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.07287784665822983
suggesting O 0 0.03087741695344448
the O 0 0.017703300341963768
involvement O 0 0.035424888134002686
of O 0 0.023684080690145493
another O 0 0.06029864400625229
susceptibility O 1 0.9999983310699463
gene O 0 0.0854828879237175
( O 0 0.05513516068458557
s O 1 0.8358569741249084
) O 0 0.060712460428476334

Paternal O 1 0.9618929624557495
transmission O 1 0.8505604267120361
of O 1 0.9998836517333984
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9997634291648865

We O 0 0.022097306326031685
report O 0 0.018963346257805824
a O 0 0.019162697717547417
rare O 0 0.023348769173026085
case O 0 0.02315204031765461
of O 0 0.0316324383020401
paternally O 1 0.9999691247940063
transmitted O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.06111873313784599
. O 0 0.04026494920253754

The O 0 0.06125539913773537
proband O 1 0.9975847005844116
is O 0 0.021378740668296814
a O 0 0.019705168902873993
23 O 0 0.024242490530014038
year O 0 0.017150742933154106
old O 0 0.05724732205271721
, O 0 0.03624599426984787
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 1 0.9982433319091797
who O 1 0.9982852339744568
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9367985725402832

He O 0 0.03528983145952225
presented O 0 0.04776160418987274
with O 0 0.06775205582380295
respiratory O 1 1.0
and O 1 0.996780276298523
feeding O 1 0.9999805688858032
difficulties O 1 0.9994731545448303
at O 1 0.8573526740074158
birth O 1 0.9953578114509583
. O 0 0.04935040697455406

His O 0 0.05855441093444824
two O 0 0.03915047645568848
sibs O 1 0.9999945163726807
suffer O 1 0.9907917976379395
from O 0 0.0636548325419426
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.11486821621656418

Their O 0 0.02879045344889164
late O 0 0.04169376567006111
father O 0 0.04480560123920441
had O 0 0.016745315864682198
the O 0 0.01959908939898014
adult O 0 0.04507594183087349
type O 0 0.052697136998176575
of O 0 0.23516573011875153
DM B-Disease 1 1.0
, O 0 0.03720735386013985
with O 0 0.03331805020570755
onset O 1 1.0
around O 0 0.03333350643515587
30 O 0 0.035194359719753265
years O 0 0.034864507615566254
. O 0 0.03875008225440979

Only O 0 0.021645914763212204
six O 0 0.01715606451034546
other O 0 0.009019247256219387
cases O 0 0.015933634713292122
of O 0 0.02630257047712803
paternal O 1 0.9983308911323547
transmission O 1 0.9934031367301941
of O 1 0.9999823570251465
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.02749490551650524
been O 0 0.02194037288427353
reported O 0 0.030948439612984657
recently O 0 0.04511595889925957
. O 0 0.03693739324808121

We O 0 0.02165631577372551
review O 0 0.03268828243017197
the O 0 0.028210267424583435
sex O 0 0.06148938834667206
related O 0 0.03560208901762962
effects O 0 0.037168439477682114
on O 0 0.02934485860168934
transmission O 0 0.32956814765930176
of O 1 0.993885338306427
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.6445493102073669

Decreased O 0 0.16831839084625244
fertility O 1 0.9988300204277039
of O 0 0.030485641211271286
males O 0 0.029205938801169395
with O 0 0.025841552764177322
adult O 1 0.9568154811859131
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.05588703602552414
contraction O 0 0.09295041114091873
of O 0 0.026722364127635956
the O 0 0.03420628234744072
repeat O 0 0.07795654237270355
upon O 0 0.04581553116440773
male O 0 0.1434379667043686
transmission O 0 0.07078191637992859
contribute O 0 0.033046457916498184
to O 0 0.016655175015330315
the O 0 0.017892373725771904
almost O 0 0.015617961063981056
absent O 0 0.05064268037676811
occurrence O 0 0.03993358463048935
of O 0 0.02671501599252224
paternal O 1 0.999240517616272
transmission O 1 0.9765571355819702
of O 1 0.9999079704284668
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.6555154919624329

Also O 0 0.031223727390170097
the O 0 0.026311485096812248
fathers O 0 0.06150982156395912
of O 0 0.025705864652991295
the O 0 0.03472461923956871
reported O 0 0.06949368119239807
congenitally O 1 0.9999980926513672
affected O 0 0.06745380163192749
children O 0 0.054528508335351944
showed O 0 0.03430332988500595
, O 0 0.019601106643676758
on O 0 0.020259739831089973
average O 0 0.025446966290473938
, O 0 0.024457015097141266
shorter O 0 0.06728342175483704
CTG O 1 0.9999592304229736
repeat O 0 0.11052314937114716
lengths O 0 0.07286979258060455
and O 0 0.02536259964108467
hence O 0 0.043776970356702805
less O 0 0.03964350000023842
severe O 1 0.9999998807907104
clinical O 1 1.0
symptoms O 1 1.0
than O 0 0.021675677970051765
the O 0 0.02891809679567814
mothers O 0 0.08581171184778214
of O 0 0.028286851942539215
children O 0 0.08336947858333588
with O 1 0.9821959733963013
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.6546654105186462

We O 0 0.0253400057554245
conclude O 0 0.04202872887253761
that O 0 0.013297929428517818
paternal O 0 0.10473236441612244
transmission O 0 0.08582529425621033
of O 1 0.9981574416160583
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.45896250009536743
rare O 0 0.04328169301152229
and O 0 0.027749747037887573
preferentially O 0 0.09586244821548462
occurs O 0 0.026686832308769226
with O 0 0.023064635694026947
onset O 1 1.0
of O 1 0.9987902045249939
DM B-Disease 1 1.0
past O 0 0.04880041629076004
30 O 0 0.03021157719194889
years O 0 0.01753723807632923
in O 0 0.016355371102690697
the O 0 0.032223790884017944
father O 0 0.0723552256822586
. O 0 0.0293116457760334
. O 0 0.036940593272447586

The O 0 0.09262211620807648
RB1 O 1 0.9999996423721313
gene O 0 0.08356813341379166
mutation O 0 0.05037129670381546
in O 0 0.015043039806187153
a O 0 0.03132489323616028
child O 0 0.08757923543453217
with O 0 0.06595947593450546
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.09973778575658798

The O 0 0.10014288127422333
RB1 O 1 0.9999988079071045
gene O 0 0.10106205940246582
mutation O 0 0.06859248876571655
was O 0 0.031134450808167458
investigated O 0 0.03684328868985176
in O 0 0.013780969195067883
a O 0 0.02777465060353279
child O 0 0.07356538623571396
with O 0 0.057771675288677216
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
using O 0 0.03777127340435982
DNA O 0 0.03164776787161827
obtained O 0 0.013448074460029602
from O 0 0.009595254436135292
both O 0 0.01044364832341671
the O 0 0.033694252371788025
pineal B-Disease 1 0.9999998807907104
and I-Disease 0 0.19560521841049194
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 0 0.07101885229349136
the O 0 0.12860864400863647
patient O 1 0.9999921321868896
. O 0 0.05756916105747223

A O 0 0.09234468638896942
nonsense O 0 0.14841531217098236
mutation O 0 0.06977918744087219
in O 0 0.028537247329950333
exon O 1 0.5020683407783508
17 O 0 0.05642816424369812
( O 0 0.0395079180598259
codon O 0 0.1195446029305458
556 O 0 0.13631334900856018
) O 0 0.018311569467186928
of O 0 0.021204303950071335
the O 0 0.05207571014761925
RB1 O 1 1.0
gene O 0 0.05929967388510704
was O 0 0.033862460404634476
found O 0 0.012848074547946453
to O 0 0.01382116973400116
be O 0 0.01078934408724308
present O 0 0.025350462645292282
homozygously O 1 0.777753472328186
in O 0 0.0152295446023345
both O 0 0.015828898176550865
the O 0 0.042228467762470245
retinal B-Disease 1 0.999998927116394
and I-Disease 0 0.03924171254038811
the I-Disease 0 0.08397085964679718
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.08314695209264755

The O 0 0.048902999609708786
same O 0 0.03475474566221237
mutation O 0 0.06055348739027977
was O 0 0.035829413682222366
present O 0 0.03424256294965744
heterozygously O 1 0.9796225428581238
in O 0 0.018009543418884277
the O 0 0.025065189227461815
DNA O 0 0.026572661474347115
from O 0 0.012499301694333553
the O 0 0.018247514963150024
constitutional O 0 0.044507961720228195
cells O 0 0.03405095264315605
of O 0 0.024357110261917114
the O 0 0.04548842832446098
patient O 1 0.9999978542327881
, O 0 0.03469250723719597
proving O 0 0.061792682856321335
it O 0 0.01158969011157751
to O 0 0.014137898571789265
be O 0 0.010434618219733238
of O 0 0.031388189643621445
germline O 1 0.573081374168396
origin O 0 0.03621372953057289
. O 0 0.03980976715683937

The O 0 0.05382722243666649
initial O 0 0.06693560630083084
mutation O 0 0.07671329379081726
was O 0 0.03717198967933655
shown O 0 0.01936192810535431
to O 0 0.01622542180120945
have O 0 0.008247049525380135
occurred O 0 0.020424984395503998
in O 0 0.013771421276032925
the O 0 0.03437918424606323
paternally O 1 0.9376758933067322
derived O 0 0.09128046035766602
RB1 O 1 0.9999945163726807
allele O 0 0.17004024982452393
. O 0 0.05489182844758034

The O 0 0.07404860109090805
mutation O 0 0.08064421266317368
is O 0 0.020474588498473167
in O 0 0.013465438038110733
an O 0 0.01506967656314373
area O 0 0.020978517830371857
of O 0 0.0166033748537302
the O 0 0.022461658343672752
gene O 0 0.024046020582318306
that O 0 0.007803806569427252
encodes O 0 0.03880057483911514
the O 0 0.026483159512281418
protein O 0 0.05494577810168266
- O 1 0.997760534286499
binding O 0 0.034224167466163635
region O 0 0.028159799054265022
known O 0 0.026937471702694893
as O 0 0.01876908354461193
the O 0 0.033637646585702896
pocket O 1 0.9979633092880249
region O 0 0.0396340936422348
and O 0 0.018869783729314804
has O 0 0.018737083300948143
been O 0 0.01791892759501934
detected O 0 0.03201000392436981
in O 0 0.012981770560145378
other O 0 0.011675190180540085
cases O 0 0.02823108434677124
of O 0 0.060673244297504425
retinoblastoma B-Disease 1 1.0
. O 0 0.045341745018959045
. O 0 0.04525121673941612

Low O 0 0.08029934018850327
levels O 0 0.0314989872276783
of O 0 0.030371811240911484
beta O 1 0.9915667176246643
hexosaminidase O 1 0.9997699856758118
A O 0 0.046519841998815536
in O 0 0.019379111006855965
healthy O 0 0.04589001089334488
individuals O 0 0.014995690435171127
with O 0 0.02474972791969776
apparent O 1 0.9999991655349731
deficiency O 1 1.0
of O 1 0.8953191041946411
this O 0 0.04241316393017769
enzyme O 0 0.4588267207145691
. O 0 0.04125302657485008

Appreciable O 1 0.9904035329818726
beta O 1 0.9846935272216797
hexosaminidase O 1 0.9996439218521118
A O 0 0.0750732347369194
( O 0 0.04515039920806885
hex O 1 0.7574395537376404
A O 0 0.063829705119133
) O 0 0.024156715720891953
activity O 0 0.018257439136505127
has O 0 0.010324614122509956
been O 0 0.010690958239138126
detected O 0 0.031172432005405426
in O 0 0.02629479207098484
cultured O 1 0.9999655485153198
skin O 1 1.0
fibroblasts O 1 1.0
and O 1 0.9998773336410522
melanoma B-Disease 1 1.0
tissue O 1 1.0
from O 0 0.05464816838502884
healthy O 1 0.6196164488792419
individuals O 0 0.015754498541355133
previously O 0 0.018959669396281242
reported O 0 0.022350091487169266
as O 0 0.02563576214015484
having O 0 0.04762575030326843
deficiency B-Disease 1 1.0
of I-Disease 0 0.335566908121109
hex I-Disease 1 0.9999563694000244
A I-Disease 0 0.06359721720218658
activity O 0 0.032606299966573715
indistinguishable O 0 0.048593997955322266
from O 0 0.009310544468462467
that O 0 0.004817470908164978
of O 0 0.013903039507567883
patients O 0 0.37517037987709045
with O 0 0.051320720463991165
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9994230270385742
TSD B-Disease 1 1.0
) O 0 0.06365185230970383
. O 0 0.04512101039290428

Identification O 0 0.06871775537729263
and O 0 0.03508971631526947
quantitation O 1 0.9780406951904297
of O 0 0.054304592311382294
hex O 1 0.9975436329841614
A O 0 0.07359190285205841
, O 0 0.031615644693374634
amounting O 0 0.06333161145448685
to O 0 0.03380691260099411
3 O 0 0.05565571412444115
. O 0 0.035637494176626205

5 O 0 0.07301078736782074
% O 0 0.0633913055062294
- O 1 0.9999663829803467
6 O 0 0.07416000217199326
. O 0 0.043244149535894394

9 O 0 0.05228300020098686
% O 0 0.019316893070936203
of O 0 0.019969703629612923
total O 0 0.034320395439863205
beta O 1 0.9990794658660889
hexosaminidase O 1 0.9999808073043823
activity O 0 0.045953456312417984
, O 0 0.01944187842309475
has O 0 0.013853468932211399
been O 0 0.010575685650110245
obtained O 0 0.016286887228488922
by O 0 0.03173453360795975
cellulose O 1 0.999808132648468
acetate O 1 0.9999947547912598
gel O 1 0.9997168183326721
electrophoresis O 0 0.13889527320861816
, O 0 0.03697378188371658
DEAE O 1 0.9999914169311523
- O 1 0.9999994039535522
cellulose O 1 0.9990397095680237
ion O 1 0.9974936246871948
- O 1 0.9999769926071167
exchange O 0 0.06486993283033371
chromatography O 1 0.9998563528060913
, O 0 0.04522743076086044
radial O 1 0.9995824694633484
immunodiffusion O 1 0.9999719858169556
, O 0 0.03992985561490059
and O 0 0.03964361548423767
radioimmunoassay O 1 0.9993892908096313
. O 0 0.05423498526215553

Previous O 0 0.07966306805610657
family O 0 0.0744621753692627
studies O 0 0.03407663851976395
suggested O 0 0.028409216552972794
that O 0 0.01227202732115984
these O 0 0.011602538637816906
individuals O 0 0.019388137385249138
may O 0 0.02204054407775402
be O 0 0.018113359808921814
compound O 0 0.09838736802339554
heterozygotes O 0 0.11115432530641556
for O 0 0.016108578070998192
the O 0 0.02166479453444481
common O 0 0.03987205773591995
mutant O 1 0.9996806383132935
TSD B-Disease 1 1.0
gene O 0 0.05238175764679909
and O 0 0.017845913767814636
a O 0 0.02944040670990944
rare O 0 0.04644482955336571
( O 0 0.0491161085665226
allelic O 1 0.9990370273590088
) O 0 0.05732133239507675
mutant O 1 0.6665423512458801
gene O 0 0.07002050429582596
. O 0 0.04274197667837143

Thus O 0 0.03905059024691582
, O 0 0.020679812878370285
the O 0 0.025894392281770706
postulated O 0 0.09848898649215698
rate O 0 0.05946316942572594
mutant O 1 0.9693889021873474
gene O 0 0.06162038818001747
appears O 0 0.038887668401002884
to O 0 0.017172319814562798
code O 0 0.021507686004042625
for O 0 0.013731434941291809
the O 0 0.020851731300354004
expression O 0 0.029618043452501297
of O 0 0.022557208314538002
low O 0 0.04610762745141983
amounts O 0 0.022875744849443436
of O 0 0.035761184990406036
hex O 1 0.8214201331138611
A O 0 0.07788271456956863
. O 0 0.044914375990629196

Heterozygotes O 0 0.44293931126594543
for O 0 0.030449656769633293
the O 0 0.03979449346661568
rare O 0 0.07745679467916489
mutant O 1 0.9928892850875854
may O 0 0.03313278406858444
be O 0 0.018008500337600708
indistinguishable O 0 0.06915803998708725
from O 0 0.030572310090065002
heterozygotes O 0 0.12479028850793839
for O 0 0.02429402992129326
the O 0 0.04098069667816162
common O 0 0.0766487643122673
TSD B-Disease 1 1.0
mutant O 1 0.9934198260307312
. O 0 0.06679633259773254

However O 0 0.038378458470106125
, O 0 0.030894795432686806
direct O 0 0.04583579674363136
visualization O 0 0.09422451257705688
and O 0 0.0322822742164135
quantitation O 1 0.9924049973487854
of O 0 0.04810972884297371
hex O 1 0.9437998533248901
A O 0 0.045612748712301254
by O 0 0.01737091690301895
the O 0 0.020165912806987762
methods O 0 0.017972063273191452
described O 0 0.0307522714138031
may O 0 0.02004564180970192
prevent O 0 0.04438958317041397
false O 0 0.05700886622071266
- O 1 0.9999973773956299
positive O 0 0.05844872072339058
prenatal O 1 1.0
diagnosis O 1 0.9999998807907104
of O 1 0.9653114676475525
TSD B-Disease 1 1.0
in O 0 0.04180407151579857
fetuses O 0 0.12297758460044861
having O 0 0.02156725339591503
the O 0 0.02245929092168808
incomplete O 0 0.05737850069999695
hex B-Disease 1 0.981992244720459
A I-Disease 1 0.9958264231681824
deficiency I-Disease 1 1.0
of O 0 0.03961798548698425
the O 0 0.046694595366716385
type O 0 0.0859113410115242
described O 0 0.033183179795742035
in O 0 0.015988344326615334
the O 0 0.025238975882530212
four O 0 0.034612368792295456
healthy O 0 0.0967225581407547
individuals O 0 0.060331571847200394

The O 0 0.085079625248909
tumor B-Disease 1 1.0
suppressor O 1 1.0
gene O 0 0.1350686401128769
Smad4 O 1 0.9999998807907104
/ O 1 0.9999982118606567
Dpc4 O 1 0.9998225569725037
is O 0 0.024900689721107483
required O 0 0.018399378284811974
for O 0 0.030335890129208565
gastrulation O 1 0.9998857975006104
and O 0 0.025979982689023018
later O 0 0.028884580358862877
for O 0 0.027443377301096916
anterior O 1 0.9970707893371582
development O 0 0.037012457847595215
of O 0 0.029524505138397217
the O 0 0.048541806638240814
mouse O 1 0.5771270394325256
embryo O 0 0.1312449872493744
. O 0 0.045910824090242386

Mutations O 0 0.04666823521256447
in O 0 0.014207237400114536
the O 0 0.03194788843393326
SMAD4 O 1 1.0
/ O 1 1.0
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 1.0
gene O 0 0.045234885066747665
, O 0 0.016917552798986435
a O 0 0.023076709359884262
key O 0 0.03868738189339638
signal O 0 0.046110399067401886
transducer O 0 0.0875876173377037
in O 0 0.010725969448685646
most O 0 0.018855417147278786
TGFbeta O 1 1.0
- O 1 1.0
related O 0 0.06305582821369171
pathways O 0 0.1646946370601654
, O 0 0.018368853256106377
are O 0 0.0066743697971105576
involved O 0 0.010860064066946507
in O 0 0.010690893046557903
50 O 0 0.020626964047551155
% O 0 0.03118246980011463
of O 1 0.6517894268035889
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.08126110583543777

Homozygous O 0 0.22978398203849792
Smad4 O 1 0.9999946355819702
mutant O 1 0.999962329864502
mice O 1 0.7386748194694519
die O 0 0.34988805651664734
before O 0 0.04212213307619095
day O 0 0.05083025246858597
7 O 0 0.06169731914997101
. O 0 0.03598206490278244

5 O 0 0.07392226159572601
of O 0 0.06317572295665741
embryogenesis O 1 0.7357967495918274
. O 0 0.06915008276700974

Mutant O 1 0.6975098252296448
embryos O 0 0.06330414116382599
have O 0 0.014039989560842514
reduced O 0 0.03857332468032837
size O 0 0.029684321954846382
, O 0 0.02638130635023117
fail O 0 0.06066609174013138
to O 0 0.03594798222184181
gastrulate O 1 0.9982214570045471
or O 0 0.028674544766545296
express O 0 0.0557890459895134
a O 0 0.044751428067684174
mesodermal O 1 0.9999796152114868
marker O 1 0.7014561891555786
, O 0 0.023494385182857513
and O 0 0.020469147711992264
show O 0 0.046408265829086304
abnormal O 1 0.9999856948852539
visceral O 1 1.0
endoderm O 1 0.9999998807907104
development O 0 0.07927767932415009
. O 0 0.05135074257850647

Growth B-Disease 1 0.9043791890144348
retardation I-Disease 1 0.999998927116394
of O 0 0.036187902092933655
the O 0 0.0498855821788311
Smad4 O 1 1.0
- O 1 1.0
deficient O 1 0.9997624754905701
embryos O 0 0.03395122289657593
results O 0 0.013406205922365189
from O 0 0.01829827018082142
reduced O 0 0.057030219584703445
cell O 1 0.9911279678344727
proliferation O 1 0.9310694336891174
rather O 0 0.02309551276266575
than O 0 0.020688336342573166
increased O 0 0.06127387285232544
apoptosis O 1 0.9985910058021545
. O 0 0.05890243873000145

Aggregation O 0 0.11690611392259598
of O 0 0.03974875062704086
mutant O 1 0.9261089563369751
Smad4 O 1 0.9999995231628418
ES O 1 0.9999998807907104
cells O 0 0.053210653364658356
with O 0 0.020668908953666687
wild O 0 0.0637025535106659
- O 1 0.9999891519546509
type O 0 0.08850173652172089
tetraploid O 1 0.9524160027503967
morulae O 1 0.9988260865211487
rescues O 1 0.8812735080718994
the O 0 0.0896642804145813
gastrulation B-Disease 1 0.9999998807907104
defect I-Disease 1 0.9999958276748657
. O 0 0.07039397209882736

These O 0 0.0243447944521904
results O 0 0.02178710512816906
indicate O 0 0.026374949142336845
that O 0 0.020271245390176773
Smad4 O 1 0.9988536834716797
is O 0 0.024212058633565903
initially O 0 0.02421961911022663
required O 0 0.01243584230542183
for O 0 0.01234414428472519
the O 0 0.025128189474344254
differentiation O 0 0.0654950737953186
of O 0 0.034834764897823334
the O 0 0.05973416194319725
visceral O 1 0.9999983310699463
endoderm O 1 0.9999877214431763
and O 0 0.02558036334812641
that O 0 0.012853874824941158
the O 0 0.03718702867627144
gastrulation B-Disease 1 0.9999992847442627
defect I-Disease 1 0.9994632601737976
in O 0 0.023069189861416817
the O 0 0.038770027458667755
epiblast O 1 0.9999986886978149
is O 0 0.026192275807261467
secondary O 0 0.04825303703546524
and O 0 0.0228134598582983
non O 1 0.9999276399612427
- O 1 1.0
cell O 0 0.09782173484563828
autonomous O 0 0.06262029707431793
. O 0 0.037758465856313705

Rescued O 0 0.2033732682466507
embryos O 0 0.08973750472068787
show O 0 0.0675031840801239
severe O 1 0.9999948740005493
anterior O 1 1.0
truncations O 1 1.0
, O 0 0.04780091717839241
indicating O 0 0.04125514253973961
a O 0 0.024212904274463654
second O 0 0.031050890684127808
important O 0 0.01783839985728264
role O 0 0.032092027366161346
for O 0 0.024641402065753937
Smad4 O 1 0.9999703168869019
in O 0 0.05134338513016701
anterior O 1 0.9999967813491821
patterning O 1 0.9999721050262451
during O 0 0.10962816327810287
embryogenesis O 1 0.9992458820343018
. O 0 0.06392849236726761

Prevalence O 1 0.9992749094963074
of O 0 0.06915207207202911
p16 O 1 0.9930510520935059
and O 0 0.047272711992263794
CDK4 O 1 0.9999997615814209
germline O 1 0.9996974468231201
mutations O 0 0.04181172698736191
in O 0 0.021466247737407684
48 O 0 0.13196969032287598
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.999853253364563
families O 0 0.04634915292263031
in O 0 0.02928970381617546
France O 0 0.08252852410078049
. O 0 0.045320600271224976

The O 0 0.05403163656592369
French O 1 0.8352429270744324
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.8780998587608337
Group O 0 0.3073282539844513
. O 0 0.043534886091947556

Germline O 1 0.9986627101898193
mutations O 0 0.06240981072187424
in O 0 0.022457221522927284
the O 0 0.04694385081529617
p16 O 1 0.9992803931236267
and O 0 0.05119793489575386
CDK4 O 1 0.9999998807907104
genes O 0 0.03238213434815407
have O 0 0.0075080301612615585
been O 0 0.009422625415027142
reported O 0 0.012992722913622856
in O 0 0.01067414227873087
a O 0 0.025376008823513985
subset O 0 0.10552407801151276
of O 0 0.07345941662788391
melanoma B-Disease 1 1.0
pedigrees O 1 0.999100923538208
, O 0 0.027600007131695747
but O 0 0.012728267349302769
their O 0 0.020886527374386787
prevalence O 1 0.9999910593032837
is O 0 0.025912778452038765
not O 0 0.015486066229641438
well O 0 0.021402571350336075
known O 0 0.045118141919374466
. O 0 0.04006728529930115

We O 0 0.026242367923259735
searched O 0 0.05428480729460716
for O 0 0.021352127194404602
such O 0 0.022538796067237854
germline O 1 0.9737161993980408
mutations O 0 0.03770187497138977
in O 0 0.01608285866677761
48 O 0 0.05396886169910431
French O 1 0.9990035891532898
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.999914288520813
families O 0 0.0405665785074234
selected O 0 0.029055260121822357
according O 0 0.01710946299135685
to O 0 0.01512208953499794
two O 0 0.011600487865507603
major O 0 0.03513164818286896
criteria O 0 0.03788738325238228
families O 0 0.02835596725344658
with O 0 0.01688515581190586
at O 0 0.020432036370038986
least O 0 0.012905733659863472
three O 0 0.01280043926090002
affected O 0 0.031861238181591034
members O 0 0.03385461866855621
( O 0 0.044887810945510864
n O 0 0.146550714969635
= O 0 0.0859794169664383
20 O 0 0.03448795527219772
) O 0 0.025065835565328598
or O 0 0.019533749669790268
families O 0 0.023835215717554092
with O 0 0.015844199806451797
two O 0 0.016040688380599022
affected O 0 0.032440610229969025
members O 0 0.026136107742786407
, O 0 0.018123600631952286
one O 0 0.015263104811310768
of O 0 0.017145823687314987
them O 0 0.014451381750404835
affected O 0 0.02614886686205864
before O 0 0.0180082805454731
the O 0 0.019133251160383224
age O 0 0.02452068030834198
of O 0 0.024567201733589172
50 O 0 0.03941481560468674
( O 0 0.03979950398206711
n O 0 0.14145594835281372
= O 0 0.08632300049066544
28 O 0 0.0497114360332489
) O 0 0.023406261578202248
, O 0 0.01583700440824032
and O 0 0.013550874777138233
one O 0 0.017057552933692932
additional O 0 0.029201356694102287
minor O 0 0.4558020830154419
criterion O 1 0.9998488426208496
. O 0 0.06456860899925232

Sixteen O 0 0.10181990265846252
different O 0 0.030509134754538536
p16 O 1 0.9986515641212463
germline O 1 0.999363362789154
mutations O 0 0.05481075495481491
were O 0 0.013830829411745071
found O 0 0.014990839175879955
in O 0 0.01629049889743328
21 O 0 0.035881586372852325
families O 0 0.02728051133453846
, O 0 0.01578620634973049
while O 0 0.01563417911529541
one O 0 0.030936308205127716
germline O 1 0.9982434511184692
mutation O 0 0.08000143617391586
, O 0 0.0359002947807312
Arg24His O 1 0.9999862909317017
, O 0 0.026256665587425232
was O 0 0.03287125751376152
detected O 0 0.033773478120565414
in O 0 0.016244791448116302
the O 0 0.041868023574352264
CDK4 O 1 0.9999991655349731
gene O 0 0.07718683779239655
. O 0 0.04088851809501648

The O 0 0.04189273715019226
frequency O 0 0.038188666105270386
of O 0 0.042852308601140976
p16 O 1 0.9993846416473389
gene O 0 0.0720759704709053
mutation O 0 0.051295336335897446
in O 0 0.017868444323539734
our O 0 0.028882412239909172
sample O 0 0.0371275432407856
( O 0 0.027136797085404396
44 O 0 0.05382314324378967
% O 0 0.03234652802348137
) O 0 0.022502686828374863
is O 0 0.013696717098355293
among O 0 0.016515538096427917
the O 0 0.021199002861976624
highest O 0 0.05816739425063133
rates O 0 0.03096684440970421
yet O 0 0.017357664182782173
reported O 0 0.01911402866244316
and O 0 0.013744866475462914
the O 0 0.03455616906285286
CDK4 O 1 0.9999998807907104
mutation O 0 0.05926072224974632
is O 0 0.013232282362878323
the O 0 0.01837478019297123
second O 0 0.048891227692365646
mutation O 0 0.06598522514104843
detected O 0 0.040394894778728485
in O 0 0.01573045551776886
this O 0 0.017792169004678726
gene O 0 0.047946542501449585
worldwide O 0 0.04745551943778992
. O 0 0.04077863693237305

In O 0 0.045059800148010254
summary O 0 0.0642000064253807
, O 0 0.02307000942528248
our O 0 0.02605343610048294
results O 0 0.0167679563164711
show O 0 0.023961400613188744
frequent O 0 0.04407421499490738
involvement O 0 0.04417984187602997
of O 0 0.025156285613775253
the O 0 0.04289502277970314
p16 O 1 0.9994463324546814
gene O 0 0.053416334092617035
in O 0 0.047222547233104706
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.0379803441464901
confirm O 0 0.03186793252825737
the O 0 0.015729082748293877
role O 0 0.02388390153646469
of O 0 0.015539474785327911
the O 0 0.028938163071870804
CDK4 O 1 0.9999996423721313
gene O 0 0.03002210147678852
as O 0 0.016517911106348038
a O 0 0.048772022128105164
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999998807907104
gene O 0 0.0727309063076973
. O 0 0.0261381845921278
. O 0 0.03354886546730995

Progression O 1 0.9983382225036621
of O 0 0.0775122344493866
somatic O 1 0.9998961687088013
CTG O 1 0.9999880790710449
repeat O 0 0.1053304597735405
length O 0 0.03613833338022232
heterogeneity O 0 0.08353720605373383
in O 0 0.015134863555431366
the O 0 0.0281094778329134
blood O 1 0.999544084072113
cells O 0 0.08375613391399384
of O 1 0.9896642565727234
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.09488346427679062

The O 0 0.038872964680194855
genetic O 0 0.026424935087561607
basis O 0 0.020517492666840553
of O 0 0.06934767961502075
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.03445926681160927
is O 0 0.012619112618267536
the O 0 0.014738068915903568
expansion O 0 0.030316835269331932
of O 0 0.02274434268474579
an O 0 0.0396876223385334
unstable O 1 0.9999954700469971
CTG O 1 0.9999996423721313
repeat O 0 0.08052851259708405
in O 0 0.015172895044088364
the O 0 0.017766503617167473
34 O 0 0.039663441479206085
UTR O 0 0.19506925344467163
of O 0 0.024330969899892807
the O 0 0.05647113174200058
DM B-Disease 1 1.0
protein O 0 0.3186623156070709
kinase O 1 0.9991459846496582
gene O 0 0.044551022350788116
on O 0 0.035101085901260376
chromosome O 0 0.07538648694753647
19 O 0 0.05668429285287857
. O 0 0.03779124096035957

One O 0 0.02780955284833908
of O 0 0.019955968484282494
the O 0 0.02386246994137764
principal O 0 0.04938138648867607
features O 0 0.01899992674589157
of O 0 0.02134062349796295
the O 0 0.06247587874531746
DM B-Disease 1 1.0
mutation O 0 0.08733569085597992
is O 0 0.01910044439136982
an O 0 0.020686576142907143
extraordinarily O 0 0.07047239691019058
high O 0 0.039253488183021545
level O 0 0.032766569405794144
of O 0 0.04752875491976738
somatic O 1 0.9999948740005493
mosaicism O 1 0.9999997615814209
, O 0 0.030036214739084244
due O 0 0.024921508505940437
to O 0 0.019710315391421318
an O 0 0.01866035722196102
extremely O 0 0.029141075909137726
high O 0 0.03562954440712929
degree O 0 0.03820209577679634
of O 0 0.05254242196679115
somatic O 1 0.9999951124191284
instability O 1 0.9989019632339478
both O 0 0.02824280597269535
within O 0 0.022938290610909462
and O 0 0.021404746919870377
between O 0 0.029044073075056076
different O 0 0.021662482991814613
tissues O 0 0.10348797589540482
. O 0 0.04926778003573418

This O 0 0.059232406318187714
instability O 1 0.9937480688095093
appears O 0 0.06544481217861176
to O 0 0.028887396678328514
be O 0 0.018591569736599922
biased O 0 0.06325908750295639
towards O 0 0.03875608742237091
further O 0 0.026622969657182693
expansion O 0 0.05000725015997887
and O 0 0.02247028984129429
continuous O 0 0.04372448846697807
throughout O 0 0.019543396309018135
the O 0 0.02343926765024662
life O 0 0.030690135434269905
of O 0 0.023863423615694046
an O 0 0.02600245736539364
individual O 0 0.023840753361582756
, O 0 0.022630443796515465
features O 0 0.023349573835730553
that O 0 0.009275555610656738
could O 0 0.011214925907552242
be O 0 0.009201332926750183
associated O 0 0.01596108265221119
with O 0 0.013209191150963306
the O 0 0.028026368468999863
progressive O 1 0.9983342289924622
nature O 0 0.035771965980529785
of O 0 0.03479481860995293
the O 0 0.14061309397220612
disease O 1 1.0
. O 0 0.06707151234149933

Although O 0 0.03771481662988663
increasing O 0 0.04227176308631897
measured O 0 0.049740128219127655
allele O 0 0.09475378692150116
size O 0 0.03293885663151741
between O 0 0.03821661323308945
patients O 1 0.8097875714302063
clearly O 0 0.046066977083683014
correlates O 0 0.07629392296075821
with O 0 0.01804908737540245
an O 0 0.02205580472946167
increased O 0 0.03422779589891434
severity O 1 0.9999667406082153
of O 1 0.9854494333267212
symptoms O 1 1.0
and O 0 0.026876388117671013
an O 0 0.0197176281362772
earlier O 0 0.021305209025740623
age O 0 0.028066741302609444
of O 0 0.042475372552871704
onset O 1 1.0
, O 0 0.033051978796720505
this O 0 0.021056436002254486
correlation O 0 0.05525432154536247
is O 0 0.018942516297101974
not O 0 0.012964247725903988
precise O 0 0.02626856043934822
and O 0 0.021118653938174248
measured O 0 0.048603933304548264
allele O 0 0.09841813892126083
length O 0 0.030164990574121475
cannot O 0 0.024482179433107376
be O 0 0.010980178602039814
used O 0 0.010829281993210316
as O 0 0.012887833639979362
an O 0 0.015734266489744186
accurate O 0 0.035360973328351974
predictor O 1 0.9398764371871948
of O 0 0.028945300728082657
age O 0 0.04918971657752991
of O 0 0.06535905599594116
onset O 1 1.0
. O 0 0.08046726137399673

In O 0 0.03609616681933403
order O 0 0.02904418669641018
to O 0 0.018459154292941093
further O 0 0.019374124705791473
characterize O 0 0.06207337602972984
the O 0 0.026731453835964203
dynamics O 0 0.060808517038822174
of O 0 0.06110846996307373
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 1 0.9999796152114868
somatic O 1 0.9999935626983643
instability O 1 0.9997262358665466
, O 0 0.03403283655643463
we O 0 0.013624218292534351
have O 0 0.01064383052289486
studied O 0 0.0330234132707119
repeat O 0 0.06414969265460968
length O 0 0.02174009196460247
changes O 0 0.01070722471922636
over O 0 0.01285893376916647
time O 0 0.014607638120651245
in O 0 0.025106973946094513
111 O 1 0.9999973773956299
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
with O 0 0.04336952418088913
varying O 0 0.05207758769392967
clinical O 1 0.999996542930603
severity O 1 0.9999996423721313
and O 0 0.26961037516593933
CTG O 1 1.0
repeat O 0 0.1006629690527916
size O 0 0.021340351551771164
over O 0 0.01400656159967184
time O 0 0.012883296236395836
intervals O 0 0.022003062069416046
of O 0 0.0205351822078228
1 O 0 0.06975880265235901
- O 1 0.9998916387557983
7 O 0 0.052914537489414215
years O 0 0.028187384828925133
. O 0 0.03763969615101814

We O 0 0.024616027250885963
have O 0 0.010065321810543537
found O 0 0.012989397160708904
a O 0 0.026768149808049202
direct O 0 0.04663641378283501
progression O 0 0.27813905477523804
of O 0 0.026620252057909966
the O 0 0.032054148614406586
size O 0 0.033203672617673874
heterogeneity O 0 0.09858895093202591
over O 0 0.023861536756157875
time O 0 0.017102453857660294
related O 0 0.018624301999807358
to O 0 0.0236215703189373
initial O 0 0.06420908868312836
CTG O 1 0.9999996423721313
repeat O 0 0.144284188747406
size O 0 0.02812698483467102
and O 0 0.017247432842850685
the O 0 0.025331158190965652
time O 0 0.02884991466999054
interval O 0 0.06912302225828171
and O 0 0.024105411022901535
always O 0 0.03310253098607063
biased O 0 0.0667790025472641
towards O 0 0.038669295608997345
further O 0 0.02816617302596569
expansion O 0 0.06438266485929489
. O 0 0.04105043783783913

Attempts O 0 0.08166493475437164
to O 0 0.030929476022720337
mathematically O 0 0.05600918456912041
model O 0 0.0390186533331871
the O 0 0.03415699303150177
dynamics O 0 0.06433457136154175
have O 0 0.014223327860236168
proved O 0 0.03996897488832474
only O 0 0.01925802044570446
partially O 0 0.06680471450090408
successful O 0 0.05181460455060005
suggesting O 0 0.03204377740621567
that O 0 0.011579839512705803
individual O 0 0.0171967726200819
specific O 0 0.02025013603270054
genetic O 0 0.04458589479327202
and O 0 0.03907548263669014
/ O 1 0.9999991655349731
or O 0 0.03265617415308952
environmental O 0 0.05226335674524307
factors O 0 0.022768445312976837
also O 0 0.012357289902865887
play O 0 0.012209477834403515
a O 0 0.020314931869506836
role O 0 0.03788372501730919
in O 0 0.03478563204407692
somatic O 1 0.9999922513961792
mosaicism O 1 0.9999991655349731
. O 0 0.04473135620355606
. O 0 0.04314764589071274

Aspartylglucosaminuria B-Disease 1 0.9999737739562988
among O 0 0.06649276614189148
Palestinian O 0 0.12353107333183289
Arabs O 0 0.11406031250953674
. O 0 0.04833072051405907

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.6281183958053589
AGU B-Disease 1 1.0
) O 0 0.02740645781159401
is O 0 0.013508464209735394
a O 0 0.02466495893895626
rare O 0 0.06853456795215607
disorder B-Disease 1 1.0
of I-Disease 1 0.9999790191650391
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999843835830688
caused O 0 0.04502624273300171
by O 0 0.02010202966630459
the O 0 0.03811994194984436
deficiency B-Disease 1 1.0
of I-Disease 0 0.03206953406333923
the I-Disease 0 0.06422103196382523
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9999850988388062
aspartylglucosaminidase I-Disease 1 0.9999998807907104
( O 0 0.08250778913497925
AGA O 1 1.0
) O 0 0.05178617313504219
. O 0 0.03727336227893829

AGU B-Disease 1 1.0
is O 0 0.053715500980615616
inherited O 1 0.7775687575340271
as O 0 0.03265366703271866
an O 0 0.047519031912088394
autosomal O 1 0.9999995231628418
recessive O 1 1.0
trait O 1 0.9999511241912842
and O 0 0.03873378410935402
occurs O 0 0.03156068176031113
with O 0 0.016955439001321793
a O 0 0.029290666803717613
high O 0 0.04416954517364502
frequency O 0 0.02572435885667801
in O 0 0.013185938820242882
Finland O 0 0.04319769889116287
because O 0 0.014316827990114689
of O 0 0.019674913957715034
a O 0 0.045455049723386765
founder O 1 0.9992238283157349
effect O 0 0.0551413968205452
. O 0 0.04216958209872246

While O 0 0.04217017814517021
very O 0 0.023409759625792503
few O 0 0.030457131564617157
patients O 1 0.995537281036377
with O 0 0.057228513062000275
AGU B-Disease 1 1.0
have O 0 0.01605948433279991
been O 0 0.011827372945845127
reported O 0 0.01742744632065296
from O 0 0.017948996275663376
non O 0 0.14435003697872162
- O 1 0.9999760389328003
Finnish O 0 0.08817818760871887
origin O 0 0.014989268034696579
, O 0 0.01575477235019207
we O 0 0.017668217420578003
diagnosed O 1 0.9999997615814209
the O 1 0.8571986556053162
disorder O 1 1.0
in O 0 0.045924004167318344
8 O 0 0.25965505838394165
patients O 1 0.9990679621696472
originating O 0 0.06308054178953171
from O 0 0.026322396472096443
3 O 0 0.049554359167814255
unrelated O 0 0.048797208815813065
families O 0 0.031769752502441406
, O 0 0.018923137336969376
all O 0 0.014260630123317242
Palestinian O 0 0.060954026877880096
Arabs O 0 0.054766424000263214
from O 0 0.01635456085205078
the O 0 0.02087835781276226
region O 0 0.031945545226335526
of O 0 0.030893051996827126
Jerusalem O 1 0.9476000666618347
. O 0 0.053231485188007355

The O 0 0.06263431906700134
clinical O 1 0.9998852014541626
diagnosis O 1 1.0
of O 1 0.9999932050704956
AGU B-Disease 1 1.0
is O 0 0.05503964051604271
often O 0 0.022744642570614815
difficult O 0 0.027689078822731972
, O 0 0.01751924678683281
in O 0 0.01313844695687294
particular O 0 0.01603313535451889
early O 0 0.018679847940802574
in O 0 0.010784007608890533
the O 0 0.015854643657803535
course O 0 0.02619660273194313
of O 0 0.02485216036438942
the O 0 0.3340887427330017
disease O 1 1.0
, O 0 0.02487356960773468
and O 0 0.01425829716026783
most O 0 0.010993079282343388
of O 0 0.02006738819181919
the O 0 0.04126110300421715
patients O 1 0.999996542930603
are O 0 0.024092918261885643
diagnosed O 1 1.0
after O 0 0.041001707315444946
the O 0 0.030833981931209564
age O 0 0.03321189060807228
of O 0 0.028923949226737022
5 O 0 0.044239580631256104
years O 0 0.03332032263278961
. O 0 0.038226522505283356

However O 0 0.035623662173748016
, O 0 0.024944579228758812
since O 0 0.028736181557178497
these O 0 0.022683849558234215
patients O 1 0.9996426105499268
excrete O 1 0.9999493360519409
early O 0 0.044802580028772354
large O 0 0.02357187308371067
amounts O 0 0.018193302676081657
of O 0 0.028463538736104965
aspartylglucosamine O 1 0.9998167157173157
in O 0 0.036462895572185516
urine O 0 0.1009223461151123
, O 0 0.039412811398506165
biochemical O 0 0.11259392648935318
screening O 0 0.09154387563467026
is O 0 0.02413334511220455
easy O 0 0.04126422852277756
by O 0 0.0419047512114048
urine O 1 0.868251621723175
chromatography O 1 0.9998278617858887
. O 0 0.03711511939764023
. O 0 0.039317116141319275

Detection O 0 0.10642742365598679
of O 0 0.03344637528061867
heterozygous O 0 0.0675785169005394
carriers O 0 0.03538898751139641
of O 0 0.019439697265625
the O 0 0.045284416526556015
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.05940986052155495
ATM O 1 0.9935594797134399
) O 0 0.021629339084029198
gene O 0 0.02332393452525139
by O 0 0.023085735738277435
G2 O 1 1.0
phase O 0 0.2827785909175873
chromosomal O 1 0.9613755345344543
radiosensitivity O 1 0.9998714923858643
of O 0 0.33960485458374023
peripheral O 1 1.0
blood O 1 1.0
lymphocytes O 1 1.0
. O 0 0.06725870072841644

In O 0 0.0554228276014328
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.04165925830602646
A B-Disease 1 0.9999904632568359
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.04479564353823662
patients O 1 0.9377799034118652
, O 0 0.025165196508169174
mutations O 0 0.026886628940701485
in O 0 0.01126459613442421
a O 0 0.025308439508080482
single O 0 0.044144853949546814
gene O 0 0.039805375039577484
, O 0 0.0266351830214262
ATM O 1 0.5287390947341919
, O 0 0.015780555084347725
result O 0 0.011665049940347672
in O 0 0.013835910707712173
an O 0 0.03909065201878548
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.045404817909002304
embraces O 1 0.9861416220664978
a O 0 0.03162023425102234
variety O 0 0.020274950191378593
of O 0 0.03144528344273567
clinical O 1 0.9988589286804199
features O 0 0.040747955441474915
and O 0 0.031162621453404427
manifests O 1 0.9994039535522461
extreme O 1 0.9997120499610901
radiosensitivity O 1 0.9999960660934448
and O 0 0.019999666139483452
a O 0 0.021915409713983536
strong O 0 0.03250156715512276
pre O 1 0.9980137348175049
- O 1 0.9999994039535522
disposition O 1 0.9986168146133423
to O 0 0.05705340951681137
malignancy B-Disease 1 0.9999998807907104
. O 0 0.06320179998874664

Heterozygotes O 0 0.4486196041107178
for O 0 0.029932765290141106
the O 0 0.04806971922516823
ATM O 1 0.9994737505912781
gene O 0 0.03701131045818329
have O 0 0.007760131731629372
no O 0 0.01561684813350439
clinical O 0 0.046978794038295746
expression O 0 0.02516910620033741
of O 0 0.02467023953795433
A B-Disease 1 0.9999897480010986
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.018670208752155304
may O 0 0.02186359092593193
be O 0 0.023421287536621094
cancer B-Disease 1 1.0
prone O 1 0.9998692274093628
with O 0 0.02523185685276985
a O 0 0.03468956798315048
moderate O 0 0.08448880910873413
increase O 0 0.023678410798311234
in O 0 0.01843479834496975
in O 0 0.03121376223862171
vitro O 1 0.5960514545440674
radiosensitivity O 1 0.9984147548675537
. O 0 0.05530868470668793

We O 0 0.026068050414323807
performed O 0 0.045078568160533905
a O 0 0.04447183758020401
blind O 1 0.9993014335632324
chromosomal O 1 0.6381193399429321
analysis O 0 0.02214139886200428
on O 0 0.03228341042995453
G2 O 1 1.0
- O 1 0.9999997615814209
phase O 1 0.817119836807251
lymphocytes O 1 0.9964297413825989
from O 0 0.015937382355332375
7 O 0 0.028406141325831413
unrelated O 0 0.03957606106996536
A B-Disease 1 0.9993595480918884
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9834158420562744
, O 0 0.018833285197615623
13 O 0 0.028174424543976784
obligate O 0 0.19867321848869324
A B-Disease 1 0.9999722242355347
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.9969409108161926
( O 0 0.027462512254714966
parents O 0 0.02504415437579155
of O 0 0.022739442065358162
the O 0 0.042943600565195084
patients O 1 0.9999996423721313
) O 0 0.028921818360686302
, O 0 0.016555266454815865
and O 0 0.013940461911261082
14 O 0 0.025482336059212685
normal O 0 0.027239039540290833
controls O 0 0.03990945219993591
following O 0 0.037299055606126785
X O 1 0.9999425411224365
- O 1 0.9999969005584717
irradiation O 0 0.13363279402256012
with O 0 0.026450010016560555
1 O 0 0.08202052116394043
Gy O 1 0.9999810457229614
in O 0 0.023450402542948723
order O 0 0.025614287704229355
to O 0 0.02338869869709015
evaluate O 0 0.061009593307971954
this O 0 0.021806595847010612
cytogenetic O 1 0.8198010921478271
method O 0 0.031074756756424904
as O 0 0.021055134013295174
a O 0 0.030612824484705925
tool O 0 0.052050478756427765
for O 0 0.023068632930517197
detection O 0 0.07713278383016586
of O 0 0.05079175904393196
ATM O 1 0.999614953994751
carriers O 0 0.10518347471952438
. O 0 0.04218041151762009

Both O 0 0.033202432096004486
A B-Disease 1 0.9987290501594543
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 1 0.9997963309288025
and O 0 0.04140402004122734
heterozygotes O 1 0.9763914942741394
showed O 0 0.0367467887699604
significantly O 0 0.02762080915272236
increased O 0 0.019289033487439156
levels O 0 0.024325525388121605
of O 0 0.03664952516555786
radiation O 1 0.9999990463256836
- O 1 1.0
induced O 1 1.0
chromatid O 1 1.0
damage O 0 0.08543165028095245
relative O 0 0.04641476646065712
to O 0 0.01959497481584549
that O 0 0.009659813717007637
of O 0 0.024775931611657143
normal O 0 0.05047222226858139
controls O 0 0.07185213267803192
. O 0 0.04488339647650719

These O 0 0.01917209103703499
results O 0 0.013917428441345692
show O 0 0.012716736644506454
that O 0 0.00661545479670167
the O 0 0.028779853135347366
G2 O 1 1.0
- O 1 0.9999997615814209
phase O 1 0.9956451654434204
chromosomal O 1 0.9999134540557861
radiosensitivity O 1 0.9999982118606567
assay O 1 0.5023396015167236
can O 0 0.0159380491822958
be O 0 0.00863710232079029
used O 0 0.007957898080348969
for O 0 0.008678733371198177
the O 0 0.01634857803583145
detection O 0 0.044312942773103714
of O 0 0.027611782774329185
A B-Disease 1 0.9999802112579346
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 1 0.98041832447052
. O 0 0.053630728274583817

In O 0 0.04348507896065712
combination O 0 0.06571520864963531
with O 0 0.03569455072283745
molecular O 0 0.07660794258117676
genetic O 0 0.04979674890637398
analyses O 0 0.03628837317228317
, O 0 0.017878202721476555
this O 0 0.01329503208398819
test O 0 0.03737310692667961
may O 0 0.017997337505221367
be O 0 0.0077524916268885136
of O 0 0.013233253732323647
value O 0 0.013745189644396305
in O 0 0.012089173309504986
studies O 0 0.017877783626317978
of O 0 0.03450169041752815
familial B-Disease 1 0.9999995231628418
and I-Disease 0 0.05927358195185661
sporadic I-Disease 1 0.9999648332595825
cancers I-Disease 1 0.9999998807907104
aimed O 0 0.07050751894712448
at O 0 0.03201312944293022
determination O 0 0.043200310319662094
of O 0 0.016618406400084496
the O 0 0.0191450584679842
potential O 0 0.023985978215932846
involvement O 0 0.041713129729032516
of O 0 0.03281885012984276
ATM O 1 0.9999334812164307
mutations O 0 0.05410308763384819
in O 0 0.04360534995794296
tumor B-Disease 1 1.0
risk O 1 0.9999417066574097
or O 0 0.03899508714675903
development O 0 0.04419739544391632
. O 0 0.026567427441477776
. O 0 0.03565895929932594

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 0.046860355883836746
identification O 0 0.03237399831414223
and O 0 0.016018923372030258
detection O 0 0.045553963631391525
of O 0 0.03214602917432785
founder O 1 0.9999992847442627
- O 1 0.9999986886978149
effect O 0 0.033806148916482925
mutations O 0 0.02347400039434433
in O 0 0.012957219034433365
the O 0 0.03470124304294586
ATM O 1 0.997729480266571
gene O 0 0.04044993221759796
in O 0 0.017565490677952766
ethnic O 0 0.04497537016868591
populations O 0 0.0492587685585022
. O 0 0.04674556478857994

To O 0 0.040427401661872864
facilitate O 0 0.05468573421239853
the O 0 0.03030211664736271
evaluation O 0 0.07325080037117004
of O 0 0.04876893386244774
ATM O 1 0.9991955161094666
heterozygotes O 1 0.9168958067893982
for O 0 0.03991876170039177
susceptibility O 1 0.7628269195556641
to O 0 0.03052792139351368
other O 0 0.028213299810886383
diseases O 1 0.9999998807907104
, O 0 0.022591210901737213
such O 0 0.020822852849960327
as O 1 0.9999321699142456
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.10511159151792526
we O 0 0.016687113791704178
have O 0 0.008361248299479485
attempted O 0 0.03670021891593933
to O 0 0.019974637776613235
define O 0 0.03502558544278145
the O 0 0.02186688221991062
most O 0 0.021006444469094276
common O 0 0.03604501858353615
mutations O 0 0.033550381660461426
and O 0 0.01163625530898571
their O 0 0.010199644602835178
frequencies O 0 0.019268730655312538
in O 0 0.02312922291457653
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0428219810128212
A B-Disease 1 0.999935507774353
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 0.04116411134600639
homozygotes O 0 0.3631819784641266
from O 0 0.02114824950695038
10 O 0 0.026511669158935547
ethnic O 0 0.043982427567243576
populations O 0 0.048243701457977295
. O 0 0.04109899699687958

Both O 0 0.059050023555755615
genomic O 0 0.13913220167160034
mutations O 0 0.052963417023420334
and O 0 0.021230550482869148
their O 0 0.02343248762190342
effects O 0 0.04161315783858299
on O 0 0.03401646018028259
cDNA O 0 0.11869470775127411
were O 0 0.0225253626704216
characterized O 0 0.07326197624206543
. O 0 0.04800103232264519

Protein O 0 0.15662223100662231
- O 1 0.9997965693473816
truncation O 0 0.15127187967300415
testing O 0 0.028538135811686516
of O 0 0.015194782987236977
the O 0 0.023127509281039238
entire O 0 0.056867558509111404
ATM O 0 0.49721163511276245
cDNA O 0 0.16059431433677673
detected O 0 0.07019282132387161
92 O 0 0.10024623572826385
( O 0 0.04181153327226639
66 O 0 0.08263880759477615
% O 0 0.04045717045664787
) O 0 0.03551094979047775
truncating O 1 0.7409958243370056
mutations O 0 0.05223942548036575
in O 0 0.026151198893785477
140 O 0 0.09819867461919785
mutant O 0 0.30852559208869934
alleles O 0 0.14592453837394714
screened O 0 0.13704141974449158
. O 0 0.05615212395787239

The O 0 0.06582208722829819
haplotyping O 1 0.9993935823440552
of O 0 0.06182406470179558
patients O 1 0.9973049163818359
with O 0 0.03491248935461044
identical O 0 0.060311514884233475
mutations O 0 0.05587083101272583
indicates O 0 0.03992987424135208
that O 0 0.010944773443043232
almost O 0 0.012590816244482994
all O 0 0.01077775377780199
of O 0 0.017827602103352547
these O 0 0.010397681035101414
represent O 0 0.026809385046362877
common O 0 0.03697492182254791
ancestry O 0 0.043082818388938904
and O 0 0.02006208337843418
that O 0 0.011656071059405804
very O 0 0.015366408973932266
few O 0 0.024263804778456688
spontaneously O 0 0.29891344904899597
recurring O 1 0.9999864101409912
ATM O 1 0.9999964237213135
mutations O 0 0.07807598263025284
exist O 0 0.03713768720626831
. O 0 0.04035871848464012

Assays O 0 0.13805456459522247
requiring O 0 0.06216178089380264
minimal O 0 0.05542534962296486
amounts O 0 0.028317289426922798
of O 0 0.03987697511911392
genomic O 0 0.09589846432209015
DNA O 0 0.03872082382440567
were O 0 0.013501198962330818
designed O 0 0.031467143446207047
to O 0 0.017950963228940964
allow O 0 0.03021237999200821
rapid O 0 0.08984045684337616
screening O 0 0.09008818119764328
for O 0 0.028694622218608856
common O 0 0.04421836510300636
ethnic O 0 0.0653734803199768
mutations O 0 0.07741198688745499
. O 0 0.05024002492427826

These O 0 0.03677811473608017
rapid O 0 0.14266513288021088
assays O 0 0.1095748022198677
detected O 0 0.07222283631563187
mutations O 0 0.0365784652531147
in O 0 0.017116935923695564
76 O 0 0.058252424001693726
% O 0 0.019327353686094284
of O 0 0.024222154170274734
Costa O 1 0.5107401013374329
Rican O 1 0.9999589920043945
patients O 1 0.9999929666519165
( O 0 0.04401983320713043
3 O 0 0.04400017485022545
) O 0 0.020032275468111038
, O 0 0.013373816385865211
50 O 0 0.016219185665249825
% O 0 0.013469948433339596
of O 0 0.021671224385499954
Norwegian O 1 0.6120050549507141
patients O 1 0.9999890327453613
( O 0 0.04547129198908806
1 O 0 0.057148806750774384
) O 0 0.021209150552749634
, O 0 0.01323771197348833
25 O 0 0.01758403889834881
% O 0 0.01569238305091858
of O 0 0.028509952127933502
Polish O 1 0.9999790191650391
patients O 1 0.9999988079071045
( O 0 0.049594055861234665
4 O 0 0.05702419951558113
) O 0 0.021257974207401276
, O 0 0.013072783127427101
and O 0 0.011621606536209583
14 O 0 0.018174268305301666
% O 0 0.015677550807595253
of O 0 0.026193631812930107
Italian O 1 0.9999933242797852
patients O 1 0.9999998807907104
( O 0 0.048674628138542175
1 O 0 0.06758420914411545
) O 0 0.022471334785223007
, O 0 0.014302099123597145
as O 0 0.014684627763926983
well O 0 0.011021467857062817
as O 0 0.014296540059149265
in O 0 0.01782284304499626
patients O 0 0.06969770044088364
of O 0 0.04761667922139168
Amish O 1 0.9999977350234985
/ O 1 0.9999914169311523
Mennonite O 1 0.989984393119812
and O 0 0.03251532092690468
Irish O 0 0.08089875429868698
English O 0 0.04884614422917366
backgrounds O 0 0.05932020768523216
. O 0 0.04262454807758331

Additional O 0 0.06365940719842911
mutations O 0 0.053181253373622894
were O 0 0.014881343580782413
observed O 0 0.022021397948265076
in O 0 0.018304970115423203
Japanese O 0 0.04610085114836693
, O 0 0.02368035353720188
Utah O 0 0.08057798445224762
Mormon O 0 0.12701423466205597
, O 0 0.022848153486847878
and O 0 0.019853906705975533
African O 0 0.06674864143133163
American O 0 0.44630157947540283
patients O 1 0.9994840621948242
. O 0 0.058284562081098557

These O 0 0.03396448493003845
assays O 0 0.061303719878196716
should O 0 0.019411060959100723
facilitate O 0 0.044264137744903564
screening O 0 0.05373504012823105
for O 0 0.02372877113521099
A B-Disease 1 0.9995627999305725
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
heterozygotes O 1 0.5148204565048218
in O 0 0.022077258676290512
the O 0 0.032705266028642654
populations O 0 0.04128817841410637
studied O 0 0.044431693851947784
. O 0 0.028537925332784653
. O 0 0.04030408710241318

The O 0 0.05310051888227463
von B-Disease 0 0.415628045797348
Hippel I-Disease 1 0.9999986886978149
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 1.0
gene O 0 0.058547209948301315
is O 0 0.017309170216321945
required O 0 0.01876535825431347
for O 0 0.028097672387957573
cell O 0 0.07450607419013977
cycle O 0 0.0777558982372284
exit O 0 0.10955735296010971
upon O 0 0.07355538010597229
serum O 1 0.9997542500495911
withdrawal O 0 0.15482871234416962
. O 0 0.05834421515464783

The O 0 0.057600852102041245
inactivation O 1 0.9145064949989319
of O 0 0.025702258571982384
the O 0 0.033789291977882385
von B-Disease 1 0.9592602252960205
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 0.07548590749502182
VHL I-Disease 1 1.0
) I-Disease 0 0.08916196972131729
tumor I-Disease 1 1.0
suppressor O 1 1.0
gene O 0 0.13800537586212158
predisposes O 1 0.9997401833534241
affected O 0 0.03340788930654526
individuals O 0 0.01151699386537075
to O 0 0.01243218220770359
the O 0 0.02281886711716652
human O 1 0.8197197914123535
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.2594456076622009
is O 0 0.018426457419991493
associated O 0 0.014384720474481583
with O 0 0.014512060210108757
sporadic B-Disease 1 0.9999769926071167
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999849796295166
RCC B-Disease 1 1.0
) O 0 0.051836445927619934
and O 0 0.04195455089211464
brain B-Disease 1 0.9989596605300903
hemangioblastomas I-Disease 1 0.9998946189880371
. O 0 0.05934391915798187

VHL O 1 0.999995231628418
- O 1 0.9998571872711182
negative O 0 0.0722135379910469
786 O 1 0.9999849796295166
- O 1 0.9999998807907104
0 O 1 0.9972203969955444
RCC B-Disease 1 1.0
cells O 0 0.06058204174041748
are O 0 0.014119751751422882
tumorigenic O 0 0.3836708664894104
in O 0 0.0402483232319355
nude O 1 0.9938064813613892
mice O 0 0.07151007652282715
which O 0 0.018330823630094528
is O 0 0.02143879048526287
suppressed O 0 0.06979279220104218
by O 0 0.01776673085987568
the O 0 0.03051924705505371
reintroduction O 0 0.3388977348804474
of O 0 0.07396744936704636
VHL B-Disease 1 0.999997615814209
. O 0 0.06878688931465149

Remarkably O 0 0.13727660477161407
, O 0 0.032861724495887756
this O 0 0.018739571794867516
occurs O 0 0.026892418041825294
without O 0 0.015474598854780197
affecting O 0 0.03375398367643356
the O 0 0.024854032322764397
growth O 0 0.033893246203660965
rate O 0 0.03190014138817787
and O 0 0.02871839515864849
cell O 0 0.07231635600328445
cycle O 0 0.06996200233697891
profile O 0 0.06257695704698563
of O 0 0.029079366475343704
these O 0 0.020686058327555656
cells O 0 0.0493469275534153
in O 0 0.028170162811875343
culture O 0 0.06593235582113266
. O 0 0.04422086104750633

The O 0 0.06161529943346977
786 O 1 0.9999420642852783
- O 1 0.9999974966049194
0 O 0 0.10087097436189651
cell O 0 0.061134081333875656
line O 0 0.036818619817495346
, O 0 0.01765253394842148
like O 0 0.023282835260033607
many O 0 0.03214893862605095
cancer B-Disease 1 1.0
cells O 1 0.6635942459106445
, O 0 0.03339119628071785
fails O 0 0.06494537740945816
to O 0 0.02256985567510128
exit O 0 0.060965679585933685
the O 0 0.034930747002363205
cell O 0 0.06642360240221024
cycle O 0 0.07069624960422516
upon O 0 0.06514675915241241
serum O 1 0.9999860525131226
withdrawal O 1 0.7209718823432922
. O 0 0.05188586190342903

Here O 0 0.050636839121580124
, O 0 0.025506455451250076
it O 0 0.0136337298899889
is O 0 0.014280295930802822
shown O 0 0.01139937061816454
that O 0 0.008447595871984959
reintroduction O 0 0.06389554589986801
of O 0 0.014945358969271183
the O 0 0.021640324965119362
wild O 0 0.05339028686285019
- O 1 0.9999996423721313
type O 1 0.5632700324058533
VHL B-Disease 1 0.9999985694885254
gene O 0 0.05018717795610428
restores O 0 0.09546685963869095
the O 0 0.015910526737570763
ability O 0 0.015982361510396004
of O 0 0.030497554689645767
VHL O 1 1.0
- O 1 1.0
negative O 1 0.9990859031677246
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.055125199258327484
to O 0 0.02368389442563057
exit O 0 0.06440333276987076
the O 0 0.031325563788414
cell O 0 0.06602830439805984
cycle O 0 0.05039024353027344
and O 0 0.02282155677676201
enter O 0 0.09283111989498138
G0 O 1 1.0
/ O 1 0.9999562501907349
quiescence O 1 0.9997549653053284
in O 0 0.05386664718389511
low O 1 0.7121919393539429
serum O 1 0.9999531507492065
. O 0 0.05419108644127846

Both O 0 0.06046527996659279
VHL O 1 0.9999997615814209
- O 1 0.999982476234436
positive O 0 0.037486735731363297
and O 0 0.02971799112856388
VHL O 1 1.0
- O 1 1.0
negative O 0 0.21146057546138763
RCC B-Disease 1 1.0
cells O 0 0.06219501048326492
exit O 0 0.06920414417982101
the O 0 0.037564199417829514
cell O 0 0.07563964277505875
cycle O 0 0.0647958517074585
by O 0 0.03795875608921051
contact O 0 0.1057284027338028
inhibition O 1 0.9628002643585205
. O 0 0.053713370114564896

The O 0 0.06196534261107445
cyclin O 1 0.9999988079071045
- O 1 0.999998927116394
dependent O 0 0.13519112765789032
kinase O 1 0.9999434947967529
inhibitor O 1 0.9999955892562866
, O 0 0.05818038061261177
p27 O 1 0.9999926090240479
, O 0 0.04521404951810837
accumulates O 0 0.18242289125919342
upon O 0 0.06444936990737915
serum O 1 0.9999886751174927
withdrawal O 0 0.15447945892810822
, O 0 0.018374798819422722
only O 0 0.008809779770672321
in O 0 0.009338338859379292
the O 0 0.017942070960998535
presence O 0 0.036844849586486816
of O 0 0.04541264474391937
VHL B-Disease 1 0.9999998807907104
, O 0 0.026298344135284424
as O 0 0.01774282194674015
a O 0 0.018781347200274467
result O 0 0.013750105164945126
of O 0 0.01644972711801529
the O 0 0.027980156242847443
stabilization O 1 0.9847463369369507
of O 0 0.03350672870874405
the O 0 0.051206234842538834
protein O 0 0.05892821401357651
. O 0 0.03409735485911369

We O 0 0.02762185037136078
propose O 0 0.03577958419919014
that O 0 0.006871641613543034
the O 0 0.013517859391868114
loss O 0 0.025679968297481537
of O 0 0.022952890023589134
wild O 0 0.06289201229810715
- O 1 1.0
type O 1 0.9827926754951477
VHL B-Disease 1 0.9999995231628418
gene O 0 0.04318324849009514
results O 0 0.011625577695667744
in O 0 0.009628012776374817
a O 0 0.019605008885264397
specific O 0 0.018294792622327805
cellular O 0 0.06875205039978027
defect O 1 0.9991114735603333
in O 0 0.03629700466990471
serum O 1 1.0
- O 1 1.0
dependent O 0 0.06409887224435806
growth O 0 0.036031853407621384
control O 0 0.036829352378845215
, O 0 0.018571430817246437
which O 0 0.017460552975535393
may O 0 0.031637564301490784
initiate O 1 0.9998502731323242
tumor B-Disease 1 1.0
formation O 1 0.9949277639389038
. O 0 0.06335199624300003

This O 0 0.0285810399800539
is O 0 0.02700718492269516
corrected O 0 0.05640529841184616
by O 0 0.013460280373692513
the O 0 0.01946190372109413
reintroduction O 0 0.08774494379758835
of O 0 0.02718210406601429
wild O 0 0.06623267382383347
- O 1 0.9999996423721313
type O 1 0.6468382477760315
VHL B-Disease 1 0.9999985694885254
, O 0 0.048303671181201935
implicating O 1 0.9999954700469971
VHL B-Disease 1 0.999998927116394
as O 0 0.021835297346115112
the O 0 0.027502596378326416
first O 0 0.1455731987953186
tumor B-Disease 1 1.0
suppressor O 1 0.9999997615814209
involved O 0 0.023572662845253944
in O 0 0.011319131590425968
the O 0 0.01853940449655056
regulation O 0 0.03148473799228668
of O 0 0.034404952079057693
cell O 0 0.2861025631427765
cycle O 0 0.07835816591978073
exit O 0 0.08853159099817276
, O 0 0.023607879877090454
which O 0 0.01353065948933363
is O 0 0.013504588045179844
consistent O 0 0.02020970918238163
with O 0 0.011650620959699154
its O 0 0.02873753011226654
gatekeeper O 1 0.9999998807907104
function O 0 0.03823132812976837
in O 0 0.02231457084417343
the O 0 0.060517679899930954
kidney O 1 1.0
. O 0 0.047463152557611465
. O 0 0.04931275174021721

Piebaldism B-Disease 1 0.9999998807907104
with O 0 0.24428673088550568
deafness B-Disease 1 1.0
: O 0 0.0648389458656311
molecular O 0 0.03552689403295517
evidence O 0 0.013019264675676823
for O 0 0.014993627555668354
an O 0 0.030500095337629318
expanded O 1 0.592791736125946
syndrome O 1 1.0
. O 0 0.06748078018426895

In O 0 0.02683284692466259
a O 0 0.025553163141012192
South O 0 0.04338245093822479
African O 0 0.050910573452711105
girl O 0 0.0857083797454834
of O 0 0.03844181075692177
Xhosa O 1 0.9999953508377075
stock O 0 0.07277783751487732
with O 0 0.030207237228751183
severe O 1 0.9999736547470093
piebaldism B-Disease 1 1.0
and O 0 0.47611063718795776
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.04315543547272682
identified O 0 0.02813476137816906
a O 0 0.02620663307607174
novel O 0 0.0568082258105278
missense O 0 0.1228831484913826
substitution O 0 0.06832944601774216
at O 0 0.023984510451555252
a O 0 0.026228126138448715
highly O 0 0.039147306233644485
conserved O 0 0.047548532485961914
residue O 0 0.06279892474412918
in O 0 0.014923080801963806
the O 0 0.03389410674571991
intracellular O 1 0.9998973608016968
kinase O 1 0.9898504018783569
domain O 0 0.03164134547114372
of O 0 0.014925329014658928
the O 0 0.02726772427558899
KIT O 1 0.9999921321868896
proto O 1 0.9999998807907104
- O 1 1.0
oncogene O 1 0.9999988079071045
, O 0 0.05351044237613678
R796G O 1 0.9974442720413208
. O 0 0.045513879507780075

Though O 0 0.08878244459629059
auditory B-Disease 1 0.9991932511329651
anomalies I-Disease 1 0.7975279688835144
have O 0 0.014272698201239109
been O 0 0.014670483767986298
observed O 0 0.018059708178043365
in O 0 0.017428508028388023
mice O 0 0.036676209419965744
with O 0 0.018042273819446564
dominant O 0 0.1452106386423111
white O 1 0.9731387495994568
spotting O 1 0.9999970197677612
( O 0 0.07619716972112656
W O 1 0.9999990463256836
) O 0 0.02357550710439682
due O 0 0.021848037838935852
to O 0 0.034730132669210434
KIT O 1 0.9999996423721313
mutations O 0 0.07806422561407089
, O 0 0.060506515204906464
deafness B-Disease 1 1.0
is O 0 0.03241269290447235
not O 0 0.016035670414566994
typical O 0 0.037158239632844925
in O 0 0.023116134107112885
human O 0 0.05185770243406296
piebaldism B-Disease 1 0.9996926784515381
. O 0 0.054954893887043

Thus O 0 0.03714270144701004
, O 0 0.015924517065286636
the O 0 0.021238815039396286
occurrence O 0 0.06661251932382584
of O 0 0.0868668183684349
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.058577366173267365
this O 0 0.03260874003171921
patient O 1 0.999609649181366
extends O 0 0.0799652710556984
considerably O 0 0.037074241787195206
the O 0 0.025315986946225166
phenotypic O 0 0.05697706714272499
range O 0 0.02101815678179264
of O 0 0.02954777516424656
piebaldism B-Disease 1 0.9975858926773071
due O 0 0.034906912595033646
to O 0 0.043336234986782074
KIT O 1 0.9999998807907104
gene O 0 0.07154785096645355
mutation O 0 0.06086668372154236
in O 0 0.02445976808667183
humans O 0 0.03052731789648533
and O 0 0.03003663755953312
tightens O 1 0.9660940170288086
the O 0 0.041897743940353394
clinical O 1 0.5938522815704346
similarity O 0 0.0508321188390255
between O 0 0.03684019297361374
piebaldism B-Disease 1 0.9990866184234619
and O 0 0.015259422361850739
the O 0 0.013541375286877155
various O 0 0.00862096156924963
forms O 0 0.029739923775196075
of O 1 0.9998663663864136
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.15560980141162872
. O 0 0.052801020443439484

Cycloheximide O 1 0.9994578957557678
facilitates O 0 0.13277241587638855
the O 0 0.03148043155670166
identification O 0 0.03443499654531479
of O 0 0.035027194768190384
aberrant O 1 0.991854190826416
transcripts O 0 0.06595095992088318
resulting O 0 0.02704690210521221
from O 0 0.014917121268808842
a O 0 0.02588384784758091
novel O 0 0.06919414550065994
splice O 1 0.9080517888069153
- O 1 0.9990054965019226
site O 0 0.054729972034692764
mutation O 0 0.046236101537942886
in O 0 0.01893984153866768
COL17A1 O 1 0.9995344877243042
in O 0 0.019954197108745575
a O 0 0.034931328147649765
patient O 1 0.988696813583374
with O 0 0.05086493864655495
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.10484573245048523

Patients O 1 0.9930478930473328
with O 0 0.06209685280919075
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.04094455763697624
show O 0 0.03086535446345806
decreased O 0 0.0388515330851078
expression O 0 0.027479304000735283
of O 0 0.029981836676597595
type O 1 0.9999725818634033
XVII O 1 1.0
collagen O 1 1.0
, O 0 0.0322917215526104
a O 0 0.04367229714989662
transmembrane O 1 0.9872287511825562
hemidesmosomal O 1 0.9999175071716309
protein O 0 0.05567276105284691
encoded O 0 0.026958845555782318
by O 0 0.029569363221526146
COL17A1 O 1 0.9988738894462585
. O 0 0.047262273728847504

This O 0 0.020314257591962814
report O 0 0.017069397494196892
documents O 0 0.01787291280925274
a O 0 0.02360246330499649
novel O 0 0.06430041044950485
splice O 1 0.9399440884590149
- O 1 0.9995993971824646
site O 0 0.04678034037351608
mutation O 0 0.040199849754571915
in O 0 0.01907270960509777
COL17A1 O 1 0.9998201727867126
in O 0 0.017535923048853874
a O 0 0.030632315203547478
patient O 1 0.9960693120956421
with O 0 0.04167906567454338
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.06476020812988281
and O 0 0.032256320118904114
applies O 0 0.043814633041620255
a O 0 0.028530946001410484
new O 0 0.029935451224446297
methodology O 0 0.04054909572005272
to O 0 0.02250724285840988
define O 0 0.04320434853434563
and O 0 0.022142337635159492
characterize O 0 0.07976718991994858
the O 0 0.03577451407909393
resulting O 0 0.06550301611423492
mRNA O 0 0.13097403943538666
splice O 0 0.19225183129310608
variants O 0 0.05854159966111183
. O 0 0.03824504837393761

Mutational O 1 0.9938403367996216
analysis O 0 0.031164400279521942
of O 0 0.03466774895787239
COL17A1 O 1 0.9989853501319885
identified O 0 0.02710622362792492
a O 0 0.027987157925963402
maternally O 0 0.1362588107585907
inherited O 1 0.9985927939414978
G O 1 0.9999926090240479
- O 1 0.9999871253967285
to O 0 0.034816909581422806
- O 1 0.9999997615814209
T O 1 0.9999613761901855
transversion O 1 0.9951587319374084
at O 0 0.022732241079211235
the O 0 0.027595670893788338
- O 1 0.9998125433921814
1 O 0 0.03423376753926277
position O 0 0.02584998309612274
of O 0 0.02721766009926796
exon O 0 0.25541648268699646
32 O 0 0.0678253024816513
. O 0 0.04201803728938103

This O 0 0.0396399199962616
acceptor O 1 0.9953734278678894
splice O 1 0.9867234826087952
- O 1 0.9999473094940186
site O 0 0.06552105396986008
mutation O 0 0.050152361392974854
led O 0 0.034902460873126984
to O 0 0.01737166754901409
the O 0 0.021578768268227577
formation O 0 0.048306018114089966
of O 0 0.03450186923146248
aberrant O 1 0.9994187355041504
transcripts O 0 0.06806735694408417
present O 0 0.028961120173335075
at O 0 0.037361375987529755
extremely O 0 0.05691885948181152
low O 0 0.08039306104183197
levels O 0 0.05366388335824013
. O 0 0.042073216289281845

Based O 0 0.043932605534791946
on O 0 0.018796026706695557
our O 0 0.019844964146614075
recent O 0 0.0174783393740654
finding O 0 0.02593841217458248
that O 0 0.017473574727773666
cycloheximide O 1 0.9995651841163635
stabilized O 1 0.999930739402771
mutant O 1 0.8944670557975769
COL17A1 O 1 0.9998897314071655
transcripts O 0 0.08049436658620834
in O 0 0.031439024955034256
keratinocytes O 1 0.9319838881492615
homozygous O 0 0.0797162875533104
for O 0 0.024592412635684013
a O 0 0.054010022431612015
frameshift O 1 0.9999159574508667
mutation O 0 0.08081265538930893
, O 0 0.022212686017155647
the O 0 0.02390812151134014
effects O 0 0.02889249287545681
of O 0 0.02147624082863331
the O 0 0.042607929557561874
splice O 1 0.9972489476203918
- O 1 0.9994933605194092
site O 0 0.05373338982462883
mutation O 0 0.04203122854232788
on O 0 0.023314861580729485
splicing O 0 0.06148394197225571
of O 0 0.03574835881590843
COL17A1 O 1 0.9998001456260681
transcripts O 0 0.05324023962020874
were O 0 0.009418843314051628
determined O 0 0.02009679563343525
using O 0 0.016383541747927666
reverse O 0 0.08600795269012451
transcriptase O 1 0.9996895790100098
polymerase O 1 0.9869046807289124
chain O 0 0.09295857697725296
reaction O 0 0.039934515953063965
of O 0 0.02361549250781536
total O 0 0.03269335255026817
RNA O 0 0.08396335691213608
from O 0 0.03237592428922653
keratinocytes O 1 0.9557534456253052
incubated O 0 0.1555914729833603
for O 0 0.03704709932208061
2 O 0 0.06636101752519608
. O 0 0.040289200842380524

5 O 0 0.09242289513349533
h O 0 0.12996651232242584
in O 0 0.019355408847332
the O 0 0.02619607374072075
presence O 0 0.039652928709983826
or O 0 0.02164142020046711
absence O 0 0.03877794370055199
of O 0 0.028331225737929344
10 O 0 0.04753439500927925
microg O 1 0.9998564720153809
cycloheximide O 1 0.9997519850730896
per O 0 0.05643996223807335
ml O 1 0.998137354850769
. O 0 0.048833295702934265

Using O 0 0.030157772824168205
this O 0 0.0164556372910738
approach O 0 0.03621906042098999
, O 0 0.021951111033558846
an O 0 0.0314498245716095
abnormally O 1 0.9630062580108643
spliced O 0 0.11821191757917404
transcript O 0 0.07486384361982346
was O 0 0.03272499889135361
identified O 0 0.023879824206233025
that O 0 0.010744341649115086
contains O 0 0.0209935512393713
an O 0 0.020553303882479668
extra O 0 0.037888046354055405
264 O 0 0.09788255393505096
bases O 0 0.0467209666967392
upstream O 0 0.05863108113408089
from O 0 0.02765679731965065
exon O 0 0.16220976412296295
32 O 0 0.04612152650952339
, O 0 0.021451666951179504
resulting O 0 0.026429733261466026
in O 0 0.017114130780100822
a O 0 0.04467238485813141
premature O 1 0.9997541308403015
termination O 1 0.9995388984680176
codon O 0 0.24764513969421387
27 O 0 0.07122830301523209
bp O 0 0.09372547268867493
downstream O 0 0.04708726704120636
from O 0 0.017774827778339386
the O 0 0.034665100276470184
cryptic O 0 0.48402807116508484
splice O 0 0.28061869740486145
site O 0 0.06927613168954849
. O 0 0.03809424862265587

Three O 0 0.03376685827970505
other O 0 0.031044254079461098
splice O 0 0.23347987234592438
variants O 0 0.051021113991737366
, O 0 0.021939914673566818
including O 0 0.018196286633610725
one O 0 0.021228421479463577
derived O 0 0.02013835497200489
from O 0 0.014901252463459969
the O 0 0.025583632290363312
skipping O 0 0.08658351749181747
of O 0 0.04298834130167961
exon O 1 0.8933624029159546
32 O 0 0.05791805684566498
, O 0 0.024243319407105446
were O 0 0.014453422278165817
also O 0 0.02323211543262005
identified O 0 0.03960532695055008
. O 0 0.037188105285167694

These O 0 0.02353302761912346
results O 0 0.01768244244158268
indicate O 0 0.01743750087916851
the O 0 0.023699849843978882
usefulness O 0 0.08929409086704254
of O 0 0.051400076597929
cycloheximide O 1 0.9999983310699463
treatment O 1 0.9986489415168762
in O 0 0.02338135801255703
evaluating O 0 0.05635954439640045
the O 0 0.03522692248225212
abnormal O 0 0.4279041886329651
processing O 0 0.02874198742210865
of O 0 0.02399587072432041
mRNA O 0 0.048451442271471024
due O 0 0.01653141714632511
to O 0 0.023568646982312202
splice O 1 0.9502289891242981
- O 1 0.9999127388000488
site O 0 0.05316099151968956
mutations O 0 0.04250885918736458
, O 0 0.023391222581267357
because O 0 0.0220025721937418
( O 0 0.030961936339735985
i O 0 0.03539566695690155
) O 0 0.03521193191409111
aberrant O 1 0.9805563688278198
splicing O 0 0.06712412089109421
often O 0 0.013439364731311798
generates O 0 0.03166351839900017
a O 0 0.03306058421730995
premature O 1 0.9978728294372559
termination O 1 0.9999138116836548
codon O 1 0.8832030892372131
, O 0 0.03249260038137436
( O 0 0.034721214324235916
ii O 1 0.999618649482727
) O 0 0.025005096569657326
transcripts O 0 0.042070697993040085
with O 0 0.023695584386587143
premature O 1 0.9998955726623535
termination O 1 0.9999948740005493
codons O 0 0.3951689600944519
can O 0 0.019466474652290344
occur O 0 0.019200878217816353
at O 0 0.03297584131360054
low O 0 0.06931553781032562
or O 0 0.043852802366018295
undetectable O 1 0.9999780654907227
levels O 0 0.03509601578116417
due O 0 0.02325258031487465
to O 0 0.02480798214673996
nonsense O 0 0.15842024981975555
- O 1 0.9998737573623657
mediated O 1 0.5693215727806091
mRNA O 0 0.09498590975999832
decay O 0 0.26752012968063354
, O 0 0.025243621319532394
and O 0 0.024389799684286118
( O 0 0.04377954080700874
iii O 1 0.9999063014984131
) O 0 0.026781480759382248
the O 0 0.02464386448264122
levels O 0 0.029740525409579277
of O 0 0.021518846973776817
these O 0 0.015125350095331669
transcripts O 0 0.055213961750268936
can O 0 0.012117167003452778
be O 0 0.010420619510114193
increased O 0 0.02392745390534401
by O 0 0.035467930138111115
cycloheximide O 1 0.99953293800354
. O 0 0.05199342966079712

A O 0 0.1134217381477356
deletion O 0 0.20574061572551727
mutation O 0 0.07533352822065353
in O 0 0.03324621170759201
COL17A1 O 1 0.9999167919158936
in O 0 0.017880046740174294
five O 0 0.01887395605444908
Austrian O 0 0.07843022048473358
families O 0 0.03399903327226639
with O 0 0.037559185177087784
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.14938046038150787
propagation O 0 0.1189083382487297
of O 0 0.03295646980404854
an O 0 0.042172446846961975
ancestral O 0 0.43924838304519653
allele O 0 0.12513983249664307
. O 0 0.047031354159116745

Patients O 1 0.9974839687347412
with O 0 0.06542305648326874
generalized O 1 1.0
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.05301312357187271
a O 0 0.03317774087190628
usually O 0 0.023688802495598793
nonlethal O 0 0.09755294770002365
form O 0 0.03241811320185661
of O 0 0.05978105217218399
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.04075615853071213
have O 0 0.017464203760027885
generalized O 1 0.9332497715950012
blistering B-Disease 1 0.9999939203262329
, O 0 0.4647974371910095
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.3892388939857483
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 0.1123591810464859
and O 1 0.702934980392456
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.07858290523290634

Skin B-Disease 1 1.0
fragility I-Disease 1 0.9999998807907104
in O 0 0.035501331090927124
most O 0 0.026598414406180382
cases O 0 0.025923501700162888
is O 0 0.019116926938295364
due O 0 0.02237607166171074
to O 0 0.02286592498421669
mutations O 0 0.023782450705766678
in O 0 0.009504269808530807
the O 0 0.020063985139131546
gene O 0 0.03709376975893974
encoding O 0 0.05711837485432625
type O 1 0.913642406463623
XVII O 1 1.0
collagen O 1 1.0
( O 0 0.20153340697288513
COL17A1 O 1 0.9999995231628418
) O 0 0.04893620312213898
. O 0 0.03611404076218605

Recently O 0 0.08838068693876266
, O 0 0.024886079132556915
we O 0 0.010775048285722733
reported O 0 0.016226518899202347
five O 0 0.015286028385162354
Austrian O 0 0.07623527944087982
families O 0 0.03772515058517456
with O 0 0.04102558270096779
generalized O 1 0.9999996423721313
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.07261085510253906
share O 0 0.03145784139633179
the O 0 0.029477238655090332
same O 0 0.04006728529930115
COL17A1 O 1 0.9999984502792358
mutation O 0 0.10394928604364395
. O 0 0.0443420335650444

Affected O 0 0.08264411985874176
individuals O 0 0.023542819544672966
in O 0 0.01675873063504696
three O 0 0.015388031490147114
families O 0 0.025942523032426834
are O 0 0.010005414485931396
homozygous O 0 0.07923039048910141
for O 0 0.04208366945385933
4003delTC O 1 0.9999960660934448
, O 0 0.03550170734524727
whereas O 0 0.03172833099961281
those O 0 0.01247015967965126
in O 0 0.014144903048872948
two O 0 0.014090615324676037
others O 0 0.02361142449080944
are O 0 0.016649020835757256
compound O 0 0.3624824285507202
heterozygotes O 1 0.9641653895378113
. O 0 0.06391426175832748

To O 0 0.038774821907281876
determine O 0 0.02384854480624199
if O 0 0.013858798891305923
the O 0 0.020847167819738388
occurrence O 0 0.058721527457237244
of O 0 0.03851200267672539
4003delTC O 1 0.9996932744979858
in O 0 0.021830733865499496
these O 0 0.01153254508972168
unrelated O 0 0.0414237305521965
families O 0 0.04416216164827347
signifies O 1 0.9783515334129333
propagation O 0 0.08212427794933319
of O 0 0.026077644899487495
an O 0 0.030868135392665863
ancestral O 1 0.8740367293357849
allele O 0 0.10059711337089539
or O 0 0.026536762714385986
a O 0 0.05275125429034233
mutational O 1 0.9999674558639526
hot O 1 0.9996463060379028
spot O 0 0.10192938894033432
, O 0 0.03796445205807686
haplotypes O 0 0.10026563704013824
were O 0 0.014402567408978939
determined O 0 0.03373083472251892
for O 0 0.027413098141551018
polymorphisms O 0 0.08329883962869644
both O 0 0.017432427033782005
within O 0 0.024918856099247932
and O 0 0.03916933760046959
flanking O 1 0.9999547004699707
COL17A1 O 1 0.9999996423721313
. O 0 0.06813535839319229

Five O 0 0.08148951828479767
intragenic O 1 0.9976469874382019
polymorphisms O 0 0.12150977551937103
were O 0 0.016334597021341324
chosen O 0 0.030297866091132164
based O 0 0.02076943963766098
on O 0 0.019460227340459824
their O 0 0.026001667603850365
informativeness O 1 0.9843553304672241
. O 0 0.052824899554252625

One O 0 0.036877214908599854
of O 0 0.027805546298623085
these O 0 0.01351197250187397
, O 0 0.015295175835490227
not O 0 0.009135439060628414
previously O 0 0.01985984295606613
reported O 0 0.02158602513372898
, O 0 0.018446441739797592
was O 0 0.03857625275850296
2988 O 1 0.9996378421783447
A O 0 0.07157193124294281
or O 0 0.03680248185992241
C O 1 0.5986029505729675
that O 0 0.013407127931714058
introduces O 0 0.05547264963388443
a O 0 0.022765139117836952
new O 0 0.025730939581990242
restriction O 0 0.049313709139823914
site O 0 0.041537363082170486
for O 0 0.033658113330602646
Eco0109 O 1 0.9999727010726929
I O 0 0.08529367297887802
. O 0 0.0455910749733448

All O 0 0.02667132206261158
the O 0 0.049761515110731125
4003delTC O 1 0.9998001456260681
alleles O 0 0.08244431763887405
showed O 0 0.029322000220417976
the O 0 0.025189658626914024
same O 0 0.024592014029622078
haplotype O 0 0.1191953718662262
for O 0 0.01811823807656765
these O 0 0.011904808692634106
five O 0 0.03610796853899956
polymorphic O 1 0.9980594515800476
markers O 0 0.13150088489055634
. O 0 0.054966215044260025

Fourteen O 0 0.20819702744483948
microsatellite O 1 0.9362395405769348
polymorphisms O 0 0.13281208276748657
were O 0 0.01750475913286209
selected O 0 0.028078339993953705
based O 0 0.01985461823642254
on O 0 0.014632214792072773
their O 0 0.017559263855218887
high O 0 0.06704459339380264
heterozygosity O 1 0.9960617423057556
and O 0 0.020277317613363266
their O 0 0.013304249383509159
location O 0 0.022092722356319427
within O 0 0.023118609562516212
10q23 O 1 0.999779999256134
- O 1 0.9999978542327881
q25 O 1 0.9994103908538818
near O 0 0.12145031988620758
COL17A1 O 1 0.9999316930770874
. O 0 0.04862196743488312

Three O 0 0.030708249658346176
families O 0 0.045524049550294876
shared O 0 0.07283182442188263
microsatellite O 1 0.9970390796661377
polymorphisms O 0 0.14773814380168915
covering O 0 0.05989060178399086
at O 0 0.03392408415675163
most O 0 0.022353269159793854
19 O 0 0.0573563314974308
cM O 0 0.07418806105852127
, O 0 0.025637106969952583
whereas O 0 0.030406959354877472
the O 0 0.023624733090400696
others O 0 0.022641103714704514
shared O 0 0.03201761469244957
smaller O 0 0.024968435987830162
regions O 0 0.02140258625149727
consistent O 0 0.03376008942723274
with O 0 0.02298644371330738
cross O 0 0.08914241939783096
- O 1 0.9999743700027466
over O 0 0.02449832484126091
events O 0 0.016229571774601936
during O 0 0.02086624875664711
passage O 0 0.04394512623548508
of O 0 0.02328301966190338
this O 0 0.02046799845993519
mutation O 0 0.05229547619819641
through O 0 0.02112402394413948
several O 0 0.020236371085047722
generations O 0 0.06874828785657883
. O 0 0.04823168367147446

These O 0 0.026653626933693886
results O 0 0.02340989001095295
indicate O 0 0.025440262630581856
that O 0 0.017833374440670013
4003delTC O 1 0.9921780228614807
occurs O 0 0.027333009988069534
on O 0 0.015969721600413322
a O 0 0.025930726900696754
single O 0 0.06209756061434746
ancestral O 1 0.9486027359962463
allele O 0 0.11831750720739365
. O 0 0.03039797581732273
. O 0 0.03522235155105591

The O 0 0.06736508756875992
haptoglobin O 1 0.9998784065246582
- O 1 0.9999969005584717
gene O 0 0.07223360985517502
deletion O 0 0.09822912514209747
responsible O 0 0.05757676810026169
for O 0 0.04635060951113701
anhaptoglobinemia B-Disease 1 0.9996920824050903
. O 0 0.05874068662524223

We O 0 0.026125798001885414
have O 0 0.009228446520864964
found O 0 0.012621346861124039
an O 0 0.020780721679329872
allelic O 0 0.17578500509262085
deletion O 0 0.08782469481229782
of O 0 0.03098570741713047
the O 0 0.05171314254403114
haptoglobin O 1 0.9999923706054688
( O 0 0.06518889218568802
Hp O 1 0.9995447993278503
) O 0 0.03868512809276581
gene O 0 0.03135574609041214
from O 0 0.015883395448327065
an O 0 0.01824842393398285
individual O 0 0.022098196670413017
with O 0 0.033290863037109375
anhaptoglobinemia B-Disease 1 0.999941349029541
. O 0 0.05500556156039238

The O 0 0.06934111565351486
Hp O 1 0.9964481592178345
gene O 0 0.07244857400655746
cluster O 0 0.07797501981258392
consists O 0 0.0363023467361927
of O 0 0.03033420257270336
coding O 0 0.05727308616042137
regions O 0 0.015075813047587872
of O 0 0.01568431593477726
the O 0 0.029853586107492447
alpha O 1 0.988579273223877
chain O 0 0.05986783653497696
and O 0 0.021091528236865997
beta O 0 0.09761945903301239
chain O 0 0.042333684861660004
of O 0 0.02145560272037983
the O 0 0.040692709386348724
haptoglobin O 1 0.9999992847442627
gene O 0 0.0708305761218071
( O 0 0.043055444955825806
Hp O 1 0.9732580184936523
) O 0 0.017360031604766846
and O 0 0.009713878855109215
of O 0 0.013994201086461544
the O 0 0.028691381216049194
alpha O 1 0.9696248769760132
chain O 0 0.06108918786048889
and O 0 0.022599011659622192
beta O 0 0.09126097708940506
chain O 0 0.04036734998226166
of O 0 0.016466962173581123
the O 0 0.032721471041440964
haptoglobin O 1 0.9999992847442627
- O 1 0.9999996423721313
related O 0 0.050660233944654465
gene O 0 0.05772715061903
( O 0 0.048812780529260635
Hpr O 1 0.9999903440475464
) O 0 0.03255869820713997
, O 0 0.019627705216407776
in O 0 0.020881125703454018
tandem O 0 0.08049345016479492
from O 0 0.024043647572398186
the O 0 0.034909773617982864
5 O 0 0.052469007670879364
side O 0 0.057778581976890564
. O 0 0.042996831238269806

Southern O 0 0.15599538385868073
blot O 1 0.9990963935852051
and O 0 0.06797145307064056
PCR O 1 0.7480350136756897
analyses O 0 0.04426819458603859
have O 0 0.011133173480629921
indicated O 0 0.02217252179980278
that O 0 0.008278598077595234
the O 0 0.017136167734861374
individual O 0 0.017307845875620842
with O 0 0.02262748032808304
anhaptoglobinemia B-Disease 1 0.9989802241325378
was O 0 0.043330997228622437
homozygous O 0 0.06282415241003036
for O 0 0.018617471680045128
the O 0 0.03854789212346077
gene O 0 0.06006006523966789
deletion O 0 0.0762845054268837
and O 0 0.01753140799701214
that O 0 0.010887646116316319
the O 0 0.029953069984912872
gene O 0 0.05272914096713066
deletion O 0 0.08707684278488159
was O 0 0.03550567477941513
included O 0 0.020638344809412956
at O 0 0.02192366123199463
least O 0 0.011965550482273102
from O 0 0.014913256280124187
the O 0 0.02858152613043785
promoter O 1 0.92558354139328
region O 0 0.036296118050813675
of O 0 0.032733723521232605
Hp O 1 0.9458868503570557
to O 0 0.05127011239528656
Hpr O 1 0.9999945163726807
alpha O 0 0.11297930032014847
but O 0 0.013752961531281471
not O 0 0.009553324431180954
to O 0 0.02895406261086464
Hpr O 1 0.999976634979248
beta O 1 0.9990429282188416
( O 0 0.07212987542152405
Hpdel O 1 0.9998844861984253
) O 0 0.04639032483100891
. O 0 0.03859082981944084

In O 0 0.04146668687462807
addition O 0 0.03583265841007233
, O 0 0.022807221859693527
we O 0 0.012867792509496212
found O 0 0.013293362222611904
seven O 0 0.018521003425121307
individuals O 0 0.016364166513085365
with O 0 0.027289073914289474
hypohaptoglobinemia B-Disease 1 0.9999473094940186
in O 0 0.022070249542593956
three O 0 0.019700048491358757
families O 0 0.03398194536566734
, O 0 0.02109750173985958
and O 0 0.018381670117378235
the O 0 0.03171055391430855
genotypes O 0 0.12909014523029327
of O 0 0.024210330098867416
six O 0 0.020780088379979134
of O 0 0.022350067272782326
the O 0 0.025911659002304077
seven O 0 0.023891475051641464
individuals O 0 0.01680636592209339
were O 0 0.011324756778776646
found O 0 0.012282799929380417
to O 0 0.01783650368452072
be O 0 0.024484902620315552
Hp2 O 1 0.9999942779541016
/ O 1 0.9999935626983643
Hpdel O 1 0.9999120235443115
. O 0 0.058521904051303864

The O 0 0.08395686000585556
phenotypes O 0 0.16656188666820526
and O 0 0.05290248990058899
genotypes O 0 0.48064401745796204
in O 0 0.02440107986330986
one O 0 0.020431455224752426
of O 0 0.019499385729432106
these O 0 0.008801031857728958
three O 0 0.013431704603135586
families O 0 0.023894747719168663
showed O 0 0.02322111651301384
the O 0 0.023157574236392975
father O 0 0.04924006760120392
to O 0 0.022519148886203766
be O 0 0.020677192136645317
hypohaptoglobinemic B-Disease 1 0.9997294545173645
( O 0 0.04848799481987953
Hp2 O 1 0.9999325275421143
) O 0 0.030510922893881798
and O 0 0.029941324144601822
Hp2 O 1 0.9999986886978149
/ O 1 0.9999995231628418
Hpdel O 1 0.9999746084213257
, O 0 0.024243494495749474
the O 0 0.02280988171696663
mother O 0 0.04525366798043251
to O 0 0.017094651237130165
be O 0 0.016335347667336464
Hp2 O 1 0.9997960925102234
- O 1 0.9997960925102234
1 O 0 0.04518737643957138
and O 0 0.03059353493154049
Hp1 O 1 0.9999986886978149
/ O 1 0.9999978542327881
Hp2 O 1 0.9999445676803589
, O 0 0.020971549674868584
one O 0 0.012098242528736591
of O 0 0.013490671291947365
the O 0 0.017256293445825577
two O 0 0.012896910309791565
children O 0 0.027145221829414368
to O 0 0.02031683921813965
be O 0 0.02109391614794731
hypohaptoglobinemic B-Disease 1 0.9998606443405151
( O 0 0.04799703136086464
Hp2 O 1 0.9999136924743652
) O 0 0.029652943834662437
and O 0 0.03427410125732422
Hp2 O 1 0.9999997615814209
/ O 1 0.9999995231628418
Hpdel O 1 0.9999940395355225
, O 0 0.026433225721120834
and O 0 0.015956755727529526
the O 0 0.020074525848031044
other O 0 0.01551319845020771
child O 0 0.04922419786453247
to O 0 0.022150594741106033
be O 0 0.018732083961367607
Hp1 O 1 0.9739694595336914
and O 0 0.04574672505259514
Hp1 O 1 0.9999995231628418
/ O 1 0.999998927116394
Hpdel O 1 0.9999291896820068
, O 0 0.02541649341583252
showing O 0 0.027438310906291008
an O 0 0.02418217621743679
anomalous O 1 0.7138893604278564
inheritance O 0 0.07606546580791473
of O 0 0.04329758509993553
Hp O 1 0.9997617602348328
phenotypes O 0 0.08584591746330261
in O 0 0.017166759818792343
the O 0 0.030149489641189575
child O 0 0.17549173533916473
with O 0 0.04459370672702789
Hp1 O 1 0.9999889135360718
. O 0 0.05518078804016113

The O 0 0.09397275745868683
Hp2 O 1 0.9999984502792358
/ O 1 0.9999963045120239
Hpdel O 1 0.999849796295166
individuals O 0 0.024729400873184204
had O 0 0.019486652687191963
an O 0 0.01988561451435089
extremely O 0 0.030566321685910225
low O 0 0.036925673484802246
level O 0 0.023132948204874992
of O 0 0.027213554829359055
Hp O 1 0.9894697666168213
( O 0 0.02483522519469261
mean O 0 0.029655590653419495
+ O 1 0.9745217561721802
/ O 1 0.9999573230743408
- O 1 0.9999992847442627
SD O 1 0.9999953508377075
= O 0 0.0670551210641861
0 O 0 0.04790124669671059
. O 0 0.02162070758640766
049 O 1 0.9998338222503662
+ O 1 0.9783868789672852
/ O 1 0.9989418387413025
- O 1 0.9987540245056152
0 O 0 0.053157053887844086
. O 0 0.021134378388524055
043 O 1 0.9985188841819763
mg O 1 0.9999942779541016
/ O 1 0.9999904632568359
ml O 1 0.9999954700469971
; O 0 0.047905053943395615
n O 0 0.12470938265323639
= O 0 0.08537784218788147
6 O 0 0.05058715119957924
) O 0 0.020793797448277473
, O 0 0.01469023060053587
compared O 0 0.015367535874247551
with O 0 0.01314192172139883
the O 0 0.024081921204924583
level O 0 0.032376911491155624
( O 0 0.021730197593569756
1 O 0 0.027203766629099846
. O 0 0.011304626241326332
64 O 0 0.04926607385277748
+ O 1 0.9980886578559875
/ O 1 0.9999852180480957
- O 1 0.9999239444732666
1 O 0 0.04250074550509453
. O 0 0.02364000491797924
07 O 1 0.9986987113952637
mg O 1 0.9999998807907104
/ O 1 0.9999996423721313
ml O 1 0.9999711513519287
) O 0 0.023111646994948387
obtained O 0 0.015334265306591988
from O 0 0.01840200461447239
52 O 0 0.07417060434818268
healthy O 0 0.08197969943284988
volunteers O 0 0.08473202586174011
having O 0 0.05919174477458
phenotype O 1 0.9196931719779968
Hp2 O 1 0.9997888207435608
, O 0 0.034696102142333984
whereas O 0 0.04308091849088669
the O 0 0.04905568063259125
serum O 1 0.9999898672103882
Hp O 1 0.9828163981437683
level O 0 0.03165007010102272
of O 0 0.01897408999502659
an O 0 0.017797626554965973
individual O 0 0.01594977080821991
with O 0 0.02845396101474762
Hp1 O 1 0.9999996423721313
/ O 1 0.9999985694885254
Hpdel O 1 0.9999895095825195
was O 0 0.06494276970624924
0 O 0 0.08500887453556061
. O 0 0.039595894515514374

50 O 0 0.10424589365720749
mg O 1 0.9999996423721313
/ O 1 0.9999994039535522
ml O 1 0.9999964237213135
, O 0 0.027733219787478447
which O 0 0.01355292834341526
was O 0 0.0220973938703537
approximately O 0 0.014105102978646755
half O 0 0.015196089632809162
the O 0 0.0204277615994215
level O 0 0.025485455989837646
of O 0 0.028748774901032448
Hp O 0 0.3241041898727417
in O 0 0.021193889901041985
control O 0 0.04693026840686798
sera O 1 0.9974179267883301
from O 0 0.01847081258893013
the O 0 0.036746591329574585
Hp1 O 1 0.9999971389770508
phenotype O 1 0.8959033489227295
( O 0 0.027968138456344604
1 O 0 0.030602185055613518
. O 0 0.011604957282543182
26 O 0 0.04075299948453903
+ O 1 0.9985287189483643
/ O 1 0.9999408721923828
- O 1 0.9998599290847778
0 O 0 0.04325845092535019
. O 0 0.011951972730457783
33 O 0 0.05435488745570183
mg O 1 0.9999891519546509
/ O 1 0.9999934434890747
ml O 1 0.9999901056289673
; O 0 0.04437255859375
n O 0 0.11336987465620041
= O 0 0.07948698103427887
9 O 0 0.0441005639731884
) O 0 0.015628360211849213
, O 0 0.011478066444396973
showing O 0 0.02059156447649002
a O 0 0.035313867032527924
gene O 0 0.077449731528759
- O 1 0.9999954700469971
dosage O 1 0.9987435936927795
effect O 0 0.05625501647591591
. O 0 0.041846320033073425

The O 0 0.04665281996130943
other O 0 0.03036000020802021
allele O 0 0.12826047837734222
( O 0 0.053875960409641266
Hp2 O 1 0.9996633529663086
) O 0 0.0230304766446352
of O 0 0.01937555894255638
individuals O 0 0.015482715331017971
with O 0 0.0317041389644146
Hp2 O 1 0.9999998807907104
/ O 1 0.9999997615814209
Hpdel O 1 0.9999992847442627
was O 0 0.04516010358929634
found O 0 0.01495998166501522
to O 0 0.01386274117976427
have O 0 0.007878324016928673
, O 0 0.011808149516582489
in O 0 0.011458870954811573
all O 0 0.015841426327824593
exons O 0 0.08547818660736084
, O 0 0.022072317078709602
no O 0 0.02368284948170185
mutation O 0 0.05663079768419266
, O 0 0.021425841376185417
by O 0 0.028925878927111626
DNA O 0 0.06207595020532608
sequencing O 0 0.06332574039697647
. O 0 0.03975149989128113

On O 0 0.03186006098985672
the O 0 0.018438119441270828
basis O 0 0.012343933805823326
of O 0 0.01627230830490589
the O 0 0.021669046953320503
present O 0 0.022565830498933792
study O 0 0.018144622445106506
, O 0 0.014423713088035583
the O 0 0.022728780284523964
mechanism O 0 0.04188580811023712
of O 0 0.033609502017498016
anhaptoglobinemia B-Disease 1 0.9999394416809082
and O 0 0.021066484972834587
the O 0 0.026158837601542473
mechanism O 0 0.04014597088098526
of O 0 0.029581356793642044
anomalous O 1 0.9982016086578369
inheritance O 0 0.25493738055229187
of O 0 0.05541842058300972
Hp O 1 0.9999873638153076
phenotypes O 0 0.11938377469778061
were O 0 0.020155346021056175
well O 0 0.024197081103920937
explained O 0 0.049258165061473846
. O 0 0.037392377853393555

However O 0 0.034175798296928406
, O 0 0.02335413172841072
the O 0 0.02797476015985012
mechanism O 0 0.05268857255578041
of O 0 0.041514039039611816
hypohaptoglobinemia B-Disease 1 0.9999713897705078
remains O 0 0.10729499161243439
unknown O 0 0.09095315635204315

ATM O 1 0.973365843296051
mutations O 0 0.05391913652420044
and O 0 0.024245010688900948
phenotypes O 0 0.08907346427440643
in O 0 0.04743115231394768
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.038569726049900055
in O 0 0.016266226768493652
the O 0 0.020743098109960556
British O 0 0.04699736833572388
Isles O 0 0.12388795614242554
: O 0 0.02634240873157978
expression O 0 0.02709365077316761
of O 0 0.025941843166947365
mutant O 1 0.657967209815979
ATM O 0 0.08523038029670715
and O 0 0.010216178372502327
the O 0 0.015068890526890755
risk O 0 0.03537860885262489
of O 0 0.053097017109394073
leukemia B-Disease 1 1.0
, O 1 1.0
lymphoma B-Disease 1 1.0
, O 1 0.999966025352478
and O 1 0.999840497970581
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0927019715309143

We O 0 0.022196413949131966
report O 0 0.017817644402384758
the O 0 0.021992690861225128
spectrum O 0 0.041748348623514175
of O 0 0.026627270504832268
59 O 0 0.0872955396771431
ATM O 1 0.9699345827102661
mutations O 0 0.03172367811203003
observed O 0 0.018288210034370422
in O 0 0.02649139240384102
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.041952114552259445
A B-Disease 1 0.9999473094940186
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.04068096727132797
patients O 0 0.07944082468748093
in O 0 0.019736582413315773
the O 0 0.0313226692378521
British O 0 0.06978783756494522
Isles O 1 0.6122750639915466
. O 0 0.04765186831355095

Of O 0 0.06282070279121399
51 O 0 0.15295948088169098
ATM O 1 0.9996795654296875
mutations O 0 0.06005695462226868
identified O 0 0.028673658147454262
in O 0 0.01623532921075821
families O 0 0.025069372728466988
native O 0 0.022487735375761986
to O 0 0.01624644361436367
the O 0 0.024537349119782448
British O 0 0.05037742108106613
Isles O 0 0.16108715534210205
, O 0 0.021209394559264183
11 O 0 0.02375667914748192
were O 0 0.01791752129793167
founder O 1 0.999895453453064
mutations O 0 0.05222582817077637
, O 0 0.022077202796936035
and O 0 0.01774551533162594
2 O 0 0.030435077846050262
of O 0 0.017337197437882423
these O 0 0.009299704805016518
11 O 0 0.025653239339590073
conferred O 0 0.06643010675907135
a O 0 0.04679509624838829
milder O 1 0.9955590963363647
clinical O 1 0.9999097585678101
phenotype O 1 0.9073621034622192
with O 0 0.020053016021847725
respect O 0 0.02793120965361595
to O 0 0.025661403313279152
both O 0 0.03975129872560501
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9992658495903015
cellular O 1 0.9889808893203735
features O 0 0.04869735613465309
. O 0 0.03406631574034691

We O 0 0.025833142921328545
report O 0 0.01891922391951084
, O 0 0.010835479944944382
in O 0 0.00799036119133234
two O 0 0.011687731370329857
A B-Disease 1 0.980484664440155
- I-Disease 1 1.0
T I-Disease 1 0.9999960660934448
families O 0 0.025584202259778976
, O 0 0.01415568683296442
an O 0 0.01814984902739525
ATM O 1 0.8143886923789978
mutation O 0 0.043065354228019714
( O 0 0.025143662467598915
7271T O 1 0.9999873638153076
- O 1 1.0
- O 1 1.0
> O 1 0.9999923706054688
G O 1 0.9998557567596436
) O 0 0.022843077778816223
that O 0 0.011768006719648838
may O 0 0.014445653185248375
be O 0 0.008160454221069813
associated O 0 0.01213518250733614
with O 0 0.009438487701117992
an O 0 0.01579422317445278
increased O 0 0.026980139315128326
risk O 0 0.4360063076019287
of O 1 0.9992526173591614
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.03713351860642433
both O 0 0.03509632125496864
homozygotes O 1 0.9998340606689453
and O 0 0.036664221435785294
heterozygotes O 1 0.9994309544563293
( O 0 0.03936752676963806
relative O 0 0.06012403964996338
risk O 0 0.04778096824884415
12 O 0 0.02761043794453144
. O 0 0.01581517793238163
7 O 0 0.03976375237107277
; O 0 0.03275224193930626
P O 1 0.9999163150787354
= O 0 0.08766820281744003
. O 0 0.03113453835248947
0025 O 1 0.999983549118042
) O 0 0.029732320457696915
, O 0 0.014935863204300404
although O 0 0.00965521764010191
there O 0 0.007329863961786032
is O 0 0.01037635002285242
a O 0 0.016834383830428123
less O 0 0.017480887472629547
severe O 1 0.9990692734718323
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 0.08944505453109741
in O 0 0.013270202092826366
terms O 0 0.010792826302349567
of O 0 0.014119446277618408
the O 0 0.02192038670182228
degree O 0 0.045661624521017075
of O 1 0.7495465278625488
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 0.2586783766746521

This O 0 0.02509595826268196
mutation O 0 0.05531701445579529
( O 0 0.030205903574824333
7271T O 1 0.9999922513961792
- O 1 1.0
- O 1 1.0
> O 1 0.9999972581863403
G O 1 0.9997251629829407
) O 0 0.02369784563779831
also O 0 0.0157270897179842
allows O 0 0.018703455105423927
expression O 0 0.020885415375232697
of O 0 0.017123185098171234
full O 0 0.04113093391060829
- O 1 0.9996320009231567
length O 0 0.04321540892124176
ATM O 1 0.9794819951057434
protein O 0 0.03936590254306793
at O 0 0.022218212485313416
a O 0 0.02559310756623745
level O 0 0.029234759509563446
comparable O 0 0.0346221849322319
with O 0 0.016142137348651886
that O 0 0.01328369602560997
in O 0 0.027253801003098488
unaffected O 1 0.7280393242835999
individuals O 0 0.035766828805208206
. O 0 0.04577796161174774

In O 0 0.04052508994936943
addition O 0 0.032019853591918945
, O 0 0.017842944711446762
we O 0 0.007981399074196815
have O 0 0.004694781266152859
studied O 0 0.013811735436320305
18 O 0 0.02489282377064228
A B-Disease 1 0.9999092817306519
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9999080896377563
, O 0 0.02046957239508629
in O 0 0.012935088947415352
15 O 0 0.019758783280849457
families O 0 0.017767062410712242
, O 0 0.01240190677344799
who O 0 0.025169674307107925
developed O 0 0.10176829248666763
leukemia B-Disease 1 1.0
, O 1 0.9998676776885986
lymphoma B-Disease 1 1.0
, O 1 0.8996278643608093
preleukemic O 1 1.0
T O 1 1.0
- O 1 1.0
cell O 0 0.10398857295513153
proliferation O 1 0.8823951482772827
, O 0 0.028358541429042816
or O 1 0.9939263463020325
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9720863103866577
mostly O 0 0.03164774924516678
in O 0 0.0317094512283802
childhood O 1 0.99943608045578
. O 0 0.05486232042312622

A O 0 0.0711945965886116
wide O 0 0.03387824073433876
variety O 0 0.024554887786507607
of O 0 0.04478096961975098
ATM O 1 0.9999775886535645
mutation O 0 0.08791866153478622
types O 0 0.027216408401727676
, O 0 0.019390087574720383
including O 0 0.02619425766170025
missense O 1 0.905375599861145
mutations O 0 0.04163828119635582
and O 0 0.01932266727089882
in O 0 0.03329245746135712
- O 1 0.9999998807907104
frame O 0 0.09900684654712677
deletions O 0 0.07810746133327484
, O 0 0.0189511738717556
were O 0 0.012489352375268936
seen O 0 0.024543195962905884
in O 0 0.02177981100976467
these O 0 0.021880807355046272
patients O 1 0.9805309772491455
. O 0 0.05579848960042

We O 0 0.029561130329966545
also O 0 0.018786093220114708
show O 0 0.017328334972262383
that O 0 0.008214361034333706
25 O 0 0.01609271764755249
% O 0 0.010935408063232899
of O 0 0.011644966900348663
all O 0 0.014236505143344402
A B-Disease 1 0.9998611211776733
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.5259515047073364
carried O 0 0.032828476279973984
in O 0 0.029984869062900543
- O 1 0.9999779462814331
frame O 0 0.08962813764810562
deletions O 0 0.10752362012863159
or O 0 0.04312286153435707
missense O 1 0.8672958612442017
mutations O 0 0.053845807909965515
, O 0 0.018206194043159485
many O 0 0.01178740430623293
of O 0 0.016639936715364456
which O 0 0.01248112041503191
were O 0 0.008643695153295994
also O 0 0.011689119972288609
associated O 0 0.015331961214542389
with O 0 0.013017106801271439
expression O 0 0.029462233185768127
of O 0 0.033517416566610336
mutant O 1 0.9997478127479553
ATM O 1 0.9999206066131592
protein O 0 0.07119326293468475
. O 0 0.03600931167602539

The O 0 0.05491013452410698
DMPK O 1 0.9999548196792603
gene O 0 0.04209457337856293
of O 0 0.03260159492492676
severely O 1 0.9999488592147827
affected O 1 0.9999423027038574
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9954881072044373
hypermethylated O 1 1.0
proximal O 1 0.9999973773956299
to O 0 0.03044145740568638
the O 0 0.02628915384411812
largely O 0 0.036258697509765625
expanded O 0 0.06666470319032669
CTG O 1 0.9999796152114868
repeat O 0 0.14925462007522583
. O 0 0.05333399400115013

Using O 0 0.04379463940858841
methylation O 0 0.13220925629138947
- O 1 0.9999929666519165
sensitive O 0 0.08937101811170578
restriction O 0 0.08534717559814453
enzymes O 0 0.0692228376865387
, O 0 0.02150825224816799
we O 0 0.01531997974961996
characterized O 0 0.04977092519402504
the O 0 0.03320736065506935
methylation O 0 0.08354626595973969
pattern O 0 0.03606148064136505
on O 0 0.017020680010318756
the O 0 0.022004367783665657
5 O 0 0.028061741963028908
side O 0 0.022897029295563698
of O 0 0.018777810037136078
the O 0 0.0367630235850811
CTG O 1 0.9999969005584717
repeat O 0 0.0660671666264534
in O 0 0.01493286807090044
the O 0 0.03307246416807175
DMPK O 1 0.9999991655349731
gene O 0 0.043067820370197296
of O 0 0.022173205390572548
normal O 0 0.02911708503961563
individuals O 0 0.013468794524669647
and O 0 0.014961090870201588
of O 0 0.03180806338787079
patients O 1 0.9999958276748657
affected O 0 0.2459321916103363
with O 1 0.9972668886184692
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.07460632920265198
showing O 0 0.046106114983558655
expansions O 0 0.06992872059345245
of O 0 0.03175387158989906
the O 0 0.0484137088060379
repetitive O 0 0.3955710232257843
sequence O 0 0.04471763223409653
. O 0 0.04082004725933075

The O 0 0.07287664711475372
gene O 0 0.06645265966653824
segment O 0 0.06446797400712967
analyzed O 0 0.029496096074581146
corresponds O 0 0.030269740149378777
to O 0 0.013370626606047153
the O 0 0.023479487746953964
genomic O 0 0.09567954391241074
SacI O 1 0.9999823570251465
- O 1 0.9999725818634033
HindIII O 1 0.9927207827568054
fragment O 0 0.07192377001047134
carrying O 0 0.040125392377376556
exons O 0 0.09196395426988602
11 O 0 0.055009398609399796
- O 1 0.9998316764831543
15 O 0 0.046690259128808975
. O 0 0.03811263293027878

There O 0 0.032411929219961166
is O 0 0.03455584868788719
constitutive O 1 0.6944122910499573
methylation O 0 0.0882418155670166
in O 0 0.03748738765716553
intron O 1 0.9995265007019043
12 O 0 0.03934637829661369
at O 0 0.03059992380440235
restriction O 0 0.03887683153152466
sites O 0 0.020131928846240044
of O 0 0.028787817806005478
SacII O 1 0.9987950325012207
and O 0 0.03750254958868027
HhaI O 1 0.9999728202819824
, O 0 0.03000795654952526
localized O 0 0.08733005076646805
1 O 0 0.04400577023625374
, O 0 0.02463441528379917
159 O 0 0.3894144594669342
- O 1 0.9999880790710449
1 O 0 0.050328969955444336
, O 0 0.024216387420892715
232 O 0 0.10051288455724716
bp O 0 0.07585731148719788
upstream O 0 0.037433575838804245
of O 0 0.01870659925043583
the O 0 0.04473559185862541
CTG O 1 0.9999998807907104
repeat O 1 0.8327043652534485
, O 0 0.03330756723880768
whereas O 0 0.0396854467689991
most O 0 0.020314572378993034
, O 0 0.022213570773601532
if O 0 0.014403136447072029
not O 0 0.009793508797883987
all O 0 0.009677808731794357
, O 0 0.013005043379962444
of O 0 0.015110057778656483
the O 0 0.017899950966238976
other O 0 0.010751460678875446
sites O 0 0.018461469560861588
of O 0 0.02727418579161167
SacII O 1 0.999982476234436
, O 0 0.04413433000445366
HhaI O 1 0.9999898672103882
, O 0 0.029544632881879807
and O 0 0.027498742565512657
HpaII O 1 0.9998779296875
in O 0 0.020715128630399704
this O 0 0.014372740872204304
region O 0 0.02794545330107212
are O 0 0.015096787363290787
unmethylated O 1 0.9990205764770508
, O 0 0.028688495978713036
in O 0 0.023040451109409332
normal O 0 0.0352463498711586
individuals O 0 0.01634827069938183
and O 0 0.0145830437541008
most O 0 0.013385731726884842
of O 0 0.026717273518443108
the O 0 0.05280207470059395
patients O 1 0.9999158382415771
. O 0 0.06187828630208969

In O 0 0.025504998862743378
a O 0 0.02212557941675186
number O 0 0.013068164698779583
of O 0 0.025220997631549835
young O 0 0.49826812744140625
and O 0 0.038364559412002563
severely O 1 0.9999996423721313
affected O 1 0.9940808415412903
patients O 1 0.9999997615814209
, O 0 0.033100686967372894
however O 0 0.018760329112410545
, O 0 0.01966860704123974
complete O 0 0.03798569738864899
methylation O 0 0.05389321222901344
of O 0 0.020707540214061737
these O 0 0.012213660404086113
restriction O 0 0.04599147289991379
sites O 0 0.02420995756983757
was O 0 0.024015992879867554
found O 0 0.01071478333324194
in O 0 0.01367499865591526
the O 0 0.038161784410476685
mutated O 0 0.16530950367450714
allele O 0 0.1413031965494156
. O 0 0.04591746628284454

In O 0 0.025133294984698296
most O 0 0.016873596236109734
of O 0 0.023409390822052956
these O 0 0.01585782878100872
patients O 1 0.7827302813529968
, O 0 0.018997348845005035
the O 0 0.02744336985051632
onset O 1 0.9999991655349731
of O 0 0.03926818445324898
the O 1 0.9986163377761841
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9230861067771912

Preliminary O 0 0.05139981582760811
in O 0 0.04348623380064964
vivo O 1 0.912960410118103
footprinting O 1 0.9987354874610901
data O 0 0.016263402998447418
gave O 0 0.02106393687427044
evidence O 0 0.013627358712255955
for O 0 0.020673563703894615
protein O 0 0.054344989359378815
- O 1 0.9981048107147217
DNA O 0 0.04179530218243599
contact O 0 0.03671470284461975
in O 0 0.017603367567062378
normal O 0 0.03724575787782669
genes O 0 0.023278310894966125
at O 0 0.02482522465288639
an O 0 0.035392098128795624
Sp1 O 1 0.9999946355819702
consensus O 0 0.05795905366539955
binding O 0 0.03806305304169655
site O 0 0.03194664418697357
upstream O 0 0.03306388109922409
of O 0 0.017834007740020752
the O 0 0.040727172046899796
CTG O 1 0.9999998807907104
repeat O 0 0.11106377094984055
and O 0 0.018131747841835022
for O 0 0.014749941416084766
a O 0 0.024151893332600594
significant O 0 0.020822476595640182
reduction O 0 0.03605303913354874
of O 0 0.022272203117609024
this O 0 0.015812905505299568
interaction O 0 0.030983714386820793
in O 0 0.01878431625664234
cells O 0 0.03241073712706566
with O 0 0.01586662046611309
a O 0 0.04938305541872978
hypermethylated O 1 0.999984860420227
DMPK O 1 0.9999995231628418
gene O 0 0.08406785130500793
. O 0 0.026366345584392548
. O 0 0.03617038577795029

The O 0 0.10304594039916992
hemochromatosis B-Disease 1 1.0
gene O 0 0.09412302076816559
product O 0 0.050568170845508575
complexes O 0 0.07395271956920624
with O 0 0.0186905637383461
the O 0 0.044192273169755936
transferrin O 1 0.9999995231628418
receptor O 1 0.9878543019294739
and O 0 0.028720667585730553
lowers O 1 0.9219207167625427
its O 0 0.030061686411499977
affinity O 0 0.07197482883930206
for O 0 0.03622549772262573
ligand O 1 0.9958129525184631
binding O 0 0.06176065653562546
. O 0 0.038831692188978195

We O 0 0.026986919343471527
recently O 0 0.03696174919605255
reported O 0 0.02508390322327614
the O 0 0.028099199756979942
positional O 0 0.09575475752353668
cloning O 0 0.04506750404834747
of O 0 0.016344258561730385
a O 0 0.02244582213461399
candidate O 0 0.04040965437889099
gene O 0 0.03479733318090439
for O 0 0.037887055426836014
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 1.0
. O 0 0.07245639711618423

The O 0 0.057845745235681534
gene O 0 0.05493736267089844
product O 0 0.027371499687433243
, O 0 0.013330590911209583
a O 0 0.01735582761466503
member O 0 0.018869174644351006
of O 0 0.013318954035639763
the O 0 0.0221889466047287
major O 0 0.15808600187301636
histocompatibility O 1 1.0
complex O 1 0.7533665299415588
class O 1 0.9982459545135498
I O 1 0.984135091304779
- O 1 0.9999991655349731
like O 0 0.030206147581338882
family O 0 0.03448258712887764
, O 0 0.0191549900919199
was O 0 0.02406356669962406
found O 0 0.011067727580666542
to O 0 0.010597813874483109
have O 0 0.00636029988527298
a O 0 0.021088456735014915
mutation O 0 0.0452321358025074
, O 0 0.027095474302768707
Cys O 1 0.9999998807907104
- O 1 0.9999048709869385
282 O 1 0.9939760565757751
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9998375177383423
Tyr O 1 0.9999996423721313
( O 0 0.06490151584148407
C282Y O 1 0.999901294708252
) O 0 0.02736268937587738
, O 0 0.014533952809870243
in O 0 0.014780060388147831
85 O 0 0.050751421600580215
% O 0 0.028758695349097252
of O 0 0.04548460245132446
patient O 1 0.9999755620956421
chromosomes O 0 0.10540192574262619
. O 0 0.051233794540166855

This O 0 0.04457126930356026
mutation O 0 0.08546070754528046
eliminates O 0 0.09430334717035294
the O 0 0.02581053227186203
ability O 0 0.025303728878498077
of O 0 0.035746581852436066
HFE O 1 0.9999954700469971
to O 0 0.024825796484947205
associate O 0 0.051169123500585556
with O 0 0.022900313138961792
beta2 O 1 0.9999769926071167
- O 1 0.9999996423721313
microglobulin O 1 0.9999692440032959
( O 0 0.04692741855978966
beta2m O 1 0.9980740547180176
) O 0 0.022178592160344124
and O 0 0.020750751718878746
prevents O 1 0.9317454695701599
cell O 1 0.999703586101532
- O 1 0.9999994039535522
surface O 0 0.06237700581550598
expression O 0 0.04912938177585602
. O 0 0.03428134694695473

A O 0 0.08595506101846695
second O 0 0.0739048421382904
mutation O 0 0.06121353060007095
that O 0 0.011678437702357769
has O 0 0.01471323799341917
no O 0 0.01427983958274126
effect O 0 0.022759145125746727
on O 0 0.026517754420638084
beta2m O 1 0.9999221563339233
association O 0 0.05687269940972328
, O 0 0.04306892305612564
H63D O 1 0.9999977350234985
, O 0 0.03100799396634102
was O 0 0.03058405965566635
found O 0 0.011704030446708202
in O 0 0.010856043547391891
eight O 0 0.014776517637073994
out O 0 0.01569182425737381
of O 0 0.020449195057153702
nine O 0 0.0438629612326622
patients O 1 0.9397589564323425
heterozygous O 0 0.07966029644012451
for O 0 0.023920459672808647
the O 0 0.05061686784029007
C282Y O 1 0.9999959468841553
mutant O 1 0.8442577123641968
. O 0 0.0528581440448761

In O 0 0.032400984317064285
this O 0 0.016629556193947792
report O 0 0.02324979566037655
, O 0 0.01586024835705757
we O 0 0.010460099205374718
demonstrate O 0 0.026668258011341095
in O 0 0.019030112773180008
cultured O 0 0.11897396296262741
293 O 1 0.9111179113388062
cells O 0 0.0830821841955185
overexpressing O 1 0.9829133152961731
wild O 0 0.08529835939407349
- O 1 0.9999992847442627
type O 0 0.07253826409578323
or O 0 0.0402626097202301
mutant O 1 0.9989711046218872
HFE O 1 0.9999998807907104
proteins O 0 0.038082875311374664
that O 0 0.006659370381385088
both O 0 0.007191595621407032
the O 0 0.015319671481847763
wild O 0 0.0437457449734211
- O 1 0.9999972581863403
type O 0 0.04924466460943222
and O 0 0.03176427260041237
H63D O 1 1.0
HFE O 1 1.0
proteins O 0 0.060235124081373215
form O 0 0.038902536034584045
stable O 0 0.08367722481489182
complexes O 0 0.07785426825284958
with O 0 0.020501025021076202
the O 0 0.05035634711384773
transferrin O 1 0.9999998807907104
receptor O 1 0.9998055100440979
( O 0 0.08670812100172043
TfR O 1 0.9999085664749146
) O 0 0.04870252311229706
. O 0 0.03842930495738983

The O 0 0.08991643041372299
C282Y O 1 0.9996839761734009
mutation O 0 0.0848669707775116
nearly O 0 0.03870497643947601
completely O 0 0.05782170966267586
prevents O 0 0.0611998625099659
the O 0 0.020792437717318535
association O 0 0.024879688397049904
of O 0 0.019509198144078255
the O 0 0.03999152034521103
mutant O 1 0.9996209144592285
HFE O 1 0.9999997615814209
protein O 0 0.05819091573357582
with O 0 0.022802574560046196
the O 0 0.05104581639170647
TfR O 1 0.9997914433479309
. O 0 0.05768100917339325

Studies O 0 0.03453010320663452
on O 0 0.033213015645742416
cell O 0 0.20327924191951752
- O 1 0.9999710321426392
associated O 0 0.04343342408537865
transferrin O 1 0.9990459084510803
at O 0 0.040548600256443024
37 O 0 0.06287594139575958
degrees O 0 0.05520420894026756
C O 0 0.25440719723701477
suggest O 0 0.017071980983018875
that O 0 0.006245418451726437
the O 0 0.01834586076438427
overexpressed O 1 0.5000759363174438
wild O 0 0.0611431747674942
- O 1 0.9999998807907104
type O 1 0.9914566874504089
HFE O 1 1.0
protein O 0 0.07245153933763504
decreases O 0 0.055112842470407486
the O 0 0.02664042077958584
affinity O 0 0.051371436566114426
of O 0 0.02273259311914444
the O 0 0.04355926066637039
TfR O 1 0.9999498128890991
for O 0 0.061461325734853745
transferrin O 1 0.9999207258224487
. O 0 0.0632840096950531

The O 0 0.09139477461576462
overexpressed O 1 0.9999972581863403
H63D O 1 1.0
protein O 0 0.08003563433885574
does O 0 0.020321138203144073
not O 0 0.009948537684977055
have O 0 0.007250009570270777
this O 0 0.011028564535081387
effect O 0 0.02873867191374302
, O 0 0.019789019599556923
providing O 0 0.02432360127568245
the O 0 0.019438961520791054
first O 0 0.024116097018122673
direct O 0 0.023497626185417175
evidence O 0 0.014751327224075794
for O 0 0.015177569352090359
a O 0 0.03504122048616409
functional O 0 0.06109752506017685
consequence O 0 0.055088602006435394
of O 0 0.033168964087963104
the O 0 0.05899239704012871
H63D O 1 0.9999988079071045
mutation O 0 0.13060571253299713
. O 0 0.05126474052667618

Addition O 0 0.03018118441104889
of O 0 0.03417535126209259
soluble O 1 0.9863027930259705
wild O 0 0.07089153677225113
- O 1 0.9999996423721313
type O 1 0.7697285413742065
HFE O 1 1.0
/ O 1 0.9999933242797852
beta2m O 1 0.9999778270721436
heterodimers O 1 0.9999632835388184
to O 0 0.05935661867260933
cultured O 1 0.9996838569641113
cells O 0 0.058167558163404465
also O 0 0.02004425600171089
decreased O 0 0.04256625100970268
the O 0 0.029340781271457672
apparent O 0 0.07605399191379547
affinity O 0 0.05934996157884598
of O 0 0.02172764390707016
the O 0 0.03254513442516327
TfR O 1 0.9996284246444702
for O 0 0.018875328823924065
its O 0 0.026839857921004295
ligand O 0 0.28145506978034973
under O 0 0.03485530614852905
steady O 1 0.6398106813430786
- O 1 0.999935507774353
state O 0 0.019476398825645447
conditions O 0 0.029294677078723907
, O 0 0.014017326757311821
both O 0 0.011036025360226631
in O 0 0.02209218218922615
293 O 1 0.9997797608375549
cells O 0 0.06050214543938637
and O 0 0.02679404802620411
in O 0 0.0461314357817173
HeLa O 1 1.0
cells O 0 0.0996464416384697
. O 0 0.047477904707193375

Furthermore O 0 0.06888438761234283
, O 0 0.027184491977095604
at O 0 0.031147761270403862
4 O 0 0.044590748846530914
degrees O 0 0.052093539386987686
C O 1 0.6503111124038696
, O 0 0.016883384436368942
the O 0 0.01994342729449272
added O 0 0.03337584435939789
soluble O 1 0.959395170211792
complex O 0 0.041448041796684265
of O 0 0.04798005148768425
HFE O 1 1.0
/ O 1 0.9999991655349731
beta2m O 1 0.9999890327453613
inhibited O 1 0.6848123073577881
binding O 0 0.040514834225177765
of O 0 0.03042026236653328
transferrin O 1 0.9737498760223389
to O 0 0.05112547054886818
HeLa O 1 0.9999997615814209
cell O 0 0.09658865630626678
TfR O 1 0.9930679798126221
in O 0 0.018160277977585793
a O 0 0.04088451340794563
concentration O 1 0.9999828338623047
- O 1 0.9999998807907104
dependent O 0 0.06788178533315659
manner O 0 0.04894036427140236
. O 0 0.03684345632791519

Scatchard O 1 0.7838589549064636
plots O 0 0.07552081346511841
of O 0 0.02987336739897728
these O 0 0.01429886557161808
data O 0 0.014385261572897434
indicate O 0 0.01482439786195755
that O 0 0.008184998296201229
the O 0 0.02051869034767151
added O 0 0.03876554220914841
heterodimer O 1 0.9991884827613831
substantially O 0 0.047074850648641586
reduced O 0 0.03238275647163391
the O 0 0.027324289083480835
affinity O 0 0.06418592482805252
of O 0 0.0466836653649807
TfR O 1 0.999992847442627
for O 0 0.0638308972120285
transferrin O 1 0.9999758005142212
. O 0 0.06558199226856232

These O 0 0.019255192950367928
results O 0 0.017878051847219467
establish O 0 0.03964482620358467
a O 0 0.03813237324357033
molecular O 0 0.05681528151035309
link O 0 0.061871979385614395
between O 0 0.041827280074357986
HFE O 1 0.9999967813491821
and O 0 0.023605074733495712
a O 0 0.03230695426464081
key O 0 0.05318603292107582
protein O 0 0.03827720507979393
involved O 0 0.020039793103933334
in O 0 0.026163345202803612
iron O 1 0.999800980091095
transport O 0 0.07301174849271774
, O 0 0.02581956796348095
the O 0 0.04256627708673477
TfR O 1 0.9999997615814209
, O 0 0.027751758694648743
and O 0 0.019177958369255066
raise O 0 0.02752833068370819
the O 0 0.02034343034029007
possibility O 0 0.02785155549645424
that O 0 0.014418616890907288
alterations O 0 0.04570896178483963
in O 0 0.01739814132452011
this O 0 0.021392103284597397
regulatory O 0 0.09415367990732193
mechanism O 0 0.06212570518255234
may O 0 0.017983555793762207
play O 0 0.012394326739013195
a O 0 0.01553650014102459
role O 0 0.02183113433420658
in O 0 0.01198604330420494
the O 0 0.029045889154076576
pathogenesis O 1 1.0
of O 1 0.9992291927337646
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9651697874069214
. O 0 0.055024102330207825

Genomic O 0 0.10646579414606094
organization O 0 0.033072374761104584
of O 0 0.020979100838303566
the O 0 0.04399372637271881
UBE3A O 1 1.0
/ O 1 0.9999991655349731
E6 O 1 1.0
- O 1 0.9999998807907104
AP O 1 0.8873273134231567
gene O 0 0.047552160918712616
and O 0 0.02355402335524559
related O 0 0.04518626630306244
pseudogenes O 1 0.5809339880943298
. O 0 0.05482012778520584

The O 0 0.07789193838834763
UBE3A O 1 0.9999836683273315
gene O 0 0.057363808155059814
encodes O 0 0.04691211134195328
the O 0 0.030825156718492508
E6 O 1 0.9999716281890869
- O 1 0.9999741315841675
AP O 0 0.3582095205783844
ubiquitin O 1 0.9998887777328491
- O 1 0.9999998807907104
protein O 0 0.06626523286104202
ligase O 0 0.07958041876554489
and O 0 0.017443187534809113
has O 0 0.01707017421722412
recently O 0 0.025421423837542534
been O 0 0.011401766911149025
shown O 0 0.00979086384177208
to O 0 0.01051020622253418
be O 0 0.011048736050724983
mutated O 0 0.08331744372844696
in O 0 0.11615042388439178
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.5314881801605225
lack O 1 0.9434120059013367
15q11 O 1 1.0
- O 1 1.0
q13 O 1 0.9999572038650513
deletions O 0 0.1158803328871727
or O 0 0.0364745557308197
chromosome O 0 0.0696413442492485
15 O 0 0.05234992876648903
paternal O 1 0.996091902256012
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999926090240479
. O 0 0.06773849576711655

Previous O 0 0.10748622566461563
UBE3A O 1 0.9999948740005493
cDNA O 0 0.2019624412059784
analysis O 0 0.026201821863651276
has O 0 0.0175583828240633
shown O 0 0.01742352731525898
a O 0 0.03132813423871994
coding O 0 0.06443071365356445
region O 0 0.03127104416489601
of O 0 0.024724602699279785
approximately O 0 0.03517906367778778
2 O 0 0.06534672528505325
. O 0 0.04135708883404732

6 O 0 0.09514638781547546
kb O 0 0.14360666275024414
and O 0 0.01895836368203163
a O 0 0.027977140620350838
3 O 0 0.05642779543995857
- O 1 0.999984860420227
untranslated O 1 0.9963292479515076
region O 0 0.044644277542829514
( O 0 0.04079228267073631
UTR O 1 0.9990538954734802
) O 0 0.02361111342906952
of O 0 0.032367903739213943
< O 1 0.9448693990707397
50 O 0 0.045278046280145645
bp O 0 0.07920365035533905
, O 0 0.022392993792891502
whereas O 0 0.029367942363023758
Northern O 0 0.03777899220585823
analysis O 0 0.014429992064833641
has O 0 0.013482404872775078
indicated O 0 0.02558652125298977
mRNA O 0 0.03727941960096359
sizes O 0 0.01398912351578474
of O 0 0.01980293169617653
5 O 0 0.05425737053155899
- O 1 0.9999964237213135
8 O 0 0.07387397438287735
kb O 0 0.23332998156547546
. O 0 0.045293115079402924

We O 0 0.025453196838498116
have O 0 0.012116572819650173
analyzed O 0 0.029363805428147316
additional O 0 0.03312131017446518
cDNA O 0 0.17350630462169647
clones O 0 0.13312411308288574
and O 0 0.024578262120485306
provide O 0 0.021956423297524452
evidence O 0 0.01686655916273594
for O 0 0.015581438317894936
an O 0 0.02252756990492344
additional O 0 0.02865389734506607
0 O 0 0.08694914728403091
. O 0 0.04356619343161583

5 O 0 0.05530620738863945
kb O 0 0.11393725872039795
of O 0 0.030240876600146294
5 O 0 0.057051800191402435
- O 1 0.999997615814209
UTR O 1 0.9990359544754028
and O 0 0.028833666816353798
> O 0 0.23668578267097473
2 O 0 0.044013068079948425
kb O 0 0.11058232188224792
of O 0 0.03360653668642044
3 O 0 0.07694000750780106
- O 1 0.9999954700469971
UTR O 1 0.9976353645324707
. O 0 0.04415662959218025

We O 0 0.02177106775343418
have O 0 0.00908719189465046
established O 0 0.028610575944185257
the O 0 0.026921231299638748
genomic O 0 0.06427810341119766
organization O 0 0.04000723361968994
of O 0 0.03816739469766617
UBE3A O 1 0.9999984502792358
and O 0 0.02024851366877556
the O 0 0.019120987504720688
sequence O 0 0.01827988028526306
of O 0 0.03530655801296234
intron O 1 0.9999998807907104
- O 1 0.9999985694885254
exon O 0 0.4543316662311554
borders O 0 0.07099437713623047
. O 0 0.04321527108550072

We O 0 0.028909409418702126
have O 0 0.011875979602336884
also O 0 0.015069562010467052
mapped O 0 0.03131642937660217
two O 0 0.013441716320812702
highly O 0 0.05065495893359184
homologous O 0 0.1117987185716629
processed O 0 0.06966887414455414
pseudogenes O 0 0.14675961434841156
, O 0 0.05034719407558441
UBE3AP1 O 1 0.9999958276748657
and O 0 0.04758542776107788
UBE3AP2 O 1 0.9999969005584717
, O 0 0.026245636865496635
to O 0 0.024482952430844307
chromosomes O 0 0.04748477786779404
2 O 0 0.03972584009170532
and O 0 0.020142918452620506
21 O 0 0.03911690413951874
, O 0 0.024223310872912407
respectively O 0 0.030663369223475456
, O 0 0.01895103044807911
and O 0 0.016314297914505005
determined O 0 0.028719210997223854
their O 0 0.020712222903966904
genomic O 0 0.0851169228553772
organization O 0 0.06165941432118416
. O 0 0.042783159762620926

These O 0 0.025431277230381966
results O 0 0.02115916647017002
will O 0 0.01615462265908718
form O 0 0.019215332344174385
the O 0 0.01791098527610302
basis O 0 0.014597989618778229
for O 0 0.014860277064144611
studies O 0 0.019737645983695984
of O 0 0.030458737164735794
mutation O 0 0.06978266686201096
and O 0 0.03546443581581116
imprinting O 1 0.9890811443328857
of O 0 0.08183281868696213
UBE3A O 1 0.9999984502792358
. O 0 0.0758369192481041

Mutation O 0 0.13027630746364594
spectrum O 0 0.07364816963672638
and O 0 0.03985423222184181
genotype O 1 0.9989895224571228
- O 1 0.9999964237213135
phenotype O 0 0.10216719657182693
analyses O 0 0.035381440073251724
in O 0 0.030044006183743477
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999992847442627
and O 0 0.040702689439058304
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0338294617831707
two O 0 0.03881482034921646
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.7800018787384033
germline O 1 1.0
PTEN O 1 1.0
mutation O 0 0.14865487813949585
. O 0 0.05311041697859764

The O 0 0.3778029680252075
tumour B-Disease 1 1.0
suppressor O 1 1.0
gene O 1 0.9642274379730225
PTEN O 1 0.9999978542327881
, O 0 0.0313723124563694
which O 0 0.016781887039542198
maps O 0 0.027139894664287567
to O 0 0.03425227850675583
10q23 O 1 0.9714720845222473
. O 0 0.048707716166973114

3 O 0 0.059709660708904266
and O 0 0.02488335780799389
encodes O 0 0.053442854434251785
a O 0 0.03406105563044548
403 O 0 0.14492015540599823
amino O 0 0.06966061890125275
acid O 0 0.08049499988555908
dual O 0 0.08176448196172714
specificity O 0 0.1801823526620865
phosphatase O 1 0.9999994039535522
( O 0 0.05771929398179054
protein O 0 0.0759899914264679
tyrosine O 1 0.9989027976989746
phosphatase O 1 0.999977707862854
; O 0 0.05068741366267204
PTPase O 1 0.9999476671218872
) O 0 0.03230392560362816
, O 0 0.020484881475567818
was O 0 0.027804745361208916
shown O 0 0.017567340284585953
recently O 0 0.025575345382094383
to O 0 0.014911348931491375
play O 0 0.013625659979879856
a O 0 0.022959038615226746
broad O 0 0.0492757186293602
role O 0 0.04575773701071739
in O 0 0.03228963539004326
human O 0 0.1037411317229271
malignancy B-Disease 1 1.0
. O 0 0.07134062796831131

Somatic O 1 0.9999576807022095
PTEN O 1 0.9999942779541016
deletions O 0 0.15629301965236664
and O 0 0.038564566522836685
mutations O 0 0.03372633829712868
were O 0 0.00874379277229309
observed O 0 0.014729063957929611
in O 0 0.015347294509410858
sporadic B-Disease 1 0.9896913170814514
breast I-Disease 1 1.0
, I-Disease 1 0.6883001327514648
brain I-Disease 1 0.9999980926513672
, I-Disease 1 0.8895955085754395
prostate I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999992847442627
lines O 0 0.031359896063804626
and O 0 0.010369080118834972
in O 0 0.008848262950778008
several O 0 0.012038661167025566
primary O 0 0.07659351825714111
tumours B-Disease 1 1.0
such O 0 0.01857847161591053
as O 0 0.05081330984830856
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999985694885254
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9394415616989136

In O 0 0.03330450877547264
addition O 0 0.03396865725517273
, O 0 0.041911493986845016
PTEN O 1 0.9999996423721313
was O 0 0.03651418909430504
identified O 0 0.024307040497660637
as O 0 0.016270974650979042
the O 0 0.02775578387081623
susceptibility O 1 0.9952545166015625
gene O 0 0.030781837180256844
for O 0 0.01524154283106327
two O 0 0.031982481479644775
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.999358594417572
CD B-Disease 1 0.9999895095825195
; O 0 0.04786224663257599
MIM O 1 1.0
158350 O 1 0.9998681545257568
) O 0 0.02364327386021614
and O 0 0.022669492289423943
Bannayan B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 0.9999982118606567
( I-Disease 0 0.06745005398988724
BZS I-Disease 1 0.9999779462814331
) I-Disease 0 0.025959467515349388
or I-Disease 0 0.021788163110613823
Ruvalcaba I-Disease 1 0.9999836683273315
- I-Disease 1 0.9999822378158569
Riley I-Disease 1 0.9996892213821411
- I-Disease 1 1.0
Smith I-Disease 1 0.999997615814209
syndrome I-Disease 1 1.0
( O 1 0.9979485869407654
MIM O 1 1.0
153480 O 1 0.9999998807907104
) O 0 0.05721158906817436
. O 0 0.0389871783554554

Constitutive O 1 0.9885289072990417
DNA O 0 0.061728231608867645
from O 0 0.027268657460808754
37 O 0 0.06890672445297241
CD B-Disease 0 0.1064000353217125
families O 0 0.03018348477780819
and O 0 0.019792677834630013
seven O 0 0.039448246359825134
BZS B-Disease 1 0.9997400641441345
families O 0 0.04037511721253395
was O 0 0.04373319819569588
screened O 0 0.08821738511323929
for O 0 0.04892859235405922
germline O 1 0.9999934434890747
PTEN O 1 0.9999996423721313
mutations O 0 0.11003069579601288
. O 0 0.05283597111701965

PTEN O 1 0.9999977350234985
mutations O 0 0.07680928707122803
were O 0 0.016704820096492767
identified O 0 0.023087194189429283
in O 0 0.013805799186229706
30 O 0 0.022265560925006866
of O 0 0.025991812348365784
37 O 0 0.06162052974104881
( O 0 0.03878322243690491
81 O 0 0.09907698631286621
% O 0 0.04273354634642601
) O 0 0.03628084436058998
CD B-Disease 0 0.09418544918298721
families O 0 0.030356166884303093
, O 0 0.01799207180738449
including O 0 0.020865444093942642
missense O 0 0.12106049805879593
and O 0 0.03431975096464157
nonsense O 0 0.351660817861557
point O 0 0.058993861079216
mutations O 0 0.04871917888522148
, O 0 0.027780035510659218
deletions O 0 0.07482907176017761
, O 0 0.027495453134179115
insertions O 0 0.09632140398025513
, O 0 0.019006751477718353
a O 0 0.04060878977179527
deletion O 1 0.9943934679031372
/ O 1 0.9999748468399048
insertion O 1 0.6360641121864319
and O 0 0.045898839831352234
splice O 1 0.8463016748428345
site O 0 0.07633547484874725
mutations O 0 0.058248091489076614
. O 0 0.03907905891537666

These O 0 0.03761446848511696
mutations O 0 0.045745208859443665
were O 0 0.012532350607216358
scattered O 0 0.024958984926342964
over O 0 0.017766281962394714
the O 0 0.02047591656446457
entire O 0 0.03461761027574539
length O 0 0.02698614075779915
of O 0 0.04793224483728409
PTEN O 1 0.9999998807907104
, O 0 0.02554027922451496
with O 0 0.014668243937194347
the O 0 0.020061427727341652
exception O 0 0.027996983379125595
of O 0 0.017020463943481445
the O 0 0.020874913781881332
first O 0 0.0279471967369318
, O 0 0.020820539444684982
fourth O 0 0.04628150165081024
and O 0 0.02256399393081665
last O 0 0.043486859649419785
exons O 0 0.12682971358299255
. O 0 0.043863579630851746

A O 0 0.09624824672937393
hot O 0 0.295908659696579
spot O 0 0.07203879207372665
for O 0 0.04144294559955597
PTEN O 1 0.9999997615814209
mutation O 0 0.07344481348991394
in O 0 0.025650350376963615
CD B-Disease 0 0.10565658658742905
was O 0 0.02971014194190502
identified O 0 0.02067999169230461
in O 0 0.017148829996585846
exon O 0 0.11779139935970306
5 O 0 0.025272374972701073
that O 0 0.008365212008357048
contains O 0 0.018101545050740242
the O 0 0.02998638153076172
PTPase O 1 0.9999802112579346
core O 1 0.9242664575576782
motif O 0 0.09302456676959991
, O 0 0.0184630136936903
with O 0 0.012598038651049137
13 O 0 0.025909511372447014
of O 0 0.024267831817269325
30 O 0 0.033245086669921875
( O 0 0.025673652067780495
43 O 0 0.053041402250528336
% O 0 0.036564651876688004
) O 0 0.03950494900345802
CD B-Disease 0 0.20227661728858948
mutations O 0 0.04783414676785469
identified O 0 0.026811888441443443
in O 0 0.01802247017621994
this O 0 0.023943956941366196
exon O 0 0.20493827760219574
. O 0 0.05019359663128853

Seven O 0 0.042357187718153
of O 0 0.03974401578307152
30 O 0 0.049652568995952606
( O 0 0.03888101875782013
23 O 0 0.051575902849435806
% O 0 0.0276127178221941
) O 0 0.015256993472576141
were O 0 0.006570738740265369
within O 0 0.013586827553808689
the O 0 0.03145361691713333
core O 1 0.8052142262458801
motif O 0 0.12033974379301071
, O 0 0.019605189561843872
the O 0 0.020866667851805687
majority O 0 0.03073999658226967
( O 0 0.01969262771308422
five O 0 0.013338920660316944
of O 0 0.019414663314819336
seven O 0 0.02467135526239872
) O 0 0.019102444872260094
of O 0 0.016492405906319618
which O 0 0.014647204428911209
were O 0 0.021025344729423523
missense O 1 0.6826140880584717
mutations O 0 0.06290769577026367
, O 0 0.026887018233537674
possibly O 0 0.032354939728975296
pointing O 0 0.034097641706466675
to O 0 0.01979782246053219
the O 0 0.028926188126206398
functional O 0 0.04810221865773201
significance O 0 0.033124133944511414
of O 0 0.023011380806565285
this O 0 0.018855152651667595
region O 0 0.04582526534795761
. O 0 0.03869970887899399

Germline O 1 0.9999942779541016
PTEN O 1 0.9999994039535522
mutations O 0 0.06987966597080231
were O 0 0.014535976573824883
identified O 0 0.020004933699965477
in O 0 0.010417699813842773
four O 0 0.012324602343142033
of O 0 0.01994818076491356
seven O 0 0.03304168954491615
( O 0 0.03900158405303955
57 O 0 0.08328138291835785
% O 0 0.049464061856269836
) O 0 0.05497755855321884
BZS B-Disease 1 0.9968475699424744
families O 0 0.06386527419090271
studied O 0 0.06043060123920441
. O 0 0.045000918209552765

Interestingly O 0 0.15525074303150177
, O 0 0.030067626386880875
none O 0 0.02162146009504795
of O 0 0.022644370794296265
these O 0 0.014980949461460114
mutations O 0 0.039033494889736176
was O 0 0.02898339368402958
observed O 0 0.019541431218385696
in O 0 0.014166496694087982
the O 0 0.03654427081346512
PTPase O 1 0.9999947547912598
core O 1 0.9645302295684814
motif O 0 0.17584620416164398
. O 0 0.04784945026040077

It O 0 0.02708844654262066
is O 0 0.021178988739848137
also O 0 0.019862765446305275
worthy O 0 0.07169652730226517
of O 0 0.02475261129438877
note O 0 0.03087514266371727
that O 0 0.008274469524621964
a O 0 0.021436696872115135
single O 0 0.03987955302000046
nonsense O 0 0.0983489379286766
point O 0 0.05173133686184883
mutation O 0 0.06730815768241882
, O 0 0.03342384472489357
R233X O 1 0.9981075525283813
, O 0 0.026165079325437546
was O 0 0.028280600905418396
observed O 0 0.017162788659334183
in O 0 0.012418251484632492
the O 0 0.03425047919154167
germline O 1 0.943697452545166
DNA O 0 0.03960755467414856
from O 0 0.016037482768297195
two O 0 0.016495300456881523
unrelated O 0 0.06339462846517563
CD B-Disease 0 0.353761225938797
families O 0 0.03434498980641365
and O 0 0.025462474673986435
one O 0 0.04681793972849846
BZS B-Disease 1 0.9999955892562866
family O 0 0.08622106909751892
. O 0 0.04727715253829956

Genotype O 1 0.9999945163726807
- O 1 0.9999998807907104
phenotype O 1 0.647361159324646
studies O 0 0.026532409712672234
were O 0 0.01228608563542366
not O 0 0.013288060203194618
performed O 0 0.02938113734126091
on O 0 0.01368161104619503
this O 0 0.009329230524599552
small O 0 0.01903018169105053
group O 0 0.04164939746260643
of O 0 0.04687289893627167
BZS B-Disease 1 0.9999768733978271
families O 0 0.0722067579627037
. O 0 0.05009455233812332

However O 0 0.03481312841176987
, O 0 0.040387701243162155
genotype O 1 0.9932048320770264
- O 1 0.9999970197677612
phenotype O 0 0.12630237638950348
analysis O 0 0.030153002589941025
inthe O 0 0.41301482915878296
group O 0 0.048593081533908844
of O 0 0.03802149370312691
CD B-Disease 0 0.22799454629421234
families O 0 0.039223648607730865
revealed O 0 0.03143993765115738
two O 0 0.013540184125304222
possible O 0 0.024132493883371353
associations O 0 0.03526811674237251
worthy O 0 0.08303505182266235
of O 0 0.03190063685178757
follow O 0 0.05226171389222145
- O 1 0.9997603297233582
up O 0 0.030142072588205338
in O 0 0.017888711765408516
independent O 0 0.04033377394080162
analyses O 0 0.05021582916378975
. O 0 0.037619322538375854

The O 0 0.0409943163394928
first O 0 0.03498101234436035
was O 0 0.03675457090139389
an O 0 0.022206468507647514
association O 0 0.02847844362258911
noted O 0 0.016799157485365868
in O 0 0.010230643674731255
the O 0 0.015475958585739136
group O 0 0.025521937757730484
of O 0 0.021748509258031845
CD B-Disease 0 0.19898554682731628
families O 0 0.04125438630580902
with O 0 0.06755179911851883
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.705943763256073

A O 0 0.0863504484295845
correlation O 0 0.07326320558786392
was O 0 0.032732341438531876
observed O 0 0.0177356768399477
between O 0 0.014449195936322212
the O 0 0.02345815673470497
presence O 0 0.04838939756155014
/ O 1 0.995882511138916
absence O 0 0.040731463581323624
of O 0 0.026359979063272476
a O 0 0.053775254637002945
PTEN O 1 1.0
mutation O 0 0.04674229025840759
and O 0 0.012726067565381527
the O 0 0.02001965045928955
type O 0 0.046539537608623505
of O 0 0.054416779428720474
breast O 1 1.0
involvement O 1 0.9999995231628418
( O 0 0.049635227769613266
unaffected O 1 0.9989839196205139
versus O 1 0.9995904564857483
benign O 1 1.0
versus O 1 0.9999998807907104
malignant O 1 1.0
) O 0 0.05894690752029419
. O 0 0.04321170598268509

Specifically O 0 0.055591221898794174
and O 0 0.02097531221807003
more O 0 0.012868192978203297
directly O 0 0.021861743181943893
, O 0 0.01863052509725094
an O 0 0.02194363623857498
association O 0 0.03806978836655617
was O 0 0.030609600245952606
also O 0 0.014162137173116207
observed O 0 0.012264024466276169
between O 0 0.009399371221661568
the O 0 0.010765690356492996
presence O 0 0.01653866097331047
of O 0 0.015275465324521065
a O 0 0.03856724873185158
PTEN O 1 1.0
mutation O 1 0.7046796083450317
and O 1 0.9937108755111694
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9865407347679138

Secondly O 1 0.8808566331863403
, O 0 0.03373274579644203
there O 0 0.017200762405991554
appeared O 0 0.029208175837993622
to O 0 0.01617501489818096
be O 0 0.012503428384661674
an O 0 0.02758043445646763
interdependent O 1 0.8504750728607178
association O 0 0.054236408323049545
between O 0 0.04390589892864227
mutations O 0 0.059153277426958084
upstream O 0 0.05097859352827072
and O 0 0.013900424353778362
within O 0 0.015703510493040085
the O 0 0.03271424397826195
PTPase O 1 0.9999983310699463
core O 1 0.9951451420783997
motif O 0 0.08977289497852325
, O 0 0.01936260797083378
the O 0 0.027283800765872
core O 0 0.08520970493555069
motif O 0 0.08097225427627563
containing O 0 0.021471137180924416
the O 0 0.01515200361609459
majority O 0 0.025256114080548286
of O 0 0.03995338827371597
missense O 1 0.9933295845985413
mutations O 0 0.058857087045907974
, O 0 0.020449284464120865
and O 0 0.013264970853924751
the O 0 0.01807234436273575
involvement O 0 0.03491455689072609
of O 0 0.015613417141139507
all O 0 0.013643879443407059
major O 0 0.05063515529036522
organ O 1 0.9999995231628418
systems O 0 0.04901289939880371
( O 0 0.024177031591534615
central O 0 0.04268250986933708
nervous O 1 0.9777146577835083
system O 0 0.035539377480745316
, O 0 0.04597313329577446
thyroid O 1 1.0
, O 1 0.9997010827064514
breast O 1 1.0
, O 1 0.9999202489852905
skin O 1 1.0
and O 1 0.9999985694885254
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.5697830319404602
. O 0 0.049316614866256714

However O 0 0.0500154010951519
, O 0 0.030652690678834915
these O 0 0.014922188594937325
observations O 0 0.0303603895008564
would O 0 0.018663153052330017
need O 0 0.020283684134483337
to O 0 0.016792399808764458
be O 0 0.009867824614048004
confirmed O 0 0.017079712823033333
by O 0 0.01267465390264988
studying O 0 0.019343728199601173
a O 0 0.01993960700929165
larger O 0 0.01777840033173561
number O 0 0.013574454002082348
of O 0 0.03269146382808685
CD B-Disease 1 0.917559027671814
families O 0 0.0571075864136219
. O 0 0.04628215357661247

Molecular O 1 0.7945041656494141
defects O 1 0.9863713383674622
leading O 0 0.05176693946123123
to O 0 0.023992858827114105
human O 0 0.032166026532649994
complement B-Disease 1 0.9954114556312561
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.02312367968261242
an O 0 0.0206393264234066
African O 1 0.6929669976234436
- O 1 0.9999979734420776
American O 0 0.048905130475759506
family O 0 0.04685990884900093
. O 0 0.035715214908123016

Complement B-Disease 1 0.9559270739555359
component I-Disease 1 0.9999996423721313
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9966446161270142
C6D B-Disease 1 1.0
) O 0 0.03536251187324524
was O 0 0.04510824754834175
diagnosed O 1 0.9999827146530151
in O 0 0.01622420735657215
a O 0 0.02363370917737484
16 O 0 0.03320154547691345
- O 1 0.9997683167457581
year O 0 0.019901227205991745
- O 1 0.9078493714332581
old O 0 0.04022286459803581
African O 0 0.04863264784216881
- O 1 0.9989442229270935
American O 0 0.033739399164915085
male O 0 0.06038661673665047
with O 0 0.06295815110206604
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9570934176445007

The O 0 0.08652349561452866
patients O 1 0.999786913394928
father O 0 0.12269720435142517
and O 0 0.024797331541776657
two O 0 0.022275932133197784
brothers O 0 0.068100705742836
also O 0 0.023223863914608955
had O 0 0.03706362098455429
C6D B-Disease 1 0.9999960660934448
, O 0 0.021733306348323822
but O 0 0.00954753253608942
gave O 0 0.017981527373194695
no O 0 0.010051286779344082
history O 0 0.025908591225743294
of O 0 0.05365242063999176
meningitis B-Disease 1 1.0
or O 0 0.05336160585284233
other O 0 0.044258635491132736
neisserial B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.07259858399629593

By O 0 0.027057524770498276
using O 0 0.023269522935152054
exon O 0 0.2586030662059784
- O 1 0.9897268414497375
specific O 0 0.027946604415774345
polymerase O 1 0.7771956324577332
chain O 0 0.09132669121026993
reaction O 0 0.06489384919404984
( O 0 0.042098090052604675
PCR O 1 0.57806396484375
) O 0 0.03722443804144859
/ O 1 0.8506026864051819
single O 0 0.05914139002561569
- O 1 0.9998399019241333
strand O 0 0.13816283643245697
conformation O 0 0.11020699143409729
polymorphism O 0 0.06917829066514969
as O 0 0.020922910422086716
a O 0 0.03251364454627037
screening O 0 0.08465608954429626
step O 0 0.05119812861084938
and O 0 0.0252384003251791
nucleotide O 0 0.06585463136434555
sequencing O 0 0.03369779512286186
of O 0 0.02453547902405262
target O 0 0.053941089659929276
exons O 0 0.08783558756113052
, O 0 0.02072184719145298
we O 0 0.01090902928262949
determined O 0 0.019259624183177948
that O 0 0.007579178083688021
the O 0 0.022880852222442627
proband O 1 0.9228595495223999
was O 0 0.02946557104587555
a O 0 0.029410088434815407
compound O 0 0.08356214314699173
heterozygote O 0 0.15490226447582245
for O 0 0.02392851561307907
two O 0 0.04334262013435364
C6 O 1 1.0
gene O 0 0.10831143707036972
mutations O 0 0.06641814857721329
. O 0 0.04178193584084511

The O 0 0.04326057434082031
first O 0 0.03363220766186714
, O 0 0.03268243372440338
1195delC O 1 0.9530580043792725
located O 0 0.04839841276407242
in O 0 0.023465773090720177
exon O 1 0.616676926612854
7 O 0 0.0467769131064415
, O 0 0.0202981885522604
is O 0 0.01789412461221218
a O 0 0.0316474549472332
novel O 0 0.07603255659341812
mutation O 0 0.06263694167137146
, O 0 0.01876980997622013
while O 0 0.016360115259885788
the O 0 0.021964533254504204
second O 0 0.04095294326543808
, O 0 0.029475437477231026
1936delG O 1 0.9061338901519775
in O 0 0.02957984432578087
exon O 1 0.8224886655807495
12 O 0 0.03775738924741745
, O 0 0.02036973275244236
has O 0 0.015276972204446793
been O 0 0.013660060241818428
described O 0 0.025696827098727226
before O 0 0.021358897909522057
to O 0 0.03027527406811714
cause O 0 0.1666819304227829
C6D B-Disease 1 0.9999933242797852
in O 0 0.020696524530649185
an O 0 0.01953228749334812
unrelated O 0 0.04823579639196396
African O 1 0.8310203552246094
- O 1 0.9999995231628418
American O 0 0.0480772964656353
individual O 0 0.028077663853764534
. O 0 0.035418927669525146

Both O 0 0.04291839152574539
mutations O 0 0.054161231964826584
result O 0 0.02447463758289814
in O 0 0.029018156230449677
premature O 1 0.9999738931655884
termination O 1 0.9999898672103882
codons O 1 0.8041982650756836
and O 0 0.06685836613178253
C6 O 1 1.0
null O 1 0.963170051574707
alleles O 0 0.12553802132606506
. O 0 0.04908452555537224

Allele O 1 0.9325721859931946
- O 1 0.9998113512992859
specific O 0 0.03490033000707626
PCR O 0 0.11083387583494186
indicated O 0 0.024704396724700928
that O 0 0.008174228481948376
the O 0 0.022272545844316483
probands O 1 0.8674457669258118
two O 0 0.019556446000933647
brothers O 0 0.0653901994228363
also O 0 0.023801235482096672
inherited O 0 0.1105036810040474
the O 0 0.05551854148507118
1195delC O 1 0.9999805688858032
mutation O 0 0.07020175457000732
from O 0 0.01897331513464451
their O 0 0.020045915618538857
heterozygous O 0 0.0880507305264473
mother O 0 0.06691989302635193
and O 0 0.02274070307612419
the O 0 0.03984753042459488
1936delG O 1 0.9999635219573975
mutation O 0 0.05959823355078697
from O 0 0.019298553466796875
their O 0 0.021782023832201958
homozygous O 0 0.10181398689746857
father O 0 0.08600137382745743
. O 0 0.03132697939872742
. O 0 0.04127635806798935

PAX6 O 1 0.9999990463256836
mutations O 0 0.12483841925859451
reviewed O 0 0.08252564817667007
. O 0 0.05061526224017143

Mutations O 0 0.09643051773309708
in O 0 0.04720062389969826
PAX6 O 1 0.9999995231628418
are O 0 0.01567426137626171
responsible O 0 0.03911370411515236
for O 0 0.02722190134227276
human O 0 0.05572480335831642
aniridia B-Disease 1 1.0
and O 0 0.028327878564596176
have O 0 0.010333896614611149
also O 0 0.01164057943969965
been O 0 0.010698511265218258
found O 0 0.011813615448772907
in O 0 0.016725637018680573
patients O 0 0.44686898589134216
with O 0 0.03161691501736641
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999997615814209
, O 0 0.03450208157300949
with O 1 0.8397351503372192
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9912533164024353
with O 0 0.09490612894296646
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.030817652121186256
and O 0 0.021654322743415833
with O 0 0.02650466002523899
isolated B-Disease 1 0.9999933242797852
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0829697996377945

No O 0 0.053821541368961334
locus O 0 0.10940247774124146
other O 0 0.015899615362286568
than O 0 0.021082861348986626
chromosome O 0 0.09036444127559662
11p13 O 1 0.9983641505241394
has O 0 0.02177438884973526
been O 0 0.019601326435804367
implicated O 0 0.09116106480360031
in O 0 0.03628210723400116
aniridia B-Disease 1 1.0
, O 0 0.03259217366576195
and O 0 0.035061635076999664
PAX6 O 1 1.0
is O 0 0.02814319171011448
clearly O 0 0.024392182007431984
the O 0 0.022117681801319122
major O 0 0.03500986844301224
, O 0 0.019766921177506447
if O 0 0.013959843665361404
not O 0 0.009151638485491276
only O 0 0.013077380135655403
, O 0 0.0266252513974905
gene O 0 0.04879995062947273
responsible O 0 0.05655110999941826
. O 0 0.043954361230134964

Twenty O 0 0.10151960700750351
- O 0 0.4245002865791321
eight O 0 0.01928190141916275
percent O 0 0.017050527036190033
of O 0 0.022300049662590027
identified O 0 0.05159880220890045
PAX6 O 1 0.9999998807907104
mutations O 0 0.052343789488077164
are O 0 0.015472711995244026
C O 1 0.9999934434890747
- O 1 1.0
T O 1 0.9981347322463989
changes O 0 0.022340524941682816
at O 0 0.043677035719156265
CpG O 1 0.9993059635162354
dinucleotides O 1 0.9990569949150085
, O 0 0.02945432998239994
20 O 0 0.025293216109275818
% O 0 0.020818127319216728
are O 0 0.012438332661986351
splicing O 0 0.0752730667591095
errors O 0 0.04357120767235756
, O 0 0.021913932636380196
and O 0 0.014642786234617233
more O 0 0.009852697141468525
than O 0 0.012919693253934383
30 O 0 0.026337986811995506
% O 0 0.02261713705956936
are O 0 0.014793195761740208
deletion O 0 0.12055107206106186
or O 0 0.05088799446821213
insertion O 0 0.3955060541629791
events O 0 0.04320251941680908
. O 0 0.041268061846494675

There O 0 0.025253264233469963
is O 0 0.019059080630540848
a O 0 0.03588367998600006
noticeably O 0 0.12853370606899261
elevated O 1 0.9999876022338867
level O 0 0.045078445225954056
of O 0 0.03590703010559082
mutation O 0 0.05376516282558441
in O 0 0.017982957884669304
the O 0 0.03213193640112877
paired O 0 0.08560021221637726
domain O 0 0.0520867258310318
compared O 0 0.01777375489473343
with O 0 0.011723686940968037
the O 0 0.01930869184434414
rest O 0 0.028748709708452225
of O 0 0.02416292391717434
the O 0 0.041783347725868225
gene O 0 0.06033721938729286
. O 0 0.035106368362903595

Increased O 0 0.07478950917720795
mutation O 0 0.06925491243600845
in O 0 0.020789286121726036
the O 0 0.04263398423790932
homeodomain O 1 0.9986487030982971
is O 0 0.02955051138997078
accounted O 0 0.030834458768367767
for O 0 0.013748150318861008
by O 0 0.017520420253276825
the O 0 0.03862728923559189
hypermutable O 1 0.9999349117279053
CpG O 1 0.9998892545700073
dinucleotide O 1 0.9991732239723206
in O 0 0.041226938366889954
codon O 0 0.13114944100379944
240 O 0 0.0898013785481453
. O 0 0.042585041373968124

Very O 0 0.03378404304385185
nearly O 0 0.03110523708164692
all O 0 0.02375725843012333
mutations O 0 0.0442463718354702
appear O 0 0.025332937017083168
to O 0 0.02601584419608116
cause O 0 0.054624043405056
loss O 0 0.04496853053569794
of O 0 0.024798206984996796
function O 0 0.025027545168995857
of O 0 0.01941310241818428
the O 0 0.03846922889351845
mutant O 1 0.9991311430931091
allele O 0 0.1031370609998703
, O 0 0.020841464400291443
and O 0 0.012983188964426517
more O 0 0.007424256764352322
than O 0 0.009875299409031868
80 O 0 0.02795340120792389
% O 0 0.01941395178437233
of O 0 0.033673159778118134
exonic O 1 0.9996132254600525
substitutions O 0 0.07981531322002411
result O 0 0.03010142222046852
in O 0 0.030807338654994965
nonsense O 1 0.514643669128418
codons O 0 0.13503344357013702
. O 0 0.0493827760219574

In O 0 0.032394591718912125
a O 0 0.04506366699934006
gene O 0 0.04083794727921486
with O 0 0.018082112073898315
such O 0 0.020068272948265076
extraordinarily O 0 0.39839643239974976
high O 0 0.06344892084598541
sequence O 0 0.03499595448374748
conservation O 0 0.04575162008404732
throughout O 0 0.022716518491506577
evolution O 0 0.033185526728630066
, O 0 0.016865916550159454
there O 0 0.010332363657653332
are O 0 0.00908732507377863
presumed O 0 0.0992962047457695
undiscovered O 1 0.9997099041938782
missense O 1 0.9968454241752625
mutations O 0 0.06894122064113617
, O 0 0.025119710713624954
these O 0 0.011652829125523567
are O 0 0.011627902276813984
hypothesized O 0 0.05183710157871246
to O 0 0.017671875655651093
exist O 0 0.013243780471384525
in O 0 0.0137238884344697
as O 0 0.02794528566300869
- O 1 0.9999617338180542
yet O 0 0.03570006415247917
unidentified O 0 0.10455077886581421
phenotypes O 0 0.11579480767250061
. O 0 0.02909068949520588
. O 0 0.03703867644071579

Genetic O 0 0.10926929116249084
heterogeneity O 0 0.15533825755119324
and O 0 0.03789317235350609
penetrance O 1 0.9978383183479309
analysis O 0 0.015963232144713402
of O 0 0.016531743109226227
the O 0 0.03289045765995979
BRCA1 O 1 0.9991284012794495
and O 0 0.0384085439145565
BRCA2 O 1 0.9999562501907349
genes O 0 0.04755397513508797
in O 0 0.052877508103847504
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.2074151635169983
. O 0 0.05742316693067551

The O 1 0.9904001355171204
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 1.0
Consortium O 1 0.9353340268135071
. O 0 0.04670143127441406

The O 0 0.0357167012989521
contribution O 0 0.04474779590964317
of O 0 0.04367620870471001
BRCA1 O 1 0.9995899796485901
and O 0 0.031841106712818146
BRCA2 O 1 0.9975302815437317
to O 0 0.052071165293455124
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.999889612197876
assessed O 0 0.0518866665661335
by O 0 0.02737642079591751
linkage O 0 0.24352754652500153
and O 0 0.028839392587542534
mutation O 0 0.05752519518136978
analysis O 0 0.016957499086856842
in O 0 0.01724497601389885
237 O 0 0.10317033529281616
families O 0 0.036355193704366684
, O 0 0.018886936828494072
each O 0 0.0082699591293931
with O 0 0.010829946026206017
at O 0 0.015053873881697655
least O 0 0.007860119454562664
four O 0 0.0103147579357028
cases O 0 0.02489463984966278
of O 1 0.9783817529678345
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.025187969207763672
collected O 0 0.012692974880337715
by O 0 0.015697874128818512
the O 0 0.06424295902252197
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 1.0
Consortium O 0 0.4411511719226837
. O 0 0.04386487975716591

Families O 0 0.060203488916158676
were O 0 0.016474200412631035
included O 0 0.021421978250145912
without O 0 0.015226198360323906
regard O 0 0.025997856631875038
to O 0 0.014600061811506748
the O 0 0.021892638877034187
occurrence O 0 0.07248509675264359
of O 1 0.8592612743377686
ovarian B-Disease 1 1.0
or I-Disease 0 0.47722846269607544
other I-Disease 0 0.048461899161338806
cancers I-Disease 1 0.9999988079071045
. O 0 0.060258977115154266

Overall O 0 0.1028958410024643
, O 0 0.0749860554933548
disease O 1 1.0
was O 1 0.7693920135498047
linked O 0 0.3308244049549103
to O 0 0.03569100424647331
BRCA1 O 1 0.9994885921478271
in O 0 0.016607265919446945
an O 0 0.016596518456935883
estimated O 0 0.023313531652092934
52 O 0 0.044744253158569336
% O 0 0.01908768340945244
of O 0 0.021369144320487976
families O 0 0.03304922953248024
, O 0 0.02420986257493496
to O 0 0.03510194271802902
BRCA2 O 1 0.9760341048240662
in O 0 0.02344825118780136
32 O 0 0.04164201393723488
% O 0 0.0235761608928442
of O 0 0.027327755466103554
families O 0 0.034220367670059204
, O 0 0.022684941068291664
and O 0 0.016700467094779015
to O 0 0.021762166172266006
neither O 0 0.04068279266357422
gene O 0 0.032312218099832535
in O 0 0.015592887997627258
16 O 0 0.03436058759689331
% O 0 0.027104802429676056
( O 0 0.024385975673794746
95 O 0 0.04188474640250206
% O 0 0.025573601946234703
confidence O 0 0.06260541081428528
interval O 0 0.1072332039475441
[ O 0 0.11571017652750015
CI O 1 0.9999998807907104
] O 0 0.07544368505477905
6 O 0 0.04680385813117027
% O 0 0.037688300013542175
- O 1 0.9996274709701538
28 O 0 0.049888454377651215
% O 0 0.03005443699657917
) O 0 0.024409163743257523
, O 0 0.023637164384126663
suggesting O 0 0.04263300821185112
other O 0 0.03442323952913284
predisposition O 1 0.999951958656311
genes O 0 0.06409460306167603
. O 0 0.0481233112514019

The O 0 0.042493175715208054
majority O 0 0.04401163384318352
( O 0 0.03164834901690483
81 O 0 0.06080751493573189
% O 0 0.016368433833122253
) O 0 0.01018061675131321
of O 0 0.012781888246536255
the O 0 0.04064973443746567
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.06899070739746094
were O 0 0.017126629129052162
due O 0 0.02629363164305687
to O 0 0.03470596671104431
BRCA1 O 1 0.9999872446060181
, O 0 0.01996924914419651
with O 0 0.01485078688710928
most O 0 0.017223499715328217
others O 0 0.02225843071937561
( O 0 0.0291569996625185
14 O 0 0.04034636542201042
% O 0 0.03377719223499298
) O 0 0.028222786262631416
due O 0 0.038127388805150986
to O 0 0.05787084251642227
BRCA2 O 1 0.9988328814506531
. O 0 0.06104213371872902

Conversely O 0 0.13577653467655182
, O 0 0.024645276367664337
the O 0 0.02004934661090374
majority O 0 0.022493071854114532
of O 0 0.018121853470802307
families O 0 0.023423129692673683
with O 0 0.014856409281492233
male B-Disease 0 0.044755686074495316
and I-Disease 0 0.033176206052303314
female I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.02488008327782154
due O 0 0.03434941545128822
to O 0 0.04634179547429085
BRCA2 O 1 0.9999889135360718
( O 0 0.046253055334091187
76 O 0 0.23602473735809326
% O 0 0.04444710537791252
) O 0 0.033642079681158066
. O 0 0.03360762819647789

The O 0 0.04889550432562828
largest O 0 0.08492697775363922
proportion O 0 0.06811875849962234
( O 0 0.03865528479218483
67 O 0 0.07674868404865265
% O 0 0.03197922185063362
) O 0 0.020209146663546562
of O 0 0.021662434563040733
families O 0 0.031903404742479324
due O 0 0.0292862206697464
to O 0 0.024363117292523384
other O 0 0.01915105991065502
genes O 0 0.027900446206331253
was O 0 0.031178725883364677
found O 0 0.016214832663536072
in O 0 0.013617875054478645
families O 0 0.022884400561451912
with O 0 0.015114463865756989
four O 0 0.014922982081770897
or O 0 0.014675157144665718
five O 0 0.012059992179274559
cases O 0 0.019348351284861565
of O 0 0.043381467461586
female O 1 0.9999998807907104
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.051056019961833954
. O 0 0.051495570689439774

These O 0 0.029876669868826866
estimates O 0 0.028913624584674835
were O 0 0.013499102555215359
not O 0 0.016888020560145378
substantially O 0 0.04553491249680519
affected O 0 0.03316120058298111
either O 0 0.018585288897156715
by O 0 0.01708832196891308
changing O 0 0.022321589291095734
the O 0 0.02470516599714756
assumed O 0 0.07426273822784424
penetrance O 1 0.9997536540031433
model O 0 0.0542878657579422
for O 0 0.03892907127737999
BRCA1 O 1 0.9996784925460815
or O 0 0.022543689236044884
by O 0 0.017863139510154724
including O 0 0.01947208307683468
or O 0 0.03242772817611694
excluding O 0 0.09174779802560806
BRCA1 O 1 0.9999985694885254
mutation O 0 0.10518118739128113
data O 0 0.028762158006429672
. O 0 0.033124472945928574

Among O 0 0.04435983672738075
those O 0 0.01890522614121437
families O 0 0.04359562322497368
with O 0 0.04681383818387985
disease O 1 1.0
due O 1 0.8029943108558655
to O 0 0.47172117233276367
BRCA1 O 1 0.999998927116394
that O 0 0.015178416855633259
were O 0 0.01355726271867752
tested O 0 0.02889999747276306
by O 0 0.01059873215854168
one O 0 0.011576456017792225
of O 0 0.015427877195179462
the O 0 0.02706398069858551
standard O 0 0.0617997981607914
screening O 0 0.08718687295913696
methods O 0 0.0313573032617569
, O 0 0.02837659977376461
mutations O 0 0.0329805351793766
were O 0 0.013284164480865002
detected O 0 0.033922385424375534
in O 0 0.014624337665736675
the O 0 0.029559656977653503
coding O 0 0.0822325125336647
sequence O 0 0.02901041880249977
or O 0 0.028739087283611298
splice O 0 0.11599909514188766
sites O 0 0.01994476653635502
in O 0 0.011386428028345108
an O 0 0.015271593816578388
estimated O 0 0.026006458327174187
63 O 0 0.06577044725418091
% O 0 0.029715538024902344
( O 0 0.025552598759531975
95 O 0 0.05103126913309097
% O 0 0.04336399585008621
CI O 1 0.9999973773956299
51 O 0 0.08179260045289993
% O 0 0.0503404326736927
- O 1 0.9999544620513916
77 O 0 0.10236550867557526
% O 0 0.04365573078393936
) O 0 0.03504718467593193
. O 0 0.037595849484205246

The O 0 0.053837668150663376
estimated O 0 0.048408735543489456
sensitivity O 0 0.0722196102142334
was O 0 0.03762142360210419
identical O 0 0.026609448716044426
for O 0 0.02262059599161148
direct O 0 0.04657739773392677
sequencing O 0 0.05790409445762634
and O 0 0.02399522438645363
other O 0 0.01976400427520275
techniques O 0 0.039849039167165756
. O 0 0.039689335972070694

The O 0 0.0678522139787674
penetrance O 1 0.999661922454834
of O 0 0.07189995050430298
BRCA2 O 1 0.9993113279342651
was O 0 0.04294687882065773
estimated O 0 0.022567763924598694
by O 0 0.017826173454523087
maximizing O 0 0.08162901550531387
the O 0 0.03545859456062317
LOD O 1 0.999984622001648
score O 0 0.03203650563955307
in O 0 0.030480273067951202
BRCA2 O 1 0.9999982118606567
- O 1 0.9999998807907104
mutation O 0 0.07126818597316742
families O 0 0.027196478098630905
, O 0 0.01610175520181656
over O 0 0.017387503758072853
all O 0 0.01664927788078785
possible O 0 0.0403374582529068
penetrance O 1 0.9992546439170837
functions O 0 0.055530913174152374
. O 0 0.04312390089035034

The O 0 0.034447990357875824
estimated O 0 0.03448963537812233
cumulative O 0 0.07771528512239456
risk O 0 0.06756627559661865
of O 1 0.8919941186904907
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 1 0.933894693851471
28 O 0 0.06050217151641846
% O 0 0.026079565286636353
( O 0 0.023498060181736946
95 O 0 0.04643450304865837
% O 0 0.0438588410615921
CI O 1 0.9999982118606567
9 O 0 0.05268686264753342
% O 0 0.040379200130701065
- O 1 0.9992509484291077
44 O 0 0.0541125051677227
% O 0 0.026366474106907845
) O 0 0.017532967031002045
by O 0 0.016146279871463776
age O 0 0.02959320694208145
50 O 0 0.027960553765296936
years O 0 0.020163031294941902
and O 0 0.020330015569925308
84 O 0 0.07456512004137039
% O 0 0.033880021423101425
( O 0 0.02825404517352581
95 O 0 0.05548984184861183
% O 0 0.04615575820207596
CI O 1 0.999994158744812
43 O 0 0.07157836109399796
% O 0 0.04763401299715042
- O 1 0.9984468817710876
95 O 0 0.06358680874109268
% O 0 0.029393961653113365
) O 0 0.019328981637954712
by O 0 0.019448652863502502
age O 0 0.03692135959863663
70 O 0 0.04878421500325203
years O 0 0.04143078997731209
. O 0 0.04498614743351936

The O 0 0.07261558622121811
corresponding O 1 0.9997768998146057
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999995231628418
were O 0 0.03679722547531128
0 O 0 0.09115353226661682
. O 0 0.04115254431962967

4 O 0 0.07621502876281738
% O 0 0.03630446642637253
( O 0 0.02775498479604721
95 O 0 0.055412571877241135
% O 0 0.046700313687324524
CI O 1 0.9999994039535522
0 O 0 0.08620107918977737
% O 0 0.04288338124752045
- O 1 0.9998841285705566
1 O 0 0.04895368590950966
% O 0 0.022904060781002045
) O 0 0.016676906496286392
by O 0 0.014557193033397198
age O 0 0.025699889287352562
50 O 0 0.02699277736246586
years O 0 0.02084735594689846
and O 0 0.019903801381587982
27 O 0 0.04469546303153038
% O 0 0.026679566130042076
( O 0 0.024482443928718567
95 O 0 0.05091279372572899
% O 0 0.04731333628296852
CI O 1 0.9999988079071045
0 O 0 0.08203314989805222
% O 0 0.04359109327197075
- O 1 0.9964858293533325
47 O 0 0.06645585596561432
% O 0 0.028868786990642548
) O 0 0.02061418630182743
by O 0 0.019556302577257156
age O 0 0.03814030438661575
70 O 0 0.04730568453669548
years O 0 0.037768084555864334
. O 0 0.045366231352090836

The O 0 0.0462663508951664
lifetime O 0 0.08785925060510635
risk O 1 0.9789206385612488
of O 1 0.9997026324272156
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.0715145543217659
similar O 0 0.01542561687529087
to O 0 0.016552845016121864
the O 0 0.02641233615577221
risk O 0 0.06111330911517143
in O 0 0.03824605792760849
BRCA1 O 1 0.9999995231628418
carriers O 0 0.16780394315719604
, O 0 0.02273232862353325
but O 0 0.012489764019846916
there O 0 0.01035370770841837
was O 0 0.020159658044576645
some O 0 0.007731886580586433
suggestion O 0 0.034559253603219986
of O 0 0.01887107640504837
a O 0 0.03372864052653313
lower O 0 0.0666939839720726
risk O 0 0.07637666910886765
in O 0 0.039462171494960785
BRCA2 O 1 0.9999874830245972
carriers O 0 0.32518401741981506
< O 1 0.9933539628982544
50 O 0 0.03032122552394867
years O 0 0.0219588503241539
of O 0 0.0294544268399477
age O 0 0.054456114768981934
. O 0 0.04642154276371002

Eye B-Disease 1 0.9999936819076538
movement I-Disease 1 0.9089381098747253
abnormalities I-Disease 1 0.9948704242706299
correlate O 0 0.07866833359003067
with O 0 0.027186894789338112
genotype O 0 0.3460423946380615
in O 0 0.03052099607884884
autosomal O 1 0.9999721050262451
dominant O 1 0.9999995231628418
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999983310699463
I I-Disease 1 0.9951552152633667
. O 0 0.05311368405818939

We O 0 0.031763605773448944
compared O 0 0.051710281521081924
horizontal O 1 0.9277142286300659
eye O 1 0.9999977350234985
movements O 0 0.0645671933889389
( O 0 0.04179036244750023
visually O 0 0.09247766435146332
guided O 0 0.13687334954738617
saccades O 1 0.9999990463256836
, O 0 0.051224563270807266
antisaccades O 1 0.999968409538269
, O 0 0.030898768454790115
and O 0 0.026611024513840675
smooth O 0 0.09428858757019043
pursuit O 0 0.4057469069957733
) O 0 0.0240626223385334
in O 0 0.016925541684031487
control O 0 0.03881065919995308
subjects O 0 0.04463082551956177
( O 0 0.042946867644786835
n O 0 0.14159590005874634
= O 0 0.0845474824309349
14 O 0 0.04355107247829437
) O 0 0.029284903779625893
and O 0 0.024320809170603752
patients O 0 0.06836722046136856
with O 0 0.014404678717255592
three O 0 0.014699218794703484
forms O 0 0.02611214481294155
of O 0 0.037111952900886536
autosomal O 1 0.9999456405639648
dominant O 1 0.9999850988388062
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9991703033447266
I I-Disease 1 0.9893468022346497
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999982118606567
1 I-Disease 0 0.053777020424604416
and I-Disease 0 0.023244734853506088
2 I-Disease 0 0.0467037633061409
( O 0 0.03715726360678673
SCA1 B-Disease 1 0.9999752044677734
, O 0 0.034963492304086685
n O 0 0.09832529723644257
= O 0 0.06210634112358093
11 O 0 0.031819362193346024
; O 0 0.029689611867070198
SCA2 B-Disease 1 0.9999426603317261
, O 0 0.036279480904340744
n O 0 0.09345144778490067
= O 0 0.058920808136463165
10 O 0 0.018355611711740494
) O 0 0.015561036765575409
and O 0 0.019463280215859413
SCA3 B-Disease 1 1.0
/ O 1 0.99996018409729
Machado B-Disease 1 0.9999940395355225
- I-Disease 1 1.0
Joseph I-Disease 1 0.9999990463256836
disease I-Disease 1 1.0
( O 1 0.9471006989479065
MJD B-Disease 1 1.0
) O 0 0.04851631447672844
( O 0 0.04353633522987366
n O 0 0.14119161665439606
= O 0 0.09022679924964905
16 O 0 0.047847405076026917
) O 0 0.03412560746073723
. O 0 0.034822698682546616

In O 0 0.058795202523469925
SCA1 B-Disease 1 0.9999076128005981
, O 0 0.05887463688850403
saccade O 1 0.9996597766876221
amplitude O 0 0.1098785400390625
was O 0 0.04383522644639015
significantly O 0 0.0344526469707489
increased O 0 0.03167947009205818
, O 0 0.02569033019244671
resulting O 0 0.037564221769571304
in O 0 0.03843638673424721
hypermetria B-Disease 1 0.999705970287323
. O 0 0.05694015696644783

The O 0 0.07095839828252792
smooth O 0 0.12585413455963135
pursuit O 0 0.13548743724822998
gain O 0 0.0688021257519722
was O 0 0.06295628100633621
decreased O 0 0.09772515296936035
. O 0 0.04775798320770264

In O 0 0.06510446965694427
SCA2 B-Disease 1 0.9999967813491821
, O 0 0.062060337513685226
saccade O 1 0.9994456171989441
velocity O 0 0.09131850302219391
was O 0 0.05947987735271454
markedly O 0 0.10356707125902176
decreased O 0 0.09216180443763733
. O 0 0.053424350917339325

The O 0 0.041992612183094025
percentage O 0 0.03871677443385124
of O 0 0.030557066202163696
errors O 0 0.04953046515583992
in O 0 0.03442668542265892
antisaccades O 1 0.9999779462814331
was O 0 0.048740774393081665
greatly O 0 0.04211370646953583
increased O 0 0.02380269579589367
and O 0 0.017630701884627342
was O 0 0.029718078672885895
significantly O 0 0.03361694887280464
correlated O 0 0.048705898225307465
with O 0 0.017087198793888092
age O 0 0.04829815402626991
at O 1 0.9996206760406494
disease O 1 1.0
onset O 1 1.0
. O 0 0.2367328256368637

In O 0 0.034903205931186676
addition O 0 0.02799922600388527
, O 0 0.021310629323124886
a O 0 0.033918146044015884
correlation O 0 0.06422391533851624
between O 0 0.03577873110771179
smooth O 0 0.10279100388288498
pursuit O 0 0.11348533630371094
gain O 0 0.03938860073685646
and O 0 0.014109182171523571
the O 0 0.015331271104514599
number O 0 0.014748083427548409
of O 0 0.03721635788679123
trinucleotide O 1 0.9999899864196777
repeats O 0 0.10906215012073517
was O 0 0.052523594349622726
found O 0 0.031654033809900284
. O 0 0.036904338747262955

In O 0 0.05621911585330963
SCA3 B-Disease 1 1.0
, O 0 0.046187590807676315
gaze B-Disease 1 0.9999072551727295
- I-Disease 1 1.0
evoked I-Disease 1 0.9998526573181152
nystagmus I-Disease 1 0.9999998807907104
was O 0 0.045393843203783035
often O 0 0.01633627340197563
present O 0 0.01958448253571987
as O 0 0.02137339487671852
was O 0 0.04941706359386444
saccade O 1 0.9999713897705078
hypometria O 1 0.9999470710754395
and O 0 0.040848441421985626
smooth O 0 0.1031869649887085
pursuit O 0 0.12903420627117157
gain O 0 0.05518930405378342
was O 0 0.055667195469141006
markedly O 0 0.11943526566028595
decreased O 0 0.10415200144052505
. O 0 0.047395654022693634

Three O 0 0.03206610679626465
major O 0 0.05149063095450401
criteria O 0 0.05759040266275406
, O 0 0.04561794549226761
saccade O 1 0.9999916553497314
amplitude O 0 0.14819371700286865
, O 0 0.04955286905169487
saccade O 1 0.9991766810417175
velocity O 0 0.06460036337375641
, O 0 0.017564445734024048
and O 0 0.011861439794301987
presence O 0 0.025570904836058617
of O 0 0.03456905856728554
gaze B-Disease 1 0.9999812841415405
- I-Disease 1 0.9999998807907104
evoked I-Disease 1 0.9988873600959778
nystagmus I-Disease 1 0.9999940395355225
, O 0 0.02875581942498684
permitted O 0 0.029265256598591805
the O 0 0.026464316993951797
correct O 0 0.05088917911052704
assignment O 0 0.05917815864086151
of O 0 0.022809991613030434
90 O 0 0.03153178095817566
% O 0 0.018896790221333504
of O 0 0.021891405805945396
the O 0 0.04112644121050835
SCA1 B-Disease 1 0.9999988079071045
, O 0 0.02674167975783348
90 O 0 0.026129761710762978
% O 0 0.015970680862665176
of O 0 0.01956379972398281
the O 0 0.03992285579442978
SCA2 B-Disease 1 0.9999998807907104
, O 0 0.027548160403966904
and O 0 0.020513325929641724
93 O 0 0.058379724621772766
% O 0 0.01872950978577137
of O 0 0.0208832249045372
the O 0 0.03670026734471321
patients O 1 0.9470430612564087
with O 0 0.03758244588971138
SCA3 B-Disease 1 1.0
to O 0 0.02234070375561714
their O 0 0.013833372853696346
genetically O 0 0.032210759818553925
confirmed O 0 0.03870517015457153
patient O 1 0.999953031539917
group O 0 0.06308164447546005
and O 0 0.023892823606729507
, O 0 0.022020237520337105
therefore O 0 0.02434839867055416
, O 0 0.019780736416578293
may O 0 0.02084043249487877
help O 0 0.04253920540213585
orient O 1 0.9953352808952332
diagnoses O 1 0.9998819828033447
of O 0 0.05716057866811752
SCA1 B-Disease 1 1.0
, O 0 0.05309697985649109
SCA2 B-Disease 1 0.9999988079071045
, O 0 0.027974646538496017
and O 0 0.029463056474924088
SCA3 B-Disease 1 0.9999998807907104
at O 0 0.031564418226480484
early O 0 0.031428467482328415
clinical O 0 0.08400587737560272
stages O 0 0.0436294786632061
of O 0 0.03724655508995056
the O 1 0.975899338722229
diseases O 1 1.0
. O 0 0.04576997831463814
. O 0 0.04686634615063667

Genetic O 0 0.05483383312821388
basis O 0 0.019825156778097153
and O 0 0.023019079118967056
molecular O 0 0.05690149962902069
mechanism O 0 0.08089498430490494
for O 1 0.7712981104850769
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9956246018409729

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.999998927116394
more O 0 0.021891094744205475
than O 0 0.015348369255661964
300 O 0 0.03257398307323456
, O 0 0.024545008316636086
000 O 0 0.0791076198220253
sudden O 1 0.8255156874656677
deaths O 0 0.05236499756574631
each O 0 0.012539464049041271
year O 0 0.019072003662586212
in O 0 0.016812464222311974
the O 0 0.03457072749733925
USA O 0 0.11075930297374725
alone O 0 0.055526506155729294
. O 0 0.041764967143535614

In O 0 0.025999728590250015
approximately O 0 0.02397211827337742
5 O 0 0.04600043222308159
- O 1 0.9992130994796753
12 O 0 0.02812063694000244
% O 0 0.017048737034201622
of O 0 0.017980456352233887
these O 0 0.009897129610180855
cases O 0 0.02164224535226822
, O 0 0.014801752753555775
there O 0 0.007313429843634367
are O 0 0.005539646837860346
no O 0 0.02200300060212612
demonstrable O 1 0.9999998807907104
cardiac O 1 1.0
or O 1 0.7961471676826477
non O 1 1.0
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.9965165853500366
to O 0 0.025546664372086525
account O 0 0.01758006401360035
for O 0 0.012707737274467945
the O 0 0.020367171615362167
episode O 0 0.04533173516392708
, O 0 0.015879975631833076
which O 0 0.008843671530485153
is O 0 0.010112505406141281
therefore O 0 0.013084815815091133
classified O 0 0.04028269648551941
as O 0 0.052809085696935654
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.059215933084487915
. O 0 0.04051969200372696

A O 0 0.052633367478847504
distinct O 0 0.029832640662789345
group O 0 0.047801222652196884
of O 0 0.06278521567583084
IVF B-Disease 1 1.0
patients O 1 0.9999967813491821
has O 0 0.030459582805633545
been O 0 0.018460718914866447
found O 0 0.01167707797139883
to O 0 0.013608795590698719
present O 0 0.018097219988703728
with O 0 0.015124013647437096
a O 0 0.038790713995695114
characteristic O 0 0.21943901479244232
electrocardiographic O 1 0.9999958276748657
pattern O 0 0.0929982140660286
. O 0 0.052955273538827896

Because O 0 0.031026016920804977
of O 0 0.023029066622257233
the O 0 0.024869512766599655
small O 0 0.02270832471549511
size O 0 0.016881398856639862
of O 0 0.016857780516147614
most O 0 0.018239857628941536
pedigrees O 0 0.07950741797685623
and O 0 0.01594546064734459
the O 0 0.02379726618528366
high O 0 0.3691489100456238
incidence O 1 0.9999969005584717
of O 0 0.06605354696512222
sudden B-Disease 1 0.9999972581863403
death I-Disease 1 0.9999368190765381
, O 0 0.02532772719860077
however O 0 0.015213417820632458
, O 0 0.020512953400611877
molecular O 0 0.042238589376211166
genetic O 0 0.030964694917201996
studies O 0 0.02340174838900566
of O 0 0.04458753764629364
IVF B-Disease 1 1.0
have O 0 0.019468823447823524
not O 0 0.014198611490428448
yet O 0 0.02196747064590454
been O 0 0.0192799624055624
done O 0 0.027128076180815697
. O 0 0.03985467925667763

Because O 0 0.08683814853429794
IVF B-Disease 1 1.0
causes O 1 1.0
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 0.03292275592684746
we O 0 0.013664647936820984
investigated O 0 0.041267722845077515
whether O 0 0.0307060144841671
malfunction O 1 0.9986932873725891
of O 0 0.04617214947938919
ion O 1 0.9780582189559937
channels O 0 0.034265823662281036
could O 0 0.019176818430423737
cause O 0 0.04546240344643593
the O 0 0.042186517268419266
disorder O 1 0.9999992847442627
by O 0 0.028927642852067947
studying O 0 0.03381096571683884
mutations O 0 0.02976323291659355
in O 0 0.017931733280420303
the O 0 0.050646793097257614
cardiac O 1 1.0
sodium O 1 0.9999847412109375
channel O 0 0.0927218347787857
gene O 0 0.08027186989784241
SCN5A O 1 0.9994045495986938
. O 0 0.04972608759999275

We O 0 0.024464184418320656
have O 0 0.009573847986757755
now O 0 0.016899678856134415
identified O 0 0.022179914638400078
a O 0 0.03248339891433716
missense O 0 0.13962207734584808
mutation O 0 0.0526890903711319
, O 0 0.016850285232067108
a O 0 0.034977059811353683
splice O 1 0.99850994348526
- O 1 0.9999997615814209
donor O 1 0.9946724772453308
mutation O 0 0.06325999647378922
, O 0 0.018627554178237915
and O 0 0.01769166998565197
a O 0 0.04392107576131821
frameshift O 1 0.9992679953575134
mutation O 0 0.0624941885471344
in O 0 0.01736920140683651
the O 0 0.028384316712617874
coding O 0 0.0614321231842041
region O 0 0.029218018054962158
of O 0 0.03361285850405693
SCN5A O 1 0.9999635219573975
in O 0 0.030137958005070686
three O 0 0.04121731221675873
IVF B-Disease 1 0.9999991655349731
families O 0 0.07454317063093185
. O 0 0.053538452833890915

We O 0 0.02840978465974331
show O 0 0.03150153532624245
that O 0 0.021397624164819717
sodium O 0 0.08086345344781876
channels O 0 0.019815485924482346
with O 0 0.012138384394347668
the O 0 0.031202945858240128
missense O 0 0.42514726519584656
mutation O 0 0.09199509024620056
recover O 0 0.09489656984806061
from O 0 0.046236176043748856
inactivation O 1 0.9999958276748657
more O 0 0.022182179614901543
rapidly O 0 0.04409920424222946
than O 0 0.01598220318555832
normal O 0 0.024517448619008064
and O 0 0.012189951725304127
that O 0 0.009111213497817516
the O 0 0.034971851855516434
frameshift O 1 0.9999765157699585
mutation O 0 0.14312726259231567
causes O 0 0.14491157233715057
the O 0 0.048704322427511215
sodium O 0 0.3552958369255066
channel O 0 0.028234537690877914
to O 0 0.013018481433391571
be O 0 0.013237537816166878
non O 0 0.26475241780281067
- O 1 0.9999986886978149
functional O 0 0.08677007257938385
. O 0 0.04054953157901764

Our O 0 0.04200752079486847
results O 0 0.019258499145507812
indicate O 0 0.017116781324148178
that O 0 0.009174618870019913
mutations O 0 0.031155262142419815
in O 0 0.031774383038282394
cardiac O 1 1.0
ion O 1 1.0
- O 1 1.0
channel O 0 0.05776311084628105
genes O 0 0.022310208529233932
contribute O 0 0.019048480316996574
to O 0 0.012827396392822266
the O 0 0.020943228155374527
risk O 0 0.043357960879802704
of O 0 0.03731326013803482
developing O 1 0.9960441589355469
IVF B-Disease 1 1.0
. O 0 0.04678324982523918
. O 0 0.04405267536640167

Molecular O 0 0.12370383739471436
heterogeneity O 0 0.1584729105234146
in O 0 0.047023676335811615
mucopolysaccharidosis B-Disease 1 0.9999719858169556
IVA I-Disease 1 0.9999998807907104
in O 0 0.034212931990623474
Australia O 0 0.03644314408302307
and O 0 0.017876209691166878
Northern O 0 0.03762122616171837
Ireland O 0 0.044985875487327576
: O 0 0.024359524250030518
nine O 0 0.027704153209924698
novel O 0 0.06325885653495789
mutations O 0 0.045549578964710236
including O 0 0.02847314067184925
T312S O 1 0.9999861717224121
, O 0 0.025548677891492844
a O 0 0.02900526113808155
common O 0 0.0357053242623806
allele O 0 0.08030569553375244
that O 0 0.01869971677660942
confers O 1 0.6422880291938782
a O 0 0.07323769479990005
mild O 1 0.9999911785125732
phenotype O 1 0.9961875081062317
. O 0 0.06078406423330307

Mucopolysaccharidosis B-Disease 1 0.9999969005584717
IVA I-Disease 1 1.0
( O 0 0.08233821392059326
MPS B-Disease 1 0.9999794960021973
IVA I-Disease 1 1.0
) O 0 0.031015336513519287
is O 0 0.014967811293900013
an O 0 0.022976448759436607
autosomal B-Disease 1 0.9999066591262817
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9978873133659363
by O 0 0.025934448465704918
a O 0 0.03664441034197807
genetic B-Disease 0 0.0634630024433136
defect I-Disease 1 0.999995231628418
in O 0 0.022998075932264328
N O 1 0.9986400008201599
- O 1 0.9999747276306152
acetylgalactosamine O 1 0.999957799911499
- O 1 0.9999837875366211
6 O 0 0.0755564421415329
- O 1 1.0
sulfate O 1 0.9999998807907104
sulfatase O 1 1.0
( O 0 0.09191745519638062
GALNS O 1 0.9999996423721313
) O 0 0.04849296435713768
. O 0 0.03590391203761101

Previous O 0 0.05482997000217438
studies O 0 0.028860412538051605
of O 0 0.03702472150325775
patients O 1 0.7989596128463745
from O 0 0.023431703448295593
a O 0 0.03361363708972931
British O 0 0.061374131590127945
- O 1 0.9994657635688782
Irish O 0 0.052937086671590805
population O 0 0.015352332033216953
showed O 0 0.017967622727155685
that O 0 0.010113001801073551
the O 0 0.03008309379220009
I113F O 1 0.9999433755874634
mutation O 0 0.06396177411079407
is O 0 0.016292693093419075
the O 0 0.01630648598074913
most O 0 0.013363279402256012
common O 0 0.022052090615034103
single O 0 0.03977689519524574
mutation O 0 0.04889952018857002
among O 0 0.038234129548072815
MPS B-Disease 1 0.9999990463256836
IVA I-Disease 1 1.0
patients O 1 0.9999998807907104
and O 0 0.03557141497731209
produces O 0 0.0469297431409359
a O 0 0.05758325010538101
severe O 1 0.9999997615814209
clinical O 1 1.0
phenotype O 1 0.9999969005584717
. O 0 0.07053250074386597

We O 0 0.03154663369059563
studied O 0 0.04185140132904053
mutations O 0 0.032728202641010284
in O 0 0.013922834768891335
the O 0 0.03449496626853943
GALNS O 1 0.9999998807907104
gene O 0 0.03824511170387268
from O 0 0.01306081097573042
23 O 0 0.0291395653039217
additional O 0 0.02898966148495674
MPS B-Disease 1 0.9999984502792358
IVA I-Disease 1 1.0
patients O 1 1.0
( O 0 0.045133400708436966
15 O 0 0.03260695934295654
from O 0 0.016850845888257027
Australia O 0 0.03244905173778534
, O 0 0.018162768334150314
8 O 0 0.026667490601539612
from O 0 0.016325978562235832
Northern O 0 0.03704218566417694
Ireland O 0 0.04551135003566742
) O 0 0.01972273737192154
, O 0 0.012635807506740093
with O 0 0.012201233766973019
various O 0 0.018609484657645226
clinical O 1 0.9999942779541016
phenotypes O 1 0.9999984502792358
( O 1 0.6577948331832886
severe O 1 0.9999986886978149
, O 0 0.03556445986032486
16 O 0 0.0414373017847538
cases O 0 0.03345843404531479
; O 0 0.03134453669190407
intermediate O 1 0.7996845841407776
, O 0 0.023380670696496964
4 O 0 0.042743463069200516
cases O 0 0.03748055920004845
; O 0 0.04389625042676926
mild O 1 0.9998229146003723
, O 0 0.041275590658187866
3 O 0 0.05882313475012779
cases O 0 0.04574955999851227
) O 0 0.04029586911201477
. O 0 0.04047387093305588

We O 0 0.02571893483400345
found O 0 0.019044864922761917
two O 0 0.018945492804050446
common O 0 0.043247006833553314
mutations O 0 0.04217732697725296
that O 0 0.013129820115864277
together O 0 0.023312553763389587
accounted O 0 0.040848493576049805
for O 0 0.020431874319911003
32 O 0 0.03510557860136032
% O 0 0.018059130758047104
of O 0 0.017729150131344795
the O 0 0.028943320736289024
44 O 0 0.06863313913345337
unrelated O 0 0.07986284792423248
alleles O 0 0.08907488733530045
in O 0 0.03097192570567131
these O 0 0.02814129926264286
patients O 1 0.9979066848754883
. O 0 0.06123986467719078

One O 0 0.03418916463851929
is O 0 0.021336043253540993
the O 0 0.03680875897407532
T312S O 1 0.9997988343238831
mutation O 0 0.07294131070375443
, O 0 0.021868610754609108
a O 0 0.03288894519209862
novel O 0 0.06850030273199081
mutation O 0 0.05565516650676727
found O 0 0.019988493993878365
exclusively O 0 0.036112070083618164
in O 0 0.0383225679397583
milder O 1 0.9971230626106262
patients O 1 0.9998334646224976
. O 0 0.07232530415058136

The O 0 0.04310539364814758
other O 0 0.015862450003623962
is O 0 0.013999426737427711
the O 0 0.01712261699140072
previously O 0 0.027628181502223015
described O 0 0.044168561697006226
I113F O 1 0.9963322281837463
that O 0 0.018503310158848763
produces O 0 0.0411100871860981
a O 0 0.05761633813381195
severe O 1 0.9999991655349731
phenotype O 1 0.9999192953109741
. O 0 0.07239590585231781

The O 0 0.06965543329715729
I113F O 1 0.9898073077201843
and O 0 0.04782019555568695
T312S O 1 0.9998538494110107
mutations O 0 0.056666646152734756
accounted O 0 0.04197011515498161
for O 0 0.02445048838853836
8 O 0 0.04573681950569153
( O 0 0.024761803448200226
18 O 0 0.03031829372048378
% O 0 0.028504233807325363
) O 0 0.022991761565208435
and O 0 0.020914971828460693
6 O 0 0.050886370241642
( O 0 0.027685584500432014
14 O 0 0.034239884465932846
% O 0 0.023630715906620026
) O 0 0.016752680763602257
of O 0 0.023327065631747246
44 O 0 0.06838385760784149
unrelated O 0 0.088633231818676
alleles O 0 0.11052947491407394
, O 0 0.04039011150598526
respectively O 0 0.05344683304429054
. O 0 0.0440773107111454

The O 0 0.05022682622075081
relatively O 0 0.048523157835006714
high O 0 0.09864795207977295
residual O 1 0.9999376535415649
GALNS O 1 0.9999995231628418
activity O 0 0.0505969300866127
seen O 0 0.024069782346487045
when O 0 0.01614045724272728
the O 0 0.024638228118419647
T312S O 1 0.9609443545341492
mutant O 0 0.1395372748374939
cDNA O 0 0.13528266549110413
is O 0 0.03256939351558685
overexpressed O 0 0.16944420337677002
in O 0 0.0356752872467041
mutant O 1 0.9587604999542236
cells O 0 0.05772567167878151
provides O 0 0.028470240533351898
an O 0 0.01680615171790123
explanation O 0 0.02693093754351139
for O 0 0.01539222989231348
the O 0 0.03527309000492096
mild O 1 0.9999613761901855
phenotype O 1 0.9996868371963501
in O 0 0.04125992953777313
patients O 1 0.9996329545974731
with O 0 0.029140062630176544
this O 0 0.029811665415763855
mutation O 0 0.08210316300392151
. O 0 0.04242098703980446

The O 0 0.05222470685839653
distribution O 0 0.038437455892562866
and O 0 0.02088344283401966
relative O 0 0.04133041203022003
frequencies O 0 0.019704274833202362
of O 0 0.016726303845643997
the O 0 0.03605686500668526
I113F O 1 0.9997490048408508
and O 0 0.04833503067493439
T312S O 1 0.9999818801879883
mutations O 0 0.05419883504509926
in O 0 0.021532254293560982
Australia O 0 0.038812849670648575
corresponded O 0 0.054638057947158813
to O 0 0.021443122997879982
those O 0 0.01274059247225523
observed O 0 0.02160382643342018
in O 0 0.01771734468638897
Northern O 0 0.049776602536439896
Ireland O 0 0.05457160249352455
and O 0 0.023190690204501152
are O 0 0.010029200464487076
unique O 0 0.018762903288006783
to O 0 0.01702762395143509
these O 0 0.008502590470016003
two O 0 0.013836867175996304
populations O 0 0.03472781553864479
, O 0 0.02509543113410473
suggesting O 0 0.034935664385557175
that O 0 0.014613822102546692
both O 0 0.020989064127206802
mutations O 0 0.040587928146123886
were O 0 0.014896528795361519
probably O 0 0.027233291417360306
introduced O 0 0.024305196478962898
to O 0 0.019161291420459747
Australia O 0 0.028214775025844574
by O 0 0.022898444905877113
Irish O 0 0.06419490277767181
migrants O 0 0.044457271695137024
during O 0 0.02733701467514038
the O 0 0.03251401707530022
19th O 0 0.07880651205778122
century O 0 0.08545611798763275
. O 0 0.04683535918593407

Haplotype O 0 0.42761915922164917
analysis O 0 0.036259692162275314
using O 0 0.02284010872244835
6 O 0 0.07189929485321045
RFLPs O 1 0.9853273630142212
provides O 0 0.03578389808535576
additional O 0 0.01735799014568329
data O 0 0.00872520636767149
that O 0 0.007625109050422907
the O 0 0.027187688276171684
I113F O 1 0.9956384301185608
mutation O 0 0.08139465749263763
originated O 0 0.04302985221147537
from O 0 0.018709730356931686
a O 0 0.03528197482228279
common O 0 0.04643101990222931
ancestor O 0 0.1284717321395874
. O 0 0.049900121986866

The O 0 0.04076724871993065
other O 0 0.021021025255322456
9 O 0 0.05374963581562042
novel O 0 0.07697263360023499
mutations O 0 0.05194299295544624
identified O 0 0.031066717579960823
in O 0 0.01888423226773739
these O 0 0.016481276601552963
23 O 0 0.06476417928934097
patients O 1 0.9878325462341309
were O 0 0.01676294207572937
each O 0 0.011757956817746162
limited O 0 0.019638020545244217
to O 0 0.019284173846244812
a O 0 0.03456459939479828
single O 0 0.054572366178035736
family O 0 0.05981530249118805
. O 0 0.04228832572698593

These O 0 0.03020639345049858
data O 0 0.018465403467416763
provide O 0 0.018828673288226128
further O 0 0.01541082002222538
evidence O 0 0.016155486926436424
for O 0 0.017502715811133385
extensive O 0 0.053056441247463226
allelic O 1 0.8409482836723328
heterogeneity O 0 0.41380295157432556
in O 0 0.03403615206480026
MPS B-Disease 1 0.998036801815033
IVA I-Disease 1 1.0
in O 0 0.028194397687911987
British O 0 0.15619094669818878
- O 1 1.0
Irish O 1 0.9884902238845825
patients O 1 0.9956306219100952
and O 0 0.02522248774766922
provide O 0 0.02137412317097187
evidence O 0 0.015854278579354286
for O 0 0.01444701012223959
their O 0 0.017957814037799835
transmission O 0 0.038275957107543945
to O 0 0.013603598810732365
Australia O 0 0.02127314917743206
by O 0 0.01737954095005989
British O 0 0.05558846890926361
- O 1 0.9999403953552246
Irish O 0 0.08153949677944183
migrants O 0 0.05888039246201515
. O 0 0.025272581726312637
. O 0 0.035510819405317307

Identification O 0 0.04730594903230667
of O 0 0.03389829024672508
constitutional O 0 0.10188685357570648
WT1 O 1 1.0
mutations O 0 0.059585992246866226
, O 0 0.0209430530667305
in O 0 0.021161815151572227
patients O 1 0.7056894898414612
with O 0 0.03334802761673927
isolated O 1 0.9999953508377075
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.05377454683184624
and O 0 0.02646825648844242
analysis O 0 0.01882460154592991
of O 0 0.04085395857691765
genotype O 1 0.9999856948852539
/ O 1 0.999993085861206
phenotype O 0 0.23053838312625885
correlations O 0 0.06656551361083984
by O 0 0.017246996983885765
use O 0 0.013001397252082825
of O 0 0.019289575517177582
a O 0 0.04569089040160179
computerized O 1 0.6688120365142822
mutation O 0 0.09145247936248779
database O 0 0.05712148919701576
. O 0 0.03702149912714958

Constitutional O 0 0.08019020408391953
mutations O 0 0.04049409180879593
of O 0 0.024627860635519028
the O 0 0.04833655431866646
WT1 O 1 1.0
gene O 0 0.04452686756849289
, O 0 0.015412217006087303
encoding O 0 0.02789313904941082
a O 0 0.03525921329855919
zinc O 1 0.9999947547912598
- O 1 0.9999997615814209
finger O 1 0.9944571256637573
transcription O 0 0.21984952688217163
factor O 0 0.04371944069862366
involved O 0 0.02232402190566063
in O 0 0.039974112063646317
renal O 1 1.0
and O 1 0.9997946619987488
gonadal O 1 1.0
development O 1 0.8835495710372925
, O 0 0.021232210099697113
are O 0 0.006315777078270912
found O 0 0.008508277125656605
in O 0 0.00936714094132185
most O 0 0.013720015063881874
patients O 0 0.04327309504151344
with O 0 0.024036861956119537
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999366998672485
DDS B-Disease 1 1.0
) O 0 0.03214704617857933
, O 0 0.020763831213116646
or O 0 0.034938324242830276
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999978542327881
DMS B-Disease 1 1.0
) O 0 0.029198748990893364
associated O 0 0.017184222117066383
with O 0 0.019277241080999374
pseudohermaphroditism B-Disease 1 0.9999998807907104
and O 0 0.03626010939478874
/ O 1 0.9999995231628418
or O 1 0.930647075176239
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9991017580032349
WT B-Disease 1 1.0
) O 0 0.04704096540808678
. O 0 0.03899316489696503

Most O 0 0.05081944167613983
mutations O 0 0.07080553472042084
in O 0 0.05800251662731171
DDS B-Disease 1 1.0
patients O 1 0.9999762773513794
lie O 0 0.08668816089630127
in O 0 0.030711544677615166
exon O 1 0.7643605470657349
8 O 0 0.044141631573438644
or O 0 0.024269649758934975
exon O 0 0.12668642401695251
9 O 0 0.03732594847679138
, O 0 0.024645309895277023
encoding O 0 0.07229408621788025
zinc O 1 0.9999362230300903
finger O 1 0.9386257529258728
2 O 0 0.07807788997888565
or O 0 0.04771823063492775
zinc O 1 0.9999998807907104
finger O 1 0.9998651742935181
3 O 0 0.048675358295440674
, O 0 0.02221125178039074
respectively O 0 0.02239052578806877
, O 0 0.014477254822850227
with O 0 0.012745692394673824
a O 0 0.03514714911580086
hot O 1 0.9722481966018677
spot O 0 0.08977125585079193
( O 0 0.046582434326410294
R394W O 1 0.9984758496284485
) O 0 0.02863648347556591
in O 0 0.027007421478629112
exon O 0 0.20021145045757294
9 O 0 0.07419876754283905
. O 0 0.043123792856931686

We O 0 0.02443854510784149
analyzed O 0 0.022263942286372185
a O 0 0.01601387932896614
series O 0 0.020524155348539352
of O 0 0.0275158379226923
24 O 0 0.053390614688396454
patients O 1 0.9637453556060791
, O 0 0.01901487074792385
10 O 0 0.018789026886224747
with O 0 0.023931607604026794
isolated B-Disease 1 0.9997773766517639
DMS I-Disease 1 1.0
( O 1 0.8693392872810364
IDMS B-Disease 1 1.0
) O 0 0.029900547116994858
, O 0 0.015401381999254227
10 O 0 0.018057243898510933
with O 0 0.02858879789710045
DDS B-Disease 1 1.0
, O 0 0.023825788870453835
and O 0 0.01538583543151617
4 O 0 0.036777302622795105
with O 0 0.03770212084054947
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9950481057167053
/ O 1 1.0
or O 0 0.38644734025001526
WT B-Disease 1 1.0
. O 0 0.055564142763614655

We O 0 0.030544470995664597
report O 0 0.04754418879747391
WT1 O 1 0.9999914169311523
heterozygous O 0 0.13722290098667145
mutations O 0 0.05260179564356804
in O 0 0.02483520098030567
16 O 0 0.058148786425590515
patients O 1 0.9958969354629517
, O 0 0.03080560825765133
4 O 0 0.03860567510128021
of O 0 0.02573770098388195
whom O 0 0.0463143065571785
presented O 0 0.0481332503259182
with O 0 0.05047422647476196
IDMS B-Disease 1 1.0
. O 0 0.07070977985858917

One O 0 0.04278403893113136
male O 0 0.04824545234441757
and O 0 0.01574217714369297
two O 0 0.019252987578511238
female O 1 0.9597672820091248
IDMS B-Disease 1 1.0
patients O 1 0.9999668598175049
with O 0 0.07260256260633469
WT1 O 1 1.0
mutations O 1 0.9877054691314697
underwent O 1 0.9999997615814209
normal O 1 0.9885454773902893
puberty O 1 0.9999934434890747
. O 0 0.06833997368812561

Two O 0 0.046179961413145065
mutations O 0 0.07528603821992874
associated O 0 0.04457978159189224
with O 0 0.047254856675863266
IDMS B-Disease 1 0.9999998807907104
are O 0 0.012022707611322403
different O 0 0.006023735739290714
from O 0 0.01209577452391386
those O 0 0.013086036778986454
described O 0 0.0471801720559597
in O 0 0.05771506577730179
DDS B-Disease 1 1.0
patients O 1 0.999996542930603
. O 0 0.07529646158218384

No O 0 0.09641850739717484
WT1 O 1 0.9999995231628418
mutations O 0 0.06497547030448914
were O 0 0.01846429705619812
detected O 0 0.035504069179296494
in O 0 0.012008380144834518
the O 0 0.01868540793657303
six O 0 0.02721223048865795
other O 0 0.03950662910938263
IDMS B-Disease 1 1.0
patients O 1 0.9999887943267822
, O 0 0.034286875277757645
suggesting O 0 0.04304184019565582
genetic O 0 0.0407966673374176
heterogeneity O 0 0.1509380340576172
of O 0 0.044009365141391754
this O 0 0.04610703885555267
disease O 1 0.9999998807907104
. O 0 0.0621163509786129

We O 0 0.03412247821688652
analyzed O 0 0.08392005413770676
genotype O 1 0.999645471572876
/ O 1 0.9999979734420776
phenotype O 1 0.9856416583061218
correlations O 0 0.09602171927690506
, O 0 0.022140290588140488
on O 0 0.015195783227682114
the O 0 0.014636004343628883
basis O 0 0.011323364451527596
of O 0 0.012778988108038902
the O 0 0.01761774532496929
constitution O 0 0.02321740798652172
of O 0 0.02218596637248993
a O 0 0.05139423534274101
WT1 O 1 0.9999992847442627
mutation O 0 0.05810101330280304
database O 0 0.02170189842581749
of O 0 0.022052813321352005
84 O 1 0.9714555740356445
germ O 1 1.0
- O 1 1.0
line O 0 0.0823550745844841
mutations O 0 0.038528602570295334
, O 0 0.015057120472192764
to O 0 0.014792349189519882
compare O 0 0.028595145791769028
the O 0 0.02030954137444496
distribution O 0 0.025604063645005226
and O 0 0.02346336655318737
type O 0 0.056276194751262665
of O 0 0.04056895896792412
mutations O 0 0.050315503031015396
, O 0 0.019305607303977013
according O 0 0.01384124718606472
to O 0 0.017833732068538666
the O 0 0.02799481339752674
different O 0 0.022850366309285164
symptoms O 1 0.9999830722808838
. O 0 0.05962369218468666

This O 0 0.031557705253362656
demonstrated O 0 0.054270438849925995
( O 0 0.03631696477532387
1 O 0 0.04428103193640709
) O 0 0.018660569563508034
the O 0 0.02069403976202011
association O 0 0.03275715559720993
between O 0 0.028976133093237877
mutations O 0 0.03842540830373764
in O 0 0.02151097171008587
exons O 0 0.08238855749368668
8 O 0 0.036062438040971756
and O 0 0.019082587212324142
9 O 0 0.04637090116739273
and O 0 0.04095115140080452
DMS B-Disease 1 1.0
; O 0 0.039030369371175766
( O 0 0.03253050521016121
2 O 0 0.04145325347781181
) O 0 0.0216959360986948
among O 0 0.03083963133394718
patients O 1 0.7930448055267334
with O 0 0.048113834112882614
DMS B-Disease 1 1.0
, O 0 0.028920907527208328
a O 0 0.024879558011889458
higher O 0 0.022977039217948914
frequency O 0 0.025871751829981804
of O 0 0.026987066492438316
exon O 0 0.21291117370128632
8 O 0 0.05382769554853439
mutations O 0 0.034615352749824524
among O 0 0.023412933573126793
46 O 0 0.06115751340985298
, O 0 0.05030807480216026
XY O 1 0.9999998807907104
patients O 1 0.9986209869384766
with O 0 0.03069477714598179
female O 1 0.5870776176452637
phenotype O 0 0.10775637626647949
than O 0 0.013690668158233166
among O 0 0.024674318730831146
46 O 0 0.05932885780930519
, O 0 0.04705226421356201
XY O 1 0.9999998807907104
patients O 1 0.9960638880729675
with O 0 0.027320584282279015
sexual O 0 0.08843851834535599
ambiguity O 1 0.8736444115638733
or O 0 0.039996396750211716
male O 1 0.9951136708259583
phenotype O 1 0.9999105930328369
; O 0 0.03424597159028053
and O 0 0.026887863874435425
( O 0 0.033742755651474
3 O 0 0.04253087192773819
) O 0 0.021468721330165863
statistically O 0 0.017985820770263672
significant O 0 0.01308075338602066
evidence O 0 0.015113769099116325
that O 0 0.01224021427333355
mutations O 0 0.026339229196310043
in O 0 0.01861012913286686
exons O 0 0.08395571261644363
8 O 0 0.03926599770784378
and O 0 0.021143678575754166
9 O 0 0.057857077568769455
preferentially O 0 0.13506022095680237
affect O 0 0.05699248984456062
amino O 0 0.06591227650642395
acids O 0 0.039750006049871445
with O 0 0.017444953322410583
different O 0 0.011111638508737087
functions O 0 0.031369149684906006
. O 0 0.025987984612584114
. O 0 0.04000525549054146

The O 0 0.08649305254220963
185delAG O 1 0.9999850988388062
BRCA1 O 1 0.9999797344207764
mutation O 0 0.08697902411222458
originated O 0 0.043329186737537384
before O 0 0.02166973426938057
the O 0 0.027338258922100067
dispersion O 0 0.07898838818073273
of O 0 0.02288256213068962
Jews O 0 0.04285179078578949
in O 0 0.017734108492732048
the O 0 0.0266100000590086
diaspora O 0 0.07592324912548065
and O 0 0.02516467124223709
is O 0 0.01909976825118065
not O 0 0.012714301235973835
limited O 0 0.02613859437406063
to O 0 0.04359465092420578
Ashkenazim O 1 0.9939257502555847
. O 0 0.0593346431851387

The O 0 0.06489882618188858
185delAG O 1 0.9997555613517761
mutation O 0 0.095177061855793
in O 0 0.044201772660017014
BRCA1 O 1 0.9997501969337463
is O 0 0.028822721913456917
detected O 0 0.039176441729068756
in O 0 0.01821639947593212
Ashkenazi O 0 0.10239087790250778
Jews O 0 0.036414794623851776
both O 0 0.012768933549523354
in O 0 0.02842775546014309
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7177097797393799
in O 0 0.020278634503483772
the O 0 0.022348714992403984
general O 0 0.037543974816799164
population O 0 0.02591734007000923
. O 0 0.031102092936635017

All O 0 0.04630272462964058
tested O 0 0.10402745008468628
Ashkenazi O 1 0.9996002316474915
mutation O 0 0.10192116349935532
carriers O 0 0.06167757511138916
share O 0 0.021754032000899315
the O 0 0.018633725121617317
same O 0 0.019986467435956
allelic O 0 0.26262927055358887
pattern O 0 0.0474805124104023
at O 0 0.033268727362155914
the O 0 0.05273014307022095
BRCA1 O 1 0.9999963045120239
locus O 1 0.9249135255813599
. O 0 0.04969220608472824

Our O 0 0.053074490278959274
previous O 0 0.030874263495206833
study O 0 0.020828817039728165
showed O 0 0.018199948593974113
that O 0 0.008706246502697468
this O 0 0.01728196255862713
Ashkenazi O 1 0.9998469352722168
mutation O 0 0.09670837223529816
also O 0 0.02761698141694069
occurs O 0 0.02564396895468235
in O 0 0.015893125906586647
Iraqi O 0 0.0386713445186615
Jews O 0 0.04400135949254036
with O 0 0.01627426967024803
a O 0 0.02825653739273548
similar O 0 0.03207579627633095
allelic O 1 0.9886077046394348
pattern O 0 0.09108124673366547
. O 0 0.05280158296227455

We O 0 0.032383453100919724
extended O 0 0.0466759130358696
our O 0 0.029558321461081505
analysis O 0 0.013840407133102417
to O 0 0.013409177772700787
other O 0 0.013272900134325027
non O 0 0.08093395084142685
- O 1 0.9995793700218201
Ashkenazi O 1 0.9329392313957214
subsets O 0 0.1577165275812149
354 O 0 0.14260666072368622
of O 0 0.04187299683690071
Moroccan O 0 0.11591216176748276
origin O 0 0.025452809408307076
, O 0 0.026120347902178764
200 O 0 0.052302706986665726
Yemenites O 1 0.7025740742683411
and O 0 0.034790754318237305
150 O 0 0.0511593222618103
Iranian O 0 0.05744823068380356
Jews O 0 0.07957696914672852
. O 0 0.04458656162023544

Heteroduplex O 1 0.9974955916404724
analysis O 0 0.04226042702794075
complemented O 0 0.07769855111837387
by O 0 0.02151879481971264
direct O 0 0.03779442235827446
DNA O 0 0.04786967486143112
sequencing O 0 0.047382257878780365
of O 0 0.04565751180052757
abnormally O 1 0.9876880049705505
migrating O 0 0.11050187796354294
bands O 0 0.07411299645900726
were O 0 0.023192796856164932
employed O 0 0.06085674464702606
. O 0 0.046117741614580154

Four O 0 0.027181195095181465
of O 0 0.03236265107989311
Moroccan O 0 0.11588937044143677
origin O 0 0.029675347730517387
( O 0 0.029094988480210304
1 O 0 0.043952781707048416
. O 0 0.020230140537023544
1 O 0 0.049045585095882416
% O 0 0.028471648693084717
) O 0 0.021608347073197365
and O 0 0.014445510692894459
none O 0 0.015989501029253006
of O 0 0.02225666306912899
the O 0 0.0451870895922184
Yemenites O 1 0.9999691247940063
or O 0 0.03511772304773331
Iranians O 0 0.04500098153948784
was O 0 0.027142425999045372
a O 0 0.02623181790113449
carrier O 0 0.0745488628745079
of O 0 0.02460065670311451
the O 0 0.04847351461648941
185delAG O 1 0.9999858140945435
mutation O 0 0.10596884042024612
. O 0 0.045505937188863754

BRCA1 O 1 0.9999760389328003
allelic O 1 0.9992469549179077
patterns O 0 0.04253702983260155
were O 0 0.01673656329512596
determined O 0 0.029429474845528603
for O 0 0.014624794013798237
four O 0 0.016083545982837677
of O 0 0.021931177005171776
these O 0 0.013420714065432549
individuals O 0 0.015290392562747002
and O 0 0.01480521634221077
for O 0 0.01556750200688839
12 O 0 0.022938061505556107
additional O 0 0.01937582902610302
non O 0 0.07103470712900162
- O 1 0.999974250793457
Ashkenazi O 1 0.9998170733451843
185delAG O 1 0.9997641444206238
mutation O 0 0.06585625559091568
carriers O 0 0.044754453003406525
who O 0 0.026676680892705917
had O 0 0.05702335387468338
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9555928707122803

Six O 0 0.05588303506374359
non O 1 0.6568096280097961
- O 1 0.9999943971633911
Ashkenazi O 1 0.7111418843269348
individuals O 0 0.019859902560710907
shared O 0 0.03062133863568306
the O 0 0.027661841362714767
common O 0 0.04922547563910484
Ashkenazi O 1 0.9999986886978149
haplotype O 1 0.999652624130249
, O 0 0.021764373406767845
four O 0 0.014888993464410305
had O 0 0.017028899863362312
a O 0 0.023829765617847443
closely O 0 0.028467759490013123
related O 0 0.032971516251564026
pattern O 0 0.0455886647105217
, O 0 0.018678756430745125
and O 0 0.014862041920423508
the O 0 0.023761283606290817
rest O 0 0.047831159085035324
( O 0 0.04309731721878052
n O 0 0.3776392638683319
= O 0 0.07648880034685135
6 O 0 0.04021627828478813
) O 0 0.017110101878643036
displayed O 0 0.02566656284034252
a O 0 0.031861890107393265
distinct O 0 0.059383973479270935
BRCA1 O 1 0.9999674558639526
allelic O 1 0.9992554783821106
pattern O 0 0.10976838320493698
. O 0 0.056686416268348694

We O 0 0.021711865440011024
conclude O 0 0.036286164075136185
that O 0 0.008930101990699768
the O 0 0.033046744763851166
185delAG O 1 0.9999997615814209
BRCA1 O 1 0.9999996423721313
mutation O 0 0.10862019658088684
occurs O 0 0.02665860578417778
in O 0 0.0117717944085598
some O 0 0.01273572351783514
non O 0 0.1753023862838745
- O 1 0.9999990463256836
Ashkenazi O 1 0.9983227849006653
populations O 0 0.038166265934705734
at O 0 0.029437275603413582
rates O 0 0.030749045312404633
comparable O 0 0.03411515802145004
with O 0 0.015737885609269142
that O 0 0.013417576439678669
of O 0 0.04411220923066139
Ashkenazim O 1 0.9996750354766846
. O 0 0.06190638989210129

The O 0 0.030967706814408302
majority O 0 0.027705874294042587
of O 0 0.03143582493066788
Jewish O 0 0.1420682668685913
185delAG O 1 0.9999974966049194
mutation O 0 0.0949939489364624
carriers O 0 0.053568486124277115
have O 0 0.010231398046016693
a O 0 0.027536222711205482
common O 0 0.03957676887512207
allelic O 1 0.999440610408783
pattern O 0 0.058669861406087875
, O 0 0.022119631990790367
supporting O 0 0.03421659395098686
the O 0 0.03475407510995865
founder O 1 0.9997337460517883
effect O 0 0.03900981321930885
notion O 0 0.04795445501804352
, O 0 0.019956015050411224
but O 0 0.01489910390228033
dating O 0 0.03807242959737778
the O 0 0.032156169414520264
mutations O 0 0.03823385015130043
origin O 0 0.013852061703801155
to O 0 0.014435473829507828
an O 0 0.01619417779147625
earlier O 0 0.02198418229818344
date O 0 0.02242165245115757
than O 0 0.011110885068774223
currently O 0 0.026949679479002953
estimated O 0 0.03855067119002342
. O 0 0.04023604840040207

However O 0 0.03476043418049812
, O 0 0.018923232331871986
the O 0 0.018247755244374275
different O 0 0.010975874960422516
allelic O 0 0.18245059251785278
pattern O 0 0.04970553517341614
at O 0 0.034443143755197525
the O 0 0.04735612869262695
BRCA1 O 1 0.9999771118164062
locus O 0 0.20221926271915436
even O 0 0.017568279057741165
in O 0 0.012700481340289116
some O 0 0.012567315250635147
Jewish O 0 0.0821496844291687
mutation O 0 0.09396333247423172
carriers O 0 0.0774334967136383
, O 0 0.025992559269070625
might O 0 0.020072903484106064
suggest O 0 0.017004618421196938
that O 0 0.009991312399506569
the O 0 0.030484093353152275
mutation O 0 0.07152847945690155
arose O 0 0.06103237345814705
independently O 0 0.03259306401014328
. O 0 0.023730969056487083
. O 0 0.03530394285917282

Crystal O 0 0.12439063936471939
structure O 0 0.037701867520809174
of O 0 0.030042244121432304
the O 0 0.20975685119628906
hemochromatosis B-Disease 1 1.0
protein O 1 0.9910863041877747
HFE O 1 0.999998927116394
and O 0 0.02654528245329857
characterization O 0 0.059022024273872375
of O 0 0.020430395379662514
its O 0 0.0264247078448534
interaction O 0 0.041120801120996475
with O 0 0.04030425101518631
transferrin O 1 0.999998927116394
receptor O 1 0.8034037947654724
. O 0 0.053673647344112396

HFE O 1 0.9999128580093384
is O 0 0.029209759086370468
an O 0 0.04122258350253105
MHC O 1 1.0
- O 1 0.9999997615814209
related O 0 0.03833648934960365
protein O 0 0.02592022344470024
that O 0 0.006706883665174246
is O 0 0.011325537227094173
mutated O 0 0.03714446723461151
in O 0 0.00995602272450924
the O 0 0.026089178398251534
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998431205749512

HFE O 1 0.9997956156730652
binds O 0 0.15509600937366486
to O 0 0.05661986768245697
transferrin O 1 0.9999994039535522
receptor O 1 0.9998499155044556
( O 0 0.0735183134675026
TfR O 1 0.9999963045120239
) O 0 0.028551502153277397
and O 0 0.01973089389503002
reduces O 0 0.05019532889127731
its O 0 0.02244214154779911
affinity O 0 0.05215856432914734
for O 0 0.026609456166625023
iron O 1 0.9999741315841675
- O 1 0.9999948740005493
loaded O 0 0.08704033493995667
transferrin O 1 0.9704684615135193
, O 0 0.042051173746585846
implicating O 1 0.9999144077301025
HFE O 1 0.9999998807907104
in O 0 0.07931982725858688
iron O 1 1.0
metabolism O 1 0.9998600482940674
. O 0 0.05970872566103935

The O 0 0.07002132385969162
2 O 0 0.08363460749387741
. O 0 0.04959294945001602

6 O 0 0.0764683410525322
A O 0 0.0721888467669487
crystal O 0 0.22327914834022522
structure O 0 0.04824037477374077
of O 0 0.04483989626169205
HFE O 1 0.9999932050704956
reveals O 0 0.06526811420917511
the O 0 0.021319830790162086
locations O 0 0.021896596997976303
of O 0 0.05322028324007988
hemochromatosis B-Disease 1 1.0
mutations O 0 0.07871115207672119
and O 0 0.026467155665159225
a O 0 0.04766302928328514
patch O 1 0.9999994039535522
of O 0 0.043481986969709396
histidines O 1 0.9999760389328003
that O 0 0.011167368851602077
could O 0 0.008741388097405434
be O 0 0.006578455679118633
involved O 0 0.015009812079370022
in O 0 0.028820032253861427
pH O 1 1.0
- O 1 1.0
dependent O 0 0.08592917025089264
interactions O 0 0.05742024630308151
. O 0 0.04015840217471123

We O 0 0.02408662997186184
also O 0 0.018056167289614677
demonstrate O 0 0.035898275673389435
that O 0 0.02379027009010315
soluble O 1 0.9997966885566711
TfR O 1 0.9999973773956299
and O 0 0.06192320957779884
HFE O 1 0.9999998807907104
bind O 0 0.1312163770198822
tightly O 0 0.06975243240594864
at O 0 0.025244396179914474
the O 0 0.022518854588270187
basic O 0 0.04753044620156288
pH O 1 0.9988389611244202
of O 0 0.028299672529101372
the O 0 0.04631548747420311
cell O 0 0.48280879855155945
surface O 0 0.039812877774238586
, O 0 0.015722816810011864
but O 0 0.008797934278845787
not O 0 0.007436150684952736
at O 0 0.020173829048871994
the O 0 0.037221550941467285
acidic O 1 0.9999524354934692
pH O 1 0.9999674558639526
of O 0 0.08444465696811676
intracellular O 1 0.9999973773956299
vesicles O 1 0.9994390606880188
. O 0 0.05450252816081047

TfR O 1 0.9999966621398926
HFE O 1 0.9999998807907104
stoichiometry O 1 0.9998075366020203
( O 0 0.053478702902793884
2 O 0 0.05375674366950989
1 O 0 0.046603068709373474
) O 0 0.018802281469106674
differs O 0 0.02549678273499012
from O 0 0.031059402972459793
TfR O 1 0.9999953508377075
transferrin O 1 0.9999983310699463
stoichiometry O 1 0.9993459582328796
( O 0 0.04739650338888168
2 O 0 0.05750130116939545
2 O 0 0.05160652473568916
) O 0 0.023012636229395866
, O 0 0.019274774938821793
implying O 0 0.04625536873936653
a O 0 0.02052638866007328
different O 0 0.007310459855943918
mode O 0 0.03936608508229256
of O 0 0.022984718903899193
binding O 0 0.04198784381151199
for O 0 0.03332359716296196
HFE O 1 0.999998927116394
and O 0 0.04752514138817787
transferrin O 1 0.9999603033065796
to O 0 0.05827097222208977
TfR O 1 0.9999977350234985
, O 0 0.027302222326397896
consistent O 0 0.03024517372250557
with O 0 0.01426631398499012
our O 0 0.02531350590288639
demonstration O 0 0.052469827234745026
that O 0 0.021235989406704903
HFE O 1 0.9999964237213135
, O 0 0.0463535375893116
transferrin O 1 0.999972939491272
, O 0 0.03034704178571701
and O 0 0.03036990575492382
TfR O 1 0.9999914169311523
form O 0 0.04317640885710716
a O 0 0.055819787085056305
ternary O 1 0.9990069270133972
complex O 0 0.0793130025267601
. O 0 0.04370419308543205

Identification O 0 0.04928334057331085
of O 0 0.025713196024298668
three O 0 0.027408147230744362
novel O 0 0.0759950801730156
mutations O 0 0.0428558811545372
and O 0 0.01975979097187519
a O 0 0.02831440046429634
high O 0 0.045411255210638046
frequency O 0 0.02732042223215103
of O 0 0.017688700929284096
the O 0 0.032764237374067307
Arg778Leu O 1 0.9999052286148071
mutation O 0 0.06631439179182053
in O 0 0.02288932539522648
Korean O 1 0.9300317168235779
patients O 1 0.9961569905281067
with O 0 0.05675569549202919
Wilson B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
. O 0 0.07295040786266327

Four O 0 0.03464353084564209
mutations O 0 0.0762377604842186
- O 1 0.9999994039535522
- O 1 0.9999988079071045
R778L O 1 0.9997730851173401
, O 0 0.03140442445874214
A874V O 1 0.9944512248039246
, O 0 0.028176212683320045
L1083F O 1 0.9948182702064514
, O 0 0.018554167822003365
and O 0 0.018457384780049324
2304delC O 1 0.9999971389770508
- O 1 0.9999996423721313
- O 1 0.9959803819656372
in O 0 0.010534572415053844
the O 0 0.01843525469303131
copper O 0 0.36410218477249146
- O 1 0.9999125003814697
transporting O 0 0.0728694349527359
enzyme O 0 0.0580458901822567
, O 0 0.02553064189851284
P O 1 0.9999611377716064
- O 1 0.9999997615814209
type O 1 0.9312045574188232
ATPase O 1 0.9999991655349731
( O 0 0.06342044472694397
ATP7B O 1 0.9999995231628418
) O 0 0.027982255443930626
, O 0 0.012611842714250088
were O 0 0.007638602051883936
identified O 0 0.01756507158279419
in O 0 0.018033992499113083
Korean O 1 0.9750794768333435
Patients O 1 0.9998733997344971
with O 0 0.05952249839901924
Wilson B-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
. O 0 0.07814827561378479

Arg778Leu O 1 0.9996658563613892
, O 0 0.03316903114318848
the O 0 0.025646746158599854
most O 0 0.01818772591650486
frequently O 0 0.023287704214453697
reported O 0 0.03241116926074028
mutation O 0 0.0475224107503891
of O 0 0.02424113266170025
this O 0 0.027966618537902832
enzyme O 0 0.09506025165319443
, O 0 0.021641086786985397
was O 0 0.025202950462698936
found O 0 0.010774152353405952
in O 0 0.008487999439239502
six O 0 0.012411096133291721
of O 0 0.018442125990986824
eight O 0 0.03449135646224022
unrelated O 0 0.0812939703464508
patients O 1 0.9981071949005127
studied O 0 0.04300142824649811
, O 0 0.024557704105973244
an O 0 0.030632415786385536
allele O 0 0.09065911918878555
frequency O 0 0.03233695775270462
of O 0 0.030178869143128395
37 O 0 0.07077386230230331
. O 0 0.04374910518527031

5 O 0 0.07954533398151398
% O 0 0.04133690521121025
, O 0 0.027330322191119194
which O 0 0.017621567472815514
is O 0 0.020138926804065704
considerably O 0 0.03391462564468384
higher O 0 0.020905062556266785
than O 0 0.011643782258033752
those O 0 0.011704548262059689
in O 0 0.01622157357633114
other O 0 0.019607530906796455
Asian O 0 0.06577486544847488
populations O 0 0.05171365290880203
. O 0 0.04559357464313507

The O 0 0.05402519181370735
novel O 0 0.08412346988916397
single O 0 0.07000207901000977
nucleotide O 0 0.10595985502004623
deletion O 0 0.10925877839326859
, O 0 0.039034947752952576
2304delC O 1 0.9980073571205139
, O 0 0.024557698518037796
was O 0 0.02940879948437214
found O 0 0.015273932367563248
in O 0 0.01651987060904503
one O 0 0.03364459425210953
patient O 1 0.9992421865463257
. O 0 0.04900526627898216

Since O 0 0.03883080184459686
a O 0 0.03930092602968216
mutation O 0 0.056866999715566635
at O 0 0.0413065105676651
cDNA O 0 0.171211838722229
nucleotide O 0 0.1523882895708084
2302 O 1 0.9999892711639404
( O 0 0.06629374623298645
2302insC O 1 0.9997013211250305
) O 0 0.027867859229445457
had O 0 0.017376616597175598
been O 0 0.013770416378974915
previously O 0 0.02535204030573368
described O 0 0.030425041913986206
, O 0 0.013894295319914818
this O 0 0.007965946570038795
region O 0 0.01841910183429718
of O 0 0.01850929670035839
the O 0 0.04219383746385574
ATP7B O 1 1.0
gene O 0 0.06393729895353317
may O 0 0.02283032424747944
be O 0 0.014477934688329697
susceptible O 0 0.07430772483348846
to O 0 0.03332885727286339
gene O 0 0.06969305127859116
rearrangements O 1 0.9984965324401855
causing O 1 0.9998701810836792
Wilson B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.07378928363323212

Disruption O 0 0.15230336785316467
of O 0 0.04557494819164276
splicing O 0 0.07210288196802139
regulated O 0 0.026554584503173828
by O 0 0.010616663843393326
a O 0 0.028971411287784576
CUG O 1 0.9999986886978149
- O 1 0.9999988079071045
binding O 0 0.06256792694330215
protein O 0 0.05556444078683853
in O 0 0.056583236902952194
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.11553334444761276

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.04632645845413208
is O 0 0.02187793143093586
caused O 0 0.032724201679229736
by O 0 0.02020876482129097
a O 0 0.0455220602452755
CTG O 1 0.9999943971633911
expansion O 0 0.04937463998794556
in O 0 0.014963782392442226
the O 0 0.021680844947695732
3 O 0 0.04637477919459343
untranslated O 0 0.14706867933273315
region O 0 0.02588353306055069
of O 0 0.02615704946219921
the O 0 0.07043364644050598
DM B-Disease 1 1.0
gene O 0 0.09408693760633469
. O 0 0.0451100654900074

One O 0 0.03150732442736626
model O 0 0.0426061786711216
of O 0 0.0765341967344284
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.06291509419679642
that O 0 0.021402383223176003
RNAs O 0 0.09714198857545853
from O 0 0.013515531085431576
the O 0 0.01943005621433258
expanded O 0 0.036698248237371445
allele O 0 0.06125176325440407
create O 0 0.01858481951057911
a O 0 0.019373102113604546
gain O 0 0.037225089967250824
- O 1 0.9996844530105591
of O 0 0.03783204406499863
- O 1 0.9999985694885254
function O 0 0.043996214866638184
mutation O 0 0.038471728563308716
by O 0 0.014275215566158295
the O 0 0.025308173149824142
inappropriate O 0 0.06175640970468521
binding O 0 0.03710257634520531
of O 0 0.026090728119015694
proteins O 0 0.027458475902676582
to O 0 0.01795009709894657
the O 0 0.04318447411060333
CUG O 1 0.999995231628418
repeats O 0 0.11792468279600143
. O 0 0.04317096993327141

Data O 0 0.03490805625915527
presented O 0 0.02958373911678791
here O 0 0.017791759222745895
indicate O 0 0.014405511319637299
that O 0 0.00632463488727808
the O 0 0.017274634912610054
conserved O 0 0.05615339055657387
heterogeneous O 0 0.11164522171020508
nuclear O 0 0.07396258413791656
ribonucleoprotein O 1 0.9996663331985474
, O 0 0.03456141799688339
CUG O 1 0.9999979734420776
- O 1 0.9999942779541016
binding O 0 0.05714777112007141
protein O 0 0.03976162150502205
( O 0 0.0337851345539093
CUG O 1 0.9999992847442627
- O 1 0.9999998807907104
BP O 1 0.5446451902389526
) O 0 0.02318405732512474
, O 0 0.01596689037978649
may O 0 0.018560409545898438
mediate O 0 0.0741599053144455
the O 0 0.03422465920448303
trans O 1 0.9999345541000366
- O 1 0.9999918937683105
dominant O 0 0.07038511335849762
effect O 0 0.025530166923999786
of O 0 0.022900022566318512
the O 0 0.04329724609851837
RNA O 0 0.10714641213417053
. O 0 0.033352650701999664

CUG O 1 0.9999997615814209
- O 1 0.9999992847442627
BP O 0 0.15572576224803925
was O 0 0.033868275582790375
found O 0 0.013791349716484547
to O 0 0.015688074752688408
bind O 0 0.03468330577015877
to O 0 0.013383463956415653
the O 0 0.022218553349375725
human O 0 0.06252598017454147
cardiac O 1 1.0
troponin O 1 1.0
T O 1 1.0
( O 0 0.050540197640657425
cTNT O 1 0.9986035227775574
) O 0 0.030576707795262337
pre O 1 0.7102733850479126
- O 1 0.9999994039535522
messenger O 1 0.7618964314460754
RNA O 0 0.07040923088788986
and O 0 0.01835581660270691
regulate O 0 0.043499842286109924
its O 0 0.02853962406516075
alternative O 0 0.06854168325662613
splicing O 0 0.08755351603031158
. O 0 0.035128019750118256

Splicing O 0 0.09723707288503647
of O 0 0.031179159879684448
cTNT O 1 0.9713770151138306
was O 0 0.04363872855901718
disrupted O 0 0.09257739782333374
in O 0 0.0575929656624794
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999994039535522
and O 0 0.029904324561357498
in O 0 0.02848288230597973
normal O 0 0.05569274723529816
cells O 0 0.04840850457549095
expressing O 0 0.054680656641721725
transcripts O 0 0.0541975311934948
that O 0 0.017087850719690323
contain O 0 0.05458330735564232
CUG O 1 0.9999687671661377
repeats O 0 0.1285458505153656
. O 0 0.05013788864016533

Altered O 0 0.08650615811347961
expression O 0 0.043169792741537094
of O 0 0.028915714472532272
genes O 0 0.028354138135910034
regulated O 0 0.04407932981848717
posttranscriptionally O 0 0.16445423662662506
by O 0 0.03804001584649086
CUG O 1 1.0
- O 1 0.9999997615814209
BP O 0 0.27649351954460144
therefore O 0 0.026187798008322716
may O 0 0.02227388508617878
contribute O 0 0.04185260459780693
to O 0 0.06793711334466934
DM B-Disease 1 1.0
pathogenesis O 1 1.0
. O 0 0.04704774543642998
. O 0 0.04326073080301285

Identification O 0 0.0510127916932106
of O 0 0.025037534534931183
a O 0 0.037613917142152786
novel O 0 0.08260103315114975
nonsense O 1 0.5658980011940002
mutation O 0 0.05804910883307457
and O 0 0.01794523186981678
a O 0 0.036403533071279526
missense O 0 0.1217518001794815
substitution O 0 0.05972808599472046
in O 0 0.014279208146035671
the O 0 0.029189100489020348
vasopressin O 1 0.9996069073677063
- O 1 0.9999995231628418
neurophysin O 1 0.9999910593032837
II O 1 0.9999997615814209
gene O 0 0.036487091332674026
in O 0 0.009600624442100525
two O 0 0.00945563055574894
Spanish O 0 0.03876688703894615
kindreds O 0 0.4423055648803711
with O 0 0.04828748479485512
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.1401960402727127

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9998716115951538
FNDI B-Disease 1 1.0
) O 0 0.025222383439540863
is O 0 0.01277446374297142
an O 0 0.021066511049866676
autosomal B-Disease 1 0.9999959468841553
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999977350234985
by O 1 0.99750816822052
deficiency O 1 1.0
in O 0 0.02917979098856449
the O 0 0.06372739374637604
antidiuretic O 1 1.0
hormone O 1 0.9999998807907104
arginine O 1 0.9999887943267822
vasopressin O 1 0.9999957084655762
( O 0 0.0712076723575592
AVP O 1 0.9999997615814209
) O 0 0.0219161007553339
encoded O 0 0.013204752467572689
by O 0 0.008963961154222488
the O 0 0.025511527433991432
AVP O 1 0.9999998807907104
- O 1 0.9999992847442627
neurophysin O 1 0.9999899864196777
II O 1 1.0
( O 0 0.06380924582481384
AVP O 1 1.0
- O 1 1.0
NPII O 1 0.9999990463256836
) O 0 0.036770835518836975
gene O 0 0.03546615317463875
on O 0 0.033545125275850296
chromosome O 0 0.10270616412162781
20p13 O 1 0.9825682044029236
. O 0 0.05473853647708893

In O 0 0.03858659788966179
this O 0 0.02032652124762535
study O 0 0.028011299669742584
, O 0 0.019116461277008057
we O 0 0.012224002741277218
analyzed O 0 0.01891346648335457
two O 0 0.009676629677414894
families O 0 0.02468341588973999
with O 0 0.028994480147957802
FNDI B-Disease 1 0.9999992847442627
using O 0 0.02331525832414627
direct O 0 0.03942659869790077
automated O 0 0.09560210257768631
fluorescent O 0 0.17294232547283173
, O 0 0.023868532851338387
solid O 0 0.04920979589223862
phase O 0 0.05702025070786476
, O 0 0.020367207005620003
single O 0 0.043520744889974594
- O 1 0.9826620817184448
stranded O 0 0.09070882201194763
DNA O 0 0.029546618461608887
sequencing O 0 0.026381097733974457
of O 0 0.025586651638150215
PCR O 1 0.6025357842445374
- O 1 0.9999598264694214
amplified O 1 0.6241277456283569
AVP O 1 0.9999997615814209
- O 1 0.9999948740005493
NPII O 1 0.9999579191207886
DNA O 0 0.08030060678720474
. O 0 0.042096156626939774

In O 0 0.028681853786110878
one O 0 0.0190602857619524
of O 0 0.02216467820107937
the O 0 0.030609289184212685
families O 0 0.041348669677972794
, O 0 0.02840217761695385
affected O 0 0.033449336886405945
individuals O 0 0.01698833517730236
presented O 0 0.030842162668704987
a O 0 0.03491147607564926
novel O 0 0.07899076491594315
nonsense O 1 0.6307637691497803
mutation O 0 0.0656876415014267
in O 0 0.022291962057352066
exon O 0 0.12625864148139954
3 O 0 0.030181169509887695
of O 0 0.02029448188841343
the O 0 0.029093138873577118
gene O 0 0.03389159217476845
, O 0 0.013962234370410442
consisting O 0 0.022272080183029175
in O 0 0.014957401901483536
a O 0 0.03628627955913544
G O 1 0.9890089631080627
to O 0 0.03870812803506851
T O 1 0.9976111650466919
transition O 0 0.06871914118528366
at O 0 0.046974726021289825
nucleotide O 0 0.12091411650180817
2101 O 1 0.9999207258224487
, O 0 0.024281226098537445
which O 0 0.0138974254950881
produces O 0 0.02433750405907631
a O 0 0.023398566991090775
stop O 0 0.0435679592192173
signal O 0 0.04272594302892685
in O 0 0.021333882585167885
codon O 0 0.10709154605865479
82 O 0 0.10469315201044083
( O 0 0.06827779859304428
Glu O 1 0.9999998807907104
) O 0 0.03906501829624176
of O 0 0.0504881925880909
NPII O 1 0.9999909400939941
. O 0 0.05863090232014656

The O 0 0.07205042243003845
premature O 1 0.9994034767150879
termination O 1 0.9994450211524963
eliminates O 0 0.30041226744651794
part O 0 0.024195536971092224
of O 0 0.017974911257624626
the O 0 0.03203608840703964
C O 1 0.9999966621398926
- O 1 0.9999997615814209
terminal O 0 0.18242992460727692
domain O 0 0.043688055127859116
of O 0 0.033093031495809555
NPII O 1 0.9999884366989136
, O 0 0.02040344476699829
including O 0 0.015024285763502121
a O 0 0.03661516681313515
cysteine O 0 0.21724677085876465
residue O 0 0.09487176686525345
in O 0 0.022775186225771904
position O 0 0.04495996609330177
85 O 0 0.05998319014906883
, O 0 0.02138911373913288
which O 0 0.012455792166292667
could O 0 0.012304130010306835
be O 0 0.008390874601900578
involved O 0 0.012314279563724995
in O 0 0.013999703340232372
the O 0 0.02861415408551693
correct O 0 0.0620400495827198
folding O 0 0.10763681679964066
of O 0 0.03862253576517105
the O 0 0.06988345831632614
prohormone O 1 0.9999995231628418
. O 0 0.0665193721652031

In O 0 0.028045102953910828
the O 0 0.027701931074261665
second O 0 0.04440617188811302
family O 0 0.03725585713982582
, O 0 0.018714433535933495
a O 0 0.0327189564704895
G279A O 1 0.9992499947547913
substitution O 0 0.06963958591222763
at O 0 0.024986721575260162
position O 0 0.038151685148477554
- O 1 0.9940797090530396
1 O 0 0.026221290230751038
of O 0 0.01528148539364338
the O 0 0.02638155035674572
signal O 0 0.06846411526203156
peptide O 0 0.0837429091334343
was O 0 0.031772907823324203
observed O 0 0.020273840054869652
in O 0 0.015640491619706154
all O 0 0.019714897498488426
affected O 0 0.045580796897411346
individuals O 0 0.031237732619047165
. O 0 0.045879777520895004

This O 0 0.041032783687114716
missense O 0 0.17920684814453125
mutation O 0 0.0696675181388855
, O 0 0.020949529483914375
which O 0 0.019080061465501785
replaces O 1 0.9990216493606567
Ala O 1 0.9999998807907104
with O 0 0.047629036009311676
Thr O 1 0.9999998807907104
, O 0 0.030365264043211937
is O 0 0.01997765339910984
frequent O 0 0.05200612172484398
among O 0 0.1654699444770813
FNDI B-Disease 1 1.0
patients O 1 1.0
and O 0 0.03648681193590164
is O 0 0.02384774386882782
thought O 0 0.02157231979072094
to O 0 0.018185222521424294
reduce O 0 0.0322384275496006
the O 0 0.022309763357043266
efficiency O 0 0.04463224485516548
of O 0 0.03783924877643585
cleavage O 1 0.9988598823547363
by O 0 0.043605707585811615
signal O 0 0.10089588165283203
peptidases O 1 0.7356194853782654
. O 0 0.033504076302051544
. O 0 0.03764317184686661

Genetic O 0 0.05508224666118622
heterogeneity O 0 0.09737753868103027
of O 0 0.04489073529839516
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.03775012865662575
due O 0 0.033666953444480896
to O 0 0.0385848693549633
TWIST O 1 0.9951679706573486
and O 0 0.05484490096569061
FGFR O 1 0.9999996423721313
mutations O 0 0.0904049426317215
. O 0 0.0453043058514595

Thirty O 0 0.12467166036367416
- O 1 0.9985839128494263
two O 0 0.023923376575112343
unrelated O 0 0.06255354732275009
patients O 0 0.10322398692369461
with O 0 0.01614094339311123
features O 0 0.02033184841275215
of O 0 0.029408959671854973
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.025497721508145332
a O 0 0.02821698598563671
common O 0 0.03345270827412605
autosomal B-Disease 1 0.9999507665634155
dominant I-Disease 1 0.999853253364563
condition I-Disease 1 0.9921942949295044
of O 1 0.9679375886917114
craniosynostosis B-Disease 1 1.0
and O 1 0.999950647354126
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999997615814209
, O 0 0.02496805042028427
were O 0 0.01381526980549097
screened O 0 0.04946045204997063
for O 0 0.020523814484477043
mutations O 0 0.036070097237825394
in O 0 0.02431812323629856
TWIST O 1 0.9978984594345093
, O 0 0.04759945720434189
FGFR2 O 1 0.9999997615814209
, O 0 0.039181988686323166
and O 0 0.04367394745349884
FGFR3 O 1 0.9999877214431763
. O 0 0.06173563376069069

Nine O 0 0.059656888246536255
novel O 0 0.06805163621902466
and O 0 0.0271769966930151
three O 0 0.038998108357191086
recurrent O 1 1.0
TWIST O 1 0.9999995231628418
mutations O 0 0.06605718284845352
were O 0 0.016269627958536148
found O 0 0.016677388921380043
in O 0 0.01874140463769436
12 O 0 0.03811689838767052
families O 0 0.04825040325522423
. O 0 0.042360592633485794

Seven O 0 0.05355466902256012
families O 0 0.038363538682460785
were O 0 0.014189725741744041
found O 0 0.012446961365640163
to O 0 0.012538189999759197
have O 0 0.008509235456585884
the O 0 0.031214024871587753
FGFR3 O 1 0.9999998807907104
P250R O 1 0.9999996423721313
mutation O 0 0.10155442357063293
, O 0 0.025135857984423637
and O 0 0.019566485658288002
one O 0 0.018466265872120857
individual O 0 0.01731896959245205
was O 0 0.027244344353675842
found O 0 0.011409292928874493
to O 0 0.012009862810373306
have O 0 0.00795955490320921
an O 0 0.025096483528614044
FGFR2 O 1 0.9999955892562866
VV269 O 1 0.9999936819076538
- O 1 0.999969482421875
270 O 0 0.1354324370622635
deletion O 0 0.1375664621591568
. O 0 0.05056837573647499

To O 0 0.04263155162334442
date O 0 0.03546798974275589
, O 0 0.021666044369339943
our O 0 0.027385441586375237
detection O 0 0.0620061494410038
rate O 0 0.02655300870537758
for O 0 0.02495105005800724
TWIST O 1 0.8967896699905396
or O 0 0.04815943166613579
FGFR O 1 0.9999995231628418
mutations O 0 0.05535214766860008
is O 0 0.0180339477956295
68 O 0 0.03980475291609764
% O 0 0.01420519407838583
in O 0 0.010665112175047398
our O 0 0.02365616150200367
Saethre B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
, O 0 0.03393258526921272
including O 0 0.020950933918356895
our O 0 0.027207445353269577
five O 0 0.03148932754993439
patients O 1 0.9399252533912659
elsewhere O 0 0.03286057710647583
reported O 0 0.0362616591155529
with O 0 0.0339089035987854
TWIST O 1 0.9978631138801575
mutations O 0 0.08178812265396118
. O 0 0.04579683765769005

More O 0 0.02195025235414505
than O 0 0.015054008923470974
35 O 0 0.03534310311079025
different O 0 0.018467864021658897
TWIST O 1 0.6861780881881714
mutations O 0 0.05200856551527977
are O 0 0.010690085589885712
now O 0 0.023421449586749077
known O 0 0.03089214861392975
in O 0 0.018216051161289215
the O 0 0.02701120637357235
literature O 0 0.040129680186510086
. O 0 0.03737638145685196

The O 0 0.04613293334841728
most O 0 0.028817029669880867
common O 0 0.045572005212306976
phenotypic O 0 0.09147744625806808
features O 0 0.04149526730179787
, O 0 0.022644875571131706
present O 0 0.019974742084741592
in O 0 0.011522303335368633
more O 0 0.006888926960527897
than O 0 0.007042312528938055
a O 0 0.015948321670293808
third O 0 0.03133002668619156
of O 0 0.02039012499153614
our O 0 0.03167712315917015
patients O 1 0.7394172549247742
with O 0 0.03319719806313515
TWIST O 1 0.999990701675415
mutations O 0 0.049195896834135056
, O 0 0.020097672939300537
are O 0 0.013787342235445976
coronal B-Disease 1 0.9999923706054688
synostosis I-Disease 1 0.9999146461486816
, O 0 0.036304377019405365
brachycephaly B-Disease 1 0.997526228427887
, O 0 0.03044857084751129
low B-Disease 1 0.971555233001709
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 1 0.9991713762283325
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.8649604916572571
ptosis B-Disease 1 1.0
, O 0 0.06603045016527176
hypertelorism B-Disease 1 0.9999997615814209
, O 0 0.03754179924726486
broad B-Disease 0 0.2216573804616928
great I-Disease 1 0.9814611077308655
toes I-Disease 1 0.9999909400939941
, O 0 0.03440670669078827
and O 0 0.038035355508327484
clinodactyly B-Disease 1 0.999903678894043
. O 0 0.050387442111968994

Significant O 0 0.06957893073558807
intra O 1 0.9999967813491821
- O 1 0.9999940395355225
and O 0 0.04402589797973633
interfamilial O 1 0.999722421169281
phenotypic O 0 0.11793042719364166
variability O 0 0.071173295378685
is O 0 0.021389123052358627
present O 0 0.018841851502656937
for O 0 0.01915971376001835
either O 0 0.03423900902271271
TWIST O 1 0.9888624548912048
mutations O 0 0.08013004809617996
or O 0 0.06131936237215996
FGFR O 1 0.9999988079071045
mutations O 0 0.09292411804199219
. O 0 0.04907160624861717

The O 0 0.06263002008199692
overlap O 0 0.06063363701105118
in O 0 0.0331292487680912
clinical O 1 0.9842308163642883
features O 0 0.03609032928943634
and O 0 0.01974252611398697
the O 0 0.025404533371329308
presence O 0 0.034934211522340775
, O 0 0.01474593672901392
in O 0 0.011040564626455307
the O 0 0.018082059919834137
same O 0 0.018523164093494415
genes O 0 0.021056896075606346
, O 0 0.015299297869205475
of O 0 0.02339864894747734
mutations O 0 0.030450817197561264
for O 0 0.011899212375283241
more O 0 0.007352721411734819
than O 0 0.00832635909318924
one O 0 0.02200756035745144
craniosynostotic B-Disease 1 0.9999668598175049
condition I-Disease 1 0.909974992275238
- O 1 0.9998403787612915
such O 0 0.012394795194268227
as O 0 0.025181569159030914
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999994039535522
Chotzen I-Disease 1 0.9999469518661499
, I-Disease 0 0.03206722438335419
Crouzon I-Disease 1 0.9973535537719727
, I-Disease 0 0.02603193186223507
and I-Disease 0 0.03952636197209358
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 1.0
support O 0 0.04239802062511444
the O 0 0.030843524262309074
hypothesis O 0 0.05064616724848747
that O 0 0.01578238233923912
TWIST O 0 0.11604609340429306
and O 0 0.030324826017022133
FGFRs O 1 0.9979077577590942
are O 0 0.011005237698554993
components O 0 0.02145741507411003
of O 0 0.014828973449766636
the O 0 0.0235206987708807
same O 0 0.027652690187096596
molecular O 0 0.06281516700983047
pathway O 0 0.05944378674030304
involved O 0 0.014002150855958462
in O 0 0.009949050843715668
the O 0 0.02231685072183609
modulation O 0 0.0737164095044136
of O 0 0.054177701473236084
craniofacial O 1 1.0
and O 1 0.9999343156814575
limb O 1 1.0
development O 1 0.8542419672012329
in O 0 0.034030549228191376
humans O 0 0.03619566932320595
. O 0 0.02529194764792919
. O 0 0.03794899955391884

Mutation O 0 0.08515051007270813
analysis O 0 0.020799176767468452
of O 0 0.037132907658815384
UBE3A O 1 0.9999998807907104
in O 1 0.9995686411857605
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9704340696334839

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9995206594467163
AS B-Disease 1 0.9999938011169434
) O 0 0.030934171751141548
is O 0 0.020311759784817696
caused O 0 0.031581953167915344
by O 0 0.026501011103391647
chromosome O 0 0.09970013052225113
15q11 O 1 0.9999876022338867
- O 1 0.9999920129776001
q13 O 1 0.9708758592605591
deletions O 0 0.08760819584131241
of O 0 0.036114372313022614
maternal O 1 0.7252331376075745
origin O 0 0.019529111683368683
, O 0 0.014814267866313457
by O 0 0.022577732801437378
paternal O 1 0.9984715580940247
uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
( O 1 0.5316468477249146
UPD B-Disease 1 1.0
) O 0 0.031193558126688004
15 O 0 0.024151839315891266
, O 0 0.01891067437827587
by O 0 0.035885103046894073
imprinting O 1 0.9999998807907104
defects O 1 0.9999970197677612
, O 0 0.027729880064725876
and O 0 0.01719590276479721
by O 0 0.02134726196527481
mutations O 0 0.03252663463354111
in O 0 0.019901614636182785
the O 0 0.05334307625889778
UBE3A O 1 0.9999998807907104
gene O 0 0.08720361441373825
. O 0 0.04275169223546982

UBE3A O 1 0.9999252557754517
encodes O 0 0.09262903779745102
a O 0 0.05379727855324745
ubiquitin O 1 0.9990266561508179
- O 1 0.9999933242797852
protein O 0 0.05894250050187111
ligase O 0 0.07127538323402405
and O 0 0.02084670215845108
shows O 0 0.04797152802348137
brain O 1 0.9997523427009583
- O 1 0.999998927116394
specific O 0 0.03863587975502014
imprinting O 1 0.9904583692550659
. O 0 0.04306017607450485

Here O 0 0.03255251422524452
we O 0 0.016831407323479652
describe O 0 0.05568023398518562
UBE3A O 1 0.9999967813491821
coding O 1 0.5790466070175171
- O 1 0.9999533891677856
region O 0 0.05886455625295639
mutations O 0 0.049442969262599945
detected O 0 0.04443350061774254
by O 0 0.03131286799907684
SSCP O 1 0.9999898672103882
analysis O 0 0.02209686115384102
in O 0 0.016826506704092026
13 O 0 0.04313593730330467
AS B-Disease 0 0.44863584637641907
individuals O 0 0.02815735898911953
or O 0 0.03049841709434986
families O 0 0.04953876882791519
. O 0 0.04347110912203789

Two O 0 0.022646643221378326
identical O 0 0.03379754722118378
de O 0 0.10979652404785156
novo O 1 0.9276708960533142
5 O 0 0.07900526374578476
- O 1 0.9991933703422546
bp O 0 0.10889028757810593
duplications O 0 0.10377474129199982
in O 0 0.028860947117209435
exon O 0 0.16779465973377228
16 O 0 0.03826158866286278
were O 0 0.017623605206608772
found O 0 0.02494652569293976
. O 0 0.03581962734460831

Among O 0 0.045076124370098114
the O 0 0.0280564296990633
other O 0 0.016865788027644157
11 O 0 0.04150834679603577
unique O 0 0.0363951213657856
mutations O 0 0.04539311304688454
, O 0 0.02216346561908722
8 O 0 0.032243553549051285
were O 0 0.013605366460978985
small O 0 0.028178542852401733
deletions O 0 0.09137188643217087
or O 0 0.03572218492627144
insertions O 0 0.12201231718063354
predicted O 0 0.04915030300617218
to O 0 0.03345027565956116
cause O 0 0.3348010778427124
frameshifts O 1 0.9999878406524658
, O 0 0.027974838390946388
1 O 0 0.038423921912908554
was O 0 0.026592664420604706
a O 0 0.028791237622499466
mutation O 0 0.03899044543504715
to O 0 0.015919094905257225
a O 0 0.02716798335313797
stop O 0 0.056281350553035736
codon O 0 0.08540002256631851
, O 0 0.018271975219249725
1 O 0 0.02969089150428772
was O 0 0.026003414765000343
a O 0 0.03349365293979645
missense O 0 0.41133880615234375
mutation O 0 0.07521907985210419
, O 0 0.021992744877934456
and O 0 0.019296865910291672
1 O 0 0.0423138290643692
was O 0 0.032303519546985626
predicted O 0 0.036470480263233185
to O 0 0.02772199921309948
cause O 0 0.06391564011573792
insertion O 0 0.10939960181713104
of O 0 0.03079269826412201
an O 0 0.037375785410404205
isoleucine O 1 0.9837014079093933
in O 0 0.018650885671377182
the O 0 0.03090103343129158
hect O 1 0.8082913160324097
domain O 0 0.03784933686256409
of O 0 0.01973639987409115
the O 0 0.043040111660957336
UBE3A O 1 1.0
protein O 0 0.05761489272117615
, O 0 0.017261307686567307
which O 0 0.012447437271475792
functions O 0 0.019057761877775192
in O 0 0.02986256405711174
E2 O 1 0.9999986886978149
binding O 0 0.06049567088484764
and O 0 0.03672541677951813
ubiquitin O 0 0.4576515257358551
transfer O 0 0.06333950161933899
. O 0 0.03917771577835083

Eight O 0 0.03484873101115227
of O 0 0.026266785338521004
the O 0 0.03111443854868412
cases O 0 0.03402082994580269
were O 0 0.032298412173986435
familial O 1 0.9999997615814209
, O 0 0.03532515838742256
and O 0 0.02158902771770954
five O 0 0.020778771489858627
were O 0 0.02171175368130207
sporadic O 0 0.08583158254623413
. O 0 0.04801175370812416

In O 0 0.0381881482899189
two O 0 0.0327005572617054
familial O 1 0.9999966621398926
cases O 0 0.04656216502189636
and O 0 0.025129765272140503
one O 0 0.026747679337859154
sporadic O 0 0.0637436956167221
case O 0 0.039174433797597885
, O 0 0.03197481855750084
mosaicism O 1 0.9999808073043823
for O 0 0.04951084032654762
UBE3A O 1 1.0
mutations O 0 0.0750744566321373
was O 0 0.04383892938494682
detected O 0 0.03592098131775856
in O 0 0.012710907496511936
the O 0 0.02014785073697567
mother O 0 0.04416594281792641
of O 0 0.018337806686758995
three O 0 0.020274408161640167
AS B-Disease 1 0.9931755661964417
sons O 1 0.9510939717292786
, O 0 0.017554854974150658
in O 0 0.013805916532874107
the O 0 0.02811015024781227
maternal O 1 0.9998483657836914
grandfather O 1 0.891345739364624
of O 0 0.02444625459611416
two O 0 0.016859497874975204
AS B-Disease 0 0.06214473024010658
first O 0 0.04184601083397865
cousins O 0 0.08281777054071426
, O 0 0.0191758144646883
and O 0 0.013446789234876633
in O 0 0.01046279538422823
the O 0 0.019475258886814117
mother O 0 0.048582129180431366
of O 0 0.024160712957382202
an O 0 0.03327536582946777
AS B-Disease 1 0.9946120977401733
daughter O 1 0.9977666139602661
. O 0 0.04976767301559448

The O 0 0.05104042962193489
frequencies O 0 0.02775753103196621
with O 0 0.016325848177075386
which O 0 0.015067404136061668
we O 0 0.01666933111846447
detected O 0 0.05746059864759445
mutations O 0 0.03541270270943642
were O 0 0.015238916501402855
5 O 0 0.041307225823402405
( O 0 0.029052801430225372
14 O 0 0.03616730123758316
% O 0 0.024908287450671196
) O 0 0.01779405027627945
of O 0 0.016944468021392822
35 O 0 0.033671993762254715
in O 0 0.022347964346408844
sporadic O 0 0.07155982404947281
cases O 0 0.03343391418457031
and O 0 0.03036392293870449
8 O 0 0.0566585548222065
( O 0 0.029584599658846855
80 O 0 0.03913894668221474
% O 0 0.024129370227456093
) O 0 0.01566147990524769
of O 0 0.01682060770690441
10 O 0 0.026341628283262253
in O 0 0.03418361395597458
familial O 1 0.9999996423721313
cases O 0 0.060570377856492996
. O 0 0.03555719926953316
. O 0 0.04124196618795395

The O 0 0.07398158311843872
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999998807907104
G O 1 1.0
- O 1 1.0
- O 1 0.9999994039535522
> O 0 0.10782507061958313
A O 0 0.026603369042277336
and O 0 0.012594652362167835
187 O 0 0.07237713783979416
C O 1 0.9998916387557983
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9992830157279968
G O 1 0.9953277111053467
mutations O 0 0.05112732946872711
: O 0 0.030373502522706985
prevalence O 1 0.9630533456802368
in O 0 0.02766890451312065
non O 1 0.9981160163879395
- O 1 1.0
Caucasian O 1 0.9994231462478638
populations O 0 0.05147423967719078
. O 0 0.04293299838900566

Hemochromatosis B-Disease 1 1.0
, O 0 0.03244401887059212
the O 0 0.0440012663602829
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999996423721313
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.035300400108098984
leads O 0 0.11885473877191544
, O 0 0.023477105423808098
if O 0 0.026246843859553337
untreated O 1 0.9999982118606567
, O 0 0.02362227998673916
to O 0 0.0330258347094059
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.06941716372966766
premature B-Disease 1 0.9999980926513672
death I-Disease 1 0.9834083318710327
. O 0 0.05285334587097168

The O 0 0.10878267884254456
hemochromatosis B-Disease 1 1.0
gene O 0 0.12827947735786438
, O 0 0.05968718230724335
HFE O 1 1.0
, O 0 0.0314672589302063
recently O 0 0.033197708427906036
has O 0 0.015869665890932083
been O 0 0.01340775191783905
identified O 0 0.02339775115251541
, O 0 0.01510302722454071
and O 0 0.016410373151302338
characterization O 0 0.05496165156364441
of O 0 0.023220986127853394
this O 0 0.019416214898228645
gene O 0 0.03752569854259491
has O 0 0.01752285845577717
shown O 0 0.015167351812124252
that O 0 0.007797968108206987
it O 0 0.00936869252473116
contains O 0 0.02036268264055252
two O 0 0.013910964131355286
mutations O 0 0.029981069266796112
that O 0 0.010675542056560516
result O 0 0.017448149621486664
in O 0 0.021729344502091408
amino O 0 0.05826509743928909
acid O 0 0.07574290782213211
substitutions O 0 0.07510777562856674
- O 1 0.8951570391654968
cDNA O 0 0.10679057985544205
nucleotides O 0 0.05089912936091423
845 O 0 0.273421972990036
G O 1 0.9998452663421631
- O 1 0.9999997615814209
- O 1 0.9999994039535522
> O 1 0.9082390666007996
A O 0 0.05331500619649887
( O 0 0.035719044506549835
C282Y O 1 0.9756858348846436
) O 0 0.01510694157332182
and O 0 0.011346753686666489
187 O 0 0.0674055963754654
C O 1 0.9999024868011475
- O 1 1.0
- O 1 1.0
> O 1 0.9999836683273315
G O 1 0.999947190284729
( O 0 0.06349688023328781
H63D O 1 0.999995231628418
) O 0 0.046546466648578644
. O 0 0.03871171921491623

Although O 0 0.10213522613048553
hemochromatosis B-Disease 1 1.0
is O 0 0.04118253290653229
common O 0 0.033218152821063995
in O 0 0.02811211533844471
Caucasians O 1 0.9991439580917358
, O 0 0.03698108717799187
affecting O 0 0.08711545169353485
> O 1 0.9999947547912598
= O 0 0.22415916621685028
1 O 0 0.08304427564144135
/ O 1 0.856978714466095
300 O 0 0.030813219025731087
individuals O 0 0.012388392351567745
of O 0 0.018601324409246445
northern O 0 0.03619544580578804
European O 0 0.028087234124541283
origin O 0 0.020082734525203705
, O 0 0.017709320411086082
it O 0 0.010619578883051872
has O 0 0.014780018478631973
not O 0 0.009860268794000149
been O 0 0.012204826809465885
recognized O 0 0.02588174119591713
in O 0 0.016991019248962402
other O 0 0.019762268289923668
populations O 0 0.040847525000572205
. O 0 0.04355614632368088

The O 0 0.04278896003961563
present O 0 0.030153216794133186
study O 0 0.022226568311452866
used O 0 0.020123464986681938
PCR O 0 0.09797236323356628
and O 0 0.02650430053472519
restriction O 0 0.20825429260730743
- O 1 1.0
enzyme O 1 0.9196670651435852
digestion O 1 0.5723050236701965
to O 0 0.024208663031458855
analyze O 0 0.030120303854346275
the O 0 0.01384678017348051
frequency O 0 0.014768232591450214
of O 0 0.011169550009071827
the O 0 0.022863373160362244
845 O 1 0.9998227953910828
G O 1 0.9999983310699463
- O 1 1.0
- O 1 0.9999984502792358
> O 0 0.09806164354085922
A O 0 0.024638410657644272
and O 0 0.011374592781066895
187 O 0 0.0704868957400322
C O 1 0.9997438788414001
- O 1 0.9999998807907104
- O 1 0.9999998807907104
> O 1 0.9988235831260681
G O 1 0.9594292044639587
mutations O 0 0.04523492231965065
in O 0 0.03959618881344795
HLA O 1 1.0
- O 1 0.9999852180480957
typed O 0 0.06403947621583939
samples O 0 0.017731722444295883
from O 0 0.017750544473528862
non O 0 0.17735855281352997
- O 1 0.9999994039535522
Caucasian O 1 0.9896594882011414
populations O 0 0.03802240267395973
, O 0 0.021327225491404533
comprising O 0 0.0417911596596241
Australian O 0 0.05622298642992973
Aboriginal O 0 0.13352906703948975
, O 0 0.028519103303551674
Chinese O 0 0.041363801807165146
, O 0 0.024040693417191505
and O 0 0.02752813883125782
Pacific O 0 0.08100913465023041
Islanders O 0 0.11310866475105286
. O 0 0.0468595027923584

Results O 0 0.027484972029924393
showed O 0 0.016949011012911797
that O 0 0.006537171080708504
the O 0 0.020102666690945625
845 O 1 0.9996688365936279
G O 1 0.9999988079071045
- O 1 1.0
- O 1 0.9999980926513672
> O 1 0.6873128414154053
A O 0 0.05909505486488342
mutation O 0 0.05292072519659996
was O 0 0.025827985256910324
present O 0 0.017774295061826706
in O 0 0.012608672492206097
these O 0 0.010251484811306
populations O 0 0.03256702050566673
( O 0 0.04026078060269356
allele O 0 0.10643399506807327
frequency O 0 0.04231581836938858
0 O 0 0.05234770476818085
. O 0 0.01665627583861351
32 O 0 0.038757484406232834
% O 0 0.030827736482024193
) O 0 0.025213496759533882
, O 0 0.021464459598064423
and O 0 0.020858174189925194
, O 0 0.025922628119587898
furthermore O 0 0.032198499888181686
, O 0 0.018524928018450737
it O 0 0.011834938079118729
was O 0 0.0268486887216568
always O 0 0.018954774364829063
seen O 0 0.01977737434208393
in O 0 0.01566591113805771
conjunction O 0 0.05582045763731003
with O 0 0.04630507156252861
HLA O 1 1.0
haplotypes O 1 0.9918010830879211
common O 0 0.04295090585947037
in O 0 0.027612468227744102
Caucasians O 1 0.997631311416626
, O 0 0.018643198534846306
suggesting O 0 0.02048668824136257
that O 0 0.010309569537639618
845 O 1 0.9996110796928406
G O 1 0.9999991655349731
- O 1 1.0
- O 1 1.0
> O 1 0.9992006421089172
A O 0 0.0532626211643219
may O 0 0.019143516197800636
have O 0 0.007623926270753145
been O 0 0.011987591162323952
introduced O 0 0.021323123946785927
into O 0 0.01742849312722683
these O 0 0.00932303536683321
populations O 0 0.025747409090399742
by O 0 0.03904500976204872
Caucasian O 1 0.9992949962615967
admixture O 1 0.9606466889381409
. O 0 0.06729400902986526

187 O 0 0.14893749356269836
C O 1 0.9999154806137085
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9995937943458557
G O 1 0.9572335481643677
was O 0 0.028375888243317604
present O 0 0.018691198900341988
at O 0 0.020448695868253708
an O 0 0.023263590410351753
allele O 0 0.07645063102245331
frequency O 0 0.03056417591869831
of O 0 0.02754826471209526
2 O 0 0.06261251866817474
. O 0 0.03716443479061127

68 O 0 0.1127060130238533
% O 0 0.030445799231529236
in O 0 0.01576642319560051
the O 0 0.019505850970745087
two O 0 0.016091160476207733
populations O 0 0.03298511356115341
analyzed O 0 0.04054528474807739
( O 0 0.026841185986995697
Australian O 0 0.05121941864490509
Aboriginal O 0 0.09230107814073563
and O 0 0.031626030802726746
Chinese O 0 0.05913706123828888
) O 0 0.036513857543468475
. O 0 0.03356575593352318

In O 0 0.03007357567548752
the O 0 0.026455696672201157
Australian O 0 0.04668522998690605
Aboriginal O 0 0.0623290054500103
samples O 0 0.021146876737475395
, O 0 0.01369625236839056
187 O 0 0.07778944820165634
C O 1 0.9999734163284302
- O 1 1.0
- O 1 1.0
> O 1 0.9998825788497925
G O 1 0.9867392778396606
was O 0 0.02996481955051422
found O 0 0.012255409732460976
to O 0 0.011927816085517406
be O 0 0.009063277393579483
associated O 0 0.02048458345234394
with O 0 0.03701857104897499
HLA O 1 1.0
haplotypes O 1 0.99970942735672
common O 0 0.04657731577754021
in O 0 0.03559857979416847
Caucasians O 1 0.9999173879623413
, O 0 0.031878482550382614
suggesting O 0 0.030710458755493164
that O 0 0.009624284692108631
it O 0 0.010008853860199451
was O 0 0.02427183836698532
introduced O 0 0.023487649857997894
by O 0 0.018089478835463524
recent O 0 0.042345140129327774
admixture O 0 0.18975798785686493
. O 0 0.05326320230960846

In O 0 0.032914310693740845
the O 0 0.03014017641544342
Chinese O 0 0.037032369524240494
samples O 0 0.022083623334765434
analyzed O 0 0.017598453909158707
, O 0 0.012406106106936932
187 O 0 0.07068819552659988
C O 1 0.999953031539917
- O 1 1.0
- O 1 1.0
> O 1 0.9997747540473938
G O 1 0.9931220412254333
was O 0 0.030027100816369057
present O 0 0.018511081114411354
in O 0 0.014876550063490868
association O 0 0.024973103776574135
with O 0 0.01486635860055685
a O 0 0.023288657888770103
wide O 0 0.022949641570448875
variety O 0 0.020813466981053352
of O 0 0.06008031964302063
HLA O 1 1.0
haplotypes O 1 0.998342752456665
, O 0 0.030960746109485626
showing O 0 0.03415501490235329
this O 0 0.019352957606315613
mutation O 0 0.046345993876457214
to O 0 0.019571293145418167
be O 0 0.01494541484862566
widespread O 0 0.04215388745069504
and O 0 0.023176424205303192
likely O 0 0.026245901361107826
to O 0 0.02342792972922325
predate O 0 0.07753194868564606
the O 0 0.017821934074163437
more O 0 0.009183448739349842
genetically O 0 0.02446814440190792
restricted O 0 0.033626705408096313
845 O 1 0.9996973276138306
G O 1 0.9999967813491821
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9913815855979919
A O 0 0.08237258344888687
mutation O 0 0.08919607102870941
. O 0 0.03957607224583626

Genotype O 1 0.9981039762496948
- O 1 0.9999676942825317
phenotype O 0 0.14657899737358093
correlations O 0 0.08821281790733337
in O 0 0.051569826900959015
attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.11140956729650497

Germ O 1 1.0
- O 1 0.9999877214431763
line O 0 0.046014029532670975
mutations O 0 0.023878777399659157
of O 0 0.01997995190322399
the O 0 0.05381430685520172
tumor B-Disease 1 1.0
suppressor O 1 1.0
APC O 1 0.9999991655349731
are O 0 0.011819317005574703
implicated O 0 0.06011289730668068
in O 0 0.03122168406844139
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.99996018409729
AAPC B-Disease 1 1.0
) O 0 0.027547281235456467
, O 0 0.013497189618647099
a O 0 0.018126841634511948
variant O 0 0.04672665521502495
of O 0 0.046296946704387665
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999995231628418
FAP B-Disease 1 1.0
) O 0 0.0687607005238533
. O 0 0.04226785898208618

AAPC B-Disease 1 0.9999990463256836
is O 0 0.037093423306941986
recognized O 0 0.02838790975511074
by O 0 0.014239730313420296
the O 0 0.02151089534163475
occurrence O 0 0.053902752697467804
of O 0 0.03889574855566025
< O 1 0.9999511241912842
100 O 0 0.07527431845664978
colonic B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and O 0 0.016280731186270714
a O 0 0.017526349052786827
later O 0 0.026921281591057777
onset O 1 1.0
of O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9996422529220581
age O 1 0.9343003034591675
> O 1 0.9999221563339233
40 O 0 0.042422518134117126
years O 0 0.031444281339645386
) O 0 0.033548664301633835
. O 0 0.03348753973841667

The O 0 0.05362541601061821
aim O 0 0.05485115945339203
of O 0 0.01998462900519371
this O 0 0.012821932323276997
study O 0 0.017354777082800865
was O 0 0.0202324278652668
to O 0 0.021216891705989838
assess O 0 0.08219949901103973
genotype O 1 0.999575674533844
- O 1 0.9999986886978149
phenotype O 0 0.3432455360889435
correlations O 0 0.11724823713302612
in O 0 0.05754939839243889
AAPC B-Disease 1 0.9999996423721313
families O 0 0.08622602373361588
. O 0 0.05707075446844101

By O 0 0.04884197935461998
protein O 0 0.07942995429039001
- O 1 0.9990082383155823
truncation O 0 0.4562320113182068
test O 0 0.06271647661924362
( O 0 0.04844501614570618
PTT O 1 0.9999361038208008
) O 0 0.031192857772111893
assay O 0 0.06731666624546051
, O 0 0.013993517495691776
the O 0 0.017599457874894142
entire O 0 0.03856934607028961
coding O 0 0.05413391441106796
region O 0 0.02097775973379612
of O 0 0.01865614950656891
the O 0 0.04075641557574272
APC B-Disease 1 0.9999998807907104
gene O 0 0.048255808651447296
was O 0 0.03367699310183525
screened O 0 0.0632915049791336
in O 0 0.0186855997890234
affected O 0 0.028355024755001068
individuals O 0 0.017744624987244606
from O 0 0.0274041760712862
11 O 0 0.10737971216440201
AAPC B-Disease 1 1.0
kindreds O 1 0.9999929666519165
, O 0 0.04023924469947815
and O 0 0.021650424227118492
their O 0 0.02442331798374653
phenotypic O 0 0.07531196624040604
differences O 0 0.03476080670952797
were O 0 0.024530144408345222
examined O 0 0.07583112269639969
. O 0 0.04347772151231766

Five O 0 0.038512032479047775
novel O 0 0.10109030455350876
germ O 1 1.0
- O 1 0.9999998807907104
line O 0 0.3232724964618683
APC B-Disease 1 0.9999985694885254
mutations O 0 0.04800911992788315
were O 0 0.012865927070379257
identified O 0 0.02205253392457962
in O 0 0.01788954995572567
seven O 0 0.04425656050443649
kindreds O 1 0.9931800365447998
. O 0 0.060113176703453064

Mutations O 0 0.08103269338607788
were O 0 0.017624802887439728
located O 0 0.03774043172597885
in O 0 0.013524970039725304
three O 0 0.00998357031494379
different O 0 0.004701988305896521
regions O 0 0.011508881114423275
of O 0 0.01598692685365677
the O 0 0.04320008307695389
APC B-Disease 1 1.0
gene O 0 0.06514181941747665
( O 0 0.030362656340003014
1 O 0 0.04366142675280571
) O 0 0.018606731668114662
at O 0 0.017782580107450485
the O 0 0.017893239855766296
5 O 0 0.028487520292401314
end O 0 0.03708640858530998
spanning O 0 0.05298759788274765
exons O 0 0.09554453939199448
4 O 0 0.03969191387295723
and O 0 0.021182140335440636
5 O 0 0.03705800697207451
, O 0 0.026213906705379486
( O 0 0.026941664516925812
2 O 0 0.03654446825385094
) O 0 0.015261916443705559
within O 0 0.018976856023073196
exon O 0 0.26980724930763245
9 O 0 0.049323078244924545
, O 0 0.02386806719005108
and O 0 0.02367880754172802
( O 0 0.027747176587581635
3 O 0 0.03646977245807648
) O 0 0.018712392076849937
at O 0 0.02040223777294159
the O 0 0.023389441892504692
3 O 0 0.053165748715400696
distal O 1 0.995591402053833
end O 0 0.043824005872011185
of O 0 0.031001776456832886
the O 0 0.0479675829410553
gene O 0 0.060346685349941254
. O 0 0.038283221423625946

Variability O 0 0.07815109193325043
in O 0 0.012722192332148552
the O 0 0.01581522822380066
number O 0 0.019850078970193863
of O 1 0.9808645844459534
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.852914035320282
most O 0 0.027174871414899826
apparent O 0 0.054694581776857376
in O 0 0.01666019670665264
individuals O 0 0.014796677976846695
with O 0 0.01773699000477791
mutations O 0 0.033119965344667435
in O 0 0.014645146206021309
region O 0 0.02705453708767891
1 O 0 0.029549289494752884
, O 0 0.013757426291704178
and O 0 0.01866629533469677
upper O 1 0.9999997615814209
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 1.0
were O 0 0.02490982972085476
more O 0 0.023427873849868774
severe O 1 0.9992172718048096
in O 0 0.027769146487116814
them O 0 0.028064563870429993
. O 0 0.03856625407934189

In O 0 0.03645525872707367
individuals O 0 0.02351231314241886
with O 0 0.02701941877603531
mutations O 0 0.04465222358703613
in O 0 0.019822021946310997
either O 0 0.026771305128932
region O 0 0.042328670620918274
2 O 0 0.054649654775857925
or O 0 0.02682274580001831
region O 0 0.035904109477996826
3 O 0 0.03735777735710144
, O 0 0.01651759259402752
the O 0 0.01821252703666687
average O 0 0.021826529875397682
number O 0 0.020062074065208435
of O 0 0.052013248205184937
adenomas B-Disease 1 0.9999998807907104
tended O 0 0.08825612813234329
to O 0 0.028442053124308586
be O 0 0.014664990827441216
lower O 0 0.03042667545378208
than O 0 0.01061204168945551
those O 0 0.01010157074779272
in O 0 0.01393501739948988
individuals O 0 0.014992846176028252
with O 0 0.021939780563116074
mutations O 0 0.04040249437093735
in O 0 0.019377559423446655
region O 0 0.036048196256160736
1 O 0 0.03956729546189308
, O 0 0.015736261382699013
although O 0 0.014128575101494789
age O 0 0.032525379210710526
at O 0 0.1759157031774521
diagnosis O 1 1.0
was O 0 0.055054083466529846
similar O 0 0.030566029250621796
. O 0 0.035946499556303024

In O 0 0.03972145542502403
all O 0 0.04482799023389816
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9914934635162354
, O 0 0.023125501349568367
a O 0 0.026359500363469124
predominance O 0 0.24255146086215973
of O 0 0.02897713892161846
right O 0 0.05335889756679535
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999984502792358
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999998807907104
was O 0 0.07573151588439941
observed O 0 0.04368998110294342
. O 0 0.03458452597260475

No O 0 0.09797370433807373
desmoid B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999998807907104
were O 0 0.024983985349535942
found O 0 0.01910259760916233
in O 0 0.01944676972925663
these O 0 0.02359248325228691
kindreds O 1 0.9693146347999573
. O 0 0.05292429029941559

Our O 0 0.05483422800898552
data O 0 0.020153718069195747
suggest O 0 0.018133683130145073
that O 0 0.010155401192605495
, O 0 0.020595401525497437
in O 0 0.03438882529735565
AAPC B-Disease 1 0.9999998807907104
families O 0 0.03824160620570183
, O 0 0.01658526435494423
the O 0 0.015394874848425388
location O 0 0.01784399151802063
of O 0 0.01805562898516655
the O 0 0.04449356719851494
APC B-Disease 1 1.0
mutation O 0 0.23800674080848694
may O 0 0.040104661136865616
partially O 0 0.08003471046686172
predict O 0 0.04723691567778587
specific O 0 0.026828989386558533
phenotypic O 0 0.10028909891843796
expression O 0 0.07175567746162415
. O 0 0.04884596914052963

This O 0 0.02998921275138855
should O 0 0.022227514535188675
help O 0 0.026412468403577805
in O 0 0.012209368869662285
the O 0 0.01739257387816906
design O 0 0.022451337426900864
of O 0 0.023402489721775055
tailored O 0 0.09079459309577942
clinical O 1 0.9999803304672241
- O 1 1.0
management O 0 0.48650163412094116
protocols O 0 0.15534420311450958
in O 0 0.012559754773974419
this O 0 0.012883489951491356
subset O 0 0.08909052610397339
of O 0 0.07560262084007263
FAP B-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.04248221591114998
. O 0 0.04762310907244682

Wilms B-Disease 1 1.0
' I-Disease 1 0.9999982118606567
tumor I-Disease 1 1.0
1 O 0 0.05986804887652397
and O 0 0.03269796445965767
Dax O 1 1.0
- O 1 0.9999904632568359
1 O 0 0.04443870112299919
modulate O 0 0.06264703720808029
the O 0 0.02120676264166832
orphan O 1 0.9999948740005493
nuclear O 0 0.09508978575468063
receptor O 1 0.999055802822113
SF O 1 1.0
- O 1 0.9998892545700073
1 O 0 0.030535977333784103
in O 0 0.01596291922032833
sex O 0 0.06381084769964218
- O 1 0.9999868869781494
specific O 0 0.02857787534594536
gene O 0 0.053433481603860855
expression O 0 0.05163593590259552
. O 0 0.037530940026044846

Products O 0 0.05822908133268356
of O 0 0.047056447714567184
steroidogenic O 1 0.9999996423721313
factor O 0 0.4846179485321045
1 O 0 0.06073051691055298
( O 0 0.04723082855343819
SF O 1 1.0
- O 1 0.9999910593032837
1 O 0 0.035944823175668716
) O 0 0.01661176048219204
and O 0 0.02820398285984993
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 1 0.9989690780639648
( O 0 0.09325437992811203
WT1 O 1 1.0
) O 0 0.038919899612665176
genes O 0 0.020905835554003716
are O 0 0.0073809996247291565
essential O 0 0.035807669162750244
for O 0 0.027357837185263634
mammalian O 0 0.1420687586069107
gonadogenesis O 1 0.9896758198738098
prior O 0 0.04588647559285164
to O 0 0.04162976145744324
sexual O 0 0.1062399223446846
differentiation O 1 0.9001762866973877
. O 0 0.06251446902751923

In O 0 0.02616705186665058
males O 0 0.03019469603896141
, O 0 0.04028981178998947
SF O 1 1.0
- O 1 1.0
1 O 0 0.06187229976058006
participates O 0 0.06194338947534561
in O 0 0.016635894775390625
sexual O 0 0.039304547011852264
development O 0 0.025490257889032364
by O 0 0.019046634435653687
regulating O 0 0.04742375761270523
expression O 0 0.02229413576424122
of O 0 0.015687081962823868
the O 0 0.03389374911785126
polypeptide O 1 0.999972939491272
hormone O 1 0.9999712705612183
Mullerian O 1 1.0
inhibiting O 1 0.9999997615814209
substance O 1 0.999984622001648
( O 0 0.13540023565292358
MIS O 1 1.0
) O 0 0.04508544132113457
. O 0 0.03616449981927872

Here O 0 0.0410451740026474
, O 0 0.01992015168070793
we O 0 0.01000184565782547
show O 0 0.01954927109181881
that O 0 0.02166447602212429
WT1 O 1 0.9999996423721313
- O 1 0.9999994039535522
KTS O 1 0.9999971389770508
isoforms O 0 0.06425034999847412
associate O 0 0.05827862024307251
and O 0 0.024477215483784676
synergize O 1 0.9996987581253052
with O 0 0.048393331468105316
SF O 1 1.0
- O 1 0.9999997615814209
1 O 0 0.04431839659810066
to O 0 0.026880590245127678
promote O 0 0.07786498963832855
MIS O 1 0.9999997615814209
expression O 0 0.07087088376283646
. O 0 0.03960946202278137

In O 0 0.04185524582862854
contrast O 0 0.06369464099407196
, O 0 0.05677201598882675
WT1 O 1 0.9999992847442627
missense O 1 0.9272119402885437
mutations O 0 0.05803730711340904
, O 0 0.020978936925530434
associated O 0 0.017490046098828316
with O 0 0.014552774839103222
male B-Disease 0 0.055275559425354004
pseudohermaphroditism I-Disease 1 0.9999996423721313
in O 0 0.03447737172245979
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.04364032670855522
fail O 0 0.06626341491937637
to O 0 0.03167630359530449
synergize O 1 0.9999911785125732
with O 0 0.05591801553964615
SF O 1 1.0
- O 1 1.0
1 O 0 0.06506228446960449
. O 0 0.03452533483505249

Additionally O 0 0.049327634274959564
, O 0 0.01797514595091343
the O 0 0.029438532888889313
X O 1 0.9999492168426514
- O 1 0.9999980926513672
linked O 0 0.04774339124560356
, O 0 0.0166472177952528
candidate O 0 0.04665909707546234
dosage O 1 0.9998266100883484
- O 1 0.9999969005584717
sensitive O 0 0.05316173657774925
sex O 0 0.06632111221551895
- O 1 0.9999934434890747
reversal O 0 0.09019417315721512
gene O 0 0.040853749960660934
, O 0 0.029120352119207382
Dax O 1 0.9999998807907104
- O 1 0.9999773502349854
1 O 0 0.03907895088195801
, O 0 0.021340347826480865
antagonizes O 1 0.9950597882270813
synergy O 0 0.1982983499765396
between O 0 0.04832915961742401
SF O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.06027485430240631
and O 0 0.036220796406269073
WT1 O 1 0.9999996423721313
, O 0 0.02493574284017086
most O 0 0.014340264722704887
likely O 0 0.01712106727063656
through O 0 0.013965200632810593
a O 0 0.02052062749862671
direct O 0 0.025411371141672134
interaction O 0 0.03174382075667381
with O 0 0.0386316254734993
SF O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.06825447082519531
. O 0 0.0342438742518425

We O 0 0.02822897769510746
propose O 0 0.053399063646793365
that O 0 0.02373546175658703
WT1 O 1 0.9999004602432251
and O 0 0.0501805879175663
Dax O 1 1.0
- O 1 0.9999996423721313
1 O 0 0.0697377398610115
functionally O 0 0.08780176192522049
oppose O 0 0.04387005418539047
each O 0 0.009210544638335705
other O 0 0.010387049987912178
in O 0 0.02105703391134739
testis O 1 0.999680757522583
development O 0 0.03306403383612633
by O 0 0.030231593176722527
modulating O 1 0.9999955892562866
SF O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.11438990384340286
- O 1 0.9999973773956299
mediated O 1 0.8980243802070618
transactivation O 1 0.9978792667388916
. O 0 0.03300300985574722
. O 0 0.034795764833688736

A O 0 0.08166545629501343
mouse O 0 0.07019779086112976
model O 0 0.025684183463454247
for O 0 0.02783140167593956
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9998657703399658
mutations O 0 0.0658261626958847
. O 0 0.03787669911980629

Imprinting O 0 0.2126438468694687
in O 0 0.01954152062535286
the O 0 0.03469511494040489
15q11 O 1 0.9999738931655884
- O 1 0.9999985694885254
q13 O 1 0.9955397248268127
region O 0 0.03325739502906799
involves O 0 0.02865503914654255
an O 0 0.02733999490737915
imprinting O 1 0.9999899864196777
centre O 1 0.9998059868812561
( O 0 0.07500501722097397
IC O 1 0.9999998807907104
) O 0 0.03162140026688576
, O 0 0.02235494554042816
mapping O 0 0.03189125284552574
in O 0 0.012212458066642284
part O 0 0.020582854747772217
to O 0 0.01779840514063835
the O 0 0.029239771887660027
promoter O 1 0.9626294374465942
and O 0 0.018687427043914795
first O 0 0.03579406440258026
exon O 0 0.17657436430454254
of O 0 0.060647934675216675
SNRPN O 1 0.999954104423523
. O 0 0.06507226824760437

Deletion O 0 0.12622332572937012
of O 0 0.031459059566259384
this O 0 0.031004425138235092
IC O 1 0.9999951124191284
abolishes O 1 0.9999294281005859
local O 0 0.04937506467103958
paternally O 0 0.15845485031604767
derived O 0 0.04468493163585663
gene O 0 0.03726471960544586
expression O 0 0.02119157463312149
and O 0 0.009326708503067493
results O 0 0.010542457923293114
in O 0 0.02456793002784252
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 0.06438947468996048
. O 0 0.04150819405913353

We O 0 0.023127593100070953
have O 0 0.010178378783166409
created O 0 0.02344692498445511
two O 0 0.018709635362029076
deletion O 0 0.1410098671913147
mutations O 0 0.061281196773052216
in O 0 0.029368996620178223
mice O 0 0.06731744110584259
to O 0 0.04061727598309517
understand O 0 0.06937304139137268
PWS B-Disease 1 1.0
and O 0 0.027806488797068596
the O 0 0.03170185163617134
mechanism O 0 0.044095415621995926
of O 0 0.029115455225110054
this O 0 0.03537239506840706
IC O 1 0.9999797344207764
. O 0 0.05085340514779091

Mice O 0 0.16953614354133606
harbouring O 1 0.9984778761863708
an O 0 0.054014191031455994
intragenic O 1 0.9999181032180786
deletion O 0 0.13046172261238098
in O 0 0.035373467952013016
Snrpn O 1 0.9999833106994629
are O 0 0.021425046026706696
phenotypically O 1 0.8748997449874878
normal O 0 0.04297745227813721
, O 0 0.02365620993077755
suggesting O 0 0.02973121777176857
that O 0 0.014101005159318447
mutations O 0 0.03732017055153847
of O 0 0.04143859073519707
SNRPN O 1 0.9999988079071045
are O 0 0.012445016764104366
not O 0 0.013234921731054783
sufficient O 0 0.038748715072870255
to O 0 0.051983583718538284
induce O 1 0.9998989105224609
PWS B-Disease 1 1.0
. O 0 0.08558940887451172

Mice O 0 0.10115823149681091
with O 0 0.024147532880306244
a O 0 0.03446692228317261
larger O 0 0.03730614483356476
deletion O 0 0.09061262011528015
involving O 0 0.035218458622694016
both O 0 0.021827824413776398
Snrpn O 1 0.9922526478767395
and O 0 0.018092773854732513
the O 0 0.032863929867744446
putative O 1 0.9999997615814209
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999991655349731
lack O 0 0.04632481560111046
expression O 0 0.03048444353044033
of O 0 0.020426681265234947
the O 0 0.03449047729372978
imprinted O 1 0.9813356399536133
genes O 0 0.049439381808042526
Zfp127 O 1 0.9997735619544983
( O 0 0.04151295870542526
mouse O 0 0.07564521580934525
homologue O 0 0.15511709451675415
of O 0 0.04460897669196129
ZNF127 O 1 0.9999994039535522
) O 0 0.03923843055963516
, O 0 0.03830697759985924
Ndn O 1 0.9999986886978149
and O 0 0.04173862561583519
Ipw O 1 0.9998860359191895
, O 0 0.025030208751559258
and O 0 0.021319730207324028
manifest O 0 0.07799273729324341
several O 0 0.021753957495093346
phenotypes O 0 0.10303830355405807
common O 0 0.04843807592988014
to O 0 0.12754859030246735
PWS B-Disease 1 1.0
infants O 1 0.9999973773956299
. O 0 0.07668700069189072

These O 0 0.02855539321899414
data O 0 0.01897740364074707
demonstrate O 0 0.029841089621186256
that O 0 0.008437947370111942
both O 0 0.008927350863814354
the O 0 0.014873902313411236
position O 0 0.02614510990679264
of O 0 0.021037189289927483
the O 0 0.03803876414895058
IC O 1 0.9999839067459106
and O 0 0.01920202746987343
its O 0 0.020004812628030777
role O 0 0.031127849593758583
in O 0 0.013206643052399158
the O 0 0.02185896970331669
coordinate O 0 0.06118686869740486
expression O 0 0.031346023082733154
of O 0 0.025215350091457367
genes O 0 0.025245416909456253
is O 0 0.01788691245019436
conserved O 0 0.04114910587668419
between O 0 0.034267865121364594
mouse O 0 0.08838682621717453
and O 0 0.02920645661652088
human O 0 0.03222106024622917
, O 0 0.02044513449072838
and O 0 0.016018832102417946
indicate O 0 0.01710651069879532
that O 0 0.009434782899916172
the O 0 0.026616297662258148
mouse O 0 0.05929999053478241
is O 0 0.018303344026207924
a O 0 0.029687805101275444
suitable O 0 0.05880206823348999
model O 0 0.04139326885342598
system O 0 0.0305923018604517
in O 0 0.013727799989283085
which O 0 0.010429720394313335
to O 0 0.015200280584394932
investigate O 0 0.05008244514465332
the O 0 0.03046797588467598
molecular O 0 0.055977605283260345
mechanisms O 0 0.03816521167755127
of O 0 0.03670676797628403
imprinting O 1 0.9957037568092346
in O 0 0.020317303016781807
this O 0 0.011362694203853607
region O 0 0.02185872010886669
of O 0 0.020618433132767677
the O 0 0.03885690122842789
genome O 0 0.05974385887384415
. O 0 0.024205120280385017
. O 0 0.03492344915866852

Mutations O 0 0.05802474915981293
of O 0 0.02412671037018299
the O 0 0.039062511175870895
ATM O 1 0.9943476319313049
gene O 0 0.035223010927438736
detected O 0 0.02702588587999344
in O 0 0.014864270575344563
Japanese O 0 0.47211331129074097
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999982118606567
: O 0 0.04017743468284607
possible O 0 0.030616220086812973
preponderance O 0 0.15098261833190918
of O 0 0.021091023460030556
the O 0 0.021792015060782433
two O 0 0.022465063259005547
founder O 1 0.9848282933235168
mutations O 0 0.09169940650463104
4612del165 O 1 0.9992522597312927
and O 0 0.05576865375041962
7883del5 O 1 0.9989939332008362
. O 0 0.05762585997581482

The O 0 0.05210309103131294
ATM O 1 0.6245221495628357
( O 0 0.02974558249115944
A O 1 0.9443252086639404
- O 1 1.0
T O 1 0.9999994039535522
, O 0 0.03257555514574051
mutated O 0 0.10134004056453705
) O 0 0.029726527631282806
gene O 0 0.031902920454740524
on O 0 0.02338765189051628
human O 0 0.053175944834947586
chromosome O 0 0.1235947534441948
11q22 O 1 0.9919463992118835
. O 0 0.061677854508161545

3 O 0 0.06538591533899307
has O 0 0.0245437640696764
recently O 0 0.031063666567206383
been O 0 0.012967584654688835
identified O 0 0.017837774008512497
as O 0 0.013945949263870716
the O 0 0.021005120128393173
gene O 0 0.028238344937562943
responsible O 0 0.022570805624127388
for O 0 0.011054922826588154
the O 0 0.019299685955047607
human O 0 0.043611977249383926
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.05215008929371834
A B-Disease 1 0.9999942779541016
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 0.03604312241077423
. O 0 0.029776079580187798

In O 0 0.029900630936026573
order O 0 0.027662236243486404
to O 0 0.01900341734290123
define O 0 0.03065355494618416
the O 0 0.018014036118984222
types O 0 0.02132573164999485
of O 0 0.04031217470765114
disease O 1 1.0
- O 1 1.0
causing O 1 0.999954342842102
ATM O 1 0.9998156428337097
mutations O 0 0.023850595578551292
in O 0 0.009923956356942654
Japanese O 0 0.03940121456980705
A B-Disease 1 0.9999203681945801
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9996554851531982
as O 0 0.02555130608379841
well O 0 0.017017154023051262
as O 0 0.017331819981336594
to O 0 0.01937531866133213
look O 0 0.023984642699360847
for O 0 0.018075425177812576
possible O 0 0.040303073823451996
mutational O 1 0.9999276399612427
hotspots O 1 0.9941601753234863
, O 0 0.033029019832611084
reverse O 0 0.10037742555141449
- O 1 0.9999921321868896
transcribed O 0 0.09851264953613281
RNA O 0 0.07371848821640015
derived O 0 0.019363882020115852
from O 0 0.015429601073265076
ten O 0 0.038660161197185516
patients O 0 0.13554193079471588
belonging O 0 0.04440407082438469
to O 0 0.01646188087761402
eight O 0 0.018126631155610085
unrelated O 0 0.038214799016714096
Japanese O 0 0.054530102759599686
A B-Disease 1 0.9999516010284424
- I-Disease 1 1.0
T I-Disease 1 0.9999990463256836
families O 0 0.03484472259879112
was O 0 0.035279251635074615
analyzed O 0 0.033632487058639526
for O 0 0.021851761266589165
mutations O 0 0.033196739852428436
by O 0 0.01771893911063671
the O 0 0.03608137369155884
restriction O 0 0.09816990047693253
endonuclease O 1 0.9982624650001526
fingerprinting O 0 0.1438368707895279
method O 0 0.04955993965268135
. O 0 0.03553271293640137

As O 0 0.04775024205446243
has O 0 0.023168664425611496
been O 0 0.015613074414432049
reported O 0 0.022603753954172134
by O 0 0.020220505073666573
others O 0 0.025850951671600342
, O 0 0.025201404467225075
mutations O 0 0.032836154103279114
that O 0 0.009707706980407238
lead O 0 0.028888840228319168
to O 0 0.028642715886235237
exon O 1 0.9858028888702393
skipping O 0 0.15827596187591553
or O 0 0.046096425503492355
premature O 1 0.9999790191650391
protein O 0 0.0767422467470169
truncation O 0 0.11647715419530869
were O 0 0.014210382476449013
also O 0 0.017544684931635857
predominant O 0 0.06685987859964371
in O 0 0.021972978487610817
our O 0 0.04981779307126999
mutants O 1 0.5636117458343506
. O 0 0.04952997341752052

Six O 0 0.04923878610134125
different O 0 0.016026869416236877
mutations O 0 0.035802096128463745
were O 0 0.012919359840452671
identified O 0 0.020447246730327606
on O 0 0.014105619862675667
12 O 0 0.018643276765942574
of O 0 0.018929732963442802
the O 0 0.029644615948200226
16 O 0 0.057977981865406036
alleles O 0 0.11048071086406708
examined O 0 0.0869620218873024
. O 0 0.047036025673151016

Four O 0 0.03224469721317291
were O 0 0.02015705034136772
deletions O 0 0.07543843984603882
involving O 0 0.035325001925230026
a O 0 0.03131268173456192
loss O 0 0.03828679025173187
of O 0 0.024383550509810448
a O 0 0.03134642913937569
single O 0 0.052592288702726364
exon O 1 0.5644128918647766
exon O 0 0.20923425257205963
7 O 0 0.04964263737201691
, O 0 0.027057813480496407
exon O 0 0.1263648122549057
16 O 0 0.03487265482544899
, O 0 0.030574388802051544
exon O 0 0.16122478246688843
33 O 0 0.06633702665567398
or O 0 0.04050181433558464
exon O 0 0.1936514675617218
35 O 0 0.06259667873382568
. O 0 0.04152863472700119

The O 0 0.051640585064888
others O 0 0.026796262711286545
were O 0 0.01682993955910206
minute O 0 0.05329195782542229
deletions O 0 0.08689987659454346
, O 0 0.031422510743141174
4649delA O 1 0.5436787009239197
in O 0 0.032376404851675034
exon O 0 0.1629609763622284
33 O 0 0.05967165157198906
and O 0 0.03289596736431122
7883del5 O 1 0.9863548874855042
in O 0 0.037876348942518234
exon O 0 0.3750554323196411
55 O 0 0.08255289494991302
. O 0 0.046667009592056274

The O 0 0.0767083540558815
mutations O 0 0.10266435891389847
4612del165 O 1 0.9999226331710815
and O 0 0.046419814229011536
7883del5 O 1 0.9993751645088196
were O 0 0.016292434185743332
found O 0 0.012859303504228592
in O 0 0.010673699900507927
more O 0 0.0070608691312372684
than O 0 0.008797144517302513
two O 0 0.013424546457827091
unrelated O 0 0.04932725802063942
families O 0 0.03833705186843872
; O 0 0.030142614617943764
44 O 0 0.05743808671832085
% O 0 0.03475543484091759
( O 0 0.029444653540849686
7 O 0 0.03859193995594978
of O 0 0.025213193148374557
16 O 0 0.03489784151315689
) O 0 0.019214190542697906
of O 0 0.018021345138549805
the O 0 0.037789247930049896
mutant O 0 0.1882268339395523
alleles O 0 0.07263892889022827
had O 0 0.019488763064146042
one O 0 0.01512059848755598
of O 0 0.0176974069327116
the O 0 0.025826994329690933
two O 0 0.027042511850595474
mutations O 0 0.06417861580848694
. O 0 0.04410978779196739

The O 0 0.09950293600559235
4612del165 O 1 0.9999531507492065
mutations O 0 0.06836086511611938
in O 0 0.01850999891757965
three O 0 0.013727567158639431
different O 0 0.00777265802025795
families O 0 0.017964957281947136
were O 0 0.009480741806328297
all O 0 0.010935775004327297
ascribed O 0 0.05226853862404823
to O 0 0.014151767827570438
the O 0 0.017843881621956825
same O 0 0.022304512560367584
T O 1 0.9999991655349731
- O 1 1.0
- O 1 0.9999934434890747
> O 0 0.14819656312465668
A O 0 0.04718048870563507
substitution O 0 0.05749562755227089
at O 0 0.02232316881418228
the O 0 0.0302678681910038
splice O 0 0.17671352624893188
donor O 0 0.08226469159126282
site O 0 0.043844711035490036
in O 0 0.03194683790206909
intron O 1 0.9999415874481201
33 O 0 0.09370257705450058
. O 0 0.04230818152427673

Microsatellite O 1 0.9918917417526245
genotyping O 1 0.5115065574645996
around O 0 0.027721382677555084
the O 0 0.0472090058028698
ATM O 1 0.9986005425453186
locus O 1 0.5218710899353027
also O 0 0.02082374133169651
indicated O 0 0.02261342853307724
that O 0 0.008857998996973038
a O 0 0.027773864567279816
common O 0 0.03891483321785927
haplotype O 0 0.48981961607933044
was O 0 0.03260724991559982
shared O 0 0.025898298248648643
by O 0 0.015068861655890942
the O 0 0.03355873376131058
mutant O 1 0.7090080976486206
alleles O 0 0.0875362977385521
in O 0 0.0276721753180027
both O 0 0.030674677342176437
mutations O 0 0.06830661743879318
. O 0 0.045998357236385345

This O 0 0.033046573400497437
suggests O 0 0.03280371427536011
that O 0 0.008425764739513397
these O 0 0.007265088148415089
two O 0 0.020749017596244812
founder O 1 0.9998869895935059
mutations O 0 0.06273529678583145
may O 0 0.02420847676694393
be O 0 0.012435924261808395
predominant O 0 0.05829280987381935
among O 0 0.027651961892843246
Japanese O 0 0.09265017509460449
ATM O 1 0.9998304843902588
mutant O 1 0.8372039794921875
alleles O 0 0.1283869445323944
. O 0 0.04800235107541084

W474C O 1 0.9997139573097229
amino O 0 0.16191785037517548
acid O 0 0.3689556121826172
substitution O 0 0.12137183547019958
affects O 0 0.0656583309173584
early O 0 0.02489682286977768
processing O 0 0.015224596485495567
of O 0 0.010706624016165733
the O 0 0.020364128053188324
alpha O 0 0.10102546215057373
- O 1 0.6522257328033447
subunit O 0 0.058718517422676086
of O 0 0.02143792062997818
beta O 1 0.8924364447593689
- O 1 0.9999723434448242
hexosaminidase O 1 0.9939725995063782
A O 0 0.03437032178044319
and O 0 0.013631775043904781
is O 0 0.013521281071007252
associated O 0 0.021107986569404602
with O 0 0.035853344947099686
subacute O 1 1.0
G B-Disease 1 1.0
( I-Disease 0 0.27413874864578247
M2 I-Disease 1 0.9999990463256836
) I-Disease 0 0.058504555374383926
gangliosidosis I-Disease 1 0.9956145286560059
. O 0 0.04563106596469879

Mutations O 0 0.06049133464694023
in O 0 0.019437260925769806
the O 0 0.04783954471349716
HEXA O 1 1.0
gene O 0 0.049681514501571655
, O 0 0.016541916877031326
encoding O 0 0.019900081679224968
the O 0 0.016761332750320435
alpha O 0 0.1060083732008934
- O 1 0.9210631251335144
subunit O 0 0.05891396105289459
of O 0 0.019687756896018982
beta O 1 0.5992276072502136
- O 1 0.9999690055847168
hexosaminidase O 1 0.9971802234649658
A O 0 0.06142623722553253
( O 0 0.04048498347401619
Hex O 1 0.9193627834320068
A O 0 0.05423364415764809
) O 0 0.01720709167420864
, O 0 0.010041431523859501
that O 0 0.008141561411321163
abolish O 0 0.07146108150482178
Hex O 0 0.13016241788864136
A O 0 0.04586581140756607
enzyme O 0 0.058179646730422974
activity O 0 0.0321170948445797
cause O 1 0.9991974234580994
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.99565190076828
TSD B-Disease 1 1.0
) O 0 0.029312582686543465
, O 0 0.016243960708379745
the O 0 0.02976805344223976
fatal O 1 0.9999978542327881
infantile B-Disease 1 1.0
form I-Disease 0 0.054872140288352966
of I-Disease 0 0.27071255445480347
G I-Disease 1 0.9999998807907104
( I-Disease 0 0.04761209338903427
M2 I-Disease 1 0.9999372959136963
) I-Disease 0 0.03935347869992256
gangliosidosis I-Disease 1 0.9996325969696045
, I-Disease 0 0.03729004040360451
Type I-Disease 0 0.08715856075286865
1 I-Disease 0 0.06728611141443253
. O 0 0.03776659071445465

Less O 0 0.04549012705683708
severe O 1 0.9995660185813904
, O 0 0.049666840583086014
subacute O 1 1.0
( O 0 0.4341125190258026
juvenile O 1 1.0
- O 1 1.0
onset O 1 1.0
) O 0 0.03951560705900192
and O 0 0.035567786544561386
chronic O 1 1.0
( O 0 0.49385955929756165
adult O 1 0.9999054670333862
- O 1 1.0
onset O 1 1.0
) O 0 0.04361430183053017
variants O 0 0.03442435339093208
are O 0 0.008301044814288616
characterized O 0 0.035291291773319244
by O 0 0.016437163576483727
a O 0 0.028255583718419075
broad O 0 0.0587601363658905
spectrum O 0 0.05936865881085396
of O 0 0.04842290282249451
clinical O 1 0.9999998807907104
manifestations O 1 1.0
and O 0 0.031201642006635666
are O 0 0.011244745925068855
associated O 0 0.020280903205275536
with O 0 0.019182030111551285
residual O 1 0.9438668489456177
levels O 0 0.031181545928120613
of O 0 0.03326541557908058
Hex O 1 0.9996553659439087
A O 1 0.601038932800293
enzyme O 0 0.11168006807565689
activity O 0 0.0471256785094738
. O 0 0.03619047999382019

We O 0 0.01511973887681961
identified O 0 0.018802793696522713
a O 0 0.02811277098953724
1422 O 1 0.9999756813049316
G O 1 0.9999980926513672
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9998660087585449
C O 1 0.9996032118797302
( O 0 0.04876651614904404
amino O 0 0.08244329690933228
acid O 0 0.268059641122818
W474C O 1 0.9995642304420471
) O 0 0.035944823175668716
substitution O 0 0.050214678049087524
in O 0 0.012075022794306278
the O 0 0.015818437561392784
first O 0 0.017667314037680626
position O 0 0.0223543718457222
of O 0 0.022126346826553345
exon O 0 0.10530684143304825
13 O 0 0.028593232855200768
of O 0 0.033625341951847076
HEXA O 1 0.9999997615814209
of O 0 0.02571895718574524
a O 0 0.03237764909863472
non O 0 0.08413399755954742
- O 1 0.9997246861457825
Jewish O 0 0.07155735045671463
proband O 1 0.9851460456848145
who O 0 0.03661378473043442
manifested O 0 0.11111827194690704
a O 0 0.058853235095739365
subacute O 1 1.0
variant O 1 0.7378720641136169
of O 0 0.0958845242857933
G B-Disease 1 1.0
( I-Disease 0 0.07244854420423508
M2 I-Disease 1 0.9999599456787109
) I-Disease 0 0.05818508565425873
gangliosidosis I-Disease 1 0.8518351912498474
. O 0 0.051161669194698334

On O 0 0.030385958030819893
the O 0 0.028105802834033966
second O 0 0.06899264454841614
maternally O 1 0.9861664772033691
inherited O 1 0.9997941851615906
allele O 0 0.11273910850286484
, O 0 0.016501814126968384
we O 0 0.007775597739964724
identified O 0 0.012682486325502396
the O 0 0.01598714478313923
common O 0 0.05226823687553406
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9989179372787476
4 O 0 0.18516910076141357
- O 1 0.9999983310699463
bp O 0 0.08414606750011444
insertion O 0 0.10055921226739883
, O 0 0.03572622686624527
+ O 1 0.8968536853790283
TATC O 1 0.9999977350234985
1278 O 1 0.999981164932251
, O 0 0.031049663200974464
in O 0 0.028708886355161667
exon O 0 0.17830277979373932
11 O 0 0.05642777681350708
. O 0 0.044071171432733536

Pulse O 1 0.9997991919517517
- O 1 0.9999297857284546
chase O 0 0.10596181452274323
analysis O 0 0.024110110476613045
using O 0 0.027171006426215172
proband O 1 0.9998032450675964
fibroblasts O 1 0.9583554863929749
revealed O 0 0.031229695305228233
that O 0 0.00768088037148118
the O 0 0.019963085651397705
W474C O 1 0.994769275188446
- O 1 0.9953016042709351
containing O 0 0.03277411684393883
alpha O 0 0.16204391419887543
- O 1 0.9998149275779724
subunit O 0 0.13333220779895782
precursor O 0 0.10089150816202164
was O 0 0.04067806154489517
normally O 0 0.03651317209005356
synthesized O 0 0.07046480476856232
, O 0 0.016492871567606926
but O 0 0.011633963324129581
not O 0 0.016368288546800613
phosphorylated O 1 0.9796133041381836
or O 0 0.03352911397814751
secreted O 0 0.07812418788671494
, O 0 0.014488410204648972
and O 0 0.01019580289721489
the O 0 0.01987418718636036
mature O 0 0.0754142478108406
lysosomal O 1 1.0
alpha O 1 0.999961256980896
- O 1 0.9999988079071045
subunit O 0 0.15119992196559906
was O 0 0.04412970691919327
not O 0 0.021071651950478554
detected O 0 0.0583026260137558
. O 0 0.03441449999809265

When O 0 0.029568200930953026
the O 0 0.0261005200445652
W474C O 1 0.9963079690933228
- O 1 0.9977090358734131
containing O 0 0.03791527450084686
alpha O 0 0.18828900158405304
- O 1 0.9991098046302795
subunit O 0 0.09333550930023193
was O 0 0.03904028981924057
transiently O 1 0.8707253336906433
co O 1 0.9300845861434937
- O 1 0.975573718547821
expressed O 0 0.01923326961696148
with O 0 0.010402053594589233
the O 0 0.023518651723861694
beta O 1 0.9208914041519165
- O 1 0.9997156262397766
subunit O 0 0.08055064082145691
to O 0 0.017286043614149094
produce O 0 0.021401233971118927
Hex O 0 0.14983361959457397
A O 0 0.055459458380937576
( O 0 0.03287810832262039
alphabeta O 1 0.989326000213623
) O 0 0.019668880850076675
in O 0 0.023145031183958054
COS O 1 1.0
- O 1 0.9999998807907104
7 O 0 0.05441683530807495
cells O 0 0.030338525772094727
, O 0 0.010760619305074215
the O 0 0.015578169375658035
mature O 0 0.05406135320663452
alpha O 1 0.9945871829986572
- O 1 0.9999879598617554
subunit O 0 0.11027030646800995
was O 0 0.031226180493831635
present O 0 0.020216042175889015
, O 0 0.015128751285374165
but O 0 0.009632237255573273
its O 0 0.01767590641975403
level O 0 0.025890547782182693
was O 0 0.025875069200992584
much O 0 0.015977343544363976
lower O 0 0.026536162942647934
than O 0 0.007374330423772335
that O 0 0.005667548161000013
from O 0 0.010494854301214218
normal O 0 0.029693257063627243
alpha O 1 0.9651169180870056
- O 1 0.9999972581863403
subunit O 1 0.7936404943466187
transfections O 1 0.9883934855461121
, O 0 0.022573677822947502
although O 0 0.013364915736019611
higher O 0 0.015386291779577732
than O 0 0.008996173739433289
in O 0 0.013043157756328583
those O 0 0.01861303672194481
cells O 0 0.0539325475692749
transfected O 0 0.14468036592006683
with O 0 0.014825246296823025
an O 0 0.02293579839169979
alpha O 1 0.9869295358657837
- O 1 0.9999386072158813
subunit O 0 0.11657710373401642
associated O 0 0.03299892693758011
with O 0 0.04594695195555687
infantile O 1 1.0
TSD B-Disease 1 1.0
. O 0 0.08211225271224976

Furthermore O 0 0.07036265730857849
, O 0 0.02165001444518566
the O 0 0.02508752979338169
precursor O 0 0.07270046323537827
level O 0 0.020195428282022476
of O 0 0.015331549569964409
the O 0 0.02692226879298687
W474C O 1 0.9999583959579468
alpha O 1 0.999382495880127
- O 1 0.9999877214431763
subunit O 0 0.11336465179920197
was O 0 0.032478004693984985
found O 0 0.014853605069220066
to O 0 0.020331721752882004
accumulate O 0 0.06776231527328491
in O 0 0.014178802259266376
comparison O 0 0.019861197099089622
to O 0 0.01197388581931591
the O 0 0.016700755804777145
normal O 0 0.037342824041843414
alpha O 1 0.9817350506782532
- O 1 0.9999986886978149
subunit O 1 0.5378912091255188
precursor O 0 0.1473609358072281
levels O 0 0.0561014823615551
. O 0 0.04002393037080765

We O 0 0.023777050897479057
conclude O 0 0.03418174758553505
that O 0 0.007978304289281368
the O 0 0.02377570979297161
1422 O 1 0.9999910593032837
G O 1 0.9999974966049194
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.999291181564331
C O 1 0.999350368976593
mutation O 0 0.05106519162654877
is O 0 0.012676779180765152
the O 0 0.017861733213067055
cause O 0 0.030753878876566887
of O 0 0.028778480365872383
Hex B-Disease 1 0.9999812841415405
A I-Disease 1 0.9999618530273438
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0361848920583725
the O 0 0.05498989671468735
proband O 1 0.999782145023346
. O 0 0.05580097809433937

The O 0 0.05759495869278908
resulting O 0 0.07341738045215607
W474C O 1 0.9967238306999207
substitution O 0 0.08546428382396698
clearly O 0 0.03251892328262329
interferes O 0 0.09001521021127701
with O 0 0.022891920059919357
alpha O 1 0.9993769526481628
- O 1 0.9999994039535522
subunit O 1 0.7290399670600891
processing O 0 0.03154512122273445
, O 0 0.01712752878665924
but O 0 0.010967167094349861
because O 0 0.013365903869271278
the O 0 0.026241930201649666
base O 0 0.07411826401948929
substitution O 0 0.09048539400100708
falls O 0 0.08527685701847076
at O 0 0.02318711392581463
the O 0 0.017310207709670067
first O 0 0.019556742161512375
position O 0 0.02368767186999321
of O 0 0.024484343826770782
exon O 0 0.14701154828071594
13 O 0 0.04188774898648262
, O 0 0.03815478831529617
aberrant O 1 0.9998243451118469
splicing O 0 0.1043582558631897
may O 0 0.021344320848584175
also O 0 0.013764324598014355
contribute O 0 0.025011755526065826
to O 0 0.027753736823797226
Hex B-Disease 1 0.9997677206993103
A I-Disease 1 0.9998307228088379
deficiency I-Disease 1 1.0
in O 0 0.03265784680843353
this O 0 0.03301424905657768
proband O 1 0.9999406337738037
. O 0 0.0302046537399292
. O 0 0.034974996000528336

Two O 0 0.027376538142561913
frequent O 0 0.07979300618171692
missense O 0 0.3780507743358612
mutations O 0 0.08163536339998245
in O 0 0.07209792733192444
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.44133251905441284

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.04158750921487808
an O 0 0.06358614563941956
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999998807907104
by O 0 0.053382374346256256
early O 1 0.9867221117019653
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999978542327881
goiter B-Disease 1 1.0
. O 1 0.7004688382148743

A O 0 0.05986867472529411
century O 0 0.048529695719480515
after O 0 0.02536340057849884
its O 0 0.017528679221868515
recognition O 0 0.024947015568614006
as O 0 0.02222949080169201
a O 0 0.052957385778427124
syndrome O 1 1.0
by O 0 0.04116303473711014
Vaughan O 1 0.9999970197677612
Pendred O 1 0.9999983310699463
, O 0 0.02611180581152439
the O 0 0.049575090408325195
disease O 1 1.0
gene O 1 0.9920938611030579
( O 0 0.06384657323360443
PDS O 1 0.9999998807907104
) O 0 0.02756623923778534
was O 0 0.025995271280407906
mapped O 0 0.03330805152654648
to O 0 0.024632202461361885
chromosome O 0 0.09497201442718506
7q22 O 1 0.9999732971191406
- O 1 0.9999994039535522
q31 O 1 0.9991697072982788
. O 0 0.049385227262973785

1 O 0 0.07821629196405411
and O 0 0.02974620647728443
, O 0 0.026323949918150902
recently O 0 0.03583144024014473
, O 0 0.01719418540596962
found O 0 0.011858176440000534
to O 0 0.01646796613931656
encode O 0 0.04038578271865845
a O 0 0.05033450573682785
putative O 1 0.9990400671958923
sulfate O 1 0.9999969005584717
transporter O 1 0.9999665021896362
. O 0 0.05966852605342865

We O 0 0.03851191699504852
performed O 0 0.05776529759168625
mutation O 0 0.04607853293418884
analysis O 0 0.012017106637358665
of O 0 0.016931993886828423
the O 0 0.04204194247722626
PDS B-Disease 1 1.0
gene O 0 0.05887208133935928
in O 0 0.02894498221576214
patients O 1 0.6364515423774719
from O 0 0.03401815518736839
14 O 0 0.06506909430027008
Pendred B-Disease 1 0.9998282194137573
families O 0 0.046907585114240646
originating O 0 0.05027604103088379
from O 0 0.019190886989235878
seven O 0 0.02242176979780197
countries O 0 0.013234585523605347
and O 0 0.019029881805181503
identified O 0 0.034952711313962936
all O 0 0.02611071616411209
mutations O 0 0.06157389283180237
. O 0 0.0455792136490345

The O 0 0.062118370085954666
mutations O 0 0.05222325399518013
include O 0 0.020097192376852036
three O 0 0.019063163548707962
single O 0 0.05152292177081108
base O 0 0.06229895353317261
deletions O 0 0.06804749369621277
, O 0 0.018483128398656845
one O 0 0.025228507816791534
splice O 0 0.14170143008232117
site O 0 0.05534754693508148
mutation O 0 0.051163140684366226
and O 0 0.02010536752641201
10 O 0 0.045050494372844696
missense O 0 0.27835819125175476
mutations O 0 0.08784782141447067
. O 0 0.04384266957640648

One O 0 0.05586882308125496
missense O 0 0.3150342106819153
mutation O 0 0.1343122124671936
( O 0 0.05955367907881737
L236P O 1 0.9999829530715942
) O 0 0.02777140773832798
was O 0 0.026548221707344055
found O 0 0.010941877961158752
in O 0 0.011537624523043633
a O 0 0.02712411805987358
homozygous O 0 0.05688466876745224
state O 0 0.014922069385647774
in O 0 0.015941355377435684
two O 0 0.023529348894953728
consanguineous O 1 0.9977045655250549
families O 0 0.04102715477347374
and O 0 0.020239772275090218
in O 0 0.018114330247044563
a O 0 0.030722767114639282
heterozygous O 0 0.050320856273174286
state O 0 0.011285285465419292
in O 0 0.009275166317820549
five O 0 0.01313310582190752
additional O 0 0.025011399760842323
non O 1 0.9517756700515747
- O 1 1.0
consanguineous O 1 0.9997538924217224
families O 0 0.06275420635938644
. O 0 0.044178105890750885

Another O 0 0.08927223831415176
missense O 1 0.8931616544723511
mutation O 0 0.13019631803035736
( O 0 0.05800819396972656
T416P O 1 0.9999474287033081
) O 0 0.03146854043006897
was O 0 0.027696192264556885
found O 0 0.01200474239885807
in O 0 0.012007293291389942
a O 0 0.024930350482463837
homozygous O 0 0.05651853233575821
state O 0 0.015942303463816643
in O 0 0.014896059408783913
one O 0 0.0207561943680048
family O 0 0.03186410665512085
and O 0 0.015965264290571213
in O 0 0.016913041472434998
a O 0 0.029990211129188538
heterozygous O 0 0.05855438485741615
state O 0 0.014345765113830566
in O 0 0.01574649289250374
four O 0 0.023342886939644814
families O 0 0.045767806470394135
. O 0 0.044321995228528976

Pendred B-Disease 1 0.9999831914901733
patients O 0 0.48086047172546387
in O 0 0.022192057222127914
three O 0 0.028581742197275162
non O 1 0.9934791326522827
- O 1 0.9999998807907104
consanguineous O 1 0.999813973903656
families O 0 0.0370514877140522
were O 0 0.01370722521096468
shown O 0 0.01645977608859539
to O 0 0.017580054700374603
be O 0 0.016984710469841957
compound O 0 0.10363408178091049
heterozygotes O 0 0.20645201206207275
for O 0 0.04317242279648781
L236P O 1 0.9998277425765991
and O 0 0.057089339941740036
T416P O 1 0.9992024302482605
. O 0 0.0540413036942482

In O 0 0.031230418011546135
total O 0 0.02710219845175743
, O 0 0.024466481059789658
one O 0 0.021214697510004044
or O 0 0.016733502969145775
both O 0 0.01347136776894331
of O 0 0.024037286639213562
these O 0 0.01788058876991272
mutations O 0 0.03566468879580498
were O 0 0.012685387395322323
found O 0 0.013277917169034481
in O 0 0.011428366415202618
nine O 0 0.018487734720110893
of O 0 0.021521378308534622
the O 0 0.030474159866571426
14 O 0 0.047612614929676056
families O 0 0.04598963260650635
analyzed O 0 0.05380493402481079
. O 0 0.040073759853839874

The O 0 0.044212713837623596
identification O 0 0.034248121082782745
of O 0 0.01991473138332367
two O 0 0.022609109058976173
frequent O 0 0.13469472527503967
PDS B-Disease 1 1.0
mutations O 0 0.05806776136159897
will O 0 0.01753549836575985
facilitate O 0 0.0385136716067791
the O 0 0.028949972242116928
molecular O 0 0.06504305452108383
diagnosis O 1 0.9999991655349731
of O 1 0.9998683929443359
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8263942003250122

Insertional O 1 0.9988732933998108
mutation O 0 0.09639669954776764
by O 0 0.03967779129743576
transposable O 1 0.9997637867927551
element O 0 0.10166952759027481
, O 0 0.03994585573673248
L1 O 1 0.999925971031189
, O 0 0.01608799770474434
in O 0 0.013650046661496162
the O 0 0.039586540311574936
DMD B-Disease 1 1.0
gene O 0 0.0357828252017498
results O 0 0.011711561121046543
in O 0 0.018488023430109024
X B-Disease 1 0.9999678134918213
- I-Disease 1 1.0
linked I-Disease 1 0.9997518658638
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
. O 0 0.11779364198446274

X B-Disease 1 0.9996138215065002
- I-Disease 1 0.9999998807907104
linked I-Disease 1 0.9997935891151428
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9996476173400879
XLDCM B-Disease 1 1.0
) O 0 0.03131315857172012
is O 0 0.01696891523897648
a O 0 0.030509864911437035
clinical O 0 0.4542689621448517
phenotype O 1 0.5868549346923828
of O 0 0.04541519656777382
dystrophinopathy B-Disease 1 0.9999973773956299
which O 0 0.02287571132183075
is O 0 0.019986871629953384
characterized O 0 0.04906019940972328
by O 0 0.0377107672393322
preferential O 1 0.9999940395355225
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9948105812072754
without O 0 0.0234958715736866
any O 0 0.020400498062372208
overt O 1 0.7355659008026123
clinical O 1 0.9995263814926147
signs O 1 0.7536948919296265
of O 1 0.9995672106742859
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.12272226810455322

To O 0 0.0358089953660965
date O 0 0.02733355388045311
, O 0 0.012554516084492207
several O 0 0.008910078555345535
mutations O 0 0.01976216398179531
in O 0 0.012566646561026573
the O 0 0.044003281742334366
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999829530715942
, O 1 0.9943071007728577
DMD O 1 1.0
, O 0 0.025375450029969215
have O 0 0.008868495933711529
been O 0 0.011052676476538181
identified O 0 0.019082406535744667
in O 0 0.020051050931215286
patients O 1 0.9946790933609009
with O 0 0.03930389881134033
XLDCM B-Disease 1 1.0
, O 0 0.025102714076638222
but O 0 0.014484835788607597
a O 0 0.02753937616944313
pathogenic O 0 0.078706294298172
correlation O 0 0.04100208356976509
of O 0 0.01883692853152752
these O 0 0.015836775302886963
cardiospecific O 1 0.9998728036880493
mutations O 0 0.05102262645959854
in O 0 0.03722818195819855
DMD O 1 1.0
with O 0 0.029531387612223625
the O 0 0.05559723079204559
XLDCM B-Disease 1 1.0
phenotype O 1 0.9935957789421082
has O 0 0.028218502178788185
remained O 0 0.04810715466737747
to O 0 0.02699706330895424
be O 0 0.023891853168606758
elucidated O 0 0.20181284844875336
. O 0 0.04357755929231644

We O 0 0.029423974454402924
report O 0 0.021301550790667534
here O 0 0.0146488007158041
the O 0 0.018378743901848793
identification O 0 0.022298138588666916
of O 0 0.01728982850909233
a O 0 0.02649318426847458
unique O 0 0.02857130765914917
de O 0 0.1177297905087471
novo O 1 0.9991293549537659
L1 O 1 0.9999704360961914
insertion O 0 0.1096007227897644
in O 0 0.018828777596354485
the O 0 0.0375337190926075
muscle O 1 0.9961684346199036
exon O 1 0.9966834187507629
1 O 0 0.057564787566661835
in O 0 0.03808193653821945
DMD O 1 1.0
in O 0 0.024110786616802216
three O 0 0.04006054252386093
XLDCM B-Disease 1 1.0
patients O 1 0.9996194839477539
from O 0 0.02787819504737854
two O 0 0.022052332758903503
unrelated O 0 0.059825748205184937
Japanese O 0 0.071432925760746
families O 0 0.05496039241552353
. O 0 0.04404325410723686

The O 0 0.05816115438938141
insertion O 0 0.1072043925523758
was O 0 0.032522913068532944
a O 0 0.02867697738111019
5 O 0 0.04750002920627594
- O 1 0.9991564750671387
truncated O 0 0.09681268781423569
form O 0 0.02625073865056038
of O 0 0.028878379613161087
human O 0 0.05106345936655998
L1 O 1 0.9999936819076538
inversely O 0 0.11535561829805374
integrated O 0 0.05698613449931145
in O 0 0.011734033934772015
the O 0 0.01938425935804844
5 O 0 0.04676418378949165
- O 1 0.9999897480010986
untranslated O 1 0.8706048130989075
region O 0 0.027733059599995613
in O 0 0.015819460153579712
the O 0 0.036739010363817215
muscle O 1 0.9999451637268066
exon O 1 0.9999732971191406
1 O 0 0.054985955357551575
, O 0 0.018658645451068878
which O 0 0.012056482955813408
affected O 0 0.02307634986937046
the O 0 0.03000946342945099
transcription O 0 0.09137801826000214
or O 0 0.01794486865401268
the O 0 0.022336997091770172
stability O 0 0.04528047889471054
of O 0 0.03052804432809353
the O 0 0.04528684914112091
muscle O 1 0.9982467889785767
form O 0 0.03874703124165535
of O 0 0.05182056874036789
dystrophin O 1 0.999985933303833
transcripts O 0 0.060106899589300156
but O 0 0.010057161562144756
not O 0 0.005551459267735481
that O 0 0.004669639281928539
of O 0 0.013297172263264656
the O 0 0.038804080337285995
brain O 1 0.9998350143432617
or O 0 0.2512715458869934
Purkinje O 1 1.0
cell O 1 0.9920902252197266
form O 0 0.04388388246297836
, O 0 0.027494532987475395
probably O 0 0.02543909102678299
due O 0 0.02100864052772522
to O 0 0.015233793295919895
its O 0 0.016903547570109367
unique O 0 0.018896140158176422
site O 0 0.037035007029771805
of O 0 0.03017881140112877
integration O 0 0.08140390366315842
. O 0 0.045518405735492706

We O 0 0.03331367298960686
speculate O 0 0.048824284225702286
that O 0 0.00877020787447691
this O 0 0.010188880376517773
insertion O 0 0.062423404306173325
of O 0 0.020870350301265717
an O 0 0.03182816132903099
L1 O 1 0.9999740123748779
sequence O 0 0.03104817494750023
in O 0 0.03840437904000282
DMD O 1 1.0
is O 0 0.030787136405706406
responsible O 0 0.03199398145079613
for O 0 0.013389036059379578
some O 0 0.008161071687936783
of O 0 0.013374664820730686
the O 0 0.016390275210142136
population O 0 0.014635751023888588
of O 0 0.02364361844956875
Japanese O 0 0.11110284924507141
patients O 1 0.9989998936653137
with O 0 0.052111122757196426
XLDCM B-Disease 1 1.0
. O 0 0.03933901712298393
. O 0 0.037899404764175415

Severe O 1 0.9708591103553772
early O 0 0.41425174474716187
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 1.0
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9997523427009583
red O 1 1.0
hair O 1 0.9999973773956299
pigmentation O 1 1.0
caused O 1 0.9993040561676025
by O 0 0.4954613149166107
POMC O 1 1.0
mutations O 0 0.06980786472558975
in O 0 0.03250204771757126
humans O 0 0.04318007454276085
. O 0 0.03986622393131256

Sequential O 0 0.14046835899353027
cleavage O 0 0.1576116681098938
of O 0 0.023832477629184723
the O 0 0.03169936314225197
precursor O 0 0.09798990935087204
protein O 0 0.038662221282720566
pre O 0 0.08173242211341858
- O 1 0.9999808073043823
pro O 1 0.996791660785675
- O 1 0.9999991655349731
opiomelanocortin O 1 0.9999489784240723
( O 0 0.0629158616065979
POMC O 1 0.9999974966049194
) O 0 0.02707434445619583
generates O 0 0.031128907576203346
the O 0 0.031605470925569534
melanocortin O 1 0.9999921321868896
peptides O 0 0.15154482424259186
adrenocorticotrophin O 1 0.9999696016311646
( O 0 0.06918785721063614
ACTH O 1 0.9999997615814209
) O 0 0.026497511193156242
, O 0 0.02853488177061081
melanocyte O 1 1.0
- O 1 1.0
stimulating O 1 0.9999985694885254
hormones O 1 0.9939600229263306
( O 0 0.0610450841486454
MSH O 1 1.0
) O 0 0.036673594266176224
alpha O 0 0.31936925649642944
, O 0 0.027135197073221207
beta O 0 0.10064911097288132
and O 0 0.02599203959107399
gamma O 0 0.09915730357170105
as O 0 0.014199585653841496
well O 0 0.008147243410348892
as O 0 0.009083748795092106
the O 0 0.021556105464696884
opioid O 1 1.0
- O 1 1.0
receptor O 1 0.9921243786811829
ligand O 1 0.9984222650527954
beta O 1 0.9993346333503723
- O 1 0.9999964237213135
endorphin O 1 0.9996880292892456
. O 0 0.049992095679044724

While O 0 0.029097488150000572
a O 0 0.020234039053320885
few O 0 0.010747565887868404
cases O 0 0.01777983270585537
of O 0 0.03873003274202347
isolated O 1 1.0
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.018212316557765007
been O 0 0.0182801540941
reported O 0 0.029449738562107086
( O 0 0.046558089554309845
OMIM O 1 0.9999998807907104
201400 O 1 0.9999840259552002
) O 0 0.022689316421747208
, O 0 0.015888599678874016
an O 0 0.03186485916376114
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 1.0
has O 0 0.030720679089426994
not O 0 0.015727844089269638
been O 0 0.018388276919722557
described O 0 0.03300407901406288
so O 0 0.018283260986208916
far O 0 0.02474108710885048
. O 0 0.03545413538813591

Recent O 0 0.05808078125119209
studies O 0 0.028188053518533707
in O 0 0.02179592102766037
animal O 0 0.03945191949605942
models O 0 0.03125568479299545
elucidated O 0 0.09864731878042221
a O 0 0.019969897344708443
central O 0 0.0249776653945446
role O 0 0.026789426803588867
of O 0 0.029399093240499496
alpha O 1 0.999975323677063
- O 1 0.9999998807907104
MSH O 1 0.9999980926513672
in O 0 0.015639785677194595
the O 0 0.01889539137482643
regulation O 0 0.02755631133913994
of O 0 0.02457233890891075
food O 0 0.05157630518078804
intake O 0 0.24860642850399017
by O 0 0.020058652386069298
activation O 0 0.04465978965163231
of O 0 0.015848351642489433
the O 0 0.026791103184223175
brain O 1 0.9434311985969543
melanocortin O 1 1.0
- O 1 0.9999992847442627
4 O 0 0.06386373192071915
- O 1 0.9999991655349731
receptor O 0 0.1094483733177185
( O 0 0.03999282047152519
MC4 O 1 1.0
- O 1 0.9999996423721313
R O 1 0.9984739422798157
; O 0 0.02851276472210884
refs O 0 0.11280618607997894
3 O 0 0.06516436487436295
- O 1 0.9999850988388062
5 O 0 0.03317755088210106
) O 0 0.013978655450046062
and O 0 0.008795531466603279
the O 0 0.01854289323091507
linkage O 0 0.07631737738847733
of O 0 0.033447105437517166
human O 1 0.559220016002655
obesity B-Disease 1 1.0
to O 0 0.10836822539567947
chromosome O 0 0.07943940162658691
2 O 0 0.032505977898836136
in O 0 0.014603836461901665
close O 0 0.025864075869321823
proximity O 0 0.03886336088180542
to O 0 0.020490139722824097
the O 0 0.0461832694709301
POMC O 1 1.0
locus O 1 0.98446124792099
, O 0 0.028457025066018105
led O 0 0.03650815412402153
to O 0 0.017177585512399673
the O 0 0.0157127995043993
proposal O 0 0.01959623210132122
of O 0 0.012683333829045296
an O 0 0.01575654000043869
association O 0 0.027917830273509026
of O 0 0.03935908526182175
POMC O 1 1.0
with O 0 0.050584904849529266
human O 1 0.9980042576789856
obesity B-Disease 1 1.0
. O 0 0.0767626017332077

The O 0 0.03768254071474075
dual O 0 0.05746561288833618
role O 0 0.03388917073607445
of O 0 0.030630143359303474
alpha O 1 0.9999406337738037
- O 1 0.9999996423721313
MSH O 1 0.9999997615814209
in O 0 0.02803618460893631
regulating O 0 0.08418428152799606
food O 0 0.06778286397457123
intake O 1 0.9800414443016052
and O 0 0.03211145102977753
influencing O 1 0.98382169008255
hair O 1 0.998927652835846
pigmentation O 1 0.9999980926513672
predicts O 0 0.0915336161851883
that O 0 0.01386759802699089
the O 0 0.03246717154979706
phenotype O 0 0.08880431950092316
associated O 0 0.02118607796728611
with O 0 0.0160606000572443
a O 0 0.04068645462393761
defect O 1 0.9999924898147583
in O 0 0.04360857605934143
POMC O 1 1.0
function O 0 0.033877547830343246
would O 0 0.017756104469299316
include O 0 0.03712138161063194
obesity B-Disease 1 1.0
, O 0 0.03860617056488991
alteration O 1 0.9988986253738403
in O 0 0.04537399485707283
pigmentation O 1 1.0
and O 1 0.9999765157699585
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.10412751138210297

The O 0 0.051683638244867325
observation O 0 0.09253302216529846
of O 0 0.03573882579803467
these O 0 0.02448924258351326
symptoms O 1 0.9999345541000366
in O 0 0.025893565267324448
two O 0 0.03198708966374397
probands O 1 0.9999665021896362
prompted O 0 0.07472310960292816
us O 0 0.031293775886297226
to O 0 0.018493806943297386
search O 0 0.029201438650488853
for O 0 0.016916802152991295
mutations O 0 0.029224710538983345
within O 0 0.019303878769278526
their O 0 0.04064081981778145
POMC O 1 0.9999998807907104
genes O 0 0.06310153752565384
. O 0 0.04321533441543579

Patient O 1 0.9999881982803345
1 O 0 0.07506604492664337
was O 0 0.04099949821829796
found O 0 0.016321077942848206
to O 0 0.01488212775439024
be O 0 0.01058837678283453
a O 0 0.03293883055448532
compound O 0 0.11079856753349304
heterozygote O 0 0.31389760971069336
for O 0 0.02003071829676628
two O 0 0.016989482566714287
mutations O 0 0.03598082438111305
in O 0 0.023392148315906525
exon O 1 0.8160494565963745
3 O 0 0.061935026198625565
( O 0 0.04723029211163521
G7013T O 1 0.9990059733390808
, O 0 0.050420574843883514
C7133delta O 1 0.9999406337738037
) O 0 0.029186274856328964
which O 0 0.015574906952679157
interfere O 0 0.04158075898885727
with O 0 0.015642136335372925
appropriate O 0 0.03588750958442688
synthesis O 0 0.05298928916454315
of O 0 0.040477778762578964
ACTH O 1 0.9999994039535522
and O 0 0.04921124875545502
alpha O 1 0.999966025352478
- O 1 0.9999998807907104
MSH O 1 0.9999949932098389
. O 0 0.06049209088087082

Patient O 1 0.9993258714675903
2 O 0 0.06214524060487747
was O 0 0.03932800516486168
homozygous O 0 0.05693060904741287
for O 0 0.016354138031601906
a O 0 0.0289754718542099
mutation O 0 0.04507782682776451
in O 0 0.02169562317430973
exon O 1 0.8600178360939026
2 O 0 0.06289976835250854
( O 0 0.041124358773231506
C3804A O 1 0.9995397329330444
) O 0 0.02975594252347946
which O 0 0.0291898176074028
abolishes O 1 0.999966025352478
POMC O 1 0.999997615814209
translation O 0 0.07990694046020508
. O 0 0.043616268783807755

These O 0 0.023602502420544624
findings O 0 0.027342697605490685
represent O 0 0.019217006862163544
the O 0 0.01933417096734047
first O 0 0.025007115676999092
examples O 0 0.024226821959018707
of O 0 0.027134215459227562
a O 0 0.0599219910800457
genetic B-Disease 0 0.15537436306476593
defect I-Disease 1 0.9999321699142456
within O 0 0.03399145230650902
the O 0 0.05984393507242203
POMC O 1 1.0
gene O 0 0.04185090959072113
and O 0 0.013923319056630135
define O 0 0.02312665805220604
a O 0 0.021599873900413513
new O 0 0.051790572702884674
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.04516006261110306
in O 0 0.018389545381069183
early O 0 0.04297628253698349
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999998807907104
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999256134033203
red O 1 1.0
hair O 1 0.9999977350234985
pigmentation O 1 1.0
. O 0 0.03971514850854874
. O 0 0.0394212044775486

A O 0 0.06590114533901215
European O 0 0.04430258646607399
multicenter O 1 0.7298994660377502
study O 0 0.03662810102105141
of O 0 0.07260741293430328
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.06774918735027313
classification O 0 0.07882967591285706
of O 0 0.03278065472841263
105 O 0 0.11997289210557938
mutations O 0 0.03878099098801613
and O 0 0.014070948585867882
a O 0 0.01922188512980938
general O 0 0.031680215150117874
system O 0 0.024100424721837044
for O 0 0.022096840664744377
genotype O 1 0.9832038879394531
- O 1 0.9981510043144226
based O 0 0.031095007434487343
prediction O 0 0.06476058065891266
of O 0 0.06089356914162636
metabolic O 1 0.9999992847442627
phenotype O 1 0.9932895302772522
. O 0 0.06277240067720413

Phenylketonuria B-Disease 1 1.0
( O 0 0.49838098883628845
PKU B-Disease 1 1.0
) O 0 0.04785674065351486
and O 0 0.03800565376877785
mild B-Disease 1 0.9999983310699463
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9995182752609253
MHP B-Disease 1 1.0
) O 0 0.03882700204849243
are O 0 0.019027315080165863
allelic B-Disease 1 0.9999992847442627
disorders I-Disease 1 1.0
caused O 1 0.9984716773033142
by O 0 0.03668968006968498
mutations O 0 0.03367728367447853
in O 0 0.01214318722486496
the O 0 0.021597309038043022
gene O 0 0.04369613528251648
encoding O 0 0.06907206028699875
phenylalanine O 1 0.9999862909317017
hydroxylase O 1 0.9999997615814209
( O 1 0.9247124791145325
PAH O 1 1.0
) O 0 0.06606633216142654
. O 0 0.041758421808481216

Previous O 0 0.06095009297132492
studies O 0 0.024115148931741714
have O 0 0.008330529555678368
suggested O 0 0.013079941272735596
that O 0 0.006037318613380194
the O 0 0.015532350167632103
highly O 0 0.04255037382245064
variable O 0 0.06210240349173546
metabolic O 1 0.9998748302459717
phenotypes O 1 0.9840429425239563
of O 1 0.9999620914459229
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9998786449432373
with O 1 0.9893794655799866
PAH O 1 1.0
genotypes O 1 0.9999550580978394
. O 0 0.059645019471645355

We O 0 0.023859359323978424
identified O 0 0.027075501158833504
both O 0 0.02731184847652912
causative O 1 0.9997257590293884
mutations O 0 0.05825567618012428
in O 0 0.03879536688327789
686 O 1 0.999998927116394
patients O 1 0.9995759129524231
from O 0 0.029833000153303146
seven O 0 0.03538324683904648
European O 0 0.04465509206056595
centers O 0 0.07717936486005783
. O 0 0.04380078986287117

On O 0 0.034448567777872086
the O 0 0.022810738533735275
basis O 0 0.014805898070335388
of O 0 0.01885179989039898
the O 0 0.028183799237012863
phenotypic O 0 0.07078533619642258
characteristics O 0 0.04138781875371933
of O 0 0.03834372013807297
297 O 1 0.9996089339256287
functionally O 1 0.9996016621589661
hemizygous O 1 0.999997615814209
patients O 1 0.9944774508476257
, O 0 0.03183186426758766
105 O 0 0.07092787325382233
of O 0 0.03129527345299721
the O 0 0.03719273582100868
mutations O 0 0.03626954182982445
were O 0 0.012147266417741776
assigned O 0 0.041698016226291656
to O 0 0.01602729596197605
one O 0 0.013118726201355457
of O 0 0.017561573535203934
four O 0 0.027187518775463104
arbitrary O 0 0.0790984258055687
phenotype O 0 0.2958851158618927
categories O 0 0.05968436598777771
. O 0 0.047484129667282104

We O 0 0.030566686764359474
proposed O 0 0.03536325320601463
and O 0 0.023741858080029488
tested O 0 0.0461779348552227
a O 0 0.03345140069723129
simple O 0 0.03526868671178818
model O 0 0.031161075457930565
for O 0 0.022533826529979706
correlation O 0 0.06297339498996735
between O 0 0.051479607820510864
genotype O 0 0.3267059624195099
and O 0 0.03793486952781677
phenotypic O 0 0.10181819647550583
outcome O 0 0.06748731434345245
. O 0 0.04794861003756523

The O 0 0.05959178879857063
observed O 0 0.05708317831158638
phenotype O 0 0.09834647923707962
matched O 0 0.04493772238492966
the O 0 0.03400237858295441
predicted O 0 0.06397825479507446
phenotype O 0 0.10310902446508408
in O 0 0.02448124811053276
79 O 0 0.07545153051614761
% O 0 0.025052500888705254
of O 0 0.022817067801952362
the O 0 0.031617116183042526
cases O 0 0.03518747165799141
, O 0 0.022263627499341965
and O 0 0.014974112622439861
in O 0 0.012098242528736591
only O 0 0.010755851864814758
5 O 0 0.02474665455520153
of O 0 0.029937071725726128
184 O 1 0.9975491166114807
patients O 1 0.9970850348472595
was O 0 0.042656898498535156
the O 0 0.03582927584648132
observed O 0 0.04607139900326729
phenotype O 0 0.07944707572460175
more O 0 0.011118054389953613
than O 0 0.012641352601349354
one O 0 0.022121332585811615
category O 0 0.042552102357149124
away O 0 0.02544182725250721
from O 0 0.01537958811968565
that O 0 0.013022597879171371
expected O 0 0.031491365283727646
. O 0 0.03562984615564346

Among O 0 0.03961393982172012
the O 0 0.025951486080884933
seven O 0 0.03248487785458565
contributing O 0 0.06293772906064987
centers O 0 0.04752657562494278
, O 0 0.018396319821476936
the O 0 0.020528877153992653
proportion O 0 0.039061177521944046
of O 0 0.03720574453473091
patients O 1 0.995194137096405
for O 0 0.02786719985306263
whom O 0 0.045231420546770096
the O 0 0.04098956286907196
observed O 0 0.0515204593539238
phenotype O 0 0.10252439975738525
did O 0 0.018048929050564766
not O 0 0.00876527652144432
match O 0 0.02104794979095459
the O 0 0.020870236679911613
predicted O 0 0.04684887453913689
phenotype O 0 0.07713551819324493
was O 0 0.031814176589250565
4 O 0 0.03692643716931343
% O 0 0.029868751764297485
- O 1 0.9976723790168762
23 O 0 0.03909862041473389
% O 0 0.030058881267905235
( O 0 0.04409339278936386
P O 1 0.9999953508377075
< O 1 0.9999701976776123
. O 0 0.04314277321100235
0001 O 1 0.9999903440475464
) O 0 0.03173191100358963
, O 0 0.021475035697221756
suggesting O 0 0.027734879404306412
that O 0 0.01091004814952612
differences O 0 0.01763840764760971
in O 0 0.014043712988495827
methods O 0 0.01756577007472515
used O 0 0.013807118870317936
for O 0 0.02495824359357357
mutation O 0 0.10186966508626938
detection O 1 0.9906402826309204
or O 0 0.0647430345416069
phenotype O 1 0.9968569278717041
classification O 0 0.12623395025730133
may O 0 0.02462986670434475
account O 0 0.015528907999396324
for O 0 0.010091191157698631
a O 0 0.016863036900758743
considerable O 0 0.023151803761720657
proportion O 0 0.039513345807790756
of O 0 0.047134943306446075
genotype O 1 0.9999879598617554
- O 1 0.9999998807907104
phenotype O 0 0.43056586384773254
inconsistencies O 0 0.10761240869760513
. O 0 0.04735327512025833

Our O 0 0.03940419852733612
data O 0 0.012521880678832531
indicate O 0 0.010744260624051094
that O 0 0.008284661918878555
the O 0 0.0445374920964241
PAH O 1 1.0
- O 1 1.0
mutation O 0 0.1016034185886383
genotype O 0 0.0941401794552803
is O 0 0.011493316851556301
the O 0 0.015348266810178757
main O 0 0.041945986449718475
determinant O 1 0.9998321533203125
of O 0 0.05726144090294838
metabolic O 1 0.9999997615814209
phenotype O 1 0.8080697655677795
in O 0 0.02008153684437275
most O 0 0.0259333997964859
patients O 1 0.9999902248382568
with O 1 0.9999911785125732
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.13020947575569153

In O 0 0.03064994141459465
the O 0 0.02957220934331417
present O 0 0.028691254556179047
study O 0 0.019129108637571335
, O 0 0.01257001981139183
the O 0 0.01800808310508728
classification O 0 0.05325521156191826
of O 0 0.040917981415987015
105 O 1 0.9999982118606567
PAH O 1 1.0
mutations O 0 0.0810018926858902
may O 0 0.02178146503865719
allow O 0 0.017013676464557648
the O 0 0.01783331297338009
prediction O 0 0.04044460877776146
of O 0 0.018958738073706627
the O 0 0.036709271371364594
biochemical O 0 0.42551904916763306
phenotype O 0 0.23043236136436462
in O 0 0.03218460828065872
> O 1 0.7013343572616577
10 O 0 0.027195274829864502
, O 0 0.025480927899479866
000 O 0 0.08782359212636948
genotypes O 1 0.9642865061759949
, O 0 0.032403331249952316
which O 0 0.01954164355993271
may O 0 0.019508250057697296
be O 0 0.009540424682199955
useful O 0 0.015070547349750996
for O 0 0.011275669559836388
the O 0 0.021572034806013107
management O 0 0.04424050450325012
of O 0 0.04546777531504631
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.062392741441726685
newborns O 1 0.9999462366104126
. O 0 0.06255144625902176

Somatic O 1 0.9820870161056519
instability O 0 0.13098348677158356
of O 0 0.036363206803798676
the O 0 0.05458594858646393
CTG O 1 0.9999994039535522
repeat O 0 0.09206048399209976
in O 0 0.025250347331166267
mice O 0 0.052186235785484314
transgenic O 0 0.07295504212379456
for O 0 0.02670229971408844
the O 0 0.3985525667667389
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9614927768707275
is O 0 0.04182616248726845
age O 0 0.045865416526794434
dependent O 0 0.049354132264852524
but O 0 0.014484548941254616
not O 0 0.012252558022737503
correlated O 0 0.03737745061516762
to O 0 0.014806384220719337
the O 0 0.021112052723765373
relative O 0 0.05950777977705002
intertissue O 1 0.9998584985733032
transcription O 1 0.9373558163642883
levels O 0 0.05503838509321213
and O 0 0.05562314763665199
proliferative O 1 1.0
capacities O 1 0.6303290724754333
. O 0 0.06308277696371078

A O 0 0.10981818288564682
( O 0 0.07480336725711823
CTG O 1 0.999998927116394
) O 0 0.036073021590709686
nexpansion O 0 0.11097286641597748
in O 0 0.0122678829357028
the O 0 0.020538941025733948
3 O 0 0.051260657608509064
- O 1 0.9999843835830688
untranslated O 1 0.9667617082595825
region O 0 0.044094670563936234
( O 0 0.0348588228225708
UTR O 1 0.9040746092796326
) O 0 0.011565244756639004
of O 0 0.01441250555217266
the O 0 0.040501609444618225
DM O 1 1.0
protein O 0 0.48817944526672363
kinase O 1 0.9998152852058411
gene O 0 0.056314218789339066
( O 0 0.03675536811351776
DMPK O 1 0.9999191761016846
) O 0 0.02045845240354538
is O 0 0.011407078243792057
responsible O 0 0.024865353479981422
for O 0 0.026033779606223106
causing O 1 0.9999994039535522
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.057996708899736404
. O 0 0.03892460837960243

Major O 1 0.9020625352859497
instability O 1 0.9996122717857361
, O 0 0.033076975494623184
with O 0 0.020930929109454155
very O 0 0.02102414146065712
large O 0 0.027415798977017403
expansions O 0 0.06753317266702652
between O 0 0.02832750417292118
generations O 0 0.04692473262548447
and O 0 0.02048070915043354
high O 0 0.04070717468857765
levels O 0 0.033393193036317825
of O 0 0.049356114119291306
somatic O 1 0.9999939203262329
mosaicism O 1 0.9999997615814209
, O 0 0.04078846052289009
is O 0 0.024961058050394058
observed O 0 0.031409505754709244
in O 0 0.0344867967069149
patients O 1 0.8675836324691772
. O 0 0.05769302695989609

There O 0 0.02591528743505478
is O 0 0.019347527995705605
a O 0 0.02794969454407692
good O 0 0.0344223752617836
correlation O 0 0.05008732154965401
between O 0 0.02925405465066433
repeat O 0 0.09199979156255722
size O 0 0.03467574715614319
( O 0 0.021130619570612907
at O 0 0.018846288323402405
least O 0 0.012749701738357544
in O 0 0.023842161521315575
leucocytes O 1 0.9996399879455566
) O 0 0.036504581570625305
, O 0 0.032493751496076584
clinical O 1 0.9983933568000793
severity O 1 0.9998726844787598
and O 0 0.035069264471530914
age O 0 0.05577772110700607
of O 1 0.5700169205665588
onset O 1 1.0
. O 0 0.07613774389028549

The O 0 0.08137965947389603
trinucleotide O 1 0.9999582767486572
repeat O 1 0.9885632991790771
instability O 1 0.9996628761291504
mechanisms O 0 0.05916731432080269
involved O 0 0.029706140980124474
in O 0 0.04044830799102783
DM B-Disease 1 1.0
and O 0 0.02507423236966133
other O 0 0.022804463282227516
human O 1 0.9751074910163879
genetic B-Disease 1 0.9999995231628418
diseases I-Disease 1 1.0
are O 0 0.026230357587337494
unknown O 0 0.054376065731048584
. O 0 0.03719749674201012

We O 0 0.040224023163318634
studied O 0 0.07395573705434799
somatic O 1 0.9272782802581787
instability O 0 0.3559126853942871
by O 0 0.03806667774915695
measuring O 0 0.0769314169883728
the O 0 0.0628473162651062
CTG O 1 0.9999990463256836
repeat O 0 0.10799746215343475
length O 0 0.02836943417787552
at O 0 0.023099085316061974
several O 0 0.012173461727797985
ages O 0 0.030030420050024986
in O 0 0.015920115634799004
various O 0 0.017473941668868065
tissues O 0 0.06388048827648163
of O 0 0.044397372752428055
transgenic O 1 0.7593336701393127
mice O 0 0.06206116825342178
carrying O 0 0.04286470264196396
a O 0 0.043258488178253174
( O 0 0.05579163506627083
CTG O 1 0.9999984502792358
) O 0 0.042316973209381104
55expansion O 0 0.46368342638015747
surrounded O 0 0.07026692479848862
by O 0 0.01809162087738514
45 O 0 0.033942811191082
kb O 0 0.09405360370874405
of O 0 0.022742118686437607
the O 0 0.03390876203775406
human O 0 0.27924296259880066
DM B-Disease 1 1.0
region O 0 0.05053490772843361
, O 0 0.018891293555498123
using O 0 0.013883962295949459
small O 0 0.032390955835580826
- O 1 0.9999886751174927
pool O 0 0.4297907054424286
PCR O 0 0.18563328683376312
. O 0 0.043009575456380844

These O 0 0.045334067195653915
mice O 0 0.06556205451488495
have O 0 0.01330732461065054
been O 0 0.016834991052746773
shown O 0 0.0166862141340971
to O 0 0.01901884563267231
reproduce O 0 0.03806685656309128
the O 0 0.03942647948861122
intergenerational O 1 0.9998283386230469
and O 0 0.05122565105557442
somatic O 1 0.9979729056358337
instability O 0 0.2659485638141632
of O 0 0.03386952355504036
the O 0 0.044164013117551804
55 O 0 0.09994708746671677
CTG O 1 0.9999963045120239
repeat O 0 0.10617876797914505
suggesting O 0 0.04222410172224045
that O 0 0.013327167369425297
surrounding O 0 0.04002529755234718
sequences O 0 0.019079435616731644
and O 0 0.01712699979543686
the O 0 0.036188557744026184
chromatin O 1 0.710484504699707
environment O 0 0.03603455051779747
are O 0 0.009120680391788483
involved O 0 0.022725719958543777
in O 0 0.03423994407057762
instability O 1 0.9999195337295532
mechanisms O 0 0.09549325704574585
. O 0 0.055233683437108994

As O 0 0.039647262543439865
observed O 0 0.018585044890642166
in O 0 0.008728234097361565
some O 0 0.0054571861401200294
of O 0 0.013299869373440742
the O 0 0.02731645293533802
tissues O 1 0.9622005820274353
of O 1 0.9998165965080261
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.028546571731567383
there O 0 0.013612489216029644
is O 0 0.015953317284584045
a O 0 0.02720920369029045
tendency O 0 0.05543246492743492
for O 0 0.024908337742090225
repeat O 0 0.08430354297161102
length O 0 0.03884609043598175
and O 0 0.04194481670856476
somatic O 1 0.9997953772544861
mosaicism O 1 0.999972939491272
to O 0 0.02991039678454399
increase O 0 0.01807801052927971
with O 0 0.013820447027683258
the O 0 0.021048469468951225
age O 0 0.02835438959300518
of O 0 0.029423605650663376
the O 0 0.05008230730891228
mouse O 0 0.10650549829006195
. O 0 0.044255580753088

Furthermore O 0 0.09394748508930206
, O 0 0.029556646943092346
we O 0 0.01446262001991272
observed O 0 0.018089039251208305
no O 0 0.014249962754547596
correlation O 0 0.03249533101916313
between O 0 0.016401031985878944
the O 0 0.03389441967010498
somatic O 1 0.9900388121604919
mutation O 0 0.07853365689516068
rate O 0 0.05015533044934273
and O 0 0.047749388962984085
tissue O 1 0.9999982118606567
proliferation O 1 0.9999971389770508
capacity O 0 0.07364986091852188
. O 0 0.043957099318504333

The O 0 0.08507730811834335
somatic O 1 0.9982942938804626
mutation O 0 0.09886171668767929
rates O 0 0.04066759720444679
in O 0 0.021377502009272575
different O 0 0.01604251004755497
tissues O 0 0.059759773313999176
were O 0 0.015199735760688782
also O 0 0.015605166554450989
not O 0 0.011864705011248589
correlated O 0 0.037505630403757095
to O 0 0.01374793704599142
the O 0 0.018641585484147072
relative O 0 0.05636073648929596
inter O 1 0.999998927116394
- O 1 1.0
tissue O 0 0.20121906697750092
difference O 0 0.031310658901929855
in O 0 0.022906718775629997
transcriptional O 0 0.09476520121097565
levels O 0 0.022641923278570175
of O 0 0.015130209736526012
the O 0 0.018505509942770004
three O 0 0.019078196957707405
genes O 0 0.03267385810613632
( O 0 0.03929590806365013
DMAHP O 1 0.9999986886978149
, O 0 0.0476006455719471
DMPK O 1 0.9999985694885254
and O 0 0.03184698149561882
59 O 0 0.072769895195961
) O 0 0.026560306549072266
surrounding O 0 0.041678737848997116
the O 0 0.038952283561229706
repeat O 0 0.11921969801187515
. O 0 0.029062487185001373
. O 0 0.037042878568172455

A O 0 0.08189104497432709
novel O 0 0.10615313798189163
missense O 0 0.44339632987976074
mutation O 0 0.0857573077082634
in O 0 0.03171912953257561
patients O 1 0.8152871131896973
from O 0 0.02996501326560974
a O 0 0.06299849599599838
retinoblastoma B-Disease 1 0.9999998807907104
pedigree O 0 0.16618214547634125
showing O 0 0.036754120141267776
only O 0 0.02000361494719982
mild O 0 0.35858646035194397
expression O 0 0.03442234545946121
of O 0 0.03183611109852791
the O 0 0.21403083205223083
tumor B-Disease 1 1.0
phenotype O 1 0.9997478127479553
. O 0 0.05423349514603615

We O 0 0.025541093200445175
have O 0 0.011958674527704716
used O 0 0.020007045939564705
single O 0 0.05738824978470802
strand O 0 0.1473318487405777
conformation O 0 0.1341697871685028
polymorphism O 0 0.09585141390562057
analysis O 0 0.018885938450694084
to O 0 0.014172672294080257
study O 0 0.014260287396609783
the O 0 0.017381567507982254
27 O 0 0.036869246512651443
exons O 0 0.060453128069639206
of O 0 0.02469903789460659
the O 0 0.0550326332449913
RB1 O 1 1.0
gene O 0 0.054071009159088135
in O 0 0.01661865785717964
individuals O 0 0.012702550739049911
from O 0 0.01465888787060976
a O 0 0.031110983341932297
family O 0 0.0473514124751091
showing O 0 0.05063430592417717
mild O 1 0.9860527515411377
expression O 0 0.045396678149700165
of O 0 0.03750427067279816
the O 0 0.06793278455734253
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9979259967803955
. O 0 0.06183836981654167

In O 0 0.026096945628523827
this O 0 0.018395785242319107
family O 0 0.04365764558315277
affected O 0 0.03716736659407616
individuals O 0 0.02493499033153057
developed O 0 0.08298555016517639
unilateral B-Disease 1 0.9999998807907104
tumors I-Disease 1 1.0
and O 0 0.03748098760843277
, O 0 0.021970734000205994
as O 0 0.01674668863415718
a O 0 0.020912814885377884
result O 0 0.019779130816459656
of O 0 0.03051775135099888
linkage O 0 0.31530600786209106
analysis O 0 0.02991468645632267
, O 0 0.037963662296533585
unaffected O 1 0.9970583915710449
mutation O 0 0.09745475649833679
carriers O 0 0.06587036699056625
were O 0 0.01492670364677906
also O 0 0.01743907667696476
identified O 0 0.02276318147778511
within O 0 0.020133066922426224
the O 0 0.04220975935459137
pedigree O 0 0.13054890930652618
. O 0 0.050474148243665695

A O 0 0.08437199145555496
single O 0 0.06101532652974129
band O 0 0.07542356103658676
shift O 0 0.049177154898643494
using O 0 0.02396886609494686
SSCP O 1 0.9997872710227966
was O 0 0.03654084727168083
identified O 0 0.024561511352658272
in O 0 0.02131652645766735
exon O 0 0.15336088836193085
21 O 0 0.03752563148736954
which O 0 0.013101563788950443
resulted O 0 0.024593302980065346
in O 0 0.014856277033686638
a O 0 0.02987009286880493
missense O 0 0.11316817253828049
mutation O 0 0.044998664408922195
converting O 0 0.04316731542348862
a O 0 0.042792532593011856
cys O 1 1.0
- O 1 1.0
- O 1 0.9999998807907104
> O 1 0.9998916387557983
arg O 1 0.9999958276748657
at O 0 0.04107532650232315
nucleotide O 0 0.05533382296562195
position O 0 0.027674023061990738
28 O 0 0.02874606102705002
in O 0 0.018188945949077606
the O 0 0.03814741596579552
exon O 0 0.40739789605140686
. O 0 0.04812127724289894

The O 0 0.06163307651877403
mutation O 0 0.08007721602916718
destroyed O 0 0.06552237272262573
an O 0 0.04052414000034332
NdeI O 1 0.999962329864502
restriction O 0 0.17252567410469055
enzyme O 0 0.12190918624401093
site O 0 0.06032077968120575
. O 0 0.03644465655088425

Analysis O 0 0.03304092213511467
of O 0 0.02029840648174286
all O 0 0.017775995656847954
family O 0 0.036464910954236984
members O 0 0.02342507243156433
demonstrated O 0 0.023380469530820847
that O 0 0.007252292241901159
the O 0 0.019411640241742134
missense O 0 0.10674496740102768
mutation O 0 0.06747422367334366
co O 1 0.8369747400283813
- O 1 0.9999895095825195
segregated O 1 0.9798422455787659
with O 0 0.03559054061770439
patients O 1 0.9999977350234985
with O 1 0.9942143559455872
tumors B-Disease 1 1.0
or O 0 0.042730506509542465
who O 0 0.03523774445056915
, O 0 0.019213519990444183
as O 0 0.016569875180721283
a O 0 0.02243487723171711
result O 0 0.023406947031617165
of O 0 0.036489784717559814
linkage O 1 0.8928045630455017
analysis O 0 0.023692164570093155
had O 0 0.019648876041173935
been O 0 0.015264109708368778
predicted O 0 0.027363738045096397
to O 0 0.019024202600121498
carry O 0 0.02819337509572506
the O 0 0.051780812442302704
predisposing O 1 0.9987825751304626
mutation O 0 0.11883500963449478
. O 0 0.0547272264957428

These O 0 0.027842923998832703
observations O 0 0.032428789883852005
point O 0 0.02369750291109085
to O 0 0.015625031664967537
another O 0 0.01963234134018421
region O 0 0.022601783275604248
of O 0 0.02426970936357975
the O 0 0.05910255387425423
RB1 O 1 1.0
gene O 0 0.07342609763145447
where O 0 0.032680828124284744
mutations O 0 0.03352523595094681
only O 0 0.013466749340295792
modify O 0 0.047415945678949356
the O 0 0.02430666796863079
function O 0 0.026679683476686478
of O 0 0.020963285118341446
the O 0 0.03733718395233154
gene O 0 0.038934893906116486
and O 0 0.018446018919348717
raise O 0 0.032385919243097305
important O 0 0.01856704242527485
questions O 0 0.02262783795595169
for O 0 0.02551046386361122
genetic O 0 0.05598919466137886
counseling O 1 0.9976317882537842
in O 0 0.024390934035182
families O 0 0.03273530304431915
with O 0 0.020614013075828552
these O 0 0.01996154710650444
distinctive O 0 0.09351525455713272
phenotypes O 0 0.22303937375545502
. O 0 0.03706289082765579
. O 0 0.0450834184885025

Maternal B-Disease 1 0.990583062171936
disomy I-Disease 1 0.9997782111167908
and O 0 0.061376359313726425
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9824302196502686
with O 0 0.0499095693230629
gamete O 1 0.9999994039535522
complementation O 1 0.9999995231628418
in O 0 0.018998341634869576
a O 0 0.021562498062849045
case O 0 0.026153964921832085
of O 0 0.04285440593957901
familial O 1 1.0
translocation O 1 0.9999984502792358
( O 0 0.039724767208099365
3 O 0 0.0435388945043087
; O 0 0.0225607231259346
15 O 0 0.032148949801921844
) O 0 0.029504725709557533
( O 0 0.04062337428331375
p25 O 1 0.9992110729217529
; O 0 0.05112111568450928
q11 O 1 0.9977496266365051
. O 0 0.03191287815570831
2 O 0 0.06252986937761307
) O 0 0.03619660437107086
. O 0 0.034300342202186584

Maternal B-Disease 1 0.999992847442627
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 0.34632042050361633
UPD I-Disease 1 1.0
) I-Disease 0 0.03562977537512779
for I-Disease 0 0.03014904446899891
chromosome I-Disease 0 0.06261976063251495
15 I-Disease 0 0.028203768655657768
is O 0 0.018694153055548668
responsible O 0 0.02796923741698265
for O 0 0.01462045032531023
an O 0 0.015669384971261024
estimated O 0 0.018839746713638306
30 O 0 0.013830232433974743
% O 0 0.009320983663201332
of O 0 0.00934396032243967
cases O 0 0.014884882606565952
of O 0 0.043442994356155396
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
PWS B-Disease 1 1.0
) O 0 0.0651966780424118
. O 0 0.04078778624534607

We O 0 0.02522401697933674
report O 0 0.018654754385352135
on O 0 0.01385584194213152
an O 0 0.014178561978042126
unusual O 0 0.01880132220685482
case O 0 0.023488903418183327
of O 0 0.02912154607474804
maternal B-Disease 1 0.999991774559021
disomy I-Disease 1 0.9999983310699463
15 I-Disease 0 0.050134483724832535
in O 0 0.043447598814964294
PWS B-Disease 1 1.0
that O 0 0.01809285767376423
is O 0 0.014465529471635818
most O 0 0.011525520123541355
consistent O 0 0.02470766007900238
with O 0 0.015664875507354736
adjacent O 0 0.05992655083537102
- O 1 0.9995502829551697
1 O 0 0.03946886584162712
segregation O 0 0.07346245646476746
of O 0 0.023107239976525307
a O 0 0.04360172525048256
paternal O 1 0.9999723434448242
t O 1 0.999518871307373
( O 0 0.03434290364384651
3 O 0 0.04052089527249336
; O 0 0.021108979359269142
15 O 0 0.031082121655344963
) O 0 0.027984319254755974
( O 0 0.03959241509437561
p25 O 1 0.9998595714569092
; O 0 0.04595981910824776
q11 O 1 0.9976422190666199
. O 0 0.023696836084127426
2 O 0 0.039112962782382965
) O 0 0.01546633429825306
with O 0 0.013706754893064499
simultaneous O 0 0.04785468801856041
maternal O 1 0.9972288012504578
meiotic O 1 0.9999996423721313
nondisjunction O 1 0.9999961853027344
for O 0 0.062467534095048904
chromosome O 0 0.10267782211303711
15 O 0 0.05075530335307121
. O 0 0.03944181278347969

The O 0 0.07139237225055695
patient O 1 0.9999680519104004
( O 0 0.07436370104551315
J O 1 1.0
. O 0 0.03962617367506027
B O 1 0.9999923706054688
. O 0 0.019235339015722275
) O 0 0.013798360712826252
, O 0 0.009668854996562004
a O 0 0.01644781231880188
17 O 0 0.03191295266151428
- O 1 0.998814582824707
year O 0 0.02431366965174675
- O 1 0.999031662940979
old O 0 0.058241140097379684
white O 0 0.06345926225185394
male O 0 0.06919070333242416
with O 0 0.04997991397976875
PWS B-Disease 1 1.0
, O 0 0.038146015256643295
was O 0 0.031836461275815964
found O 0 0.012564314529299736
to O 0 0.013178322464227676
have O 0 0.008329308591783047
47 O 0 0.04069782793521881
chromosomes O 0 0.031017864122986794
with O 0 0.014286135323345661
a O 0 0.04035775735974312
supernumerary O 1 0.9999667406082153
, O 0 0.05194331705570221
paternal O 1 0.9998001456260681
der O 1 0.9999946355819702
( O 0 0.037711624056100845
15 O 0 0.03174953907728195
) O 0 0.01798507384955883
consisting O 0 0.02412625215947628
of O 0 0.018753807991743088
the O 0 0.027899034321308136
short O 0 0.037669502198696136
arm O 0 0.11095298826694489
and O 0 0.022501416504383087
the O 0 0.038959067314863205
proximal O 1 0.9999998807907104
long O 0 0.057382527738809586
arm O 1 0.7288963198661804
of O 0 0.040563568472862244
chromosome O 0 0.06745646893978119
15 O 0 0.028140993788838387
, O 0 0.02091272361576557
and O 0 0.03382037207484245
distal O 1 1.0
chromosome O 1 0.998467743396759
arm O 1 0.9998334646224976
3p O 1 0.9999961853027344
. O 0 0.056183554232120514

The O 0 0.08939072489738464
t O 1 0.9986371397972107
( O 0 0.043142445385456085
3 O 0 0.051778245717287064
; O 0 0.026259999722242355
15 O 0 0.03198694810271263
) O 0 0.0211041197180748
was O 0 0.022742869332432747
present O 0 0.017181362956762314
in O 0 0.013217895291745663
the O 0 0.019087547436356544
balanced O 0 0.033109501004219055
state O 0 0.012397239916026592
in O 0 0.015452138148248196
the O 0 0.0350041538476944
patients O 1 0.999804675579071
father O 1 0.8387531042098999
and O 0 0.030612541362643242
a O 0 0.052847933024168015
sister O 1 0.5803632140159607
. O 0 0.051737770438194275

Fluorescent O 1 0.8448215126991272
in O 0 0.05519195273518562
situ O 1 0.9937200546264648
hybridization O 0 0.08660425990819931
analysis O 0 0.019783124327659607
demonstrated O 0 0.026329280808568
that O 0 0.011135566979646683
the O 0 0.044535692781209946
PWS B-Disease 1 1.0
critical O 0 0.07321382313966751
region O 0 0.04061421379446983
resided O 0 0.06732652336359024
on O 0 0.020436285063624382
the O 0 0.03394655883312225
derivative O 1 0.9989405274391174
chromosome O 0 0.08108925819396973
3 O 0 0.03645971417427063
and O 0 0.014361773617565632
that O 0 0.008472555316984653
there O 0 0.00879750121384859
was O 0 0.021098170429468155
no O 0 0.01514857355505228
deletion O 0 0.05784527584910393
of O 0 0.027946989983320236
the O 0 0.0636109858751297
PWS B-Disease 1 1.0
region O 0 0.04749288782477379
on O 0 0.02191094309091568
the O 0 0.022322116419672966
normal O 0 0.03157960623502731
pair O 0 0.031201530247926712
of O 0 0.03172348812222481
15s O 1 0.9999339580535889
present O 0 0.04403237625956535
in O 0 0.04489297792315483
J O 1 0.9999996423721313
. O 0 0.060377512127161026

B O 1 0.9995598196983337
. O 0 0.07590486854314804

Methylation O 0 0.12879523634910583
analysis O 0 0.022090256214141846
at O 0 0.031241493299603462
exon O 0 0.13444912433624268
alpha O 0 0.0669383704662323
of O 0 0.013395646587014198
the O 0 0.015396594069898129
small O 0 0.018019210547208786
nuclear O 0 0.057209525257349014
ribonucleoprotein O 1 0.9999979734420776
- O 1 0.9999938011169434
associated O 0 0.05882503464818001
polypeptide O 1 0.9996380805969238
N O 1 0.9959805011749268
( O 0 0.058990661054849625
SNRPN O 1 0.9999964237213135
) O 0 0.041516032069921494
gene O 0 0.032779011875391006
showed O 0 0.022598545998334885
a O 0 0.028682880103588104
pattern O 0 0.04633798450231552
characteristic O 0 0.03537135198712349
of O 0 0.018227379769086838
only O 0 0.013797648251056671
the O 0 0.03206200525164604
maternal O 1 0.999679684638977
chromosome O 0 0.08868096768856049
15 O 0 0.042954493314027786
in O 0 0.04322528839111328
J O 1 0.9999985694885254
. O 0 0.05896303057670593

B O 1 0.9989025592803955
. O 0 0.0745243951678276

Maternal B-Disease 1 0.9999419450759888
disomy I-Disease 1 0.9998492002487183
was O 0 0.04590364173054695
confirmed O 0 0.03065081313252449
by O 0 0.029275381937623024
polymerase O 1 0.9959165453910828
chain O 0 0.09345104545354843
reaction O 0 0.05011121183633804
analysis O 0 0.01664705201983452
of O 0 0.027141455560922623
microsatellite O 0 0.1520978808403015
repeats O 0 0.050259340554475784
at O 0 0.01969003863632679
the O 0 0.022936737164855003
gamma O 1 0.984718918800354
- O 1 0.9999876022338867
aminobutyric O 1 0.9997896552085876
acid O 0 0.14526686072349548
receptor O 1 0.5249145030975342
beta3 O 1 0.9988458156585693
subunit O 1 0.5264334678649902
( O 0 0.06694632768630981
GABRB3 O 1 0.9999481439590454
) O 0 0.05962933972477913
locus O 0 0.1529880315065384
. O 0 0.04740329831838608

A O 0 0.1090078055858612
niece O 1 0.9999831914901733
( O 0 0.0726303830742836
B O 1 0.9999983310699463
. O 0 0.04073452204465866
B O 1 0.9999810457229614
. O 0 0.02293260022997856
) O 0 0.01883971132338047
with O 0 0.015094189904630184
45 O 0 0.03676220774650574
chromosomes O 0 0.03846383094787598
and O 0 0.016644611954689026
the O 0 0.030360201373696327
derivative O 0 0.0871647521853447
3 O 0 0.03105985000729561
but O 0 0.011221141554415226
without O 0 0.013624743558466434
the O 0 0.03392539173364639
der O 1 0.9997896552085876
( O 0 0.03724514693021774
15 O 0 0.035466212779283524
) O 0 0.025780480355024338
demonstrated O 0 0.03962865471839905
a O 0 0.047069866210222244
phenotype O 0 0.11813509464263916
consistent O 0 0.04318495839834213
with O 0 0.014717934653162956
that O 0 0.008535820059478283
reported O 0 0.01803511567413807
for O 0 0.020152350887656212
haploinsufficiency O 1 0.999273955821991
of O 0 0.05817711353302002
distal O 1 0.9999996423721313
3 O 0 0.12063008546829224
p O 1 0.8373282551765442
. O 0 0.04852892830967903

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999992847442627
associated O 0 0.04820043221116066
with O 0 0.027422642335295677
unbalanced O 1 0.9866533875465393
segregation O 1 0.6996126770973206
of O 0 0.042638346552848816
non O 1 0.9998445510864258
- O 1 1.0
Robertsonian O 1 0.9999973773956299
translocations O 1 0.6348426342010498
has O 0 0.025997472926974297
been O 0 0.01677904650568962
reported O 0 0.02340519428253174
previously O 0 0.025458935648202896
but O 0 0.013570803217589855
has O 0 0.016110604628920555
not O 0 0.011337759904563427
, O 0 0.014683371409773827
to O 0 0.01858624257147312
our O 0 0.02775616943836212
knowledge O 0 0.02828475646674633
, O 0 0.017512651160359383
been O 0 0.013621744699776173
observed O 0 0.017677247524261475
in O 0 0.012996691279113293
a O 0 0.02689037285745144
case O 0 0.043508268892765045
of O 0 0.07061944156885147
PWS B-Disease 1 1.0
. O 0 0.07991973310709

Furthermore O 0 0.10184388607740402
, O 0 0.0349314883351326
our O 0 0.03155478090047836
findings O 0 0.02657606638967991
are O 0 0.007926976308226585
best O 0 0.020513245835900307
interpreted O 0 0.020399384200572968
as O 0 0.020836276933550835
true O 0 0.05787722393870354
gamete O 1 0.9991164803504944
complementation O 1 0.9999986886978149
resulting O 0 0.06240851804614067
in O 0 0.046668436378240585
maternal B-Disease 1 0.9999996423721313
UPD I-Disease 1 1.0
15 I-Disease 0 0.09472211450338364
and O 0 0.08383115381002426
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9996389150619507
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 1 0.9594533443450928
2 I-Disease 0 0.04510117322206497
and O 0 0.025913765653967857
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.04065879061818123
a O 0 0.029198121279478073
case O 0 0.033041585236787796
for O 0 0.025353996083140373
" O 0 0.053480032831430435
lumping O 1 0.8755054473876953
" O 0 0.06422813981771469
. O 0 0.03907287120819092

Recent O 0 0.05645456537604332
studies O 0 0.026761827990412712
demonstrated O 0 0.027298713102936745
the O 0 0.0180515069514513
existence O 0 0.0256651621311903
of O 0 0.021007271483540535
a O 0 0.035388439893722534
genetically O 0 0.04573649913072586
distinct O 0 0.02484281174838543
, O 0 0.020320994779467583
usually O 0 0.017807459458708763
lethal O 0 0.04622967541217804
form O 0 0.014942305162549019
of O 0 0.012711080722510815
the O 0 0.023055627942085266
Schwartz B-Disease 1 0.9999873638153076
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996949434280396
SJS B-Disease 1 1.0
) O 0 0.030541377142071724
of O 0 0.0385136604309082
myotonia B-Disease 1 1.0
and O 1 0.9121054410934448
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.03678642585873604
which O 0 0.01574467495083809
we O 0 0.015065649524331093
called O 0 0.174460306763649
SJS B-Disease 1 1.0
type I-Disease 0 0.1258554607629776
2 I-Disease 0 0.06884151697158813
. O 0 0.041116368025541306

This O 0 0.06349438428878784
disorder O 1 0.9999997615814209
is O 0 0.038909394294023514
reminiscent O 0 0.08643075078725815
of O 0 0.02805262617766857
another O 0 0.034258417785167694
rare O 0 0.03468947485089302
condition O 0 0.035245150327682495
, O 0 0.014348982833325863
the O 0 0.0248591136187315
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996250867843628
SWS B-Disease 1 1.0
) O 0 0.032816942781209946
, O 0 0.014470670372247696
which O 0 0.010836486704647541
comprises O 0 0.0405847392976284
campomelia B-Disease 1 0.655656099319458
at O 0 0.03197867423295975
birth O 0 0.07225337624549866
with O 0 0.04745110496878624
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9998657703399658
contractures B-Disease 1 1.0
, O 0 0.038167838007211685
and O 0 0.025259608402848244
early B-Disease 0 0.041398849338293076
death I-Disease 1 0.501627504825592
. O 0 0.04762371629476547

To O 0 0.03758498653769493
test O 0 0.03674783930182457
for O 0 0.020619595423340797
possible O 0 0.033422164618968964
nosologic O 1 0.9917526841163635
identity O 0 0.04866453632712364
between O 0 0.03833905979990959
these O 0 0.03700990602374077
disorders O 1 1.0
, O 0 0.032429564744234085
we O 0 0.017608635127544403
reviewed O 0 0.0343359149992466
the O 0 0.02207014709711075
literature O 0 0.020283278077840805
and O 0 0.014371638186275959
obtained O 0 0.01861407421529293
a O 0 0.025049181655049324
follow O 0 0.04229603335261345
- O 1 0.9976950287818909
up O 0 0.019286278635263443
of O 0 0.0129653075709939
the O 0 0.013359030708670616
only O 0 0.00839019101113081
two O 0 0.013173660263419151
surviving O 1 0.7393951416015625
patients O 1 0.9995343685150146
, O 0 0.02064930647611618
one O 0 0.021775949746370316
with O 0 0.0405995175242424
SJS B-Disease 1 1.0
type I-Disease 1 0.7610871195793152
2 I-Disease 0 0.04826614633202553
at O 0 0.03257443383336067
age O 0 0.026294276118278503
10 O 0 0.017863089218735695
years O 0 0.01516091451048851
and O 0 0.014171740040183067
another O 0 0.029087038710713387
with O 0 0.03211718797683716
SWS B-Disease 1 0.9999998807907104
at O 0 0.04840631037950516
age O 0 0.04478682950139046
7 O 0 0.05322738736867905
years O 0 0.03410245105624199
. O 0 0.03816332295536995

Patients O 1 0.9907324314117432
reported O 0 0.03517373651266098
as O 0 0.021121103316545486
having O 0 0.029767610132694244
either O 0 0.06371704488992691
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.08015096187591553
SWS B-Disease 1 0.9999980926513672
presented O 0 0.03697784245014191
a O 0 0.02345941960811615
combination O 0 0.027759360149502754
of O 0 0.015757737681269646
a O 0 0.02729646861553192
severe O 1 0.9940763711929321
, O 0 0.035159628838300705
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9830155968666077
with O 1 0.9897981882095337
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999494552612305
feeding O 1 0.9999942779541016
difficulties O 1 0.9957971572875977
, O 0 0.03169505298137665
tendency O 0 0.4124760329723358
to O 0 0.051366325467824936
hyperthermia B-Disease 1 1.0
, O 0 0.02806674689054489
and O 0 0.019025038927793503
frequent O 0 0.04908257722854614
death O 1 0.7564023733139038
in O 0 0.027036618441343307
infancy O 1 0.9998637437820435
) O 0 0.015236402861773968
with O 0 0.008002289570868015
a O 0 0.015330773778259754
distinct O 0 0.025759385898709297
campomelic B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.09046989679336548

The O 0 0.043640561401844025
similarity O 0 0.03838396444916725
of O 0 0.02698161080479622
the O 0 0.04124646261334419
clinical O 1 0.9991698265075684
and O 0 0.045481517910957336
radiographic O 1 0.999998927116394
findings O 0 0.04684077948331833
is O 0 0.022933168336749077
so O 0 0.015265249647200108
extensive O 0 0.030441004782915115
that O 0 0.018910178914666176
these O 0 0.027387969195842743
disorders O 1 0.9999997615814209
appear O 0 0.034806713461875916
to O 0 0.02266201563179493
be O 0 0.01342912670224905
a O 0 0.029446059837937355
single O 0 0.052551839500665665
entity O 0 0.07676294445991516
. O 0 0.04120675474405289

The O 0 0.048683710396289825
follow O 0 0.05959448963403702
- O 1 0.9950822591781616
up O 0 0.03162103891372681
observation O 0 0.05675631761550903
of O 0 0.019514771178364754
an O 0 0.016638267785310745
identical O 0 0.018437465652823448
and O 0 0.012004408985376358
unique O 0 0.01603199914097786
pattern O 0 0.03364609181880951
of O 0 0.04718625545501709
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.0323348194360733
the O 0 0.02587793953716755
two O 0 0.021513557061553
patients O 1 0.9897871017456055
( O 0 0.022285157814621925
one O 0 0.01925220526754856
with O 0 0.03592155501246452
SJS B-Disease 1 1.0
type I-Disease 0 0.47510504722595215
2 I-Disease 0 0.04138459637761116
, O 0 0.016169346868991852
one O 0 0.016899093985557556
with O 0 0.02874014712870121
SWS B-Disease 1 0.9999996423721313
) O 0 0.04204251617193222
surviving O 0 0.11645994335412979
beyond O 0 0.06659377366304398
infancy O 1 0.7285848259925842
adds O 0 0.05201110988855362
to O 0 0.01714751124382019
the O 0 0.01819395087659359
evidence O 0 0.014648628421127796
in O 0 0.012880141846835613
favor O 0 0.026230493560433388
of O 0 0.031073693186044693
identity O 0 0.05672295391559601
. O 0 0.04328535497188568

The O 0 0.04272899404168129
hypothesis O 0 0.05763666331768036
that O 0 0.02172185480594635
SWS B-Disease 1 0.9999995231628418
and O 0 0.072701096534729
SJS B-Disease 1 1.0
type I-Disease 1 0.5613791346549988
2 I-Disease 0 0.03597554564476013
are O 0 0.006554740481078625
the O 0 0.022353539243340492
same O 0 0.038812216371297836
disorder O 1 1.0
should O 0 0.02519007958471775
be O 0 0.016252627596259117
testable O 0 0.07697752863168716
by O 0 0.030255412682890892
molecular O 0 0.05624333396553993
methods O 0 0.026800503954291344
. O 0 0.02229444310069084
. O 0 0.03340469300746918

A O 0 0.07881998270750046
mouse O 0 0.07387794554233551
model O 0 0.029325829818844795
of O 0 0.030277468264102936
severe O 1 0.9999967813491821
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999988079071045
defects O 1 1.0
in O 1 0.6529081463813782
hemostasis O 1 1.0
and O 1 0.9992538094520569
thrombosis B-Disease 1 1.0
. O 0 0.09038589149713516

von B-Disease 1 0.9983121156692505
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9987599849700928
( I-Disease 0 0.07207372784614563
vWf I-Disease 1 0.9999997615814209
) I-Disease 1 0.9650329947471619
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9964287877082825
humans O 0 0.055835455656051636
. O 0 0.03991486877202988

We O 0 0.02640966698527336
generated O 0 0.029065150767564774
a O 0 0.04119929298758507
mouse O 0 0.07813742011785507
model O 0 0.033375661820173264
for O 0 0.021147439256310463
this O 0 0.02559850551187992
disease O 1 0.9999432563781738
by O 0 0.03429294750094414
using O 0 0.033936552703380585
gene O 0 0.05497848615050316
targeting O 0 0.06821111589670181
. O 0 0.03900854289531708

vWf B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
deficient I-Disease 1 0.9999997615814209
mice O 0 0.08362908661365509
appeared O 0 0.04134567081928253
normal O 0 0.03795979544520378
at O 0 0.04214894399046898
birth O 1 0.545113205909729
; O 0 0.021425768733024597
they O 0 0.008814537897706032
were O 0 0.01373157650232315
viable O 0 0.06810588389635086
and O 0 0.03455035760998726
fertile O 0 0.14517831802368164
. O 0 0.05196424573659897

Neither O 0 0.12298282980918884
vWf O 1 0.9932355284690857
nor O 0 0.10775227099657059
vWf O 1 0.9969226717948914
propolypeptide O 1 0.9980672001838684
( O 0 0.0636603981256485
von B-Disease 1 0.9998717308044434
Willebrand I-Disease 1 1.0
antigen O 1 1.0
II O 1 1.0
) O 0 0.02822713367640972
were O 0 0.014206135645508766
detectable O 0 0.0740668773651123
in O 0 0.025466779246926308
plasma O 1 0.9881701469421387
, O 0 0.04462720826268196
platelets O 1 0.9999994039535522
, O 0 0.040219761431217194
or O 0 0.050342004746198654
endothelial O 1 0.9999966621398926
cells O 0 0.04126664623618126
of O 0 0.022125860676169395
the O 0 0.03986752778291702
homozygous O 0 0.1479617953300476
mutant O 1 0.9837856292724609
mice O 0 0.1158537045121193
. O 0 0.05105406045913696

The O 0 0.07358527183532715
mutant O 1 0.9889252781867981
mice O 0 0.14019373059272766
exhibited O 1 0.530131995677948
defects O 1 0.9998877048492432
in O 0 0.04716319590806961
hemostasis O 1 0.9999994039535522
with O 0 0.02793748304247856
a O 0 0.04391440749168396
highly O 1 0.8554162979125977
prolonged O 1 1.0
bleeding O 1 1.0
time O 0 0.04959852993488312
and O 0 0.05111730471253395
spontaneous O 1 0.9999954700469971
bleeding O 1 1.0
events O 0 0.030393242835998535
in O 0 0.017917603254318237
approximately O 0 0.018914170563220978
10 O 0 0.023308636620640755
% O 0 0.02770593762397766
of O 0 0.05011048913002014
neonates O 1 0.9994407296180725
. O 0 0.06508664786815643

As O 0 0.027298754081130028
in O 0 0.015179072506725788
the O 0 0.03126770630478859
human O 0 0.18685981631278992
disease O 1 0.9999998807907104
, O 0 0.026230260729789734
the O 0 0.036093760281801224
factor O 1 0.9982841610908508
VIII O 1 1.0
level O 0 0.04327487573027611
in O 0 0.019865700975060463
these O 0 0.014393823221325874
mice O 0 0.04793400689959526
was O 0 0.035115987062454224
reduced O 0 0.03415556997060776
strongly O 0 0.028934450820088387
as O 0 0.019427930936217308
a O 0 0.021121948957443237
result O 0 0.01616460084915161
of O 0 0.017668532207608223
the O 0 0.024070270359516144
lack O 0 0.03140673413872719
of O 0 0.031613487750291824
protection O 0 0.08210626989603043
provided O 0 0.0404934324324131
by O 0 0.046762797981500626
vWf O 1 0.99957674741745
. O 0 0.05277072265744209

Defective O 1 0.9999998807907104
thrombosis B-Disease 1 1.0
in O 0 0.08856198936700821
mutant O 1 0.9999990463256836
mice O 0 0.10137765109539032
was O 0 0.03929147869348526
also O 0 0.017366955056786537
evident O 0 0.03274282068014145
in O 0 0.011579317040741444
an O 0 0.01396182645112276
in O 0 0.01795440912246704
vivo O 0 0.11926250904798508
model O 0 0.05094801262021065
of O 1 0.6029223203659058
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.08356649428606033

In O 0 0.03313765302300453
this O 0 0.018600035458803177
model O 0 0.029219530522823334
, O 0 0.016632838174700737
the O 0 0.03015381097793579
exteriorized O 1 0.9997739195823669
mesentery O 1 0.9999635219573975
was O 0 0.06837302446365356
superfused O 1 0.9993745684623718
with O 0 0.06409259885549545
ferric O 1 1.0
chloride O 1 0.9999977350234985
and O 0 0.026885056868195534
the O 0 0.032285865396261215
accumulation O 0 0.09740134328603745
of O 0 0.04768682271242142
fluorescently O 1 0.9999986886978149
labeled O 1 0.9988721013069153
platelets O 1 0.9999617338180542
was O 0 0.05258055403828621
observed O 0 0.03154478594660759
by O 0 0.03624601289629936
intravital O 1 0.9968175888061523
microscopy O 0 0.13907375931739807
. O 0 0.05182401090860367

We O 0 0.030208313837647438
conclude O 0 0.053998593240976334
that O 0 0.013906464911997318
these O 0 0.012670442461967468
mice O 0 0.04497934505343437
very O 0 0.017757611349225044
closely O 0 0.0356806218624115
mimic O 1 0.870247483253479
severe O 1 0.9999638795852661
human O 1 0.9995825886726379
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.8521401286125183
will O 0 0.025860698893666267
be O 0 0.01249215193092823
very O 0 0.013406705111265182
useful O 0 0.015088841319084167
for O 0 0.010261480696499348
investigating O 0 0.02579408884048462
the O 0 0.018079038709402084
role O 0 0.036132801324129105
of O 0 0.036546967923641205
vWf O 1 0.9999738931655884
in O 0 0.02816794253885746
normal O 0 0.0492013581097126
physiology O 1 0.8264555335044861
and O 0 0.02992841973900795
in O 0 0.06049506738781929
disease O 1 1.0
models O 0 0.05608762055635452
. O 0 0.03030085749924183
. O 0 0.03542804345488548

Oral O 1 0.9955484867095947
contraceptives O 1 0.9993070363998413
and O 0 0.021606309339404106
the O 0 0.02710973098874092
risk O 0 0.056048355996608734
of O 1 0.9854937791824341
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.998577356338501

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.9908685684204102
Group O 1 0.862960159778595
. O 0 0.03496010974049568

BACKGROUND O 0 0.1094987615942955
Women O 0 0.04738263785839081
with O 0 0.02734164334833622
mutations O 0 0.033428944647312164
in O 0 0.014591805636882782
either O 0 0.018839482218027115
the O 0 0.036720894277095795
BRCA1 O 1 0.9999256134033203
or O 0 0.030456187203526497
the O 0 0.04709694907069206
BRCA2 O 1 0.9999827146530151
gene O 0 0.030821694061160088
have O 0 0.005688495002686977
a O 0 0.016175827011466026
high O 0 0.0397760309278965
lifetime O 0 0.07546895742416382
risk O 1 0.9981749057769775
of O 1 0.9999978542327881
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9336363673210144

Oral O 1 0.9452884793281555
contraceptives O 1 0.9999213218688965
protect O 1 0.9931877851486206
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.34212812781333923
general O 1 0.9798095226287842
, O 0 0.022209329530596733
but O 0 0.011075581423938274
it O 0 0.008916444145143032
is O 0 0.012501579709351063
not O 0 0.010314480401575565
known O 0 0.023401781916618347
whether O 0 0.011606668122112751
they O 0 0.005732439924031496
also O 0 0.00916921067982912
protect O 0 0.02553597278892994
against O 0 0.03474867716431618
hereditary B-Disease 1 0.9999998807907104
forms I-Disease 1 0.6779855489730835
of I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9866893887519836

METHODS O 0 0.05177251994609833
We O 0 0.015747182071208954
enrolled O 0 0.05564599484205246
207 O 0 0.11012639850378036
women O 0 0.03839501366019249
with O 0 0.053243398666381836
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.7315865159034729
161 O 1 0.9890590310096741
of O 0 0.025347020477056503
their O 0 0.020877903327345848
sisters O 0 0.07768997550010681
as O 0 0.01862378604710102
controls O 0 0.02759706974029541
in O 0 0.010681450366973877
a O 0 0.024198954924941063
case O 0 0.051240209490060806
- O 1 0.999998927116394
control O 0 0.05438489094376564
study O 0 0.03360908105969429
. O 0 0.03319644555449486

All O 0 0.026549017056822777
the O 0 0.03819091618061066
patients O 0 0.12325254827737808
carried O 0 0.03314581513404846
a O 0 0.04039711132645607
pathogenic O 0 0.14698565006256104
mutation O 0 0.057016145437955856
in O 0 0.020705899223685265
either O 0 0.03895871341228485
BRCA1 O 1 0.9998698234558105
( O 0 0.036007944494485855
179 O 0 0.14813336730003357
women O 0 0.04739461839199066
) O 0 0.035881537944078445
or O 0 0.043160829693078995
BRCA2 O 1 0.9999924898147583
( O 0 0.04484889283776283
28 O 0 0.06441806256771088
women O 0 0.05860516428947449
) O 0 0.03640800341963768
. O 0 0.03438418731093407

The O 0 0.06233853101730347
control O 0 0.06033162772655487
women O 0 0.04136648774147034
were O 0 0.01869700476527214
enrolled O 0 0.06792756915092468
regardless O 0 0.03863902390003204
of O 0 0.028103752061724663
whether O 0 0.027295002713799477
or O 0 0.02068394236266613
not O 0 0.01156942080706358
they O 0 0.00939227920025587
had O 0 0.023372430354356766
either O 0 0.03797111660242081
mutation O 0 0.09018853306770325
. O 0 0.04584355652332306

Lifetime O 0 0.09452977031469345
histories O 0 0.06925540417432785
of O 0 0.046862442046403885
oral O 1 0.9999996423721313
- O 1 1.0
contraceptive O 1 1.0
use O 0 0.02133115567266941
were O 0 0.01046398002654314
obtained O 0 0.016468405723571777
by O 0 0.017630277201533318
interview O 0 0.04034540429711342
or O 0 0.01569700427353382
by O 0 0.015657054260373116
written O 0 0.02266545407474041
questionnaire O 0 0.05917355790734291
and O 0 0.01529490202665329
were O 0 0.012510282918810844
compared O 0 0.026322176679968834
between O 0 0.037422049790620804
patients O 1 0.9998600482940674
and O 0 0.0320592038333416
control O 0 0.08376763015985489
women O 0 0.03975936025381088
, O 0 0.02399640716612339
after O 0 0.03242090716958046
adjustment O 0 0.05510875955224037
for O 0 0.017513945698738098
year O 0 0.019898416474461555
of O 0 0.03240274637937546
birth O 0 0.1073031947016716
and O 0 0.04198313504457474
parity O 0 0.350084125995636
. O 0 0.052376970648765564

RESULTS O 0 0.0343763642013073
The O 0 0.022779494524002075
adjusted O 0 0.040371544659137726
odds O 0 0.06161722540855408
ratio O 0 0.08415576815605164
for O 1 0.8500672578811646
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.14358015358448029
with O 0 0.020962605252861977
any O 0 0.015205355361104012
past O 0 0.021585922688245773
use O 0 0.014364183880388737
of O 0 0.028170760720968246
oral O 1 0.9964828491210938
contraceptives O 1 0.9999979734420776
was O 0 0.07124105095863342
0 O 0 0.09608512371778488
. O 0 0.04467944800853729

5 O 0 0.0703510195016861
( O 0 0.03499402478337288
95 O 0 0.048543065786361694
percent O 0 0.03571565821766853
confidence O 0 0.07314649969339371
interval O 0 0.07942552119493484
, O 0 0.029243480414152145
0 O 0 0.05535325035452843
. O 0 0.014594252221286297
3 O 0 0.02735881879925728
to O 0 0.02241186797618866
0 O 0 0.06389854103326797
. O 0 0.02338177151978016
8 O 0 0.0506509505212307
) O 0 0.03191685304045677
. O 0 0.036419350653886795

The O 0 0.07739458233118057
risk O 0 0.4529801309108734
decreased O 0 0.06100059673190117
with O 0 0.023230746388435364
increasing O 0 0.039103422313928604
duration O 0 0.05722961947321892
of O 0 0.02791934460401535
use O 0 0.026582518592476845
( O 0 0.035520587116479874
P O 1 0.954683244228363
for O 0 0.02253081277012825
trend O 0 0.055419113487005234
, O 0 0.037076059728860855
< O 1 0.9944983124732971
0 O 0 0.07837174087762833
. O 0 0.03562125563621521
001 O 1 0.9996789693832397
) O 0 0.035320546478033066
; O 0 0.018806863576173782
use O 0 0.013913110829889774
for O 0 0.014152873307466507
six O 0 0.01980510726571083
or O 0 0.016532812267541885
more O 0 0.009773057885468006
years O 0 0.01953713782131672
was O 0 0.02922576665878296
associated O 0 0.01905602402985096
with O 0 0.012443787418305874
a O 0 0.022614024579524994
60 O 0 0.03162139281630516
percent O 0 0.03250578045845032
reduction O 0 0.0620834156870842
in O 0 0.03391971439123154
risk O 0 0.09844845533370972
. O 0 0.046143315732479095

Oral O 1 0.9996346235275269
- O 1 0.9999998807907104
contraceptive O 1 0.9999982118606567
use O 0 0.026211699470877647
protected O 0 0.07978739589452744
against O 1 0.9999969005584717
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.028616389259696007
for O 0 0.01979147456586361
carriers O 0 0.03636503964662552
of O 0 0.01976357027888298
the O 0 0.044798702001571655
BRCA1 O 1 0.9999996423721313
mutation O 0 0.08632080256938934
( O 0 0.0354725606739521
odds O 0 0.0816512405872345
ratio O 0 0.06646598875522614
, O 0 0.024587182328104973
0 O 0 0.05553781986236572
. O 0 0.0166054368019104
5 O 0 0.029013091698288918
; O 0 0.017609337344765663
95 O 0 0.03544075787067413
percent O 0 0.0287455003708601
confidence O 0 0.06043547764420509
interval O 0 0.07327956706285477
, O 0 0.026853999122977257
0 O 0 0.051648132503032684
. O 0 0.014785198494791985
3 O 0 0.026196859776973724
to O 0 0.021924549713730812
0 O 0 0.05918518081307411
. O 0 0.020329255610704422
9 O 0 0.04030006751418114
) O 0 0.017681652680039406
and O 0 0.012381835840642452
for O 0 0.014983207918703556
carriers O 0 0.038882408291101456
of O 0 0.02194826677441597
the O 0 0.0520319938659668
BRCA2 O 1 0.9999967813491821
mutation O 0 0.09960296005010605
( O 0 0.03610285371541977
odds O 0 0.08402834087610245
ratio O 0 0.0693562850356102
, O 0 0.027835648506879807
0 O 0 0.05526231974363327
. O 0 0.018474837765097618
4 O 0 0.035715024918317795
; O 0 0.017403030768036842
95 O 0 0.03617730364203453
percent O 0 0.029478425160050392
confidence O 0 0.05766870453953743
interval O 0 0.07232662290334702
, O 0 0.026238860562443733
0 O 0 0.04873856529593468
. O 0 0.014882686547935009
2 O 0 0.026907533407211304
to O 0 0.01957576349377632
1 O 0 0.04227545112371445
. O 0 0.020126163959503174
1 O 0 0.05090225115418434
) O 0 0.029189249500632286
. O 0 0.03102775849401951

CONCLUSIONS O 0 0.10415951907634735
Oral O 1 0.9999308586120605
- O 1 1.0
contraceptive O 1 0.9999998807907104
use O 0 0.023970410227775574
may O 0 0.016764366999268532
reduce O 0 0.025695426389575005
the O 0 0.0211445614695549
risk O 0 0.24455276131629944
of O 1 0.9997193217277527
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.044712796807289124
women O 0 0.040826309472322464
with O 0 0.024857094511389732
pathogenic O 0 0.31919750571250916
mutations O 0 0.03007795847952366
in O 0 0.01712474226951599
the O 0 0.04151003435254097
BRCA1 O 1 0.9999995231628418
or O 0 0.06953071802854538
BRCA2 O 1 0.9999903440475464
gene O 0 0.11397093534469604

A O 0 0.07285188138484955
Japanese O 0 0.06387834250926971
family O 0 0.04870762303471565
with O 0 0.03504288196563721
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.028082704171538353
a O 0 0.03796134516596794
codon O 0 0.10625561326742172
291 O 0 0.1228942722082138
deletion O 0 0.0973723754286766
: O 0 0.027071386575698853
a O 0 0.03273802995681763
clinical O 1 0.9983856678009033
, O 0 0.038015637546777725
biochemical O 1 0.888802707195282
, O 0 0.04127879440784454
pathological O 1 0.9999980926513672
, O 0 0.03632929176092148
and O 0 0.033059488981962204
genetic O 0 0.045225340873003006
report O 0 0.03132906183600426
. O 0 0.03586748614907265

We O 0 0.018857138231396675
report O 0 0.015049652196466923
a O 0 0.01814108155667782
Japanese O 0 0.04233695939183235
family O 0 0.043674666434526443
with O 0 0.054328493773937225
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999823570251465
ALD B-Disease 1 1.0
) O 0 0.03482067212462425
with O 0 0.013981672003865242
a O 0 0.0183551125228405
three O 0 0.014200234785676003
base O 0 0.0462346151471138
pair O 0 0.04812242090702057
deletion O 0 0.10051985830068588
( O 0 0.0451795794069767
delGAG O 1 0.9992204904556274
291 O 0 0.12889514863491058
) O 0 0.022313518449664116
in O 0 0.01746165193617344
the O 0 0.06066383421421051
ALD B-Disease 1 1.0
gene O 0 0.09258076548576355
. O 0 0.048665329813957214

A O 0 0.08029449731111526
variety O 0 0.03353246673941612
of O 0 0.0400812104344368
phenotypes O 0 0.09758505970239639
were O 0 0.018132571130990982
observed O 0 0.023967744782567024
within O 0 0.019227486103773117
this O 0 0.019299212843179703
family O 0 0.05676264315843582
. O 0 0.04388834536075592

While O 0 0.03169090300798416
the O 0 0.04299568012356758
proband O 1 0.9999990463256836
( O 0 0.061384908854961395
patient O 1 0.9999433755874634
1 O 0 0.06397663056850433
) O 0 0.024186624214053154
was O 0 0.02546669915318489
classified O 0 0.02970016375184059
as O 0 0.014490392059087753
having O 0 0.017494920641183853
a O 0 0.02547282911837101
rare O 0 0.037904754281044006
intermediate O 1 0.9207863807678223
type O 0 0.046111561357975006
of O 0 0.029493670910596848
adult O 1 0.6040549874305725
cerebral O 1 0.9999997615814209
and O 0 0.04654558748006821
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999340772628784
stem O 0 0.05972481891512871
forms O 0 0.026528509333729744
, O 0 0.016054248437285423
his O 0 0.02752300165593624
younger O 0 0.3987734615802765
brother O 1 0.9993029832839966
( O 0 0.04532376676797867
patient O 1 0.9999732971191406
2 O 0 0.05124812573194504
) O 0 0.021304814144968987
and O 0 0.02143643982708454
nephew O 1 0.9999934434890747
( O 0 0.048138123005628586
patient O 1 0.999961256980896
3 O 0 0.040160320699214935
) O 0 0.017023200169205666
had O 0 0.018087487667798996
a O 0 0.04993846267461777
childhood O 1 1.0
ALD B-Disease 1 1.0
type O 1 0.9999710321426392
. O 0 0.06172475218772888

Another O 0 0.09857022017240524
nephew O 1 0.9999853372573853
( O 0 0.06461480259895325
patient O 1 0.9997660517692566
4 O 0 0.05343414470553398
) O 0 0.02248247340321541
of O 0 0.0287626925855875
patient O 1 0.999290943145752
1 O 0 0.045211657881736755
was O 0 0.03303379565477371
classified O 0 0.03135039657354355
as O 0 0.015034478157758713
having O 0 0.022140350192785263
an O 0 0.03381713479757309
adolescent O 1 0.9999997615814209
form O 0 0.06736231595277786
. O 0 0.052747942507267

The O 0 0.05546863004565239
tau O 1 0.9879276156425476
level O 0 0.032256945967674255
in O 0 0.01818784326314926
the O 0 0.04826812446117401
cerebrospinal O 1 1.0
fluid O 1 0.9999926090240479
( O 0 0.2867627739906311
CSF O 1 1.0
) O 0 0.029282987117767334
in O 0 0.023512987419962883
patient O 1 0.9925643801689148
1 O 0 0.04347682744264603
was O 0 0.02633480541408062
as O 0 0.016345350071787834
high O 0 0.023825520649552345
as O 0 0.011284110136330128
that O 0 0.006166404578834772
of O 0 0.020644042640924454
patients O 1 0.9997881054878235
with O 1 0.9996628761291504
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9987126588821411
AD B-Disease 1 0.9998600482940674
) O 0 0.037399739027023315
. O 0 0.03108813613653183

His O 0 0.12915043532848358
brain O 1 0.997977077960968
magnetic O 0 0.09633921831846237
resonance O 1 0.5022793412208557
image O 1 0.9328019618988037
( O 0 0.05619439855217934
MRI O 1 0.9998226761817932
) O 0 0.03124217875301838
showed O 0 0.036906491965055466
abnormalities B-Disease 0 0.23579473793506622
in I-Disease 0 0.016491437330842018
the I-Disease 0 0.030959365889430046
bilateral I-Disease 1 0.9940710663795471
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999790191650391
and O 1 0.9943450689315796
brain O 1 0.9999998807907104
stem O 1 0.9840556383132935
, O 0 0.02297438308596611
but O 0 0.010566040873527527
not O 0 0.008183597587049007
in O 0 0.01338227465748787
the O 0 0.04267541691660881
cerebral O 1 0.9999997615814209
white O 1 0.9699224233627319
matter O 0 0.034318022429943085
, O 0 0.01987607218325138
where O 0 0.01883058436214924
marked O 0 0.03278765827417374
reductions O 0 0.035377535969018936
of O 0 0.02654409594833851
the O 0 0.06274813413619995
cerebral O 1 1.0
blood O 1 0.9999996423721313
flow O 0 0.18565577268600464
and O 0 0.05094803869724274
oxygen O 1 0.9998087286949158
metabolism O 0 0.3153047263622284
were O 0 0.011676556430757046
clearly O 0 0.020175201818346977
demonstrated O 0 0.02902182564139366
by O 0 0.03121994435787201
positron O 1 0.9993426203727722
emission O 1 0.8906728625297546
tomography O 1 0.9816972613334656
( O 0 0.07741411030292511
PET O 1 0.9985442161560059
) O 0 0.04376426711678505
. O 0 0.03805844113230705

In O 0 0.06524048745632172
patients O 1 0.9997661709785461
2 O 0 0.05900498107075691
and O 0 0.025925079360604286
3 O 0 0.03581709414720535
, O 0 0.01589084230363369
the O 0 0.021352823823690414
autopsy O 0 0.07040449976921082
findings O 0 0.02651614509522915
showed O 0 0.03199455887079239
massive O 1 0.8380200862884521
demyelination B-Disease 1 1.0
of I-Disease 0 0.050608307123184204
the I-Disease 0 0.30470484495162964
cerebral I-Disease 1 1.0
white I-Disease 1 0.6048418879508972
matter I-Disease 0 0.021269306540489197
with O 0 0.01248987577855587
sparing O 0 0.0607670433819294
of O 0 0.019359610974788666
the O 0 0.04136619344353676
U O 1 1.0
- O 1 1.0
fibers O 1 0.7572755813598633
, O 0 0.02636866271495819
compatible O 0 0.04493323713541031
with O 0 0.012094013392925262
the O 0 0.0197390578687191
findings O 0 0.03166394680738449
of O 0 0.056363243609666824
childhood O 1 0.9999998807907104
ALD B-Disease 1 1.0
. O 0 0.10645105689764023

Oleic O 1 0.9992522597312927
and O 0 0.08798941224813461
erucic O 1 0.9999998807907104
acids O 0 0.12008744478225708
( O 0 0.06303504854440689
Lorenzos O 1 0.9999769926071167
Oil O 0 0.05698654055595398
) O 0 0.017972763627767563
were O 0 0.011107097379863262
administered O 0 0.06381683051586151
to O 0 0.03327368199825287
patients O 1 0.9982727766036987
1 O 0 0.06667739152908325
and O 0 0.02909269742667675
4 O 0 0.044066693633794785
, O 0 0.018193168565630913
but O 0 0.015220663510262966
sufficient O 0 0.04088219255208969
effectiveness O 0 0.06431662291288376
was O 0 0.03953352943062782
not O 0 0.01793609745800495
obtained O 0 0.02889348194003105
. O 0 0.03263934329152107

The O 0 0.0487486757338047
findings O 0 0.034948576241731644
in O 0 0.017682572826743126
this O 0 0.017118949443101883
family O 0 0.039457470178604126
suggest O 0 0.026745539158582687
that O 0 0.016987459734082222
delGAG291 O 1 0.9920374155044556
is O 0 0.01892942190170288
part O 0 0.020742226392030716
of O 0 0.018849708139896393
the O 0 0.027884729206562042
cause O 0 0.04800327867269516
of O 0 0.0418693907558918
Japanese O 1 0.9994632601737976
ALD B-Disease 1 1.0
with O 0 0.05222620069980621
phenotypic O 0 0.1164221316576004
variations O 0 0.05595666915178299
. O 0 0.04255211353302002

Moreover O 0 0.09135682135820389
, O 0 0.02507137693464756
although O 0 0.014311070553958416
the O 0 0.01932787150144577
scale O 0 0.03040226735174656
of O 0 0.020305946469306946
the O 0 0.02794172801077366
study O 0 0.02483460307121277
is O 0 0.018831560388207436
limited O 0 0.021915676072239876
, O 0 0.014660939574241638
there O 0 0.010007865726947784
is O 0 0.012461083941161633
a O 0 0.021448522806167603
possibility O 0 0.03138447552919388
that O 0 0.019815903156995773
PET O 1 0.9979175925254822
can O 0 0.01903785951435566
detect O 0 0.06380140781402588
an O 0 0.043437883257865906
insidious B-Disease 1 1.0
lesion I-Disease 1 0.9999998807907104
which O 0 0.024827836081385612
is O 0 0.026133429259061813
undetectable O 1 0.6762714982032776
by O 0 0.028116339817643166
computed O 0 0.07794735580682755
tomogram O 1 0.9999415874481201
( O 0 0.08159450441598892
CT O 1 1.0
) O 0 0.05081593617796898
or O 0 0.04484416916966438
MRI O 1 0.9991030693054199
analysis O 0 0.026471413671970367
, O 0 0.017386211082339287
and O 0 0.011728141456842422
that O 0 0.007511867675930262
the O 0 0.015817217528820038
higher O 0 0.02027665451169014
level O 0 0.025540359318256378
of O 0 0.030598482117056847
tau O 1 0.9897511601448059
reflects O 0 0.040560293942689896
the O 0 0.01851401850581169
process O 0 0.02041262947022915
of O 0 0.04696168377995491
neuronal B-Disease 1 0.9999585151672363
degeneration I-Disease 1 1.0
in O 1 0.9519923329353333
ALD B-Disease 1 1.0
. O 0 0.08530423045158386

Lorenzos O 1 0.9999547004699707
Oil O 0 0.07850831001996994
should O 0 0.022625762969255447
be O 0 0.010568269528448582
given O 0 0.013239980675280094
in O 0 0.01260082796216011
the O 0 0.026175327599048615
early O 0 0.04756699502468109
stage O 0 0.07737769931554794
. O 0 0.027347465977072716
. O 0 0.03860310837626457

Nonsense O 0 0.245404914021492
mutation O 0 0.07889926433563232
in O 0 0.027345970273017883
exon O 0 0.1346847414970398
4 O 0 0.03499350696802139
of O 0 0.024150017648935318
human O 0 0.03992633521556854
complement O 0 0.3843306005001068
C9 O 1 1.0
gene O 0 0.053975023329257965
is O 0 0.015828726813197136
the O 0 0.02050980180501938
major O 0 0.03301560506224632
cause O 0 0.041863661259412766
of O 0 0.03264250233769417
Japanese O 1 0.8472882509231567
complement B-Disease 1 0.9999773502349854
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08561587333679199

Deficiency B-Disease 1 1.0
of I-Disease 0 0.03937544301152229
the I-Disease 0 0.03740348294377327
ninth I-Disease 1 0.9983416795730591
component I-Disease 0 0.06265972554683685
of I-Disease 0 0.024592969566583633
human I-Disease 0 0.03527097404003143
complement I-Disease 1 0.6580548286437988
( O 0 0.05646122246980667
C9 O 1 1.0
) O 0 0.022327523678541183
is O 0 0.010831310413777828
the O 0 0.012857489287853241
most O 0 0.016794102266430855
common O 0 0.05572415515780449
complement B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
in O 0 0.044616661965847015
Japan O 0 0.07221147418022156
but O 0 0.021780014038085938
is O 0 0.0215844064950943
rare O 0 0.03079337440431118
in O 0 0.019176380708813667
other O 0 0.01627395674586296
countries O 0 0.018399138003587723
. O 0 0.0355159267783165

We O 0 0.023015251383185387
studied O 0 0.025982053950428963
the O 0 0.02124861069023609
molecular O 0 0.03010980226099491
basis O 0 0.021477725356817245
of O 0 0.05884430930018425
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.025058235973119736
four O 0 0.021833689883351326
Japanese O 0 0.2087039053440094
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
patients O 1 0.9976418018341064
who O 0 0.037509314715862274
had O 0 0.03688818961381912
suffered O 1 0.9999990463256836
from O 1 0.9989281296730042
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9716265797615051

Direct O 0 0.06422266364097595
sequencing O 0 0.05173904076218605
of O 0 0.04184586554765701
amplified O 0 0.20015667378902435
C9 O 1 0.9999986886978149
cDNA O 0 0.15524311363697052
and O 0 0.02592664211988449
DNA O 0 0.030505407601594925
revealed O 0 0.026131020858883858
a O 0 0.027390621602535248
nonsense O 0 0.09450189769268036
substitution O 0 0.07000051438808441
( O 0 0.03204624727368355
CGA O 1 0.7404777407646179
- O 1 0.9999994039535522
- O 1 0.9999997615814209
> O 1 0.9996869564056396
TGA O 1 0.9999798536300659
) O 0 0.030423494055867195
at O 0 0.03261754661798477
codon O 0 0.0794156864285469
95 O 0 0.035579849034547806
in O 0 0.018749447539448738
exon O 0 0.11331483721733093
4 O 0 0.02536935545504093
in O 0 0.009235084056854248
the O 0 0.01610260270535946
four O 0 0.03903462365269661
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.999933123588562
individuals O 0 0.04229201376438141
. O 0 0.04658766835927963

An O 0 0.04826672002673149
allele O 0 0.1453385353088379
- O 1 0.9994286894798279
specific O 0 0.031300101429224014
polymerase O 1 0.9931865930557251
chain O 0 0.12379531562328339
reaction O 0 0.0739210918545723
system O 0 0.04881128668785095
designed O 0 0.04838646575808525
to O 0 0.030616166070103645
detect O 0 0.06012516841292381
exclusively O 0 0.02509874664247036
only O 0 0.009333540685474873
one O 0 0.01241297833621502
of O 0 0.017266355454921722
the O 0 0.028154605999588966
normal O 0 0.039908286184072495
and O 0 0.03838318958878517
mutant O 1 0.927756667137146
alleles O 0 0.10264076292514801
indicated O 0 0.030658917501568794
that O 0 0.009002785198390484
all O 0 0.009086080826818943
the O 0 0.020358668640255928
four O 0 0.0276249498128891
patients O 0 0.08842914551496506
were O 0 0.01755407452583313
homozygous O 0 0.06991113722324371
for O 0 0.02094930037856102
the O 0 0.03288935124874115
mutation O 0 0.059000708162784576
in O 0 0.029849953949451447
exon O 1 0.9766219258308411
4 O 0 0.04260750114917755
and O 0 0.015398476272821426
that O 0 0.008573564700782299
the O 0 0.018108418211340904
parents O 0 0.038860950618982315
of O 0 0.03997093066573143
patient O 1 0.9998739957809448
2 O 0 0.062093183398246765
were O 0 0.02691386640071869
heterozygous O 0 0.09698586910963058
. O 0 0.04238361120223999

The O 0 0.06281737238168716
common O 0 0.05805564299225807
mutation O 0 0.0730416551232338
at O 0 0.04437820985913277
codon O 0 0.10240571200847626
95 O 0 0.047994233667850494
in O 0 0.027754848822951317
exon O 1 0.5884652733802795
4 O 0 0.039826080203056335
might O 0 0.015423567965626717
be O 0 0.008908129297196865
responsible O 0 0.021893324330449104
for O 0 0.01181217934936285
most O 0 0.020976809784770012
Japanese O 1 0.9997091889381409
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05364954099059105
. O 0 0.050212312489748

BRCA1 O 1 0.7712224125862122
required O 0 0.025504156947135925
for O 0 0.028917908668518066
transcription O 1 0.9825300574302673
- O 1 0.9999936819076538
coupled O 0 0.10916691273450851
repair O 1 0.9885071516036987
of O 0 0.06422003358602524
oxidative O 1 0.9999881982803345
DNA O 0 0.09653429687023163
damage O 0 0.08261815458536148
. O 0 0.04817996174097061

The O 0 0.07607876509428024
breast B-Disease 1 1.0
and I-Disease 1 0.9999537467956543
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9744466543197632
BRCA1 O 1 0.9998728036880493
encodes O 0 0.08178232610225677
a O 0 0.05389682203531265
zinc O 1 0.9999984502792358
finger O 1 0.9978330731391907
protein O 0 0.04791514202952385
of O 0 0.029461942613124847
unknown O 0 0.05544942244887352
function O 0 0.04785951226949692
. O 0 0.03915964439511299

Association O 0 0.051268626004457474
of O 0 0.029127275571227074
the O 0 0.049125030636787415
BRCA1 O 1 0.9999879598617554
protein O 0 0.035048723220825195
with O 0 0.011993613094091415
the O 0 0.025359665974974632
DNA O 0 0.06639284640550613
repair O 1 0.9998825788497925
protein O 0 0.08737041801214218
Rad51 O 1 0.9993983507156372
and O 0 0.0196069348603487
changes O 0 0.012741337530314922
in O 0 0.011125968769192696
the O 0 0.025403255596756935
phosphorylation O 0 0.07384610921144485
and O 0 0.02363385260105133
cellular O 0 0.051188237965106964
localization O 0 0.06268109381198883
of O 0 0.020304275676608086
the O 0 0.03050806187093258
protein O 0 0.03847077861428261
after O 0 0.030668698251247406
exposure O 0 0.0543401837348938
to O 0 0.02649015001952648
DNA O 0 0.07088463008403778
- O 1 0.9999974966049194
damaging O 0 0.08706659078598022
agents O 0 0.02975359559059143
are O 0 0.007029959000647068
consistent O 0 0.021548917517066002
with O 0 0.010639563202857971
a O 0 0.02256450057029724
role O 0 0.03965853899717331
for O 0 0.03164977952837944
BRCA1 O 1 0.9999794960021973
in O 0 0.04212598502635956
DNA O 0 0.08777496218681335
repair O 1 0.9899068474769592
. O 0 0.05190104618668556

Here O 0 0.04380333423614502
, O 0 0.018949320539832115
it O 0 0.008545526303350925
is O 0 0.010644499212503433
shown O 0 0.011059547774493694
that O 0 0.012169000692665577
mouse O 0 0.0775044783949852
embryonic O 0 0.25321897864341736
stem O 1 0.8714966177940369
cells O 0 0.16802434623241425
deficient B-Disease 1 0.9999698400497437
in I-Disease 0 0.056828975677490234
BRCA1 I-Disease 1 0.9999876022338867
are O 0 0.02515977993607521
defective O 1 0.9380078315734863
in O 0 0.02255718596279621
the O 0 0.026140356436371803
ability O 0 0.019312545657157898
to O 0 0.01324464101344347
carry O 0 0.015956830233335495
out O 0 0.02270970121026039
transcription O 1 0.7662016153335571
- O 1 0.9999957084655762
coupled O 0 0.09429550915956497
repair O 1 0.6474249362945557
of O 0 0.05381414666771889
oxidative O 1 0.9999949932098389
DNA O 0 0.09688672423362732
damage O 0 0.06062345579266548
, O 0 0.023039624094963074
and O 0 0.017838092520833015
are O 0 0.013240291737020016
hypersensitive O 1 0.9999691247940063
to O 0 0.05839802697300911
ionizing O 1 0.9999995231628418
radiation O 1 0.9995964169502258
and O 0 0.047083545476198196
hydrogen O 1 0.6000487208366394
peroxide O 1 0.992159366607666
. O 0 0.049527253955602646

These O 0 0.021718401461839676
results O 0 0.01814783364534378
suggest O 0 0.024731388315558434
that O 0 0.02446800097823143
BRCA1 O 1 0.9999958276748657
participates O 1 0.8644126057624817
, O 0 0.029366128146648407
directly O 0 0.02409530058503151
or O 0 0.019102653488516808
indirectly O 0 0.033949967473745346
, O 0 0.012950317934155464
in O 0 0.016726819798350334
transcription O 1 0.9323208332061768
- O 1 0.9999969005584717
coupled O 0 0.10360296815633774
repair O 1 0.9855726361274719
of O 0 0.06372158974409103
oxidative O 1 0.9999994039535522
DNA O 0 0.1074768528342247
damage O 0 0.07629550993442535
. O 0 0.028897028416395187
. O 0 0.03630538657307625

Truncation O 1 0.9790938496589661
mutations O 0 0.05689433962106705
in O 0 0.018921876326203346
the O 0 0.035250067710876465
transactivation O 1 0.9945969581604004
region O 0 0.043725479394197464
of O 0 0.04284735396504402
PAX6 O 1 0.9999998807907104
result O 0 0.029976796358823776
in O 0 0.02636474184691906
dominant O 1 0.9993999004364014
- O 1 0.9999991655349731
negative O 0 0.06831042468547821
mutants O 0 0.17723199725151062
. O 0 0.04780140891671181

PAX6 O 1 0.9999943971633911
is O 0 0.04023532569408417
a O 0 0.04520100727677345
transcription O 0 0.09656204283237457
factor O 0 0.03964895382523537
with O 0 0.010021363385021687
two O 0 0.01247924193739891
DNA O 0 0.05330730602145195
- O 1 0.9998822212219238
binding O 0 0.0551198348402977
domains O 0 0.05828998610377312
( O 0 0.02967105060815811
paired O 0 0.06583819538354874
box O 0 0.07828235626220703
and O 0 0.03352426365017891
homeobox O 1 0.9999922513961792
) O 0 0.01896076090633869
and O 0 0.011289702728390694
a O 0 0.025368904694914818
proline O 1 0.9991371035575867
- O 1 0.9999980926513672
serine O 1 0.9999680519104004
- O 1 0.9999998807907104
threonine O 1 0.9993711113929749
( O 0 0.048643141984939575
PST O 1 0.9999932050704956
) O 0 0.04409795626997948
- O 1 0.9994819760322571
rich O 0 0.08370477706193924
transactivation O 1 0.9961721301078796
domain O 0 0.08911953121423721
. O 0 0.04287022352218628

PAX6 O 1 1.0
regulates O 1 0.9999713897705078
eye O 1 0.9999910593032837
development O 0 0.04979255422949791
in O 0 0.0232920553535223
animals O 0 0.022138897329568863
ranging O 0 0.03268539905548096
from O 0 0.03252336010336876
jellyfish O 0 0.11620116233825684
to O 0 0.040293313562870026
Drosophila O 0 0.12375755608081818
to O 0 0.04100324586033821
humans O 0 0.045462485402822495
. O 0 0.044622570276260376

Heterozygous O 0 0.16406792402267456
mutations O 0 0.0470515713095665
in O 0 0.016864247620105743
the O 0 0.0296280849725008
human O 0 0.06830024719238281
PAX6 O 1 1.0
gene O 0 0.06247464567422867
result O 0 0.0215239729732275
in O 0 0.01616516150534153
various O 0 0.016254378482699394
phenotypes O 0 0.07518740743398666
, O 0 0.022354410961270332
including O 0 0.024723302572965622
aniridia B-Disease 1 1.0
, O 0 0.042877521365880966
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999997615814209
, O 0 0.04051557555794716
autosomal B-Disease 1 0.9999885559082031
dominant I-Disease 1 0.9999998807907104
keratitis I-Disease 1 1.0
, O 0 0.05124247446656227
and O 0 0.05515655130147934
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.08814435452222824

It O 0 0.025153283029794693
is O 0 0.017947474494576454
believed O 0 0.017144955694675446
that O 0 0.006651872768998146
the O 0 0.02039784938097
mutated O 0 0.0897500067949295
allele O 0 0.08502054959535599
of O 0 0.04565805569291115
PAX6 O 1 0.9999994039535522
produces O 0 0.049734558910131454
an O 0 0.03412249684333801
inactive O 1 0.9997783303260803
protein O 0 0.055723097175359726
and O 0 0.03346255049109459
aniridia B-Disease 1 1.0
is O 0 0.03903132304549217
caused O 0 0.05260920524597168
due O 0 0.039493586868047714
to O 0 0.04861334338784218
genetic O 0 0.07832376658916473
haploinsufficiency O 1 0.9977516531944275
. O 0 0.05534141883254051

However O 0 0.03468748554587364
, O 0 0.02409113384783268
several O 0 0.024645378813147545
truncation O 1 0.9986541271209717
mutations O 0 0.05215228348970413
have O 0 0.01243449654430151
been O 0 0.01395073626190424
found O 0 0.01168085914105177
to O 0 0.01416487991809845
occur O 0 0.011557216756045818
in O 0 0.010990612208843231
the O 0 0.027988042682409286
C O 1 0.9999936819076538
- O 1 0.9999991655349731
terminal O 0 0.09307929128408432
half O 0 0.023529358208179474
of O 0 0.034895818680524826
PAX6 O 1 0.9999998807907104
in O 0 0.034772176295518875
patients O 1 0.8738555908203125
with O 0 0.03509284928441048
Aniridia B-Disease 1 1.0
resulting O 0 0.04709794372320175
in O 0 0.03056568279862404
mutant O 1 0.9641554951667786
proteins O 0 0.02426246739923954
that O 0 0.006164143793284893
retain O 0 0.02991519868373871
the O 0 0.023954028263688087
DNA O 0 0.06447664648294449
- O 1 0.9999973773956299
binding O 0 0.05517486482858658
domains O 0 0.041357576847076416
but O 0 0.010509560815989971
have O 0 0.006992465816438198
lost O 0 0.023944538086652756
most O 0 0.011451883241534233
of O 0 0.02175813354551792
the O 0 0.047367893159389496
transactivation O 1 0.9999805688858032
domain O 0 0.10084237903356552
. O 0 0.046025313436985016

It O 0 0.03056832030415535
is O 0 0.01892959326505661
not O 0 0.010810485109686852
clear O 0 0.020726541057229042
whether O 0 0.016999948769807816
such O 0 0.01843211054801941
mutants O 1 0.8922131061553955
really O 0 0.03773825243115425
behave O 0 0.033912092447280884
as O 0 0.016931772232055664
loss O 0 0.046280890703201294
- O 1 0.9999880790710449
of O 0 0.0393560491502285
- O 1 0.9999998807907104
function O 0 0.04502672702074051
mutants O 0 0.11184389889240265
as O 0 0.025227606296539307
predicted O 0 0.04226977005600929
by O 0 0.0401679128408432
haploinsufficiency O 1 0.9940590858459473
. O 0 0.05811185762286186

Contrary O 0 0.06776614487171173
to O 0 0.029018284752964973
this O 0 0.018759168684482574
theory O 0 0.032538946717977524
, O 0 0.017380326986312866
our O 0 0.021808559074997902
data O 0 0.01189842727035284
showed O 0 0.015202549286186695
that O 0 0.008020798675715923
these O 0 0.008258294314146042
mutants O 0 0.08127062767744064
are O 0 0.010668096132576466
dominant O 1 0.8525465726852417
- O 1 0.9999940395355225
negative O 0 0.043733224272727966
in O 0 0.03361435979604721
transient O 1 0.9998854398727417
transfection O 1 0.9999978542327881
assays O 0 0.08042294532060623
when O 0 0.02056831493973732
they O 0 0.007280325051397085
are O 0 0.0072900778613984585
coexpressed O 0 0.1144055426120758
with O 0 0.021787095814943314
wild O 0 0.07159370929002762
- O 1 0.9999998807907104
type O 1 0.8989752531051636
PAX6 O 1 0.9999997615814209
. O 0 0.06788428127765656

We O 0 0.019854238256812096
found O 0 0.010386088863015175
that O 0 0.0061418721452355385
the O 0 0.02158951200544834
dominant O 1 0.999393105506897
- O 1 0.9999998807907104
negative O 0 0.06226825341582298
effects O 0 0.041168734431266785
result O 0 0.021926216781139374
from O 0 0.01822066493332386
the O 0 0.03078927844762802
enhanced O 0 0.0788484737277031
DNA O 0 0.0472358800470829
binding O 0 0.03505498915910721
ability O 0 0.019561542198061943
of O 0 0.022337190806865692
these O 0 0.020150072872638702
mutants O 0 0.20082993805408478
. O 0 0.05045199766755104

Kinetic O 0 0.12943436205387115
studies O 0 0.025857562199234962
of O 0 0.027539286762475967
binding O 0 0.048856448382139206
and O 0 0.030337434262037277
dissociation O 1 0.9661523103713989
revealed O 0 0.03457930311560631
that O 0 0.010025584138929844
various O 0 0.015114904381334782
truncation O 0 0.45414283871650696
mutants O 0 0.1149526908993721
have O 0 0.012138532474637032
3 O 0 0.0451682023704052
- O 1 0.9997231364250183
5 O 0 0.05334324762225151
- O 1 0.9999222755432129
fold O 0 0.07302063703536987
higher O 0 0.03050445392727852
affinity O 0 0.04683947563171387
to O 0 0.01527344435453415
various O 0 0.01379589643329382
DNA O 0 0.05452248081564903
- O 1 0.999729573726654
binding O 0 0.03421439602971077
sites O 0 0.019497372210025787
when O 0 0.013696573674678802
compared O 0 0.012896625325083733
with O 0 0.010013268329203129
the O 0 0.022012174129486084
wild O 0 0.05968901142477989
- O 1 0.9999992847442627
type O 0 0.44330447912216187
PAX6 O 1 0.9999996423721313
. O 0 0.06661234050989151

These O 0 0.022703902795910835
results O 0 0.020471986383199692
provide O 0 0.020139355212450027
a O 0 0.02683199942111969
new O 0 0.03489338606595993
insight O 0 0.04607045277953148
into O 0 0.014937778934836388
the O 0 0.01616544835269451
role O 0 0.030660752207040787
of O 0 0.033961355686187744
mutant O 1 0.9985209107398987
PAX6 O 1 1.0
in O 0 0.05929567664861679
causing O 1 0.9996213912963867
aniridia B-Disease 1 1.0
. O 0 0.04182416573166847
. O 0 0.03963034227490425

Reversal O 0 0.16952428221702576
of O 0 0.09457921236753464
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9998550415039062
excellent O 1 0.998376727104187
neuropsychologic O 1 0.9999887943267822
outcome O 0 0.025007516145706177
in O 0 0.010372589342296124
very B-Disease 0 0.01484767533838749
- I-Disease 1 0.9989961981773376
long I-Disease 0 0.03261653333902359
- I-Disease 1 0.999951958656311
chain I-Disease 0 0.09075433015823364
acyl I-Disease 1 0.9999889135360718
- I-Disease 1 0.9999995231628418
coenzyme I-Disease 1 0.9998732805252075
A I-Disease 1 0.9999301433563232
dehydrogenase I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08001728355884552

Very B-Disease 0 0.03856903687119484
- I-Disease 1 0.9989455342292786
long I-Disease 0 0.042434606701135635
- I-Disease 1 0.9999586343765259
chain I-Disease 0 0.09199895709753036
acyl I-Disease 1 0.9999666213989258
- I-Disease 1 0.9999951124191284
coenzyme I-Disease 1 0.9944865107536316
A I-Disease 1 0.7081336975097656
dehydrogenase I-Disease 1 0.9999971389770508
( I-Disease 0 0.05878249555826187
VLCAD I-Disease 1 1.0
) I-Disease 0 0.08261509239673615
deficiency I-Disease 1 1.0
is O 0 0.02586694434285164
a O 0 0.04308433085680008
disorder O 1 1.0
of O 1 0.9993588328361511
fatty O 1 1.0
acid O 1 0.9999994039535522
beta O 1 0.9999910593032837
oxidation O 0 0.27348682284355164
that O 0 0.012127993628382683
reportedly O 0 0.03331372141838074
has O 0 0.014041777700185776
high O 0 0.03468388691544533
rates O 0 0.03140528127551079
of O 0 0.04577239602804184
morbidity O 1 0.9999998807907104
and O 0 0.06902796030044556
mortality O 1 0.9999434947967529
. O 0 0.06143960356712341

We O 0 0.024604033678770065
describe O 0 0.02932826429605484
the O 0 0.015705427154898643
outcome O 0 0.01910877414047718
of O 0 0.01386827602982521
a O 0 0.023221349343657494
5 O 0 0.03507194668054581
- O 1 0.9833121299743652
year O 0 0.021401694044470787
- O 1 0.9957740902900696
old O 0 0.059711966663599014
girl O 0 0.43838244676589966
with O 0 0.053397636860609055
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.24932898581027985
was O 0 0.0368136391043663
first O 0 0.027795881032943726
seen O 0 0.023887183517217636
at O 0 0.018662653863430023
5 O 0 0.01820373348891735
months O 0 0.012011373415589333
of O 0 0.012292538769543171
age O 0 0.022686554118990898
with O 0 0.03047262132167816
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 0 0.43185001611709595
and O 0 0.05838252604007721
hypotonia B-Disease 1 0.9999985694885254
. O 0 0.06174607202410698

Biochemical O 0 0.1491071879863739
studies O 0 0.046687982976436615
indicated O 0 0.12780246138572693
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9997096657752991
by O 0 0.0357259102165699
a O 0 0.043633874505758286
stable O 0 0.10096781700849533
yet O 0 0.051564253866672516
inactive O 1 0.9995589852333069
enzyme O 0 0.11829216778278351
. O 0 0.0427829772233963

Molecular O 0 0.11543317884206772
genetic O 0 0.03998313471674919
analysis O 0 0.014314367435872555
of O 0 0.020331010222434998
her O 0 0.057665787637233734
VLCAD O 1 0.9999998807907104
gene O 0 0.05054352059960365
revealed O 0 0.0363520011305809
a O 0 0.044768594205379486
T1372C O 1 0.9991402626037598
( O 0 0.05869622528553009
F458L O 1 0.9983933568000793
) O 0 0.046983540058135986
missense O 0 0.14636243879795074
mutation O 0 0.05872217193245888
and O 0 0.020187802612781525
a O 0 0.04790626838803291
1668 O 1 0.99997878074646
ACAG O 1 0.9999991655349731
1669 O 1 0.9999905824661255
splice O 1 0.9821313619613647
site O 0 0.08853834122419357
mutation O 0 0.08334791660308838
. O 0 0.03832476586103439

After O 0 0.05464949458837509
initial O 0 0.05731172114610672
treatment O 1 0.9927791953086853
with O 0 0.05086406692862511
intravenous O 1 1.0
glucose O 1 1.0
and O 0 0.29461297392845154
carnitine O 1 1.0
, O 0 0.030246082693338394
the O 0 0.03325553983449936
patient O 1 0.9920532703399658
has O 0 0.01958957314491272
thrived O 0 0.0537075474858284
on O 0 0.012249868363142014
a O 0 0.023729119449853897
low O 1 0.5551573038101196
- O 1 1.0
fat O 1 0.9706301689147949
diet O 0 0.07069399207830429
supplemented O 0 0.04155130311846733
with O 0 0.01972593553364277
medium O 0 0.0902039110660553
- O 1 0.9999985694885254
chain O 0 0.12483104318380356
triglyceride O 1 0.9971615076065063
oil O 0 0.06024865433573723
and O 0 0.046149883419275284
carnitine O 1 0.9999996423721313
and O 0 0.05179450660943985
avoidance O 1 0.9999978542327881
of O 0 0.07337217777967453
fasting O 1 0.9990085959434509
. O 0 0.06039522588253021

Her O 1 0.9998966455459595
ventricular O 1 1.0
hypertrophy O 1 1.0
resolved O 0 0.4603707194328308
significantly O 0 0.03884555771946907
over O 0 0.025238055735826492
1 O 0 0.03780966252088547
year O 0 0.0208043921738863
, O 0 0.021439023315906525
and O 0 0.026838090270757675
cognitively O 1 0.9999675750732422
, O 0 0.031170222908258438
she O 0 0.0267845019698143
is O 0 0.015026557259261608
in O 0 0.012708556838333607
the O 0 0.02473423071205616
superior O 0 0.06233219802379608
range O 0 0.03133653849363327
for O 0 0.027532581239938736
age O 0 0.05257340520620346
. O 0 0.046766962856054306

Clinical O 0 0.12426480650901794
recognition O 0 0.0581221841275692
of O 1 0.9995525479316711
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.4966100752353668
important O 0 0.02707161195576191
because O 0 0.015672488138079643
it O 0 0.008056007325649261
is O 0 0.008882838301360607
one O 0 0.008835935033857822
of O 0 0.011266987770795822
the O 0 0.016797205433249474
few O 0 0.017407624050974846
directly O 0 0.04187552630901337
treatable O 1 1.0
causes O 1 0.9999344348907471
of O 1 0.9999576807022095
cardiomyopathy B-Disease 1 1.0
in O 1 0.9916058778762817
children O 1 0.6569392085075378
. O 0 0.031454455107450485
. O 0 0.038971543312072754

Cloning O 0 0.09181354194879532
of O 0 0.026270901784300804
a O 0 0.0278270673006773
novel O 0 0.03890595957636833
member O 0 0.022520575672388077
of O 0 0.011890862137079239
the O 0 0.019510511308908463
low O 0 0.13108611106872559
- O 1 0.9999998807907104
density O 1 0.9204663038253784
lipoprotein O 1 1.0
receptor O 1 0.9997280240058899
family O 0 0.07404831051826477
. O 0 0.03891856223344803

A O 0 0.08355217427015305
gene O 0 0.04577123373746872
encoding O 0 0.03119121491909027
a O 0 0.032049067318439484
novel O 0 0.0947539284825325
transmembrane O 1 0.9988290667533875
protein O 0 0.0513676255941391
was O 0 0.031670451164245605
identified O 0 0.020766280591487885
by O 0 0.015519208274781704
DNA O 0 0.02657516673207283
sequence O 0 0.011613748967647552
analysis O 0 0.006407010834664106
within O 0 0.007777408231049776
the O 0 0.02244753949344158
insulin B-Disease 1 0.9999953508377075
- I-Disease 1 1.0
dependent I-Disease 1 0.999972939491272
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.998063862323761
IDDM B-Disease 1 0.9999998807907104
) O 0 0.0542546845972538
locus O 0 0.24933278560638428
IDDM4 O 1 0.9999527931213379
on O 0 0.05664750188589096
chromosome O 0 0.11926348507404327
11q13 O 1 0.9928138852119446
. O 0 0.04809947684407234

Based O 0 0.034555595368146896
on O 0 0.02025504969060421
its O 0 0.03422144055366516
chromosomal O 1 0.9426358938217163
position O 0 0.03933129459619522
, O 0 0.01982947066426277
this O 0 0.013447510078549385
gene O 0 0.02541087009012699
is O 0 0.012003261595964432
a O 0 0.01776188053190708
candidate O 0 0.032375216484069824
for O 0 0.0222539771348238
conferring O 1 0.866854727268219
susceptibility O 1 0.9999994039535522
to O 1 0.8185766339302063
diabetes B-Disease 1 1.0
. O 0 0.08085678517818451

The O 0 0.051239263266325
gene O 0 0.04034372419118881
, O 0 0.018371641635894775
termed O 0 0.059107620269060135
low O 0 0.0666380226612091
- O 1 0.999994158744812
density O 0 0.10936030745506287
lipoprotein O 1 1.0
receptor O 1 0.9999160766601562
related O 0 0.04843238368630409
protein O 0 0.04654204845428467
5 O 0 0.04016270115971565
( O 0 0.04221006855368614
LRP5 O 1 0.9999805688858032
) O 0 0.025882555171847343
, O 0 0.01851414516568184
encodes O 0 0.044977765530347824
a O 0 0.032332342118024826
protein O 0 0.039491649717092514
of O 0 0.03599308803677559
1615 O 1 0.9971628785133362
amino O 0 0.07509253174066544
acids O 0 0.038157880306243896
that O 0 0.012694367207586765
contains O 0 0.0323612317442894
conserved O 0 0.05201583728194237
modules O 0 0.05465610697865486
which O 0 0.00996413454413414
are O 0 0.005610959138721228
characteristic O 0 0.020690055564045906
of O 0 0.01283716969192028
the O 0 0.0221074391156435
low O 0 0.15629397332668304
- O 1 0.9999997615814209
density O 1 0.5772861838340759
lipoprotein O 1 1.0
( O 1 0.8332608938217163
LDL O 1 1.0
) O 0 0.0703875795006752
receptor O 1 0.6556092500686646
family O 0 0.058428000658750534
. O 0 0.04024752229452133

These O 0 0.0298737995326519
modules O 0 0.05976003780961037
include O 0 0.021135173738002777
a O 0 0.037064775824546814
putative O 1 0.9257639050483704
signal O 0 0.08292213827371597
peptide O 0 0.094533272087574
for O 0 0.02674134448170662
protein O 0 0.03424755111336708
export O 0 0.021585220471024513
, O 0 0.015128751285374165
four O 0 0.02779432199895382
epidermal O 1 0.9999972581863403
growth O 0 0.07766206562519073
factor O 1 0.898389995098114
( O 0 0.07540502399206161
EGF O 1 0.9999998807907104
) O 0 0.03561047092080116
repeats O 0 0.04943951964378357
with O 0 0.017996689304709435
associated O 0 0.035732388496398926
spacer O 1 0.6394686698913574
domains O 0 0.05139053612947464
, O 0 0.01716540940105915
three O 0 0.028934692963957787
LDL O 1 1.0
- O 1 1.0
receptor O 1 0.9997381567955017
( O 0 0.0461958609521389
LDLR O 1 0.9999775886535645
) O 0 0.03120463341474533
repeats O 0 0.04567016661167145
, O 0 0.016112137585878372
a O 0 0.026943586766719818
single O 0 0.05983950197696686
transmembrane O 0 0.4338715374469757
spanning O 0 0.06820666790008545
domain O 0 0.06068788468837738
, O 0 0.019437598064541817
and O 0 0.019480597227811813
a O 0 0.04990642890334129
cytoplasmic O 1 0.9950732588768005
domain O 0 0.07696594297885895
. O 0 0.03506746143102646

The O 0 0.062203459441661835
encoded O 0 0.06468518078327179
protein O 0 0.034505996853113174
has O 0 0.012549255974590778
a O 0 0.017011500895023346
unique O 0 0.017656121402978897
organization O 0 0.031192900612950325
of O 0 0.04282074794173241
EGF O 1 1.0
and O 0 0.05727066472172737
LDLR O 1 1.0
repeats O 0 0.11232133954763412
; O 0 0.031011715531349182
therefore O 0 0.027043242007493973
, O 0 0.03132941946387291
LRP5 O 1 0.9999712705612183
likely O 0 0.032041750848293304
represents O 0 0.03292951360344887
a O 0 0.021099824458360672
new O 0 0.02425597794353962
category O 0 0.03066728636622429
of O 0 0.02137785218656063
the O 0 0.04919500648975372
LDLR O 1 0.9999998807907104
family O 0 0.08190496265888214
. O 0 0.04860956221818924

Both O 0 0.04102633148431778
human O 0 0.04450181871652603
and O 0 0.041735026985406876
mouse O 1 0.676964282989502
LRP5 O 1 0.9999998807907104
cDNAs O 1 0.999868631362915
have O 0 0.015144269913434982
been O 0 0.02047119289636612
isolated O 0 0.05339252948760986
and O 0 0.018467286601662636
the O 0 0.03390835225582123
encoded O 0 0.060427598655223846
mature O 0 0.07915634661912918
proteins O 0 0.03395047038793564
are O 0 0.008414839394390583
95 O 0 0.04380415007472038
% O 0 0.026386866346001625
identical O 0 0.02597758173942566
, O 0 0.0195668563246727
indicating O 0 0.03316668048501015
a O 0 0.02779846452176571
high O 0 0.047084249556064606
degree O 0 0.03946104273200035
of O 0 0.03516632318496704
evolutionary O 0 0.06566747277975082
conservation O 0 0.06649243086576462
. O 0 0.027074282988905907
. O 0 0.035753972828388214

The O 0 0.0815165787935257
APC B-Disease 1 0.9999388456344604
variants O 0 0.07281427085399628
I1307K O 1 0.8904527425765991
and O 0 0.03171367198228836
E1317Q O 1 0.8368902802467346
are O 0 0.01056140661239624
associated O 0 0.03559714928269386
with O 1 0.9918988943099976
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.7623239159584045
but O 0 0.02033267356455326
not O 0 0.010739770717918873
always O 0 0.015888383612036705
with O 0 0.012807797640562057
a O 0 0.028095517307519913
family O 0 0.047162532806396484
history O 0 0.04436789080500603
. O 0 0.042296528816223145

Classical O 0 0.14257840812206268
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999984502792358
FAP B-Disease 1 1.0
) O 0 0.028513973578810692
is O 0 0.011015747673809528
a O 0 0.016806576400995255
high O 0 0.048685092478990555
- O 1 0.9999997615814209
penetrance O 1 0.9999997615814209
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 0.030494553968310356
predisposes O 1 0.999976634979248
to O 0 0.022662650793790817
hundreds O 0 0.020170388743281364
or O 0 0.011216042563319206
thousands O 0 0.02979082427918911
of O 1 0.869655191898346
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.04135803505778313
that O 0 0.014336667023599148
results O 0 0.014124040491878986
from O 0 0.020750800147652626
truncating O 1 0.9391718506813049
mutations O 0 0.03868921101093292
in O 0 0.018242694437503815
the O 0 0.051867980509996414
APC B-Disease 1 0.9999996423721313
gene O 0 0.07837582379579544
. O 0 0.037179041653871536

A O 0 0.06677037477493286
variant O 0 0.06771833449602127
of O 0 0.0424337200820446
FAP B-Disease 1 1.0
is O 0 0.06222862750291824
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.03539709746837616
which O 0 0.013447479344904423
results O 0 0.013998215086758137
from O 0 0.02566573955118656
germ O 1 1.0
- O 1 0.9999996423721313
line O 0 0.06271275132894516
mutations O 0 0.031391434371471405
in O 0 0.013142101466655731
the O 0 0.02270222082734108
5 O 0 0.032465942203998566
and O 0 0.018577368929982185
3 O 0 0.028898445889353752
regions O 0 0.016199374571442604
of O 0 0.021554898470640182
the O 0 0.05489858612418175
APC B-Disease 1 0.9999997615814209
gene O 0 0.0837239995598793
. O 0 0.04570502042770386

Attenuated B-Disease 1 0.9999982118606567
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999998807907104
have O 0 0.022146524861454964
" O 0 0.04021942988038063
multiple O 0 0.04528231546282768
" O 1 0.9999876022338867
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.11037001758813858
typically O 0 0.02661188878118992
fewer O 0 0.017605774104595184
than O 0 0.011829591356217861
100 O 0 0.02823125384747982
) O 0 0.01699524000287056
without O 0 0.013209426775574684
the O 0 0.030550936236977577
florid O 1 0.9997627139091492
phenotype O 0 0.13801226019859314
of O 0 0.05618695169687271
classical O 0 0.13871408998966217
FAP B-Disease 1 1.0
. O 0 0.07407160103321075

Another O 0 0.05734233558177948
group O 0 0.05277656018733978
of O 0 0.03789922595024109
patients O 1 0.998860239982605
with O 0 0.037917446345090866
multiple O 0 0.0734885111451149
adenomas B-Disease 1 1.0
has O 0 0.03603034466505051
no O 0 0.024678513407707214
mutations O 0 0.027946757152676582
in O 0 0.01533492747694254
the O 0 0.04357462748885155
APC B-Disease 1 1.0
gene O 0 0.05464411526918411
, O 0 0.020369352772831917
and O 0 0.016944855451583862
their O 0 0.026377510279417038
phenotype O 0 0.40469884872436523
probably O 0 0.022700129076838493
results O 0 0.010495971888303757
from O 0 0.012178153730928898
variation O 0 0.024051090702414513
at O 0 0.02407463826239109
a O 0 0.037583548575639725
locus O 1 0.9955928921699524
, O 0 0.038356177508831024
or O 0 0.03903502598404884
loci O 0 0.10460899770259857
, O 0 0.02432965859770775
elsewhere O 0 0.022733347490429878
in O 0 0.01747513934969902
the O 0 0.037189967930316925
genome O 0 0.06509014964103699
. O 0 0.03883235901594162

Recently O 0 0.07486065477132797
, O 0 0.023745929822325706
however O 0 0.012676958926022053
, O 0 0.013278422877192497
a O 0 0.024750854820013046
missense O 0 0.11565394699573517
variant O 0 0.07454729080200195
of O 0 0.05075358599424362
APC B-Disease 1 1.0
( O 0 0.061591800302267075
I1307K O 1 0.999975323677063
) O 0 0.025219015777111053
was O 0 0.02494063600897789
described O 0 0.022135984152555466
that O 0 0.009216847829520702
confers O 0 0.056986644864082336
an O 0 0.014928841963410378
increased O 0 0.023578446358442307
risk O 1 0.5154581665992737
of O 1 0.9999911785125732
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.700456440448761
including O 0 0.03971502184867859
multiple O 0 0.13321486115455627
adenomas B-Disease 1 1.0
, O 0 0.039073992520570755
in O 0 0.039010871201753616
Ashkenazim O 1 0.999811589717865
. O 0 0.054495882242918015

We O 0 0.024790171533823013
have O 0 0.009770830161869526
studied O 0 0.01735609583556652
a O 0 0.015134353190660477
set O 0 0.014527194201946259
of O 0 0.017968716099858284
164 O 0 0.105201356112957
patients O 1 0.7604867219924927
with O 0 0.030826536938548088
multiple O 1 0.9991979002952576
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999972581863403
/ I-Disease 1 1.0
or I-Disease 1 0.9959763884544373
carcinoma I-Disease 1 1.0
and O 0 0.029287874698638916
analyzed O 0 0.041928742080926895
codons O 0 0.10287382453680038
1263 O 1 0.9999535083770752
- O 1 0.9999988079071045
1377 O 1 0.9999374151229858
( O 0 0.055394601076841354
exon O 1 0.9179600477218628
15G O 1 0.9917504191398621
) O 0 0.01906033232808113
of O 0 0.016097277402877808
the O 0 0.03358658403158188
APC B-Disease 1 0.9999774694442749
gene O 0 0.043614618480205536
for O 0 0.03597651422023773
germ O 1 0.9999998807907104
- O 1 0.9999992847442627
line O 0 0.0827530100941658
variants O 0 0.058135513216257095
. O 0 0.0361345112323761

Three O 0 0.042615439742803574
patients O 0 0.10574385523796082
with O 0 0.025674117729067802
the O 0 0.050907183438539505
I1307K O 1 0.9999947547912598
allele O 0 0.10938951373100281
were O 0 0.022348931059241295
detected O 0 0.042255550622940063
, O 0 0.014605714939534664
each O 0 0.010360130108892918
of O 0 0.03434726968407631
Ashkenazi O 1 0.9991734623908997
descent O 0 0.11505528539419174
. O 0 0.048333171755075455

Four O 0 0.04709640517830849
patients O 0 0.07905614376068115
had O 0 0.02817661128938198
a O 0 0.05255621299147606
germ O 1 1.0
- O 1 0.9999971389770508
line O 0 0.0701357051730156
E1317Q O 1 0.9908801317214966
missense O 0 0.2073649913072586
variant O 0 0.0767604410648346
of O 0 0.047053154557943344
APC O 1 0.999990701675415
that O 0 0.016130276024341583
was O 0 0.025084633380174637
not O 0 0.00937129557132721
present O 0 0.01784343086183071
in O 0 0.019688310101628304
controls O 0 0.048925139009952545
; O 0 0.0207801703363657
one O 0 0.015624752268195152
of O 0 0.01971261017024517
these O 0 0.010228664614260197
individuals O 0 0.014394277706742287
had O 0 0.01916574314236641
an O 0 0.020598480477929115
unusually O 0 0.043900199234485626
large O 0 0.016624853014945984
number O 0 0.013706226833164692
of O 0 0.03716805949807167
metaplastic B-Disease 1 0.999997615814209
polyps I-Disease 1 0.999996542930603
of I-Disease 0 0.048007939010858536
the I-Disease 0 0.06294706463813782
colorectum I-Disease 1 0.9998155236244202
. O 0 0.056709788739681244

There O 0 0.0318710058927536
is O 0 0.021423911675810814
increasing O 0 0.023385995998978615
evidence O 0 0.016096899285912514
that O 0 0.008356964215636253
there O 0 0.011426442302763462
exist O 0 0.030808519572019577
germ O 1 0.9999997615814209
- O 1 0.9999773502349854
line O 0 0.04835772514343262
variants O 0 0.02387833409011364
of O 0 0.02025034837424755
the O 0 0.04300091788172722
APC B-Disease 1 0.9999998807907104
gene O 0 0.04946507140994072
that O 0 0.01726648397743702
predispose O 0 0.08866702020168304
to O 0 0.013377093710005283
the O 0 0.014645778574049473
development O 0 0.018441949039697647
of O 0 0.02753707394003868
multiple O 1 0.9951304197311401
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.039587028324604034
but O 0 0.013478048145771027
without O 0 0.011384528130292892
the O 0 0.025921080261468887
florid O 1 0.9999557733535767
phenotype O 0 0.10427557677030563
of O 0 0.04258552938699722
classical O 1 0.658833384513855
FAP B-Disease 1 1.0
, O 0 0.02823360078036785
and O 0 0.013113874942064285
possibly O 0 0.014578646048903465
with O 0 0.009239868260920048
importance O 0 0.03276803344488144
for O 1 0.9999383687973022
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 1.0
in O 0 0.025642942637205124
the O 0 0.026120347902178764
general O 0 0.038518428802490234
population O 0 0.024877678602933884
. O 0 0.022910969331860542
. O 0 0.03263139724731445

Genomic O 0 0.09710594266653061
structure O 0 0.024204730987548828
of O 0 0.01608198508620262
the O 0 0.03230687230825424
human O 1 0.9999758005142212
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.07651054859161377
gene O 0 0.05211595073342323
. O 0 0.03359762951731682

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.04861569404602051
is O 0 0.024542896077036858
caused O 0 0.03524812310934067
by O 0 0.019364679232239723
mutations O 0 0.023968147113919258
in O 0 0.011350460350513458
a O 0 0.02352921850979328
gene O 0 0.026499442756175995
which O 0 0.014833467081189156
encodes O 0 0.06847710907459259
an O 0 0.059488069266080856
intestinal O 1 1.0
anion O 1 1.0
transporter O 1 0.999998927116394
. O 0 0.06230498105287552

We O 0 0.026650141924619675
report O 0 0.019143080338835716
here O 0 0.013615564443171024
the O 0 0.016719402745366096
complete O 0 0.038821615278720856
genomic O 0 0.05790538713335991
organization O 0 0.028930796310305595
of O 0 0.019294997677206993
the O 0 0.030901925638318062
human O 0 0.06431673467159271
CLD B-Disease 1 1.0
gene O 0 0.057323310524225235
which O 0 0.01878204755485058
spans O 0 0.05649593099951744
approximately O 0 0.03571886569261551
39kb O 1 0.9979137778282166
, O 0 0.02753211371600628
and O 0 0.024004582315683365
comprises O 0 0.06610184907913208
21 O 0 0.06601395457983017
exons O 0 0.13207580149173737
. O 0 0.04633617401123047

All O 0 0.058292970061302185
exon O 1 0.9916223883628845
/ O 1 0.9988349080085754
intron O 1 0.9740468263626099
boundaries O 0 0.0324767529964447
conform O 0 0.044476624578237534
to O 0 0.020153339952230453
the O 0 0.040650904178619385
GT O 1 0.999998927116394
/ O 1 0.9999992847442627
AG O 1 0.9999990463256836
rule O 0 0.08143691718578339
. O 0 0.04861707240343094

An O 0 0.03285614773631096
analysis O 0 0.015097743831574917
of O 0 0.017090754583477974
the O 0 0.035267699509859085
putative O 1 0.9990777969360352
promoter O 1 0.8825900554656982
region O 0 0.034968312829732895
sequence O 0 0.018994202837347984
shows O 0 0.014203871600329876
a O 0 0.032619211822748184
putative O 1 0.9995352029800415
TATA O 1 1.0
box O 0 0.10325434058904648
and O 0 0.029825210571289062
predicts O 0 0.09387210756540298
multiple O 0 0.04749355837702751
transcription O 0 0.30327755212783813
factor O 0 0.0850633904337883
binding O 0 0.05711713805794716
sites O 0 0.037382662296295166
. O 0 0.03156641870737076

The O 0 0.06585678458213806
genomic O 0 0.11134080588817596
structure O 0 0.05505627393722534
was O 0 0.038434725254774094
determined O 0 0.03395671397447586
using O 0 0.018489953130483627
DNA O 0 0.02690155990421772
from O 0 0.011499310843646526
several O 0 0.008285545744001865
sources O 0 0.012092607095837593
including O 0 0.012710817158222198
multiple O 0 0.02556399442255497
large O 0 0.04015316814184189
- O 1 0.9999945163726807
insert O 1 0.6914101243019104
libaries O 1 0.9821177124977112
and O 0 0.02955002896487713
genomic O 0 0.06336501985788345
DNA O 0 0.035492777824401855
from O 0 0.031758472323417664
Finnish O 1 0.999955415725708
CLD B-Disease 1 1.0
patients O 1 0.9999971389770508
and O 0 0.05079120397567749
controls O 0 0.08827341347932816
. O 0 0.049060750752687454

Exon O 1 0.9996864795684814
- O 1 0.9998084902763367
specific O 0 0.040927767753601074
primers O 0 0.368314266204834
developed O 0 0.037158239632844925
in O 0 0.016167262569069862
this O 0 0.011338443495333195
study O 0 0.01800432801246643
will O 0 0.016715656965970993
facilitate O 0 0.06281573325395584
mutation O 0 0.0781257152557373
screening O 0 0.07380590587854385
studies O 0 0.02096877247095108
of O 0 0.031021922826766968
patients O 1 0.9997963309288025
with O 0 0.036515314131975174
the O 1 0.9775445461273193
disease O 1 1.0
. O 0 0.0646020695567131

Genomic O 0 0.11406368017196655
sequencing O 0 0.044833216816186905
of O 0 0.02528695948421955
a O 0 0.05448945239186287
BAC O 1 0.9999998807907104
clone O 1 0.9999872446060181
H O 1 0.9999998807907104
_ O 0 0.06582821905612946
RG364P16 O 1 0.9517783522605896
revealed O 0 0.033156923949718475
the O 0 0.01873406581580639
presence O 0 0.027352018281817436
of O 0 0.01873696781694889
another O 0 0.02883877046406269
, O 0 0.02130817249417305
highly O 0 0.04555767402052879
homologous O 0 0.09246445447206497
gene O 0 0.03638991713523865
3 O 0 0.0246359221637249
of O 0 0.02250376157462597
the O 0 0.049837157130241394
CLD B-Disease 1 1.0
gene O 0 0.05376620590686798
, O 0 0.01644255220890045
with O 0 0.013192567974328995
a O 0 0.025057505816221237
similar O 0 0.02442285045981407
genomic O 0 0.07562209665775299
structure O 0 0.032632723450660706
, O 0 0.014987592585384846
recently O 0 0.018798815086483955
identified O 0 0.012421748600900173
as O 0 0.011592317372560501
the O 0 0.037856925278902054
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999855756759644
( O 1 0.9782957434654236
PDS B-Disease 1 1.0
) O 0 0.04637104272842407
. O 0 0.026787400245666504
. O 0 0.03289606422185898

The O 0 0.06810539960861206
APCI1307K O 1 0.9999995231628418
allele O 1 0.9391738772392273
and O 0 0.05597590655088425
cancer B-Disease 1 1.0
risk O 1 0.9672876000404358
in O 0 0.02115717902779579
a O 0 0.029459113255143166
community O 0 0.04586911201477051
- O 1 0.9993832111358643
based O 0 0.023082058876752853
study O 0 0.016883479431271553
of O 0 0.03163066878914833
Ashkenazi O 1 0.9969101548194885
Jews O 0 0.09954886883497238
. O 0 0.04991357773542404

Mutations O 0 0.09171098470687866
in O 0 0.03711135685443878
APC O 1 0.9999629259109497
are O 0 0.017357314005494118
classically O 1 0.691301167011261
associated O 0 0.027380235493183136
with O 0 0.0354803167283535
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.030565207824110985
, O 0 0.01340347621589899
a O 0 0.021335361525416374
highly O 0 0.054001517593860626
penetrant O 1 0.9999996423721313
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999988079071045
by O 1 0.8241339921951294
multiple O 1 0.9999845027923584
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.07252278923988342
, O 0 0.02776484191417694
without O 0 0.025830373167991638
surgical O 1 1.0
intervention O 1 0.9952234625816345
, O 0 0.013482081703841686
the O 0 0.013879276812076569
development O 0 0.026295511052012444
of O 1 0.9993108510971069
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999996423721313
CRC B-Disease 1 1.0
) O 0 0.04496666416525841
. O 0 0.03686220943927765

APC B-Disease 1 0.9985195994377136
is O 0 0.025596745312213898
a O 0 0.05107865482568741
tumour O 1 1.0
- O 1 1.0
suppressor O 1 1.0
gene O 0 0.04566068574786186
, O 0 0.017741316929459572
and O 0 0.022717757150530815
somatic O 1 0.9950785636901855
loss O 1 0.8848250508308411
occurs O 0 0.05342064052820206
in O 0 0.053260400891304016
tumours B-Disease 1 1.0
. O 0 0.07495879381895065

The O 0 0.06690993160009384
germline O 1 0.9999473094940186
T O 1 0.9999978542327881
- O 1 0.9994660019874573
to O 0 0.029554333537817
- O 1 0.9994551539421082
A O 0 0.055697061121463776
transversion O 1 0.9735370874404907
responsible O 0 0.0324808694422245
for O 0 0.017015909776091576
the O 0 0.03704754263162613
APC O 1 0.9999984502792358
I1307K O 1 0.999609649181366
allele O 0 0.10565707832574844
converts O 0 0.055295977741479874
the O 0 0.02257711812853813
wild O 0 0.05226178467273712
- O 1 0.9997846484184265
type O 0 0.03684262931346893
sequence O 0 0.011912193149328232
to O 0 0.012178267352283001
a O 0 0.03614255413413048
homopolymer O 1 0.9999998807907104
tract O 1 1.0
( O 1 0.9805785417556763
A8 O 1 1.0
) O 0 0.02605249173939228
that O 0 0.010429572314023972
is O 0 0.020286360755562782
genetically O 0 0.05569297447800636
unstable O 1 0.9985606074333191
and O 0 0.03868335485458374
prone O 1 0.999388575553894
to O 0 0.06176186725497246
somatic O 1 0.9997766613960266
mutation O 0 0.1118537187576294
. O 0 0.047211457043886185

The O 0 0.07276975363492966
I1307K O 1 0.999447762966156
allele O 0 0.12726731598377228
was O 0 0.043591294437646866
found O 0 0.020086536183953285
in O 0 0.022769242525100708
6 O 0 0.06531576067209244
. O 0 0.04514620825648308

1 O 0 0.06666230410337448
% O 0 0.02909281849861145
of O 0 0.04113870486617088
unselected O 1 0.9992862343788147
Ashkenazi O 1 0.9992857575416565
Jews O 0 0.075050488114357
and O 0 0.024098334833979607
higher O 0 0.02836902253329754
proportions O 0 0.06969854980707169
of O 0 0.04149719700217247
Ashkenazim O 1 0.9999494552612305
with O 0 0.032592736184597015
family O 0 0.04165666922926903
or O 0 0.020024428144097328
personal O 0 0.036467600613832474
histories O 0 0.06443584710359573
of O 0 0.06069508567452431
CRC B-Disease 1 1.0
( O 0 0.07381780445575714
ref O 1 0.9999793767929077
. O 0 0.02966957539319992
2 O 0 0.0581335611641407
) O 0 0.0339379608631134
. O 0 0.03244427964091301

To O 0 0.0382659025490284
evaluate O 0 0.050326209515333176
the O 0 0.020587805658578873
role O 0 0.03449602425098419
of O 0 0.03669433295726776
I1307K O 1 0.9999982118606567
in O 0 0.05859275162220001
cancer B-Disease 1 1.0
, O 0 0.030883759260177612
we O 0 0.023227646946907043
genotyped O 1 0.9900777339935303
5 O 0 0.04706030339002609
, O 0 0.037447597831487656
081 O 1 0.999715268611908
Ashkenazi O 1 0.9847986102104187
volunteers O 0 0.0708712488412857
in O 0 0.020201049745082855
a O 0 0.032317135483026505
community O 0 0.04464607685804367
survey O 0 0.04286536946892738
. O 0 0.03710414096713066

Risk O 0 0.08272121846675873
of O 0 0.04825815185904503
developing O 1 0.9999862909317017
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999927282333374
breast I-Disease 1 1.0
and I-Disease 0 0.11426468193531036
other I-Disease 0 0.034389954060316086
cancers I-Disease 1 0.9999966621398926
were O 0 0.015789993107318878
compared O 0 0.02238543890416622
between O 0 0.03325219824910164
genotyped O 1 0.9999583959579468
I1307K O 1 0.9999159574508667
carriers O 0 0.07562736421823502
and O 0 0.028074683621525764
non O 1 0.9407851696014404
- O 1 0.9999966621398926
carriers O 0 0.05436258390545845
and O 0 0.012831978499889374
their O 0 0.012320969253778458
first O 0 0.036779094487428665
- O 1 0.9997836947441101
degree O 0 0.054693397134542465
relatives O 0 0.08203450590372086
. O 0 0.042782142758369446

Sperm O 0 0.11285372823476791
DNA O 0 0.04143324866890907
analysis O 0 0.013025099411606789
in O 0 0.013923739083111286
a O 0 0.05132874473929405
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999998807907104
carrier O 1 0.9998213648796082
suggests O 0 0.04704613983631134
both O 0 0.02687709778547287
meiotic O 1 0.9997362494468689
and O 0 0.039425015449523926
mitotic O 1 0.9947471022605896
expansion O 0 0.05779675394296646
in O 0 0.019847966730594635
the O 0 0.04647856950759888
FRDA B-Disease 1 0.9999998807907104
gene O 0 0.07196669280529022
. O 0 0.039694804698228836

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.06375837326049805
usually O 0 0.03487822413444519
caused O 0 0.038724783807992935
by O 0 0.01625906303524971
an O 0 0.018211105838418007
expansion O 0 0.03174716606736183
of O 0 0.019789718091487885
a O 0 0.03873511776328087
GAA O 1 0.9140672087669373
trinucleotide O 1 0.9974368810653687
repeat O 0 0.09876388311386108
in O 0 0.03414538875222206
intron O 1 0.9996219873428345
1 O 0 0.04058799520134926
of O 0 0.02562161721289158
the O 0 0.050316184759140015
FRDA B-Disease 1 0.9999996423721313
gene O 0 0.07430697232484818
. O 0 0.0382489413022995

Occasionally O 0 0.06749016791582108
, O 0 0.02677019312977791
a O 0 0.033896125853061676
fully O 0 0.05135006085038185
expanded O 0 0.059867944568395615
allele O 0 0.09786656498908997
has O 0 0.023289134725928307
been O 0 0.015993522480130196
found O 0 0.015394007787108421
to O 0 0.021319326013326645
arise O 0 0.03724461793899536
from O 0 0.01747008040547371
a O 0 0.03427822142839432
premutation O 1 0.9949080348014832
of O 0 0.02749350294470787
100 O 0 0.036967214196920395
or O 0 0.025069942697882652
less O 0 0.036514781415462494
triplet O 1 0.9997671246528625
repeats O 0 0.12396521121263504
. O 0 0.04677535966038704

We O 0 0.024083929136395454
have O 0 0.01016472838819027
examined O 0 0.036950886249542236
the O 0 0.025634795427322388
sperm O 0 0.049596212804317474
DNA O 0 0.02919774129986763
of O 0 0.02198532037436962
a O 0 0.047806400805711746
premutation O 1 0.9995951056480408
carrier O 1 0.8938519954681396
. O 0 0.04565495625138283

This O 0 0.04396861419081688
mans O 0 0.24350939691066742
leucocyte O 1 0.9955020546913147
DNA O 0 0.051156383007764816
showed O 0 0.02852391079068184
one O 0 0.024382200092077255
normal O 0 0.0487632229924202
allele O 0 0.08270634710788727
and O 0 0.019083311781287193
one O 0 0.025027871131896973
allele O 0 0.06806192547082901
of O 0 0.025268178433179855
approximately O 0 0.028027459979057312
100 O 0 0.049734558910131454
repeats O 0 0.09376277029514313
. O 0 0.046607423573732376

His O 0 0.077939473092556
sperm O 0 0.06857814639806747
showed O 0 0.026156576350331306
an O 0 0.02182786539196968
expanded O 0 0.044808994978666306
allele O 0 0.08112930506467819
in O 0 0.019805217161774635
a O 0 0.035390812903642654
tight O 0 0.0622367262840271
range O 0 0.032636966556310654
centering O 0 0.09363894164562225
on O 0 0.020658576861023903
a O 0 0.022667111828923225
size O 0 0.0175427608191967
of O 0 0.019431021064519882
approximately O 0 0.03539062291383743
320 O 0 0.13833190500736237
trinucleotide O 1 0.9987078905105591
repeats O 0 0.14796459674835205
. O 0 0.056078821420669556

His O 0 0.07638134062290192
affected O 0 0.06550456583499908
son O 1 0.9970613121986389
has O 0 0.034115880727767944
repeat O 0 0.08163683116436005
sizes O 0 0.03288332745432854
of O 0 0.045457057654857635
1040 O 1 0.9992544054985046
and O 0 0.04482362046837807
540 O 0 0.23100599646568298
. O 0 0.04888268932700157

These O 0 0.02439003810286522
data O 0 0.018007133156061172
suggest O 0 0.02023359015583992
that O 0 0.013095448724925518
expansion O 0 0.04996180534362793
occurs O 0 0.027105996385216713
in O 0 0.014943251386284828
two O 0 0.017489487305283546
stages O 0 0.04412310570478439
, O 0 0.02057165838778019
the O 0 0.022277750074863434
first O 0 0.03077017515897751
during O 0 0.044340699911117554
meiosis O 0 0.14138458669185638
followed O 0 0.03656066954135895
by O 0 0.018864355981349945
a O 0 0.032643213868141174
second O 0 0.06605386734008789
mitotic O 1 0.9964283108711243
expansion O 0 0.10069042444229126
. O 0 0.053756728768348694

We O 0 0.03102884441614151
also O 0 0.022094978019595146
show O 0 0.020014895126223564
that O 0 0.008505976758897305
in O 0 0.012366360053420067
all O 0 0.016296682879328728
informative O 0 0.0787120908498764
carrier O 0 0.11831479519605637
father O 0 0.05785008519887924
to O 0 0.033886220306158066
affected O 0 0.05561726167798042
child O 1 0.9953101277351379
transmissions O 0 0.08978147059679031
, O 0 0.020540602505207062
with O 0 0.013640779070556164
the O 0 0.0192802045494318
notable O 0 0.0272049643099308
exception O 0 0.029065251350402832
of O 0 0.021080052480101585
the O 0 0.0380302257835865
premutation O 1 0.9999891519546509
carrier O 1 0.8792213797569275
, O 0 0.01869114488363266
the O 0 0.02124299295246601
expansion O 0 0.05655118450522423
size O 0 0.04247407242655754
decreases O 0 0.07204359024763107
. O 0 0.026564735919237137
. O 0 0.03460704907774925

The O 0 0.06451239436864853
R496H O 1 0.9898903369903564
mutation O 0 0.07389497756958008
of O 0 0.042401235550642014
arylsulfatase O 1 0.9999731779098511
A O 0 0.066378653049469
does O 0 0.02607741579413414
not O 0 0.024420786648988724
cause O 1 0.8331869840621948
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.09268994629383087

Deficiency B-Disease 1 1.0
of I-Disease 0 0.05917704105377197
arylsulfatase I-Disease 1 0.999998927116394
A I-Disease 1 0.8297357559204102
( O 0 0.054248299449682236
ARSA O 1 1.0
) O 0 0.04789534956216812
enzyme O 0 0.09232105314731598
activity O 0 0.05238352715969086
causes O 1 0.9982195496559143
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9978627562522888
MLD B-Disease 1 1.0
) O 0 0.058977097272872925
. O 0 0.04407992213964462

A O 0 0.053154557943344116
number O 0 0.020341044291853905
of O 0 0.04738672822713852
ARSA O 1 0.9999998807907104
gene O 0 0.0860910415649414
mutations O 0 0.05746147781610489
responsible O 0 0.06275667995214462
for O 0 0.05354688689112663
MLD B-Disease 1 1.0
have O 0 0.02119520865380764
been O 0 0.023398185148835182
identified O 0 0.03765598312020302
. O 0 0.03482000529766083

Recently O 0 0.05585308000445366
, O 0 0.020999757573008537
the O 0 0.03244204819202423
R496H O 1 0.9993098974227905
mutation O 0 0.07906031608581543
of O 0 0.048581235110759735
ARSA O 1 0.9999998807907104
was O 0 0.037400152534246445
proposed O 0 0.02030310034751892
to O 0 0.012189182452857494
be O 0 0.008437100797891617
a O 0 0.021846828982234
cause O 0 0.043764714151620865
of O 0 0.05308021605014801
MLD B-Disease 1 1.0
( O 0 0.06738997250795364
Draghia O 1 0.9999980926513672
et O 1 0.5996044874191284
al O 1 0.7711294293403625
. O 0 0.020547490566968918
, O 0 0.026224931702017784
1997 O 0 0.05257920175790787
) O 0 0.03604282811284065
. O 0 0.03664558753371239

We O 0 0.021687934175133705
have O 0 0.011125899851322174
investigated O 0 0.043813932687044144
the O 0 0.04119371250271797
R496H O 1 0.99998939037323
mutation O 0 0.07848148792982101
and O 0 0.02069832943379879
found O 0 0.01597687229514122
this O 0 0.014810905791819096
mutation O 0 0.045213647186756134
at O 0 0.024115104228258133
a O 0 0.025527533143758774
relatively O 0 0.026842525228857994
high O 0 0.038364559412002563
frequency O 0 0.02295350655913353
in O 0 0.009695296175777912
an O 0 0.013888468034565449
African O 0 0.035476766526699066
American O 0 0.031693968921899796
population O 0 0.024095363914966583
( O 0 0.03724190220236778
f O 0 0.11583776026964188
= O 0 0.07744388282299042
0 O 0 0.05833053961396217
. O 0 0.021465618163347244
09 O 0 0.11727313697338104
, O 0 0.03687116503715515
n O 0 0.11299576610326767
= O 0 0.09012258797883987
61 O 0 0.09439243376255035
subjects O 0 0.05870779603719711
) O 0 0.03643367066979408
. O 0 0.0355958417057991

The O 0 0.11318992078304291
ARSA O 1 1.0
enzyme O 1 0.9429344534873962
activity O 0 0.04277336224913597
in O 0 0.02035808004438877
subjects O 0 0.02933221496641636
with O 0 0.015239058062434196
and O 0 0.014058075845241547
without O 0 0.015039590187370777
the O 0 0.035462088882923126
R496H O 1 0.9999985694885254
mutation O 0 0.08013416826725006
was O 0 0.03893643990159035
determined O 0 0.03178885579109192
and O 0 0.01800973154604435
found O 0 0.014513356611132622
to O 0 0.01904664933681488
be O 0 0.017297234386205673
normal O 0 0.041519030928611755
. O 0 0.03977254778146744

It O 0 0.030642909929156303
is O 0 0.02337411791086197
therefore O 0 0.01955740712583065
concluded O 0 0.02548893168568611
that O 0 0.008942987769842148
the O 0 0.027793753892183304
R496H O 1 0.9995129108428955
mutation O 0 0.08249305188655853
of O 0 0.05762458220124245
ARSA O 1 0.9999998807907104
does O 0 0.031658582389354706
not O 0 0.013566608540713787
negatively O 0 0.029598644003272057
influence O 0 0.022700024768710136
the O 0 0.02025419846177101
activity O 0 0.02993084117770195
of O 0 0.03968682140111923
ARSA O 1 1.0
and O 0 0.025990022346377373
is O 0 0.016858896240592003
not O 0 0.011265946552157402
a O 0 0.03374442085623741
cause O 0 0.06888800114393234
of O 0 0.08890271931886673
MLD B-Disease 1 1.0

Down O 0 0.09580031037330627
- O 1 0.9936752915382385
regulation O 0 0.03399476036429405
of O 0 0.029185006394982338
transmembrane O 1 0.9673278331756592
carbonic O 1 0.9997544884681702
anhydrases O 1 0.9998637437820435
in O 0 0.06208817660808563
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.995092511177063
lines O 0 0.024603039026260376
by O 0 0.014745437540113926
wild O 0 0.04330730438232422
- O 1 0.9999598264694214
type O 0 0.07334652543067932
von B-Disease 1 0.9895049333572388
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999988079071045
transgenes O 1 0.8008480668067932
. O 0 0.06190149113535881

To O 0 0.05387916788458824
discover O 0 0.07498011738061905
genes O 0 0.02133321762084961
involved O 0 0.01402654405683279
in O 0 0.018377255648374557
von B-Disease 1 0.868955671787262
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 0.06504809856414795
VHL B-Disease 1 0.9999994039535522
) O 0 0.048077333718538284
- O 1 0.999998927116394
mediated O 1 0.99875807762146
carcinogenesis O 1 0.9999988079071045
, O 0 0.018186397850513458
we O 0 0.011726582422852516
used O 0 0.03223222866654396
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9987351298332214
lines O 0 0.053668063133955
stably O 0 0.42972075939178467
transfected O 0 0.3153221905231476
with O 0 0.021409761160612106
wild O 0 0.059316761791706085
- O 1 0.9999995231628418
type O 1 0.879107654094696
VHL O 1 1.0
- O 1 0.9999994039535522
expressing O 0 0.12809018790721893
transgenes O 0 0.40372705459594727
. O 0 0.05380525067448616

Large O 0 0.06513732671737671
- O 1 0.9999200105667114
scale O 0 0.0826626792550087
RNA O 0 0.11402109265327454
differential O 0 0.08697856962680817
display O 0 0.051872801035642624
technology O 0 0.03892271965742111
applied O 0 0.0225310530513525
to O 0 0.017301572486758232
these O 0 0.013559279032051563
cell O 0 0.05323221534490585
lines O 0 0.027250418439507484
identified O 0 0.019455621019005775
several O 0 0.0148556437343359
differentially O 0 0.20322054624557495
expressed O 0 0.04696838557720184
genes O 0 0.024818023666739464
, O 0 0.01233162172138691
including O 0 0.012220514006912708
an O 0 0.025054382160305977
alpha O 1 0.9956458210945129
carbonic O 1 0.9999910593032837
anhydrase O 1 0.9999974966049194
gene O 0 0.07391782850027084
, O 0 0.04040907323360443
termed O 0 0.49681082367897034
CA12 O 1 0.9999978542327881
. O 0 0.05614780634641647

The O 0 0.0656093955039978
deduced O 0 0.11784154921770096
protein O 0 0.04607079178094864
sequence O 0 0.018796607851982117
was O 0 0.023785406723618507
classified O 0 0.02725381962954998
as O 0 0.012899046763777733
a O 0 0.019908536225557327
one O 0 0.02862519770860672
- O 1 0.9999943971633911
pass O 0 0.0667596310377121
transmembrane O 1 0.9756307601928711
CA O 0 0.06401978433132172
possessing O 0 0.036665111780166626
an O 0 0.019399935379624367
apparently O 0 0.03582629933953285
intact O 0 0.07360992580652237
catalytic O 0 0.30322057008743286
domain O 0 0.04254025220870972
in O 0 0.016394486650824547
the O 0 0.0439007505774498
extracellular O 1 0.9998767375946045
CA O 1 0.6517983078956604
module O 0 0.1930570751428604
. O 0 0.044358991086483

Reintroduced O 0 0.15149280428886414
wild O 0 0.0983065739274025
- O 1 0.9999988079071045
type O 1 0.9183500409126282
VHL B-Disease 1 0.9999992847442627
strongly O 0 0.05909454822540283
inhibited O 0 0.10962881147861481
the O 0 0.031021103262901306
overexpression O 0 0.10834287852048874
of O 0 0.02037978731095791
the O 0 0.03209013119339943
CA12 O 1 0.999998927116394
gene O 0 0.021861711516976357
in O 0 0.008704202249646187
the O 0 0.027033057063817978
parental O 1 1.0
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999960660934448
lines O 0 0.05842965841293335
. O 0 0.03873872011899948

Similar O 0 0.03377275913953781
results O 0 0.017983540892601013
were O 0 0.009869925677776337
obtained O 0 0.020678387954831123
with O 0 0.027401959523558617
CA9 O 1 0.9999951124191284
, O 0 0.03082183748483658
encoding O 0 0.047582924365997314
another O 0 0.05316096544265747
transmembrane O 1 0.9479127526283264
CA O 0 0.06117457151412964
with O 0 0.017235467210412025
an O 0 0.02676697075366974
intact O 0 0.2196531444787979
catalytic O 1 0.9954015016555786
domain O 0 0.08093172311782837
. O 0 0.03898425027728081

Although O 0 0.03080318123102188
both O 0 0.018689876422286034
domains O 0 0.0410432443022728
of O 0 0.026519745588302612
the O 0 0.058158304542303085
VHL B-Disease 1 1.0
protein O 0 0.05971881002187729
contribute O 0 0.029120469465851784
to O 0 0.01736893132328987
regulation O 0 0.03164542466402054
of O 0 0.036222197115421295
CA12 O 1 0.9999996423721313
expression O 0 0.05037979409098625
, O 0 0.021369535475969315
the O 0 0.03243701905012131
elongin O 1 0.9990218877792358
binding O 0 0.07149332016706467
domain O 0 0.062038689851760864
alone O 0 0.030606897547841072
could O 0 0.02065275050699711
effectively O 0 0.06150424852967262
regulate O 0 0.13919492065906525
CA9 O 1 0.9999985694885254
expression O 0 0.09543093293905258
. O 0 0.05155082419514656

We O 0 0.03690974786877632
mapped O 0 0.10445866733789444
CA12 O 1 0.9994719624519348
and O 0 0.06678194552659988
CA9 O 1 0.9999996423721313
loci O 0 0.15868738293647766
to O 0 0.052332498133182526
chromosome O 0 0.10356295853853226
bands O 0 0.09773604571819305
15q22 O 1 0.9981289505958557
and O 0 0.0581401064991951
17q21 O 1 0.9982397556304932
. O 0 0.06160376965999603

2 O 0 0.07775158435106277
respectively O 0 0.04678269848227501
, O 0 0.028699850663542747
regions O 0 0.04163341596722603
prone O 1 0.9763210415840149
to O 0 0.039745528250932693
amplification O 0 0.0984790250658989
in O 0 0.021356556564569473
some O 0 0.025765322148799896
human O 0 0.07350035011768341
cancers B-Disease 1 0.999997615814209
. O 0 0.0640416070818901

Additional O 0 0.05670497193932533
experiments O 0 0.043153028935194016
are O 0 0.00937583763152361
needed O 0 0.023027975112199783
to O 0 0.01744329370558262
define O 0 0.02919888310134411
the O 0 0.018086398020386696
role O 0 0.038299620151519775
of O 0 0.03596658632159233
CA O 1 0.9836483001708984
IX O 1 1.0
and O 0 0.0533914677798748
CA O 1 0.9990254640579224
XII O 1 1.0
enzymes O 0 0.07566855847835541
in O 0 0.016142401844263077
the O 0 0.023206651210784912
regulation O 0 0.03585324063897133
of O 0 0.033594317734241486
pH O 1 0.9838744401931763
in O 0 0.020556723698973656
the O 0 0.038591932505369186
extracellular O 1 0.9993483424186707
microenvironment O 1 0.9997662901878357
and O 0 0.01654597371816635
its O 0 0.015985501930117607
potential O 0 0.025784889236092567
impact O 0 0.028323683887720108
on O 0 0.044216759502887726
cancer B-Disease 1 1.0
cell O 1 0.9999492168426514
growth O 0 0.05875598266720772
. O 0 0.04296882823109627

A O 0 0.07184455543756485
gene O 0 0.04086034744977951
encoding O 0 0.03044879622757435
a O 0 0.03606745973229408
transmembrane O 1 0.9842758178710938
protein O 0 0.04009484499692917
is O 0 0.014372286386787891
mutated O 0 0.05142812803387642
in O 0 0.01704334281384945
patients O 1 0.881206750869751
with O 1 0.9201476573944092
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999996423721313
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.08221511542797089
. O 0 0.04583000764250755

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997290968894958
WFS B-Disease 1 1.0
; O 0 0.08240637928247452
OMIM O 1 1.0
222300 O 1 0.9999939203262329
) O 0 0.022232292219996452
is O 0 0.012726841494441032
an O 0 0.0247819684445858
autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.05299776792526245
by O 0 0.022646794095635414
young O 1 0.9872180819511414
- O 1 0.9999998807907104
onset O 1 0.9999997615814209
non O 1 0.9999685287475586
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.999969482421875
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999947547912598
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 0.08100660890340805

Linkage O 0 0.18053826689720154
to O 0 0.03899707645177841
markers O 0 0.07896214723587036
on O 0 0.0410933680832386
chromosome O 0 0.12569987773895264
4p O 1 0.9999970197677612
was O 0 0.04623904451727867
confirmed O 0 0.028596214950084686
in O 0 0.015782946720719337
five O 0 0.022718168795108795
families O 0 0.047303859144449234
. O 0 0.044285230338573456

On O 0 0.028107985854148865
the O 0 0.016714952886104584
basis O 0 0.014179056510329247
of O 0 0.030357107520103455
meiotic O 1 0.9999992847442627
recombinants O 1 0.9999994039535522
and O 0 0.06716614216566086
disease O 1 1.0
- O 1 1.0
associated O 0 0.046232786029577255
haplotypes O 0 0.13482974469661713
, O 0 0.02310960739850998
the O 0 0.04432687908411026
WFS B-Disease 1 1.0
gene O 0 0.05778234452009201
was O 0 0.0385756678879261
localized O 0 0.07042474299669266
to O 0 0.02512938901782036
a O 0 0.05545184388756752
BAC O 1 0.9999998807907104
/ O 1 0.9999957084655762
P1 O 1 0.9999849796295166
contig O 1 0.9957068562507629
of O 0 0.02973485365509987
less O 0 0.02010010927915573
than O 0 0.01719365455210209
250 O 0 0.06412695348262787
kb O 0 0.38236483931541443
. O 0 0.049599867314100266

Mutations O 0 0.06019545719027519
in O 0 0.017491955310106277
a O 0 0.03503512591123581
novel O 0 0.07924886792898178
gene O 0 0.06011975556612015
( O 0 0.0417158380150795
WFS1 O 1 0.9999734163284302
) O 0 0.024033501744270325
encoding O 0 0.028021451085805893
a O 0 0.03769315406680107
putative O 1 0.9996116757392883
transmembrane O 1 0.9998507499694824
protein O 0 0.04947829991579056
were O 0 0.011656245216727257
found O 0 0.013514222577214241
in O 0 0.012528780847787857
all O 0 0.015509268268942833
affected O 0 0.02917337603867054
individuals O 0 0.014592228457331657
in O 0 0.01824810542166233
six O 0 0.05096539482474327
WFS B-Disease 1 1.0
families O 0 0.052229639142751694
, O 0 0.025091735646128654
and O 0 0.017667489126324654
these O 0 0.011992063373327255
mutations O 0 0.029363593086600304
were O 0 0.010716133750975132
associated O 0 0.01929895021021366
with O 0 0.021736782044172287
the O 0 0.1788502186536789
disease O 1 1.0
phenotype O 1 0.9999991655349731
. O 0 0.0696733295917511

WFS1 O 1 0.9999936819076538
appears O 0 0.056790854781866074
to O 0 0.022368695586919785
function O 0 0.020610816776752472
in O 0 0.01109260506927967
survival O 0 0.03917169198393822
of O 0 0.02722342498600483
islet O 1 0.9999994039535522
beta O 1 0.9999998807907104
- O 1 1.0
cells O 0 0.07736466079950333
and O 0 0.04144821688532829
neurons O 0 0.06353607773780823
. O 0 0.026865439489483833
. O 0 0.03537268191576004

Stable O 0 0.46308863162994385
interaction O 0 0.04487977921962738
between O 0 0.02086428552865982
the O 0 0.020984118804335594
products O 0 0.01953849010169506
of O 0 0.01782982237637043
the O 0 0.0363072045147419
BRCA1 O 1 0.9999890327453613
and O 0 0.05540181323885918
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 1.0
genes O 0 0.045327890664339066
in O 0 0.029840296134352684
mitotic O 1 0.9977705478668213
and O 0 0.06782125681638718
meiotic O 1 0.9999996423721313
cells O 0 0.12095410376787186
. O 0 0.05470754951238632

BRCA1 O 1 0.9999798536300659
and O 0 0.07231071591377258
BRCA2 O 1 0.995590090751648
account O 0 0.026384489610791206
for O 0 0.014183620922267437
most O 0 0.011281976476311684
cases O 0 0.017797427251935005
of O 0 0.028035515919327736
familial O 1 0.9999997615814209
, O 0 0.025051549077033997
early O 0 0.051264554262161255
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9989210367202759
/ I-Disease 1 1.0
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9058237075805664
encode O 0 0.07678056508302689
products O 0 0.033569157123565674
that O 0 0.010798840783536434
each O 0 0.013413744978606701
interact O 0 0.03678440675139427
with O 0 0.03303080424666405
hRAD51 O 1 0.9886397123336792
. O 0 0.05641227215528488

Results O 0 0.0363415889441967
presented O 0 0.030183596536517143
here O 0 0.019817661494016647
show O 0 0.026257960125803947
that O 0 0.02180095762014389
BRCA1 O 1 0.9991374015808105
and O 0 0.050087589770555496
BRCA2 O 1 0.9985963702201843
coexist O 0 0.08862902224063873
in O 0 0.02607441321015358
a O 0 0.04698100686073303
biochemical O 0 0.09902430325746536
complex O 0 0.047896526753902435
and O 0 0.025537917390465736
colocalize O 1 0.9517111778259277
in O 0 0.03307648003101349
subnuclear O 1 0.9999450445175171
foci O 1 0.9998779296875
in O 0 0.05534066632390022
somatic O 1 0.999974250793457
cells O 0 0.061025094240903854
and O 0 0.019639678299427032
on O 0 0.01929178461432457
the O 0 0.02766374684870243
axial O 0 0.0940512865781784
elements O 0 0.030856609344482422
of O 0 0.03319130465388298
developing O 0 0.07983826100826263
synaptonemal O 1 0.9999922513961792
complexes O 1 0.958396315574646
. O 0 0.05290168151259422

Like O 0 0.09477855265140533
BRCA1 O 1 0.999868631362915
and O 0 0.06080309674143791
RAD51 O 1 0.9999992847442627
, O 0 0.06824714690446854
BRCA2 O 1 0.9912235736846924
relocates O 1 0.9317163228988647
to O 0 0.06973600387573242
PCNA O 1 0.9999864101409912
+ O 1 0.7827401161193848
replication O 0 0.09766020625829697
sites O 0 0.02081894874572754
following O 0 0.022065432742238045
exposure O 0 0.04975498095154762
of O 0 0.03736117109656334
S O 1 1.0
phase O 1 0.9994914531707764
cells O 0 0.05386633053421974
to O 0 0.0417528860270977
hydroxyurea O 1 0.999993085861206
or O 0 0.08435557037591934
UV O 1 1.0
irradiation O 1 0.9985533356666565
. O 0 0.05630876496434212

Thus O 0 0.05638693645596504
, O 0 0.05229360610246658
BRCA1 O 1 0.9998302459716797
and O 0 0.0503840371966362
BRCA2 O 1 0.9999719858169556
participate O 0 0.038924843072891235
, O 0 0.020733226090669632
together O 0 0.014495927840471268
, O 0 0.011717688292264938
in O 0 0.01367355789989233
a O 0 0.04366855323314667
pathway O 1 0.9974400997161865
( O 0 0.04572366550564766
s O 1 0.9881991147994995
) O 0 0.02336079627275467
associated O 0 0.016617892310023308
with O 0 0.011275043711066246
the O 0 0.019742092117667198
activation O 0 0.04701763018965721
of O 0 0.021366305649280548
double O 0 0.0679294764995575
- O 1 0.9999978542327881
strand O 0 0.10025589168071747
break O 0 0.07528791576623917
repair O 1 0.99814772605896
and O 0 0.0441652350127697
/ O 1 0.9999880790710449
or O 0 0.052179813385009766
homologous O 0 0.16023162007331848
recombination O 0 0.15708333253860474
. O 0 0.04785287752747536

Dysfunction O 1 1.0
of O 0 0.05637870356440544
this O 0 0.04293481260538101
pathway O 1 0.9987493753433228
may O 0 0.020351119339466095
be O 0 0.010226868093013763
a O 0 0.02304156869649887
general O 0 0.04040009155869484
phenomenon O 0 0.03957897797226906
in O 0 0.011231186799705029
the O 0 0.013454875908792019
majority O 0 0.016069741919636726
of O 0 0.01154998131096363
cases O 0 0.016653377562761307
of O 0 0.035158753395080566
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999971389770508
/ I-Disease 1 1.0
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.23885095119476318
. O 0 0.042416397482156754

A O 0 0.09313321113586426
novel O 0 0.10489340871572495
Arg362Ser O 1 0.9957441687583923
mutation O 0 0.053647708147764206
in O 0 0.012709610164165497
the O 0 0.02277766726911068
sterol O 1 0.8647688627243042
27 O 0 0.07268329709768295
- O 1 1.0
hydroxylase O 1 0.9999997615814209
gene O 0 0.06578639149665833
( O 0 0.04656018689274788
CYP27 O 1 0.9999992847442627
) O 0 0.02713710255920887
: O 0 0.015820419415831566
its O 0 0.015271794982254505
effects O 0 0.023135103285312653
on O 0 0.018771283328533173
pre O 0 0.18631288409233093
- O 1 0.9999598264694214
mRNA O 0 0.0887710228562355
splicing O 0 0.07714292407035828
and O 0 0.031246405094861984
enzyme O 0 0.09522034227848053
activity O 0 0.04924972355365753
. O 0 0.037258896976709366

A O 0 0.08884723484516144
novel O 0 0.08583829551935196
C O 0 0.2743726670742035
to O 0 0.024191057309508324
A O 0 0.046048641204833984
mutation O 0 0.03643627464771271
in O 0 0.010363088920712471
the O 0 0.02190011367201805
sterol O 1 0.881754457950592
27 O 0 0.06969510763883591
- O 1 0.9999998807907104
hydroxylase O 1 0.999998927116394
gene O 0 0.06370998919010162
( O 0 0.047676410526037216
CYP27 O 1 0.9999879598617554
) O 0 0.02406374178826809
was O 0 0.021955179050564766
identified O 0 0.017983943223953247
by O 0 0.016990413889288902
sequencing O 0 0.05345867574214935
amplified O 0 0.1209532767534256
CYP27 O 1 0.9999980926513672
gene O 0 0.052379507571458817
products O 0 0.021097585558891296
from O 0 0.014139365404844284
a O 0 0.028466256335377693
patient O 1 0.7461758255958557
with O 0 0.037506621330976486
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.9065632224082947
CTX B-Disease 1 1.0
) O 0 0.050286393612623215
. O 0 0.03782180696725845

The O 0 0.06380738317966461
mutation O 0 0.06984338909387589
changed O 0 0.02849501557648182
the O 0 0.039561569690704346
adrenodoxin O 1 0.9999171495437622
cofactor O 1 0.9998283386230469
binding O 0 0.0769498273730278
residue O 0 0.12531639635562897
362Arg O 0 0.320388525724411
to O 0 0.04040779545903206
362Ser O 1 0.9997093081474304
( O 0 0.05517486482858658
CGT O 1 0.9999504089355469
362Arg O 1 0.9993032217025757
to O 0 0.07117165625095367
AGT O 1 1.0
362Ser O 1 0.9999994039535522
) O 0 0.03042546473443508
, O 0 0.01443678792566061
and O 0 0.011249438859522343
was O 0 0.026062235236167908
responsible O 0 0.03904963657259941
for O 0 0.0376889742910862
deficiency O 1 1.0
in O 0 0.021874001249670982
the O 0 0.034710317850112915
sterol O 1 0.9999814033508301
27 O 0 0.4594758450984955
- O 1 1.0
hydroxylase O 1 0.9999966621398926
activity O 0 0.0331781767308712
, O 0 0.013978938572108746
as O 0 0.013283885084092617
confirmed O 0 0.016635067760944366
by O 0 0.011697865091264248
expression O 0 0.021611632779240608
of O 0 0.020474720746278763
mutant O 0 0.09891257435083389
cDNA O 0 0.11154302209615707
into O 0 0.046864718198776245
COS O 1 1.0
- O 1 0.9999998807907104
1 O 0 0.09890122711658478
cells O 0 0.06317751854658127
. O 0 0.03738563507795334

Quantitative O 0 0.08882661163806915
analysis O 0 0.022669492289423943
showed O 0 0.01840640790760517
that O 0 0.007879475131630898
the O 0 0.01826963946223259
expression O 0 0.03433985263109207
of O 0 0.03869286924600601
CYP27 O 1 0.999998927116394
gene O 0 0.061023369431495667
mRNA O 0 0.048413559794425964
in O 0 0.013833679258823395
the O 0 0.028801439329981804
patient O 0 0.3008507192134857
represented O 0 0.04234714061021805
52 O 0 0.0883263498544693
. O 0 0.04648706316947937

5 O 0 0.0581110380589962
% O 0 0.024345317855477333
of O 0 0.02481633983552456
the O 0 0.03883163630962372
normal O 0 0.05776597931981087
level O 0 0.060308363288640976
. O 0 0.046075254678726196

As O 0 0.04535427689552307
the O 0 0.043724026530981064
mutation O 0 0.06776393949985504
occurred O 0 0.033156704157590866
at O 0 0.025016238912940025
the O 0 0.03068663366138935
penultimate O 1 0.9198210835456848
nucleotide O 0 0.05832189694046974
of O 0 0.027293169870972633
exon O 1 0.5260149240493774
6 O 0 0.05799810588359833
( O 0 0.03605709969997406
- O 1 0.9779311418533325
2 O 0 0.027185872197151184
position O 0 0.019785510376095772
of O 0 0.0181290153414011
exon O 0 0.17123228311538696
6 O 0 0.06792062520980835
- O 1 0.9999711513519287
intron O 1 0.9998216032981873
6 O 0 0.07471171021461487
splice O 0 0.1440037041902542
site O 0 0.03588752821087837
) O 0 0.013482760637998581
of O 0 0.017662828788161278
the O 0 0.031246932223439217
gene O 0 0.0423126295208931
, O 0 0.01941697672009468
we O 0 0.013450408354401588
hypothesized O 0 0.047264464199543
that O 0 0.010138041339814663
the O 0 0.03214625269174576
mutation O 0 0.07373540103435516
may O 0 0.03133409842848778
partially O 0 0.0575447641313076
affect O 0 0.028019113466143608
the O 0 0.024545123800635338
normal O 0 0.0482301190495491
splicing O 0 0.07618212699890137
efficiency O 0 0.042021967470645905
in O 0 0.023105692118406296
exon O 0 0.2145688533782959
6 O 0 0.0537506565451622
and O 0 0.03003818541765213
cause O 0 0.0697692334651947
alternative O 0 0.07543855160474777
splicing O 0 0.08510561287403107
elsewhere O 0 0.029696159064769745
, O 0 0.017400652170181274
which O 0 0.012656938284635544
resulted O 0 0.031213732436299324
in O 0 0.021376878023147583
decreased O 0 0.056952834129333496
transcript O 0 0.06506384909152985
in O 0 0.020953286439180374
the O 0 0.044217485934495926
patient O 1 0.9996196031570435
. O 0 0.05473964661359787

Transfection O 1 0.9909343123435974
of O 0 0.05551212280988693
constructed O 0 0.11284332722425461
minigenes O 1 0.9999788999557495
, O 0 0.027556899935007095
with O 0 0.016450179740786552
or O 0 0.015395981259644032
without O 0 0.01084403321146965
the O 0 0.020336436107754707
mutation O 0 0.03799205645918846
, O 0 0.015719233080744743
into O 0 0.035460736602544785
COS O 1 1.0
- O 1 1.0
1 O 0 0.06152821704745293
cells O 0 0.030315713956952095
confirmed O 0 0.015429780818521976
that O 0 0.006638973951339722
the O 0 0.022991472855210304
mutant O 1 0.9155656099319458
minigene O 1 0.9996463060379028
was O 0 0.042985837906599045
responsible O 0 0.03559569641947746
for O 0 0.018764937296509743
a O 0 0.03290059044957161
mRNA O 0 0.054745785892009735
species O 0 0.012333485297858715
alternatively O 0 0.05053931102156639
spliced O 0 0.06370862573385239
at O 0 0.02868824452161789
an O 0 0.033996809273958206
activated O 1 0.9987722039222717
cryptic O 0 0.3380730152130127
5 O 0 0.06058081239461899
splice O 0 0.14747393131256104
site O 0 0.04750736057758331
88 O 0 0.08964645862579346
bp O 0 0.08858665078878403
upstream O 0 0.048145994544029236
from O 0 0.012719708494842052
the O 0 0.020199701189994812
3 O 0 0.031816188246011734
end O 0 0.03520818427205086
of O 0 0.03630242496728897
exon O 1 0.839362382888794
6 O 0 0.07504560053348541
. O 0 0.045451242476701736

Our O 0 0.05864337831735611
data O 0 0.019173339009284973
suggest O 0 0.01726273074746132
that O 0 0.009350283071398735
the O 0 0.02483518049120903
C O 0 0.11545797437429428
to O 0 0.026365071535110474
A O 0 0.0534207858145237
mutation O 0 0.05197775736451149
at O 0 0.02401326596736908
the O 0 0.028612498193979263
penultimate O 1 0.994495689868927
nucleotide O 0 0.06036262959241867
of O 0 0.025443820282816887
exon O 0 0.12008040398359299
6 O 0 0.029391417279839516
of O 0 0.017672710120677948
the O 0 0.034101083874702454
CYP27 O 1 0.9999998807907104
gene O 0 0.03526662662625313
not O 0 0.009380396455526352
only O 0 0.01515028066933155
causes O 0 0.06030545011162758
the O 0 0.05587850138545036
deficiency B-Disease 1 1.0
in I-Disease 0 0.022449204698204994
the I-Disease 0 0.03164399415254593
sterol I-Disease 1 0.9999457597732544
27 I-Disease 0 0.10496533662080765
- I-Disease 1 1.0
hydroxylase I-Disease 1 0.9999992847442627
activity I-Disease 0 0.040761396288871765
, O 0 0.019845182076096535
but O 0 0.011892217211425304
also O 0 0.016835415735840797
partially O 0 0.04884248971939087
leads O 0 0.04235026612877846
to O 0 0.01953248307108879
alternative O 0 0.03743470832705498
pre O 0 0.15421783924102783
- O 1 0.9998315572738647
mRNA O 0 0.06771022081375122
splicing O 0 0.043208472430706024
of O 0 0.018376139923930168
the O 0 0.037200335413217545
gene O 0 0.05663939192891121
. O 0 0.038145020604133606

To O 0 0.04809974133968353
our O 0 0.03913401812314987
knowledge O 0 0.03365396708250046
, O 0 0.01824061945080757
this O 0 0.010369976982474327
is O 0 0.013091678731143475
the O 0 0.01675126701593399
first O 0 0.022040434181690216
report O 0 0.01868421956896782
regarding O 0 0.02399512380361557
effects O 0 0.02908732183277607
on O 0 0.02335180714726448
pre O 1 0.617805004119873
- O 1 0.9996862411499023
mRNA O 0 0.06099819391965866
splicing O 0 0.03347395360469818
of O 0 0.01198118831962347
a O 0 0.024300578981637955
mutation O 0 0.040549371391534805
at O 0 0.023349780589342117
the O 0 0.032680854201316833
- O 1 0.9998940229415894
2 O 0 0.03312745317816734
position O 0 0.024175135418772697
of O 0 0.01818985491991043
a O 0 0.033694297075271606
5 O 0 0.06392484903335571
splice O 0 0.16797268390655518
site O 0 0.060315120965242386
. O 0 0.037818022072315216

ATM O 1 0.9933434724807739
germline O 1 0.7088965177536011
mutations O 0 0.043122146278619766
in O 0 0.02145203948020935
classical O 0 0.08468300849199295
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9996563196182251
in O 0 0.025119919329881668
the O 0 0.03560376912355423
Dutch O 0 0.08196012675762177
population O 0 0.03186856955289841
. O 0 0.03865906968712807

Germline O 1 0.9980238676071167
mutations O 0 0.05664505437016487
in O 0 0.017928313463926315
the O 0 0.039084844291210175
ATM O 1 0.9993682503700256
gene O 0 0.027762429788708687
are O 0 0.004515398293733597
responsible O 0 0.016625413671135902
for O 0 0.01148570328950882
the O 0 0.03117228113114834
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.44969144463539124
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.03538280725479126
. O 0 0.03093276359140873

In O 0 0.04222940653562546
our O 0 0.03758985921740532
study O 0 0.026998914778232574
, O 0 0.015993110835552216
we O 0 0.008728589862585068
have O 0 0.006713983602821827
determined O 0 0.022772807627916336
the O 0 0.03383510932326317
ATM O 1 0.9977765679359436
mutation O 0 0.06628256291151047
spectrum O 0 0.03746912628412247
in O 0 0.010837973095476627
19 O 0 0.023426968604326248
classical O 0 0.03553599491715431
A B-Disease 1 0.9998037219047546
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9994482398033142
, O 0 0.023192018270492554
including O 0 0.01575353741645813
some O 0 0.014655664563179016
immigrant O 0 0.07989174872636795
populations O 0 0.03606906905770302
, O 0 0.02099532261490822
as O 0 0.01906311884522438
well O 0 0.014881087467074394
as O 0 0.017430849373340607
12 O 0 0.023382462561130524
of O 0 0.02419312857091427
Dutch O 0 0.06583113968372345
ethnic O 0 0.044677939265966415
origin O 0 0.03092007339000702
. O 0 0.03741154447197914

Both O 0 0.029879191890358925
the O 0 0.040815629065036774
protein O 0 0.0665149837732315
truncation O 0 0.2737865447998047
test O 0 0.06744357198476791
( O 0 0.05080143362283707
PTT O 1 0.9992884397506714
) O 0 0.019593263044953346
and O 0 0.011275495402514935
the O 0 0.02250662073493004
restriction O 0 0.07498001307249069
endonuclease O 1 0.9992735981941223
fingerprinting O 1 0.6654235124588013
( O 0 0.0756848081946373
REF O 1 0.9999994039535522
) O 0 0.03465750813484192
method O 0 0.023862522095441818
were O 0 0.010419769212603569
used O 0 0.013612164184451103
and O 0 0.014366412535309792
compared O 0 0.019537584856152534
for O 0 0.018686508759856224
their O 0 0.02510388009250164
detection O 0 0.1041048914194107
efficiency O 0 0.05943617969751358
, O 0 0.025086265057325363
identifying O 0 0.05182477831840515
76 O 0 0.07961078733205795
% O 0 0.026337910443544388
and O 0 0.016465088352560997
60 O 0 0.025310326367616653
% O 0 0.01742357574403286
of O 0 0.023190511390566826
the O 0 0.04114485904574394
mutations O 0 0.061655525118112564
, O 0 0.029762037098407745
respectively O 0 0.04592474177479744
. O 0 0.03991895914077759

Most O 0 0.07568296790122986
patients O 1 0.5863812565803528
were O 0 0.018270181491971016
found O 0 0.018630648031830788
to O 0 0.021464364603161812
be O 0 0.023295896127820015
compound O 0 0.17570020258426666
heterozygote O 1 0.928584635257721
. O 0 0.05905912071466446

Seventeen O 0 0.17294418811798096
mutations O 0 0.060635004192590714
were O 0 0.016029613092541695
distinct O 0 0.02485000155866146
, O 0 0.01977679133415222
of O 0 0.021402858197689056
which O 0 0.018931688740849495
10 O 0 0.020099887624382973
were O 0 0.010490239597856998
not O 0 0.011487716808915138
reported O 0 0.02950899861752987
previously O 0 0.041321974247694016
. O 0 0.03938877210021019

Mutations O 0 0.09274978935718536
are O 0 0.014026252552866936
small O 0 0.035494741052389145
deletions O 0 0.1068681851029396
or O 0 0.035568561404943466
point O 0 0.053212497383356094
mutations O 0 0.054807718843221664
frequently O 0 0.042016685009002686
affecting O 0 0.0874950960278511
splice O 0 0.2476533055305481
sites O 0 0.048048295080661774
. O 0 0.03581109270453453

Moreover O 0 0.10017092525959015
, O 0 0.03627346456050873
a O 0 0.0407516174018383
16 O 0 0.05355798080563545
. O 0 0.046054575592279434

7 O 0 0.11252598464488983
- O 1 0.9999834299087524
kb O 1 0.9450888633728027
genomic O 0 0.11279275268316269
deletion O 0 0.08173151314258575
of O 0 0.0253432746976614
the O 0 0.028602084144949913
3 O 0 0.03636027127504349
end O 0 0.028958134353160858
of O 0 0.02201068587601185
the O 0 0.03354784846305847
gene O 0 0.040957238525152206
, O 0 0.017588118091225624
most O 0 0.014669841155409813
likely O 0 0.021810756996273994
a O 0 0.022792596369981766
result O 0 0.021116280928254128
of O 0 0.03222671523690224
recombination O 0 0.09180670231580734
between O 0 0.024602562189102173
two O 0 0.01826375722885132
LINE O 0 0.07788068801164627
elements O 0 0.03722204640507698
, O 0 0.024423692375421524
was O 0 0.03661127761006355
identified O 0 0.039945200085639954
. O 0 0.035664789378643036

The O 0 0.046000514179468155
most O 0 0.028533218428492546
frequently O 0 0.03288662061095238
found O 0 0.027629278600215912
mutation O 0 0.060559824109077454
, O 0 0.01957397721707821
identified O 0 0.01826462894678116
in O 0 0.00913753267377615
three O 0 0.009556220844388008
unrelated O 0 0.03202241286635399
Turkish O 0 0.0611497163772583
A B-Disease 1 0.9999581575393677
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
individuals O 0 0.02166232466697693
, O 0 0.019261784851551056
was O 0 0.025839678943157196
previously O 0 0.021890362724661827
described O 0 0.022889241576194763
to O 0 0.011056477203965187
be O 0 0.005931698717176914
a O 0 0.01216677762567997
Turkish O 0 0.035142213106155396
A B-Disease 1 0.9814873933792114
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
founder O 1 0.9998908042907715
mutation O 0 0.10037007927894592
. O 0 0.044963616877794266

The O 0 0.03746508061885834
presence O 0 0.02959745191037655
of O 0 0.022795530036091805
a O 0 0.043915484100580215
founder O 1 0.9999630451202393
mutation O 0 0.0683632344007492
among O 0 0.02865590527653694
relatively O 0 0.026895128190517426
small O 0 0.019654635339975357
ethnic O 0 0.028683742508292198
population O 0 0.021011004224419594
groups O 0 0.01826126128435135
in O 0 0.01829719915986061
Western O 0 0.04289870709180832
Europe O 0 0.03765755891799927
could O 0 0.016706474125385284
indicate O 0 0.02100721374154091
a O 0 0.030016504228115082
high O 0 0.06417615711688995
carrier O 0 0.2303399294614792
frequency O 0 0.03922826051712036
in O 0 0.019446996971964836
such O 0 0.017338203266263008
communities O 0 0.041228145360946655
. O 0 0.045433204621076584

In O 0 0.05629557743668556
patients O 0 0.33804965019226074
of O 0 0.0383065827190876
Dutch O 0 0.0854479968547821
ethnic O 0 0.041999343782663345
origin O 0 0.024559136480093002
, O 0 0.01722455769777298
however O 0 0.013073017820715904
, O 0 0.014019371010363102
no O 0 0.01521623507142067
significant O 0 0.02832394279539585
founder O 1 0.9999516010284424
effect O 0 0.03798145800828934
could O 0 0.018027491867542267
be O 0 0.014390401542186737
identified O 0 0.034315966069698334
. O 0 0.03426196426153183

The O 0 0.06224094331264496
observed O 0 0.051013458520174026
genetic O 0 0.05622508004307747
heterogeneity O 0 0.10597150772809982
including O 0 0.019471753388643265
the O 0 0.0246136374771595
relative O 0 0.04163007438182831
high O 0 0.03860514238476753
percentage O 0 0.028069935739040375
of O 0 0.03369313105940819
splice O 1 0.9983799457550049
- O 1 0.9999837875366211
site O 0 0.06022319942712784
mutations O 0 0.032602280378341675
had O 0 0.01880498044192791
no O 0 0.019717929884791374
reflection O 0 0.05753464624285698
on O 0 0.026377789676189423
the O 0 0.04837134853005409
phenotype O 0 0.30400827527046204
. O 0 0.053149353712797165

All O 0 0.036170151084661484
patients O 0 0.4987369477748871
manifested O 1 0.8624821305274963
classical O 0 0.062056198716163635
A B-Disease 1 0.9999904632568359
- I-Disease 1 1.0
T I-Disease 1 0.9999970197677612
and O 0 0.022354913875460625
increased O 0 0.037201184779405594
cellular O 0 0.10621537268161774
radioresistant O 1 0.9999090433120728
DNA O 0 0.08708701282739639
synthesis O 0 0.08373156934976578
. O 0 0.040303051471710205

Determination O 0 0.09140364825725555
of O 0 0.029146283864974976
the O 0 0.03462733328342438
genomic O 0 0.06583648920059204
structure O 0 0.02564886584877968
of O 0 0.01961035467684269
the O 0 0.039506956934928894
COL4A4 O 1 0.9999990463256836
gene O 0 0.03382830321788788
and O 0 0.012012375518679619
of O 0 0.021098269149661064
novel O 0 0.06818557530641556
mutations O 0 0.06494374573230743
causing O 1 0.9473469853401184
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9993207454681396

Autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0824294462800026
a O 0 0.06397347897291183
progressive O 1 0.9999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9685705900192261
by O 0 0.06184595078229904
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999997615814209
abnormalities I-Disease 1 0.9999598264694214
and O 0 0.028840508311986923
associated O 0 0.028264105319976807
with O 0 0.021888840943574905
mutations O 0 0.03153401240706444
in O 0 0.013126717880368233
either O 0 0.017009250819683075
the O 0 0.029573777690529823
COL4A3 O 1 0.9999979734420776
or O 0 0.025018086656928062
the O 0 0.04085410758852959
COL4A4 O 1 0.9999998807907104
gene O 0 0.05109598487615585
, O 0 0.01679106242954731
which O 0 0.009711269289255142
encode O 0 0.023221421986818314
the O 0 0.020361417904496193
alpha3 O 0 0.2709006071090698
and O 0 0.03149189054965973
alpha4 O 1 0.999991774559021
type O 1 0.999993085861206
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9945092797279358
, O 0 0.04269833862781525
respectively O 0 0.04908100515604019
. O 0 0.040673449635505676

To O 0 0.03922848775982857
date O 0 0.03636137396097183
, O 0 0.030034417286515236
mutation O 0 0.06531094014644623
screening O 0 0.05639675632119179
in O 0 0.013494275510311127
the O 0 0.01912500336766243
two O 0 0.016285961493849754
genes O 0 0.02339267171919346
has O 0 0.01641492173075676
been O 0 0.01797482557594776
hampered O 0 0.07010921835899353
by O 0 0.018927477300167084
the O 0 0.023624062538146973
lack O 0 0.03789575397968292
of O 0 0.04260191693902016
genomic O 0 0.10963418334722519
structure O 0 0.0588313452899456
information O 0 0.02729928307235241
. O 0 0.03163322061300278

We O 0 0.03247830644249916
report O 0 0.02274525724351406
here O 0 0.016013113781809807
the O 0 0.019940940663218498
complete O 0 0.037601057440042496
characterization O 0 0.06252981722354889
of O 0 0.020833604037761688
the O 0 0.024244140833616257
48 O 0 0.0427732989192009
exons O 0 0.06353683769702911
of O 0 0.021813606843352318
the O 0 0.04109959676861763
COL4A4 O 1 0.9999996423721313
gene O 0 0.051840998232364655
, O 0 0.019013606011867523
a O 0 0.03225063532590866
comprehensive O 0 0.08629775792360306
gene O 0 0.05860774219036102
screen O 0 0.04968356341123581
, O 0 0.0203323345631361
and O 0 0.015251156874001026
the O 0 0.022562677040696144
subsequent O 0 0.047216445207595825
detection O 0 0.05892038717865944
of O 0 0.023808063939213753
10 O 0 0.02755082957446575
novel O 0 0.05075313523411751
mutations O 0 0.028854975476861
in O 0 0.014574863947927952
eight O 0 0.03722763434052467
patients O 1 0.9999992847442627
diagnosed O 1 1.0
with O 1 0.9733877778053284
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.998640239238739

Furthermore O 0 0.09054192155599594
, O 0 0.02563568949699402
we O 0 0.013398054987192154
identified O 0 0.02444678731262684
a O 0 0.032628659158945084
glycine O 0 0.12167181074619293
to O 0 0.03841009363532066
alanine O 0 0.1832571178674698
substitution O 0 0.07380463927984238
in O 0 0.02072875387966633
the O 0 0.048501238226890564
collagenous O 1 0.9999996423721313
domain O 0 0.0654444545507431
that O 0 0.014984355308115482
is O 0 0.01785408891737461
apparently O 0 0.03014238551259041
silent O 0 0.06304369121789932
in O 0 0.015763094648718834
the O 0 0.031129473820328712
heterozygous O 0 0.09697616100311279
carriers O 0 0.07865410298109055
, O 0 0.025519389659166336
in O 0 0.022616125643253326
11 O 0 0.05048668012022972
. O 0 0.04190865159034729

5 O 0 0.052384860813617706
% O 0 0.024140676483511925
of O 0 0.022860530763864517
all O 0 0.022892631590366364
control O 0 0.05187906697392464
individuals O 0 0.02384262904524803
, O 0 0.02088736556470394
and O 0 0.01579219289124012
in O 0 0.016121234744787216
one O 0 0.02204899489879608
control O 0 0.037556469440460205
individual O 0 0.02293703518807888
homozygous O 0 0.0716734454035759
for O 0 0.023982882499694824
this O 0 0.02967340499162674
glycine O 0 0.401678204536438
substitution O 0 0.11970623582601547
. O 0 0.049128178507089615

There O 0 0.031485769897699356
has O 0 0.022100502625107765
been O 0 0.013788930140435696
no O 0 0.01240665465593338
previous O 0 0.020963545888662338
finding O 0 0.023737620562314987
of O 0 0.021272609010338783
a O 0 0.04583289846777916
glycine O 1 0.8123503923416138
substitution O 0 0.07311587780714035
that O 0 0.012972107157111168
is O 0 0.01450458075851202
not O 0 0.010879084467887878
associated O 0 0.018889330327510834
with O 0 0.016278499737381935
any O 0 0.02497386746108532
obvious O 0 0.07297690957784653
phenotype O 0 0.33704692125320435
in O 0 0.03990335389971733
homozygous O 0 0.1256188154220581
individuals O 0 0.039645202457904816
. O 0 0.04623129218816757

Founder O 1 0.9999746084213257
BRCA1 O 1 0.9999735355377197
and O 0 0.05870555713772774
BRCA2 O 1 0.9998807907104492
mutations O 0 0.038300804793834686
in O 0 0.01426367275416851
French O 0 0.052511066198349
Canadian O 1 0.9252383708953857
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9987044334411621
. O 0 0.06245600804686546

We O 0 0.02597738802433014
have O 0 0.010667909868061543
identified O 0 0.02208494022488594
four O 0 0.01822027377784252
mutations O 0 0.025868184864521027
in O 0 0.008180316537618637
each O 0 0.0051874336786568165
of O 0 0.01554029993712902
the O 0 0.040398623794317245
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999998807907104
genes O 0 0.04720752686262131
, O 0 0.036043886095285416
BRCA1 O 1 0.9998043179512024
and O 0 0.03181927278637886
BRCA2 O 1 0.9797795414924622
, O 0 0.01300771813839674
in O 0 0.00997372530400753
French O 0 0.04339813441038132
Canadian O 0 0.3453819155693054
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999988079071045
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9820420145988464
from O 0 0.03703516349196434
Quebec O 0 0.12294849008321762
. O 0 0.038996510207653046

To O 0 0.050152942538261414
identify O 0 0.07494602352380753
founder O 1 0.9999842643737793
effects O 0 0.07053379714488983
, O 0 0.02663228288292885
we O 0 0.013481613248586655
examined O 0 0.03702274337410927
independently O 0 0.023726025596261024
ascertained O 0 0.07663682103157043
French O 0 0.07266812771558762
Canadian O 0 0.1670064479112625
cancer B-Disease 1 0.9999994039535522
families O 0 0.034756120294332504
for O 0 0.019500762224197388
the O 0 0.02402704395353794
distribution O 0 0.02265133522450924
of O 0 0.019841350615024567
these O 0 0.012869876809418201
eight O 0 0.04017438367009163
mutations O 0 0.06628474593162537
. O 0 0.04585771635174751

Mutations O 0 0.07714330404996872
were O 0 0.015726979821920395
found O 0 0.01433717180043459
in O 0 0.01534185465425253
41 O 0 0.04928934946656227
of O 0 0.03810157999396324
97 O 0 0.12580335140228271
families O 0 0.06221146881580353
. O 0 0.0492168590426445

Six O 0 0.036470334976911545
of O 0 0.03292204812169075
eight O 0 0.04536734148859978
mutations O 0 0.045784760266542435
were O 0 0.016672536730766296
observed O 0 0.02719273418188095
at O 0 0.027827929705381393
least O 0 0.02238365449011326
twice O 0 0.040743570774793625
. O 0 0.03802839294075966

The O 0 0.08644984662532806
BRCA1 O 1 0.9999860525131226
C4446T O 1 0.9999889135360718
mutation O 0 0.08195862174034119
was O 0 0.031730588525533676
the O 0 0.022262010723352432
most O 0 0.02237892895936966
common O 0 0.03865205496549606
mutation O 0 0.054007723927497864
found O 0 0.0154196722432971
, O 0 0.015034520998597145
followed O 0 0.02325446344912052
by O 0 0.018851827830076218
the O 0 0.0498352088034153
BRCA2 O 1 0.9999865293502808
8765delAG O 1 0.9999954700469971
mutation O 0 0.12732841074466705
. O 0 0.049891550093889236

Together O 0 0.055742621421813965
, O 0 0.03355005756020546
these O 0 0.017060671001672745
mutations O 0 0.03421971946954727
were O 0 0.011395909823477268
found O 0 0.013937617652118206
in O 0 0.015486138872802258
28 O 0 0.031664103269577026
of O 0 0.025984231382608414
41 O 0 0.05943869426846504
families O 0 0.03280354291200638
identified O 0 0.02576208859682083
to O 0 0.01656751148402691
have O 0 0.012217152863740921
a O 0 0.0426916740834713
mutation O 0 0.08816542476415634
. O 0 0.047256551682949066

The O 0 0.05382188409566879
odds O 0 0.08762035518884659
of O 0 0.03836711868643761
detection O 0 0.06047917529940605
of O 0 0.018192939460277557
any O 0 0.011180814355611801
of O 0 0.016715388745069504
the O 0 0.023532669991254807
four O 0 0.03745667263865471
BRCA1 O 1 0.9999734163284302
mutations O 0 0.0661362037062645
was O 0 0.04699501767754555
18 O 0 0.049921464174985886
. O 0 0.0410497710108757

7x O 1 0.9998780488967896
greater O 0 0.05804411694407463
if O 0 0.023879868909716606
one O 0 0.017394009977579117
or O 0 0.011882124468684196
more O 0 0.008098536171019077
cases O 0 0.029336348176002502
of O 1 0.9998725652694702
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.03246382996439934
also O 0 0.018919160589575768
present O 0 0.019056685268878937
in O 0 0.014467569999396801
the O 0 0.02950034849345684
family O 0 0.05511844530701637
. O 0 0.04210972413420677

The O 0 0.052430037409067154
odds O 0 0.0826372429728508
of O 0 0.03439927473664284
detection O 0 0.05662011727690697
of O 0 0.01671581342816353
any O 0 0.011696116998791695
of O 0 0.014207758009433746
the O 0 0.02401435561478138
four O 0 0.03760432079434395
BRCA2 O 1 0.9999788999557495
mutations O 0 0.06706571578979492
was O 0 0.050040289759635925
5 O 0 0.05678240582346916
. O 0 0.04053530469536781

3x O 1 0.9976956248283386
greater O 0 0.05869917571544647
if O 0 0.024081025272607803
there O 0 0.011236653663218021
were O 0 0.008093465119600296
at O 0 0.014024460688233376
least O 0 0.008363477885723114
five O 0 0.01091734692454338
cases O 0 0.023101959377527237
of O 1 0.5719606876373291
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.04113411530852318
the O 0 0.04536601901054382
family O 0 0.0589638389647007
. O 0 0.039583224803209305

Interestingly O 0 0.10986513644456863
, O 0 0.017362967133522034
the O 0 0.014286256395280361
presence O 0 0.023411177098751068
of O 0 0.023819155991077423
a O 1 0.6470654010772705
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.9998908042907715
< O 1 0.9999784231185913
36 O 0 0.04270947724580765
years O 0 0.019225869327783585
of O 0 0.025584295392036438
age O 0 0.037462636828422546
was O 0 0.03759918734431267
strongly O 0 0.03601325675845146
predictive O 0 0.05273297429084778
of O 0 0.019710170105099678
the O 0 0.02475983276963234
presence O 0 0.026562536135315895
of O 0 0.015554757788777351
any O 0 0.012377452105283737
of O 0 0.01841067150235176
the O 0 0.02699587121605873
eight O 0 0.04550858214497566
mutations O 0 0.07333003729581833
screened O 0 0.11684424430131912
. O 0 0.04748905450105667

Carriers O 0 0.08493567258119583
of O 0 0.02556944265961647
the O 0 0.030606135725975037
same O 0 0.029784128069877625
mutation O 0 0.0621468760073185
, O 0 0.018995486199855804
from O 0 0.015225525014102459
different O 0 0.007608921732753515
families O 0 0.026071149855852127
, O 0 0.021865515038371086
shared O 0 0.03991733491420746
similar O 0 0.03272738680243492
haplotypes O 0 0.13731013238430023
, O 0 0.02845286764204502
indicating O 0 0.031393397599458694
that O 0 0.011604075320065022
the O 0 0.0332769975066185
mutant O 1 0.5816477537155151
alleles O 0 0.08260533213615417
were O 0 0.017502011731266975
likely O 0 0.025883181020617485
to O 0 0.019474301487207413
be O 0 0.01189522072672844
identical O 0 0.017688065767288208
by O 0 0.017481230199337006
descent O 0 0.04758607596158981
for O 0 0.018695911392569542
a O 0 0.03263446316123009
mutation O 0 0.048226580023765564
in O 0 0.017017710953950882
the O 0 0.035804104059934616
founder O 1 0.9933018684387207
population O 0 0.03687863051891327
. O 0 0.04077288135886192

The O 0 0.032882023602724075
identification O 0 0.031539496034383774
of O 0 0.030140608549118042
common O 0 0.06582500040531158
BRCA1 O 1 0.9999986886978149
and O 0 0.06151600182056427
BRCA2 O 1 0.9999897480010986
mutations O 0 0.05895041301846504
will O 0 0.02149342931807041
facilitate O 0 0.05568814277648926
carrier O 0 0.10738910734653473
detection O 0 0.042517028748989105
in O 0 0.010794948786497116
French O 0 0.04232031852006912
Canadian O 0 0.3374648988246918
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999990463256836
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9912920594215393
. O 0 0.04968276247382164

Are O 0 0.024429453536868095
Dp71 O 1 0.9914600849151611
and O 0 0.046457793563604355
Dp140 O 1 0.9999998807907104
brain O 1 0.9999877214431763
dystrophin O 1 0.9999985694885254
isoforms O 0 0.06067818030714989
related O 0 0.02477116696536541
to O 0 0.028156261891126633
cognitive B-Disease 1 0.9957142472267151
impairment I-Disease 1 1.0
in O 1 0.9992671608924866
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999673366546631

Molecular O 0 0.1205364242196083
study O 0 0.03951696306467056
and O 0 0.03535368666052818
neuropsychological O 1 0.9432615637779236
analysis O 0 0.023087043315172195
were O 0 0.011538760736584663
performed O 0 0.02957998402416706
concurrently O 0 0.03688114508986473
on O 0 0.017267553135752678
49 O 0 0.04848350211977959
patients O 1 0.95741206407547
with O 0 0.2070959210395813
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.03458061441779137
in O 0 0.014825164340436459
order O 0 0.02143503911793232
to O 0 0.017299942672252655
find O 0 0.027014588937163353
a O 0 0.026749571785330772
molecular O 0 0.0338737815618515
explanation O 0 0.024630945175886154
for O 0 0.01691238395869732
the O 0 0.03622305393218994
cognitive B-Disease 1 0.9597340226173401
impairment I-Disease 1 0.9999957084655762
observed O 0 0.03904653713107109
in O 0 0.03234639763832092
most O 0 0.06535390764474869
DMD B-Disease 1 1.0
patients O 1 0.9999960660934448
. O 0 0.07215084880590439

Complete O 0 0.054619502276182175
analysis O 0 0.016192452982068062
of O 0 0.02101927623152733
the O 0 0.047993775457143784
dystrophin O 1 0.999997615814209
gene O 0 0.06143052875995636
was O 0 0.038320496678352356
performed O 0 0.034863684326410294
to O 0 0.01859523355960846
define O 0 0.03407888114452362
the O 0 0.024431545287370682
localization O 0 0.09361647069454193
of O 0 0.03760557994246483
deletions O 0 0.09497365355491638
and O 0 0.03095848858356476
duplications O 0 0.09423480927944183
in O 0 0.0209114458411932
relation O 0 0.032946862280368805
to O 0 0.019727036356925964
the O 0 0.02875158190727234
different O 0 0.02740907296538353
DMD B-Disease 1 1.0
promoters O 1 0.9960194230079651
. O 0 0.05308125540614128

Qualitative O 0 0.09240693598985672
analysis O 0 0.02118680812418461
of O 0 0.02546662651002407
the O 0 0.045543123036623
Dp71 O 1 0.9998295307159424
transcript O 0 0.08910810202360153
and O 0 0.025365814566612244
testing O 0 0.030570369213819504
for O 0 0.014733042567968369
the O 0 0.019344443455338478
specific O 0 0.012382980436086655
first O 0 0.02968752570450306
exon O 0 0.13918490707874298
of O 0 0.04595251381397247
Dp140 O 1 0.9939716458320618
were O 0 0.020969627425074577
also O 0 0.021091721951961517
carried O 0 0.029678629711270332
out O 0 0.029706379398703575
. O 0 0.03643632307648659

Neuropsychological O 1 0.9900766015052795
analysis O 0 0.04602489620447159
assessed O 0 0.06625432521104813
verbal O 0 0.08472283184528351
and O 0 0.04692249745130539
visuospatial O 1 0.9999920129776001
intelligence O 0 0.05340638756752014
, O 0 0.035075340420007706
verbal O 1 0.9406781196594238
memory O 1 0.9998751878738403
, O 0 0.036715369671583176
and O 0 0.02963271737098694
reading O 0 0.06497714668512344
skills O 0 0.05881420895457268
. O 0 0.04447653889656067

Comparison O 0 0.07358701527118683
of O 0 0.049043938517570496
molecular O 0 0.07207444310188293
and O 0 0.034208741039037704
psychometric O 1 0.9772202372550964
findings O 0 0.04626315459609032
demonstrated O 0 0.043695323169231415
that O 0 0.017705688253045082
deletions O 0 0.07700679451227188
and O 0 0.03054771013557911
duplications O 0 0.09517555683851242
that O 0 0.014686034061014652
were O 0 0.015292893163859844
localized O 0 0.06725828349590302
in O 0 0.019278131425380707
the O 0 0.036809585988521576
distal O 1 0.9999572038650513
part O 0 0.036470819264650345
of O 0 0.026266906410455704
the O 0 0.035188063979148865
gene O 0 0.039187267422676086
seemed O 0 0.028187163174152374
to O 0 0.016451409086585045
be O 0 0.014351977035403252
preferentially O 0 0.07722889631986618
associated O 0 0.03348121419548988
with O 0 0.04119127243757248
cognitive B-Disease 1 0.9995923638343811
impairment I-Disease 1 0.9999998807907104
. O 0 0.07475229352712631

Two O 0 0.04106747359037399
altered O 0 0.08104410767555237
Dp71 O 1 0.9139717221260071
transcripts O 0 0.07197143137454987
and O 0 0.019661899656057358
two O 0 0.019166629761457443
deleted O 0 0.09617333859205246
Dp140 O 1 0.9312826991081238
DNA O 0 0.04619096592068672
sequences O 0 0.01509164646267891
were O 0 0.0069404779933393
found O 0 0.00795305147767067
in O 0 0.00970330648124218
four O 0 0.020929962396621704
patients O 1 0.9999288320541382
with O 1 0.9506946206092834
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9854362607002258

These O 0 0.029101544991135597
findings O 0 0.03396060690283775
suggest O 0 0.0228533037006855
that O 0 0.009331644512712955
some O 0 0.0091575738042593
sequences O 0 0.016023943200707436
located O 0 0.03087509796023369
in O 0 0.01347359362989664
the O 0 0.03169650584459305
distal O 1 0.9988695979118347
part O 0 0.03246684372425079
of O 0 0.024646859616041183
the O 0 0.03351477533578873
gene O 0 0.03572719171643257
and O 0 0.01654304936528206
, O 0 0.014005707576870918
in O 0 0.013414029963314533
particular O 0 0.01796836405992508
, O 0 0.018102101981639862
some O 0 0.023486368358135223
DMD B-Disease 1 1.0
isoforms O 0 0.05771835893392563
expressed O 0 0.029623936861753464
in O 0 0.025639930739998817
the O 0 0.06701426953077316
brain O 1 0.9998667240142822
may O 0 0.02677426114678383
be O 0 0.012681667692959309
related O 0 0.015371655113995075
to O 0 0.017204105854034424
the O 0 0.0382574088871479
cognitive B-Disease 1 0.9899590611457825
impairment I-Disease 1 0.9999991655349731
associated O 0 0.07253511250019073
with O 0 0.23471134901046753
DMD B-Disease 1 1.0
. O 0 0.047473739832639694
. O 0 0.046928808093070984

I1307K O 1 0.9999452829360962
APC O 1 0.9999879598617554
and O 0 0.048917192965745926
hMLH1 O 1 0.9999737739562988
mutations O 0 0.03879420831799507
in O 0 0.01245464850217104
a O 0 0.023161252960562706
non O 0 0.06059957668185234
- O 1 0.9952627420425415
Jewish O 0 0.03837402164936066
family O 0 0.020287666469812393
with O 0 0.012647531926631927
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9986798167228699

We O 0 0.021722301840782166
describe O 0 0.024603882804512978
a O 0 0.016790825873613358
French O 0 0.0323946475982666
Canadian O 0 0.04033729061484337
hereditary B-Disease 1 0.9999979734420776
non I-Disease 1 0.9999995231628418
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.07517484575510025
kindred O 1 0.9999402761459351
which O 0 0.01665022224187851
carries O 0 0.02430206723511219
a O 0 0.03039064072072506
novel O 0 0.07596781104803085
truncating O 1 0.9859858751296997
mutation O 0 0.09510985761880875
in O 0 0.04236247017979622
hMLH1 O 1 0.9991439580917358
. O 0 0.05382430925965309

Interestingly O 0 0.11080648750066757
, O 0 0.028158539906144142
the O 0 0.045271702110767365
I1307K O 1 0.9999902248382568
APC O 1 0.9999992847442627
polymorphism O 0 0.12648732960224152
, O 0 0.02064613439142704
associated O 0 0.0143532520160079
with O 0 0.00864947959780693
an O 0 0.011033638380467892
increased O 0 0.02241504192352295
risk O 1 0.9851475358009338
of O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9996839761734009
is O 0 0.02114420011639595
also O 0 0.01266433484852314
present O 0 0.01492560375481844
in O 0 0.014332071878015995
this O 0 0.01554812304675579
family O 0 0.05065775662660599
. O 0 0.04099611937999725

The O 0 0.08641491085290909
I1307K O 1 0.9997602105140686
polymorphism O 0 0.13529886305332184
has O 0 0.025220071896910667
previously O 0 0.022600434720516205
only O 0 0.011565594002604485
been O 0 0.013131275773048401
identified O 0 0.017954997718334198
in O 0 0.010433265008032322
individuals O 0 0.011008975096046925
of O 0 0.024433033540844917
self O 1 0.999134361743927
- O 1 0.9999948740005493
reported O 0 0.04355282336473465
Ashkenazi O 1 0.9829302430152893
Jewish O 0 0.08890172839164734
origins O 0 0.07586762309074402
. O 0 0.03752341866493225

In O 0 0.03156398981809616
addition O 0 0.025406595319509506
, O 0 0.018265167251229286
in O 0 0.015135830268263817
this O 0 0.014751756563782692
family O 0 0.03852507844567299
, O 0 0.021031580865383148
there O 0 0.015392613597214222
appears O 0 0.03172742947936058
to O 0 0.01833372935652733
be O 0 0.011914773844182491
no O 0 0.0164028313010931
relationship O 0 0.029608000069856644
between O 0 0.02240559458732605
the O 0 0.03948357701301575
I1307K O 1 0.9998797178268433
polymorphism O 0 0.08634807169437408
and O 0 0.017486603930592537
the O 0 0.02228880487382412
presence O 0 0.0344855897128582
or O 0 0.02309247851371765
absence O 0 0.09345163404941559
of O 1 0.8002141118049622
cancer B-Disease 1 1.0
. O 0 0.039668746292591095
. O 0 0.04412325099110603

Identification O 0 0.04820003733038902
of O 0 0.0243376437574625
a O 0 0.03548714891076088
novel O 0 0.059537000954151154
mutation O 0 0.046444643288850784
of O 0 0.024559393525123596
the O 0 0.04512491449713707
CPO O 1 0.9999830722808838
gene O 0 0.03470779210329056
in O 0 0.012896145693957806
a O 0 0.027686867862939835
Japanese O 0 0.08490768820047379
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999998807907104
family O 0 0.0977887287735939
. O 0 0.05228494852781296

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.7493374943733215
HCP B-Disease 1 1.0
) O 0 0.023991605266928673
is O 0 0.012748423032462597
an O 0 0.023828959092497826
autosomal B-Disease 1 0.9999936819076538
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
characterized O 1 0.9125919342041016
by O 0 0.025222158059477806
a O 0 0.3504463732242584
deficiency B-Disease 1 1.0
of I-Disease 1 0.9994727969169617
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 0 0.07572546601295471
CPO O 1 0.9999958276748657
) O 0 0.028688110411167145
caused O 0 0.02933570370078087
by O 0 0.018376260995864868
a O 0 0.03281174972653389
mutation O 0 0.04377323389053345
in O 0 0.017276713624596596
the O 0 0.041904572397470474
CPO O 1 0.9999902248382568
gene O 0 0.07196809351444244
. O 0 0.03959330543875694

Only O 0 0.029691588133573532
11 O 0 0.04259449243545532
mutations O 0 0.032993294298648834
of O 0 0.019427577033638954
the O 0 0.02905527502298355
gene O 0 0.029774758964776993
have O 0 0.007488501723855734
been O 0 0.013255962170660496
reported O 0 0.031118886545300484
in O 0 0.047260209918022156
HCP B-Disease 1 1.0
patients O 1 0.9999651908874512
. O 0 0.06279363483190536

We O 0 0.023310255259275436
report O 0 0.024006841704249382
another O 0 0.03680974990129471
mutation O 0 0.05193151533603668
in O 0 0.018406130373477936
a O 0 0.032666128128767014
Japanese O 0 0.0687713772058487
family O 0 0.06338252872228622
. O 0 0.042036090046167374

Polymerase O 1 0.9948853850364685
chain O 0 0.13574576377868652
reaction O 0 0.09844201058149338
- O 1 0.9999078512191772
single O 0 0.0745910182595253
strand O 0 0.13611672818660736
conformational O 0 0.1269516944885254
polymorphism O 0 0.09415929019451141
and O 0 0.02371164970099926
direct O 0 0.030185455456376076
sequence O 0 0.02050086483359337
analyses O 0 0.02423207089304924
demonstrated O 0 0.03037884272634983
a O 0 0.03750113770365715
C O 1 0.8708158135414124
to O 0 0.04260635003447533
T O 1 0.9980744123458862
substitution O 0 0.06199094280600548
in O 0 0.022027065977454185
exon O 0 0.11395896971225739
1 O 0 0.03218091279268265
of O 0 0.01954403519630432
the O 0 0.03846793994307518
CPO O 1 0.9993925094604492
gene O 0 0.05084961652755737
at O 0 0.037857845425605774
nucleotide O 0 0.06642556935548782
position O 0 0.03838326409459114
85 O 0 0.05540905147790909
, O 0 0.0212817694991827
which O 0 0.01390097290277481
lies O 0 0.0316292941570282
in O 0 0.01269184984266758
the O 0 0.03147042915225029
putative O 1 0.968559980392456
presequence O 1 0.9957303404808044
for O 0 0.029090669006109238
targeting O 0 0.05879491940140724
to O 0 0.04115898907184601
mitochondria O 0 0.13110922276973724
. O 0 0.04733492434024811

This O 0 0.04182859882712364
mutation O 0 0.06635135412216187
changes O 0 0.01910475268959999
the O 0 0.029110819101333618
codon O 0 0.09547481685876846
for O 0 0.024865418672561646
glutamine O 0 0.0827040746808052
to O 0 0.018250077962875366
a O 0 0.03339030593633652
termination O 1 0.7829059362411499
codon O 0 0.14544466137886047
at O 0 0.056846339255571365
amino O 0 0.08645550161600113
acid O 0 0.0936191976070404
position O 0 0.055122390389442444
29 O 0 0.06958621740341187
. O 0 0.0414104238152504

MaeI O 1 0.9998509883880615
restriction O 0 0.09921818226575851
analysis O 0 0.021385932341217995
showed O 0 0.01804707571864128
two O 0 0.009885062463581562
other O 0 0.014139632694423199
carriers O 0 0.049763213843107224
in O 0 0.01690608076751232
the O 0 0.03139840066432953
family O 0 0.058017730712890625
. O 0 0.04138358309864998

The O 0 0.06672784686088562
C O 1 0.9999996423721313
- O 1 1.0
T O 1 0.9999996423721313
mutation O 0 0.06629525125026703
is O 0 0.017944641411304474
located O 0 0.028555870056152344
within O 0 0.011826091445982456
a O 0 0.018813861533999443
recently O 0 0.028463663533329964
proposed O 0 0.028371024876832962
putative O 0 0.11794746667146683
alternative O 0 0.043265990912914276
translation O 0 0.038875214755535126
initiation O 0 0.350961297750473
codon O 0 0.13630829751491547
( O 0 0.059226568788290024
TIC O 1 1.0
- O 1 0.9999991655349731
1 O 0 0.04603757709264755
) O 0 0.01517779566347599
, O 0 0.010719657875597477
supporting O 0 0.026057731360197067
that O 0 0.018906261771917343
TIC O 1 1.0
- O 1 0.9999995231628418
1 O 0 0.03689706698060036
is O 0 0.012731239199638367
the O 0 0.020109403878450394
real O 0 0.0493747852742672
TIC O 1 0.999988317489624
rather O 0 0.019697092473506927
than O 0 0.026264561340212822
TIC O 1 1.0
- O 1 0.9999998807907104
2 O 0 0.059789013117551804
. O 0 0.02302245795726776
. O 0 0.02927606925368309

Human B-Disease 0 0.05019044131040573
complement I-Disease 0 0.09999404847621918
factor I-Disease 1 0.9998538494110107
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.09532681107521057
with O 1 0.9999843835830688
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999871253967285

This O 0 0.026130549609661102
study O 0 0.02155419997870922
reports O 0 0.016410943120718002
on O 0 0.01291243638843298
six O 0 0.015402785502374172
cases O 0 0.027008311823010445
of O 0 0.12264128774404526
deficiency B-Disease 1 1.0
in I-Disease 0 0.02388554811477661
the I-Disease 0 0.023051928728818893
human I-Disease 0 0.025705518200993538
complement I-Disease 0 0.05649092048406601
regulatory I-Disease 0 0.07120928913354874
protein I-Disease 0 0.06421134620904922
Factor I-Disease 1 0.9920939803123474
H I-Disease 1 1.0
( O 0 0.0689094141125679
FH O 1 0.9999997615814209
) O 0 0.016992444172501564
in O 0 0.00707604642957449
the O 0 0.010380188934504986
context O 0 0.014940837398171425
of O 0 0.024467529729008675
an O 1 0.9993141889572144
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999934434890747

Five O 0 0.029596049338579178
of O 0 0.024722307920455933
the O 0 0.02791714295744896
cases O 0 0.022030547261238098
were O 0 0.012598264962434769
observed O 0 0.015425506979227066
in O 0 0.010331515222787857
children O 0 0.022943299263715744
presenting O 0 0.0382009893655777
with O 0 0.04685632511973381
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 0.32631567120552063
. O 0 0.046456675976514816

Two O 0 0.019759133458137512
of O 0 0.021151797845959663
the O 0 0.030592909082770348
children O 0 0.0454280748963356
exhibited O 0 0.06198166310787201
a O 0 0.0672130212187767
homozygous O 1 0.9999874830245972
deficiency O 1 1.0
characterized O 1 0.9878429174423218
by O 0 0.026335660368204117
the O 0 0.026966547593474388
absence O 0 0.03835548087954521
of O 0 0.01791665516793728
the O 0 0.02142617106437683
150 O 0 0.04553447291254997
- O 1 0.9999834299087524
kD O 1 0.9990556836128235
form O 0 0.0268108993768692
of O 0 0.03596670180559158
Factor O 1 0.9997032284736633
H O 1 0.9999998807907104
and O 0 0.020221978425979614
the O 0 0.02338828332722187
presence O 0 0.03484705090522766
, O 0 0.018463263288140297
upon O 0 0.02749382145702839
immunoblotting O 1 0.985977053642273
, O 0 0.013040824793279171
of O 0 0.010627573356032372
the O 0 0.014738082885742188
42 O 0 0.045501459389925
- O 1 0.9999892711639404
kD O 1 0.9999958276748657
Factor O 1 0.9618673920631409
H O 1 1.0
- O 1 0.9999967813491821
like O 0 0.029779262840747833
protein O 0 0.033251646906137466
1 O 0 0.03688576817512512
( O 0 0.03711580112576485
FHL O 1 0.9999988079071045
- O 1 0.9999967813491821
1 O 0 0.04162702336907387
) O 0 0.012457235716283321
and O 0 0.008604004979133606
other O 0 0.013505694456398487
FH O 1 1.0
- O 1 1.0
related O 0 0.06728661805391312
protein O 0 0.062011368572711945
( O 0 0.049211423844099045
FHR O 1 0.9999973773956299
) O 0 0.0426030270755291
bands O 0 0.07290539890527725
. O 0 0.04046977311372757

Southern O 0 0.1405068188905716
blot O 1 0.9889349341392517
and O 0 0.052657876163721085
PCR O 0 0.12484654784202576
analysis O 0 0.01478717103600502
of O 0 0.016664166003465652
DNA O 0 0.023003676906228065
of O 0 0.0166423711925745
one O 0 0.023990191519260406
patient O 1 0.9778380990028381
with O 0 0.04111732542514801
homozygous O 1 0.9998414516448975
deficiency O 1 1.0
ruled O 0 0.2286262810230255
out O 0 0.029425498098134995
the O 0 0.023040708154439926
presence O 0 0.02767151966691017
of O 0 0.016052832826972008
a O 0 0.020029449835419655
large O 0 0.02002158761024475
deletion O 0 0.05658906698226929
of O 0 0.02316184528172016
the O 0 0.047303225845098495
FH O 1 1.0
gene O 0 0.04333918169140816
as O 0 0.018866660073399544
the O 0 0.03184262290596962
underlying O 1 0.9436309337615967
defect O 1 0.9999966621398926
for O 0 0.041501063853502274
the O 1 0.9243104457855225
deficiency O 1 1.0
. O 0 0.07475915551185608

The O 0 0.03576291725039482
other O 0 0.01282057911157608
four O 0 0.016554195433855057
children O 0 0.034367140382528305
presented O 0 0.035230398178100586
with O 0 0.0400400273501873
heterozygous O 1 0.999707043170929
deficiency O 1 1.0
and O 0 0.04522312805056572
exhibited O 0 0.11062990874052048
a O 0 0.04464685171842575
normal O 0 0.05857638642191887
immunoblotting O 1 0.9992399215698242
pattern O 0 0.04364392161369324
of O 0 0.029394736513495445
proteins O 0 0.027920356020331383
of O 0 0.02254464104771614
the O 0 0.05329625681042671
FH O 1 1.0
family O 0 0.08255252242088318
. O 0 0.045388784259557724

Factor B-Disease 1 0.9999955892562866
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.025779688730835915
the O 0 0.02215968444943428
only O 0 0.02683684416115284
complement B-Disease 1 0.9999979734420776
deficiency I-Disease 1 1.0
associated O 0 0.46046149730682373
with O 0 0.49444785714149475
HUS B-Disease 1 1.0
. O 0 0.07614881545305252

These O 0 0.0250144824385643
observations O 0 0.029659461230039597
suggest O 0 0.016299940645694733
a O 0 0.01838204264640808
role O 0 0.033892672508955
for O 0 0.029788579791784286
FH O 1 1.0
and O 0 0.0505150705575943
/ O 1 0.9999996423721313
or O 0 0.05096350982785225
FH O 1 1.0
receptors O 0 0.04988419637084007
in O 0 0.012476055882871151
the O 0 0.03027956746518612
pathogenesis O 1 1.0
of O 1 0.9999239444732666
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.1131923645734787
. O 0 0.04771214351058006

Further O 0 0.03379802033305168
evidence O 0 0.01850539818406105
for O 0 0.015299341641366482
a O 0 0.022868124768137932
major O 0 0.03405768424272537
ancient O 0 0.05996125563979149
mutation O 0 0.26795411109924316
underlying O 1 0.9999922513961792
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9989703893661499
linkage O 1 0.9999958276748657
disequilibrium O 1 0.9999914169311523
studies O 0 0.03230377659201622
in O 0 0.018018679693341255
the O 0 0.02797791361808777
Japanese O 0 0.06105777248740196
population O 0 0.031114879995584488
. O 0 0.039311569184064865

The O 0 0.26265987753868103
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.05192731320858002
mutation O 0 0.050461295992136
is O 0 0.017016882076859474
an O 0 0.03109721653163433
unstable O 1 0.9999899864196777
( O 0 0.05880727246403694
CTG O 1 0.9999997615814209
) O 0 0.0468643382191658
n O 0 0.1032426580786705
repeat O 0 0.0754973292350769
, O 0 0.01876091957092285
present O 0 0.017298895865678787
at O 0 0.021182456985116005
a O 0 0.02025638520717621
copy O 0 0.026541464030742645
number O 0 0.008851629681885242
of O 0 0.01876019686460495
5 O 0 0.05153196305036545
- O 1 0.9998630285263062
37 O 0 0.055274609476327896
repeats O 0 0.05610817298293114
on O 0 0.02461778186261654
normal O 0 0.03646751865744591
chromosomes O 0 0.0424724817276001
but O 0 0.01670667715370655
amplified O 0 0.0615704208612442
to O 0 0.019706960767507553
50 O 0 0.03662186488509178
- O 1 0.9275923371315002
3000 O 0 0.07914113998413086
copies O 0 0.0351359099149704
on O 0 0.05638021603226662
DM B-Disease 1 1.0
chromosomes O 0 0.10587860643863678
. O 0 0.04507998749613762

Previous O 0 0.04863276705145836
findings O 0 0.030081911012530327
in O 0 0.020722361281514168
Caucasian O 0 0.10938232392072678
populations O 0 0.024836614727973938
of O 0 0.027217959985136986
a O 0 0.4532806873321533
DM B-Disease 1 1.0
founder O 1 0.9999998807907104
chromosome O 0 0.08946395665407181
raise O 0 0.038424428552389145
a O 0 0.024054063484072685
question O 0 0.01826450042426586
about O 0 0.011208366602659225
the O 0 0.025922078639268875
molecular O 0 0.041525840759277344
events O 0 0.016365403309464455
involved O 0 0.016283081844449043
in O 0 0.014548425562679768
the O 0 0.030792152509093285
expansion O 0 0.08332084119319916
mutation O 0 0.09382028132677078
. O 0 0.045492466539144516

To O 0 0.0330289825797081
investigate O 0 0.04697034880518913
whether O 0 0.01695917546749115
a O 0 0.027745209634304047
founder O 1 0.9255552291870117
chromosome O 0 0.0560896135866642
for O 0 0.02121039293706417
the O 0 0.0641888901591301
DM B-Disease 1 1.0
mutation O 0 0.13861295580863953
exists O 0 0.032761987298727036
in O 0 0.014089886099100113
the O 0 0.024126581847667694
Japanese O 0 0.05001169070601463
population O 0 0.021044177934527397
, O 0 0.02064760960638523
we O 0 0.01849661022424698
genotyped O 0 0.1740758717060089
families O 0 0.037704989314079285
using O 0 0.023486826568841934
polymorphic O 0 0.26210927963256836
markers O 0 0.07187677919864655
near O 0 0.05335870385169983
the O 0 0.03576461970806122
( O 0 0.056529875844717026
CTG O 1 0.9999980926513672
) O 0 0.05091910809278488
n O 0 0.11155053228139877
repeat O 0 0.08903810381889343
region O 0 0.04870991036295891
and O 0 0.03571775183081627
constructed O 0 0.1088237538933754
haplotypes O 0 0.22317689657211304
. O 0 0.0591997355222702

Six O 0 0.03907039761543274
different O 0 0.014209982939064503
haplotypes O 0 0.09175543487071991
were O 0 0.014153111726045609
found O 0 0.02352471649646759
and O 0 0.04998444393277168
DM B-Disease 1 1.0
alleles O 0 0.11122458428144455
were O 0 0.023815326392650604
always O 0 0.04788999259471893
haplotype O 0 0.2452397495508194
A O 0 0.07962813228368759
. O 0 0.048515189439058304

To O 0 0.0395519956946373
find O 0 0.0287183690816164
an O 0 0.01334008201956749
origin O 0 0.010463446378707886
of O 0 0.015340211801230907
the O 0 0.031056327745318413
( O 0 0.05206698924303055
CTG O 1 0.9999996423721313
) O 0 0.051215920597314835
n O 0 0.12319349497556686
repeat O 0 0.12749464809894562
mutation O 0 0.06365510821342468
and O 0 0.018484244123101234
to O 0 0.021688705310225487
investigate O 0 0.05320942401885986
the O 0 0.02650446444749832
mechanism O 0 0.037362780421972275
of O 0 0.01837891899049282
the O 0 0.029170161113142967
expansion O 0 0.06787382066249847
mutation O 0 0.05606028810143471
in O 0 0.016078392043709755
the O 0 0.023344887420535088
Japanese O 0 0.04602313041687012
population O 0 0.019318291917443275
we O 0 0.009813139215111732
have O 0 0.007982830516994
studied O 0 0.023945478722453117
90 O 0 0.04073966667056084
Japanese O 0 0.10812047123908997
DM B-Disease 1 1.0
families O 0 0.04949541017413139
comprising O 0 0.06489310413599014
190 O 0 0.09424783289432526
affected O 0 0.043831717222929
and O 0 0.02973717637360096
130 O 0 0.08184138685464859
unaffected O 0 0.3204159140586853
members O 0 0.04812401533126831
. O 0 0.04379982873797417

The O 0 0.04966890811920166
results O 0 0.024520624428987503
suggest O 0 0.01827932707965374
that O 0 0.008747898042201996
a O 0 0.018018603324890137
few O 0 0.017118185758590698
common O 0 0.03833530843257904
ancestral O 1 0.9974284768104553
mutations O 0 0.048989057540893555
in O 0 0.02012111432850361
both O 0 0.02632102183997631
Caucasian O 1 0.9978690147399902
and O 0 0.029684802517294884
Japanese O 0 0.05899576097726822
populations O 0 0.026194924488663673
have O 0 0.008896632120013237
originated O 0 0.024040980264544487
by O 0 0.011628241278231144
expansion O 0 0.030090898275375366
of O 0 0.018432600423693657
an O 0 0.029798991978168488
ancestral O 1 0.8827831745147705
n O 0 0.1273009181022644
= O 0 0.06961134821176529
5 O 0 0.032829415053129196
repeat O 0 0.05686420574784279
to O 0 0.03055112063884735
n O 0 0.10157567262649536
= O 0 0.07812550663948059
19 O 0 0.0644569918513298
- O 1 0.9965302348136902
37 O 0 0.059800077229738235
copies O 0 0.04305370897054672
. O 0 0.035120584070682526

These O 0 0.021071400493383408
data O 0 0.019328609108924866
support O 0 0.03711235895752907
multistep O 0 0.1335000991821289
models O 0 0.033010292798280716
of O 0 0.042898230254650116
triplet O 1 0.9999816417694092
repeat O 0 0.12089169025421143
expansion O 0 0.057486142963171005
that O 0 0.010712691582739353
have O 0 0.006007705815136433
been O 0 0.0077418251894414425
proposed O 0 0.013992332853376865
for O 0 0.01547081395983696
both O 0 0.03491063416004181
DM B-Disease 1 1.0
and O 0 0.090683214366436
Friedreichs B-Disease 1 1.0
ataxia I-Disease 1 1.0
. O 0 0.04805678129196167
. O 0 0.04893134906888008

The O 0 0.04032059758901596
molecular O 0 0.037508681416511536
basis O 0 0.02456822246313095
of O 1 0.8866163492202759
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.032296907156705856
the O 0 0.030851293355226517
western O 0 0.0445520281791687
Cape O 0 0.221150204539299
, O 0 0.026756923645734787
South O 0 0.058506112545728683
Africa O 0 0.07755298167467117
. O 0 0.044614583253860474

Deficiency B-Disease 1 1.0
of I-Disease 0 0.04275235906243324
the I-Disease 0 0.03590131923556328
sixth I-Disease 1 0.9923575520515442
component I-Disease 0 0.06225656718015671
of I-Disease 0 0.025644993409514427
human I-Disease 0 0.035604845732450485
complement I-Disease 1 0.996900200843811
( O 1 0.6457366347312927
C6 O 1 1.0
) O 0 0.02751610241830349
has O 0 0.014603766612708569
been O 0 0.011021957732737064
reported O 0 0.016803504899144173
in O 0 0.011202375404536724
a O 0 0.01902840845286846
number O 0 0.011295228265225887
of O 0 0.01752549409866333
families O 0 0.02376343123614788
from O 0 0.01598021388053894
the O 0 0.024237537756562233
western O 0 0.046248890459537506
Cape O 0 0.1524209827184677
, O 0 0.029666129499673843
South O 0 0.06157300993800163
Africa O 0 0.0757535770535469
. O 0 0.04479455202817917

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.09295327216386795
endemic O 1 0.9981163740158081
in O 0 0.025871485471725464
the O 0 0.034655746072530746
Cape O 0 0.09870439767837524
and O 0 0.01643809676170349
almost O 0 0.01093382015824318
all O 0 0.009625720791518688
pedigrees O 0 0.05672397091984749
of O 0 0.028736978769302368
total O 1 0.5229887962341309
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9999310970306396
C6Q0 O 1 1.0
) O 0 0.024486051872372627
have O 0 0.00742917088791728
been O 0 0.012259425595402718
ascertained O 0 0.058018431067466736
because O 0 0.020465876907110214
of O 0 0.059653908014297485
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.4003467261791229

We O 0 0.024930650368332863
have O 0 0.012555059976875782
sequenced O 0 0.03571810945868492
the O 0 0.016465602442622185
expressed O 0 0.027345512062311172
exons O 0 0.06608641892671585
of O 0 0.02844344452023506
the O 0 0.06258968263864517
C6 O 1 1.0
gene O 0 0.053509850054979324
from O 0 0.02133663184940815
selected O 0 0.02919662557542324
cases O 0 0.025585485622286797
and O 0 0.016923613846302032
have O 0 0.009008531458675861
found O 0 0.01271283533424139
three O 0 0.019608089700341225
molecular O 0 0.07393309473991394
defects O 1 0.9965611100196838
leading O 0 0.053111981600522995
to O 0 0.03053227625787258
total O 0 0.06723511964082718
deficiency O 1 1.0
879delG O 1 1.0
, O 0 0.02889356203377247
which O 0 0.012964569963514805
is O 0 0.013611574657261372
the O 0 0.02473917230963707
common O 0 0.0443575419485569
defect O 1 0.9997103810310364
in O 0 0.02276054583489895
the O 0 0.03487195447087288
Cape O 0 0.17068101465702057
and O 0 0.03309810906648636
hitherto O 0 0.14880309998989105
unreported O 0 0.11086222529411316
, O 0 0.028659585863351822
and O 0 0.03157178685069084
1195delC O 1 0.9999974966049194
and O 0 0.046741336584091187
1936delG O 1 0.9999991655349731
, O 0 0.027667518705129623
which O 0 0.012411201372742653
have O 0 0.006960759405046701
been O 0 0.009442344307899475
previously O 0 0.01696038246154785
reported O 0 0.019189685583114624
in O 0 0.02000114880502224
African O 0 0.1016479954123497
- O 1 0.9999916553497314
Americans O 0 0.05510590597987175
. O 0 0.03931882604956627

We O 0 0.026400474831461906
also O 0 0.017202848568558693
show O 0 0.01591469533741474
that O 0 0.007234123535454273
the O 0 0.022894863039255142
879delG O 1 0.9997319579124451
and O 0 0.04128263145685196
1195delC O 1 1.0
defects O 1 0.9999583959579468
are O 0 0.009618673473596573
associated O 0 0.019216015934944153
with O 0 0.02440846525132656
characteristic O 1 0.9999938011169434
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 0.06678086519241333
DNA O 0 0.06893497705459595
marker O 1 0.9217696189880371
haplotypes O 0 0.22319599986076355
, O 0 0.022655721753835678
although O 0 0.017794284969568253
small O 0 0.023096609860658646
variations O 0 0.028842097148299217
were O 0 0.016672395169734955
observed O 0 0.03672352060675621
. O 0 0.04343152046203613

The O 0 0.10012511909008026
1936delG O 1 0.9999961853027344
defect O 1 0.9999904632568359
was O 0 0.05784729868173599
observed O 0 0.0257057324051857
only O 0 0.013510282151401043
once O 0 0.02668466418981552
in O 0 0.014329283498227596
the O 0 0.0280796866863966
Cape O 0 0.2892765402793884
, O 0 0.018674533814191818
but O 0 0.01153284590691328
its O 0 0.02649148926138878
associated O 0 0.04243750870227814
haplotype O 0 0.3956829309463501
could O 0 0.022323453798890114
be O 0 0.01878117024898529
deduced O 0 0.08010973036289215
. O 0 0.03840260952711105

The O 0 0.04856039956212044
data O 0 0.019303282722830772
from O 0 0.017423421144485474
the O 0 0.03595716133713722
haplotypes O 0 0.1311982125043869
indicate O 0 0.027592990547418594
that O 0 0.009355103597044945
these O 0 0.008584714494645596
three O 0 0.0271539855748415
molecular O 0 0.08690869063138962
defects O 1 0.9106342792510986
account O 0 0.029561441391706467
for O 0 0.024036968126893044
the O 0 0.043756552040576935
defects O 1 0.9974110722541809
in O 0 0.018551921471953392
all O 0 0.014711477793753147
the O 0 0.02799016237258911
38 O 0 0.0746040791273117
unrelated O 0 0.10916660726070404
C6Q0 O 1 0.9999977350234985
individuals O 0 0.030161581933498383
we O 0 0.015163348987698555
have O 0 0.009756122715771198
studied O 0 0.024561991915106773
from O 0 0.02033953368663788
the O 0 0.03709203377366066
Cape O 0 0.2466752529144287
. O 0 0.05073411017656326

We O 0 0.02483806386590004
have O 0 0.011749329045414925
also O 0 0.013434560038149357
observed O 0 0.019358061254024506
the O 0 0.03383137285709381
879delG O 1 0.9998801946640015
defect O 1 0.9106166362762451
in O 0 0.013639772310853004
two O 0 0.015020051039755344
Dutch O 1 0.9982059001922607
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 1 0.999366819858551
, O 0 0.022801334038376808
but O 0 0.01359468325972557
the O 0 0.03234385326504707
879delG O 1 0.9999970197677612
defect O 1 0.9998905658721924
in O 0 0.025901269167661667
the O 0 0.037464164197444916
Cape O 1 0.9199935793876648
probably O 0 0.03433574363589287
did O 0 0.016754308715462685
not O 0 0.011075325310230255
come O 0 0.014362497255206108
from O 0 0.01629294641315937
The O 0 0.029661202803254128
Netherlands O 0 0.07883123308420181
. O 0 0.027750913053750992
. O 0 0.036727845668792725

Complement B-Disease 1 0.9999991655349731
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.051123861223459244
seven O 0 0.03526301681995392
further O 0 0.043002448976039886
molecular O 1 0.8965056538581848
defects O 1 0.9995279312133789
and O 0 0.024799343198537827
their O 0 0.02819838374853134
associated O 0 0.053566258400678635
marker O 1 0.9942189455032349
haplotypes O 1 0.829281210899353
. O 0 0.05184386670589447

Seven O 0 0.034854382276535034
further O 0 0.027438540011644363
molecular O 0 0.0449901819229126
bases O 0 0.047742243856191635
of O 1 0.9827097654342651
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.035505712032318115
described O 0 0.061219342052936554
. O 0 0.04053770750761032

All O 0 0.020927298814058304
these O 0 0.012464387342333794
new O 0 0.042288657277822495
molecular O 0 0.08428315073251724
defects O 1 0.9634957313537598
involve O 0 0.042741548269987106
single O 0 0.09028678387403488
- O 1 0.9999998807907104
nucleotide O 0 0.07270393520593643
events O 0 0.024042516946792603
, O 0 0.026966871693730354
deletions O 0 0.07514779269695282
and O 0 0.027318105101585388
substitutions O 0 0.05671870708465576
, O 0 0.015895474702119827
some O 0 0.007544088177382946
of O 0 0.01863306388258934
which O 0 0.02155112288892269
alter O 0 0.07614274322986603
splice O 0 0.20151343941688538
sites O 0 0.03570587933063507
, O 0 0.022354045882821083
and O 0 0.02320171147584915
others O 0 0.03386474400758743
codons O 0 0.11434070765972137
. O 0 0.048727575689554214

They O 0 0.0201279204338789
are O 0 0.008183743804693222
distributed O 0 0.01872418075799942
along O 0 0.025683779269456863
the O 0 0.055816907435655594
C7 O 1 1.0
gene O 0 0.06246661767363548
, O 0 0.018647821620106697
but O 0 0.013309289701282978
predominantly O 0 0.032072924077510834
towards O 0 0.03904439136385918
the O 0 0.03190730884671211
3 O 0 0.05123452842235565
end O 0 0.05741552636027336
. O 0 0.0442156121134758

All O 0 0.026407675817608833
were O 0 0.015277072787284851
found O 0 0.017771366983652115
in O 0 0.027351897209882736
compound O 0 0.13455672562122345
heterozygous O 0 0.11736258864402771
individuals O 0 0.03972818702459335
. O 0 0.04805195704102516

The O 0 0.11176230758428574
C6 O 1 1.0
/ O 1 0.9999996423721313
C7 O 1 1.0
marker O 1 0.9968074560165405
haplotypes O 0 0.13196545839309692
associated O 0 0.028877858072519302
with O 0 0.020837942138314247
most O 0 0.054529931396245956
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999997615814209
are O 0 0.01928737945854664
tabulated O 0 0.05403118208050728
. O 0 0.02338961884379387
. O 0 0.035286083817481995

A O 0 0.09693573415279388
genome O 0 0.08321648091077805
- O 0 0.25004398822784424
wide O 0 0.024173105135560036
search O 0 0.02921924740076065
for O 0 0.027865178883075714
chromosomal O 1 0.9998947381973267
loci O 1 0.8082882761955261
linked O 0 0.07268891483545303
to O 0 0.04439358785748482
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
in O 0 0.02642100490629673
relatives O 0 0.0462142638862133
at O 0 0.023645035922527313
high O 0 0.046592727303504944
risk O 1 0.6157526969909668
for O 1 0.9897536039352417
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.3157932758331299
the O 0 0.04498393088579178
Old O 0 0.13403570652008057
Order O 0 0.05907458811998367
Amish O 0 0.208053857088089
. O 0 0.04752283915877342

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9993731379508972
BPAD B-Disease 1 1.0
; O 1 0.9505557417869568
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.054777976125478745
is O 0 0.021046647801995277
characterized O 0 0.03177011013031006
by O 0 0.01448970939964056
episodes O 0 0.03124002180993557
of O 0 0.05038659647107124
mania B-Disease 1 1.0
and O 1 0.6985622644424438
/ O 1 0.9999998807907104
or O 0 0.0684291273355484
hypomania B-Disease 1 1.0
interspersed O 0 0.10197317600250244
with O 0 0.028247715905308723
periods O 0 0.056628454476594925
of O 0 0.06766544282436371
depression B-Disease 1 1.0
. O 0 0.07452838867902756

Compelling O 0 0.08947495371103287
evidence O 0 0.032108888030052185
supports O 0 0.04527229443192482
a O 0 0.028740452602505684
significant O 0 0.032131195068359375
genetic O 0 0.04752616956830025
component O 0 0.05976089462637901
in O 0 0.021150628104805946
the O 0 0.041390493512153625
susceptibility O 1 0.9975264668464661
to O 0 0.05099813640117645
develop O 0 0.10822328180074692
BPAD B-Disease 1 1.0
. O 0 0.06707681715488434

To O 0 0.04625284671783447
date O 0 0.04105594754219055
, O 0 0.026718029752373695
however O 0 0.02301875688135624
, O 0 0.03533415496349335
linkage O 0 0.13812373578548431
studies O 0 0.024045171216130257
have O 0 0.010170589201152325
attempted O 0 0.036916982382535934
only O 0 0.01232263632118702
to O 0 0.023151686415076256
identify O 0 0.06461083143949509
chromosomal O 1 0.9996069073677063
loci O 0 0.499981552362442
that O 0 0.02643708884716034
cause O 0 0.05932701379060745
or O 0 0.02043144404888153
increase O 0 0.019267190247774124
the O 0 0.030303724110126495
risk O 0 0.05429629236459732
of O 0 0.04232243448495865
developing O 1 0.879450261592865
BPAD B-Disease 1 1.0
. O 0 0.07046979665756226

To O 0 0.044071994721889496
determine O 0 0.026580533012747765
whether O 0 0.01722322590649128
there O 0 0.010926330462098122
could O 0 0.01490449346601963
be O 0 0.020702987909317017
protective O 1 0.9998225569725037
alleles O 0 0.09191176295280457
that O 0 0.020743824541568756
prevent O 0 0.056247588247060776
or O 0 0.026537705212831497
reduce O 0 0.04267861321568489
the O 0 0.03160809725522995
risk O 0 0.0512390062212944
of O 0 0.03814459964632988
developing O 1 0.9638121128082275
BPAD B-Disease 1 1.0
, O 0 0.02938154526054859
similar O 0 0.015344706363976002
to O 0 0.01643041893839836
what O 0 0.011559429578483105
is O 0 0.012044458650052547
observed O 0 0.014645475894212723
in O 0 0.014033337123692036
other O 0 0.028438230976462364
genetic B-Disease 1 0.9999874830245972
disorders I-Disease 1 1.0
, O 0 0.036007869988679886
we O 0 0.019594985991716385
used O 0 0.03016193024814129
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
( O 0 0.036620527505874634
absence O 0 0.044210284948349
of O 0 0.029286937788128853
any O 0 0.04460379108786583
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.04040765017271042
as O 0 0.021440861746668816
the O 0 0.02929685451090336
phenotype O 0 0.0716695636510849
in O 0 0.015997078269720078
our O 0 0.030335022136569023
genome O 0 0.06541972607374191
- O 1 0.9997699856758118
wide O 0 0.05563780292868614
linkage O 0 0.12196841835975647
scan O 0 0.06312274932861328
of O 0 0.01831096038222313
several O 0 0.012970422394573689
large O 0 0.02779960446059704
multigeneration O 1 0.9854117035865784
Old O 0 0.07793869078159332
Order O 0 0.051297709345817566
Amish O 0 0.25921833515167236
pedigrees O 0 0.1319316029548645
exhibiting O 0 0.06850294768810272
an O 0 0.028697513043880463
extremely O 0 0.048193830996751785
high O 0 0.4909985661506653
incidence O 1 0.9999942779541016
of O 1 0.9381958246231079
BPAD B-Disease 1 1.0
. O 0 0.06980758160352707

We O 0 0.029792416840791702
have O 0 0.012993965297937393
found O 0 0.01432234887033701
strong O 0 0.02020198293030262
evidence O 0 0.014520587399601936
for O 0 0.014563335105776787
a O 0 0.03363499790430069
locus O 0 0.10506155341863632
on O 0 0.034155238419771194
chromosome O 0 0.10318931192159653
4p O 1 0.9999967813491821
at O 0 0.06321626156568527
D4S2949 O 1 0.9973617196083069
( O 0 0.03127635642886162
maximum O 0 0.05264845862984657
GENEHUNTER O 1 0.9999966621398926
- O 1 0.9999533891677856
PLUS O 0 0.11153430491685867
nonparametric O 0 0.19668839871883392
linkage O 0 0.12020748108625412
score O 0 0.041826289147138596
= O 0 0.06944059580564499
4 O 0 0.03853161260485649
. O 0 0.021191101521253586
05 O 0 0.21152950823307037
, O 0 0.03998764231801033
P O 1 0.9996564388275146
= O 0 0.06816394627094269
5 O 0 0.025941314175724983
. O 0 0.011945554986596107
22 O 0 0.029297810047864914
x O 0 0.058247506618499756
10 O 0 0.028715938329696655
( O 0 0.03766033425927162
- O 1 0.9998346567153931
4 O 0 0.045188650488853455
) O 0 0.022048138082027435
; O 0 0.023370882496237755
SIBPAL O 1 0.9992154836654663
Pempirical O 1 0.9991994500160217
value O 0 0.037464968860149384
< O 1 0.9184948801994324
3 O 0 0.0417536124587059
x O 0 0.06152249872684479
10 O 0 0.030556440353393555
( O 0 0.04452817142009735
- O 1 0.9999948740005493
5 O 0 0.04929216578602791
) O 0 0.028986245393753052
) O 0 0.02079903893172741
and O 0 0.019245559349656105
suggestive O 0 0.0722651481628418
evidence O 0 0.016988765448331833
for O 0 0.0154091352596879
a O 0 0.033909860998392105
locus O 0 0.11293204873800278
on O 0 0.042450595647096634
chromosome O 0 0.1104627177119255
4q O 1 0.9999418258666992
at O 0 0.05312234163284302
D4S397 O 1 0.9993712306022644
( O 0 0.03209336847066879
maximum O 0 0.05296711251139641
GENEHUNTER O 1 0.9999969005584717
- O 1 0.9998928308486938
PLUS O 0 0.10710764676332474
nonparametric O 0 0.21602967381477356
linkage O 0 0.11949186027050018
score O 0 0.042878758162260056
= O 0 0.06512287259101868
3 O 0 0.029942771419882774
. O 0 0.014068765565752983
29 O 0 0.04053927958011627
, O 0 0.034106601029634476
P O 1 0.9997013211250305
= O 0 0.07156464457511902
2 O 0 0.034436702728271484
. O 0 0.013252233155071735
57 O 0 0.054055698215961456
x O 0 0.07168740034103394
10 O 0 0.03212056681513786
( O 0 0.042202480137348175
- O 1 0.9997813105583191
3 O 0 0.04719864949584007
) O 0 0.022854380309581757
; O 0 0.026666834950447083
SIBPAL O 1 0.9987480640411377
Pempirical O 1 0.9828610420227051
value O 0 0.03634856268763542
< O 1 0.7450041770935059
1 O 0 0.045241206884384155
x O 0 0.061169590801000595
10 O 0 0.026888132095336914
( O 0 0.0397903211414814
- O 1 0.9999985694885254
3 O 0 0.04793814197182655
) O 0 0.021544691175222397
) O 0 0.013204815797507763
that O 0 0.0070573934353888035
are O 0 0.007092579267919064
linked O 0 0.04583197832107544
to O 0 0.042267050594091415
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 0 0.08174578845500946

These O 0 0.027943672612309456
findings O 0 0.0318424329161644
are O 0 0.00950192753225565
consistent O 0 0.0294690802693367
with O 0 0.01723511889576912
the O 0 0.028722558170557022
hypothesis O 0 0.05699838697910309
that O 0 0.012464231811463833
certain O 0 0.022573119029402733
alleles O 0 0.07129956036806107
could O 0 0.023493770509958267
prevent O 0 0.055016737431287766
or O 0 0.027410877868533134
modify O 0 0.05588572472333908
the O 0 0.03486977517604828
clinical O 1 0.8639652132987976
manifestations O 1 0.9999914169311523
of O 1 0.986383855342865
BPAD B-Disease 1 1.0
and O 0 0.029407257214188576
perhaps O 0 0.02768515981733799
other O 0 0.02299817092716694
related O 1 0.8913502097129822
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.6309362649917603

Segregation O 1 0.9999520778656006
distortion O 1 0.999974250793457
in O 1 0.7901747822761536
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.1575983166694641

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999978542327881
DM B-Disease 1 1.0
) O 0 0.029173066839575768
is O 0 0.016038687899708748
an O 0 0.024637334048748016
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 0.025955775752663612
, O 0 0.01771497167646885
in O 0 0.013413626700639725
the O 0 0.024913284927606583
typical O 0 0.055988818407058716
pedigree O 0 0.08016249537467957
, O 0 0.019871219992637634
shows O 0 0.016171373426914215
a O 0 0.020050883293151855
three O 0 0.022085921838879585
generation O 0 0.1181785836815834
anticipation O 0 0.1999351531267166
cascade O 1 0.9954447746276855
. O 0 0.057726968079805374

This O 0 0.01715420000255108
results O 0 0.015216662548482418
in O 0 0.024031367152929306
infertility B-Disease 1 1.0
and O 1 0.9999914169311523
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.02078147605061531
with O 0 0.009733153507113457
the O 0 0.018888181075453758
disappearance O 0 0.07592369616031647
of O 0 0.05591864138841629
DM B-Disease 1 1.0
in O 0 0.031312305480241776
that O 0 0.024156175553798676
pedigree O 0 0.10266570001840591
. O 0 0.040696628391742706

The O 0 0.03443247079849243
concept O 0 0.03568045422434807
of O 0 0.040710896253585815
segregation O 1 0.999997615814209
distortion O 1 0.9999933242797852
, O 0 0.02769499458372593
where O 0 0.020758692175149918
there O 0 0.01209703367203474
is O 0 0.019499441608786583
preferential O 0 0.08761855959892273
transmission O 0 0.046823203563690186
of O 0 0.017145711928606033
the O 0 0.01951444335281849
larger O 0 0.02687789499759674
allele O 0 0.06389401108026505
at O 0 0.02992328070104122
the O 0 0.05928913131356239
DM B-Disease 1 1.0
locus O 1 0.9998501539230347
, O 0 0.030481668189167976
has O 0 0.02035306766629219
been O 0 0.015903489664196968
put O 0 0.028309140354394913
forward O 0 0.021184545010328293
to O 0 0.01785046048462391
explain O 0 0.02690775878727436
partially O 0 0.042208101600408554
the O 0 0.02508188597857952
maintenance O 1 0.5890744924545288
of O 0 0.07442740350961685
DM B-Disease 1 1.0
in O 0 0.0315551720559597
the O 0 0.03138125315308571
population O 0 0.029850931838154793
. O 0 0.038392167538404465

In O 0 0.026977859437465668
a O 0 0.027948690578341484
survey O 0 0.03220754489302635
of O 0 0.050022609531879425
DM B-Disease 1 1.0
in O 0 0.030218102037906647
Northern O 0 0.05030696839094162
Ireland O 0 0.05412456393241882
, O 0 0.031189389526844025
59 O 0 0.08374471217393875
pedigrees O 0 0.12553896009922028
were O 0 0.0295027457177639
ascertained O 0 0.12852708995342255
. O 0 0.04205847904086113

Sibships O 1 0.9925050735473633
where O 0 0.033774059265851974
the O 0 0.027145611122250557
status O 0 0.04547172784805298
of O 0 0.01974795199930668
all O 0 0.01337518822401762
the O 0 0.022385593503713608
members O 0 0.02265799790620804
had O 0 0.020037546753883362
been O 0 0.015664853155612946
identified O 0 0.020964743569493294
were O 0 0.01120750978589058
examined O 0 0.03148409724235535
to O 0 0.012579902075231075
determine O 0 0.015149308368563652
the O 0 0.018298670649528503
transmission O 0 0.03772206977009773
of O 0 0.024068020284175873
the O 0 0.062240999191999435
DM B-Disease 1 1.0
expansion O 0 0.09491382539272308
from O 0 0.03202904015779495
affected O 0 0.04294085130095482
parents O 0 0.04222695901989937
to O 0 0.025589032098650932
their O 0 0.02850206196308136
offspring O 0 0.09418816864490509
. O 0 0.045704133808612823

Where O 0 0.0366920605301857
the O 0 0.035776540637016296
transmitting O 0 0.42873260378837585
parent O 0 0.18004269897937775
was O 0 0.047142330557107925
male O 0 0.06685084104537964
, O 0 0.03096003457903862
58 O 0 0.08449938893318176
. O 0 0.04716654494404793

3 O 0 0.05523836240172386
% O 0 0.02238471992313862
of O 0 0.022788740694522858
the O 0 0.03652413561940193
offspring O 0 0.08121031522750854
were O 0 0.019648995250463486
affected O 0 0.03817809000611305
, O 0 0.019657237455248833
and O 0 0.013942841440439224
in O 0 0.011036073789000511
the O 0 0.016337178647518158
case O 0 0.021736249327659607
of O 0 0.01738508604466915
a O 0 0.031112248077988625
female O 0 0.08850312978029251
transmitting O 1 0.9974668025970459
parent O 1 0.8606552481651306
, O 0 0.03390497341752052
68 O 0 0.08952777087688446
. O 0 0.043654296547174454

7 O 0 0.0829811617732048
% O 0 0.034520555287599564
were O 0 0.021243872120976448
affected O 0 0.05348542332649231
. O 0 0.04481402039527893

Studies O 0 0.04575086385011673
on O 0 0.04042436182498932
meiotic O 1 0.9999395608901978
drive O 0 0.11607053130865097
in O 0 0.06188342720270157
DM B-Disease 1 1.0
have O 0 0.018380381166934967
shown O 0 0.02211979404091835
increased O 0 0.027841025963425636
transmission O 0 0.03802499175071716
of O 0 0.01696896366775036
the O 0 0.021745193749666214
larger O 0 0.025499818846583366
allele O 0 0.05865560099482536
at O 0 0.025232335552573204
the O 0 0.041569970548152924
DM B-Disease 1 1.0
locus O 0 0.39096754789352417
in O 0 0.02898881398141384
non O 1 0.9984281063079834
- O 1 1.0
DM O 1 1.0
heterozygotes O 1 0.9954732060432434
for O 0 0.056674547493457794
CTGn O 1 0.9994589686393738
. O 0 0.061835285276174545

This O 0 0.032686248421669006
study O 0 0.028946392238140106
provides O 0 0.025103986263275146
further O 0 0.012768044136464596
evidence O 0 0.01223847921937704
that O 0 0.010097439400851727
the O 0 0.04676517844200134
DM B-Disease 1 1.0
expansion O 0 0.11302926391363144
tends O 0 0.06812552362680435
to O 0 0.028298459947109222
be O 0 0.02505386620759964
transmitted O 0 0.10500704497098923
preferentially O 0 0.1253618597984314
. O 0 0.04480047523975372

Diagnosis O 1 0.9999994039535522
of O 1 0.9977066516876221
hemochromatosis B-Disease 1 1.0
. O 0 0.12123790383338928

If O 0 0.0693800300359726
untreated O 1 1.0
, O 1 0.9989470839500427
hemochromatosis B-Disease 1 1.0
can O 0 0.06202107295393944
cause O 1 0.9999973773956299
serious O 1 0.9999998807907104
illness O 1 1.0
and O 0 0.038934893906116486
early B-Disease 0 0.05472930893301964
death I-Disease 1 0.9941913485527039
, O 0 0.017614509910345078
but O 0 0.012638983316719532
the O 0 0.034297529608011246
disease O 1 0.9999986886978149
is O 0 0.020020222291350365
still O 0 0.01859637163579464
substantially O 0 0.0411691777408123
under O 0 0.06862929463386536
- O 1 1.0
diagnosed O 1 1.0
. O 0 0.0626508966088295

The O 0 0.055627305060625076
cornerstone O 1 0.9994619488716125
of O 0 0.04588812589645386
screening O 0 0.28671085834503174
and O 0 0.025969376787543297
case O 0 0.044236838817596436
detection O 0 0.06165130436420441
is O 0 0.015092519111931324
the O 0 0.021504033356904984
measurement O 0 0.04870103672146797
of O 0 0.04543370008468628
serum O 1 0.9999972581863403
transferrin O 1 0.9999773502349854
saturation O 1 0.7062735557556152
and O 0 0.032059844583272934
the O 0 0.057750262320041656
serum O 1 0.9999994039535522
ferritin O 1 0.9999990463256836
level O 0 0.07960892468690872
. O 0 0.0470077209174633

Once O 0 0.06622853130102158
the O 0 0.051720719784498215
diagnosis O 1 0.9999995231628418
is O 0 0.03396763280034065
suspected O 0 0.07613908499479294
, O 0 0.02789483219385147
physicians O 0 0.07558766007423401
must O 0 0.022301701828837395
use O 0 0.03509555011987686
serum O 1 0.9999997615814209
ferritin O 1 0.9999997615814209
levels O 0 0.06718184798955917
and O 0 0.05556070804595947
hepatic O 1 1.0
iron O 1 1.0
stores O 0 0.08935832232236862
on O 0 0.11109760403633118
liver O 1 1.0
biopsy O 1 0.9999998807907104
specimens O 0 0.05580426752567291
to O 0 0.03151942417025566
assess O 0 0.07182993739843369
patients O 0 0.08319204300642014
for O 0 0.016288917511701584
the O 0 0.022208811715245247
presence O 0 0.04294992983341217
of O 0 0.05370796099305153
iron B-Disease 1 1.0
overload I-Disease 1 1.0
. O 0 0.060353267937898636

Liver O 1 1.0
biopsy O 1 1.0
is O 0 0.045869700610637665
also O 0 0.021644292399287224
used O 0 0.011536302976310253
to O 0 0.013185950927436352
establish O 0 0.027016937732696533
the O 0 0.018503665924072266
presence O 0 0.029993383213877678
or O 0 0.01927575282752514
absence O 0 0.05867033079266548
of O 1 0.8398972153663635
cirrhosis B-Disease 1 1.0
, O 0 0.043362632393836975
which O 0 0.020020904019474983
can O 0 0.0170736126601696
affect O 0 0.046059295535087585
prognosis O 1 1.0
and O 0 0.044601183384656906
management O 1 0.7447253465652466
. O 0 0.045474398881196976

A O 0 0.09078101813793182
DNA O 0 0.07459602504968643
- O 1 0.6356171369552612
based O 0 0.021441061049699783
test O 0 0.020986266434192657
for O 0 0.015224160626530647
the O 0 0.04398040845990181
HFE O 1 1.0
gene O 0 0.067828468978405
is O 0 0.02775602787733078
commercially O 0 0.04929482191801071
available O 0 0.016059666872024536
, O 0 0.011887489818036556
but O 0 0.00719547038897872
its O 0 0.011381677351891994
place O 0 0.0171880554407835
in O 0 0.010969660244882107
the O 0 0.027911774814128876
diagnosis O 1 0.9999998807907104
of O 1 0.9997952580451965
hemochromatosis B-Disease 1 1.0
is O 0 0.08696387708187103
still O 0 0.037060439586639404
being O 0 0.03254428133368492
evaluated O 0 0.0772661492228508
. O 0 0.03929612413048744

Currently O 0 0.048987191170454025
, O 0 0.023283014073967934
the O 0 0.022968679666519165
most O 0 0.01916787400841713
useful O 0 0.026179993525147438
role O 0 0.03234324976801872
for O 0 0.016886478289961815
this O 0 0.013014222495257854
test O 0 0.030460800975561142
is O 0 0.012101068161427975
in O 0 0.009890337474644184
the O 0 0.02099592238664627
detection O 0 0.06881273537874222
of O 0 0.0520564541220665
hemochromatosis B-Disease 1 1.0
in O 0 0.02764848805963993
the O 0 0.029852328822016716
family O 0 0.03774028271436691
members O 0 0.02504473738372326
of O 0 0.030687879770994186
patients O 1 0.9570604562759399
with O 0 0.02160068415105343
a O 0 0.03370942175388336
proven O 0 0.04836396500468254
case O 0 0.02912219613790512
of O 0 0.031062111258506775
the O 0 0.06409768760204315
disease O 1 0.9999994039535522
. O 0 0.06571739166975021

It O 0 0.021430138498544693
is O 0 0.016454489901661873
crucial O 0 0.03439119830727577
to O 0 0.03770069405436516
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999631643295288
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.7269964218139648
phlebotomy O 1 1.0
therapy O 1 1.0
can O 0 0.02703285589814186
avert O 1 0.9999998807907104
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9999712705612183
can O 0 0.0228984747081995
even O 0 0.018877118825912476
lead O 0 0.03323793411254883
to O 0 0.024406496435403824
normal O 0 0.043015819042921066
life O 0 0.05668143555521965
expectancy O 1 0.7407839894294739
. O 0 0.031950943171978
. O 0 0.03989367559552193

Prevalence O 1 0.9910033941268921
of O 0 0.039321187883615494
the O 0 0.05892254784703255
I1307K O 1 0.9999995231628418
APC B-Disease 1 0.9999998807907104
gene O 0 0.07727958261966705
variant O 0 0.05538364499807358
in O 0 0.01637844927608967
Israeli O 0 0.038801409304142
Jews O 0 0.039267003536224365
of O 0 0.01724943518638611
differing O 0 0.014680260792374611
ethnic O 0 0.02054544724524021
origin O 0 0.015524075366556644
and O 0 0.019413601607084274
risk O 1 0.7470520734786987
for O 1 0.9999573230743408
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9981091022491455

BACKGROUND O 0 0.15606766939163208
& O 1 0.5928288102149963
AIMS O 0 0.09707310795783997
Israeli O 0 0.05092518776655197
Jews O 0 0.04053981229662895
of O 0 0.023286303505301476
European O 0 0.03539956733584404
birth O 0 0.46531298756599426
, O 0 0.03036380372941494
i O 0 0.031267695128917694
. O 0 0.021187985315918922
e O 0 0.05979558080434799
. O 0 0.01601589284837246
, O 0 0.023941513150930405
Ashkenazim O 1 0.9760322570800781
, O 0 0.013226380571722984
have O 0 0.005643599200993776
the O 0 0.023434769362211227
highest O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 1.0
of O 0 0.06381735950708389
any O 0 0.024426065385341644
Israeli O 0 0.04695607349276543
ethnic O 0 0.043686673045158386
group O 0 0.05586378276348114
. O 0 0.03234186768531799

The O 0 0.07438678294420242
I1307K O 1 0.9999700784683228
APC B-Disease 1 0.9999998807907104
gene O 0 0.08430008590221405
variant O 0 0.07257451862096786
was O 0 0.037894438952207565
found O 0 0.018886493518948555
in O 0 0.02147996611893177
6 O 0 0.06342271715402603
. O 0 0.042742446064949036

1 O 0 0.06153427064418793
% O 0 0.02410983107984066
of O 0 0.023449353873729706
American O 0 0.03858688473701477
Jews O 0 0.046378400176763535
, O 0 0.016857584938406944
28 O 0 0.0216357484459877
% O 0 0.012024875730276108
of O 0 0.01562531664967537
their O 0 0.039405662566423416
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.999995231628418
, O 0 0.03262500837445259
but O 0 0.010997278615832329
not O 0 0.0075149619951844215
in O 0 0.013845646753907204
non O 1 0.7465143203735352
- O 1 0.9999891519546509
Jews O 0 0.07622657716274261
. O 0 0.041985150426626205

We O 0 0.02826889604330063
assessed O 0 0.04888533055782318
the O 0 0.04765947908163071
I1307K O 1 0.9998587369918823
prevalence O 1 0.9971936345100403
in O 0 0.02771449275314808
Israeli O 0 0.04898742586374283
Jews O 0 0.038516610860824585
of O 0 0.019456174224615097
differing O 0 0.016935795545578003
ethnic O 0 0.023890139535069466
origin O 0 0.01771468110382557
and O 0 0.02096722461283207
risk O 1 0.8041932582855225
for O 1 0.9998682737350464
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9767231345176697

METHODS O 0 0.08752521872520447
DNA O 0 0.056353870779275894
samples O 0 0.028961896896362305
from O 0 0.018000571057200432
500 O 0 0.042418256402015686
unrelated O 0 0.040454763919115067
Jews O 0 0.04365922883152962
of O 0 0.025966951623558998
European O 0 0.034347012639045715
or O 0 0.029551103711128235
non O 1 0.6050402522087097
- O 1 0.9998818635940552
European O 0 0.029719462618231773
origin O 0 0.01711052842438221
, O 0 0.01648261770606041
with O 0 0.015846149995923042
or O 0 0.017158791422843933
without O 0 0.013905915431678295
a O 0 0.026938412338495255
personal O 0 0.042178329080343246
and O 0 0.03444680571556091
/ O 1 0.9999393224716187
or O 0 0.02314746007323265
family O 0 0.032618723809719086
history O 0 0.030393637716770172
of O 0 0.05719361454248428
neoplasia B-Disease 1 1.0
, O 0 0.027596989646553993
were O 0 0.012314495630562305
examined O 0 0.03096139244735241
for O 0 0.014294196851551533
the O 0 0.03018767386674881
I1307K O 1 0.998572826385498
variant O 0 0.04560096561908722
by O 0 0.014212287962436676
the O 0 0.026147956028580666
allele O 0 0.10979760438203812
- O 1 0.9986041188240051
specific O 0 0.029671216383576393
oligonucleotide O 1 0.9963043928146362
( O 0 0.0622025728225708
ASO O 1 1.0
) O 0 0.046980489045381546
method O 0 0.04101479426026344
. O 0 0.03518086299300194

RESULTS O 0 0.03990927338600159
In O 0 0.01780390739440918
persons O 0 0.022578012198209763
at O 0 0.02128220535814762
average O 0 0.027683526277542114
risk O 0 0.1184275820851326
for O 1 0.9986799359321594
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9991940855979919
I1307K O 1 0.9999998807907104
was O 0 0.041389502584934235
found O 0 0.016578564420342445
in O 0 0.017472101375460625
5 O 0 0.04292741045355797
. O 0 0.03639885410666466

0 O 0 0.09313391149044037
% O 0 0.03069806471467018
of O 0 0.025587115436792374
120 O 0 0.049413394182920456
European O 0 0.036110471934080124
and O 0 0.02886597253382206
1 O 0 0.0640404149889946
. O 0 0.038514528423547745

6 O 0 0.05672942101955414
% O 0 0.020252650603652
of O 0 0.02155309170484543
188 O 0 0.1142631322145462
non O 0 0.15406937897205353
- O 1 0.9986636638641357
European O 0 0.030107561498880386
Jews O 0 0.0641586184501648
( O 0 0.04827883839607239
P O 1 0.9998383522033691
= O 0 0.10114449262619019
0 O 0 0.07430063933134079
. O 0 0.032845694571733475
08 O 0 0.2465410977602005
) O 0 0.0369030237197876
. O 0 0.035036832094192505

It O 0 0.032436203211545944
occurred O 0 0.03833227604627609
in O 0 0.025878002867102623
15 O 0 0.0495440699160099
. O 0 0.041961316019296646

4 O 0 0.05389278754591942
% O 0 0.020101090893149376
of O 0 0.020314902067184448
52 O 0 0.05619968846440315
Ashkenazi O 0 0.4198285937309265
Israelis O 0 0.054410673677921295
with O 0 0.04078355431556702
familial O 1 1.0
cancer B-Disease 1 1.0
( O 1 0.9856892824172974
P O 1 0.9999997615814209
= O 0 0.09969642758369446
0 O 0 0.07457499206066132
. O 0 0.03238793835043907
02 O 1 0.9999750852584839
) O 0 0.026043793186545372
and O 0 0.016869956627488136
was O 0 0.025954196229577065
not O 0 0.010584122501313686
detected O 0 0.024800626561045647
in O 0 0.011134432628750801
51 O 0 0.04762951284646988
non O 0 0.06835012137889862
- O 1 0.9773534536361694
European O 0 0.02052951231598854
Jews O 0 0.04262545332312584
at O 0 0.041658394038677216
increased O 1 0.8225318789482117
cancer B-Disease 1 1.0
risk O 1 0.9999532699584961
. O 0 0.05663326382637024

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 0 0.41047608852386475
personally O 1 0.7207754254341125
or O 0 0.022847283631563187
in O 0 0.013013262301683426
the O 0 0.019087888300418854
families O 0 0.02053218148648739
of O 0 0.016961807385087013
13 O 0 0.025083765387535095
of O 0 0.022420434281229973
20 O 0 0.04026038572192192
Ashkenazi O 1 0.9999254941940308
I1307K O 1 0.999993085861206
carriers O 0 0.08914456516504288
, O 0 0.02239767089486122
8 O 0 0.029407944530248642
of O 0 0.022194532677531242
whom O 0 0.03657345473766327
also O 0 0.01675674505531788
had O 0 0.019357645884156227
a O 0 0.027901969850063324
personal O 0 0.03968079015612602
or O 0 0.020079711452126503
family O 0 0.03111237846314907
history O 0 0.031168298795819283
of O 0 0.0528673380613327
noncolonic O 1 1.0
neoplasia B-Disease 1 1.0
. O 0 0.08031892776489258

CONCLUSIONS O 0 0.07657235860824585
The O 0 0.056230347603559494
I1307K O 1 0.999994158744812
APC O 1 0.9999988079071045
variant O 0 0.0791243389248848
may O 0 0.016719600185751915
represent O 0 0.014775949530303478
a O 0 0.03562242165207863
susceptibility O 1 0.9999487400054932
gene O 0 0.061664607375860214
for O 0 0.05011119320988655
colorectal B-Disease 1 1.0
, I-Disease 0 0.043211035430431366
or I-Disease 0 0.025342484936118126
other I-Disease 0 0.01824529841542244
, I-Disease 0 0.032055389136075974
cancers I-Disease 1 0.9996780157089233
in O 0 0.032813988626003265
Ashkenazi O 1 0.9999949932098389
Jews O 0 0.08655455708503723
, O 0 0.026422463357448578
and O 0 0.021302733570337296
partially O 0 0.04843764007091522
explains O 0 0.027388514950871468
the O 0 0.014603985473513603
higher O 0 0.026806745678186417
incidence O 1 0.9999951124191284
of O 1 0.9999982118606567
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8226074576377869
European O 0 0.05082860216498375
Israelis O 0 0.07284896820783615
. O 0 0.040798310190439224

Systematic O 0 0.10377804934978485
analysis O 0 0.022471722215414047
of O 0 0.0377807542681694
coproporphyrinogen O 1 0.9999994039535522
oxidase O 1 0.9999998807907104
gene O 0 0.10490338504314423
defects O 1 0.9662028551101685
in O 0 0.04283617436885834
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 0.060128889977931976
mutation O 0 0.10904217511415482
update O 0 0.1023702472448349
. O 0 0.04065188765525818

Hereditary B-Disease 1 0.9999995231628418
coproporphyria I-Disease 1 0.9999998807907104
( O 0 0.1452929824590683
HC B-Disease 1 1.0
) O 0 0.027026096358895302
is O 0 0.019870255142450333
an O 0 0.042691729962825775
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9993253946304321
autosomal O 1 1.0
dominant O 1 0.9999918937683105
inheritance O 1 0.9997910857200623
caused O 1 0.6912846565246582
by O 0 0.02975146286189556
deficient B-Disease 1 0.9997773766517639
activity I-Disease 0 0.02679050713777542
of I-Disease 0 0.03335260972380638
coproporphyrinogen I-Disease 1 1.0
III I-Disease 1 1.0
oxidase I-Disease 1 1.0
( O 0 0.08247299492359161
CPO O 1 0.9996602535247803
) O 0 0.04340355470776558
. O 0 0.03413936495780945

Clinical O 1 0.9957621693611145
manifestations O 1 0.9996398687362671
of O 0 0.04872041940689087
the O 1 0.9671705961227417
disease O 1 1.0
are O 0 0.015858467668294907
characterized O 0 0.05396886169910431
by O 0 0.032034918665885925
acute O 1 1.0
attacks O 1 0.9947769641876221
of O 1 0.9999878406524658
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.25608354806900024
precipitated O 1 0.9999998807907104
by O 0 0.033713459968566895
drugs O 0 0.3737918436527252
, O 0 0.02857726439833641
fasting O 1 0.9848780035972595
, O 0 0.0431823767721653
cyclical O 1 0.9999995231628418
hormonal O 1 0.9999997615814209
changes O 0 0.029141293838620186
, O 0 0.03720301389694214
or O 1 0.9405457377433777
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.6573522686958313

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.07236550003290176
also O 0 0.026707807555794716
be O 0 0.015928762033581734
present O 0 0.029246125370264053
. O 0 0.03528428077697754

The O 0 0.04034049063920975
seven O 0 0.03819941356778145
exons O 0 0.08618055284023285
, O 0 0.02288074977695942
the O 0 0.0407467819750309
exon O 1 0.9973710775375366
/ O 1 0.9995232820510864
intron O 1 0.9991639852523804
boundaries O 0 0.03116345778107643
and O 0 0.0178095530718565
part O 0 0.026019541546702385
of O 0 0.026275668293237686
3 O 0 0.05234155431389809
noncoding O 0 0.10946624726057053
sequence O 0 0.01962747424840927
of O 0 0.021708639338612556
the O 0 0.044409479945898056
CPO O 1 0.9999047517776489
gene O 0 0.03928530216217041
were O 0 0.012247421778738499
systematically O 0 0.04599509388208389
analyzed O 0 0.01991775818169117
by O 0 0.011828839778900146
an O 0 0.022252297028899193
exon O 1 0.6980114579200745
- O 1 0.9910706281661987
by O 0 0.028770137578248978
- O 1 0.9990405440330505
exon O 1 0.795988917350769
denaturing O 1 0.9997263550758362
gradient O 1 0.9994327425956726
gel O 1 0.999991774559021
electrophoresis O 1 0.9976599216461182
( O 0 0.07839978486299515
DGGE O 1 0.9999980926513672
) O 0 0.04020419344305992
strategy O 0 0.041411858052015305
followed O 0 0.029195670038461685
by O 0 0.019227182492613792
direct O 0 0.03144785389304161
sequencing O 0 0.0317668691277504
in O 0 0.012341586872935295
seven O 0 0.023396210744976997
unrelated O 0 0.07359496504068375
heterozygous O 0 0.2163451910018921
HC B-Disease 1 1.0
patients O 1 0.9999932050704956
from O 0 0.04112689197063446
France O 1 0.549200177192688
, O 0 0.035309646278619766
Holland O 1 0.7874436974525452
, O 0 0.02758108079433441
and O 0 0.023228337988257408
Czech O 0 0.09973431378602982
Republic O 0 0.08895239979028702
. O 0 0.04814916104078293

Seven O 0 0.07510532438755035
novel O 0 0.09845032542943954
mutations O 0 0.04668710008263588
and O 0 0.01654716208577156
two O 0 0.015972651541233063
new O 0 0.04370235651731491
polymorphisms O 0 0.09968549758195877
were O 0 0.024333788082003593
detected O 0 0.06868518888950348
. O 0 0.037511445581912994

Among O 0 0.05709906294941902
these O 0 0.02011781558394432
mutations O 0 0.03155645355582237
two O 0 0.012229887768626213
are O 0 0.013254552148282528
missense O 0 0.1363830417394638
( O 0 0.04803963378071785
G197W O 1 0.9998225569725037
, O 0 0.051017917692661285
W427R O 1 0.999991774559021
) O 0 0.024592826142907143
, O 0 0.013009073212742805
two O 0 0.007838069461286068
are O 0 0.009385303594172001
nonsense O 0 0.09558665752410889
( O 0 0.04273682460188866
Q306X O 1 0.9998825788497925
, O 0 0.044458162039518356
Q385X O 1 0.9999830722808838
) O 0 0.026156652718782425
, O 0 0.014035303145647049
two O 0 0.008449669927358627
are O 0 0.007121554110199213
small O 0 0.024115176871418953
deletions O 0 0.09588281810283661
( O 0 0.050919096916913986
662de14bp O 1 0.9998618364334106
; O 0 0.04579341039061546
1168del3bp O 1 0.9935176372528076
removing O 0 0.08526203781366348
a O 0 0.04560578241944313
glycine O 0 0.14144785702228546
at O 0 0.03616488352417946
position O 0 0.046671271324157715
390 O 0 0.18961097300052643
) O 0 0.024103108793497086
, O 0 0.01437763124704361
and O 0 0.01194939948618412
one O 0 0.011746039614081383
is O 0 0.0129466000944376
a O 0 0.027700571343302727
splicing O 0 0.07142479717731476
mutation O 0 0.04667261987924576
( O 0 0.029203364625573158
IVS1 O 1 0.9999932050704956
- O 1 0.9999974966049194
15c O 1 0.999996542930603
- O 1 1.0
- O 1 1.0
> O 1 0.9999586343765259
g O 0 0.29471471905708313
) O 0 0.022756164893507957
which O 0 0.01378406211733818
creates O 0 0.039469268172979355
a O 0 0.02853628620505333
new O 0 0.054596953094005585
acceptor O 1 0.983366072177887
splice O 0 0.37681424617767334
site O 0 0.06878823786973953
. O 0 0.038800548762083054

The O 0 0.0683126300573349
pathological O 0 0.37229976058006287
significance O 0 0.03486671298742294
of O 0 0.023271523416042328
the O 0 0.026723211631178856
point O 0 0.04296893998980522
mutations O 0 0.05684741213917732
G197W O 1 0.9996803998947144
, O 0 0.042715977877378464
W427R O 1 0.9998326301574707
, O 0 0.0181373693048954
and O 0 0.01201613899320364
the O 0 0.017390340566635132
in O 0 0.025369836017489433
- O 1 0.9999988079071045
frame O 0 0.10602104663848877
deletion O 0 0.1434011310338974
390delGly O 1 0.9721055626869202
were O 0 0.01750488206744194
assessed O 0 0.030895506963133812
by O 0 0.01314709335565567
their O 0 0.014176083728671074
respective O 0 0.0364767462015152
expression O 0 0.03262186422944069
in O 0 0.014835920184850693
a O 0 0.028596047312021255
prokaryotic O 0 0.08196142315864563
system O 0 0.034014541655778885
using O 0 0.017166536301374435
site O 0 0.05190274864435196
- O 1 0.9969737529754639
directed O 0 0.06922909617424011
mutagenesis O 0 0.14269474148750305
. O 0 0.04507123678922653

These O 0 0.03402121737599373
mutations O 0 0.04965788125991821
resulted O 0 0.03717959299683571
in O 0 0.01953040435910225
the O 0 0.030040837824344635
absence O 0 0.06485027819871902
or O 0 0.02263961359858513
a O 0 0.028125708922743797
dramatic O 0 0.04663831740617752
decrease O 0 0.05280020087957382
of O 0 0.05413675308227539
CPO O 1 0.999997615814209
activity O 0 0.06401047855615616
. O 0 0.04024120047688484

The O 0 0.04742354527115822
two O 0 0.028526147827506065
polymorphisms O 0 0.09453649818897247
were O 0 0.019722040742635727
localized O 0 0.07960022985935211
in O 0 0.025967715308070183
noncoding O 0 0.09971321374177933
part O 0 0.0241733118891716
of O 0 0.016106385737657547
the O 0 0.025499509647488594
gene O 0 0.03363223746418953
1 O 0 0.031019626185297966
) O 0 0.017456520348787308
a O 0 0.037009347230196
C O 1 0.9999730587005615
/ O 1 0.9999791383743286
G O 1 0.9945036172866821
polymorphism O 0 0.0830489993095398
in O 0 0.019391339272260666
the O 0 0.04148655757308006
promotor O 1 0.9999957084655762
region O 0 0.05675148218870163
, O 0 0.029939759522676468
142 O 0 0.11679564416408539
bp O 0 0.08942931890487671
upstream O 0 0.04057740420103073
from O 0 0.01301337219774723
the O 0 0.022889308631420135
transcriptional O 0 0.10619289427995682
initiation O 0 0.1097119152545929
site O 0 0.04597898945212364
( O 0 0.035032644867897034
- O 1 0.9999946355819702
142C O 1 0.9999977350234985
/ O 1 0.9999990463256836
G O 1 0.9999799728393555
) O 0 0.02698725461959839
, O 0 0.01909393072128296
and O 0 0.01683550328016281
2 O 0 0.037894438952207565
) O 0 0.01768905110657215
a O 0 0.023700689896941185
6 O 0 0.05232412368059158
bp O 0 0.09650807082653046
deletion O 0 0.10442252457141876
polymorphism O 0 0.07587636262178421
in O 0 0.015324778854846954
the O 0 0.023936564102768898
3 O 0 0.04579029232263565
noncoding O 0 0.09195876121520996
part O 0 0.024798840284347534
of O 0 0.021320179104804993
the O 0 0.03995030000805855
CPO O 1 0.9999349117279053
gene O 0 0.05956728756427765
, O 0 0.03556634113192558
574 O 1 0.9915385842323303
bp O 0 0.09327760338783264
downstream O 0 0.042551152408123016
of O 0 0.014009158127009869
the O 0 0.018299443647265434
last O 0 0.022179177030920982
base O 0 0.026788009330630302
of O 0 0.013205412775278091
the O 0 0.021563107147812843
normal O 0 0.040877800434827805
termination O 1 0.9992828965187073
codon O 1 0.7614668607711792
( O 0 0.05870457738637924
+ O 1 0.8223578333854675
574 O 1 0.99968421459198
delATTCTT O 1 0.9999810457229614
) O 0 0.04424901306629181
. O 0 0.03913922607898712

Five O 0 0.06446118652820587
intragenic O 1 0.9999490976333618
dimorphisms O 1 0.9998478889465332
are O 0 0.017000555992126465
now O 0 0.02889862284064293
well O 0 0.022542797029018402
characterized O 0 0.050633758306503296
and O 0 0.020637240260839462
the O 0 0.028107907623052597
high O 0 0.04680800810456276
degree O 0 0.03956285119056702
of O 0 0.04479343816637993
allelic O 1 0.995452344417572
heterogeneity O 1 0.9305551052093506
in O 0 0.052112698554992676
HC B-Disease 1 1.0
is O 0 0.039077021181583405
demonstrated O 0 0.03179755434393883
with O 0 0.013532211072742939
seven O 0 0.017154401168227196
new O 0 0.02370314858853817
different O 0 0.008030293509364128
mutations O 0 0.025607839226722717
making O 0 0.01443665474653244
a O 0 0.015516849234700203
total O 0 0.013357083313167095
of O 0 0.024068046361207962
nineteen O 1 0.7137385606765747
CPO O 1 0.9999998807907104
gene B-Disease 0 0.4522181749343872
defects I-Disease 1 0.9995860457420349
reported O 0 0.04235401377081871
so O 0 0.022518612444400787
far O 0 0.021849269047379494
. O 0 0.022763662040233612
. O 0 0.03655749186873436

Coincidence O 0 0.08535655587911606
of O 0 0.02398395724594593
two O 0 0.0173630490899086
novel O 0 0.06561453640460968
arylsulfatase O 1 0.6866534948348999
A O 0 0.06798219680786133
alleles O 0 0.07943559437990189
and O 0 0.028606070205569267
mutation O 0 0.09950456023216248
459 O 1 0.9999788999557495
+ O 1 0.9999837875366211
1G O 1 0.9999998807907104
> O 0 0.31379884481430054
A O 0 0.036613114178180695
within O 0 0.014871086925268173
a O 0 0.022361014038324356
family O 0 0.03881671652197838
with O 0 0.03912024945020676
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.058479685336351395
molecular O 0 0.03982819616794586
basis O 0 0.016123171895742416
of O 0 0.03503190353512764
phenotypic O 0 0.12582440674304962
heterogeneity O 1 0.9301277995109558
. O 0 0.056494008749723434

In O 0 0.032179851084947586
a O 0 0.037401940673589706
family O 0 0.040062226355075836
with O 0 0.01818261668086052
three O 0 0.022303929552435875
siblings O 0 0.0772671028971672
, O 0 0.02179744280874729
one O 0 0.017910096794366837
developed O 0 0.024058938026428223
classical O 0 0.03879157826304436
late O 0 0.07734525948762894
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9991274476051331
MLD B-Disease 1 1.0
) O 0 0.04170664772391319
, O 0 0.030803745612502098
fatal O 1 0.9998531341552734
at O 0 0.036000289022922516
age O 0 0.03017893061041832
5 O 0 0.02960347756743431
years O 0 0.017307311296463013
, O 0 0.014695283025503159
with O 0 0.02259198948740959
deficient O 1 0.9999611377716064
arylsulfatase O 1 0.9999885559082031
A O 1 0.530367910861969
( O 0 0.0682249665260315
ARSA O 1 0.9999998807907104
) O 0 0.03371512144804001
activity O 0 0.02339077740907669
and O 0 0.01561166625469923
increased O 0 0.040330614894628525
galactosylsulfatide O 1 0.9999997615814209
( O 1 0.6275871396064758
GS O 1 1.0
) O 0 0.07018111646175385
excretion O 1 0.983207106590271
. O 0 0.05260466784238815

The O 0 0.03685642033815384
two O 0 0.01533247996121645
other O 0 0.019063085317611694
siblings O 0 0.07378452271223068
, O 0 0.02698490582406521
apparently O 0 0.03862261399626732
healthy O 0 0.05349959060549736
at O 0 0.02707156166434288
12 O 0 0.03234318271279335
( O 0 0.03277793154120445
1 O 0 0.08000649511814117
/ O 1 0.9999792575836182
2 O 0 0.053083304315805435
) O 0 0.022236162796616554
and O 0 0.016162287443876266
15 O 0 0.025329051539301872
years O 0 0.022756345570087433
, O 0 0.024459797888994217
respectively O 0 0.029916735365986824
, O 0 0.016831666231155396
and O 0 0.013456356711685658
their O 0 0.01577090658247471
father O 0 0.09608837962150574
, O 0 0.02795773558318615
apparently O 0 0.04336368292570114
healthy O 0 0.05260632932186127
as O 0 0.02084001526236534
well O 0 0.015825720503926277
, O 0 0.02158013917505741
presented O 0 0.05341226980090141
ARSA O 1 1.0
and O 0 0.056288957595825195
GS O 1 0.9999998807907104
values O 0 0.03319970890879631
within O 0 0.012821043841540813
the O 0 0.01767021045088768
range O 0 0.024921299889683723
of O 0 0.06211213394999504
MLD B-Disease 1 1.0
patients O 1 0.999998927116394
. O 0 0.06852197647094727

Mutation O 0 0.19626890122890472
screening O 0 0.11313749849796295
and O 0 0.030062396079301834
sequence O 0 0.024862123653292656
analysis O 0 0.015056856907904148
disclosed O 0 0.03353804349899292
the O 0 0.01781638339161873
involvement O 0 0.04629729315638542
of O 0 0.0222961213439703
three O 0 0.020891424268484116
different O 0 0.02183089777827263
ARSA O 1 0.9999991655349731
mutations O 0 0.05190538614988327
being O 0 0.021376606076955795
the O 0 0.024094948545098305
molecular O 0 0.0329715795814991
basis O 0 0.018041661009192467
of O 0 0.03804449737071991
intrafamilial O 1 0.9998435974121094
phenotypic O 0 0.156186044216156
heterogeneity O 1 0.9221793413162231
. O 0 0.05947495624423027

The O 0 0.05213724821805954
late O 0 0.12398049235343933
infantile O 1 1.0
patient O 1 0.9999998807907104
inherited O 1 0.9999793767929077
from O 0 0.032271746546030045
his O 0 0.03649267554283142
mother O 0 0.05751242861151695
the O 0 0.022189876064658165
frequent O 0 0.04799007624387741
0 O 0 0.08361127227544785
- O 1 0.9999624490737915
type O 0 0.05543462559580803
mutation O 0 0.07416654378175735
459 O 1 0.9999380111694336
+ O 1 0.9999750852584839
1G O 1 1.0
> O 1 0.9987062215805054
A O 0 0.058929797261953354
, O 0 0.021462898701429367
and O 0 0.01474419143050909
from O 0 0.01484654564410448
his O 0 0.032105375081300735
father O 0 0.05992607772350311
a O 0 0.03533501550555229
novel O 0 0.05360579118132591
, O 0 0.022892877459526062
single O 0 0.050672780722379684
basepair O 1 0.9587722420692444
microdeletion O 1 0.9758791327476501
of O 0 0.0421113595366478
guanine O 0 0.12491784989833832
at O 0 0.03576122969388962
nucleotide O 0 0.047961268573999405
7 O 0 0.026807062327861786
in O 0 0.01898270659148693
exon O 0 0.44017454981803894
1 O 0 0.07337385416030884
( O 0 0.05624502897262573
7delG O 1 0.9992818236351013
) O 0 0.04179222881793976
. O 0 0.03756142035126686

The O 0 0.044810228049755096
two O 0 0.03408072143793106
clinically O 1 0.9944043159484863
unaffected O 1 0.9471814036369324
siblings O 0 0.08001214265823364
carried O 0 0.028607159852981567
the O 0 0.0294461902230978
maternal O 1 0.9962278604507446
mutation O 0 0.135309100151062
459 O 1 0.9999980926513672
+ O 1 0.9999966621398926
1G O 1 1.0
> O 1 0.9984514713287354
A O 0 0.054779209196567535
and O 0 0.020319251343607903
, O 0 0.015396928414702415
on O 0 0.014570276252925396
their O 0 0.018941538408398628
paternal O 1 0.7234639525413513
allele O 0 0.09368845075368881
, O 0 0.02367297001183033
a O 0 0.02946525625884533
novel O 0 0.06663177907466888
cytosine O 0 0.11780910938978195
to O 0 0.03834644705057144
thymidine O 1 0.5125534534454346
transition O 0 0.07822517305612564
at O 0 0.04501475766301155
nucleotide O 0 0.09896214306354523
2435 O 1 0.9917144179344177
in O 0 0.03236377611756325
exon O 1 0.5262592434883118
8 O 0 0.046942390501499176
, O 0 0.021053025498986244
resulting O 0 0.02411520481109619
in O 0 0.01743250899016857
substitution O 0 0.062100958079099655
of O 0 0.04013257473707199
alanine O 1 0.9646883010864258
464 O 1 0.9989801049232483
by O 0 0.058961693197488785
valine O 1 0.9999485015869141
( O 0 0.07609459012746811
A464V O 1 0.9999039173126221
) O 0 0.0481378436088562
. O 0 0.03765226900577545

The O 0 0.05838637799024582
fathers O 0 0.13521866500377655
genotype O 0 0.1715247482061386
thus O 0 0.03483474999666214
was O 0 0.06258580833673477
7delG O 1 0.9999891519546509
/ O 1 0.9999830722808838
A464V O 1 0.9993529915809631
. O 0 0.05832168832421303

Mutation O 0 0.19265849888324738
A464V O 1 0.9978005290031433
was O 0 0.039721712470054626
not O 0 0.010227389633655548
found O 0 0.010704891756176949
in O 0 0.01490625087171793
18 O 0 0.04684312641620636
unrelated O 1 0.9789698719978333
MLD B-Disease 1 1.0
patients O 1 0.9999972581863403
and O 0 0.04235824942588806
50 O 0 0.06129740923643112
controls O 0 0.07778794318437576
. O 0 0.042702749371528625

A464V O 1 0.9976155757904053
, O 0 0.02904980070888996
although O 0 0.01755537837743759
clearly O 0 0.03514723852276802
modifying O 0 0.11840180307626724
ARSA O 1 1.0
and O 0 0.126680389046669
GS O 1 1.0
levels O 0 0.06000158190727234
, O 0 0.02671312540769577
apparently O 0 0.03185838460922241
bears O 0 0.03352419286966324
little O 0 0.02602372318506241
significance O 0 0.026691129431128502
for O 0 0.02385820262134075
clinical O 1 0.989459753036499
manifestation O 1 0.9999997615814209
of O 1 0.9414048194885254
MLD B-Disease 1 1.0
, O 0 0.04938974976539612
mimicking O 0 0.11206350475549698
the O 0 0.038765911012887955
frequent O 0 0.11936071515083313
ARSA O 1 0.9999996423721313
pseudodeficiency O 1 0.9999949932098389
allele O 0 0.21959300339221954
. O 0 0.051629550755023956

Our O 0 0.05598418414592743
results O 0 0.021557344123721123
demonstrate O 0 0.028868218883872032
that O 0 0.007957234978675842
in O 0 0.010711681097745895
certain O 0 0.017607036978006363
genetic O 0 0.04259990528225899
conditions O 0 0.08223246037960052
MLD B-Disease 1 1.0
- O 1 1.0
like O 0 0.06464002281427383
ARSA O 1 1.0
and O 0 0.06866320967674255
GS O 1 1.0
values O 0 0.041949398815631866
need O 0 0.01869395561516285
not O 0 0.008104735985398293
be O 0 0.00857448484748602
paralleled O 0 0.07443435490131378
by O 0 0.04473353549838066
clinical O 1 0.9999998807907104
disease O 1 1.0
, O 0 0.03301823511719704
a O 0 0.03240218758583069
finding O 0 0.03448738530278206
with O 0 0.02388341911137104
serious O 1 0.9828961491584778
diagnostic O 1 0.9999969005584717
and O 0 0.09693930298089981
prognostic O 1 1.0
implications O 1 0.5130234956741333
. O 0 0.0529962033033371

Moreover O 0 0.08634408563375473
, O 0 0.03657631203532219
further O 0 0.05529101938009262
ARSA O 1 0.9999984502792358
alleles O 0 0.16286300122737885
functionally O 0 0.13411134481430054
similar O 0 0.029187841340899467
to O 0 0.03942680358886719
A464V O 1 0.9997642636299133
might O 0 0.030281515792012215
exist O 0 0.015566941350698471
which O 0 0.009846216067671776
, O 0 0.01013109926134348
together O 0 0.010929912328720093
with O 0 0.015948109328746796
0 O 0 0.10986524820327759
- O 1 0.9999998807907104
type O 0 0.08645668625831604
mutations O 0 0.04420211538672447
, O 0 0.0235180351883173
may O 0 0.029610153287649155
cause O 1 0.7408411502838135
pathological O 1 0.9999998807907104
ARSA O 1 1.0
and O 1 0.901380181312561
GS O 1 1.0
levels O 0 0.04500462859869003
, O 0 0.01627640798687935
but O 0 0.009516919031739235
not O 0 0.011045053601264954
clinical O 1 0.6951262354850769
outbreak O 1 0.9999690055847168
of O 0 0.23231887817382812
the O 1 0.9995898604393005
disease O 1 1.0
. O 0 0.044322479516267776
. O 0 0.046159498393535614

Human O 1 0.9761766195297241
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 1.0
to O 0 0.3314647972583771
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999573230743408
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999904632568359
1 I-Disease 0 0.1349715143442154
. O 0 0.03895740583539009

Heterozygous O 0 0.37800198793411255
germ O 1 0.9999995231628418
- O 1 0.9999978542327881
line O 0 0.0753965973854065
mutations O 0 0.03313693404197693
in O 0 0.012897626496851444
the O 0 0.02750696800649166
DNA O 0 0.0715956911444664
mismatch O 1 0.9996324777603149
repair O 1 0.7664893269538879
genes O 0 0.028707461431622505
lead O 0 0.03266184777021408
to O 0 0.03689495846629143
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9901661276817322

The O 1 0.7250946760177612
disease O 1 1.0
susceptibility O 1 0.9999997615814209
of O 0 0.053625915199518204
individuals O 0 0.03069184720516205
who O 0 0.037224628031253815
constitutionally O 0 0.0881652757525444
lack O 0 0.032783351838588715
both O 0 0.01976623758673668
wild O 0 0.06319819390773773
- O 1 0.9999997615814209
type O 0 0.12607312202453613
alleles O 0 0.09045632183551788
is O 0 0.03158733248710632
unknown O 0 0.04761996865272522
. O 0 0.036237671971321106

We O 0 0.02258092723786831
have O 0 0.00963384285569191
identified O 0 0.015674231573939323
three O 0 0.010877754539251328
offspring O 0 0.03360014036297798
in O 0 0.011355744674801826
a O 0 0.03509708121418953
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999915361404419
who O 0 0.38268616795539856
developed O 1 0.7430495023727417
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.14956209063529968
a O 0 0.03046407550573349
very O 0 0.016357582062482834
early O 0 0.0300972331315279
age O 0 0.03424213454127312
, O 0 0.02072393335402012
and O 0 0.017392974346876144
at O 0 0.019973071292042732
least O 0 0.009774991311132908
two O 0 0.007004376035183668
of O 0 0.012140225619077682
them O 0 0.009817740879952908
displayed O 0 0.02529231272637844
signs O 0 0.040534861385822296
of O 0 0.051879461854696274
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999872446060181
1 I-Disease 1 0.9832514524459839
( O 0 0.07358764857053757
NF1 B-Disease 1 0.9999959468841553
) O 0 0.04460861161351204
. O 0 0.039053481072187424

DNA O 0 0.06827475875616074
sequence O 0 0.026807114481925964
analysis O 0 0.016759352758526802
and O 0 0.022763581946492195
allele O 0 0.1280355006456375
- O 1 0.9997028708457947
specific O 0 0.0263019111007452
amplification O 0 0.07154997438192368
in O 0 0.013919386081397533
two O 0 0.014003006741404533
siblings O 0 0.06236303225159645
revealed O 0 0.03565908223390579
a O 0 0.03544504567980766
homozygous O 0 0.12818081676959991
MLH1 O 1 0.999997615814209
mutation O 0 0.07890217006206512
( O 0 0.0361914187669754
C676T O 1 0.9999958276748657
- O 1 1.0
- O 1 1.0
> O 1 0.999806821346283
Arg226Stop O 1 0.9998016953468323
) O 0 0.04239249974489212
. O 0 0.03334964066743851

Thus O 0 0.03689669445157051
, O 0 0.017791936174035072
a O 0 0.027752770110964775
homozygous O 0 0.11707604676485062
germ O 1 0.9999994039535522
- O 1 0.9999949932098389
line O 0 0.08888769894838333
MLH1 O 1 0.9999984502792358
mutation O 0 0.07773784548044205
and O 0 0.03223511949181557
consequent O 1 0.9999998807907104
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.029893096536397934
in O 0 0.018996458500623703
a O 0 0.04368458315730095
mutator O 1 0.9999990463256836
phenotype O 0 0.1835254579782486
characterized O 0 0.06151819974184036
by O 0 0.04491366818547249
leukemia B-Disease 1 1.0
and O 1 0.991853654384613
/ O 1 1.0
or O 1 0.9979664087295532
lymphoma B-Disease 1 1.0
associated O 0 0.3974117040634155
with O 1 0.9246626496315002
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999849796295166
1 I-Disease 0 0.07872437685728073
. O 0 0.024981394410133362
. O 0 0.03278535604476929

Missense O 1 0.9408484101295471
mutations O 0 0.06226174533367157
in O 0 0.01933060958981514
the O 0 0.02158137410879135
most O 0 0.016669822856783867
ancient O 0 0.0334969125688076
residues O 0 0.03896235302090645
of O 0 0.019953904673457146
the O 0 0.041992150247097015
PAX6 O 1 0.9999998807907104
paired O 0 0.10988516360521317
domain O 0 0.06431231647729874
underlie O 0 0.0819975957274437
a O 0 0.028241019695997238
spectrum O 0 0.0496375672519207
of O 0 0.04848858341574669
human O 1 0.9999992847442627
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.8864659667015076

Mutations O 0 0.04814030975103378
of O 0 0.020371152088046074
the O 0 0.028241930529475212
human O 0 0.04840637370944023
PAX6 O 1 1.0
gene O 0 0.0978335589170456
underlie O 1 0.9999935626983643
aniridia B-Disease 1 1.0
( O 1 0.9969760179519653
congenital B-Disease 1 1.0
absence I-Disease 1 0.9910427331924438
of I-Disease 0 0.04563181474804878
the I-Disease 0 0.07704179733991623
iris I-Disease 1 0.9999957084655762
) O 0 0.021238191053271294
, O 0 0.012462520971894264
a O 0 0.021492084488272667
rare O 0 0.04254476726055145
dominant O 1 0.9993728995323181
malformation B-Disease 1 1.0
of I-Disease 0 0.06885328143835068
the I-Disease 1 0.719100832939148
eye I-Disease 1 0.999998927116394
. O 0 0.051344625651836395

The O 0 0.04539251700043678
spectrum O 0 0.06900876015424728
of O 0 0.054107666015625
PAX6 O 1 1.0
mutations O 0 0.08523765951395035
in O 0 0.04979643225669861
aniridia B-Disease 1 1.0
patients O 1 0.9999852180480957
is O 0 0.03673243150115013
highly O 0 0.057964909821748734
biased O 0 0.07198744267225266
, O 0 0.02077215537428856
with O 0 0.017555847764015198
92 O 0 0.07056928426027298
% O 0 0.020092817023396492
of O 0 0.017967673018574715
all O 0 0.015556063503026962
reported O 0 0.03461362048983574
mutations O 0 0.03928147256374359
leading O 0 0.044943369925022125
to O 0 0.02973170205950737
premature O 1 0.998051643371582
truncation O 0 0.4384552240371704
of O 0 0.029471583664417267
the O 0 0.0415278859436512
protein O 0 0.05339212343096733
( O 0 0.03064914047718048
nonsense O 0 0.10051310062408447
, O 0 0.033433474600315094
splicing O 0 0.07195144146680832
, O 0 0.03060065768659115
insertions O 0 0.11793600767850876
and O 0 0.03409939631819725
deletions O 0 0.1012117862701416
) O 0 0.028132570907473564
and O 0 0.01804990880191326
just O 0 0.02415807545185089
2 O 0 0.04201243445277214
% O 0 0.021797340363264084
leading O 0 0.038145385682582855
to O 0 0.02164669893682003
substitution O 0 0.04901259392499924
of O 0 0.02276577427983284
one O 0 0.030584879219532013
amino O 0 0.0616508349776268
acid O 0 0.06563223153352737
by O 0 0.022964516654610634
another O 0 0.047484640032052994
( O 0 0.05464532598853111
missense O 0 0.21996954083442688
) O 0 0.04323195293545723
. O 0 0.039835747331380844

The O 0 0.042183876037597656
extraordinary O 0 0.05073259025812149
conservation O 0 0.03810202330350876
of O 0 0.023312045261263847
the O 0 0.04738825187087059
PAX6 O 1 1.0
protein O 0 0.05253637582063675
at O 0 0.02764759212732315
the O 0 0.03277643397450447
amino O 0 0.06518714874982834
acid O 0 0.07719408720731735
level O 0 0.04110756888985634
amongst O 0 0.06454800814390182
vertebrates O 0 0.09279096871614456
predicts O 0 0.08981689810752869
that O 0 0.024595092982053757
pathological O 1 0.9998549222946167
missense O 1 0.9992140531539917
mutations O 0 0.06108972802758217
should O 0 0.01927371509373188
in O 0 0.017401328310370445
fact O 0 0.023815564811229706
be O 0 0.017180362716317177
common O 0 0.027866413816809654
even O 0 0.019938386976718903
though O 0 0.015543036162853241
they O 0 0.008814257569611073
are O 0 0.008071972988545895
hardly O 0 0.03538495674729347
ever O 0 0.029113108292222023
seen O 0 0.036040034145116806
in O 0 0.04479680210351944
aniridia B-Disease 1 1.0
patients O 1 0.9998874664306641
. O 0 0.06863128393888474

This O 0 0.03125665709376335
indicates O 0 0.03901541605591774
that O 0 0.010094922035932541
there O 0 0.011375107802450657
is O 0 0.015517722815275192
a O 0 0.03293382376432419
heavy O 0 0.35391828417778015
ascertainment O 1 0.9999991655349731
bias O 0 0.08172853291034698
in O 0 0.017278453335165977
the O 0 0.019742101430892944
selection O 0 0.03293242305517197
of O 0 0.0345190092921257
patients O 1 0.9940419793128967
for O 0 0.0754610225558281
PAX6 O 1 1.0
mutation O 0 0.18026494979858398
analysis O 0 0.022764012217521667
and O 0 0.01199731882661581
that O 0 0.008598081767559052
the O 0 0.024302495643496513
missing O 0 0.08075983822345734
PAX6 O 1 0.9999997615814209
missense O 1 0.9862533211708069
mutations O 0 0.09012556076049805
frequently O 0 0.05097433924674988
may O 0 0.045282863080501556
underlie O 1 0.9736637473106384
phenotypes O 0 0.11987665295600891
distinct O 0 0.03800645470619202
from O 0 0.044649168848991394
textbook O 1 0.9999864101409912
aniridia B-Disease 1 0.9999998807907104
. O 0 0.061642881482839584

Here O 0 0.03483007848262787
we O 0 0.011948809027671814
present O 0 0.01846599020063877
four O 0 0.024341532960534096
novel O 0 0.11128701269626617
PAX6 O 1 0.9999998807907104
missense O 1 0.9864631295204163
mutations O 0 0.06399156153202057
, O 0 0.019019201397895813
two O 0 0.010665579698979855
in O 0 0.014524239115417004
association O 0 0.03336802497506142
with O 0 0.032287921756505966
atypical O 1 0.9999998807907104
phenotypes O 1 0.9999474287033081
ectopia B-Disease 1 0.9999998807907104
pupillae I-Disease 1 0.9999990463256836
( O 0 0.04836064577102661
displaced B-Disease 0 0.0956387147307396
pupils I-Disease 0 0.29603591561317444
) O 0 0.04790985956788063
and O 0 0.08023057132959366
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 0.45425575971603394
searching B-Disease 0 0.3474828898906708
gaze I-Disease 1 0.9998478889465332
) O 0 0.02947445958852768
, O 0 0.017719030380249023
and O 0 0.012304708361625671
two O 0 0.009680003859102726
in O 0 0.015079651959240437
association O 0 0.026624539867043495
with O 0 0.0151602728292346
more O 0 0.01850273832678795
recognizable O 1 0.995468020439148
aniridia B-Disease 1 1.0
phenotypes O 1 0.9785978198051453
. O 0 0.053247153759002686

Strikingly O 0 0.1296098381280899
, O 0 0.028150131925940514
all O 0 0.016869325190782547
four O 0 0.024849269539117813
mutations O 0 0.034351643174886703
are O 0 0.008337536826729774
located O 0 0.029098499566316605
within O 0 0.015699412673711777
the O 0 0.04136429354548454
PAX6 O 1 0.9999998807907104
paired O 0 0.14429230988025665
domain O 0 0.06853827834129333
and O 0 0.02602684497833252
affect O 0 0.05253157019615173
amino O 0 0.07322245836257935
acids O 0 0.04078793525695801
which O 0 0.012806466780602932
are O 0 0.007593595422804356
highly O 0 0.03438275679945946
conserved O 0 0.032421715557575226
in O 0 0.01246056891977787
all O 0 0.01752621866762638
known O 0 0.05401851236820221
paired O 0 0.11133600771427155
domain O 0 0.0948614552617073
proteins O 0 0.054950401186943054
. O 0 0.0376238189637661

Our O 0 0.05070151016116142
results O 0 0.022824468091130257
support O 0 0.029014047235250473
the O 0 0.027040159329771996
hypothesis O 0 0.039205312728881836
that O 0 0.006207745987921953
the O 0 0.014279443770647049
under O 0 0.02906898781657219
- O 1 0.9790109992027283
representation O 0 0.031059956178069115
of O 0 0.03379138931632042
missense O 1 0.885649561882019
mutations O 0 0.05918899178504944
is O 0 0.029207846149802208
caused O 0 0.0526132695376873
by O 0 0.04716546833515167
ascertainment O 1 0.9999998807907104
bias O 1 0.7133746147155762
and O 0 0.027452288195490837
suggest O 0 0.019616441801190376
that O 0 0.007111124694347382
a O 0 0.015010797418653965
substantial O 0 0.023247823119163513
burden O 0 0.06876165419816971
of O 0 0.05377812683582306
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.962103545665741
disease I-Disease 1 1.0
remains O 1 0.9597846269607544
to O 0 0.032246291637420654
be O 0 0.02047804929316044
uncovered O 0 0.06276661902666092
. O 0 0.02192707173526287
. O 0 0.031440287828445435

The O 0 0.062311649322509766
chromosomal O 0 0.12128224223852158
order O 0 0.03253217041492462
of O 0 0.02889099344611168
genes O 0 0.02647428959608078
controlling O 0 0.0460805781185627
the O 0 0.028658907860517502
major O 0 0.13506239652633667
histocompatibility O 1 1.0
complex O 0 0.062096238136291504
, O 0 0.032848816365003586
properdin O 1 0.9999874830245972
factor O 1 0.9848490953445435
B O 1 0.9999992847442627
, O 0 0.03161568567156792
and O 0 0.03421669825911522
deficiency B-Disease 1 1.0
of I-Disease 0 0.027738111093640327
the I-Disease 0 0.03231589123606682
second I-Disease 0 0.05771273002028465
component I-Disease 0 0.07541762292385101
of I-Disease 0 0.03600549325346947
complement I-Disease 0 0.09184732288122177
. O 0 0.04113122820854187

The O 0 0.04255837947130203
relationship O 0 0.04032343998551369
of O 0 0.024673879146575928
the O 0 0.0348377451300621
genes O 0 0.04048342630267143
coding O 0 0.07333754003047943
for O 0 0.039141036570072174
HLA O 1 1.0
to O 0 0.025710511952638626
those O 0 0.01661854051053524
coding O 0 0.052590467035770416
for O 0 0.022614622488617897
properdin O 1 0.9989833235740662
Factor O 1 0.9405694603919983
B O 1 0.9999904632568359
allotypes O 1 0.9998108744621277
and O 0 0.030233412981033325
for O 0 0.04252743721008301
deficiency B-Disease 1 1.0
of I-Disease 0 0.02543955296278
the I-Disease 0 0.025811264291405678
second I-Disease 0 0.03874588757753372
component I-Disease 0 0.05042285844683647
of I-Disease 0 0.028342818841338158
complement I-Disease 1 0.948652446269989
( O 0 0.06418103724718094
C2 O 1 1.0
) O 0 0.025901678949594498
was O 0 0.02264280803501606
studied O 0 0.015539782121777534
in O 0 0.009562903083860874
families O 0 0.018352985382080078
of O 0 0.027151497080922127
patients O 1 0.999971866607666
with O 1 0.999859094619751
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9897464513778687

Patients O 1 0.9946514964103699
were O 0 0.024154918268322945
selected O 0 0.034445930272340775
because O 0 0.0150687200948596
they O 0 0.007181286346167326
were O 0 0.010068248026072979
heterozygous O 0 0.05686896666884422
or O 0 0.027756033465266228
homozygous O 0 0.1262187361717224
for O 1 0.983226478099823
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.23119069635868073

12 O 0 0.04437904432415962
families O 0 0.03180671110749245
with O 0 0.019666511565446854
15 O 0 0.04008040577173233
matings O 0 0.2086849957704544
informative O 0 0.11597708612680435
for O 1 0.6922343969345093
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.04338796064257622
found O 0 0.037040770053863525
. O 0 0.0408182255923748

Of O 0 0.05990796536207199
57 O 0 0.1208990290760994
informative O 0 0.13151490688323975
meioses O 1 0.9878091812133789
, O 0 0.022930007427930832
two O 0 0.012675777077674866
crossovers O 0 0.05551471561193466
were O 0 0.008289935998618603
noted O 0 0.013423568569123745
between O 0 0.020318638533353806
the O 0 0.3679652512073517
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.05908707529306412
and O 0 0.019898463040590286
the O 0 0.04116295278072357
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999996423721313
gene O 0 0.03844250366091728
, O 0 0.011531040072441101
with O 0 0.011697760783135891
a O 0 0.028032179921865463
recombinant O 0 0.1058734655380249
fraction O 0 0.05400994420051575
of O 0 0.037192996591329575
0 O 0 0.09431444853544235
. O 0 0.04501534625887871

035 O 1 0.9909257888793945
. O 0 0.07580168545246124

A O 0 0.1187184751033783
lod O 1 0.9994226694107056
score O 0 0.03385273367166519
of O 0 0.023407993838191032
13 O 0 0.02807900309562683
was O 0 0.025249794125556946
calculated O 0 0.020848607644438744
for O 0 0.016365984454751015
linkage O 0 0.10396227985620499
between O 0 0.08269032835960388
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999901056289673
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999892711639404
at O 0 0.027134409174323082
a O 0 0.02135258913040161
maximum O 0 0.02705341950058937
likelihood O 0 0.03151211887598038
value O 0 0.010954191908240318
of O 0 0.013650629669427872
the O 0 0.028054235503077507
recombinant O 0 0.11398088186979294
fraction O 0 0.055188558995723724
of O 0 0.03663188964128494
0 O 0 0.09445727616548538
. O 0 0.04360952973365784

04 O 1 0.9769589304924011
. O 0 0.07246348261833191

18 O 0 0.05751965939998627
families O 0 0.04026706516742706
with O 0 0.024519605562090874
21 O 0 0.056954603642225266
informative O 0 0.08826733380556107
matings O 0 0.11326542496681213
for O 0 0.017451444640755653
both O 0 0.02032540738582611
properdin O 1 0.9991212487220764
Factor O 0 0.16357506811618805
B O 1 0.9999004602432251
allotype O 1 0.9999040365219116
and O 0 0.05651997774839401
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999611377716064
were O 0 0.01717367395758629
found O 0 0.02139143832027912
. O 0 0.031094316393136978

Of O 0 0.06382058560848236
72 O 0 0.11806152015924454
informative O 0 0.1284673810005188
meioses O 1 0.9971534013748169
, O 0 0.03037838451564312
three O 0 0.025852754712104797
recombinants O 1 0.9874541759490967
were O 0 0.015525476075708866
found O 0 0.014463403262197971
, O 0 0.014756929129362106
giving O 0 0.021252745762467384
a O 0 0.032610345631837845
recombinant O 0 0.10799716413021088
fraction O 0 0.05626032128930092
of O 0 0.036952581256628036
0 O 0 0.09396803379058838
. O 0 0.04215313494205475

042 O 1 0.990159809589386
. O 0 0.08039397746324539

A O 0 0.10422338545322418
lod O 1 0.9973863959312439
score O 0 0.025785140693187714
of O 0 0.01645636186003685
16 O 0 0.026311637833714485
between O 0 0.042189549654722214
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999712705612183
and O 0 0.03179549798369408
Factor O 1 0.9471395015716553
B O 1 0.9999946355819702
allotypes O 1 0.9990527033805847
was O 0 0.040157750248909
calculated O 0 0.028782453387975693
at O 0 0.02212669886648655
a O 0 0.021426329389214516
maximum O 0 0.026579322293400764
likelihood O 0 0.03709518536925316
value O 0 0.013363506644964218
of O 0 0.017317086458206177
the O 0 0.030231526121497154
recombinant O 0 0.11299798637628555
fraction O 0 0.05915149673819542
of O 0 0.039533309638500214
0 O 0 0.09969323873519897
. O 0 0.04780840873718262

04 O 1 0.984298825263977
. O 0 0.07532873004674911

A O 0 0.09327363222837448
crossover O 0 0.13914969563484192
was O 0 0.041216250509023666
shown O 0 0.019299184903502464
to O 0 0.014130975119769573
have O 0 0.007796602323651314
occurred O 0 0.020947901532053947
between O 0 0.015440557152032852
genes O 0 0.01557894330471754
for O 0 0.014610697515308857
Factor O 0 0.06933699548244476
B O 1 0.9999673366546631
and O 0 0.03765286132693291
HLA O 1 1.0
- O 1 1.0
D O 1 0.9999818801879883
, O 0 0.012646866030991077
in O 0 0.009268341585993767
which O 0 0.019529923796653748
HLA O 1 1.0
- O 1 0.9999996423721313
D O 1 0.9999383687973022
segregared O 1 0.9632190465927124
with O 0 0.03960898891091347
HLA O 1 1.0
- O 1 0.9999998807907104
A O 0 0.06708580255508423
and O 0 0.03604057803750038
B O 1 0.9998264908790588
. O 0 0.04292896017432213

These O 0 0.029036974534392357
studies O 0 0.022877322509884834
suggest O 0 0.01523669809103012
that O 0 0.006444040685892105
the O 0 0.013611715286970139
genes O 0 0.014977557584643364
for O 0 0.016086185351014137
Factor O 1 0.9227948188781738
B O 1 1.0
and O 1 0.999546468257904
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.018595442175865173
located O 0 0.04075811803340912
outside O 0 0.024429600685834885
those O 0 0.01167965866625309
for O 0 0.03421357646584511
HLA O 1 1.0
, O 0 0.021001914516091347
that O 0 0.006308431271463633
the O 0 0.010254107415676117
order O 0 0.015764186158776283
of O 0 0.021784920245409012
genese O 1 0.9994804263114929
is O 0 0.03891636058688164
HLA O 1 1.0
- O 1 0.9999784231185913
A O 0 0.03896258398890495
, O 0 0.02295563742518425
- O 1 0.9999781847000122
B O 1 0.9999210834503174
, O 0 0.02953065186738968
- O 1 0.9999990463256836
D O 1 0.9997159838676453
, O 0 0.019863247871398926
Factor O 0 0.07078664749860764
B O 1 0.9999961853027344
allotype O 1 0.9999998807907104
, O 1 0.9994174242019653
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.02784772776067257
that O 0 0.008797043934464455
the O 0 0.017039883881807327
genes O 0 0.02317499928176403
coding O 0 0.06300252676010132
for O 0 0.05605431646108627
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.7394409775733948
Factor O 1 0.9999985694885254
B O 1 0.9999997615814209
allotypes O 1 0.9972794651985168
are O 0 0.005794675089418888
approximately O 0 0.012594539672136307
3 O 0 0.037137310951948166
- O 1 0.9999762773513794
- O 1 0.9967247843742371
5 O 0 0.027781827375292778
centimorgans O 0 0.0939069539308548
from O 0 0.013122839853167534
the O 0 0.03129797801375389
HLA O 1 1.0
- O 1 0.9999829530715942
A O 0 0.04458468034863472
and O 0 0.035913966596126556
HLA O 1 1.0
- O 1 1.0
B O 1 1.0
loci O 0 0.19142763316631317
, O 0 0.02323487214744091
and O 0 0.015061482787132263
that O 0 0.008497350849211216
the O 0 0.01913122832775116
apparent O 0 0.04883730411529541
lack O 0 0.030619356781244278
of O 0 0.03005758486688137
recombinants O 1 0.9875648617744446
between O 0 0.016930367797613144
the O 0 0.02328326925635338
Factor O 0 0.33880192041397095
B O 1 0.9999986886978149
gene O 0 0.06233050674200058
and O 0 0.22586344182491302
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.6468379497528076
suggests O 0 0.04103605076670647
that O 0 0.011798623017966747
these O 0 0.00822796206921339
two O 0 0.014971353113651276
genes O 0 0.030349431559443474
lie O 0 0.052529480308294296
in O 0 0.020372893661260605
close O 0 0.038014840334653854
proximity O 0 0.056771159172058105
to O 0 0.02202473394572735
one O 0 0.024183113127946854
another O 0 0.044361717998981476
. O 0 0.03781169280409813

Distribution O 0 0.05538886412978172
of O 0 0.04755090922117233
emerin O 1 0.9965419173240662
and O 0 0.0403556302189827
lamins O 1 0.9998769760131836
in O 0 0.025042803958058357
the O 0 0.03853948414325714
heart O 1 0.9999697208404541
and O 0 0.021931016817688942
implications O 0 0.0377994030714035
for O 0 0.024653278291225433
Emery B-Disease 1 0.9999992847442627
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.12604539096355438

Emerin O 1 0.995469331741333
is O 0 0.02553011104464531
a O 0 0.04063164442777634
nuclear O 0 0.09942935407161713
membrane O 1 0.9352928400039673
protein O 0 0.03822222724556923
which O 0 0.011689571663737297
is O 0 0.013884576968848705
missing O 0 0.030268006026744843
or O 0 0.019896311685442924
defective O 0 0.21424709260463715
in O 0 0.022352319210767746
Emery B-Disease 1 0.9999783039093018
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999970197677612
EDMD B-Disease 1 1.0
) O 0 0.05474907159805298
. O 0 0.03919105604290962

It O 0 0.022200172767043114
is O 0 0.014436409808695316
one O 0 0.011002923361957073
member O 0 0.019563809037208557
of O 0 0.012476027011871338
a O 0 0.019451333209872246
family O 0 0.03284400701522827
of O 0 0.04337020590901375
lamina O 1 1.0
- O 1 1.0
associated O 0 0.03622560203075409
proteins O 0 0.023258058354258537
which O 0 0.01067215297371149
includes O 0 0.02557477541267872
LAP1 O 1 0.9999868869781494
, O 0 0.031105898320674896
LAP2 O 1 0.9999772310256958
and O 0 0.040828946977853775
lamin O 1 1.0
B O 1 1.0
receptor O 1 0.9999840259552002
( O 0 0.07883019000291824
LBR O 1 0.999975323677063
) O 0 0.04881531745195389
. O 0 0.03795213997364044

A O 0 0.0620618611574173
panel O 0 0.04739778861403465
of O 0 0.03504104167222977
16 O 0 0.07686475664377213
monoclonal O 1 0.9999945163726807
antibodies O 1 0.9996234178543091
( O 0 0.08548351377248764
mAbs O 1 0.9997712969779968
) O 0 0.03735635429620743
has O 0 0.022399291396141052
been O 0 0.019732175394892693
mapped O 0 0.04144670069217682
to O 0 0.016952062025666237
six O 0 0.017877986654639244
specific O 0 0.013867220841348171
sites O 0 0.016534464433789253
throughout O 0 0.015046528540551662
the O 0 0.030920950695872307
emerin O 1 0.9960784316062927
molecule O 0 0.07903324067592621
using O 0 0.028703253716230392
phage O 1 0.9999537467956543
- O 1 0.9999381303787231
displayed O 0 0.07083247601985931
peptide O 0 0.11595863848924637
libraries O 0 0.043825414031744
and O 0 0.01982109062373638
has O 0 0.017152881249785423
been O 0 0.014567921869456768
used O 0 0.01306474581360817
to O 0 0.024782273918390274
localize O 1 0.9605501294136047
emerin O 1 0.9992600083351135
in O 0 0.02983858250081539
human O 0 0.04100455716252327
and O 0 0.05143481492996216
rabbit O 1 0.9999995231628418
heart O 1 0.9999992847442627
. O 0 0.0645861029624939

Several O 0 0.05249984189867973
mAbs O 1 0.6529025435447693
against O 0 0.0572475790977478
different O 0 0.021991482004523277
emerin O 1 0.998809814453125
epitopes O 1 0.8137680888175964
did O 0 0.027244742959737778
not O 0 0.01735154166817665
recognize O 0 0.06762051582336426
intercalated O 1 0.9999680519104004
discs O 0 0.0679745003581047
in O 0 0.023901361972093582
the O 0 0.04671220853924751
heart O 1 0.9999978542327881
, O 0 0.027040721848607063
though O 0 0.015492670238018036
they O 0 0.00983629934489727
recognized O 0 0.04973940551280975
cardiomyocyte O 1 0.9999874830245972
nuclei O 0 0.29342275857925415
strongly O 0 0.04073305428028107
, O 0 0.017432615160942078
both O 0 0.013574517332017422
at O 0 0.024004686623811722
the O 0 0.02837556228041649
rim O 0 0.17232240736484528
and O 0 0.019720565527677536
in O 0 0.027298104017972946
intranuclear O 1 0.9999902248382568
spots O 0 0.10020016133785248
or O 0 0.03640858829021454
channels O 0 0.04639888182282448
. O 0 0.03603817895054817

A O 0 0.1454559564590454
polyclonal O 1 0.9997621178627014
rabbit O 1 0.9945536851882935
antiserum O 1 0.9962840676307678
against O 0 0.08086253702640533
emerin O 1 0.9991704225540161
did O 0 0.03010631911456585
recognize O 0 0.03744883090257645
both O 0 0.023085569962859154
nuclear O 0 0.09263049066066742
membrane O 0 0.3473571836948395
and O 0 0.03853568062186241
intercalated O 1 0.9999933242797852
discs O 0 0.0749388113617897
but O 0 0.016563354060053825
, O 0 0.016590267419815063
after O 0 0.03332912176847458
affinity O 0 0.07402422279119492
purification O 0 0.21493083238601685
against O 0 0.03294773027300835
a O 0 0.03631562739610672
pure O 0 0.09447978436946869
- O 1 0.9999983310699463
emerin O 1 0.9931286573410034
band O 0 0.04878300428390503
on O 0 0.016442568972706795
a O 0 0.022507909685373306
western O 0 0.04424332082271576
blot O 1 0.9980751276016235
, O 0 0.02586919255554676
it O 0 0.01761719398200512
stained O 1 0.9966017007827759
only O 0 0.01776382513344288
the O 0 0.03346908837556839
nuclear O 0 0.09099692851305008
membrane O 0 0.11038975417613983
. O 0 0.040914759039878845

These O 0 0.029757890850305557
results O 0 0.0214163139462471
would O 0 0.014417355880141258
not O 0 0.01091761514544487
be O 0 0.009613372385501862
expected O 0 0.0207339096814394
if O 0 0.02724386565387249
immunostaining O 1 0.9983981251716614
at O 0 0.08005158603191376
intercalated O 1 0.9999772310256958
discs O 0 0.07145260274410248
were O 0 0.01390413660556078
due O 0 0.021303430199623108
to O 0 0.015385822393000126
a O 0 0.020857462659478188
product O 0 0.018712835386395454
of O 0 0.019172055646777153
the O 0 0.04127029329538345
emerin O 1 0.9999986886978149
gene O 0 0.06032427400350571
and O 0 0.027034426108002663
, O 0 0.027569375932216644
therefore O 0 0.02141713909804821
, O 0 0.01690039224922657
cast O 0 0.021494591608643532
some O 0 0.008662174455821514
doubt O 0 0.0254770889878273
upon O 0 0.018688101321458817
the O 0 0.022121572867035866
hypothesis O 0 0.05668829381465912
that O 0 0.03286806121468544
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 0 0.31290555000305176
EDMD B-Disease 1 1.0
are O 0 0.01882694475352764
caused O 0 0.03668782114982605
by O 0 0.02197422832250595
absence O 0 0.052926428616046906
of O 0 0.04486841335892677
emerin O 1 0.9999535083770752
from O 0 0.07036179304122925
intercalated O 1 0.9999454021453857
discs O 0 0.13129675388336182
. O 0 0.05029267072677612

Although O 0 0.053453657776117325
emerin O 1 0.6690062880516052
was O 0 0.04488561674952507
abundant O 0 0.03760143741965294
in O 0 0.015217755921185017
the O 0 0.02965111844241619
membranes O 0 0.0887036994099617
of O 0 0.04790792986750603
cardiomyocyte O 1 1.0
nuclei O 1 0.7957801818847656
, O 0 0.021351657807826996
it O 0 0.009460720233619213
was O 0 0.025007491931319237
absent O 0 0.035565223544836044
from O 0 0.010951134376227856
many O 0 0.01217989157885313
non O 1 0.9185823798179626
- O 1 1.0
myocyte O 1 1.0
cells O 0 0.06125475466251373
in O 0 0.02399928867816925
the O 0 0.04885813221335411
heart O 1 0.9999914169311523
. O 0 0.05859027057886124

This O 0 0.02582191489636898
distribution O 0 0.03339921683073044
of O 0 0.04083745554089546
emerin O 1 0.9996949434280396
was O 0 0.03818429633975029
similar O 0 0.012916618026793003
to O 0 0.012456824071705341
that O 0 0.008489441126585007
of O 0 0.02749447338283062
lamin O 1 0.9999969005584717
A O 0 0.057142723351716995
, O 0 0.019201939925551414
a O 0 0.02561253495514393
candidate O 0 0.04626576229929924
gene O 0 0.029533518478274345
for O 0 0.015842052176594734
an O 0 0.028643954545259476
autosomal O 1 0.9860386252403259
form O 0 0.04798288270831108
of O 0 0.06981630623340607
EDMD B-Disease 1 1.0
. O 0 0.06963908672332764

In O 0 0.03545050695538521
contrast O 0 0.05708892270922661
, O 0 0.05766622722148895
lamin O 1 0.9999998807907104
B1 O 1 1.0
was O 0 0.06770028918981552
absent O 0 0.08270920813083649
from O 0 0.04227077588438988
cardiomyocyte O 1 0.9999580383300781
nuclei O 0 0.10716169327497482
, O 0 0.024801308289170265
showing O 0 0.036854203790426254
that O 0 0.03263216093182564
lamin O 1 1.0
B1 O 1 1.0
is O 0 0.030412573367357254
not O 0 0.01370929554104805
essential O 0 0.03191709145903587
for O 0 0.021570010110735893
localization O 0 0.09349893033504486
of O 0 0.03856474906206131
emerin O 1 0.6968613862991333
to O 0 0.02887563779950142
the O 0 0.040609683841466904
nuclear O 0 0.11397811770439148
lamina O 1 0.9999977350234985
. O 0 0.05684654042124748

Lamin O 1 1.0
B1 O 1 1.0
is O 0 0.033704712986946106
also O 0 0.015045766718685627
almost O 0 0.014884008094668388
completely O 0 0.039018869400024414
absent O 0 0.08024980872869492
from O 0 0.06113260239362717
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9998809099197388
. O 0 0.06429391354322433

In O 0 0.07228535413742065
EDMD B-Disease 1 0.9999984502792358
, O 0 0.02400217391550541
the O 0 0.017907269299030304
additional O 0 0.015314744785428047
absence O 0 0.04149804636836052
of O 0 0.043811675161123276
lamin O 1 1.0
B1 O 1 1.0
from O 0 0.0577305406332016
heart O 1 1.0
and O 1 0.9993042945861816
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.9998875856399536
which O 0 0.02230614237487316
already O 0 0.027749698609113693
lack O 0 0.05326593294739723
emerin O 1 0.9999517202377319
may O 0 0.025426458567380905
offer O 0 0.023304002359509468
an O 0 0.017543919384479523
alternative O 0 0.03292955085635185
explanation O 0 0.027352232486009598
of O 0 0.02291695587337017
why O 0 0.03497902303934097
these O 0 0.019724097102880478
tissues O 0 0.12357744574546814
are O 0 0.016442198306322098
particularly O 0 0.04104376584291458
affected O 0 0.05061439797282219
. O 0 0.03201092779636383
. O 0 0.040305234491825104

Genetic O 0 0.0764269009232521
mapping O 0 0.04307065159082413
of O 0 0.026304718106985092
the O 0 0.04787568375468254
copper B-Disease 1 0.9988908171653748
toxicosis I-Disease 1 0.9999991655349731
locus O 0 0.4917066991329193
in O 0 0.039369940757751465
Bedlington O 1 0.9998660087585449
terriers O 1 0.9437887668609619
to O 0 0.05062217637896538
dog O 1 0.9970229268074036
chromosome O 0 0.07901017367839813
10 O 0 0.024359293282032013
, O 0 0.01408639457076788
in O 0 0.012022260576486588
a O 0 0.022382088005542755
region O 0 0.03993729501962662
syntenic O 1 0.862450897693634
to O 0 0.027551233768463135
human O 0 0.04206619784235954
chromosome O 0 0.0808982327580452
region O 0 0.06985823065042496
2p13 O 1 0.999984622001648
- O 1 0.9999991655349731
p16 O 1 0.9490947127342224
. O 0 0.04855535924434662

Abnormal O 1 0.9999998807907104
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999998807907104
accumulation I-Disease 1 0.9999814033508301
is O 0 0.019121987745165825
recognized O 0 0.02059515193104744
as O 0 0.015221850946545601
an O 0 0.030006013810634613
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.14589257538318634
man O 1 0.9994914531707764
, O 0 0.03397337347269058
mouse O 0 0.14098799228668213
, O 0 0.04293060675263405
rat O 1 0.9999710321426392
and O 0 0.04249493405222893
dog O 0 0.48614779114723206
. O 0 0.04538975656032562

The O 0 0.04474475979804993
major O 0 0.05371365696191788
cause O 1 0.6335851550102234
of O 1 0.9893955588340759
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999403953552246
in O 0 0.02262897975742817
man O 0 0.03774410858750343
is O 0 0.01142327580600977
a O 0 0.023881342262029648
dysfunctional O 1 0.9999157190322876
ATP7B O 1 0.9999998807907104
gene O 0 0.04676898196339607
, O 0 0.024266069754958153
causing O 1 0.9831146001815796
Wilson B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9999642372131348
WD B-Disease 1 1.0
) O 0 0.04896347224712372
. O 0 0.03704747557640076

Mutations O 0 0.07051751762628555
in O 0 0.024216430261731148
the O 0 0.049076396971940994
ATP7B O 1 0.9999998807907104
genes O 0 0.03618035838007927
have O 0 0.009387688711285591
also O 0 0.012955913320183754
been O 0 0.014370916411280632
demonstrated O 0 0.03604908660054207
in O 0 0.03192302584648132
mouse O 0 0.10711756348609924
and O 0 0.05152569338679314
rat O 1 0.9997228980064392
. O 0 0.0530085414648056

The O 0 0.08653242886066437
ATP7B O 1 0.9999991655349731
gene O 0 0.062015555799007416
has O 0 0.020073309540748596
been O 0 0.01633789762854576
excluded O 0 0.038364049047231674
in O 0 0.011347352527081966
the O 0 0.01666608639061451
much O 0 0.022506730630993843
rarer O 0 0.30924874544143677
human O 0 0.055176857858896255
copper B-Disease 1 0.9999997615814209
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9999982118606567
- I-Disease 1 1.0
Indian I-Disease 0 0.12433374673128128
childhood I-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
, O 0 0.11263439804315567
indicating O 0 0.08633328974246979
genetic O 0 0.06803566962480545
heterogeneity O 1 0.7739119529724121
. O 0 0.047617919743061066

By O 0 0.026523051783442497
investigating O 0 0.040956951677799225
the O 0 0.027114219963550568
common O 0 0.05028475075960159
autosomal O 1 0.9999991655349731
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9968363046646118
CT B-Disease 1 1.0
) O 0 0.03287554159760475
in O 0 0.02870422601699829
Bedlington O 1 0.9999970197677612
terriers O 1 0.9922332763671875
, O 0 0.025604763999581337
we O 0 0.009298703633248806
have O 0 0.005120871588587761
identified O 0 0.011567413806915283
a O 0 0.014206923544406891
new O 0 0.02367735281586647
locus O 0 0.0798061341047287
involved O 0 0.023593569174408913
in O 0 0.043113790452480316
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9992627501487732

We O 0 0.02303530089557171
examined O 0 0.03891786187887192
whether O 0 0.017674606293439865
the O 0 0.03882676362991333
WD B-Disease 1 1.0
gene O 0 0.07892207056283951
ATP7B O 1 0.9999756813049316
was O 0 0.04253100976347923
also O 0 0.02770419605076313
causative O 1 0.9978193044662476
for O 0 0.03266002610325813
CT B-Disease 1 0.9999940395355225
by O 0 0.01880676858127117
investigating O 0 0.03735196217894554
the O 0 0.032853707671165466
chromosomal O 1 0.9871047735214233
co O 1 0.9960896968841553
- O 1 0.9999657869338989
localization O 0 0.1043519377708435
of O 0 0.04412298649549484
ATP7B O 1 0.9999992847442627
and O 0 0.038471005856990814
C04107 O 1 0.9996223449707031
, O 0 0.02319684438407421
using O 0 0.01849755458533764
fluorescence O 0 0.07370014488697052
in O 0 0.035367488861083984
situ O 1 0.9993202686309814
hybridization O 0 0.11053343117237091
( O 0 0.047527849674224854
FISH O 0 0.06153718754649162
) O 0 0.03317913040518761
. O 0 0.03074941411614418

C04107 O 1 0.9968558549880981
is O 0 0.03268591687083244
an O 0 0.02962411381304264
anonymous O 0 0.10035551339387894
microsatellite O 0 0.4377709627151489
marker O 0 0.1594090461730957
closely O 0 0.04494917020201683
linked O 0 0.07194320857524872
to O 0 0.05523209273815155
CT B-Disease 1 0.9999985694885254
. O 0 0.06045835465192795

However O 0 0.041726402938365936
, O 0 0.048175305128097534
BAC O 1 0.9999958276748657
clones O 1 0.6900611519813538
containing O 0 0.08725909888744354
ATP7B O 1 0.9999631643295288
and O 0 0.04068661853671074
C04107 O 1 0.6889291405677795
mapped O 0 0.045810550451278687
to O 0 0.017240723595023155
the O 0 0.0347655825316906
canine O 1 0.999993085861206
chromosome O 0 0.09274681657552719
regions O 0 0.04796186834573746
CFA22q11 O 1 0.9999744892120361
and O 0 0.042533621191978455
CFA10q26 O 1 0.9999823570251465
, O 0 0.030516229569911957
respectively O 0 0.02856551483273506
, O 0 0.020045693963766098
demonstrating O 0 0.047031890600919724
that O 0 0.03039804846048355
WD B-Disease 1 0.9999998807907104
cannot O 0 0.03488358482718468
be O 0 0.018992353230714798
homologous O 0 0.09896647185087204
to O 0 0.06380901485681534
CT B-Disease 1 0.9999986886978149
. O 0 0.05467026308178902

The O 0 0.06473057717084885
copper O 1 0.9175577163696289
transport O 0 0.09752121567726135
genes O 0 0.057977937161922455
CTR1 O 1 0.9999932050704956
and O 0 0.040892720222473145
CTR2 O 1 0.9999853372573853
were O 0 0.015616276301443577
also O 0 0.014837565831840038
excluded O 0 0.04655793681740761
as O 0 0.020553287118673325
candidate O 0 0.04959854856133461
genes O 0 0.03168915957212448
for O 0 0.03468244895339012
CT B-Disease 1 0.9999998807907104
since O 0 0.024680493399500847
they O 0 0.008148977532982826
both O 0 0.013022119179368019
mapped O 0 0.04452541097998619
to O 0 0.03853129968047142
canine O 1 0.9999918937683105
chromosome O 0 0.12492852658033371
region O 0 0.08468442410230637
CFA11q22 O 1 0.9999208450317383
. O 0 0.05725961551070213

2 O 0 0.12942242622375488
- O 1 0.9997276663780212
22 O 0 0.0663071796298027
. O 0 0.04317966103553772

5 O 0 0.09693705290555954
. O 0 0.05843271315097809

A O 0 0.0944133847951889
transcribed O 0 0.0748247280716896
sequence O 0 0.019402965903282166
identified O 0 0.015166747383773327
from O 0 0.010980094783008099
the O 0 0.02762020379304886
C04107 O 1 0.9999827146530151
- O 1 0.9999994039535522
containing O 0 0.06542063504457474
BAC O 1 0.9999954700469971
was O 0 0.03893071040511131
found O 0 0.014294753782451153
to O 0 0.015970367938280106
be O 0 0.0136806545779109
homologous O 0 0.054599545896053314
to O 0 0.018453821539878845
a O 0 0.029097244143486023
gene O 0 0.026802467182278633
expressed O 0 0.019354676827788353
from O 0 0.01689624972641468
human O 0 0.03672318160533905
chromosome O 0 0.10858077555894852
2p13 O 1 0.9999995231628418
- O 1 1.0
p16 O 1 0.9945175051689148
, O 0 0.023618508130311966
a O 0 0.024291150271892548
region O 0 0.033286429941654205
devoid O 0 0.06563341617584229
of O 0 0.02471190132200718
any O 0 0.027855904772877693
positional O 1 0.6626507639884949
candidate O 0 0.08932585269212723
genes O 0 0.044730935245752335
. O 0 0.04018350690603256

Molecular O 0 0.07188393920660019
analysis O 0 0.015858326107263565
of O 0 0.019429180771112442
the O 0 0.04199238494038582
APC B-Disease 1 0.9999971389770508
gene O 0 0.03783140331506729
in O 0 0.017548400908708572
205 O 0 0.08920332044363022
families O 0 0.03342527523636818
: O 0 0.02768584154546261
extended O 0 0.06530247628688812
genotype O 1 0.9933806657791138
- O 1 0.9999969005584717
phenotype O 0 0.29253149032592773
correlations O 0 0.10612441599369049
in O 0 0.04652662202715874
FAP B-Disease 1 1.0
and O 0 0.024212289601564407
evidence O 0 0.014347679913043976
for O 0 0.010130010545253754
the O 0 0.015596277080476284
role O 0 0.033524565398693085
of O 0 0.03647717088460922
APC B-Disease 1 0.9999998807907104
amino O 0 0.06770320981740952
acid O 0 0.06867850571870804
changes O 0 0.02672932669520378
in O 0 0.10063478350639343
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.5223835706710815

BACKGROUND O 0 0.13483411073684692
/ O 1 0.9330099821090698
AIMS O 0 0.06671649217605591
The O 0 0.022380882874131203
development O 0 0.040889840573072433
of O 1 0.9999653100967407
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.4627053439617157
a O 0 0.04020668566226959
variable O 0 0.034891098737716675
range O 0 0.013950618915259838
of O 0 0.02349221706390381
extracolonic O 1 0.9992817044258118
manifestations O 1 0.9948870539665222
in O 0 0.051208943128585815
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999997615814209
FAP B-Disease 1 1.0
) O 0 0.03649807721376419
is O 0 0.015322611667215824
the O 0 0.014263874851167202
result O 0 0.01010533981025219
of O 0 0.01179015263915062
the O 0 0.018127083778381348
dominant O 0 0.05996327102184296
inheritance O 0 0.06116781011223793
of O 0 0.08556238561868668
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9998977184295654
APC B-Disease 1 1.0
) O 0 0.061486028134822845
gene O 0 0.06636719405651093
mutations O 0 0.05727904662489891
. O 0 0.038402263075113297

In O 0 0.03223245590925217
this O 0 0.017880823463201523
study O 0 0.024106884375214577
, O 0 0.022557353600859642
direct O 0 0.037279244512319565
mutation O 0 0.04569532722234726
analysis O 0 0.010924908332526684
of O 0 0.017812781035900116
the O 0 0.04437124356627464
APC B-Disease 1 0.9999997615814209
gene O 0 0.04677766561508179
was O 0 0.029904423281550407
performed O 0 0.031239638105034828
to O 0 0.019203897565603256
determine O 0 0.032116103917360306
genotype O 1 0.9937884211540222
- O 1 0.9999977350234985
phenotype O 0 0.12132198363542557
correlations O 0 0.06334058940410614
for O 0 0.020562149584293365
nine O 0 0.0512295700609684
extracolonic O 1 0.999992847442627
manifestations O 1 0.9995294809341431
and O 0 0.02181316539645195
to O 0 0.017393967136740685
investigate O 0 0.036549270153045654
the O 0 0.023912513628602028
incidence O 1 0.9851898550987244
of O 0 0.04096713289618492
APC B-Disease 1 0.9999998807907104
mutations O 0 0.028891287744045258
in O 0 0.015122969634830952
non O 1 0.9999138116836548
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7520955204963684

METHODS O 0 0.06212267652153969
The O 0 0.060692302882671356
APC B-Disease 1 0.9999994039535522
gene O 0 0.04997355118393898
was O 0 0.0329253226518631
analysed O 0 0.04143349453806877
in O 0 0.01501490268856287
190 O 0 0.06427682191133499
unrelated O 0 0.0717783197760582
FAP B-Disease 1 1.0
and O 0 0.020069405436515808
15 O 0 0.03072255291044712
non O 1 0.9994008541107178
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
using O 0 0.06169622763991356
denaturing O 1 0.9999991655349731
gradient O 1 0.9999606609344482
gel O 1 0.9999933242797852
electrophoresis O 0 0.18000571429729462
, O 0 0.02548828348517418
the O 0 0.035220611840486526
protein O 0 0.053036708384752274
truncation O 0 0.1299435794353485
test O 0 0.05060043931007385
, O 0 0.02326093055307865
and O 0 0.02278926409780979
direct O 0 0.04624607414007187
sequencing O 0 0.06391265988349915
. O 0 0.03708125650882721

RESULTS O 0 0.09518356621265411
Chain O 0 0.20764774084091187
terminating O 0 0.44244879484176636
signals O 0 0.03962414339184761
were O 0 0.009484123438596725
only O 0 0.01197169627994299
identified O 0 0.02290685474872589
in O 0 0.019763339310884476
patients O 0 0.062268443405628204
belonging O 0 0.03883693367242813
to O 0 0.021514099091291428
the O 0 0.04514569044113159
FAP B-Disease 1 1.0
group O 1 0.6224834322929382
( O 0 0.043428435921669006
105 O 1 0.9718905687332153
patients O 1 0.9999420642852783
) O 0 0.04833831265568733
. O 0 0.04157561436295509

Amino O 0 0.19734328985214233
acid O 0 0.11396414786577225
changes O 0 0.02063802443444729
were O 0 0.013219536282122135
identified O 0 0.025450624525547028
in O 0 0.017613058909773827
four O 0 0.03390839323401451
patients O 1 0.9002251029014587
, O 0 0.022083668038249016
three O 0 0.012548991478979588
of O 0 0.019984355196356773
whom O 0 0.032720137387514114
belonged O 0 0.04104415699839592
to O 0 0.011582830920815468
the O 0 0.01663440465927124
non O 0 0.3238702416419983
- O 1 0.9999998807907104
FAP O 1 1.0
group O 0 0.33046969771385193
of O 1 0.9998759031295776
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.46642550826072693

Genotype O 1 0.9999436140060425
- O 1 0.9999994039535522
phenotype O 1 0.6844520568847656
correlations O 0 0.0989009365439415
identified O 0 0.03550995513796806
significant O 0 0.019668230786919594
differences O 0 0.018854958936572075
in O 0 0.013394349254667759
the O 0 0.019346507266163826
nature O 0 0.019781405106186867
of O 0 0.018070407211780548
certain O 0 0.024597615003585815
extracolonic O 1 0.999981164932251
manifestations O 1 0.9999979734420776
in O 0 0.10655008256435394
FAP B-Disease 1 1.0
patients O 1 0.9999997615814209
belonging O 0 0.062281280755996704
to O 0 0.02344512939453125
three O 0 0.02951858565211296
mutation O 0 0.09324577450752258
subgroups O 0 0.1559189409017563
. O 0 0.052446626126766205

CONCLUSIONS O 0 0.08126389980316162
Extended O 0 0.10484815388917923
genotype O 1 0.9998323917388916
- O 1 0.9999994039535522
phenotype O 0 0.3613545000553131
correlations O 0 0.08079816401004791
made O 0 0.02429601550102234
in O 0 0.0182278323918581
this O 0 0.015187415294349194
study O 0 0.02508378215134144
may O 0 0.01998605951666832
have O 0 0.008733912371098995
the O 0 0.0192341897636652
potential O 0 0.029348300769925117
to O 0 0.017838377505540848
determine O 0 0.016592150554060936
the O 0 0.016287734732031822
most O 0 0.015482577495276928
appropriate O 0 0.03220286965370178
surveillance O 0 0.06415511667728424
and O 0 0.03803325816988945
prophylactic O 1 1.0
treatment O 1 1.0
regimens O 1 1.0
for O 0 0.03774163872003555
those O 0 0.03008321300148964
patients O 1 0.9995947480201721
with O 0 0.031854163855314255
mutations O 0 0.05259215086698532
associated O 0 0.02913673035800457
with O 0 0.026115166023373604
life O 0 0.07905690371990204
threatening O 1 0.9990260601043701
conditions O 0 0.09137105941772461
. O 0 0.051191989332437515

This O 0 0.031868696212768555
study O 0 0.026961171999573708
also O 0 0.01782844588160515
provided O 0 0.017642877995967865
evidence O 0 0.013024792075157166
for O 0 0.014316963031888008
the O 0 0.02900676615536213
pathological O 1 0.9888398051261902
nature O 0 0.04222363978624344
of O 0 0.04364638403058052
amino O 0 0.07191123068332672
acid O 0 0.06967746466398239
changes O 0 0.015694452449679375
in O 0 0.022532125934958458
APC O 1 0.999985933303833
associated O 0 0.020398451015353203
with O 0 0.010479780845344067
both O 0 0.015803566202521324
FAP B-Disease 1 1.0
and O 0 0.023740652948617935
non O 1 0.9999954700469971
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.05636681988835335
. O 0 0.04589063301682472

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999998807907104
cancer B-Disease 1 1.0
risk O 1 0.999840497970581
of O 0 0.03944067656993866
the O 0 0.07192137837409973
APC O 1 0.9999998807907104
I1307K O 1 0.9998940229415894
polymorphism O 0 0.12421931326389313
. O 0 0.04521072655916214

Germ O 1 1.0
- O 1 0.9999929666519165
line O 0 0.06608646363019943
and O 0 0.0348745621740818
somatic O 1 0.6128586530685425
truncating O 1 0.985292375087738
mutations O 0 0.04377162083983421
of O 0 0.02704475075006485
the O 0 0.05117703974246979
APC B-Disease 1 0.9999997615814209
gene O 0 0.03455224633216858
are O 0 0.005693705286830664
thought O 0 0.01259264163672924
to O 0 0.02145957760512829
initiate O 1 0.9998937845230103
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9991150498390198
in O 0 0.05020449310541153
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999817609786987
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.15100109577178955
respectively O 0 0.0519951768219471
. O 0 0.0355074368417263

Recently O 0 0.05297320708632469
, O 0 0.01922977901995182
an O 0 0.02493118867278099
isoleucine O 1 0.9999970197677612
- O 1 1.0
- O 1 0.9999996423721313
> O 1 0.9853816032409668
lysine O 0 0.17298172414302826
polymorphism O 0 0.0841400995850563
at O 0 0.04054587334394455
codon O 0 0.1404724419116974
1307 O 1 0.995630145072937
( O 0 0.044015564024448395
I1307K O 1 0.9829878807067871
) O 0 0.016723284497857094
of O 0 0.01714121177792549
the O 0 0.0391644723713398
APC B-Disease 1 0.9999998807907104
gene O 0 0.04511762037873268
has O 0 0.014747406356036663
been O 0 0.011820720508694649
identified O 0 0.017021195963025093
in O 0 0.013899078592658043
6 O 0 0.043189018964767456
% O 0 0.0361899733543396
- O 1 0.9991236329078674
7 O 0 0.03673819452524185
% O 0 0.015480099245905876
of O 0 0.016520537436008453
the O 0 0.03204331919550896
Ashkenazi O 1 0.9957524538040161
Jewish O 0 0.08091060817241669
population O 0 0.03633728623390198
. O 0 0.03893110156059265

To O 0 0.04482527822256088
assess O 0 0.0637512132525444
the O 0 0.030748233199119568
risk O 0 0.0408373661339283
of O 0 0.019847918301820755
this O 0 0.015387042425572872
common O 0 0.03841302916407585
APC B-Disease 1 0.9999995231628418
allelic O 1 0.9999281167984009
variant O 1 0.9294201731681824
in O 0 0.0757262110710144
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.04100358113646507
we O 0 0.012448680587112904
have O 0 0.0062278760597109795
analyzed O 0 0.015608170069754124
a O 0 0.015253791585564613
large O 0 0.021566960960626602
cohort O 0 0.1288161277770996
of O 0 0.036917779594659805
unselected O 1 0.9951080679893494
Ashkenazi O 1 0.9828190207481384
Jewish O 0 0.07755575329065323
subjects O 0 0.0417645238339901
with O 0 0.03931518271565437
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.03290282562375069
. O 0 0.029709534719586372
or O 1 0.9999582767486572
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.04479680210351944
for O 0 0.02215680293738842
the O 0 0.04213956743478775
APC O 1 0.999998927116394
I1307K O 1 0.9999362230300903
polymorphism O 0 0.131386861205101
. O 0 0.04247314855456352

The O 0 0.07579994946718216
APC O 1 0.9999886751174927
I1307K O 1 0.999882698059082
allele O 0 0.10952696949243546
was O 0 0.03530125319957733
identified O 0 0.02474437840282917
in O 0 0.018064990639686584
48 O 0 0.04695490002632141
( O 0 0.02683204784989357
10 O 0 0.02201610431075096
. O 0 0.015605197288095951
1 O 0 0.04139239713549614
% O 0 0.024446308612823486
) O 0 0.02097168006002903
of O 0 0.042598165571689606
476 O 1 0.9997215867042542
patients O 1 0.999549925327301
. O 0 0.06841090321540833

Compared O 0 0.043946508318185806
with O 0 0.023535912856459618
the O 0 0.02760118432343006
frequency O 0 0.024650467559695244
in O 0 0.010328640230000019
two O 0 0.00887527596205473
separate O 0 0.016556616872549057
population O 0 0.01774437353014946
control O 0 0.030545150861144066
groups O 0 0.015466740354895592
, O 0 0.015772609040141106
the O 0 0.03729836642742157
APC O 1 0.9999998807907104
I1307K O 1 0.9999971389770508
allele O 0 0.11389785259962082
is O 0 0.023103568702936172
associated O 0 0.017978839576244354
with O 0 0.012478054501116276
an O 0 0.01697676070034504
estimated O 0 0.028524387627840042
relative O 0 0.054268039762973785
risk O 0 0.0557292178273201
of O 0 0.03817114979028702
1 O 0 0.07543160766363144
. O 0 0.04141442850232124

5 O 0 0.10693416744470596
- O 1 0.9999301433563232
1 O 0 0.08121153712272644
. O 0 0.04292891547083855

7 O 0 0.07239548861980438
for O 0 0.0773768424987793
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.05626126751303673
both O 0 0.04161481186747551
P O 1 0.9999988079071045
= O 0 0.12475194782018661
. O 0 0.039754096418619156
01 O 1 0.9999792575836182
) O 0 0.04354313388466835
. O 0 0.035196494311094284

Furthermore O 0 0.07971737533807755
, O 0 0.02605416812002659
compared O 0 0.027233975008130074
with O 0 0.02782643586397171
noncarriers O 1 0.9999688863754272
, O 0 0.05098673328757286
APC O 1 0.9999977350234985
I1307K O 1 0.9999082088470459
carriers O 0 0.06246544420719147
had O 0 0.016592929139733315
increased O 0 0.01638825424015522
numbers O 0 0.01370964478701353
of O 0 0.035090021789073944
adenomas B-Disease 1 1.0
and O 1 0.930743396282196
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.05776557698845863
patient O 1 0.9999996423721313
( O 0 0.06343559175729752
P O 1 0.9999996423721313
= O 0 0.11742536723613739
. O 0 0.030380962416529655
03 O 1 0.9998588562011719
) O 0 0.023762833327054977
, O 0 0.015114251524209976
as O 0 0.0142019959166646
well O 0 0.009856448508799076
as O 0 0.013718466274440289
a O 0 0.025779293850064278
younger O 0 0.06569581478834152
age O 0 0.05273453891277313
at O 1 0.8873336911201477
diagnosis O 1 0.9999998807907104
. O 0 0.05628105252981186

We O 0 0.025485839694738388
conclude O 0 0.0407290980219841
that O 0 0.010873924009501934
the O 0 0.032622188329696655
APC O 1 0.9999958276748657
I1307K O 1 0.9999158382415771
variant O 0 0.08526182919740677
leads O 0 0.06333861500024796
to O 0 0.03771315887570381
increased O 0 0.09288429468870163
adenoma B-Disease 1 1.0
formation O 1 0.9918803572654724
and O 0 0.032987166196107864
directly O 0 0.0287457387894392
contributes O 0 0.04630598798394203
to O 0 0.020002370700240135
3 O 0 0.03595094010233879
% O 0 0.030397625640034676
- O 1 0.9940688610076904
4 O 0 0.026676788926124573
% O 0 0.010574523359537125
of O 0 0.011703102849423885
all O 0 0.01727079041302204
Ashkenazi O 1 0.9999579191207886
Jewish O 1 0.9999991655349731
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5537959337234497

The O 0 0.04545457288622856
estimated O 0 0.04261476546525955
relative O 0 0.07397777587175369
risk O 0 0.12940070033073425
for O 0 0.03686847910284996
carriers O 0 0.09620935469865799
may O 0 0.03234058618545532
justify O 0 0.06464742869138718
specific O 0 0.026433518156409264
clinical O 1 0.9826595783233643
screening O 0 0.1421438604593277
for O 0 0.025284990668296814
the O 0 0.03852636739611626
360 O 0 0.08509418368339539
, O 0 0.027255887165665627
000 O 0 0.05070584639906883
Americans O 0 0.026419177651405334
expected O 0 0.0224160123616457
to O 0 0.02576819248497486
harbor O 0 0.11862099915742874
this O 0 0.025165829807519913
allele O 0 0.09100359678268433
, O 0 0.026359904557466507
and O 0 0.02611147239804268
genetic O 0 0.036393918097019196
testing O 0 0.02473147213459015
in O 0 0.010921250097453594
the O 0 0.014499368146061897
setting O 0 0.022998489439487457
of O 0 0.018549267202615738
long O 0 0.04012175649404526
- O 1 0.9999929666519165
term O 0 0.058273524045944214
- O 1 0.9996950626373291
outcome O 0 0.03002581000328064
studies O 0 0.016122860834002495
may O 0 0.01346862968057394
impact O 0 0.02080252394080162
significantly O 0 0.03350557014346123
on O 1 0.6567867398262024
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.038061968982219696
this O 0 0.018371544778347015
population O 0 0.024816790595650673
. O 0 0.03004639968276024

Localization O 0 0.15562283992767334
of O 0 0.04791893810033798
human O 0 0.06076271831989288
BRCA1 O 1 0.9983013868331909
and O 0 0.015958258882164955
its O 0 0.01643815077841282
loss O 0 0.026220321655273438
in O 0 0.013355826959013939
high O 0 0.16874916851520538
- O 1 0.9999996423721313
grade O 0 0.19270329177379608
, O 0 0.01650552824139595
non B-Disease 1 0.9226791858673096
- I-Disease 1 1.0
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.09613867104053497

Although O 0 0.0237384345382452
the O 0 0.02079121395945549
link O 0 0.031669940799474716
between O 0 0.014772007241845131
the O 0 0.03439077362418175
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 1.0
suppressor O 1 0.9999991655349731
gene O 0 0.030174866318702698
and O 0 0.02122480235993862
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9792858958244324
established O 0 0.036779843270778656
, O 0 0.014412899501621723
the O 0 0.017535638064146042
role O 0 0.03222045674920082
, O 0 0.014913591556251049
if O 0 0.009330692701041698
any O 0 0.007935727015137672
, O 0 0.00973411463201046
of O 0 0.019052395597100258
BRCA1 O 1 0.9954309463500977
in O 0 0.023466840386390686
non B-Disease 1 0.9999274015426636
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.045455485582351685
unclear O 0 0.04886298626661301
. O 0 0.03339126706123352

BRCA1 O 1 0.9999703168869019
mutations O 0 0.06937254220247269
are O 0 0.011232818476855755
rare O 0 0.03631847724318504
in O 0 0.03385838121175766
sporadic B-Disease 1 0.9998999834060669
cancers I-Disease 1 0.9999998807907104
, O 0 0.027860496193170547
but O 0 0.015642458572983742
loss O 0 0.04105185344815254
of O 0 0.044706542044878006
BRCA1 O 1 0.9999964237213135
resulting O 0 0.04630448296666145
from O 0 0.029594125226140022
reduced O 0 0.0534047968685627
expression O 0 0.048647068440914154
or O 0 0.029604390263557434
incorrect O 0 0.07458830624818802
subcellular O 0 0.18126598000526428
localization O 0 0.11568710952997208
is O 0 0.027530735358595848
postulated O 0 0.06044172868132591
to O 0 0.013856139965355396
be O 0 0.006151849403977394
important O 0 0.007313920650631189
in O 0 0.010739415884017944
non B-Disease 0 0.1261012703180313
- I-Disease 1 1.0
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9328680634498596

Epigenetic O 1 0.9837438464164734
loss O 1 0.6240876317024231
, O 0 0.03176949545741081
however O 0 0.019216718152165413
, O 0 0.017595699056982994
has O 0 0.01501816138625145
not O 0 0.01179144810885191
received O 0 0.027609506621956825
general O 0 0.046789586544036865
acceptance O 0 0.09843237698078156
due O 0 0.03536922112107277
to O 0 0.025017481297254562
controversy O 0 0.04863637685775757
regarding O 0 0.025260621681809425
the O 0 0.02971608005464077
subcellular O 0 0.14279207587242126
localization O 0 0.13986288011074066
of O 0 0.06970158219337463
BRCA1 O 1 0.9999970197677612
proteins O 0 0.053708259016275406
, O 0 0.01983449049293995
reports O 0 0.020405329763889313
of O 0 0.01998458243906498
which O 0 0.016285616904497147
have O 0 0.010331214405596256
ranged O 0 0.043892890214920044
from O 0 0.02209380827844143
exclusively O 0 0.041899558156728745
nuclear O 0 0.046942029148340225
, O 0 0.01920141652226448
to O 0 0.023256391286849976
conditionally O 0 0.1347392201423645
nuclear O 0 0.041723430156707764
, O 0 0.012103531509637833
to O 0 0.015270847827196121
the O 0 0.04481690749526024
ER O 1 1.0
/ O 1 0.9999998807907104
golgi O 1 0.9999910593032837
, O 0 0.03278553485870361
to O 0 0.03686122968792915
cytoplasmic O 1 0.5244219303131104
invaginations O 1 0.9446859359741211
into O 0 0.030923904851078987
the O 0 0.04275837540626526
nucleus O 0 0.11777731031179428
. O 0 0.046226829290390015

In O 0 0.03706943243741989
an O 0 0.029262302443385124
attempt O 0 0.05096755921840668
to O 0 0.027644386515021324
resolve O 0 0.05897529795765877
this O 0 0.01694316416978836
issue O 0 0.031019391492009163
, O 0 0.01618199795484543
we O 0 0.008271547965705395
have O 0 0.00800962932407856
comprehensively O 0 0.08535874634981155
characterized O 0 0.05534641817212105
19 O 0 0.06164722517132759
anti O 1 0.9999998807907104
- O 1 1.0
BRCA1 O 1 0.9999996423721313
antibodies O 1 0.6612985730171204
. O 0 0.05171838030219078

These O 0 0.03969622403383255
reagents O 0 0.14321182668209076
detect O 0 0.06204485148191452
a O 0 0.03621183708310127
220 O 0 0.10780617594718933
- O 1 0.9999983310699463
kD O 1 0.9999938011169434
protein O 0 0.0736280083656311
localized O 0 0.07303117960691452
in O 0 0.020705781877040863
discrete O 0 0.05592447891831398
nuclear O 0 0.06245371699333191
foci O 0 0.17004629969596863
in O 0 0.02277234196662903
all O 0 0.037463996559381485
epithelial O 1 1.0
cell O 1 0.9424811601638794
lines O 0 0.03379257023334503
, O 0 0.013108637183904648
including O 0 0.010226724669337273
those O 0 0.012475411407649517
derived O 0 0.03450791910290718
from O 0 0.0491771437227726
breast B-Disease 1 1.0
malignancies I-Disease 1 1.0
. O 0 0.07936940342187881

Immunohistochemical O 1 0.9999604225158691
staining O 1 0.9995788931846619
of O 0 0.07075686007738113
human O 0 0.12153232842683792
breast O 1 0.9999998807907104
specimens O 0 0.05325137451291084
also O 0 0.02518584579229355
revealed O 0 0.05292152613401413
BRCA1 O 1 0.9968209266662598
nuclear O 0 0.0662405863404274
foci O 1 0.9415944218635559
in O 0 0.040130093693733215
benign O 1 1.0
breast O 1 1.0
, O 1 0.9908672571182251
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.045710377395153046
low B-Disease 1 0.9999912977218628
- I-Disease 1 1.0
grade I-Disease 1 0.999998927116394
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.08100714534521103

Conversely O 0 0.26947134733200073
, O 0 0.06974992156028748
BRCA1 O 1 0.9999749660491943
expression O 0 0.053005728870630264
was O 0 0.0446535125374794
reduced O 0 0.04526570439338684
or O 0 0.028767496347427368
undetectable O 1 0.9849120378494263
in O 0 0.011959243565797806
the O 0 0.012178021483123302
majority O 0 0.01602269522845745
of O 0 0.01685722917318344
high O 0 0.15727253258228302
- O 1 0.9999998807907104
grade O 1 0.9995598196983337
, O 0 0.11157523840665817
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.037410181015729904
suggesting O 0 0.030395712703466415
that O 0 0.010648109950125217
absence O 0 0.0463532917201519
of O 0 0.05487798899412155
BRCA1 O 1 0.9999998807907104
may O 0 0.03777986764907837
contribute O 0 0.03118073008954525
to O 0 0.02034112997353077
the O 0 0.032085124403238297
pathogenesis O 1 0.9999852180480957
of O 0 0.0203592199832201
a O 0 0.019980764016509056
significant O 0 0.013849535025656223
percentage O 0 0.025826698169112206
of O 0 0.040658749639987946
sporadic B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.05144224315881729
. O 0 0.04394051805138588

